data_2mmy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mmy _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.558 0.218 . . . . 53.44 110.706 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 103.38 15.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.192 -0.603 . . . . 65.45 110.569 167.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.3 m -143.73 143.55 31.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.535 -0.913 . . . . 72.21 108.535 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.94 142.24 36.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 119.262 0.937 . . . . 70.05 109.915 163.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.09 130.51 46.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.23 -1.026 . . . . 71.33 108.23 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.48 141.56 43.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.565 -0.532 . . . . 73.04 109.565 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.33 150.63 48.4 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 63.42 110.423 -176.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.07 14.01 59.72 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 124.383 1.052 . . . . 63.21 112.782 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.5 mt -103.48 74.56 1.27 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.984 -1.117 . . . . 74.25 107.984 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.91 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.513 -0.851 . . . . 73.3 113.55 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.21 112.4 12.64 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.432 0.634 . . . . 64.53 111.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.14 21.02 51.27 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.308 -0.86 . . . . 63.42 111.686 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.59 151.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.393 -0.595 . . . . 74.32 109.393 -172.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.8 t -91.81 170.78 9.61 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.05 -0.722 . . . . 71.35 109.05 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -167.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.535 2.334 . . . . 74.24 114.039 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -44.29 -12.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 126.24 1.816 . . . . 50.21 115.26 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -46.0 -22.58 0.22 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.605 1.962 . . . . 72.44 113.471 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.3 -32.49 35.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 CA-C-N 118.914 0.779 . . . . 75.11 109.912 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.58 -32.58 83.78 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.281 -0.262 . . . . 73.35 113.197 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.12 -32.63 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.418 0.687 . . . . 73.54 110.481 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 7.5 t80 -56.76 -44.38 81.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.433 1.093 . . . . 74.11 110.806 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.24 -24.29 47.0 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 111.956 0.354 . . . . 74.41 111.956 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -66.87 -21.34 66.01 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.936 0.895 . . . . 72.44 111.46 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.55 -25.0 68.04 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 122.195 -0.316 . . . . 74.13 111.365 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.4 mm -124.59 70.86 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.024 -0.732 . . . . 43.15 109.024 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.36 -176.0 24.61 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 119.096 -1.526 . . . . 53.35 114.575 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.01 139.58 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.347 0.659 . . . . 74.1 109.727 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.68 116.53 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.119 0.485 . . . . 74.53 110.262 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 290' ' ' PHE . 22.8 tttm -95.73 137.49 34.71 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.543 0.687 . . . . 72.4 111.048 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 26.7 m -85.2 117.85 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.666 -1.152 . . . . 65.22 108.471 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -75.24 137.98 41.59 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.147 -0.479 . . . . 71.02 110.554 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -80.01 -10.15 59.75 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.393 0.886 . . . . 73.22 113.393 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.85 -41.16 78.85 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.364 0.505 . . . . 62.4 112.364 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.6 t -125.36 -18.86 5.21 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.739 0.304 . . . . 64.23 111.089 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.67 57.11 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 116.292 -0.413 . . . . 61.44 113.165 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -98.13 153.3 38.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.016 0.376 . . . . 71.22 112.016 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.16 155.84 68.9 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.646 2.898 . . . . 65.35 112.353 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.444 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.55 98.11 2.25 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.175 0.988 . . . . 61.25 113.353 -174.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.2 mm -144.15 112.58 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.034 -1.469 . . . . 75.15 107.034 163.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.422 ' HB2' ' HG1' ' A' ' 287' ' ' THR . 39.6 m-80 -129.07 116.33 19.12 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.425 1.011 . . . . 64.24 109.865 162.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 111.25 21.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.51 110.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.6 112.0 24.55 Favored 'General case' 0 C--O 1.26 1.625 0 CA-C-O 121.241 0.543 . . . . 72.11 110.025 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.1 p -143.46 120.43 11.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.317 -1.311 . . . . 75.45 109.807 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -87.9 113.14 23.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.804 1.288 . . . . 73.52 111.884 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -7.61 59.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.633 -1.167 . . . . 73.4 111.639 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.81 -29.51 66.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.246 0.618 . . . . 75.5 111.371 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -91.11 -29.41 17.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.412 -0.588 . . . . 74.05 109.412 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 107.18 -19.3 34.96 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.316 -0.856 . . . . 52.11 112.633 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -113.17 141.64 26.03 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.292 -0.262 . . . . 73.43 110.292 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.35 140.35 94.1 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 123.316 2.678 . . . . 71.04 114.958 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -64.18 -36.52 84.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.706 -1.134 . . . . 64.32 112.247 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.87 20.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.519 -0.764 . . . . 63.11 112.421 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.62 141.03 49.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 119.724 -0.79 . . . . 71.32 109.81 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.74 144.69 23.7 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.908 -0.587 . . . . 37.83 109.887 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.422 ' HG1' ' HB2' ' A' ' 272' ' ' ASN . 76.3 p -127.7 140.22 52.21 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 122.017 -0.427 . . . . 72.32 109.964 173.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.412 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 19.6 m -134.58 146.78 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.006 0.432 . . . . 72.22 110.428 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.444 ' H ' ' CB ' ' A' ' 270' ' ' MET . 27.6 t -98.61 113.98 26.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.725 0.81 . . . . 63.42 112.49 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.406 ' O ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 m-85 -88.08 162.77 16.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.592 0.219 . . . . 74.32 111.592 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.47 -47.62 19.19 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.434 0.459 . . . . 70.41 111.199 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.76 135.44 22.19 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 120.967 -0.293 . . . . 62.32 110.277 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.67 -40.45 22.72 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.213 1.942 . . . . 65.1 116.376 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.66 -30.02 51.31 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 123.082 2.136 . . . . 74.32 113.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 67.9 m -63.82 -27.36 69.12 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.44 0.696 . . . . 62.14 112.709 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.97 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.24 0.616 . . . . 75.2 111.838 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.84 -40.76 88.06 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.079 0.552 . . . . 63.32 111.159 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.05 -32.94 74.71 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.438 -0.801 . . . . 62.24 111.583 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -70.59 -29.56 66.01 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.54 -33.81 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 110.384 -0.228 . . . . 74.44 110.384 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.21 -59.41 2.79 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 114.264 1.209 . . . . 70.31 114.264 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -91.37 -34.07 15.02 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.117 1.895 . . . . 74.24 116.117 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 67.7 t80 -86.74 -14.99 40.79 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.339 0.59 . . . . 74.31 110.558 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.38 175.77 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.81 14.49 46.27 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.903 -0.665 . . . . 71.03 112.809 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -133.72 -154.04 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.097 -0.705 . . . . 75.02 109.097 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 149.91 52.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.85 0.833 . . . . 75.12 111.264 174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -113.49 114.81 27.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.61 -1.177 . . . . 74.43 108.211 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.9 m170 64.52 28.35 13.4 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.606 1.163 . . . . 75.45 112.5 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.35 -2.75 86.68 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 119.891 -0.394 . . . . 61.3 113.905 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.69 141.93 47.17 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.927 -0.768 . . . . 64.13 108.927 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.14 131.23 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.127 0.489 . . . . 73.3 111.481 -169.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.86 142.68 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.597 -0.729 . . . . 73.24 109.569 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -137.11 129.1 29.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 75.0 111.359 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.66 134.64 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.811 -0.631 . . . . 64.21 110.188 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -136.12 173.49 11.65 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.149 0.98 . . . . 75.13 109.816 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.9 0.56 43.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.409 0.892 . . . . 74.24 113.409 175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 124.359 1.064 . . . . 54.04 112.88 176.539 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.239 0.511 0 N-CA-C 110.164 -0.309 . . . . 52.03 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.39 105.53 17.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.272 0.558 . . . . 64.05 110.407 165.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 14.0 m -142.29 145.21 33.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.047 -1.094 . . . . 55.25 108.047 165.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.16 144.42 31.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 118.937 0.79 . . . . 73.41 109.117 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 136.62 43.26 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.279 -0.638 . . . . 75.24 109.279 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -127.02 143.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.58 0.705 . . . . 62.34 112.515 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.56 147.36 49.88 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.102 -1.408 . . . . 62.21 110.387 -176.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.4 21.93 30.76 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.524 0.515 . . . . 62.24 113.373 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.407 HD13 ' HB ' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -114.96 75.48 0.94 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.566 -1.272 . . . . 74.21 107.566 176.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -131.32 -86.87 0.39 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.513 -0.851 . . . . 73.12 113.495 -170.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.31 113.21 12.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.179 0.514 . . . . 73.31 111.549 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.26 40.08 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.219 -0.9 . . . . 55.32 111.707 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.82 151.67 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.508 -0.552 . . . . 73.31 109.508 -174.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.2 m -89.34 169.97 10.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.213 -0.903 . . . . 70.11 110.09 173.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.594 1.957 . . . . 64.23 113.868 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -42.64 -14.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 C-N-CA 126.36 1.864 . . . . 75.51 114.728 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.94 -20.78 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.748 2.019 . . . . 74.24 114.229 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.46 -31.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.81 0.732 . . . . 64.43 110.25 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.89 -35.82 91.02 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.548 -0.585 . . . . 61.22 113.964 172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.99 -35.46 80.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.943 0.897 . . . . 74.03 111.757 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.0 t80 -57.24 -44.35 83.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.005 0.922 . . . . 71.52 111.125 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.85 -24.34 44.41 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 111.821 0.304 . . . . 75.52 111.821 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -63.93 -23.4 67.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.095 0.958 . . . . 73.13 111.905 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.79 -24.39 67.71 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 121.037 -0.265 . . . . 63.23 111.521 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 257' ' ' ILE . 6.1 mm -126.29 67.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 109.086 -0.709 . . . . 75.53 109.086 169.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.77 -177.01 24.44 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 119.38 -1.39 . . . . 74.55 114.574 171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.02 138.44 31.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.112 0.565 . . . . 54.24 109.669 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.8 mm -66.86 115.98 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.662 0.601 . . . . 62.11 110.066 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -95.97 139.2 32.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.241 -0.89 . . . . 72.4 111.135 -176.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 29.4 m -86.92 117.57 25.74 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.101 -1.074 . . . . 71.23 108.101 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.68 132.02 36.86 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.854 -0.425 . . . . 75.24 109.854 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -10.11 59.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.098 1.147 . . . . 75.2 114.098 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.09 -31.22 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 111.772 0.286 . . . . 71.44 111.772 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.2 t -124.66 -31.7 3.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.772 0.32 . . . . 75.14 111.267 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.01 6.65 69.12 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.176 -0.466 . . . . 37.74 112.506 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -98.18 152.0 37.79 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.295 0.638 . . . . 75.54 112.217 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.01 154.42 74.09 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.662 2.908 . . . . 73.4 112.306 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.459 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.9 ptm -71.0 99.53 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.894 1.072 . . . . 64.42 113.894 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.6 mm -144.4 114.21 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.565 -1.272 . . . . 62.41 107.565 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -129.54 116.45 18.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.997 0.817 . . . . 74.02 110.41 161.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 111.32 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.836 -0.431 . . . . 74.43 109.836 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -103.16 112.52 25.41 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-O 121.159 0.504 . . . . 73.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.412 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.1 p -141.99 122.99 14.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.524 -1.216 . . . . 65.45 110.336 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.62 112.22 20.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.118 0.485 . . . . 65.42 111.627 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -11.06 50.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.094 0.776 . . . . 75.21 113.094 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -28.79 57.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.487 . . . . 61.32 110.175 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 51.5 p -89.56 -21.8 22.7 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.742 -0.663 . . . . 70.21 109.624 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.46 -35.68 4.56 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.584 -0.734 . . . . 51.54 112.536 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -97.96 141.63 23.28 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 123.379 0.105 . . . . 74.31 111.163 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.57 135.44 70.4 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.493 2.795 . . . . 63.22 114.173 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.3 mttt -63.85 -36.68 84.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.607 -1.179 . . . . 64.4 112.082 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.55 23.95 19.81 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.777 -0.725 . . . . 62.41 112.682 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -117.78 142.96 46.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.793 -0.447 . . . . 74.13 109.793 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.53 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.278 -0.419 . . . . 63.54 110.535 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 20.7 p -134.97 137.01 42.65 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.964 -0.384 . . . . 71.13 109.964 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.61 150.06 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.259 -0.428 . . . . 52.33 110.125 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.459 ' H ' ' CB ' ' A' ' 270' ' ' MET . 30.7 t -105.47 117.73 34.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.972 0.73 . . . . 63.31 112.972 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 159.93 20.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.097 -0.241 . . . . 73.44 111.227 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.29 -47.03 16.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.119 -0.491 . . . . 74.3 109.951 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.62 135.4 29.25 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 123.212 0.32 . . . . 73.42 110.468 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.32 -40.71 30.53 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.434 2.089 . . . . 73.1 116.133 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.33 -29.22 32.22 Favored 'Trans proline' 0 C--N 1.389 2.696 0 CA-C-N 122.682 1.994 . . . . 63.33 113.535 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 61.3 m -63.55 -25.78 68.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.175 0.59 . . . . 75.45 112.361 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -72.98 -45.68 56.59 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.037 0.384 . . . . 70.12 112.037 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -32.69 68.59 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.257 0.551 . . . . 62.22 111.415 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.74 -30.62 61.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.284 -0.871 . . . . 75.15 110.6 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.62 -31.23 71.11 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 122.252 0.221 . . . . 70.34 111.218 173.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 296' ' ' ALA . 67.2 mt -67.04 -34.57 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 120.484 0.183 . . . . 65.24 110.748 173.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.9 -59.86 2.61 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.393 1.257 . . . . 73.42 114.393 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.93 -35.33 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.509 1.67 . . . . 74.11 115.509 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.6 t80 -83.32 -18.66 38.2 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.101 0.477 . . . . 72.55 110.156 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.97 -174.08 2.46 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.043 -0.98 . . . . 62.22 109.219 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.08 65.35 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.121 -0.561 . . . . 75.42 112.322 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -135.98 -160.88 1.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.622 0.369 . . . . 70.41 110.137 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.17 145.68 47.97 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.784 0.802 . . . . 72.43 111.884 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -114.74 114.93 26.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.43 -1.259 . . . . 71.24 107.858 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.9 m170 64.37 28.66 13.68 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.915 1.286 . . . . 74.5 112.649 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.94 -2.97 85.96 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.148 0.419 . . . . 71.52 114.148 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.74 144.4 41.1 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 122.801 0.441 . . . . 71.12 110.05 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.66 129.66 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 123.331 0.394 . . . . 71.2 110.33 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.0 tt -108.41 145.8 14.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.9 -0.591 . . . . 74.41 109.514 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 42.5 tttp -135.4 127.94 30.66 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.071 -0.513 . . . . 54.24 111.256 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.61 133.76 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.37 0.605 . . . . 71.44 109.385 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -132.53 173.36 11.4 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.997 0.919 . . . . 74.41 109.313 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.26 -1.07 52.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 113.076 0.769 . . . . 75.12 113.076 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 124.404 1.082 . . . . 37.74 113.321 175.353 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.397 0.141 . . . . 72.14 111.359 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.42 104.21 16.75 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.45 -0.781 . . . . 74.03 110.676 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -144.12 149.51 36.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.467 0.707 . . . . 72.43 109.344 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.76 137.16 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.726 0.694 . . . . 64.43 110.512 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.55 125.51 48.21 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.556 -0.535 . . . . 75.03 109.556 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -120.05 143.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.745 0.784 . . . . 74.12 111.93 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 26.1 tp60 -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.986 -1.461 . . . . 61.2 108.927 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.78 43.94 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.098 -0.573 . . . . 61.43 112.958 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.0 78.65 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.579 -0.896 . . . . 63.41 108.579 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.54 -81.44 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.491 -0.861 . . . . 71.14 113.486 -172.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.68 107.14 9.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 72.14 111.21 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.23 20.92 24.07 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.556 -0.747 . . . . 61.13 112.078 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.54 152.55 4.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.384 0.611 . . . . 73.32 110.572 -173.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -93.84 169.24 10.44 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.597 -0.729 . . . . 60.15 109.408 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -167.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 127.136 2.174 . . . . 71.11 114.208 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -44.14 -13.12 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 126.241 1.817 . . . . 75.41 115.528 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.9 OUTLIER -46.94 -22.96 0.38 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 126.499 1.92 . . . . 73.43 113.998 169.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -56.21 -30.59 30.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 O-C-N 122.001 -0.437 . . . . 74.41 110.287 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.38 -33.49 84.79 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 122.054 -0.403 . . . . 75.11 113.378 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.22 -32.13 64.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.527 0.731 . . . . 45.04 110.697 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 11.0 t80 -55.56 -45.85 77.24 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.162 -0.926 . . . . 74.33 111.182 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.82 -24.12 48.83 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.195 -0.315 . . . . 71.15 111.613 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -74.83 -11.11 60.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.661 0.785 . . . . 63.2 112.183 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -15.83 61.88 Favored 'General case' 0 CA--C 1.557 1.238 0 O-C-N 121.854 -0.529 . . . . 61.5 111.733 172.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 -44.41 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.909 0.484 . . . . 71.04 111.115 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -139.08 -162.09 8.99 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.365 -0.921 . . . . 64.24 114.72 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.0 138.2 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.832 0.453 . . . . 73.4 110.835 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.82 114.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 O-C-N 123.885 0.741 . . . . 75.44 110.947 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -100.96 144.16 30.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.763 -1.108 . . . . 53.42 111.308 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.8 m -83.39 118.1 23.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.369 -1.287 . . . . 74.53 108.114 168.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.94 133.96 45.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.605 0.565 . . . . 71.33 109.676 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -77.38 -11.55 59.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.474 0.546 . . . . 72.52 112.474 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.31 -31.21 68.43 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.106 0.41 . . . . 60.44 112.106 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.2 t -124.86 -31.68 3.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.625 0.232 . . . . 71.4 111.625 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.85 69.19 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 116.48 -0.327 . . . . 64.34 112.515 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -98.45 152.4 37.91 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 123.256 0.623 . . . . 64.44 112.247 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.02 154.35 74.38 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 123.178 2.585 . . . . 71.12 111.113 166.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.469 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.94 102.15 6.27 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.651 0.982 . . . . 64.52 113.651 -168.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.86 112.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.126 -1.435 . . . . 74.53 107.126 163.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -128.5 114.78 17.2 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.685 0.675 . . . . 72.51 109.367 161.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.56 110.24 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.363 -0.606 . . . . 73.05 109.363 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -103.06 112.22 24.96 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 121.356 0.598 . . . . 75.14 111.009 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.7 p -144.18 120.99 11.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.594 -1.185 . . . . 71.01 109.997 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.96 112.94 21.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.448 0.642 . . . . 64.21 111.864 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -7.9 58.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.407 -0.815 . . . . 73.35 112.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -33.0 69.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.021 0.438 . . . . 72.23 111.138 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 7.7 t -91.53 -14.53 30.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.776 -0.647 . . . . 74.31 109.886 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.59 -49.76 1.62 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.589 -0.732 . . . . 43.14 112.628 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.11 142.09 59.06 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.716 0.304 . . . . 74.23 110.54 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -57.15 134.56 64.97 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.314 2.676 . . . . 73.24 114.228 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -60.26 -42.46 95.37 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.928 -1.033 . . . . 74.45 111.889 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.77 14.59 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.796 -0.716 . . . . 52.31 113.565 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -118.27 145.86 44.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.086 0.443 . . . . 73.24 110.517 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.86 156.13 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 61.51 110.456 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.71 136.08 46.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.74 0.305 . . . . 74.43 110.211 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.68 148.05 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 116.176 -0.465 . . . . 72.31 109.747 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.469 ' H ' ' CB ' ' A' ' 270' ' ' MET . 47.4 t -97.66 141.74 30.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.227 1.011 . . . . 74.32 111.74 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.81 164.89 12.31 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.195 -0.315 . . . . 74.25 110.538 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.0 -47.51 65.35 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.442 0.464 . . . . 74.23 110.872 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.11 138.18 23.36 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 116.481 -0.327 . . . . 72.1 110.232 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -61.88 -37.8 63.65 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 C-N-CA 123.137 2.558 . . . . 70.21 117.782 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.6 -27.3 7.63 Favored 'Trans proline' 0 C--N 1.392 2.824 0 CA-C-N 123.645 2.337 . . . . 74.42 112.999 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.5 m -59.57 -27.94 66.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.258 1.023 . . . . 73.25 111.738 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.458 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.1 -39.28 82.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.506 0.723 . . . . 71.55 112.892 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -75.07 -32.77 61.57 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.821 0.343 . . . . 65.21 111.116 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.17 79.99 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.156 -0.475 . . . . 74.4 110.314 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.13 68.04 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.152 -0.476 . . . . 63.13 112.204 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.8 mt -67.41 -30.56 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 O-C-N 122.164 -0.335 . . . . 64.32 110.582 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -59.73 2.66 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 113.904 1.076 . . . . 60.45 113.904 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -90.73 -37.48 13.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.272 1.953 . . . . 73.43 116.272 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -82.42 -21.12 35.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.304 0.573 . . . . 75.24 110.436 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.401 ' HB2' HG13 ' A' ' 315' ' ' VAL . 13.9 t70 -83.85 -172.52 4.2 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.083 -0.962 . . . . 63.33 109.971 168.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 80.86 11.8 83.44 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.854 -0.529 . . . . 42.21 113.106 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 -159.21 0.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.481 -0.563 . . . . 74.33 109.481 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.84 145.2 51.41 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.597 0.713 . . . . 74.45 110.784 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -112.35 113.57 25.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.485 -1.302 . . . . 72.12 107.485 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.1 m170 64.41 28.51 13.6 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 124.455 1.097 . . . . 74.24 112.663 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.77 3.37 88.14 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.408 -0.36 . . . . 73.52 113.458 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -112.87 141.47 46.65 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.739 -0.837 . . . . 73.52 108.739 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.21 127.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.966 0.413 . . . . 63.35 110.462 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.6 tt -108.5 144.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.764 -0.653 . . . . 72.44 109.629 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 39.1 tptt -136.5 121.12 18.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.993 -0.548 . . . . 72.23 109.95 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 304' ' ' ASP . 8.2 p -107.65 136.74 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.489 -0.778 . . . . 65.12 109.892 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 m -138.08 174.15 10.87 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 124.146 0.978 . . . . 71.13 110.13 -173.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -7.25 59.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.632 0.975 . . . . 74.53 113.632 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 114.593 1.331 . . . . 70.41 114.593 172.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 110.26 -0.274 . . . . 74.41 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 103.95 16.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.905 -0.718 . . . . 71.45 110.24 162.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.9 m -142.27 144.87 33.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.948 -1.501 . . . . 62.22 106.948 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 11.8 pt -123.59 141.26 44.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 119.406 1.003 . . . . 74.45 109.689 168.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.53 122.53 43.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.677 -0.86 . . . . 72.42 108.677 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.9 141.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.087 -0.709 . . . . 71.0 109.087 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.15 151.03 49.71 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.489 0.716 . . . . 72.32 110.516 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.9 21.48 36.12 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 124.158 0.911 . . . . 71.31 113.638 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 76.92 1.0 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.79 -1.189 . . . . 60.24 107.79 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.68 -90.93 0.42 Allowed Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.587 -0.816 . . . . 63.23 113.753 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.68 112.9 16.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.929 0.395 . . . . 70.21 110.791 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.59 20.15 25.41 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.321 -0.854 . . . . 74.43 111.996 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -87.29 151.83 3.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.681 -0.489 . . . . 75.33 109.681 -173.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.2 m -93.55 170.63 9.45 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.0 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -165.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.344 2.258 . . . . 73.13 114.233 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -42.89 -14.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 127.384 2.273 . . . . 73.32 114.819 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -46.93 -22.08 0.28 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.671 1.988 . . . . 64.3 114.723 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -57.46 -32.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 119.341 0.973 . . . . 63.4 110.699 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.86 85.93 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 120.065 -0.297 . . . . 62.24 113.463 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.47 -31.47 63.78 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.39 0.676 . . . . 71.45 111.23 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.9 t80 -56.8 -43.44 80.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.144 0.578 . . . . 74.24 111.298 170.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -79.04 -24.46 43.6 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.471 0.545 . . . . 74.34 112.471 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -63.01 -23.17 67.33 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.356 1.062 . . . . 72.34 111.681 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.15 -20.38 65.95 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.63 0.604 . . . . 75.43 112.63 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.5 mm -123.61 41.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 121.419 0.628 . . . . 65.5 110.233 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 150.64 -168.81 30.49 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 118.835 -1.65 . . . . 65.54 115.02 172.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.29 136.56 37.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.372 -0.414 . . . . 63.2 110.573 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 38.3 mm -67.46 115.25 5.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.86 -1.064 . . . . 73.51 110.027 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -98.18 140.54 32.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.505 0.669 . . . . 73.22 111.3 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.7 m -84.35 116.71 23.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.688 -1.142 . . . . 73.14 108.074 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.67 126.64 31.19 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 109.132 -0.692 . . . . 72.21 109.132 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -74.98 -6.32 48.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.229 1.196 . . . . 75.42 114.229 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.97 -33.47 74.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.23 0.212 . . . . 73.15 111.147 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.5 t -125.38 -29.33 3.25 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.729 0.299 . . . . 72.21 111.511 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 91.5 11.02 61.3 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.194 -0.457 . . . . 62.13 112.811 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -98.62 151.53 37.49 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 122.933 0.493 . . . . 73.24 112.182 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.99 155.52 63.96 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 123.981 3.12 . . . . 64.11 112.837 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.418 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -70.35 98.91 1.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.03 1.122 . . . . 71.35 114.03 -173.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.5 mm -144.19 113.07 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.224 -1.398 . . . . 74.01 107.224 164.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -128.7 115.05 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 119.262 0.937 . . . . 71.24 109.891 161.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.69 111.21 21.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.957 0.408 . . . . 64.23 110.083 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 62.2 m-85 -103.54 111.53 24.02 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 121.356 0.598 . . . . 74.31 110.39 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.2 p -143.2 122.51 13.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.027 -1.442 . . . . 63.3 110.136 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.7 112.02 20.65 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.207 0.527 . . . . 62.15 111.497 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.21 -9.82 54.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.146 0.795 . . . . 54.11 113.146 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -28.65 56.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.566 0.222 . . . . 65.51 110.582 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 56.8 p -88.69 -21.04 24.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.375 0.607 . . . . 72.1 109.454 169.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.32 -12.14 70.29 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 114.932 -1.031 . . . . 75.11 112.944 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -121.08 140.26 30.72 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 110.184 -0.302 . . . . 72.22 110.184 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.47 133.5 55.06 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 123.187 2.591 . . . . 70.24 114.209 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -62.12 -34.37 76.23 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.798 -1.092 . . . . 74.14 112.357 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.34 24.46 18.89 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.94 -0.648 . . . . 43.05 112.723 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 35.9 mt-10 -119.35 142.1 48.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.764 -0.774 . . . . 74.31 109.901 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.59 143.04 23.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.264 -0.643 . . . . 43.53 109.264 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 62.4 p -128.43 139.62 52.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.289 -0.634 . . . . 75.32 109.289 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.89 144.47 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 120.947 0.404 . . . . 52.35 110.17 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.418 ' H ' ' CB ' ' A' ' 270' ' ' MET . 43.3 t -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.49 0.716 . . . . 61.04 112.041 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.82 164.97 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.658 -0.246 . . . . 75.15 111.422 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.11 -48.05 63.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.117 0.567 . . . . 75.21 112.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -122.23 136.45 26.42 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.641 -0.874 . . . . 72.24 108.641 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.9 -37.9 62.68 Favored 'Trans proline' 0 CA--C 1.567 2.151 0 C-N-CA 123.099 2.532 . . . . 65.2 117.462 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 -29.01 18.08 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.762 2.379 . . . . 61.12 113.238 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.0 m -60.04 -29.02 68.23 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.306 1.043 . . . . 74.45 112.063 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.458 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.49 -38.61 81.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.639 0.775 . . . . 61.43 112.759 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -74.36 -36.01 63.57 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.258 0.551 . . . . 74.43 111.126 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.75 81.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.074 -0.967 . . . . 73.31 110.929 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.72 -29.66 68.13 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 123.583 0.552 . . . . 64.34 111.976 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 296' ' ' ALA . 78.9 mt -63.29 -34.72 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 117.772 0.26 . . . . 75.02 110.713 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.41 -60.05 2.52 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 114.19 1.181 . . . . 71.52 114.19 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.44 -34.05 15.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.194 1.924 . . . . 73.54 116.194 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 60.3 t80 -85.65 -18.47 33.14 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.191 0.52 . . . . 65.4 110.167 -171.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -107.59 -175.51 2.81 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.339 -0.986 . . . . 73.12 108.339 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.45 56.42 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.679 -0.296 . . . . 62.22 112.378 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.56 -153.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.939 -0.393 . . . . 75.53 109.939 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -120.68 146.24 46.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.82 0.448 . . . . 72.12 110.783 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -113.7 110.76 20.71 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.68 -1.23 . . . . 71.03 107.68 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 18.8 m170 64.96 29.64 12.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.638 1.175 . . . . 73.11 112.245 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.14 83.84 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.394 -0.366 . . . . 74.41 113.98 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -110.22 148.72 31.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 117.222 0.511 . . . . 64.43 110.159 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.6 mm -68.78 126.0 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 123.467 0.48 . . . . 74.51 110.767 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.22 142.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.939 -0.573 . . . . 72.14 109.944 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -136.42 129.84 31.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 71.43 111.034 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.91 137.33 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.201 0.524 . . . . 62.44 109.75 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -136.38 172.94 12.28 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.102 0.961 . . . . 71.23 109.451 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.77 -4.66 55.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.193 0.812 . . . . 74.05 113.193 174.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 124.914 1.286 . . . . 73.34 112.883 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.9 0.381 . . . . 62.01 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.8 105.66 17.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.495 -0.482 . . . . 75.34 110.186 162.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -142.25 150.25 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.066 -1.457 . . . . 71.12 107.066 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.23 137.22 57.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 119.154 0.888 . . . . 65.45 109.837 165.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.94 33.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.789 -0.819 . . . . 73.24 108.789 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.02 139.7 36.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.42 -0.585 . . . . 71.01 109.42 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 25.6 tp60 -128.9 142.71 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.761 -0.829 . . . . 65.11 108.761 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.8 20.75 11.09 Favored Glycine 0 N--CA 1.462 0.371 0 C-N-CA 121.139 -0.553 . . . . 53.32 112.464 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.72 73.06 0.8 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.55 -0.907 . . . . 71.52 108.55 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.86 -178.44 26.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.477 -0.783 . . . . 71.03 112.018 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . 0.261 12.0 pt-20 40.84 87.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.833 2.053 . . . . 45.52 114.845 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.18 21.11 25.95 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.008 -0.837 . . . . 65.15 111.008 -173.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.94 151.59 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.242 -0.651 . . . . 71.23 109.242 -173.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.6 m -84.61 168.69 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.76 -0.655 . . . . 75.52 110.23 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -169.13 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.618 1.967 . . . . 74.44 113.07 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -44.11 -12.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 126.422 1.889 . . . . 75.44 115.468 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 1.0 OUTLIER -46.09 -23.17 0.28 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.314 1.846 . . . . 71.15 113.701 170.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -57.78 -31.33 39.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 109.585 -0.524 . . . . 73.54 109.585 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.07 83.68 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-O 119.907 -0.385 . . . . 60.14 113.438 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -76.1 -29.65 57.99 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.243 0.617 . . . . 74.34 111.241 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.562 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.8 t80 -55.5 -44.56 76.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.498 0.719 . . . . 73.13 110.419 169.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -77.82 -24.54 48.68 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.685 0.254 . . . . 74.12 111.685 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -68.98 -18.78 64.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.585 0.754 . . . . 74.32 111.292 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -62.86 -22.12 66.46 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 122.297 -0.252 . . . . 73.13 110.802 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 257' ' ' ILE . 6.1 mm -122.83 63.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.369 -0.604 . . . . 70.31 109.369 168.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.07 -172.84 26.59 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 118.803 -1.665 . . . . 37.77 115.366 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.48 138.48 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.165 -1.018 . . . . 73.14 109.62 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.35 116.05 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.272 0.558 . . . . 73.12 110.373 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -96.42 140.15 31.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 72.33 111.404 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 89.7 m -86.0 117.5 24.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.132 -0.94 . . . . 74.43 108.597 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -72.75 136.97 45.59 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.42 -0.354 . . . . 71.24 111.069 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -78.76 -9.39 59.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.003 0.742 . . . . 64.24 113.003 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.43 -39.56 77.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.011 0.374 . . . . 64.25 112.011 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 t -126.25 -19.4 4.71 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.532 0.206 . . . . 73.15 111.359 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.49 57.17 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.519 -0.309 . . . . 74.14 113.063 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -99.93 153.91 37.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.99 0.367 . . . . 74.41 111.99 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.41 153.06 76.89 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.056 2.504 . . . . 64.0 111.723 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 1.4 ptm -76.73 100.15 5.33 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.162 0.801 . . . . 71.53 113.162 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.5 mm -143.14 113.92 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 165.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -128.13 117.61 21.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 119.177 0.898 . . . . 75.53 109.815 162.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.53 112.74 23.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 64.2 110.218 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -101.62 111.68 24.01 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-N 115.907 -0.588 . . . . 62.02 109.663 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.2 p -143.74 122.07 12.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.317 -1.311 . . . . 73.34 109.231 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.49 110.7 18.87 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.256 0.55 . . . . 62.21 111.043 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -7.43 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.213 0.82 . . . . 63.22 113.213 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -32.43 70.09 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.252 0.345 . . . . 72.34 110.816 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -91.88 -19.18 22.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.149 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 102.27 -44.43 1.52 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.004 -0.543 . . . . 70.03 112.911 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -81.95 142.1 48.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.587 0.227 . . . . 54.14 111.187 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.69 130.86 39.06 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.909 2.406 . . . . 51.04 113.508 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -59.98 -39.12 84.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.926 -1.034 . . . . 70.14 112.165 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.9 25.23 15.24 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.668 -0.777 . . . . 62.21 113.076 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.81 143.56 46.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.101 0.451 . . . . 73.52 110.084 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.13 143.36 23.26 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.455 0.302 . . . . 61.43 110.341 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 70.6 p -125.53 138.86 53.98 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 122.074 -0.391 . . . . 71.44 110.296 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.86 148.06 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.992 -0.373 . . . . 75.21 109.992 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -108.44 117.48 34.27 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.978 0.733 . . . . 51.02 112.978 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.44 163.94 19.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.759 0.424 . . . . 72.2 111.897 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.2 -48.42 20.47 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 116.536 -0.302 . . . . 61.01 110.686 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.01 135.61 23.41 Favored Pre-proline 0 C--O 1.239 0.548 0 O-C-N 123.203 0.314 . . . . 74.32 110.743 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.81 -41.16 19.08 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 122.802 2.334 . . . . 62.43 116.813 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.58 -29.74 52.15 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 122.946 2.088 . . . . 74.42 113.806 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 49.8 m -64.29 -27.42 69.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.099 0.96 . . . . 71.43 112.465 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.19 88.75 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 122.841 0.457 . . . . 71.14 111.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.62 -39.68 88.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.153 0.581 . . . . 63.31 110.349 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.86 76.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.521 -0.763 . . . . 75.21 111.448 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.92 -33.14 73.26 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.709 0.404 . . . . 71.12 111.623 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 75.2 mt -64.8 -33.41 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.849 0.357 . . . . 71.24 110.603 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.49 -60.33 2.4 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.766 1.024 . . . . 75.14 113.766 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -91.72 -31.84 15.65 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.867 1.803 . . . . 73.2 115.867 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 72.2 t80 -87.49 -14.79 39.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.371 0.605 . . . . 75.22 109.937 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -104.89 173.81 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.337 -0.986 . . . . 74.24 108.337 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.28 14.21 51.83 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.731 -0.747 . . . . 71.23 112.228 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -131.25 -156.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.699 -0.852 . . . . 71.42 108.699 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -132.84 148.77 52.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.618 0.723 . . . . 65.5 111.011 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -113.61 117.7 32.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.4 m170 64.69 28.47 13.08 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.722 1.209 . . . . 74.44 112.17 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.07 86.52 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.405 -0.361 . . . . 72.11 113.762 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.55 144.84 42.19 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 109.197 -0.668 . . . . 72.24 109.197 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.65 130.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.165 0.507 . . . . 64.42 111.673 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.5 tt -110.43 142.51 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.324 -0.853 . . . . 74.22 110.023 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -136.86 126.87 25.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.236 0.614 . . . . 61.53 111.341 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 31.6 t -108.7 138.83 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.276 -0.42 . . . . 74.01 110.877 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -134.95 176.61 8.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 63.55 110.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.77 -11.58 59.83 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.97 1.1 . . . . 71.32 113.97 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 124.289 1.036 . . . . 65.55 113.319 176.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.7 t30 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.596 0.236 . . . . 71.11 110.382 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.47 103.96 15.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 118.623 -1.231 . . . . 74.4 110.477 160.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -143.03 149.0 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.241 -1.392 . . . . 52.31 107.241 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.0 pt -125.18 139.46 51.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 118.8 0.727 . . . . 63.1 109.605 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.51 120.52 39.78 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.987 -0.746 . . . . 73.43 108.987 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.81 138.19 45.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.962 -0.563 . . . . 74.32 109.973 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.54 144.32 51.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 72.0 110.984 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.17 20.78 11.76 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.878 0.736 . . . . 63.54 112.969 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.48 75.08 0.92 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.602 -0.888 . . . . 71.42 108.602 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -127.31 -97.16 0.96 Allowed Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.524 -0.846 . . . . 63.11 113.565 -170.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -76.74 117.07 17.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.853 0.358 . . . . 64.52 111.104 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.17 19.66 30.04 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.218 -0.901 . . . . 72.31 111.675 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.22 151.29 4.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.357 0.599 . . . . 74.43 109.494 -174.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.9 t -93.46 170.61 9.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.235 -0.654 . . . . 72.55 109.235 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -167.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.489 2.316 . . . . 71.43 113.379 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -44.44 -12.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 126.497 1.919 . . . . 73.34 115.253 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.3 -23.04 0.49 Allowed 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 126.692 1.997 . . . . 73.43 112.892 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -31.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-N 118.653 0.661 . . . . 70.1 109.523 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.29 -35.48 88.34 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.248 -0.751 . . . . 41.4 114.383 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -28.21 58.33 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 117.961 0.881 . . . . 72.23 110.832 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.58 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 6.7 t80 -55.66 -47.35 76.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.013 0.925 . . . . 72.23 110.671 171.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.59 -23.36 46.03 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.057 0.391 . . . . 75.34 112.057 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.3 -26.21 67.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.387 1.075 . . . . 74.43 111.221 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.84 -19.73 64.39 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 111.905 0.335 . . . . 74.24 111.905 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.1 mm -124.23 62.62 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 109.598 -0.519 . . . . 73.1 109.598 170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.76 -174.09 25.86 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 118.621 -1.752 . . . . 72.34 115.056 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.18 137.74 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.1 mm -71.48 113.22 7.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.298 0.571 . . . . 55.22 110.391 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -99.66 140.05 34.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.998 -1.001 . . . . 73.22 110.991 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 59.2 m -85.07 116.38 23.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.066 -0.97 . . . . 74.24 108.606 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.16 131.1 41.62 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.086 0.554 . . . . 75.12 110.213 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.7 -7.03 55.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.42 0.896 . . . . 54.34 113.42 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.25 -35.95 80.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.745 0.307 . . . . 72.15 111.108 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.8 p -125.25 -33.56 2.84 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.029 -0.532 . . . . 64.33 111.927 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.76 11.41 65.76 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.959 -0.564 . . . . 64.13 111.927 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -97.35 150.83 37.23 Favored Pre-proline 0 C--O 1.239 0.528 0 C-N-CA 123.238 0.615 . . . . 74.45 110.877 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.87 153.92 74.28 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.998 2.466 . . . . 72.32 111.241 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.42 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -73.22 101.19 3.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.645 0.979 . . . . 75.24 113.645 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -143.2 113.32 2.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.139 -1.391 . . . . 64.42 107.342 163.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -127.6 113.71 16.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 119.182 0.901 . . . . 64.1 109.768 163.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 110.53 20.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.205 -0.294 . . . . 72.33 110.205 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 36.3 m-85 -103.0 111.54 23.93 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 121.266 0.555 . . . . 74.54 110.156 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 20.9 p -145.0 120.98 10.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.984 -1.462 . . . . 54.13 109.624 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -87.47 112.67 22.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.462 0.648 . . . . 62.52 111.762 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -10.23 55.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.167 -0.47 . . . . 74.13 112.22 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.363 0.415 . . . . 61.22 111.191 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.2 p -90.81 -20.45 22.31 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.337 0.589 . . . . 70.51 109.892 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 85.62 7.73 81.39 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.077 -0.965 . . . . 62.45 112.697 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 139.99 25.95 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 110.338 -0.245 . . . . 71.12 110.338 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -58.97 130.75 38.04 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.185 2.59 . . . . 53.34 113.893 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 40.9 mtpt -63.16 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.874 -1.057 . . . . 75.21 111.992 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.78 14.86 Favored Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.436 -0.802 . . . . 74.01 112.671 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.7 mt-10 -115.48 140.65 48.96 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.212 -0.595 . . . . 74.43 110.239 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.96 143.16 22.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.106 -0.497 . . . . 73.31 109.893 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 72.3 p -128.98 139.78 51.95 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.756 -0.377 . . . . 73.54 110.538 173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.45 147.63 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 121.176 0.512 . . . . 54.03 110.433 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.42 ' H ' ' CB ' ' A' ' 270' ' ' MET . 44.3 t -94.29 128.03 40.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.729 0.812 . . . . 74.32 112.583 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.28 165.78 12.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.678 0.621 . . . . 75.13 112.678 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -42.37 59.61 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.573 0.546 . . . . 61.51 111.661 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 136.96 29.83 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 109.843 -0.429 . . . . 72.13 109.843 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -59.94 -37.19 87.11 Favored 'Trans proline' 0 CA--C 1.562 1.92 0 C-N-CA 123.53 2.82 . . . . 73.4 117.203 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 -29.75 10.71 Favored 'Trans proline' 0 C--N 1.392 2.825 0 CA-C-N 123.321 2.222 . . . . 64.24 112.691 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 33.6 m -62.97 -32.75 74.15 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.158 0.983 . . . . 64.0 111.315 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.74 83.71 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.011 0.819 . . . . 41.03 111.822 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -48.18 78.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.376 0.422 . . . . 75.23 111.268 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.78 97.53 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 123.714 0.634 . . . . 74.43 110.862 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.85 68.15 Favored 'General case' 0 C--O 1.184 -2.389 0 CA-C-N 115.283 -0.871 . . . . 64.32 111.156 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.19 -34.47 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.128 0.571 . . . . 73.33 112.428 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.28 -54.91 22.14 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.688 0.625 . . . . 72.34 112.688 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -27.26 19.22 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.248 2.314 . . . . 74.44 117.248 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.57 -20.39 39.98 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.175 0.99 . . . . 75.34 112.038 -170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.8 166.65 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.213 -0.662 . . . . 75.2 109.213 175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.98 12.87 54.8 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.156 -0.545 . . . . 73.43 112.627 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -122.05 -159.37 0.82 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.29 -1.004 . . . . 74.42 108.29 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -130.56 143.02 50.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.555 0.693 . . . . 71.14 111.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -113.14 110.73 20.92 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.14 -1.059 . . . . 73.12 108.14 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.3 m170 64.33 30.11 13.43 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.516 1.135 . . . . 74.33 112.095 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.76 84.46 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 114.369 0.507 . . . . 62.53 114.369 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.2 147.39 37.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.548 -0.538 . . . . 70.53 109.548 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.69 124.92 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.177 0.513 . . . . 73.31 111.202 -172.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 134.83 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.403 -0.817 . . . . 73.22 110.65 -174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -130.56 145.22 51.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.856 -0.611 . . . . 62.23 111.017 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.42 140.08 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.984 -0.553 . . . . 73.14 109.903 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -133.48 176.5 8.48 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.1 0.96 . . . . 72.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -83.13 -8.61 59.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.596 0.962 . . . . 74.41 113.596 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 124.332 1.053 . . . . 64.5 112.61 178.498 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.448 -0.575 . . . . 64.52 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.0 106.4 18.49 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.529 -0.868 . . . . 62.41 110.34 168.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.9 m -142.05 142.21 32.84 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.532 -0.914 . . . . 71.03 108.532 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 pt -121.83 138.97 50.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 119.897 -0.721 . . . . 72.04 110.241 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.7 120.66 40.95 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.818 -0.628 . . . . 64.22 109.928 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -112.82 142.82 23.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.87 0.843 . . . . 74.43 113.046 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.32 151.99 48.04 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.1 -1.864 . . . . 55.41 109.493 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.81 16.95 46.34 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.171 -0.537 . . . . 74.35 113.172 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.07 64.15 0.67 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.659 0.743 . . . . 61.21 109.273 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -106.03 -103.89 2.9 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 115.348 -0.842 . . . . 38.44 112.951 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.86 119.6 17.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.547 0.689 . . . . 74.51 112.415 -173.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.24 18.96 29.56 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.634 -1.166 . . . . 61.35 111.694 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.01 151.94 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.129 0.49 . . . . 72.21 109.804 -172.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.3 m -90.64 170.46 10.14 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.691 -0.686 . . . . 72.33 109.619 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -167.75 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.637 1.975 . . . . 73.55 114.239 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -43.38 -12.91 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 C-N-CA 126.148 1.779 . . . . 73.53 115.444 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -46.78 -20.99 0.16 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 126.26 1.824 . . . . 74.34 114.243 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -55.72 -32.7 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.454 0.57 . . . . 73.44 110.491 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.71 81.66 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 119.953 -0.359 . . . . 74.22 113.611 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.95 -31.52 64.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.023 0.929 . . . . 74.51 111.003 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.0 t80 -58.61 -44.79 90.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.873 0.869 . . . . 63.22 110.887 171.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.413 ' HD1' ' O ' ' A' ' 250' ' ' VAL . 94.3 m-85 -76.87 -24.37 52.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 121.196 -0.202 . . . . 73.54 111.32 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -73.05 -15.91 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.497 0.719 . . . . 71.1 111.342 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.82 -17.68 64.81 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.805 -0.559 . . . . 73.34 111.12 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.06 58.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 109.377 -0.601 . . . . 74.52 109.377 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.71 -179.05 26.81 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 119.903 -1.142 . . . . 70.03 114.692 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 11.8 mt -106.73 139.7 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.435 0.694 . . . . 64.44 110.326 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.85 114.76 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.958 -0.564 . . . . 75.23 110.437 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.87 138.36 35.33 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.423 -0.808 . . . . 61.31 110.342 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 57.7 m -84.45 116.12 22.91 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.836 -1.172 . . . . 75.41 107.836 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.48 128.35 35.33 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 109.323 -0.621 . . . . 63.43 109.323 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -78.57 -8.38 58.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.128 0.788 . . . . 72.51 113.128 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -68.97 -29.88 68.19 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.54 0.2 . . . . 62.0 111.54 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.8 t -125.46 -30.07 3.15 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 111.643 0.238 . . . . 74.22 111.643 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.79 13.61 60.72 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.566 -0.288 . . . . 38.44 113.027 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -99.18 152.71 37.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 122.852 0.461 . . . . 73.44 112.093 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.46 154.78 66.38 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.579 2.853 . . . . 65.41 111.695 165.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.494 ' SD ' ' HB ' ' A' ' 288' ' ' VAL . 0.0 OUTLIER -77.83 98.64 5.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.31 0.856 . . . . 75.1 113.31 -168.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 36.4 mm -143.43 113.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 75.54 107.253 165.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -129.36 114.45 16.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.836 0.743 . . . . 75.21 109.909 161.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.91 111.29 21.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.962 -0.385 . . . . 74.34 109.962 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -103.63 113.23 26.59 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 115.972 -0.558 . . . . 71.41 110.774 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.3 p -142.4 123.79 14.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.469 -1.242 . . . . 75.33 110.337 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.85 112.52 21.21 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.272 0.558 . . . . 72.21 111.763 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -86.83 -10.93 52.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.622 0.971 . . . . 63.1 113.622 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.28 -34.55 61.33 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.998 0.428 . . . . 74.24 110.652 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -90.33 -15.25 31.5 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.705 -0.68 . . . . 72.13 109.716 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.16 -45.06 1.61 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.874 -0.603 . . . . 72.45 113.111 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -83.85 141.85 41.5 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 111.854 0.316 . . . . 73.43 111.854 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 136.96 72.28 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.345 2.697 . . . . 64.14 113.848 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -68.79 -33.4 73.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.027 -0.988 . . . . 73.12 111.621 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.85 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.729 -0.669 . . . . 38.44 113.081 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -115.5 143.21 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.944 -0.391 . . . . 65.31 109.944 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.01 155.37 37.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.386 . . . . 75.52 111.05 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.3 p -131.12 135.42 47.47 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.76 -0.459 . . . . 73.34 109.76 165.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.494 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 11.4 m -137.06 148.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 109.055 -0.72 . . . . 74.34 109.055 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.49 ' H ' ' CB ' ' A' ' 270' ' ' MET . 17.4 m -114.15 119.41 36.99 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.038 0.755 . . . . 55.2 113.038 -168.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.95 165.14 17.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.269 0.84 . . . . 73.12 113.269 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.53 -47.24 34.03 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.811 -1.086 . . . . 74.21 111.087 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 137.66 21.53 Favored Pre-proline 0 C--O 1.237 0.402 0 O-C-N 123.523 0.515 . . . . 54.14 110.701 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.55 -38.75 60.23 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.192 2.594 . . . . 52.13 117.246 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.87 -29.79 22.81 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 123.185 2.173 . . . . 61.24 113.047 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -61.41 -28.37 69.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.336 1.054 . . . . 72.54 112.078 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -70.39 -43.49 69.97 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -73.73 -34.15 64.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.346 0.593 . . . . 75.11 111.054 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.53 -32.43 71.25 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.569 -0.741 . . . . 73.32 110.444 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.48 -27.71 65.45 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 122.297 0.239 . . . . 65.41 111.204 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 296' ' ' ALA . 44.9 mt -66.98 -32.3 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 121.881 -0.512 . . . . 64.03 110.702 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.06 -59.09 2.92 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.09 1.144 . . . . 71.42 114.09 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -36.35 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.606 1.706 . . . . 70.03 115.606 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -84.9 -22.99 29.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.437 0.295 . . . . 72.42 110.452 -168.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -85.59 -177.11 6.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.715 -0.675 . . . . 74.52 110.238 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.21 3.83 84.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 114.191 0.437 . . . . 61.11 114.191 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -123.48 -154.47 0.61 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.611 -0.514 . . . . 73.24 109.611 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.96 140.74 52.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.43 0.633 . . . . 64.53 110.958 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -114.22 111.28 21.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.136 -1.431 . . . . 73.5 107.136 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 20.6 m170 64.85 30.52 12.1 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.818 1.247 . . . . 73.15 112.672 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.2 10.54 77.76 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 116.298 -0.41 . . . . 74.31 113.875 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -126.72 148.62 49.86 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.269 -0.641 . . . . 74.5 109.269 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.62 130.76 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 123.523 0.515 . . . . 73.13 110.628 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.5 tt -107.75 143.32 18.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.824 -0.806 . . . . 74.02 108.824 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 4.3 tmtp? -135.95 122.55 20.89 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.292 -0.633 . . . . 74.44 109.292 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.45 137.35 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.701 0.625 . . . . 75.52 109.608 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -138.21 173.5 11.55 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 123.177 0.591 . . . . 72.04 110.564 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -3.23 51.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.126 0.787 . . . . 73.31 113.126 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 C-N-CA 124.319 1.047 . . . . 52.53 113.183 174.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 C--O 1.238 0.491 0 CA-C-O 120.488 0.185 . . . . 62.24 110.653 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.81 106.83 18.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.192 0.52 . . . . 71.23 110.207 165.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.7 m -141.96 148.88 39.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.889 -1.152 . . . . 55.32 107.889 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.7 pt -122.69 141.24 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.722 0.692 . . . . 63.22 109.173 166.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.84 134.8 43.27 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -128.03 144.55 37.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.664 0.745 . . . . 74.41 112.637 178.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.04 147.11 50.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 113.988 -1.46 . . . . 75.31 109.773 -176.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.13 32.75 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 123.823 0.702 . . . . 63.02 112.644 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 72.21 0.81 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.967 -1.123 . . . . 63.12 107.967 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.31 157.33 27.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.271 -0.877 . . . . 42.2 112.868 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.66 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.642 . . . . 71.4 113.062 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.71 21.64 36.21 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.198 -0.91 . . . . 37.27 111.04 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.48 150.1 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.535 -0.543 . . . . 63.23 109.535 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 24.6 m -88.55 170.35 10.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.74 -0.663 . . . . 64.15 110.831 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -169.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.547 1.939 . . . . 73.43 113.37 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -43.91 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 127.028 2.131 . . . . 71.11 116.074 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -48.31 -23.19 0.83 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 126.511 1.924 . . . . 74.12 113.77 170.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -57.4 -29.78 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.834 0.453 . . . . 74.3 110.63 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.31 -38.04 94.01 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.714 -0.492 . . . . 72.1 113.37 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.95 -30.56 66.88 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.795 0.838 . . . . 71.2 111.389 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.8 t80 -56.62 -45.87 81.25 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.83 0.852 . . . . 64.51 111.186 171.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -77.61 -22.64 50.48 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 122.055 -0.403 . . . . 75.05 111.53 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.54 -10.63 59.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.527 1.131 . . . . 73.01 111.94 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.01 -16.72 62.26 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 121.807 -0.558 . . . . 64.34 111.523 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.1 mm -103.49 -48.19 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.458 0.703 . . . . 75.33 110.274 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -135.8 -159.51 8.55 Favored Glycine 0 C--O 1.22 -0.747 0 C-N-CA 120.769 -0.729 . . . . 73.31 113.428 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.9 mt -107.65 142.09 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.339 0.656 . . . . 73.14 111.754 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.7 mm -65.39 115.14 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 123.717 0.636 . . . . 75.5 110.142 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -98.08 140.11 32.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.453 -0.794 . . . . 65.12 111.369 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.0 m -85.52 117.75 24.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.106 -0.952 . . . . 72.24 108.478 168.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.1 125.79 29.9 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 109.062 -0.718 . . . . 72.42 109.062 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.8 -9.51 58.66 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.637 0.977 . . . . 54.11 113.637 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 -29.14 65.31 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 111.884 0.328 . . . . 73.33 111.884 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.6 t -124.16 -31.79 3.29 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.469 -0.332 . . . . 63.1 111.641 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.6 6.65 70.1 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 123.338 0.399 . . . . 64.12 112.679 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -97.17 151.87 37.95 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.093 0.405 . . . . 75.54 112.093 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.93 154.06 75.55 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.523 2.815 . . . . 51.34 111.794 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.428 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.7 ptm -71.98 99.79 2.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.451 1.278 . . . . 65.22 114.451 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.4 mm -144.16 113.85 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.58 -1.266 . . . . 74.13 107.58 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -128.99 119.48 24.36 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.077 0.853 . . . . 72.14 110.57 161.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 113.07 25.18 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.376 0.422 . . . . 71.3 110.278 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.35 112.68 25.48 Favored 'General case' 0 C--O 1.262 1.761 0 CA-C-O 121.31 0.576 . . . . 75.21 110.627 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.9 p -144.8 121.16 10.94 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.809 -1.541 . . . . 74.04 109.455 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.8 113.01 22.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.407 0.623 . . . . 63.24 111.719 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -8.72 58.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.715 1.006 . . . . 71.53 113.715 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -30.41 64.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 51.44 112.08 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -90.66 -19.03 24.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 120.735 -0.386 . . . . 73.12 110.185 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.5 22.93 38.39 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.951 -0.568 . . . . 74.02 113.802 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -146.82 147.69 30.62 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.744 -0.465 . . . . 74.12 109.744 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.38 126.75 22.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.047 1.831 . . . . 73.55 113.594 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -62.19 -40.11 94.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.88 -1.055 . . . . 74.24 111.628 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.95 25.15 15.24 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.812 -0.708 . . . . 63.42 111.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -119.03 143.75 46.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 73.13 109.609 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 158.64 44.26 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.623 -0.262 . . . . 62.52 111.179 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 19.4 p -136.18 137.78 41.25 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.104 -0.332 . . . . 60.21 110.104 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.12 147.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 116.356 -0.384 . . . . 64.44 110.461 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.3 t -99.1 117.49 33.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.309 0.644 . . . . 64.03 112.664 -174.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 162.81 16.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 121.154 -0.219 . . . . 71.24 110.867 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.88 -48.63 17.75 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.307 0.484 . . . . 44.53 112.307 -172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.44 137.18 21.52 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.695 -0.402 . . . . 74.03 110.904 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.08 -38.02 80.28 Favored 'Trans proline' 0 CA--C 1.566 2.086 0 C-N-CA 123.265 2.644 . . . . 63.22 116.234 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.65 -30.89 41.62 Favored 'Trans proline' 0 C--N 1.396 3.043 0 CA-C-N 123.314 2.219 . . . . 55.11 113.177 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 39.7 m -69.76 -29.4 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.477 -0.783 . . . . 65.51 111.115 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.03 -41.75 58.61 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 122.956 0.502 . . . . 70.11 111.347 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -33.43 66.83 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 112.009 0.374 . . . . 72.11 112.009 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.21 75.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.354 -0.384 . . . . 75.05 110.675 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.44 -25.28 64.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.977 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.75 -33.64 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.132 -0.355 . . . . 71.04 110.489 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.97 -58.82 3.05 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 113.865 1.061 . . . . 74.44 113.865 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.56 -29.69 18.73 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.219 1.933 . . . . 73.12 116.219 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.58 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 75.0 t80 -89.03 -8.25 54.35 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 118.345 0.521 . . . . 62.41 111.017 -168.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 165.23 11.34 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 108.217 -1.031 . . . . 73.31 108.217 170.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.17 13.43 52.4 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.76 -0.734 . . . . 65.24 112.363 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -122.31 -160.5 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.495 -1.298 . . . . 63.41 107.495 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.09 143.27 46.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.474 0.654 . . . . 72.5 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -113.81 113.93 25.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.196 -1.039 . . . . 75.21 108.196 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.17 28.46 14.06 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.809 1.244 . . . . 74.22 112.593 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.14 74.7 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.568 -0.349 . . . . 71.23 113.831 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.74 143.52 51.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.419 -0.956 . . . . 65.23 108.419 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.94 127.68 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.88 0.372 . . . . 74.42 111.079 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.7 tt -109.78 137.62 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.025 -0.534 . . . . 72.34 111.101 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -130.48 128.42 41.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.77 -0.65 . . . . 74.32 111.051 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.97 130.49 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 122.99 0.516 . . . . 74.52 110.759 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -129.42 175.78 8.49 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.626 1.17 . . . . 71.33 109.414 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.83 -3.13 59.03 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.884 1.068 . . . . 74.3 113.884 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 C-N-CA 124.084 0.954 . . . . 62.24 113.128 177.398 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 110.427 -0.212 . . . . 73.4 110.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.75 106.83 18.78 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.395 0.616 . . . . 74.34 110.466 165.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.6 m -142.16 149.19 39.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.135 -1.061 . . . . 70.3 108.135 166.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.96 140.57 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.614 0.643 . . . . 74.32 109.533 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.07 135.04 43.18 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.037 -0.727 . . . . 70.11 109.037 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -126.61 143.68 39.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.626 0.727 . . . . 53.44 112.538 177.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.78 148.06 50.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.272 -1.331 . . . . 73.25 110.849 -176.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.27 20.0 37.02 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 123.814 0.696 . . . . 71.45 113.186 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 74.14 0.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.684 -1.228 . . . . 75.11 107.684 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.22 -82.6 0.22 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.368 -0.92 . . . . 75.41 112.808 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 110.39 10.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.785 0.803 . . . . 74.03 111.532 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.73 19.88 33.18 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.079 -0.964 . . . . 73.2 111.566 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.95 151.94 4.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.719 -0.474 . . . . 63.05 109.719 -172.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.5 m -91.49 170.49 9.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.523 -0.762 . . . . 64.01 109.93 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.928 2.091 . . . . 72.32 113.971 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -43.85 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.606 1.962 . . . . 74.43 115.319 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.73 -21.47 0.2 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.636 1.975 . . . . 63.32 113.957 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -56.49 -31.53 34.04 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 CA-C-N 118.618 0.645 . . . . 75.41 109.818 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.92 -33.53 83.94 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 119.858 -0.412 . . . . 70.21 113.704 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -74.74 -30.47 61.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.907 0.883 . . . . 70.01 111.184 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 4.7 t80 -57.5 -46.82 83.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.541 0.736 . . . . 74.05 110.646 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.93 -23.59 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.432 0.158 . . . . 72.21 111.325 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -69.72 -20.0 63.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.586 0.754 . . . . 73.44 111.519 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -65.31 -20.01 66.21 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 122.187 -0.321 . . . . 71.4 111.325 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.1 63.04 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.823 -0.436 . . . . 75.2 109.823 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.11 178.37 23.22 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.209 -0.996 . . . . 74.15 115.044 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.08 138.35 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.5 0.72 . . . . 73.22 110.337 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.23 111.9 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.271 0.557 . . . . 74.14 110.417 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -102.28 144.26 31.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 73.13 111.32 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.29 132.38 34.63 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.857 -0.794 . . . . 73.24 108.857 165.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.64 123.52 26.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.479 -0.934 . . . . 62.21 108.479 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.12 58.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.941 0.719 . . . . 55.32 112.941 -173.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -68.51 -34.22 75.5 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.579 0.352 . . . . 73.24 111.304 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 p -125.53 -32.0 2.93 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 111.863 0.32 . . . . 73.53 111.863 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.84 10.18 65.18 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.925 -0.58 . . . . 73.21 113.487 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -97.19 145.61 29.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 117.335 0.568 . . . . 74.24 111.224 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.8 153.45 77.79 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.975 2.45 . . . . 64.44 111.448 168.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.465 ' CB ' ' H ' ' A' ' 289' ' ' SER . 3.4 ptm -71.6 98.63 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.176 1.176 . . . . 73.35 114.176 -171.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -144.5 112.53 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.026 -1.472 . . . . 71.13 107.026 164.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -130.09 116.72 18.91 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.139 0.882 . . . . 72.43 109.786 159.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.01 110.55 19.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.786 -0.45 . . . . 72.15 109.786 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -102.88 112.87 25.88 Favored 'General case' 0 C--O 1.261 1.706 0 CA-C-O 121.247 0.546 . . . . 74.43 110.896 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.0 p -143.32 123.34 13.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.109 -1.405 . . . . 72.41 110.292 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.63 112.12 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.153 0.501 . . . . 70.34 111.974 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -11.04 51.07 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.187 0.81 . . . . 74.33 113.187 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.88 -28.59 58.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.604 0.24 . . . . 74.55 111.641 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 71.1 p -89.33 -22.22 22.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.146 -0.687 . . . . 64.12 109.146 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.35 57.25 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.191 -0.913 . . . . 35.95 112.679 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -109.45 139.59 21.27 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.957 -0.386 . . . . 61.14 109.957 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.02 136.99 78.57 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.152 2.568 . . . . 72.11 114.448 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -67.85 -35.62 78.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.938 -1.028 . . . . 52.45 112.053 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.25 22.23 25.34 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.03 -0.605 . . . . 51.53 112.992 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -116.22 142.67 46.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.682 -0.407 . . . . 71.42 109.929 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.73 153.65 34.77 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.596 0.56 . . . . 75.13 110.661 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 136.21 40.88 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.755 0.312 . . . . 64.44 110.446 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.27 148.13 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.933 -0.576 . . . . 74.04 110.139 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.465 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.8 t -105.34 120.26 41.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.65 0.78 . . . . 73.14 112.664 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -85.77 163.66 18.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.082 0.401 . . . . 73.4 112.082 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -78.81 -47.46 16.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.299 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -98.67 135.94 20.89 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.348 -0.387 . . . . 73.35 111.176 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.63 -40.51 29.54 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 122.559 2.173 . . . . 73.43 115.87 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 -29.74 47.99 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.759 2.021 . . . . 61.2 113.602 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 75.0 m -64.77 -26.26 68.28 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -74.08 -48.34 30.45 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.469 0.308 . . . . 72.34 111.664 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -33.72 71.69 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.261 0.553 . . . . 74.53 112.103 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.65 62.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.746 -0.661 . . . . 61.52 110.937 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.89 -28.7 65.85 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.468 0.175 . . . . 40.21 111.187 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.34 -33.75 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 O-C-N 122.225 -0.297 . . . . 72.4 110.468 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.11 -59.4 2.8 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 114.389 1.255 . . . . 61.54 114.389 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -90.05 -33.68 16.23 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.746 1.758 . . . . 70.45 115.746 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.4 t80 -85.65 -19.62 30.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.091 0.472 . . . . 73.32 109.984 -169.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -105.59 174.38 5.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.081 -0.963 . . . . 74.41 109.207 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.31 53.51 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.893 -0.67 . . . . 35.95 111.731 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -136.0 -154.52 0.57 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.64 -0.504 . . . . 71.3 109.64 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.51 145.54 51.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.77 0.795 . . . . 71.3 111.416 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -114.82 115.96 27.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.546 -1.206 . . . . 62.34 108.274 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.2 m170 64.44 28.93 13.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.607 1.163 . . . . 53.33 112.834 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.05 84.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.462 -0.399 . . . . 53.11 113.887 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -122.62 147.97 45.8 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.92 -0.77 . . . . 63.53 108.92 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.4 mm -69.97 129.74 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.721 0.408 . . . . 74.23 110.614 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.4 tt -108.41 147.08 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.206 -0.664 . . . . 74.43 109.206 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -137.2 123.82 21.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.408 -0.36 . . . . 63.43 111.279 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.74 135.83 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.22 0.608 . . . . 53.41 110.266 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.1 m -138.09 175.24 9.76 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.546 1.139 . . . . 73.34 109.591 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -85.7 2.0 47.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 71.24 113.975 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 C-N-CA 123.726 0.81 . . . . 64.54 112.173 178.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.755 0.312 . . . . 71.3 110.337 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.55 105.48 17.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.654 -0.818 . . . . 74.42 110.182 166.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.4 m -143.2 144.16 32.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.486 -1.301 . . . . 74.44 107.486 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.3 pt -120.58 136.62 56.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 119.233 0.924 . . . . 72.04 109.727 164.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.402 ' HA ' HG23 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.14 121.21 41.06 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.39 0.614 . . . . 70.31 109.526 -178.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.14 139.59 44.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.309 -0.859 . . . . 63.33 109.954 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.57 141.23 51.43 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.038 -0.727 . . . . 73.52 109.038 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 104.52 26.64 6.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.156 -0.545 . . . . 70.5 113.221 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 78.93 1.87 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.227 -0.657 . . . . 60.14 109.227 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -141.42 -79.63 0.05 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 120.058 -1.067 . . . . 74.33 112.946 -175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.26 110.48 10.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.902 0.382 . . . . 74.1 111.846 -173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.58 18.73 43.78 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.683 -0.77 . . . . 61.34 111.686 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.57 151.32 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.195 0.522 . . . . 71.43 109.764 -170.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 245' ' ' VAL . 24.7 m -86.24 169.76 12.73 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.774 -0.648 . . . . 72.24 109.949 171.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -168.45 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.694 1.998 . . . . 73.13 112.709 -177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.63 -12.21 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.774 2.03 . . . . 52.44 115.873 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.8 OUTLIER -47.07 -23.89 0.56 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 126.901 2.081 . . . . 75.01 113.304 170.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -56.75 -31.45 35.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-N 118.171 0.442 . . . . 52.41 110.116 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.14 -32.51 76.39 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 121.645 -0.659 . . . . 75.35 113.659 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -75.71 -31.23 59.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.382 0.673 . . . . 71.25 110.98 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.7 t80 -54.67 -46.77 74.11 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.36 0.664 . . . . 64.03 110.874 170.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.74 -23.27 49.4 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.218 -0.301 . . . . 73.31 111.68 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -67.46 -19.27 65.33 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.579 0.752 . . . . 62.23 111.549 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.4 pt20 -63.01 -18.99 63.92 Favored 'General case' 0 CA--C 1.558 1.254 0 O-C-N 122.24 -0.287 . . . . 74.12 111.424 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 mm -120.75 54.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-O 121.211 0.529 . . . . 75.32 109.838 171.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.29 -169.6 27.56 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 118.268 -1.92 . . . . 61.42 115.214 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.35 137.66 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.282 -0.959 . . . . 75.22 109.761 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.5 mm -72.04 114.15 10.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.57 0.7 . . . . 61.52 110.438 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -98.53 144.3 28.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.65 -1.159 . . . . 75.12 110.393 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.8 m -84.29 118.92 24.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.631 -0.877 . . . . 62.32 108.631 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.59 128.4 35.45 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 109.354 -0.61 . . . . 71.55 109.354 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -79.29 -8.38 59.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.378 0.881 . . . . 71.42 113.378 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.15 -30.52 68.77 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.144 0.277 . . . . 74.44 111.132 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.0 t -125.46 -31.07 3.04 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.572 -0.285 . . . . 70.34 111.572 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.93 5.98 67.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.321 -0.4 . . . . 64.42 112.726 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -97.22 152.64 38.39 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 123.052 0.541 . . . . 74.35 111.721 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.59 153.31 75.8 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.318 2.678 . . . . 72.1 111.802 166.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.23 101.62 1.92 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.966 1.099 . . . . 72.42 113.966 -173.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.2 mm -143.59 112.9 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.624 -1.25 . . . . 73.3 107.624 163.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -128.33 116.72 20.24 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.381 0.991 . . . . 52.24 110.227 164.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 112.12 22.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.007 0.432 . . . . 74.23 110.426 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 112.34 25.03 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-N 115.852 -0.613 . . . . 73.43 110.243 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.4 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.4 p -142.28 122.03 13.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.249 -1.341 . . . . 73.13 110.488 -176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.73 110.98 19.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.229 0.538 . . . . 72.22 111.217 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -10.8 49.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.53 0.937 . . . . 73.41 113.53 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.3 -29.27 53.61 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 62.22 109.718 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 60.9 p -89.1 -20.37 24.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.31 -0.859 . . . . 64.11 109.836 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.27 -34.65 5.25 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.301 -0.863 . . . . 74.43 113.061 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -101.35 143.77 27.26 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 109.804 -0.443 . . . . 73.44 109.804 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.22 141.03 88.52 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.275 2.65 . . . . 63.04 114.018 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 275' ' ' THR . 52.0 mttt -65.62 -33.14 75.21 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.774 -1.103 . . . . 74.4 111.606 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.77 23.31 23.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.517 -0.765 . . . . 71.0 112.237 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.82 143.0 47.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.308 -0.557 . . . . 73.31 110.702 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.03 143.18 24.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.626 -0.715 . . . . 70.3 109.496 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 237' ' ' PHE . 68.9 p -126.88 137.86 53.22 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.609 -0.436 . . . . 70.02 110.023 173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.49 145.43 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 121.043 0.449 . . . . 74.42 109.991 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.71 129.18 45.16 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.623 0.972 . . . . 72.51 113.623 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.64 165.61 15.29 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.702 0.63 . . . . 74.11 112.702 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.69 73.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.448 -0.796 . . . . 72.51 111.935 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.4 139.8 35.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.891 -0.781 . . . . 71.51 108.891 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -58.79 -40.09 75.74 Favored 'Trans proline' 0 CA--C 1.576 2.588 0 C-N-CA 122.488 2.125 . . . . 65.2 117.368 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 -30.34 14.13 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 123.614 2.326 . . . . 73.21 114.106 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 55.0 p -62.97 -29.82 71.11 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.131 0.572 . . . . 74.42 111.627 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.11 -37.17 78.24 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.627 1.204 . . . . 43.4 112.214 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -68.56 -38.79 81.06 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 123.55 0.531 . . . . 72.42 111.839 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.55 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.937 -0.574 . . . . 65.12 111.428 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -66.51 -26.88 67.37 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 123.316 0.647 . . . . 54.14 112.257 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 296' ' ' ALA . 72.7 mt -68.71 -32.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.843 -1.161 . . . . 74.23 111.377 172.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.27 -58.27 3.38 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 113.169 0.803 . . . . 63.22 113.169 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.95 -30.72 17.64 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.385 1.995 . . . . 73.54 116.385 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 66.0 t80 -88.53 -17.5 30.13 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.086 0.403 . . . . 73.42 110.742 -169.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.473 ' OD1' ' HA ' ' A' ' 314' ' ' LYS . 1.6 t70 -87.56 159.59 18.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.16 50.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.478 -0.391 . . . . 73.43 113.154 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 -162.04 0.84 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.414 -0.958 . . . . 73.4 108.414 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.66 143.69 51.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.715 0.769 . . . . 70.45 111.367 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -113.74 115.83 28.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.966 -1.016 . . . . 74.23 108.454 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 63.85 28.43 14.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.67 1.231 . . . . 75.31 112.406 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.12 11.54 80.86 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.113 0.405 . . . . 51.31 114.113 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.53 147.86 50.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.73 -0.841 . . . . 60.43 108.73 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.2 127.66 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.777 0.431 . . . . 73.11 111.369 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 14.8 tt -110.71 134.15 53.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.732 -0.667 . . . . 71.14 110.551 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.473 ' HA ' ' OD1' ' A' ' 304' ' ' ASP . 3.1 mttm -124.06 141.19 52.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.469 -0.787 . . . . 64.32 110.729 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 300' ' ' ILE . 0.3 OUTLIER -123.4 140.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.8 m -140.39 174.2 10.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.853 0.461 . . . . 72.1 110.86 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -2.63 55.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.609 0.966 . . . . 72.54 113.609 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 C-N-CA 124.264 1.026 . . . . 64.34 111.922 -178.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.3 t30 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.402 -0.222 . . . . 63.41 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.29 106.47 18.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 119.675 -0.81 . . . . 70.11 110.724 165.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.1 m -142.1 147.08 36.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.735 -1.209 . . . . 70.35 107.735 166.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.27 137.0 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.106 0.867 . . . . 75.03 109.959 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.54 124.51 44.78 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.207 -0.664 . . . . 53.11 109.207 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.79 140.7 44.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.718 -0.674 . . . . 71.02 109.556 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.69 141.56 51.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.599 . . . . 64.13 109.442 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.32 27.61 6.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.291 -0.481 . . . . 62.14 112.773 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.14 80.34 1.95 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.246 -0.65 . . . . 74.3 109.246 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.7 -69.6 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.396 -0.907 . . . . 60.13 113.126 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.7 107.2 11.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.741 0.781 . . . . 72.43 111.232 -171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.22 20.77 44.22 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.228 -0.897 . . . . 51.34 111.569 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 246' ' ' SER . 0.3 OUTLIER -79.97 152.33 4.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.104 0.478 . . . . 73.31 109.937 -172.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 245' ' ' VAL . 17.7 m -89.28 171.05 10.06 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.609 -0.723 . . . . 70.25 109.571 170.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.852 1.661 . . . . 54.33 113.887 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -43.44 -14.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 127.764 2.426 . . . . 71.0 115.257 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.62 -21.46 0.36 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.942 2.097 . . . . 74.24 114.429 171.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -55.37 -31.62 27.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 C-N-CA 122.951 0.5 . . . . 64.21 110.102 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.65 -33.56 82.76 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.684 -0.509 . . . . 42.51 114.018 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.2 -30.87 60.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.226 0.611 . . . . 75.12 110.946 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.547 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.6 t80 -54.39 -46.32 73.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 71.44 110.619 170.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.07 -23.31 48.1 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.906 0.336 . . . . 74.23 111.906 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -70.63 -15.21 62.72 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.145 0.978 . . . . 74.3 111.514 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.49 -14.53 57.61 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 122.036 -0.415 . . . . 72.33 112.021 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.0 -31.54 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.097 0.559 . . . . 63.22 111.157 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -156.86 -160.78 10.31 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 119.429 -1.367 . . . . 75.31 114.845 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.91 138.81 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.913 -0.643 . . . . 75.44 110.369 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 30.9 mm -68.94 115.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 123.77 0.669 . . . . 71.5 110.565 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -97.84 142.37 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.318 -0.855 . . . . 74.32 110.94 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 80.2 m -85.94 115.84 23.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.198 -1.038 . . . . 62.24 108.198 167.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 122.92 22.64 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.046 -0.724 . . . . 71.1 109.046 -177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -72.58 -8.92 57.64 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.238 1.199 . . . . 75.53 114.238 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -69.87 -29.85 67.17 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.334 0.254 . . . . 65.42 111.614 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.4 t -124.41 -31.9 3.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.641 -0.254 . . . . 71.24 111.121 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.68 66.41 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 116.382 -0.372 . . . . 71.44 112.321 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -97.62 153.19 38.39 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.246 0.618 . . . . 63.42 111.388 173.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.26 153.79 67.67 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 123.493 2.795 . . . . 74.11 112.048 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 1.1 ptm -75.2 100.73 4.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.704 0.764 . . . . 55.32 112.746 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.73 114.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.285 -1.376 . . . . 72.15 107.285 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -128.5 117.07 20.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.151 0.887 . . . . 73.43 109.957 161.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.09 111.78 22.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.177 0.513 . . . . 71.34 110.152 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.45 112.41 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.948 -0.569 . . . . 75.35 109.942 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.2 p -144.35 119.36 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.23 -1.35 . . . . 75.33 109.908 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -87.63 111.91 21.76 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.619 1.2 . . . . 63.42 112.274 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -7.92 58.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.185 -0.916 . . . . 71.23 112.525 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.73 -27.96 64.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.723 0.409 . . . . 74.24 111.94 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 44.0 p -89.64 -25.85 21.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.571 -0.529 . . . . 75.45 109.571 168.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.49 61.31 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.195 -0.911 . . . . 72.14 112.661 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 140.85 37.96 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.367 -0.975 . . . . 71.54 108.367 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.07 137.33 70.92 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.348 2.032 . . . . 62.25 114.285 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -61.13 -35.07 76.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.058 -1.428 . . . . 74.15 111.739 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.07 30.73 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.484 -0.78 . . . . 62.43 112.744 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -119.97 143.39 48.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.988 -0.685 . . . . 63.22 110.476 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.62 24.15 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.941 -0.572 . . . . 71.35 110.018 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 60.3 p -127.0 137.85 53.16 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 110.148 -0.316 . . . . 71.11 110.148 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.93 147.88 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 110.034 -0.358 . . . . 74.12 110.034 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.5 m -108.48 123.95 49.68 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.531 0.567 . . . . 73.35 112.531 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.8 163.44 13.52 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.963 0.357 . . . . 74.22 111.963 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -76.25 -48.27 20.89 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.641 -0.254 . . . . 73.21 110.4 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.55 135.21 19.35 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 120.366 -0.533 . . . . 74.41 110.03 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.4 -39.34 29.53 Favored 'Trans proline' 0 CA--C 1.568 2.208 0 C-N-CA 122.572 2.181 . . . . 75.21 116.029 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.51 -31.05 61.45 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 122.978 2.099 . . . . 63.23 113.958 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.8 m -70.32 -30.3 67.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.897 -0.592 . . . . 73.22 110.794 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.64 64.18 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.795 -0.638 . . . . 73.23 111.08 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -71.82 -37.07 70.39 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 120.887 0.375 . . . . 71.22 111.967 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.41 78.12 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.339 -0.391 . . . . 73.4 110.842 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -65.25 -35.15 80.13 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 116.154 -0.476 . . . . 53.34 111.76 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.74 -32.57 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 O-C-N 122.052 -0.405 . . . . 70.24 111.106 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -72.34 -58.43 3.41 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.973 1.101 . . . . 63.21 113.973 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.55 -30.92 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.569 2.063 . . . . 71.33 116.569 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 85.4 t80 -83.94 -11.21 57.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.443 0.697 . . . . 74.43 111.107 -168.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.21 170.44 7.88 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.624 -0.88 . . . . 74.31 108.624 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.64 6.21 59.69 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.272 -0.49 . . . . 72.54 112.48 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 -157.55 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.393 -0.965 . . . . 61.33 108.393 174.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -129.87 147.15 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.428 0.632 . . . . 65.34 111.329 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -114.32 111.88 22.2 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.8 28.78 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.423 1.089 . . . . 73.34 112.253 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.06 -2.07 87.69 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 116.359 -0.382 . . . . 63.24 113.546 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -108.64 144.9 35.77 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 109.125 -0.694 . . . . 70.32 109.125 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.28 126.99 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.863 0.363 . . . . 75.1 111.126 -173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 20.3 tt -110.34 136.31 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.568 0.699 . . . . 64.22 111.191 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -130.64 131.74 45.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.052 -0.976 . . . . 72.14 110.545 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.24 139.06 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 110.006 -0.368 . . . . 54.14 110.006 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.4 m -137.88 174.71 10.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.195 0.998 . . . . 54.15 109.647 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.68 1.59 51.46 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.051 1.13 . . . . 74.23 114.051 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.012 0.925 . . . . 73.13 113.178 176.017 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.237 0.443 0 N-CA-C 109.47 -0.567 . . . . 72.11 109.47 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 107.02 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.329 -0.548 . . . . 65.44 109.819 168.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.9 m -142.9 149.01 37.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.584 -0.895 . . . . 71.12 108.584 169.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.79 141.15 45.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 118.625 0.648 . . . . 75.22 109.58 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 315' ' ' VAL . 0.3 OUTLIER -102.31 130.2 48.95 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 177.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -121.38 144.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.636 0.731 . . . . 62.01 112.642 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 114.257 -1.338 . . . . 62.33 110.049 -178.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 95.45 7.89 58.91 Favored Glycine 0 CA--C 1.519 0.296 0 O-C-N 123.599 0.562 . . . . 60.25 113.688 174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 76.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.374 -0.973 . . . . 63.1 108.374 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -134.4 -87.65 0.28 Allowed Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 120.419 -0.896 . . . . 64.31 113.822 -171.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.96 112.91 9.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.753 0.311 . . . . 75.21 111.21 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.01 19.87 38.27 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.709 -0.678 . . . . 70.22 111.977 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.33 150.87 4.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.311 0.576 . . . . 72.25 109.674 -173.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.1 m -90.29 170.65 10.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.539 -0.755 . . . . 65.02 110.364 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -167.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 127.117 2.167 . . . . 70.44 113.36 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.2 -11.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.285 1.834 . . . . 74.21 115.673 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -45.87 -22.31 0.19 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 126.869 2.068 . . . . 74.1 113.756 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -32.28 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 118.815 0.734 . . . . 72.4 110.058 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -36.67 92.78 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.737 -0.479 . . . . 71.0 113.168 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.11 -34.27 76.06 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.502 0.721 . . . . 71.24 110.635 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.1 t80 -57.56 -43.18 84.27 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.252 -0.886 . . . . 72.05 111.486 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.64 -24.45 45.26 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.181 0.438 . . . . 72.32 112.181 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 23.4 tptm -66.66 -18.96 65.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.795 1.238 . . . . 64.35 112.189 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.23 -15.09 62.11 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 113.172 0.804 . . . . 64.24 113.172 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.2 -6.73 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 120.882 0.372 . . . . 72.51 110.792 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . -171.59 -160.44 20.13 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 118.95 -1.595 . . . . 75.34 114.721 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.59 139.44 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.443 0.697 . . . . 74.24 110.518 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.412 HG12 ' HD3' ' A' ' 255' ' ' LYS . 20.8 mm -66.38 116.31 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 123.643 0.589 . . . . 74.4 109.674 173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.11 133.24 42.03 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.447 -0.797 . . . . 72.35 110.454 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 50.3 m -84.8 117.09 23.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.299 -1.0 . . . . 73.24 108.299 167.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.29 136.67 42.63 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 112.196 0.443 . . . . 74.45 112.196 -174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -80.07 -10.77 59.79 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.668 0.988 . . . . 73.11 113.668 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -70.12 -38.48 75.6 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 112.477 0.547 . . . . 72.42 112.477 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.37 -24.55 4.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.482 0.182 . . . . 75.4 111.279 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.85 16.52 54.39 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.121 0.408 . . . . 74.42 114.121 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -100.34 152.94 37.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.398 0.599 . . . . 72.43 111.496 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.62 152.12 83.04 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.443 2.096 . . . . 73.33 111.572 166.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.472 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.09 97.9 4.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.764 1.024 . . . . 65.21 113.764 -172.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 35.7 mm -143.11 112.87 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.614 -1.254 . . . . 75.15 107.614 165.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -129.07 117.61 21.15 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.107 0.867 . . . . 63.4 109.852 161.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 111.04 20.61 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.595 -0.52 . . . . 75.05 109.595 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -101.92 112.29 24.86 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 121.259 0.552 . . . . 71.34 110.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 23.0 p -142.6 120.93 12.32 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.985 -1.461 . . . . 72.33 110.207 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 26.0 t70 -87.47 113.49 23.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.288 0.566 . . . . 72.31 111.147 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -9.9 55.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.662 -0.699 . . . . 63.34 112.797 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -29.95 61.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.652 0.263 . . . . 62.21 111.547 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.4 t -91.3 -15.41 29.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.417 0.627 . . . . 75.4 109.686 167.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.98 -37.4 3.46 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.71 -0.677 . . . . 53.31 113.237 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -96.73 141.85 23.69 Favored Pre-proline 0 N--CA 1.443 -0.814 0 O-C-N 123.635 0.256 . . . . 72.43 110.971 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.49 136.26 74.78 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.636 2.891 . . . . 74.22 114.129 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 56.2 mtpt -65.6 -37.82 87.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 75.14 111.604 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.97 25.05 13.57 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.862 -0.685 . . . . 61.2 113.021 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -115.82 142.24 47.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.711 -0.477 . . . . 70.01 109.711 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 155.26 38.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.308 -0.405 . . . . 41.53 110.828 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 137.31 41.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.098 -0.334 . . . . 72.1 110.098 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.56 145.36 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.152 -0.684 . . . . 72.25 109.152 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.472 ' H ' ' CB ' ' A' ' 270' ' ' MET . 22.7 t -97.68 117.59 32.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.639 0.775 . . . . 75.11 111.645 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.4 164.09 13.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 121.139 -0.225 . . . . 72.02 111.442 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.53 -48.53 55.06 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.715 0.635 . . . . 74.2 112.715 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -119.57 136.16 24.53 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.33 -38.35 65.6 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 123.682 2.921 . . . . 54.1 117.699 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.68 -29.94 15.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 123.55 2.304 . . . . 64.45 112.487 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -64.27 -27.4 69.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.725 1.21 . . . . 72.23 112.181 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -67.7 -40.97 84.3 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.595 0.559 . . . . 62.41 112.23 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -72.79 -34.67 67.08 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.292 0.567 . . . . 75.0 110.713 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.27 -33.76 76.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.337 -0.847 . . . . 71.14 111.048 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.22 -28.69 67.47 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.91 -0.586 . . . . 55.31 111.707 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 296' ' ' ALA . 49.3 mt -69.88 -30.59 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 O-C-N 122.035 -0.416 . . . . 63.12 110.812 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.88 -60.67 2.29 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.959 1.096 . . . . 63.14 113.959 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -91.87 -29.58 16.63 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.438 2.014 . . . . 73.15 116.438 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 23.6 t80 -86.62 -24.12 25.46 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 -171.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . 0.432 ' HB2' HG13 ' A' ' 315' ' ' VAL . 7.5 t70 -82.87 -170.51 3.04 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.957 -1.02 . . . . 73.12 109.531 166.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 78.25 13.48 83.25 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.198 -0.525 . . . . 62.44 112.853 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -135.67 -161.88 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.883 0.373 . . . . 73.34 110.179 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -128.69 144.62 51.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.21 0.529 . . . . 45.44 110.467 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -113.12 112.04 23.14 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.21 -1.033 . . . . 74.42 108.21 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 65.03 29.25 12.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.764 1.29 . . . . 75.52 112.167 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.78 5.79 80.82 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 114.211 0.444 . . . . 72.54 114.211 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -124.21 148.42 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.778 -0.823 . . . . 55.12 108.778 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.59 129.27 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 123.303 0.377 . . . . 70.43 110.901 -171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.1 tt -108.5 143.95 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.791 -0.641 . . . . 75.52 109.54 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 15.3 tptp -136.94 121.89 18.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.914 0.388 . . . . 73.52 110.361 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 237' ' ' PHE . 7.7 p -111.89 138.39 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.522 -0.763 . . . . 61.24 111.226 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -142.79 172.79 12.22 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.286 1.034 . . . . 72.2 109.837 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -5.25 48.48 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.942 1.09 . . . . 74.23 113.942 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 124.508 1.123 . . . . 72.12 113.176 177.11 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--O 1.237 0.427 0 CA-C-O 120.64 0.257 . . . . 74.4 111.541 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.79 104.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.821 -0.752 . . . . 73.44 110.276 160.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 21.9 m -143.0 147.19 34.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.212 -1.032 . . . . 61.34 108.212 165.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 288' ' ' VAL . 2.5 pp -121.7 141.9 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 118.754 0.706 . . . . 62.43 109.588 164.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.67 122.31 45.39 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.754 -0.657 . . . . 74.44 109.39 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -114.3 144.52 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.755 0.788 . . . . 73.45 112.756 176.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.29 151.28 47.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.768 -1.56 . . . . 73.54 110.124 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.12 15.3 54.33 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.266 -0.492 . . . . 72.32 113.539 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.36 76.86 1.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.083 -1.081 . . . . 75.11 108.083 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.18 -88.26 0.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.152 -1.023 . . . . 70.11 114.301 -169.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -78.55 109.3 12.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 75.24 111.225 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.95 21.2 21.6 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.27 -0.877 . . . . 62.15 111.783 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -85.41 151.42 3.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.752 -0.462 . . . . 72.03 109.752 -173.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.0 m -90.54 170.01 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.788 -0.642 . . . . 73.02 110.696 172.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.811 2.044 . . . . 75.01 113.555 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -43.19 -12.7 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 126.634 1.974 . . . . 73.2 115.749 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.22 -22.04 0.34 Allowed 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 126.473 1.909 . . . . 73.43 113.668 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -56.57 -31.55 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 118.482 0.583 . . . . 73.11 110.236 178.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.07 -32.02 82.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.707 -0.496 . . . . 72.4 114.267 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -72.73 -33.58 66.5 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.706 0.802 . . . . 74.34 110.758 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.7 t80 -57.22 -43.15 82.58 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.083 -0.962 . . . . 73.14 111.256 173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.02 -24.9 43.34 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 122.144 -0.347 . . . . 74.31 111.851 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.87 -22.32 66.97 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.402 1.081 . . . . 75.21 112.199 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -13.79 53.12 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 112.963 0.727 . . . . 52.34 112.963 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 46.6 mm -111.49 -26.46 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 122.698 0.399 . . . . 75.44 110.589 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -160.9 -174.95 31.39 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 119.982 -1.104 . . . . 62.42 115.127 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.22 138.8 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 73.43 111.201 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 23.7 mm -70.98 115.54 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.818 -0.628 . . . . 75.13 110.785 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -98.28 138.11 36.03 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.579 0.704 . . . . 71.2 111.078 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 94.7 m -84.2 116.83 23.14 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.605 -1.18 . . . . 70.24 108.509 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 131.51 37.05 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 109.504 -0.554 . . . . 63.3 109.504 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -76.08 -5.65 47.48 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.704 1.002 . . . . 71.54 113.704 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -66.94 -34.83 78.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.636 0.255 . . . . 70.03 111.156 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 21.3 p -124.6 -31.45 3.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.854 0.462 . . . . 65.43 111.578 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.88 67.17 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.431 -0.804 . . . . 74.45 112.034 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.32 151.73 37.53 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.101 0.56 . . . . 74.11 111.677 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.45 153.92 76.01 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.066 2.51 . . . . 74.12 111.38 166.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.423 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -76.93 99.2 5.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.373 0.879 . . . . 73.41 113.373 -169.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.9 mm -143.07 112.87 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.59 -1.263 . . . . 54.42 107.59 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -128.69 116.2 19.19 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.953 0.797 . . . . 73.44 110.276 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.81 110.89 20.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.638 -0.504 . . . . 71.12 109.638 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 31.7 m-85 -103.03 112.94 26.02 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.088 0.471 . . . . 72.25 110.651 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 p -144.77 122.07 11.58 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.55 -1.205 . . . . 74.23 110.088 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.21 112.2 21.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.441 0.638 . . . . 73.42 112.618 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -85.75 -10.42 55.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.799 -0.637 . . . . 70.23 112.017 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.69 -31.36 66.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.407 0.623 . . . . 65.54 110.221 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 47.3 p -91.21 -21.92 20.88 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.212 -0.904 . . . . 75.4 109.57 173.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.11 -33.25 6.29 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.263 -0.88 . . . . 62.35 113.029 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -99.37 141.42 22.8 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 110.302 -0.259 . . . . 75.44 110.302 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.58 132.72 53.82 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.418 2.745 . . . . 74.33 114.385 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -59.54 -42.09 91.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 75.14 112.294 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.49 24.76 15.19 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.64 -0.791 . . . . 54.04 113.145 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.4 mt-10 -116.45 142.87 46.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.722 -0.473 . . . . 71.22 109.722 -174.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.18 32.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 74.23 110.966 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 p -131.31 136.74 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.88 0.372 . . . . 71.03 110.2 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 236' ' ' ILE . 6.1 m -135.56 146.22 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 109.221 -0.659 . . . . 75.45 109.221 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.423 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.6 m -110.21 117.81 34.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.25 165.23 13.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.918 0.71 . . . . 74.35 112.918 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.66 -47.16 76.45 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.852 0.861 . . . . 73.11 112.857 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -122.45 136.7 26.8 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.964 -0.384 . . . . 73.02 109.964 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -61.26 -38.5 65.27 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.229 2.619 . . . . 74.25 117.259 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -28.18 14.2 Favored 'Trans proline' 0 C--N 1.386 2.502 0 CA-C-N 123.682 2.351 . . . . 71.32 112.466 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.7 m -62.48 -27.9 69.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.056 0.942 . . . . 72.13 112.026 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.14 -39.38 78.87 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.267 0.627 . . . . 70.1 111.904 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -69.49 -37.88 77.42 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.87 0.367 . . . . 74.41 110.772 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.03 72.09 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.633 -0.712 . . . . 71.24 110.941 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.73 -29.56 66.97 Favored 'General case' 0 C--O 1.213 -0.852 0 O-C-N 123.395 0.434 . . . . 75.13 111.726 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 296' ' ' ALA . 56.6 mt -69.84 -32.06 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 121.716 -0.615 . . . . 65.43 110.428 173.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.71 -60.61 2.3 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 113.381 0.882 . . . . 72.24 113.381 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -93.52 -30.76 14.85 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.283 1.957 . . . . 73.44 116.283 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 37.5 t80 -84.57 -23.19 29.77 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.492 0.587 . . . . 73.51 109.69 -169.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -87.78 -164.65 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.459 -0.792 . . . . 62.32 110.649 168.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.06 7.21 87.39 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.528 -0.76 . . . . 73.14 113.061 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -137.78 -164.35 1.6 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.56 0.219 . . . . 71.51 110.634 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.77 144.62 45.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.719 0.771 . . . . 62.23 112.035 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -113.82 114.83 26.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.794 -1.187 . . . . 62.13 107.794 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.09 28.5 14.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 124.64 1.213 . . . . 75.22 112.211 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.18 -4.47 84.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 114.106 0.403 . . . . 71.04 114.106 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -113.11 145.51 40.8 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.699 -0.482 . . . . 64.33 109.699 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.11 132.0 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.203 0.314 . . . . 74.02 110.635 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.8 tt -107.28 145.19 14.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.747 -0.834 . . . . 64.42 108.747 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 7.0 tppt? -136.19 121.32 18.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.095 -0.706 . . . . 72.03 109.095 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.23 134.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.399 0.618 . . . . 74.44 110.153 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.8 m -133.72 173.45 11.51 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.191 -0.913 . . . . 62.2 109.495 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -3.35 45.58 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.948 0.721 . . . . 75.13 112.948 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.508 1.123 . . . . 62.53 112.771 177.221 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.1 t30 . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.751 0.31 . . . . 75.24 110.462 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.74 105.03 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.936 -0.574 . . . . 74.41 110.159 167.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 m -144.01 148.81 35.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 74.43 108.564 163.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.1 pt -126.09 144.47 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 118.83 0.741 . . . . 75.14 109.329 161.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -99.95 133.0 44.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.756 -0.831 . . . . 74.22 108.756 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.76 137.76 56.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.011 -0.737 . . . . 72.42 109.011 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.47 140.58 52.36 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.741 -0.663 . . . . 72.24 111.214 -177.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.04 3.93 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.246 0.966 . . . . 63.42 112.316 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.21 79.13 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.906 -0.776 . . . . 70.43 108.906 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -123.97 -99.06 1.32 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.542 -0.754 . . . . 61.43 113.996 -171.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.48 119.39 17.64 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.019 0.438 . . . . 74.05 111.526 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.58 30.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.26 -0.882 . . . . 62.23 111.592 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.23 152.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.674 -0.491 . . . . 62.13 109.674 -172.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.0 m -88.29 169.28 11.99 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.681 -0.69 . . . . 73.54 109.935 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.177 1.791 . . . . 71.3 114.201 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -42.6 -14.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.726 2.01 . . . . 72.14 115.547 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -47.61 -22.06 0.44 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 126.374 1.87 . . . . 74.25 113.912 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.8 OUTLIER -56.11 -32.62 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.38 -0.6 . . . . 72.3 109.38 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.94 84.45 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.699 0.639 . . . . 73.44 114.699 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.77 -31.13 63.15 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.312 0.577 . . . . 53.22 111.231 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 3.9 t80 -56.48 -45.15 81.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.434 -0.803 . . . . 70.33 111.015 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -78.0 -23.45 48.33 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.033 -0.417 . . . . 73.41 111.651 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.26 -14.95 62.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.849 0.86 . . . . 71.21 111.806 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -64.65 -13.37 53.55 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 121.88 -0.512 . . . . 74.44 112.046 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.3 mm -104.19 -43.13 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.02 0.528 . . . . 75.25 110.563 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -147.08 -160.11 8.66 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 120.236 -0.983 . . . . 40.24 114.613 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.51 138.45 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.007 0.523 . . . . 55.42 111.452 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.76 116.81 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.688 -0.687 . . . . 75.21 110.689 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -97.93 140.75 31.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.436 0.636 . . . . 75.13 111.158 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.6 m -86.06 118.59 25.62 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.916 -1.038 . . . . 51.32 108.44 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.84 136.97 45.44 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.292 -0.413 . . . . 64.55 111.208 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.49 -9.83 59.68 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.61 0.596 . . . . 74.44 112.61 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -69.64 -39.57 77.04 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 22.4 p -123.19 -26.52 4.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.967 0.413 . . . . 75.41 111.181 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.87 9.86 65.52 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.427 -0.806 . . . . 72.1 112.813 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -97.96 150.74 37.07 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.416 0.525 . . . . 64.21 112.416 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 154.53 70.66 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 123.283 2.655 . . . . 61.41 111.993 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.417 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.8 ptm -68.31 102.48 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.118 1.155 . . . . 71.53 114.118 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 24.0 mm -144.44 112.45 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.139 -1.8 . . . . 72.4 106.139 161.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -128.72 114.5 16.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.091 0.86 . . . . 62.32 109.986 163.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.21 111.85 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.895 -0.409 . . . . 74.12 109.895 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -102.04 111.4 23.66 Favored 'General case' 0 C--O 1.265 1.884 0 CA-C-O 121.487 0.66 . . . . 73.15 109.866 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.0 p -144.4 120.5 10.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 113.86 -1.518 . . . . 72.41 109.694 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.81 112.92 22.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.43 0.634 . . . . 63.52 111.454 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -10.38 56.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.802 0.668 . . . . 53.13 112.802 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.21 66.34 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.965 0.357 . . . . 72.25 111.965 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.2 t -91.16 -18.26 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.702 -0.481 . . . . 65.43 109.702 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 100.22 -40.88 2.29 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.884 -0.598 . . . . 74.3 113.021 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -87.79 141.61 31.88 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-O 119.889 -0.101 . . . . 75.31 110.804 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.65 132.9 54.89 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.061 2.507 . . . . 62.45 114.102 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -56.53 -40.13 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.413 -1.267 . . . . 74.11 112.571 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.36 23.14 20.17 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.98 -0.554 . . . . 63.41 112.864 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -120.31 142.05 49.47 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.82 0.364 . . . . 74.25 110.562 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 148.68 28.13 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.62 -0.264 . . . . 60.25 110.875 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 67.6 p -128.76 138.57 52.17 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.571 -0.529 . . . . 74.52 109.571 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 8.1 m -138.38 152.02 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.272 -0.64 . . . . 75.41 109.272 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.417 ' H ' ' CB ' ' A' ' 270' ' ' MET . 34.0 t -113.67 131.19 56.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.813 1.042 . . . . 73.1 113.813 -171.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.0 163.42 13.66 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.434 0.531 . . . . 64.44 112.434 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.62 -46.2 80.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.5 -0.773 . . . . 73.43 111.896 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -119.91 136.15 24.73 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.684 -0.487 . . . . 72.2 109.684 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -61.41 -38.87 60.7 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.272 2.648 . . . . 60.41 117.4 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.04 -30.5 13.5 Favored 'Trans proline' 0 C--N 1.381 2.261 0 CA-C-N 123.37 2.239 . . . . 63.44 112.716 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 48.9 m -64.06 -27.92 69.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.384 -0.825 . . . . 72.41 111.394 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -72.05 -34.92 69.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.473 0.545 . . . . 54.44 112.473 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -71.86 -36.07 70.0 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.932 0.396 . . . . 64.21 110.695 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.31 88.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.784 -0.644 . . . . 71.11 111.093 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.12 -25.86 64.61 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.059 0.456 . . . . 74.5 111.586 176.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.31 -34.32 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 O-C-N 121.7 -0.625 . . . . 75.51 110.804 172.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.25 -56.89 4.17 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.378 0.881 . . . . 71.34 113.378 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -89.55 -29.1 19.15 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.245 1.943 . . . . 72.41 116.245 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 81.3 t80 -91.09 -9.26 46.33 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 122.01 -0.432 . . . . 73.42 111.402 -167.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.17 169.06 8.71 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.956 -0.757 . . . . 63.43 108.956 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.91 49.67 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 120.851 -0.69 . . . . 64.05 112.315 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -125.81 -162.72 1.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.244 -1.021 . . . . 73.1 108.244 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.78 145.93 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.621 0.724 . . . . 74.02 112.456 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -113.73 112.96 24.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.536 -1.211 . . . . 73.02 107.756 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.1 m170 64.88 28.95 12.67 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.132 . . . . 72.22 112.264 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.86 -1.38 85.15 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.465 -0.397 . . . . 63.12 113.97 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -115.22 143.51 45.13 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.202 -0.666 . . . . 72.13 109.202 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.24 129.22 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 122.632 0.373 . . . . 62.5 111.321 -171.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.8 tt -109.84 134.3 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.697 -0.683 . . . . 73.43 110.814 -174.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.42 131.22 53.5 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.522 -0.763 . . . . 63.53 110.197 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.01 126.77 67.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.965 0.412 . . . . 72.12 110.27 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -127.72 174.13 9.36 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 123.925 0.89 . . . . 75.54 109.119 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -1.72 57.31 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.954 1.094 . . . . 73.21 113.954 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.11 0.964 . . . . 75.45 112.526 179.609 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.687 0.28 . . . . 64.14 111.309 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.1 101.95 14.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.841 -0.743 . . . . 71.11 110.071 164.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 150.2 36.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.805 -1.183 . . . . 75.33 107.805 167.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.82 140.25 48.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.272 0.942 . . . . 63.24 110.013 163.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.02 128.71 45.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.601 -0.888 . . . . 74.52 108.601 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.81 138.61 52.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.775 -0.454 . . . . 72.13 109.775 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -128.82 141.74 51.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 75.44 109.21 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 106.91 14.92 17.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.183 -0.532 . . . . 61.41 113.197 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 78.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.853 -0.795 . . . . 74.32 108.853 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.506 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.1 -89.19 0.39 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.317 -0.944 . . . . 51.21 113.984 -171.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.59 117.93 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.437 0.637 . . . . 71.42 111.133 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.85 20.96 37.92 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.514 -0.766 . . . . 52.41 111.583 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.05 150.45 4.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.438 -0.578 . . . . 74.15 109.438 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.5 t -91.38 170.23 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.433 -0.58 . . . . 53.12 109.433 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -169.05 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.332 1.853 . . . . 70.4 113.848 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -43.38 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.768 2.027 . . . . 71.42 114.985 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.06 -22.04 0.3 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.55 1.94 . . . . 71.22 113.995 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -55.28 -31.88 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.631 0.651 . . . . 62.3 110.556 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.78 85.66 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 121.935 -0.174 . . . . 53.42 113.504 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.67 -33.3 66.45 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.616 0.767 . . . . 75.13 110.152 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.574 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.9 t80 -56.57 -44.46 81.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.548 -0.751 . . . . 71.01 111.72 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -78.9 -22.2 46.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.002 0.429 . . . . 75.4 111.462 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -73.03 -13.01 61.13 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.357 0.663 . . . . 74.11 111.803 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.67 -14.48 52.39 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 120.662 0.268 . . . . 75.55 111.505 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.9 mm -104.57 -47.99 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 122.924 0.49 . . . . 55.44 111.313 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -140.41 -161.52 8.74 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.066 -0.588 . . . . 62.21 113.667 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.24 138.1 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.324 0.65 . . . . 52.45 110.836 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.01 116.05 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.709 -0.678 . . . . 64.13 110.911 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -98.57 142.89 29.59 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.323 -0.853 . . . . 74.34 111.111 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 51.0 m -84.75 117.29 23.73 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.25 -1.018 . . . . 64.33 108.25 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.68 133.11 43.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.328 -0.396 . . . . 75.11 110.211 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -80.0 -8.03 59.14 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.572 0.582 . . . . 75.14 112.572 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 266' ' ' THR . 21.8 pttt -67.24 -36.85 82.51 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.275 0.23 . . . . 74.12 111.529 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 265' ' ' LYS . 15.0 p -124.15 -30.19 3.49 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.654 0.382 . . . . 63.2 111.372 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.7 64.48 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 116.14 -0.482 . . . . 62.2 112.952 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -98.23 151.53 37.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.182 0.438 . . . . 60.45 112.182 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.57 155.34 69.45 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 123.464 2.776 . . . . 65.22 112.597 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.438 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.6 ptm -71.48 102.01 2.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.665 0.987 . . . . 72.13 113.665 -172.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.8 mm -143.06 113.02 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.618 -1.623 . . . . 61.43 106.618 163.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -128.12 115.9 19.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.016 0.825 . . . . 73.22 109.98 162.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.95 111.72 21.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.183 -0.303 . . . . 74.42 110.183 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 45.2 m-85 -102.92 112.25 24.98 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 121.222 0.534 . . . . 72.41 110.388 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -144.7 122.91 12.2 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.295 -1.321 . . . . 70.13 110.003 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -85.82 111.95 20.66 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.113 0.482 . . . . 74.35 111.36 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -10.52 54.48 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.884 0.698 . . . . 73.22 112.884 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.38 -32.82 68.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.046 0.45 . . . . 60.2 110.381 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 77.6 p -90.71 -18.94 24.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.667 -0.697 . . . . 73.13 109.547 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.78 -29.29 10.73 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.557 -0.747 . . . . 72.34 113.102 170.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -105.84 142.49 24.92 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 110.196 -0.298 . . . . 74.22 110.196 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.5 136.86 78.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.422 2.748 . . . . 75.4 114.594 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -64.33 -38.48 91.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.045 -0.979 . . . . 72.1 111.873 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.67 17.38 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.459 -0.791 . . . . 72.13 113.057 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 43.6 mt-10 -116.55 142.2 47.18 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.333 -0.547 . . . . 62.33 110.454 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.27 143.86 23.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.751 -0.659 . . . . 74.13 109.948 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 77.1 p -127.25 138.71 53.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.181 0.515 . . . . 74.52 110.445 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.48 147.45 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.836 -0.62 . . . . 71.3 110.783 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.438 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.8 t -98.19 136.55 38.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.213 0.605 . . . . 75.24 112.526 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.72 164.35 11.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.596 0.221 . . . . 71.02 111.596 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.84 -46.46 68.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.914 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -123.49 136.55 27.31 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.49 -0.559 . . . . 75.32 109.49 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.41 -37.59 80.36 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.381 2.72 . . . . 74.32 117.076 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -29.12 12.68 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 123.3 2.214 . . . . 64.11 113.023 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.5 m -61.39 -27.96 68.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.732 -0.667 . . . . 72.52 111.517 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.06 -35.44 61.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.094 -0.503 . . . . 74.41 111.439 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 120.74 -0.384 . . . . 64.53 110.934 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.03 86.04 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 120.839 0.352 . . . . 72.11 110.869 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.42 -26.62 66.51 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.74 -0.664 . . . . 74.25 112.337 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.84 -33.97 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 121.731 -0.605 . . . . 74.02 110.214 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.4 -56.06 5.29 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.623 0.971 . . . . 63.52 113.623 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -31.78 17.31 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.809 1.781 . . . . 74.31 115.809 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.4 t80 -88.51 -8.82 54.2 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 118.535 0.607 . . . . 71.2 111.647 -167.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.53 9.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.66 -0.867 . . . . 75.13 108.66 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.84 51.33 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.207 -0.997 . . . . 73.25 112.369 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -126.9 -162.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.32 -0.622 . . . . 60.43 109.32 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.96 147.53 46.51 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.568 0.699 . . . . 61.4 112.197 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -115.46 112.4 22.22 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.836 -1.172 . . . . 74.42 107.836 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.14 29.43 14.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.695 1.198 . . . . 75.44 112.427 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.55 11.97 73.53 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.458 -0.401 . . . . 38.33 113.675 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -128.0 143.3 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.047 -0.723 . . . . 73.21 109.047 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.63 127.66 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.043 0.449 . . . . 71.43 111.457 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 19.4 tt -110.42 131.7 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.835 0.826 . . . . 74.01 111.133 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -123.54 139.18 54.27 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.877 -1.056 . . . . 72.13 109.643 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.8 t -122.29 137.43 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 121.058 0.456 . . . . 73.52 111.112 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -131.65 176.5 8.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.547 1.139 . . . . 72.41 110.164 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.45 -8.77 58.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.761 1.022 . . . . 75.43 113.761 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 124.612 1.165 . . . . 70.2 113.494 -178.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.21 -0.293 . . . . 70.53 110.21 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.68 103.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.495 -0.882 . . . . 72.3 109.452 162.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.3 m -143.58 143.96 31.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.455 -1.313 . . . . 74.13 107.455 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.13 139.15 50.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.144 0.884 . . . . 70.41 110.652 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.42 134.16 42.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.52 -0.918 . . . . 74.35 108.52 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.77 140.14 47.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 109.39 -0.596 . . . . 72.52 109.39 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.59 143.34 50.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 124.256 0.972 . . . . 72.42 109.231 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 89.59 22.66 36.1 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.836 -0.697 . . . . 53.54 113.366 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.91 70.83 1.02 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.344 -0.984 . . . . 74.34 108.344 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.37 -176.86 22.18 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.13 -1.033 . . . . 72.44 112.779 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 42.15 86.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.686 1.994 . . . . 71.32 114.867 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.71 22.46 26.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.333 -0.849 . . . . 61.32 111.528 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.0 150.92 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.23 110.094 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.4 m -84.55 169.47 14.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.691 -0.686 . . . . 75.03 110.939 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -167.81 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.323 1.849 . . . . 62.32 113.592 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -44.24 -13.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 126.949 2.1 . . . . 72.0 115.671 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.93 -23.42 0.45 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 126.72 2.008 . . . . 62.05 114.348 172.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.5 OUTLIER -56.92 -32.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 CA-C-N 118.735 0.698 . . . . 74.05 109.767 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.06 -33.82 86.97 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.825 -0.431 . . . . 63.44 113.445 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.41 -29.14 59.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.206 0.602 . . . . 64.41 111.055 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.4 t80 -56.41 -42.52 78.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.512 . . . . 72.13 110.708 168.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -77.58 -24.1 49.82 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.067 0.395 . . . . 75.41 112.067 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.19 -16.25 62.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.638 0.775 . . . . 53.42 111.675 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -64.61 -15.09 60.62 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 121.572 -0.705 . . . . 63.31 112.012 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 mm -119.14 20.41 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-O 121.592 0.711 . . . . 74.44 110.327 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.5 34.15 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 119.386 -2.071 . . . . 36.55 116.009 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 23.2 mt -107.31 138.13 34.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.167 -1.017 . . . . 74.5 110.204 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 48.7 mm -73.17 114.7 12.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.576 0.547 . . . . 72.13 110.001 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -98.88 143.92 28.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.142 -0.936 . . . . 74.22 110.311 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.51 131.59 34.63 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.55 -0.908 . . . . 74.01 108.55 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 122.04 27.56 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 108.974 -0.751 . . . . 50.33 108.974 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -67.14 -8.57 32.01 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.275 1.213 . . . . 61.01 114.275 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.02 -30.39 68.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 117.679 0.218 . . . . 74.24 111.053 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.6 t -126.75 -29.06 2.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.735 0.302 . . . . 74.34 111.376 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.73 7.49 68.71 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.104 -0.498 . . . . 73.44 112.387 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -98.91 149.13 35.46 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 122.81 0.444 . . . . 74.32 111.051 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.15 153.86 71.31 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.839 3.026 . . . . 73.42 112.76 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.433 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -69.28 97.51 0.95 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.758 1.021 . . . . 73.2 113.758 -175.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 mm -144.5 112.37 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.425 -1.324 . . . . 61.34 107.425 165.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.19 117.55 20.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.015 0.825 . . . . 71.41 109.836 162.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 112.03 22.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.802 -0.444 . . . . 64.42 109.802 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -101.87 112.92 25.71 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.8 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.3 p -141.56 122.02 14.09 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.497 -1.229 . . . . 64.25 109.993 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -86.22 111.83 20.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.405 1.097 . . . . 52.34 111.602 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -6.54 59.27 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.484 -0.78 . . . . 71.15 112.765 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.64 -28.1 65.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.136 -0.484 . . . . 64.25 111.186 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 46.6 p -90.63 -29.48 17.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.822 -0.436 . . . . 75.32 109.822 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.01 57.49 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.645 -0.707 . . . . 75.03 112.658 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -113.54 144.32 31.11 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.349 -0.612 . . . . 71.14 109.349 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.83 126.48 21.28 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.201 1.934 . . . . 74.45 113.507 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -57.28 -43.0 82.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.285 0.991 . . . . 75.31 110.757 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.77 19.43 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.024 -0.989 . . . . 55.43 112.706 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -116.78 148.44 41.16 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.599 -0.84 . . . . 65.02 109.929 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 160.35 43.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.14 111.669 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.21 137.11 42.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.905 -0.588 . . . . 73.21 109.878 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.411 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 27.4 m -134.09 143.33 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.663 -0.866 . . . . 63.3 108.663 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.433 ' H ' ' CB ' ' A' ' 270' ' ' MET . 1.1 p -101.06 121.35 41.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.238 0.615 . . . . 71.14 112.304 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.36 165.9 13.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.138 -0.483 . . . . 73.34 111.836 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.48 -49.31 69.56 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.029 0.831 . . . . 74.32 112.442 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.99 138.05 31.88 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 110.115 -0.328 . . . . 74.51 110.115 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -59.16 -38.02 88.68 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.686 2.924 . . . . 73.12 117.735 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 -30.29 32.59 Favored 'Trans proline' 0 C--N 1.386 2.509 0 CA-C-N 123.681 2.35 . . . . 74.24 112.992 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 19.7 m -62.88 -28.27 69.92 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.248 1.019 . . . . 72.33 112.21 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.85 -40.2 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.876 0.735 . . . . 42.13 112.434 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -71.16 -38.64 72.19 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.128 0.489 . . . . 75.02 111.08 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.66 81.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.446 -0.797 . . . . 74.52 111.041 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.76 -28.55 66.9 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.725 -0.67 . . . . 70.44 112.05 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 296' ' ' ALA . 45.7 mt -67.4 -32.83 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.996 -0.44 . . . . 75.44 110.647 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.87 -60.34 2.41 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.783 1.031 . . . . 61.43 113.783 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -91.09 -32.71 15.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.125 1.898 . . . . 75.32 116.125 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 41.1 t80 -84.37 -25.27 29.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.243 0.474 . . . . 72.2 110.237 -170.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -94.89 177.05 6.03 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.968 -1.015 . . . . 62.13 110.127 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.97 13.49 59.02 Favored Glycine 0 CA--C 1.509 -0.326 0 C-N-CA 121.22 -0.514 . . . . 62.14 112.223 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 -153.75 0.59 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 73.32 108.814 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -131.61 142.18 49.82 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.569 0.699 . . . . 64.14 111.357 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -113.74 117.36 31.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.604 -1.258 . . . . 72.12 107.604 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.15 27.78 14.05 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.756 1.222 . . . . 75.32 112.51 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.21 -3.85 86.53 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.848 0.299 . . . . 61.42 113.848 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -108.77 146.11 34.1 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.723 -0.843 . . . . 75.53 108.723 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.78 131.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.99 0.424 . . . . 73.02 110.904 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 15.0 tt -108.54 140.0 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.91 -0.774 . . . . 74.13 108.91 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.18 125.0 22.51 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.591 -0.522 . . . . 64.33 109.591 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.23 139.98 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 107.733 -1.21 . . . . 65.33 107.733 -170.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 m -140.57 171.62 13.86 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 121.716 -0.615 . . . . 73.31 110.936 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.01 -3.13 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.881 0.697 . . . . 73.22 112.881 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 124.766 1.227 . . . . 75.21 112.985 175.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.241 0.65 0 CA-C-O 120.74 0.305 . . . . 72.23 110.77 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.99 105.4 17.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.463 -0.495 . . . . 65.55 110.287 164.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.8 m -142.1 147.83 37.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.679 -1.23 . . . . 61.02 107.679 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.0 pt -125.46 138.45 54.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 119.279 0.945 . . . . 73.14 110.072 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.84 119.86 39.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.546 -0.539 . . . . 75.44 109.546 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.45 138.87 45.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.545 -0.752 . . . . 72.0 109.288 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -128.87 142.33 50.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.365 0.666 . . . . 75.31 109.226 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.51 8.49 Favored Glycine 0 C--N 1.332 0.358 0 O-C-N 123.331 0.394 . . . . 38.46 113.259 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 76.39 1.52 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.565 -0.902 . . . . 73.23 108.565 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.22 -77.13 0.06 OUTLIER Glycine 0 CA--C 1.499 -0.944 0 C-N-CA 120.237 -0.983 . . . . 60.45 112.999 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.54 109.18 11.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.638 0.732 . . . . 75.04 111.633 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.72 20.62 33.63 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.185 -0.916 . . . . 71.33 111.349 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.87 151.56 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.331 0.586 . . . . 72.43 109.901 -173.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.8 t -91.7 170.44 9.91 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 109.152 -0.684 . . . . 62.31 109.152 171.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 127.529 2.332 . . . . 74.24 113.829 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -44.86 -11.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 126.161 1.784 . . . . 73.52 115.513 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 252' ' ' GLU . 1.3 pp0? -46.79 -22.11 0.27 Allowed 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 126.72 2.008 . . . . 71.34 113.73 168.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -56.23 -30.66 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.384 -0.822 . . . . 73.03 109.33 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.26 91.7 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.964 -0.909 . . . . 38.46 114.718 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 249' ' ' GLN . 8.9 pt-20 -75.55 -27.65 58.72 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.367 1.084 . . . . 72.53 111.457 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.52 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.7 t80 -55.61 -45.06 77.56 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.046 0.841 . . . . 75.15 110.612 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -78.79 -23.77 45.02 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.12 0.415 . . . . 74.42 112.12 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -75.5 -11.22 59.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.45 0.7 . . . . 70.13 111.93 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.53 -16.16 63.4 Favored 'General case' 0 CA--C 1.555 1.137 0 O-C-N 121.883 -0.51 . . . . 62.41 111.827 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.06 -36.87 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.257 0.623 . . . . 54.31 111.133 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -148.04 -161.13 9.35 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 119.29 -1.433 . . . . 71.3 114.31 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.41 139.24 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 122.759 0.424 . . . . 74.34 110.959 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.0 mm -67.37 115.87 6.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.496 -0.774 . . . . 73.1 110.874 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -97.47 138.86 34.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.209 -0.905 . . . . 65.52 110.962 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -84.49 116.17 22.96 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.982 -1.118 . . . . 74.33 107.982 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.92 129.21 36.58 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 109.274 -0.639 . . . . 75.03 109.274 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -78.63 -7.1 57.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.417 0.895 . . . . 73.12 113.417 -173.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.54 -30.28 69.05 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.354 0.262 . . . . 71.23 111.439 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.5 t -125.94 -32.41 2.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.559 0.219 . . . . 74.34 111.579 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.76 11.23 64.02 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 112.232 -0.347 . . . . 53.23 112.232 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -98.52 151.29 37.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.438 0.695 . . . . 61.52 111.781 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.04 154.84 72.43 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.671 2.914 . . . . 38.46 112.459 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.417 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.4 ptm -73.56 100.81 3.4 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.713 1.005 . . . . 75.54 113.713 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.66 112.51 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.684 -1.599 . . . . 74.3 106.684 162.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -127.89 117.35 21.63 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.495 1.043 . . . . 61.44 110.363 162.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.43 113.2 24.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.087 0.47 . . . . 74.34 110.776 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 51.0 m-85 -101.96 110.72 22.76 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.596 -0.729 . . . . 73.33 109.285 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 37.8 p -143.11 122.04 12.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.64 -1.164 . . . . 65.12 109.676 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -86.45 112.44 21.5 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.399 0.619 . . . . 75.34 111.718 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -85.73 -10.56 55.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.664 0.616 . . . . 71.13 112.664 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.42 -33.96 67.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.031 0.382 . . . . 72.54 112.031 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 12.9 t -91.03 -16.21 28.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.43 0.633 . . . . 75.31 109.723 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.92 -48.87 1.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.585 -0.734 . . . . 52.52 112.607 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -74.34 138.52 74.95 Favored Pre-proline 0 N--CA 1.456 -0.172 0 N-CA-C 110.122 -0.325 . . . . 71.21 110.122 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.99 139.38 90.65 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.541 2.161 . . . . 64.55 113.238 171.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -59.4 -39.98 85.14 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.357 1.036 . . . . 75.14 111.874 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.91 24.78 12.41 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.612 -0.722 . . . . 62.1 112.969 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 2.1 mp0 -117.72 144.01 45.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.859 -0.736 . . . . 72.3 110.621 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -148.84 142.37 25.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 72.15 109.107 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 81.5 p -125.31 138.12 54.07 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.708 -0.478 . . . . 71.23 109.708 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.68 148.22 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.066 0.46 . . . . 75.13 110.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.417 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.9 t -101.23 127.6 47.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.856 0.862 . . . . 75.24 112.505 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 164.33 12.26 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.177 -0.327 . . . . 74.02 111.606 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.03 -46.82 49.75 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.66 0.6 . . . . 71.21 110.76 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -109.41 135.36 20.3 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 120.795 -0.362 . . . . 73.52 110.302 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.61 -39.51 20.93 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 C-N-CA 122.775 2.317 . . . . 61.53 116.887 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.49 -29.92 52.83 Favored 'Trans proline' 0 C--N 1.39 2.752 0 CA-C-N 123.459 2.271 . . . . 54.42 113.721 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 47.8 m -63.72 -27.34 69.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.829 0.852 . . . . 73.44 112.174 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -71.59 -34.19 69.68 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.602 0.564 . . . . 73.15 112.204 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -71.82 -39.13 70.02 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.959 0.409 . . . . 71.32 110.338 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.99 74.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.359 -0.837 . . . . 45.32 111.013 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.47 -29.31 66.94 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 116.14 -0.482 . . . . 70.4 112.129 174.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 296' ' ' ALA . 52.7 mt -67.33 -31.48 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 122.229 -0.294 . . . . 73.31 110.49 172.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -78.52 -61.4 2.02 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.958 1.096 . . . . 63.24 113.958 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -92.07 -29.63 16.46 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.296 1.961 . . . . 73.44 116.296 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -87.6 -21.56 25.27 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.469 0.652 . . . . 73.22 109.914 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -93.31 175.33 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.975 -1.011 . . . . 70.11 109.672 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.54 12.4 61.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.305 -0.474 . . . . 62.15 112.047 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -126.14 -158.13 0.83 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.267 -0.642 . . . . 62.34 109.267 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.76 143.97 50.62 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.573 0.701 . . . . 74.42 110.601 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.1 114.03 25.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.716 -1.129 . . . . 74.31 108.155 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.0 m170 64.66 29.12 13.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.597 1.186 . . . . 65.14 112.611 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 10.11 80.61 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 113.923 0.329 . . . . 74.43 113.923 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.58 146.01 50.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.699 -0.852 . . . . 73.1 108.699 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.33 127.99 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.271 0.557 . . . . 74.3 111.02 -170.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.7 137.11 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.324 -0.853 . . . . 73.13 109.374 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.24 128.38 41.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.61 -0.723 . . . . 65.14 110.228 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.57 142.05 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 -174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -142.1 175.23 9.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.331 0.652 . . . . 70.23 110.492 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.33 -4.34 58.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.048 1.129 . . . . 70.03 114.048 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 123.944 0.898 . . . . 64.11 112.865 -179.8 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--O 1.24 0.575 0 N-CA-C 110.149 -0.315 . . . . 61.22 110.149 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.14 106.61 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 73.23 109.98 165.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 16.0 m -141.79 148.06 38.31 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.902 -1.148 . . . . 63.33 107.902 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.66 137.23 56.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 118.891 0.769 . . . . 52.15 110.051 164.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.46 119.0 37.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.243 -0.651 . . . . 75.23 109.243 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.63 141.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.496 -0.775 . . . . 64.24 109.44 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.01 149.17 50.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.831 -0.622 . . . . 72.44 110.461 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 94.74 18.47 34.87 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 123.63 0.581 . . . . 70.41 113.362 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.78 76.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.02 -91.76 0.53 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.333 -0.937 . . . . 73.15 113.873 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.05 114.42 16.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.024 0.44 . . . . 75.03 110.943 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.55 19.86 33.73 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.263 -0.88 . . . . 74.22 111.89 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -83.58 151.47 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.351 -0.611 . . . . 55.23 109.351 -173.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.3 m -90.35 170.36 10.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.162 -0.472 . . . . 74.11 109.944 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -167.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.108 2.163 . . . . 73.23 113.198 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.26 -13.66 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 127.44 2.296 . . . . 62.21 115.018 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 252' ' ' GLU . 0.7 OUTLIER -47.7 -21.3 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.751 2.021 . . . . 62.21 114.136 169.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.34 -31.25 26.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.975 0 CA-C-N 119.207 0.912 . . . . 65.23 109.363 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -56.74 -37.85 79.48 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.003 -0.887 . . . . 64.41 114.419 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 249' ' ' GLN . 0.0 OUTLIER -74.91 -28.6 60.69 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.046 0.923 . . . . 70.41 110.468 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.1 t80 -56.44 -45.7 80.67 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 123.805 0.69 . . . . 74.2 110.833 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.63 -24.5 45.24 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.228 0.455 . . . . 74.21 112.228 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -63.1 -24.97 68.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.186 0.994 . . . . 63.0 111.744 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.6 pt20 -62.95 -22.09 66.55 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.403 0.52 . . . . 72.33 112.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.6 mm -125.1 55.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 117.979 0.354 . . . . 73.34 110.114 171.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.41 -176.43 27.23 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 119.143 -1.503 . . . . 72.23 114.573 170.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.32 137.96 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.531 -0.334 . . . . 75.34 110.156 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.0 mm -73.77 114.24 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.723 -0.671 . . . . 71.31 110.121 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -98.59 140.24 33.12 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.67 0.748 . . . . 75.13 110.886 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.0 m -84.43 121.15 27.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.502 -1.226 . . . . 72.02 108.415 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.73 134.73 50.22 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.528 0.518 . . . . 61.1 111.246 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -81.98 -7.54 59.62 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.875 1.065 . . . . 75.34 113.875 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -68.38 -42.9 78.43 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.238 0.336 . . . . 64.31 111.485 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 24.6 p -124.4 -25.62 4.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.758 0.313 . . . . 75.13 111.337 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.26 16.46 57.37 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.905 -0.588 . . . . 38.2 113.601 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 152.13 38.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.794 0.297 . . . . 71.24 111.715 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.92 152.66 81.49 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.579 2.186 . . . . 71.51 111.361 165.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.428 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.1 ptm -72.82 99.48 2.65 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.808 1.04 . . . . 71.54 113.808 -174.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.4 mm -143.72 114.07 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.781 -1.563 . . . . 73.51 106.781 165.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -129.02 113.63 15.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.901 0.773 . . . . 73.43 109.425 162.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.08 111.34 21.45 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.828 0.347 . . . . 74.44 110.081 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.8 m-85 -103.81 111.83 24.52 Favored 'General case' 0 C--O 1.263 1.767 0 CA-C-O 121.308 0.575 . . . . 75.53 110.555 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.422 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.2 p -143.26 121.97 12.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.196 -1.365 . . . . 74.14 110.165 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.52 113.97 22.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.649 0.738 . . . . 74.22 112.24 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.54 -9.78 56.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.021 0.749 . . . . 71.01 113.021 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.94 -33.94 66.23 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.963 0.411 . . . . 72.1 110.904 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -90.56 -14.99 31.44 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.443 0.64 . . . . 63.35 110.114 170.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 89.67 -12.19 67.87 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.704 -0.68 . . . . 53.12 113.907 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.11 142.02 27.9 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.618 -0.512 . . . . 63.51 109.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.18 133.01 55.7 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.108 2.539 . . . . 75.21 113.796 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.422 ' H ' ' HA ' ' A' ' 275' ' ' THR . 22.5 mttt -62.3 -33.93 75.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.493 -1.231 . . . . 73.1 112.116 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.38 23.78 20.79 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.495 -0.775 . . . . 65.33 112.782 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.9 mt-10 -119.75 141.86 49.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.072 -0.651 . . . . 53.23 109.822 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.94 143.46 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 72.15 109.665 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 70.8 p -128.6 140.35 51.82 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.924 -0.399 . . . . 73.45 109.924 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.18 146.7 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.208 0.527 . . . . 60.31 109.993 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 270' ' ' MET . 25.6 t -98.95 119.96 38.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.566 0.747 . . . . 73.11 111.83 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.52 165.1 12.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.23 0.456 . . . . 74.55 112.23 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.34 -47.93 45.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 124.481 1.113 . . . . 71.13 111.988 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -124.12 137.23 28.64 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 109.558 -0.534 . . . . 75.31 109.558 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.43 -38.06 86.04 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 C-N-CA 123.58 2.853 . . . . 72.23 116.977 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.73 -29.27 29.57 Favored 'Trans proline' 0 C--N 1.397 3.082 0 CA-C-N 123.419 2.257 . . . . 71.2 113.373 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.7 m -65.84 -27.81 68.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.013 0.925 . . . . 72.52 112.208 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -74.89 -44.02 51.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.167 0.587 . . . . 51.4 112.086 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -74.77 -31.3 61.73 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.257 0.551 . . . . 75.33 111.916 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.14 73.52 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.635 -0.711 . . . . 71.45 110.601 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -67.56 -28.3 67.67 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.58 -0.736 . . . . 63.35 111.497 172.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 296' ' ' ALA . 43.7 mt -67.41 -32.34 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 122.171 -0.331 . . . . 72.32 111.08 172.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.24 -60.07 2.52 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.72 1.007 . . . . 73.11 113.72 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -35.52 15.32 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.032 1.864 . . . . 74.32 116.032 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.158 0.504 . . . . 71.33 110.325 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.3 -178.29 3.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.266 -0.879 . . . . 71.12 109.601 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.16 64.31 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.943 0.19 . . . . 38.2 112.717 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.29 -158.64 0.9 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.286 -0.457 . . . . 73.13 109.997 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.87 145.78 50.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.658 0.742 . . . . 50.34 111.257 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -115.86 116.07 27.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.35 -1.295 . . . . 74.02 107.828 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 23.3 m170 64.29 28.89 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.657 1.183 . . . . 74.54 112.631 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.66 7.0 84.97 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 114.126 0.41 . . . . 63.14 114.126 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.23 147.93 48.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.803 -0.814 . . . . 51.31 108.803 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.86 130.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.083 0.468 . . . . 75.51 111.269 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.4 tt -109.14 142.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.009 -0.996 . . . . 73.54 109.502 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -136.28 128.01 29.05 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.715 -0.675 . . . . 63.45 110.718 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.11 141.87 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 N-CA-C 108.478 -0.934 . . . . 70.44 108.478 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.1 m -144.52 174.25 11.11 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 121.633 -0.667 . . . . 73.12 110.623 -173.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.2 -3.35 54.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.636 0.976 . . . . 75.01 113.636 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 124.552 1.141 . . . . 70.42 112.991 176.792 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 110.113 -0.328 . . . . 72.43 110.113 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 104.99 17.49 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.121 -0.632 . . . . 74.31 109.564 165.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.1 m -142.39 148.84 38.51 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.413 -0.958 . . . . 73.43 108.413 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.11 137.8 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.675 0.671 . . . . 54.34 111.061 164.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.43 130.55 45.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.018 -0.734 . . . . 71.03 109.018 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 141.01 44.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.356 -0.838 . . . . 63.12 109.41 -173.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.65 150.62 50.16 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.36 -179.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.58 14.17 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 124.067 0.854 . . . . 72.1 112.857 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.03 74.88 1.32 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.903 -1.147 . . . . 64.1 107.903 175.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -136.05 -77.24 0.08 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.249 -0.976 . . . . 73.53 112.957 -175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -78.26 102.86 7.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.964 0.888 . . . . 75.24 111.919 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.53 20.67 24.11 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.109 -0.951 . . . . 71.11 112.064 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -79.16 152.5 4.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.549 0.69 . . . . 64.43 110.492 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t -91.71 168.57 11.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.297 -0.865 . . . . 73.23 109.715 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.6 t -63.52 -168.26 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.274 2.23 . . . . 73.3 113.497 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -43.94 -12.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 126.625 1.97 . . . . 61.13 115.645 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.96 -22.35 0.32 Allowed 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 126.361 1.864 . . . . 63.11 114.319 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -55.91 -32.61 33.15 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 CA-C-N 118.899 0.772 . . . . 72.2 111.001 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.17 84.19 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.646 -0.312 . . . . 73.35 113.416 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -74.6 -30.43 61.68 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.675 0.79 . . . . 70.44 111.289 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.5 t80 -56.05 -45.19 79.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 70.23 111.232 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.52 -23.71 50.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.823 0.305 . . . . 74.5 111.823 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.98 -14.32 61.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.477 0.711 . . . . 70.43 112.382 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.2 -11.81 44.67 Favored 'General case' 0 CA--C 1.557 1.223 0 O-C-N 121.666 -0.646 . . . . 75.4 112.14 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mm -106.56 -42.18 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.972 0.509 . . . . 64.03 111.102 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.61 -158.97 7.78 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 120.898 -0.668 . . . . 65.21 113.942 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 14.5 mt -104.93 139.88 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.138 0.575 . . . . 62.3 110.589 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.6 mm -65.98 113.29 2.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 109.523 -0.547 . . . . 64.12 109.523 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.04 141.64 32.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.338 -0.847 . . . . 74.24 110.767 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 11.0 m -85.07 117.71 24.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.85 -1.068 . . . . 61.31 108.511 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.61 130.29 39.28 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.152 -0.684 . . . . 73.22 109.152 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -73.36 -9.15 58.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.674 0.99 . . . . 73.02 113.674 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -69.67 -34.35 73.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 111.997 0.369 . . . . 60.43 111.997 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.5 t -125.68 -30.24 3.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.478 0.311 . . . . 73.43 111.519 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.19 9.08 67.82 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.543 -0.298 . . . . 64.51 112.612 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -98.14 152.08 37.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.026 0.53 . . . . 71.42 112.196 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.09 156.24 63.88 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.892 3.061 . . . . 70.44 112.562 169.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.41 ' SD ' ' HB ' ' A' ' 288' ' ' VAL . 0.0 OUTLIER -72.04 98.52 2.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.841 1.052 . . . . 75.42 113.841 -172.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -143.43 112.38 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.266 -1.383 . . . . 63.43 107.266 164.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -128.71 113.74 15.73 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.957 0.798 . . . . 62.11 109.367 160.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -114.52 107.89 16.12 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.721 -0.844 . . . . 53.54 108.721 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -103.81 112.72 25.8 Favored 'General case' 0 C--O 1.26 1.634 0 CA-C-O 121.211 0.529 . . . . 73.21 110.935 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.6 p -144.42 122.92 12.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.468 -1.242 . . . . 63.41 110.308 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.99 113.39 22.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.427 0.632 . . . . 63.41 112.118 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 -8.95 57.48 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.517 -0.765 . . . . 73.22 112.715 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -35.4 71.33 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.753 0.279 . . . . 74.41 111.753 175.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.0 t -90.97 -14.26 31.83 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.204 0.526 . . . . 75.01 110.136 171.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.2 -46.32 1.7 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.579 -0.737 . . . . 60.41 113.043 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -86.19 142.84 36.2 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 110.547 -0.168 . . . . 72.35 110.547 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 139.13 83.2 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.563 2.842 . . . . 64.44 114.459 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -67.22 -34.21 76.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.179 -0.919 . . . . 61.52 112.146 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.76 27.75 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.093 -0.575 . . . . 62.43 112.772 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.92 143.12 45.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.812 -0.355 . . . . 75.4 110.429 -171.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.47 154.74 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.233 -0.44 . . . . 71.53 110.78 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.2 137.39 37.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.782 -0.451 . . . . 74.31 109.782 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.41 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 32.8 m -136.35 144.75 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.361 -0.607 . . . . 74.04 109.361 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.404 ' H ' ' CB ' ' A' ' 270' ' ' MET . 26.7 t -93.35 121.69 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.61 0.764 . . . . 72.34 111.789 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -94.15 164.14 13.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.664 -0.244 . . . . 74.42 111.596 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.5 -48.78 73.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.926 0.891 . . . . 65.51 112.852 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -127.11 137.89 31.56 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 109.512 -0.551 . . . . 73.51 109.512 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.27 -38.41 75.81 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 123.078 2.519 . . . . 71.22 117.137 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.18 -28.92 15.03 Favored 'Trans proline' 0 C--N 1.391 2.799 0 CA-C-N 124.139 2.514 . . . . 72.44 113.054 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 37.9 m -61.45 -28.31 69.19 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.381 1.072 . . . . 71.03 112.027 174.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.21 -37.13 77.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.644 0.778 . . . . 54.54 112.777 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.8 -35.14 62.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 120.981 0.419 . . . . 74.54 111.288 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.563 -0.744 . . . . 74.52 111.035 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.66 -28.12 65.61 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.809 -0.632 . . . . 71.3 112.08 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 296' ' ' ALA . 42.3 mt -67.84 -31.86 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 122.026 -0.421 . . . . 75.3 110.811 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.43 -59.76 2.63 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.863 1.061 . . . . 74.45 113.863 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -91.27 -34.97 14.74 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.48 2.03 . . . . 63.11 116.48 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.44 -25.28 31.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.177 0.513 . . . . 73.11 110.188 -169.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -93.46 176.38 6.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.801 -1.09 . . . . 71.44 109.95 173.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.53 12.95 57.74 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.275 -0.488 . . . . 61.25 112.31 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -128.99 -154.58 0.65 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.854 -0.424 . . . . 73.41 109.854 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.72 139.84 49.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.268 0.556 . . . . 75.41 110.868 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.52 112.74 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.716 -1.216 . . . . 70.43 107.716 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.9 m170 64.66 28.4 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.947 1.299 . . . . 75.04 112.205 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.98 88.19 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 121.629 -0.32 . . . . 43.04 113.428 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.03 143.29 33.41 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.28 -1.007 . . . . 60.33 108.28 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.82 126.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.655 0.264 . . . . 53.34 110.501 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.1 tt -107.9 140.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.976 -0.556 . . . . 60.45 109.636 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.89 126.23 28.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.863 -0.608 . . . . 75.1 109.654 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.52 138.69 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.76 -1.2 . . . . 71.14 107.76 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.0 m -144.56 171.7 14.0 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 123.0 0.52 . . . . 72.41 110.192 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.48 -4.49 42.89 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.229 1.196 . . . . 73.55 114.229 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 124.403 1.081 . . . . 64.14 113.097 177.272 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 C--O 1.236 0.363 0 CA-C-O 120.733 0.301 . . . . 61.14 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.33 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.424 0.631 . . . . 70.44 110.509 167.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.6 m -143.17 150.06 38.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.861 -1.162 . . . . 63.31 107.861 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.58 140.71 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.023 0.828 . . . . 62.31 111.223 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.67 136.18 41.95 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.791 -0.64 . . . . 65.55 109.433 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.36 142.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 122.028 0.918 . . . . 70.31 112.401 177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -127.25 141.34 51.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.594 -1.639 . . . . 62.14 108.151 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.68 29.25 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.044 -0.598 . . . . 63.1 112.193 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -107.72 71.72 0.83 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.632 -0.877 . . . . 74.34 108.632 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.46 -79.91 0.07 OUTLIER Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 119.89 -1.148 . . . . 73.23 113.741 -174.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.99 106.76 7.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.106 0.955 . . . . 74.01 111.756 -171.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.7 20.02 32.86 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.83 -1.077 . . . . 72.43 111.58 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.38 151.34 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.13 0.491 . . . . 72.41 109.825 -171.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.7 m -92.01 170.85 9.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 72.12 110.072 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.814 2.046 . . . . 74.44 114.042 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -42.44 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 127.181 2.193 . . . . 74.35 115.854 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -21.92 0.41 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.56 1.944 . . . . 75.34 114.408 169.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.3 t -56.36 -32.03 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.114 0.87 . . . . 40.2 110.762 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.4 -31.56 81.26 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.878 -0.401 . . . . 71.44 113.559 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -75.51 -30.7 59.91 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.34 0.591 . . . . 73.11 110.251 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.5 t80 -59.21 -42.91 92.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.412 -0.813 . . . . 65.01 110.72 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.4 ' HD1' ' O ' ' A' ' 250' ' ' VAL . 78.8 m-85 -78.17 -24.04 47.41 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.894 0.378 . . . . 74.14 112.015 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 22.7 tptm -66.83 -21.88 66.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.475 1.11 . . . . 72.12 112.197 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.42 -20.54 65.64 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 112.119 0.414 . . . . 63.13 112.119 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.91 54.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 117.871 0.305 . . . . 72.34 110.191 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . 147.04 -168.72 28.19 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.178 -1.487 . . . . 37.38 115.011 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.55 138.42 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.407 0.683 . . . . 74.43 110.994 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.428 HG12 ' HD3' ' A' ' 255' ' ' LYS . 6.7 mm -74.12 116.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.306 0.379 . . . . 74.15 110.17 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -98.93 142.92 29.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.401 0.619 . . . . 53.53 111.11 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 12.7 m -84.62 115.66 22.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 166.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.76 136.07 48.63 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.789 0.292 . . . . 65.22 111.789 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -11.05 59.98 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.739 0.644 . . . . 64.2 112.739 -174.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -74.11 -26.94 60.63 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.452 0.168 . . . . 73.03 111.236 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.8 t -125.32 -31.54 3.03 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.096 0.406 . . . . 62.05 112.096 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.8 83.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 116.308 -0.405 . . . . 53.31 112.934 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -96.24 148.41 34.45 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.442 0.697 . . . . 73.22 111.325 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.0 153.58 74.79 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.787 2.325 . . . . 55.23 111.022 165.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.429 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.6 OUTLIER -76.32 101.24 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.263 0.838 . . . . 73.41 113.263 -170.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.2 mm -142.55 112.82 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.024 -1.473 . . . . 71.11 107.024 162.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -129.07 113.34 15.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.333 -0.617 . . . . 71.24 109.333 162.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.42 110.5 19.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.032 -0.729 . . . . 62.11 109.032 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -103.44 111.83 24.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.095 0.474 . . . . 72.12 110.897 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.1 p -145.39 120.81 10.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.56 -1.2 . . . . 74.42 109.815 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -87.76 113.87 23.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.411 1.1 . . . . 75.23 112.595 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -4.05 58.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.119 -0.946 . . . . 63.15 112.574 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.64 79.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 64.42 110.836 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -92.69 -21.43 20.0 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.691 -0.686 . . . . 73.43 109.801 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 103.67 -45.29 1.34 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.905 -0.588 . . . . 74.13 112.673 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -79.75 143.98 59.42 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 121.224 -0.19 . . . . 72.34 110.628 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -57.12 140.51 92.92 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.959 2.439 . . . . 74.23 114.378 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.52 -37.24 82.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.877 -1.056 . . . . 74.41 111.571 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.11 17.18 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.872 -0.604 . . . . 64.43 113.891 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.44 146.18 47.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.449 -0.5 . . . . 73.34 111.478 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.48 152.67 33.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.81 -0.632 . . . . 55.32 110.632 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.75 135.17 50.72 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.101 166.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.96 146.81 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' SER . . . . . 0.429 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.7 m -113.58 133.82 55.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.502 0.556 . . . . 65.14 112.502 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.71 165.23 11.49 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.661 0.615 . . . . 75.21 112.661 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.89 -47.95 60.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.339 -0.846 . . . . 64.23 111.949 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -117.79 135.78 23.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.351 -0.611 . . . . 71.23 109.351 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.13 -38.84 53.25 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 123.274 2.649 . . . . 71.43 117.238 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.19 -28.39 15.6 Favored 'Trans proline' 0 C--N 1.393 2.874 0 CA-C-N 123.426 2.259 . . . . 51.42 112.544 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.4 m -61.92 -27.44 68.82 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.301 1.04 . . . . 71.52 111.946 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ALA . . . . . 0.451 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.26 -39.58 78.36 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.307 0.38 . . . . 71.45 111.712 175.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -41.07 87.74 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.744 0.307 . . . . 73.12 110.387 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.82 76.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.722 -0.672 . . . . 54.51 111.395 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.64 -31.18 71.7 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 122.806 0.443 . . . . 60.22 111.725 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.2 mt -68.86 -31.11 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 O-C-N 122.197 -0.315 . . . . 74.43 110.86 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.11 -59.74 2.65 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.385 0.883 . . . . 72.01 113.385 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . 0.253 1.7 p-90 -91.69 -34.26 14.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.534 2.049 . . . . 73.32 116.534 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -84.82 -22.48 29.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.376 0.607 . . . . 61.44 110.193 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.31 -176.02 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.009 -0.996 . . . . 61.41 109.435 171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 84.53 9.83 80.76 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 114.123 0.409 . . . . 64.52 114.123 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 -160.97 1.04 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.151 -0.685 . . . . 63.32 109.151 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.21 146.14 49.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.694 0.759 . . . . 74.34 111.401 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.88 114.28 26.72 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.749 -1.204 . . . . 73.31 107.749 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.7 m170 62.54 28.37 16.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.672 1.189 . . . . 62.54 111.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 88.89 -2.34 84.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.462 -0.399 . . . . 70.41 114.092 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -110.5 142.58 42.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.399 0.599 . . . . 55.54 109.597 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.82 126.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.177 0.513 . . . . 70.15 110.944 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 10.6 tt -108.78 139.42 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.65 -0.704 . . . . 74.13 109.963 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -136.4 123.79 22.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.55 111.075 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.29 138.85 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 CA-C-N 115.022 -0.99 . . . . 75.32 110.226 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 115.767 -0.652 . . . . 73.34 109.866 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -79.14 -3.63 46.49 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 114.618 1.34 . . . . 73.51 114.618 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 124.402 1.081 . . . . 72.22 112.535 179.218 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.055 0 N-CA-C 111.358 -0.697 . . . . 37.83 111.358 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.8 t 68.4 -171.7 0.18 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.959 1.304 . . . . 55.24 112.111 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -90.89 118.88 30.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.95 0.5 . . . . 63.1 111.001 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 67.5 mtt -123.29 88.59 2.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.685 0.278 . . . . 63.32 110.542 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m 69.6 177.56 0.26 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.292 1.437 . . . . 75.23 113.186 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -100.38 7.42 44.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.374 -0.83 . . . . 62.03 110.474 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -84.96 110.61 19.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.59 -0.732 . . . . 53.44 110.706 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 103.38 15.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.192 -0.603 . . . . 65.45 110.569 167.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.3 m -143.73 143.55 31.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.535 -0.913 . . . . 72.21 108.535 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.94 142.24 36.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 119.262 0.937 . . . . 70.05 109.915 163.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -100.09 130.51 46.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.23 -1.026 . . . . 71.33 108.23 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.48 141.56 43.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.565 -0.532 . . . . 73.04 109.565 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.33 150.63 48.4 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 63.42 110.423 -176.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.07 14.01 59.72 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 124.383 1.052 . . . . 63.21 112.782 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 6.5 mt -103.48 74.56 1.27 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.984 -1.117 . . . . 74.25 107.984 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.91 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.513 -0.851 . . . . 73.3 113.55 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.21 112.4 12.64 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.432 0.634 . . . . 64.53 111.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.14 21.02 51.27 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.308 -0.86 . . . . 63.42 111.686 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.59 151.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.393 -0.595 . . . . 74.32 109.393 -172.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.8 t -91.81 170.78 9.61 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.05 -0.722 . . . . 71.35 109.05 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -167.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.535 2.334 . . . . 74.24 114.039 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -44.29 -12.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 126.24 1.816 . . . . 50.21 115.26 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -46.0 -22.58 0.22 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.605 1.962 . . . . 72.44 113.471 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.3 -32.49 35.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 CA-C-N 118.914 0.779 . . . . 75.11 109.912 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.58 -32.58 83.78 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.281 -0.262 . . . . 73.35 113.197 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.12 -32.63 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.418 0.687 . . . . 73.54 110.481 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 7.5 t80 -56.76 -44.38 81.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.433 1.093 . . . . 74.11 110.806 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.24 -24.29 47.0 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 111.956 0.354 . . . . 74.41 111.956 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -66.87 -21.34 66.01 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.936 0.895 . . . . 72.44 111.46 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.55 -25.0 68.04 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 122.195 -0.316 . . . . 74.13 111.365 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.4 mm -124.59 70.86 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.024 -0.732 . . . . 43.15 109.024 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.36 -176.0 24.61 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 119.096 -1.526 . . . . 53.35 114.575 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.01 139.58 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.347 0.659 . . . . 74.1 109.727 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.68 116.53 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.119 0.485 . . . . 74.53 110.262 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 290' ' ' PHE . 22.8 tttm -95.73 137.49 34.71 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.543 0.687 . . . . 72.4 111.048 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 26.7 m -85.2 117.85 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.666 -1.152 . . . . 65.22 108.471 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -75.24 137.98 41.59 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.147 -0.479 . . . . 71.02 110.554 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -80.01 -10.15 59.75 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.393 0.886 . . . . 73.22 113.393 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.85 -41.16 78.85 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.364 0.505 . . . . 62.4 112.364 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.6 t -125.36 -18.86 5.21 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.739 0.304 . . . . 64.23 111.089 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.67 57.11 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 116.292 -0.413 . . . . 61.44 113.165 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -98.13 153.3 38.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.016 0.376 . . . . 71.22 112.016 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.16 155.84 68.9 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.646 2.898 . . . . 65.35 112.353 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.444 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.55 98.11 2.25 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.175 0.988 . . . . 61.25 113.353 -174.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.2 mm -144.15 112.58 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.034 -1.469 . . . . 75.15 107.034 163.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.422 ' HB2' ' HG1' ' A' ' 287' ' ' THR . 39.6 m-80 -129.07 116.33 19.12 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.425 1.011 . . . . 64.24 109.865 162.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 111.25 21.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.51 110.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -102.6 112.0 24.55 Favored 'General case' 0 C--O 1.26 1.625 0 CA-C-O 121.241 0.543 . . . . 72.11 110.025 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.1 p -143.46 120.43 11.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.317 -1.311 . . . . 75.45 109.807 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -87.9 113.14 23.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.804 1.288 . . . . 73.52 111.884 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -7.61 59.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.633 -1.167 . . . . 73.4 111.639 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.81 -29.51 66.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.246 0.618 . . . . 75.5 111.371 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -91.11 -29.41 17.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.412 -0.588 . . . . 74.05 109.412 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 107.18 -19.3 34.96 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.316 -0.856 . . . . 52.11 112.633 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -113.17 141.64 26.03 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.292 -0.262 . . . . 73.43 110.292 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.35 140.35 94.1 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 123.316 2.678 . . . . 71.04 114.958 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -64.18 -36.52 84.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.706 -1.134 . . . . 64.32 112.247 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.87 20.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.519 -0.764 . . . . 63.11 112.421 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -119.62 141.03 49.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 119.724 -0.79 . . . . 71.32 109.81 -174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.74 144.69 23.7 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.908 -0.587 . . . . 37.83 109.887 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.422 ' HG1' ' HB2' ' A' ' 272' ' ' ASN . 76.3 p -127.7 140.22 52.21 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 122.017 -0.427 . . . . 72.32 109.964 173.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.412 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 19.6 m -134.58 146.78 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.006 0.432 . . . . 72.22 110.428 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.444 ' H ' ' CB ' ' A' ' 270' ' ' MET . 27.6 t -98.61 113.98 26.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.725 0.81 . . . . 63.42 112.49 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.406 ' O ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 m-85 -88.08 162.77 16.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.592 0.219 . . . . 74.32 111.592 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.47 -47.62 19.19 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.434 0.459 . . . . 70.41 111.199 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.76 135.44 22.19 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 120.967 -0.293 . . . . 62.32 110.277 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.67 -40.45 22.72 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.213 1.942 . . . . 65.1 116.376 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.66 -30.02 51.31 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 123.082 2.136 . . . . 74.32 113.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 67.9 m -63.82 -27.36 69.12 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.44 0.696 . . . . 62.14 112.709 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.97 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.24 0.616 . . . . 75.2 111.838 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.84 -40.76 88.06 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.079 0.552 . . . . 63.32 111.159 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.05 -32.94 74.71 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.438 -0.801 . . . . 62.24 111.583 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -70.59 -29.56 66.01 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.54 -33.81 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 110.384 -0.228 . . . . 74.44 110.384 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.21 -59.41 2.79 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 114.264 1.209 . . . . 70.31 114.264 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -91.37 -34.07 15.02 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.117 1.895 . . . . 74.24 116.117 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 67.7 t80 -86.74 -14.99 40.79 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.339 0.59 . . . . 74.31 110.558 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.38 175.77 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.81 14.49 46.27 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.903 -0.665 . . . . 71.03 112.809 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -133.72 -154.04 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.097 -0.705 . . . . 75.02 109.097 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 149.91 52.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.85 0.833 . . . . 75.12 111.264 174.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -113.49 114.81 27.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.61 -1.177 . . . . 74.43 108.211 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.9 m170 64.52 28.35 13.4 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.606 1.163 . . . . 75.45 112.5 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.35 -2.75 86.68 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 119.891 -0.394 . . . . 61.3 113.905 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.69 141.93 47.17 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.927 -0.768 . . . . 64.13 108.927 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.14 131.23 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.127 0.489 . . . . 73.3 111.481 -169.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.86 142.68 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.597 -0.729 . . . . 73.24 109.569 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -137.11 129.1 29.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 75.0 111.359 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.66 134.64 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.811 -0.631 . . . . 64.21 110.188 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -136.12 173.49 11.65 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.149 0.98 . . . . 75.13 109.816 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.9 0.56 43.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.409 0.892 . . . . 74.24 113.409 175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.08 -158.3 0.32 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.359 1.064 . . . . 54.04 112.88 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 4.9 m -103.89 145.55 29.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.792 -0.447 . . . . 63.4 109.792 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -92.16 173.56 7.76 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.244 -0.28 . . . . 60.23 110.244 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 65.29 86.89 0.13 Allowed Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.462 1.105 . . . . 73.43 112.045 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.83 111.83 3.42 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.241 1.961 . . . . 71.21 112.845 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.227 -0.892 . . . . 72.23 110.375 -178.358 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 111.418 -0.673 . . . . 72.15 111.418 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 37.2 m 63.72 29.32 14.93 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.457 1.28 . . . . 61.32 114.457 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 60.32 81.68 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.611 1.164 . . . . 75.43 111.714 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 13.0 mmt -109.0 -3.83 17.15 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.549 -0.75 . . . . 75.0 112.358 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -140.76 140.58 34.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.926 0.393 . . . . 71.41 111.62 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 -11.77 46.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.365 -0.834 . . . . 73.25 109.953 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.77 110.2 14.91 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.556 -0.747 . . . . 52.03 110.164 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.39 105.53 17.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.272 0.558 . . . . 64.05 110.407 165.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 14.0 m -142.29 145.21 33.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.047 -1.094 . . . . 55.25 108.047 165.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -122.16 144.42 31.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 118.937 0.79 . . . . 73.41 109.117 166.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 136.62 43.26 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.279 -0.638 . . . . 75.24 109.279 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -127.02 143.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.58 0.705 . . . . 62.34 112.515 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.56 147.36 49.88 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.102 -1.408 . . . . 62.21 110.387 -176.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.4 21.93 30.76 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.524 0.515 . . . . 62.24 113.373 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.407 HD13 ' HB ' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -114.96 75.48 0.94 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.566 -1.272 . . . . 74.21 107.566 176.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -131.32 -86.87 0.39 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.513 -0.851 . . . . 73.12 113.495 -170.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.31 113.21 12.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.179 0.514 . . . . 73.31 111.549 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.26 40.08 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.219 -0.9 . . . . 55.32 111.707 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.82 151.67 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.508 -0.552 . . . . 73.31 109.508 -174.281 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.2 m -89.34 169.97 10.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.213 -0.903 . . . . 70.11 110.09 173.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.594 1.957 . . . . 64.23 113.868 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -42.64 -14.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 C-N-CA 126.36 1.864 . . . . 75.51 114.728 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.94 -20.78 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.748 2.019 . . . . 74.24 114.229 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.46 -31.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.81 0.732 . . . . 64.43 110.25 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.89 -35.82 91.02 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.548 -0.585 . . . . 61.22 113.964 172.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.99 -35.46 80.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.943 0.897 . . . . 74.03 111.757 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.479 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.0 t80 -57.24 -44.35 83.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.005 0.922 . . . . 71.52 111.125 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.85 -24.34 44.41 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 111.821 0.304 . . . . 75.52 111.821 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -63.93 -23.4 67.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.095 0.958 . . . . 73.13 111.905 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.79 -24.39 67.71 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 121.037 -0.265 . . . . 63.23 111.521 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 257' ' ' ILE . 6.1 mm -126.29 67.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 109.086 -0.709 . . . . 75.53 109.086 169.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.77 -177.01 24.44 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 119.38 -1.39 . . . . 74.55 114.574 171.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.02 138.44 31.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.112 0.565 . . . . 54.24 109.669 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.8 mm -66.86 115.98 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.662 0.601 . . . . 62.11 110.066 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -95.97 139.2 32.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.241 -0.89 . . . . 72.4 111.135 -176.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 29.4 m -86.92 117.57 25.74 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.101 -1.074 . . . . 71.23 108.101 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.68 132.02 36.86 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.854 -0.425 . . . . 75.24 109.854 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -10.11 59.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.098 1.147 . . . . 75.2 114.098 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.09 -31.22 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 111.772 0.286 . . . . 71.44 111.772 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.2 t -124.66 -31.7 3.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.772 0.32 . . . . 75.14 111.267 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.01 6.65 69.12 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.176 -0.466 . . . . 37.74 112.506 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -98.18 152.0 37.79 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.295 0.638 . . . . 75.54 112.217 174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.01 154.42 74.09 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.662 2.908 . . . . 73.4 112.306 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.459 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.9 ptm -71.0 99.53 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.894 1.072 . . . . 64.42 113.894 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.6 mm -144.4 114.21 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.565 -1.272 . . . . 62.41 107.565 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -129.54 116.45 18.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.997 0.817 . . . . 74.02 110.41 161.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 111.32 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.836 -0.431 . . . . 74.43 109.836 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -103.16 112.52 25.41 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-O 121.159 0.504 . . . . 73.0 110.861 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.412 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.1 p -141.99 122.99 14.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.524 -1.216 . . . . 65.45 110.336 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.62 112.22 20.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.118 0.485 . . . . 65.42 111.627 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -11.06 50.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.094 0.776 . . . . 75.21 113.094 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -28.79 57.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.487 . . . . 61.32 110.175 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 51.5 p -89.56 -21.8 22.7 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.742 -0.663 . . . . 70.21 109.624 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.46 -35.68 4.56 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.584 -0.734 . . . . 51.54 112.536 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -97.96 141.63 23.28 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 123.379 0.105 . . . . 74.31 111.163 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.57 135.44 70.4 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.493 2.795 . . . . 63.22 114.173 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.3 mttt -63.85 -36.68 84.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.607 -1.179 . . . . 64.4 112.082 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.55 23.95 19.81 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.777 -0.725 . . . . 62.41 112.682 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -117.78 142.96 46.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.793 -0.447 . . . . 74.13 109.793 -172.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.53 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.278 -0.419 . . . . 63.54 110.535 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 20.7 p -134.97 137.01 42.65 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.964 -0.384 . . . . 71.13 109.964 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.61 150.06 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.259 -0.428 . . . . 52.33 110.125 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.459 ' H ' ' CB ' ' A' ' 270' ' ' MET . 30.7 t -105.47 117.73 34.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.972 0.73 . . . . 63.31 112.972 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 159.93 20.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.097 -0.241 . . . . 73.44 111.227 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.29 -47.03 16.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.119 -0.491 . . . . 74.3 109.951 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.62 135.4 29.25 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 123.212 0.32 . . . . 73.42 110.468 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.32 -40.71 30.53 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.434 2.089 . . . . 73.1 116.133 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.33 -29.22 32.22 Favored 'Trans proline' 0 C--N 1.389 2.696 0 CA-C-N 122.682 1.994 . . . . 63.33 113.535 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 61.3 m -63.55 -25.78 68.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.175 0.59 . . . . 75.45 112.361 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -72.98 -45.68 56.59 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.037 0.384 . . . . 70.12 112.037 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -32.69 68.59 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.257 0.551 . . . . 62.22 111.415 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.74 -30.62 61.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.284 -0.871 . . . . 75.15 110.6 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.62 -31.23 71.11 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 122.252 0.221 . . . . 70.34 111.218 173.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 296' ' ' ALA . 67.2 mt -67.04 -34.57 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 120.484 0.183 . . . . 65.24 110.748 173.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.9 -59.86 2.61 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.393 1.257 . . . . 73.42 114.393 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.93 -35.33 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.509 1.67 . . . . 74.11 115.509 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.6 t80 -83.32 -18.66 38.2 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.101 0.477 . . . . 72.55 110.156 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.97 -174.08 2.46 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.043 -0.98 . . . . 62.22 109.219 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.08 65.35 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.121 -0.561 . . . . 75.42 112.322 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -135.98 -160.88 1.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.622 0.369 . . . . 70.41 110.137 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.17 145.68 47.97 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.784 0.802 . . . . 72.43 111.884 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -114.74 114.93 26.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.43 -1.259 . . . . 71.24 107.858 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.9 m170 64.37 28.66 13.68 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.915 1.286 . . . . 74.5 112.649 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.94 -2.97 85.96 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.148 0.419 . . . . 71.52 114.148 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.74 144.4 41.1 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 122.801 0.441 . . . . 71.12 110.05 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.66 129.66 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 123.331 0.394 . . . . 71.2 110.33 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.0 tt -108.41 145.8 14.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.9 -0.591 . . . . 74.41 109.514 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 42.5 tttp -135.4 127.94 30.66 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.071 -0.513 . . . . 54.24 111.256 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 25.2 t -103.61 133.76 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.37 0.605 . . . . 71.44 109.385 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -132.53 173.36 11.4 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.997 0.919 . . . . 74.41 109.313 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.26 -1.07 52.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 113.076 0.769 . . . . 75.12 113.076 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 62.75 -165.92 0.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.404 1.082 . . . . 37.74 113.321 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.3 m -89.05 146.48 24.81 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.614 -0.721 . . . . 73.21 109.401 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -164.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.783 -0.821 . . . . 72.53 108.783 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 43.91 84.34 0.19 Allowed Pre-proline 0 N--CA 1.502 2.143 0 C-N-CA 125.274 1.43 . . . . 73.24 114.501 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.44 111.79 3.23 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 121.936 1.757 . . . . 73.23 112.578 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.129 -0.938 . . . . 55.11 110.882 -174.57 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 CA-C-O 119.575 -0.569 . . . . 60.24 112.347 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.9 m 73.71 -60.3 0.53 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.575 1.55 . . . . 73.34 112.584 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -111.53 149.7 31.01 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.934 -0.765 . . . . 65.21 108.934 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 70.1 mmm -113.23 12.04 18.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.265 0.555 . . . . 63.14 110.886 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.4 p -151.19 139.33 20.16 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.534 -0.757 . . . . 64.32 110.956 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -123.35 69.28 1.01 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.517 1.151 . . . . 72.43 110.063 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -90.13 121.76 32.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.976 -1.465 . . . . 72.14 111.359 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.42 104.21 16.75 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.45 -0.781 . . . . 74.03 110.676 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -144.12 149.51 36.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.467 0.707 . . . . 72.43 109.344 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.76 137.16 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.726 0.694 . . . . 64.43 110.512 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.55 125.51 48.21 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.556 -0.535 . . . . 75.03 109.556 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -120.05 143.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.745 0.784 . . . . 74.12 111.93 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 26.1 tp60 -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.986 -1.461 . . . . 61.2 108.927 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.78 43.94 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.098 -0.573 . . . . 61.43 112.958 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.0 78.65 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.579 -0.896 . . . . 63.41 108.579 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.54 -81.44 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.491 -0.861 . . . . 71.14 113.486 -172.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.68 107.14 9.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 72.14 111.21 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.23 20.92 24.07 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.556 -0.747 . . . . 61.13 112.078 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.54 152.55 4.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.384 0.611 . . . . 73.32 110.572 -173.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -93.84 169.24 10.44 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.597 -0.729 . . . . 60.15 109.408 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -167.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 127.136 2.174 . . . . 71.11 114.208 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -44.14 -13.12 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 126.241 1.817 . . . . 75.41 115.528 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.9 OUTLIER -46.94 -22.96 0.38 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 126.499 1.92 . . . . 73.43 113.998 169.226 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -56.21 -30.59 30.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 O-C-N 122.001 -0.437 . . . . 74.41 110.287 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.38 -33.49 84.79 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 122.054 -0.403 . . . . 75.11 113.378 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.22 -32.13 64.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.527 0.731 . . . . 45.04 110.697 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 11.0 t80 -55.56 -45.85 77.24 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.162 -0.926 . . . . 74.33 111.182 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.82 -24.12 48.83 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.195 -0.315 . . . . 71.15 111.613 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -74.83 -11.11 60.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.661 0.785 . . . . 63.2 112.183 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -15.83 61.88 Favored 'General case' 0 CA--C 1.557 1.238 0 O-C-N 121.854 -0.529 . . . . 61.5 111.733 172.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 -44.41 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.909 0.484 . . . . 71.04 111.115 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -139.08 -162.09 8.99 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.365 -0.921 . . . . 64.24 114.72 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.0 138.2 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.832 0.453 . . . . 73.4 110.835 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.82 114.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 O-C-N 123.885 0.741 . . . . 75.44 110.947 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -100.96 144.16 30.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.763 -1.108 . . . . 53.42 111.308 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.8 m -83.39 118.1 23.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.369 -1.287 . . . . 74.53 108.114 168.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.94 133.96 45.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.605 0.565 . . . . 71.33 109.676 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -77.38 -11.55 59.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.474 0.546 . . . . 72.52 112.474 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.31 -31.21 68.43 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.106 0.41 . . . . 60.44 112.106 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.2 t -124.86 -31.68 3.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.625 0.232 . . . . 71.4 111.625 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.85 69.19 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 116.48 -0.327 . . . . 64.34 112.515 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -98.45 152.4 37.91 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 123.256 0.623 . . . . 64.44 112.247 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.02 154.35 74.38 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 123.178 2.585 . . . . 71.12 111.113 166.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.469 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.94 102.15 6.27 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.651 0.982 . . . . 64.52 113.651 -168.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.86 112.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.126 -1.435 . . . . 74.53 107.126 163.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -128.5 114.78 17.2 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.685 0.675 . . . . 72.51 109.367 161.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.56 110.24 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.363 -0.606 . . . . 73.05 109.363 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -103.06 112.22 24.96 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 121.356 0.598 . . . . 75.14 111.009 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.7 p -144.18 120.99 11.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.594 -1.185 . . . . 71.01 109.997 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.96 112.94 21.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.448 0.642 . . . . 64.21 111.864 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -7.9 58.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.407 -0.815 . . . . 73.35 112.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -33.0 69.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.021 0.438 . . . . 72.23 111.138 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 7.7 t -91.53 -14.53 30.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.776 -0.647 . . . . 74.31 109.886 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.59 -49.76 1.62 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.589 -0.732 . . . . 43.14 112.628 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.11 142.09 59.06 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.716 0.304 . . . . 74.23 110.54 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -57.15 134.56 64.97 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.314 2.676 . . . . 73.24 114.228 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -60.26 -42.46 95.37 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.928 -1.033 . . . . 74.45 111.889 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.77 14.59 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.796 -0.716 . . . . 52.31 113.565 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -118.27 145.86 44.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.086 0.443 . . . . 73.24 110.517 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.86 156.13 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 61.51 110.456 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.71 136.08 46.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.74 0.305 . . . . 74.43 110.211 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.68 148.05 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 116.176 -0.465 . . . . 72.31 109.747 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.469 ' H ' ' CB ' ' A' ' 270' ' ' MET . 47.4 t -97.66 141.74 30.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.227 1.011 . . . . 74.32 111.74 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.81 164.89 12.31 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.195 -0.315 . . . . 74.25 110.538 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.0 -47.51 65.35 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.442 0.464 . . . . 74.23 110.872 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -115.11 138.18 23.36 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 116.481 -0.327 . . . . 72.1 110.232 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -61.88 -37.8 63.65 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 C-N-CA 123.137 2.558 . . . . 70.21 117.782 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.6 -27.3 7.63 Favored 'Trans proline' 0 C--N 1.392 2.824 0 CA-C-N 123.645 2.337 . . . . 74.42 112.999 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.5 m -59.57 -27.94 66.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.258 1.023 . . . . 73.25 111.738 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.458 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.1 -39.28 82.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.506 0.723 . . . . 71.55 112.892 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -75.07 -32.77 61.57 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.821 0.343 . . . . 65.21 111.116 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.17 79.99 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.156 -0.475 . . . . 74.4 110.314 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.13 68.04 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.152 -0.476 . . . . 63.13 112.204 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.8 mt -67.41 -30.56 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 O-C-N 122.164 -0.335 . . . . 64.32 110.582 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -59.73 2.66 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 113.904 1.076 . . . . 60.45 113.904 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -90.73 -37.48 13.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.272 1.953 . . . . 73.43 116.272 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -82.42 -21.12 35.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.304 0.573 . . . . 75.24 110.436 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.401 ' HB2' HG13 ' A' ' 315' ' ' VAL . 13.9 t70 -83.85 -172.52 4.2 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.083 -0.962 . . . . 63.33 109.971 168.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 80.86 11.8 83.44 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.854 -0.529 . . . . 42.21 113.106 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 -159.21 0.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.481 -0.563 . . . . 74.33 109.481 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.84 145.2 51.41 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.597 0.713 . . . . 74.45 110.784 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -112.35 113.57 25.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.485 -1.302 . . . . 72.12 107.485 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.1 m170 64.41 28.51 13.6 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 124.455 1.097 . . . . 74.24 112.663 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.77 3.37 88.14 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.408 -0.36 . . . . 73.52 113.458 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -112.87 141.47 46.65 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.739 -0.837 . . . . 73.52 108.739 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.21 127.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.966 0.413 . . . . 63.35 110.462 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.6 tt -108.5 144.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.764 -0.653 . . . . 72.44 109.629 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 39.1 tptt -136.5 121.12 18.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.993 -0.548 . . . . 72.23 109.95 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 304' ' ' ASP . 8.2 p -107.65 136.74 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.489 -0.778 . . . . 65.12 109.892 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 m -138.08 174.15 10.87 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 124.146 0.978 . . . . 71.13 110.13 -173.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -7.25 59.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.632 0.975 . . . . 74.53 113.632 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 69.73 8.53 6.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.593 1.331 . . . . 70.41 114.593 172.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m 65.83 121.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.858 1.263 . . . . 73.41 111.724 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -84.86 93.77 8.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.661 -0.7 . . . . 74.51 111.056 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -166.56 88.86 0.82 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.568 0.747 . . . . 64.43 111.545 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -80.97 94.34 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.195 1.264 . . . . 64.34 113.326 171.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.351 -0.84 . . . . 63.34 109.875 177.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.964 0 N-CA-C 112.317 -0.313 . . . . 60.54 112.317 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.5 m -129.7 -49.53 1.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.465 0.174 . . . . 64.32 111.374 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -125.55 125.54 43.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.544 0.211 . . . . 71.32 110.556 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.5 mtt -143.86 30.76 1.31 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.424 -0.353 . . . . 74.31 111.894 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 151.66 38.17 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.895 -0.409 . . . . 63.32 109.895 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.3 -5.7 55.97 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.577 0.548 . . . . 73.34 109.807 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -76.39 107.51 8.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.458 -0.792 . . . . 74.41 110.26 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 103.95 16.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.905 -0.718 . . . . 71.45 110.24 162.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.9 m -142.27 144.87 33.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.948 -1.501 . . . . 62.22 106.948 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 11.8 pt -123.59 141.26 44.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 119.406 1.003 . . . . 74.45 109.689 168.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.53 122.53 43.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.677 -0.86 . . . . 72.42 108.677 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.9 141.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.087 -0.709 . . . . 71.0 109.087 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.15 151.03 49.71 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.489 0.716 . . . . 72.32 110.516 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.9 21.48 36.12 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 124.158 0.911 . . . . 71.31 113.638 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 76.92 1.0 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.79 -1.189 . . . . 60.24 107.79 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.432 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.68 -90.93 0.42 Allowed Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.587 -0.816 . . . . 63.23 113.753 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.68 112.9 16.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.929 0.395 . . . . 70.21 110.791 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.59 20.15 25.41 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.321 -0.854 . . . . 74.43 111.996 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -87.29 151.83 3.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.681 -0.489 . . . . 75.33 109.681 -173.187 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.2 m -93.55 170.63 9.45 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.0 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -165.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.344 2.258 . . . . 73.13 114.233 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -42.89 -14.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 127.384 2.273 . . . . 73.32 114.819 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -46.93 -22.08 0.28 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.671 1.988 . . . . 64.3 114.723 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -57.46 -32.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 119.341 0.973 . . . . 63.4 110.699 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.86 85.93 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 120.065 -0.297 . . . . 62.24 113.463 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.47 -31.47 63.78 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.39 0.676 . . . . 71.45 111.23 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.9 t80 -56.8 -43.44 80.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.144 0.578 . . . . 74.24 111.298 170.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -79.04 -24.46 43.6 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.471 0.545 . . . . 74.34 112.471 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -63.01 -23.17 67.33 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.356 1.062 . . . . 72.34 111.681 174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.15 -20.38 65.95 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.63 0.604 . . . . 75.43 112.63 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.5 mm -123.61 41.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 121.419 0.628 . . . . 65.5 110.233 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 150.64 -168.81 30.49 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 118.835 -1.65 . . . . 65.54 115.02 172.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.29 136.56 37.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.372 -0.414 . . . . 63.2 110.573 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 38.3 mm -67.46 115.25 5.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.86 -1.064 . . . . 73.51 110.027 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -98.18 140.54 32.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.505 0.669 . . . . 73.22 111.3 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.7 m -84.35 116.71 23.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.688 -1.142 . . . . 73.14 108.074 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.67 126.64 31.19 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 109.132 -0.692 . . . . 72.21 109.132 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -74.98 -6.32 48.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.229 1.196 . . . . 75.42 114.229 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.97 -33.47 74.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.23 0.212 . . . . 73.15 111.147 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.5 t -125.38 -29.33 3.25 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.729 0.299 . . . . 72.21 111.511 176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 91.5 11.02 61.3 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.194 -0.457 . . . . 62.13 112.811 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -98.62 151.53 37.49 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 122.933 0.493 . . . . 73.24 112.182 173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.99 155.52 63.96 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 123.981 3.12 . . . . 64.11 112.837 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.418 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -70.35 98.91 1.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.03 1.122 . . . . 71.35 114.03 -173.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.5 mm -144.19 113.07 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.224 -1.398 . . . . 74.01 107.224 164.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -128.7 115.05 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 119.262 0.937 . . . . 71.24 109.891 161.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.69 111.21 21.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.957 0.408 . . . . 64.23 110.083 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 62.2 m-85 -103.54 111.53 24.02 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 121.356 0.598 . . . . 74.31 110.39 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.2 p -143.2 122.51 13.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.027 -1.442 . . . . 63.3 110.136 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.7 112.02 20.65 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.207 0.527 . . . . 62.15 111.497 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.21 -9.82 54.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.146 0.795 . . . . 54.11 113.146 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -28.65 56.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.566 0.222 . . . . 65.51 110.582 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 56.8 p -88.69 -21.04 24.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.375 0.607 . . . . 72.1 109.454 169.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.32 -12.14 70.29 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 114.932 -1.031 . . . . 75.11 112.944 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -121.08 140.26 30.72 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 110.184 -0.302 . . . . 72.22 110.184 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.47 133.5 55.06 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 123.187 2.591 . . . . 70.24 114.209 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -62.12 -34.37 76.23 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.798 -1.092 . . . . 74.14 112.357 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.34 24.46 18.89 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.94 -0.648 . . . . 43.05 112.723 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 35.9 mt-10 -119.35 142.1 48.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.764 -0.774 . . . . 74.31 109.901 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.59 143.04 23.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.264 -0.643 . . . . 43.53 109.264 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 62.4 p -128.43 139.62 52.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.289 -0.634 . . . . 75.32 109.289 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.89 144.47 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 120.947 0.404 . . . . 52.35 110.17 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.418 ' H ' ' CB ' ' A' ' 270' ' ' MET . 43.3 t -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.49 0.716 . . . . 61.04 112.041 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.82 164.97 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.658 -0.246 . . . . 75.15 111.422 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.11 -48.05 63.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.117 0.567 . . . . 75.21 112.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -122.23 136.45 26.42 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.641 -0.874 . . . . 72.24 108.641 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.9 -37.9 62.68 Favored 'Trans proline' 0 CA--C 1.567 2.151 0 C-N-CA 123.099 2.532 . . . . 65.2 117.462 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 -29.01 18.08 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.762 2.379 . . . . 61.12 113.238 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.0 m -60.04 -29.02 68.23 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.306 1.043 . . . . 74.45 112.063 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.458 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.49 -38.61 81.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.639 0.775 . . . . 61.43 112.759 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -74.36 -36.01 63.57 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.258 0.551 . . . . 74.43 111.126 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.75 81.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.074 -0.967 . . . . 73.31 110.929 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.72 -29.66 68.13 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 123.583 0.552 . . . . 64.34 111.976 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 296' ' ' ALA . 78.9 mt -63.29 -34.72 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 117.772 0.26 . . . . 75.02 110.713 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.41 -60.05 2.52 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 114.19 1.181 . . . . 71.52 114.19 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.44 -34.05 15.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.194 1.924 . . . . 73.54 116.194 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 60.3 t80 -85.65 -18.47 33.14 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.191 0.52 . . . . 65.4 110.167 -171.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -107.59 -175.51 2.81 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.339 -0.986 . . . . 73.12 108.339 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.45 56.42 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.679 -0.296 . . . . 62.22 112.378 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.56 -153.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.939 -0.393 . . . . 75.53 109.939 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -120.68 146.24 46.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.82 0.448 . . . . 72.12 110.783 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -113.7 110.76 20.71 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.68 -1.23 . . . . 71.03 107.68 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 18.8 m170 64.96 29.64 12.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.638 1.175 . . . . 73.11 112.245 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.14 83.84 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.394 -0.366 . . . . 74.41 113.98 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -110.22 148.72 31.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 117.222 0.511 . . . . 64.43 110.159 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.6 mm -68.78 126.0 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 123.467 0.48 . . . . 74.51 110.767 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.22 142.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.939 -0.573 . . . . 72.14 109.944 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -136.42 129.84 31.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 71.43 111.034 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.91 137.33 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.201 0.524 . . . . 62.44 109.75 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -136.38 172.94 12.28 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.102 0.961 . . . . 71.23 109.451 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.77 -4.66 55.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.193 0.812 . . . . 74.05 113.193 174.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.56 -165.22 0.24 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.914 1.286 . . . . 73.34 112.883 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 171.84 12.18 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.677 -0.692 . . . . 70.31 109.377 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -75.53 -170.72 1.32 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.676 0.621 . . . . 75.41 112.676 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -60.09 151.09 67.78 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.247 1.019 . . . . 74.42 112.501 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.14 90.37 0.26 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.423 2.748 . . . . 74.42 112.706 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 125.481 1.512 . . . . 74.42 111.989 -175.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 119.612 -0.549 . . . . 71.11 113.007 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.0 p 55.41 19.9 3.35 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 126.144 1.778 . . . . 64.34 115.303 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 63.65 174.21 0.17 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.442 1.497 . . . . 74.31 113.062 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 8.5 ptm -152.43 83.02 1.24 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.983 -0.553 . . . . 63.34 111.209 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.2 p -166.47 127.23 1.69 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.605 -0.725 . . . . 70.21 111.443 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.71 -15.62 53.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.523 -0.762 . . . . 73.42 110.06 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.9 106.78 2.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.359 -0.837 . . . . 62.01 111.201 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.8 105.66 17.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.495 -0.482 . . . . 75.34 110.186 162.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -142.25 150.25 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.066 -1.457 . . . . 71.12 107.066 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.23 137.22 57.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 119.154 0.888 . . . . 65.45 109.837 165.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.91 116.94 33.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.789 -0.819 . . . . 73.24 108.789 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.02 139.7 36.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.42 -0.585 . . . . 71.01 109.42 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 25.6 tp60 -128.9 142.71 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.761 -0.829 . . . . 65.11 108.761 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.8 20.75 11.09 Favored Glycine 0 N--CA 1.462 0.371 0 C-N-CA 121.139 -0.553 . . . . 53.32 112.464 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.72 73.06 0.8 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.55 -0.907 . . . . 71.52 108.55 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.86 -178.44 26.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.477 -0.783 . . . . 71.03 112.018 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . 0.261 12.0 pt-20 40.84 87.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.833 2.053 . . . . 45.52 114.845 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.18 21.11 25.95 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.008 -0.837 . . . . 65.15 111.008 -173.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.94 151.59 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.242 -0.651 . . . . 71.23 109.242 -173.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.6 m -84.61 168.69 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.76 -0.655 . . . . 75.52 110.23 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -169.13 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.618 1.967 . . . . 74.44 113.07 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -44.11 -12.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 126.422 1.889 . . . . 75.44 115.468 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.428 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 1.0 OUTLIER -46.09 -23.17 0.28 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.314 1.846 . . . . 71.15 113.701 170.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.562 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -57.78 -31.33 39.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 109.585 -0.524 . . . . 73.54 109.585 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.07 83.68 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-O 119.907 -0.385 . . . . 60.14 113.438 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -76.1 -29.65 57.99 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.243 0.617 . . . . 74.34 111.241 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.562 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.8 t80 -55.5 -44.56 76.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.498 0.719 . . . . 73.13 110.419 169.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -77.82 -24.54 48.68 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.685 0.254 . . . . 74.12 111.685 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -68.98 -18.78 64.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.585 0.754 . . . . 74.32 111.292 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -62.86 -22.12 66.46 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 122.297 -0.252 . . . . 73.13 110.802 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 257' ' ' ILE . 6.1 mm -122.83 63.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.369 -0.604 . . . . 70.31 109.369 168.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.07 -172.84 26.59 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 118.803 -1.665 . . . . 37.77 115.366 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.48 138.48 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.165 -1.018 . . . . 73.14 109.62 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.7 mm -70.35 116.05 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.272 0.558 . . . . 73.12 110.373 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -96.42 140.15 31.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 72.33 111.404 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 89.7 m -86.0 117.5 24.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.132 -0.94 . . . . 74.43 108.597 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -72.75 136.97 45.59 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.42 -0.354 . . . . 71.24 111.069 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -78.76 -9.39 59.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.003 0.742 . . . . 64.24 113.003 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.43 -39.56 77.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.011 0.374 . . . . 64.25 112.011 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 t -126.25 -19.4 4.71 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.532 0.206 . . . . 73.15 111.359 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.49 57.17 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.519 -0.309 . . . . 74.14 113.063 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -99.93 153.91 37.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.99 0.367 . . . . 74.41 111.99 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.41 153.06 76.89 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.056 2.504 . . . . 64.0 111.723 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 1.4 ptm -76.73 100.15 5.33 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.162 0.801 . . . . 71.53 113.162 -171.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.5 mm -143.14 113.92 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 165.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -128.13 117.61 21.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 119.177 0.898 . . . . 75.53 109.815 162.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.53 112.74 23.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 64.2 110.218 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -101.62 111.68 24.01 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-N 115.907 -0.588 . . . . 62.02 109.663 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.2 p -143.74 122.07 12.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.317 -1.311 . . . . 73.34 109.231 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.49 110.7 18.87 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.256 0.55 . . . . 62.21 111.043 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -7.43 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.213 0.82 . . . . 63.22 113.213 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -32.43 70.09 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.252 0.345 . . . . 72.34 110.816 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -91.88 -19.18 22.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.149 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 102.27 -44.43 1.52 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.004 -0.543 . . . . 70.03 112.911 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -81.95 142.1 48.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.587 0.227 . . . . 54.14 111.187 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.69 130.86 39.06 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.909 2.406 . . . . 51.04 113.508 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -59.98 -39.12 84.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.926 -1.034 . . . . 70.14 112.165 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.9 25.23 15.24 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.668 -0.777 . . . . 62.21 113.076 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.81 143.56 46.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.101 0.451 . . . . 73.52 110.084 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.13 143.36 23.26 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.455 0.302 . . . . 61.43 110.341 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 70.6 p -125.53 138.86 53.98 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 122.074 -0.391 . . . . 71.44 110.296 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.86 148.06 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.992 -0.373 . . . . 75.21 109.992 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 49.8 m -108.44 117.48 34.27 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.978 0.733 . . . . 51.02 112.978 -172.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.44 163.94 19.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.759 0.424 . . . . 72.2 111.897 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.2 -48.42 20.47 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 116.536 -0.302 . . . . 61.01 110.686 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.01 135.61 23.41 Favored Pre-proline 0 C--O 1.239 0.548 0 O-C-N 123.203 0.314 . . . . 74.32 110.743 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.81 -41.16 19.08 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 122.802 2.334 . . . . 62.43 116.813 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.58 -29.74 52.15 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 122.946 2.088 . . . . 74.42 113.806 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 49.8 m -64.29 -27.42 69.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.099 0.96 . . . . 71.43 112.465 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.19 88.75 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 122.841 0.457 . . . . 71.14 111.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.62 -39.68 88.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.153 0.581 . . . . 63.31 110.349 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.86 76.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.521 -0.763 . . . . 75.21 111.448 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.92 -33.14 73.26 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.709 0.404 . . . . 71.12 111.623 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 75.2 mt -64.8 -33.41 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.849 0.357 . . . . 71.24 110.603 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.49 -60.33 2.4 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.766 1.024 . . . . 75.14 113.766 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -91.72 -31.84 15.65 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.867 1.803 . . . . 73.2 115.867 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.488 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 72.2 t80 -87.49 -14.79 39.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.371 0.605 . . . . 75.22 109.937 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -104.89 173.81 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.337 -0.986 . . . . 74.24 108.337 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.28 14.21 51.83 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.731 -0.747 . . . . 71.23 112.228 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -131.25 -156.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.699 -0.852 . . . . 71.42 108.699 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -132.84 148.77 52.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.618 0.723 . . . . 65.5 111.011 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -113.61 117.7 32.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.4 m170 64.69 28.47 13.08 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.722 1.209 . . . . 74.44 112.17 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.07 86.52 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.405 -0.361 . . . . 72.11 113.762 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.55 144.84 42.19 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 109.197 -0.668 . . . . 72.24 109.197 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.65 130.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.165 0.507 . . . . 64.42 111.673 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.5 tt -110.43 142.51 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.324 -0.853 . . . . 74.22 110.023 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -136.86 126.87 25.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.236 0.614 . . . . 61.53 111.341 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 31.6 t -108.7 138.83 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.276 -0.42 . . . . 74.01 110.877 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -134.95 176.61 8.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 63.55 110.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.77 -11.58 59.83 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.97 1.1 . . . . 71.32 113.97 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 67.32 -170.08 0.19 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.289 1.036 . . . . 65.55 113.319 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.85 158.94 19.83 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.103 -0.953 . . . . 74.24 110.136 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -91.36 147.92 22.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.101 -0.5 . . . . 72.24 109.867 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 74.32 165.28 0.13 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 124.622 1.201 . . . . 72.53 113.669 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.52 -170.87 0.8 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.381 2.054 . . . . 65.04 113.515 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.786 -1.097 . . . . 52.44 110.976 -177.069 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 111.831 -0.508 . . . . 61.12 111.831 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 14.3 m -116.88 48.57 1.28 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.739 0.304 . . . . 71.44 110.826 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 62.95 23.02 13.78 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.715 1.206 . . . . 75.2 112.088 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 19.5 mmt 54.68 69.33 0.74 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.228 1.411 . . . . 63.35 112.127 -174.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 24.1 p -88.67 120.49 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.21 -0.905 . . . . 71.53 111.551 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.06 -19.73 61.78 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.143 -0.935 . . . . 62.23 110.605 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.11 101.72 4.66 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.222 -0.899 . . . . 71.11 110.382 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.47 103.96 15.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 118.623 -1.231 . . . . 74.4 110.477 160.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -143.03 149.0 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.241 -1.392 . . . . 52.31 107.241 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.0 pt -125.18 139.46 51.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 118.8 0.727 . . . . 63.1 109.605 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.51 120.52 39.78 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.987 -0.746 . . . . 73.43 108.987 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.81 138.19 45.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.962 -0.563 . . . . 74.32 109.973 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.54 144.32 51.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 72.0 110.984 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.17 20.78 11.76 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.878 0.736 . . . . 63.54 112.969 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.48 75.08 0.92 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.602 -0.888 . . . . 71.42 108.602 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -127.31 -97.16 0.96 Allowed Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.524 -0.846 . . . . 63.11 113.565 -170.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -76.74 117.07 17.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.853 0.358 . . . . 64.52 111.104 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.17 19.66 30.04 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.218 -0.901 . . . . 72.31 111.675 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.22 151.29 4.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.357 0.599 . . . . 74.43 109.494 -174.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.9 t -93.46 170.61 9.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.235 -0.654 . . . . 72.55 109.235 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -167.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.489 2.316 . . . . 71.43 113.379 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -44.44 -12.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 126.497 1.919 . . . . 73.34 115.253 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.3 -23.04 0.49 Allowed 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 126.692 1.997 . . . . 73.43 112.892 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -31.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-N 118.653 0.661 . . . . 70.1 109.523 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.29 -35.48 88.34 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.248 -0.751 . . . . 41.4 114.383 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -28.21 58.33 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 117.961 0.881 . . . . 72.23 110.832 177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.58 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 6.7 t80 -55.66 -47.35 76.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.013 0.925 . . . . 72.23 110.671 171.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.59 -23.36 46.03 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.057 0.391 . . . . 75.34 112.057 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.3 -26.21 67.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.387 1.075 . . . . 74.43 111.221 175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.84 -19.73 64.39 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 111.905 0.335 . . . . 74.24 111.905 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.1 mm -124.23 62.62 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 109.598 -0.519 . . . . 73.1 109.598 170.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.76 -174.09 25.86 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 118.621 -1.752 . . . . 72.34 115.056 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.18 137.74 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.1 mm -71.48 113.22 7.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.298 0.571 . . . . 55.22 110.391 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -99.66 140.05 34.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.998 -1.001 . . . . 73.22 110.991 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 59.2 m -85.07 116.38 23.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.066 -0.97 . . . . 74.24 108.606 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.16 131.1 41.62 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.086 0.554 . . . . 75.12 110.213 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.7 -7.03 55.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.42 0.896 . . . . 54.34 113.42 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.25 -35.95 80.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.745 0.307 . . . . 72.15 111.108 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.8 p -125.25 -33.56 2.84 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.029 -0.532 . . . . 64.33 111.927 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.76 11.41 65.76 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.959 -0.564 . . . . 64.13 111.927 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -97.35 150.83 37.23 Favored Pre-proline 0 C--O 1.239 0.528 0 C-N-CA 123.238 0.615 . . . . 74.45 110.877 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.87 153.92 74.28 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.998 2.466 . . . . 72.32 111.241 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.42 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -73.22 101.19 3.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.645 0.979 . . . . 75.24 113.645 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -143.2 113.32 2.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.139 -1.391 . . . . 64.42 107.342 163.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -127.6 113.71 16.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 119.182 0.901 . . . . 64.1 109.768 163.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 110.53 20.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.205 -0.294 . . . . 72.33 110.205 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 36.3 m-85 -103.0 111.54 23.93 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 121.266 0.555 . . . . 74.54 110.156 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 20.9 p -145.0 120.98 10.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.984 -1.462 . . . . 54.13 109.624 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -87.47 112.67 22.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.462 0.648 . . . . 62.52 111.762 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -10.23 55.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.167 -0.47 . . . . 74.13 112.22 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.363 0.415 . . . . 61.22 111.191 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.2 p -90.81 -20.45 22.31 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.337 0.589 . . . . 70.51 109.892 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 85.62 7.73 81.39 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.077 -0.965 . . . . 62.45 112.697 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 139.99 25.95 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 110.338 -0.245 . . . . 71.12 110.338 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -58.97 130.75 38.04 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.185 2.59 . . . . 53.34 113.893 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 40.9 mtpt -63.16 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.874 -1.057 . . . . 75.21 111.992 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.78 14.86 Favored Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.436 -0.802 . . . . 74.01 112.671 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.7 mt-10 -115.48 140.65 48.96 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.212 -0.595 . . . . 74.43 110.239 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.96 143.16 22.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.106 -0.497 . . . . 73.31 109.893 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 72.3 p -128.98 139.78 51.95 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.756 -0.377 . . . . 73.54 110.538 173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.45 147.63 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 121.176 0.512 . . . . 54.03 110.433 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.42 ' H ' ' CB ' ' A' ' 270' ' ' MET . 44.3 t -94.29 128.03 40.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.729 0.812 . . . . 74.32 112.583 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.28 165.78 12.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.678 0.621 . . . . 75.13 112.678 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -42.37 59.61 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.573 0.546 . . . . 61.51 111.661 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 136.96 29.83 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 109.843 -0.429 . . . . 72.13 109.843 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -59.94 -37.19 87.11 Favored 'Trans proline' 0 CA--C 1.562 1.92 0 C-N-CA 123.53 2.82 . . . . 73.4 117.203 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 -29.75 10.71 Favored 'Trans proline' 0 C--N 1.392 2.825 0 CA-C-N 123.321 2.222 . . . . 64.24 112.691 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 33.6 m -62.97 -32.75 74.15 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.158 0.983 . . . . 64.0 111.315 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.74 83.71 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.011 0.819 . . . . 41.03 111.822 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -48.18 78.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.376 0.422 . . . . 75.23 111.268 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.78 97.53 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 123.714 0.634 . . . . 74.43 110.862 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.85 68.15 Favored 'General case' 0 C--O 1.184 -2.389 0 CA-C-N 115.283 -0.871 . . . . 64.32 111.156 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.19 -34.47 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.128 0.571 . . . . 73.33 112.428 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.28 -54.91 22.14 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.688 0.625 . . . . 72.34 112.688 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -27.26 19.22 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.248 2.314 . . . . 74.44 117.248 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.57 -20.39 39.98 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.175 0.99 . . . . 75.34 112.038 -170.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.8 166.65 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.213 -0.662 . . . . 75.2 109.213 175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.98 12.87 54.8 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.156 -0.545 . . . . 73.43 112.627 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -122.05 -159.37 0.82 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.29 -1.004 . . . . 74.42 108.29 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -130.56 143.02 50.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.555 0.693 . . . . 71.14 111.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -113.14 110.73 20.92 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.14 -1.059 . . . . 73.12 108.14 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.3 m170 64.33 30.11 13.43 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.516 1.135 . . . . 74.33 112.095 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.76 84.46 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 114.369 0.507 . . . . 62.53 114.369 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.2 147.39 37.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.548 -0.538 . . . . 70.53 109.548 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.69 124.92 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.177 0.513 . . . . 73.31 111.202 -172.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 134.83 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.403 -0.817 . . . . 73.22 110.65 -174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -130.56 145.22 51.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.856 -0.611 . . . . 62.23 111.017 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.42 140.08 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.984 -0.553 . . . . 73.14 109.903 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -133.48 176.5 8.48 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.1 0.96 . . . . 72.0 109.984 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -83.13 -8.61 59.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.596 0.962 . . . . 74.41 113.596 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 66.93 -162.35 0.23 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.332 1.053 . . . . 64.5 112.61 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 14.5 t -90.33 172.95 8.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.59 -0.522 . . . . 64.21 109.59 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -81.48 -175.07 5.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 70.45 112.087 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.32 149.0 84.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.138 -0.937 . . . . 75.42 112.844 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.91 115.55 2.7 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.603 2.869 . . . . 73.03 113.381 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.037 -0.983 . . . . 63.41 110.225 -175.3 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.442 -0.263 . . . . 60.11 112.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.0 t -156.27 164.08 38.77 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.025 -0.361 . . . . 74.34 110.025 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -114.7 145.16 42.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.266 -0.424 . . . . 74.24 110.683 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 293' ' ' PRO . 2.5 ptp -136.83 28.84 2.9 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.184 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 54.8 m 75.44 144.74 0.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.021 1.728 . . . . 73.23 111.519 -171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.99 -2.28 58.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.203 0.525 . . . . 74.13 111.079 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.96 106.84 13.28 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.885 -0.598 . . . . 64.52 109.448 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.0 106.4 18.49 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.529 -0.868 . . . . 62.41 110.34 168.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.9 m -142.05 142.21 32.84 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.532 -0.914 . . . . 71.03 108.532 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 pt -121.83 138.97 50.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 119.897 -0.721 . . . . 72.04 110.241 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.7 120.66 40.95 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.818 -0.628 . . . . 64.22 109.928 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -112.82 142.82 23.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.87 0.843 . . . . 74.43 113.046 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.32 151.99 48.04 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.1 -1.864 . . . . 55.41 109.493 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.81 16.95 46.34 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.171 -0.537 . . . . 74.35 113.172 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.07 64.15 0.67 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.659 0.743 . . . . 61.21 109.273 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -106.03 -103.89 2.9 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 115.348 -0.842 . . . . 38.44 112.951 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.86 119.6 17.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.547 0.689 . . . . 74.51 112.415 -173.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.24 18.96 29.56 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.634 -1.166 . . . . 61.35 111.694 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.01 151.94 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.129 0.49 . . . . 72.21 109.804 -172.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.3 m -90.64 170.46 10.14 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.691 -0.686 . . . . 72.33 109.619 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -167.75 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.637 1.975 . . . . 73.55 114.239 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -43.38 -12.91 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 C-N-CA 126.148 1.779 . . . . 73.53 115.444 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -46.78 -20.99 0.16 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 126.26 1.824 . . . . 74.34 114.243 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -55.72 -32.7 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.454 0.57 . . . . 73.44 110.491 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.71 81.66 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 119.953 -0.359 . . . . 74.22 113.611 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.95 -31.52 64.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.023 0.929 . . . . 74.51 111.003 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.0 t80 -58.61 -44.79 90.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.873 0.869 . . . . 63.22 110.887 171.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.413 ' HD1' ' O ' ' A' ' 250' ' ' VAL . 94.3 m-85 -76.87 -24.37 52.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 121.196 -0.202 . . . . 73.54 111.32 177.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -73.05 -15.91 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.497 0.719 . . . . 71.1 111.342 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.82 -17.68 64.81 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.805 -0.559 . . . . 73.34 111.12 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.06 58.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 109.377 -0.601 . . . . 74.52 109.377 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.71 -179.05 26.81 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 119.903 -1.142 . . . . 70.03 114.692 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 11.8 mt -106.73 139.7 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.435 0.694 . . . . 64.44 110.326 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.85 114.76 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.958 -0.564 . . . . 75.23 110.437 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.87 138.36 35.33 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.423 -0.808 . . . . 61.31 110.342 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 57.7 m -84.45 116.12 22.91 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.836 -1.172 . . . . 75.41 107.836 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.48 128.35 35.33 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 109.323 -0.621 . . . . 63.43 109.323 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -78.57 -8.38 58.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.128 0.788 . . . . 72.51 113.128 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -68.97 -29.88 68.19 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.54 0.2 . . . . 62.0 111.54 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 4.8 t -125.46 -30.07 3.15 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 111.643 0.238 . . . . 74.22 111.643 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.79 13.61 60.72 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.566 -0.288 . . . . 38.44 113.027 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -99.18 152.71 37.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 122.852 0.461 . . . . 73.44 112.093 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.46 154.78 66.38 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.579 2.853 . . . . 65.41 111.695 165.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.494 ' SD ' ' HB ' ' A' ' 288' ' ' VAL . 0.0 OUTLIER -77.83 98.64 5.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.31 0.856 . . . . 75.1 113.31 -168.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 36.4 mm -143.43 113.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 75.54 107.253 165.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -129.36 114.45 16.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.836 0.743 . . . . 75.21 109.909 161.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.91 111.29 21.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.962 -0.385 . . . . 74.34 109.962 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -103.63 113.23 26.59 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 115.972 -0.558 . . . . 71.41 110.774 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.3 p -142.4 123.79 14.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.469 -1.242 . . . . 75.33 110.337 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.85 112.52 21.21 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.272 0.558 . . . . 72.21 111.763 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -86.83 -10.93 52.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.622 0.971 . . . . 63.1 113.622 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.28 -34.55 61.33 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.998 0.428 . . . . 74.24 110.652 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -90.33 -15.25 31.5 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.705 -0.68 . . . . 72.13 109.716 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.16 -45.06 1.61 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.874 -0.603 . . . . 72.45 113.111 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -83.85 141.85 41.5 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 111.854 0.316 . . . . 73.43 111.854 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 136.96 72.28 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.345 2.697 . . . . 64.14 113.848 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -68.79 -33.4 73.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.027 -0.988 . . . . 73.12 111.621 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.85 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.729 -0.669 . . . . 38.44 113.081 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -115.5 143.21 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.944 -0.391 . . . . 65.31 109.944 -171.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.01 155.37 37.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.386 . . . . 75.52 111.05 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.3 p -131.12 135.42 47.47 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.76 -0.459 . . . . 73.34 109.76 165.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.494 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 11.4 m -137.06 148.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 109.055 -0.72 . . . . 74.34 109.055 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.49 ' H ' ' CB ' ' A' ' 270' ' ' MET . 17.4 m -114.15 119.41 36.99 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.038 0.755 . . . . 55.2 113.038 -168.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.95 165.14 17.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.269 0.84 . . . . 73.12 113.269 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.53 -47.24 34.03 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.811 -1.086 . . . . 74.21 111.087 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 137.66 21.53 Favored Pre-proline 0 C--O 1.237 0.402 0 O-C-N 123.523 0.515 . . . . 54.14 110.701 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.441 ' HB2' ' SD ' ' A' ' 230' ' ' MET . 10.2 Cg_endo -61.55 -38.75 60.23 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.192 2.594 . . . . 52.13 117.246 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.87 -29.79 22.81 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 123.185 2.173 . . . . 61.24 113.047 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -61.41 -28.37 69.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.336 1.054 . . . . 72.54 112.078 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -70.39 -43.49 69.97 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -73.73 -34.15 64.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.346 0.593 . . . . 75.11 111.054 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.53 -32.43 71.25 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.569 -0.741 . . . . 73.32 110.444 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.48 -27.71 65.45 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 122.297 0.239 . . . . 65.41 111.204 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 296' ' ' ALA . 44.9 mt -66.98 -32.3 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 121.881 -0.512 . . . . 64.03 110.702 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.06 -59.09 2.92 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.09 1.144 . . . . 71.42 114.09 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -36.35 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.606 1.706 . . . . 70.03 115.606 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -84.9 -22.99 29.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.437 0.295 . . . . 72.42 110.452 -168.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -85.59 -177.11 6.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.715 -0.675 . . . . 74.52 110.238 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.21 3.83 84.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 114.191 0.437 . . . . 61.11 114.191 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -123.48 -154.47 0.61 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.611 -0.514 . . . . 73.24 109.611 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.96 140.74 52.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.43 0.633 . . . . 64.53 110.958 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -114.22 111.28 21.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.136 -1.431 . . . . 73.5 107.136 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 20.6 m170 64.85 30.52 12.1 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.818 1.247 . . . . 73.15 112.672 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.2 10.54 77.76 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 116.298 -0.41 . . . . 74.31 113.875 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -126.72 148.62 49.86 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.269 -0.641 . . . . 74.5 109.269 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.62 130.76 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 123.523 0.515 . . . . 73.13 110.628 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.5 tt -107.75 143.32 18.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.824 -0.806 . . . . 74.02 108.824 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 4.3 tmtp? -135.95 122.55 20.89 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.292 -0.633 . . . . 74.44 109.292 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 9.8 p -111.45 137.35 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.701 0.625 . . . . 75.52 109.608 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -138.21 173.5 11.55 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 123.177 0.591 . . . . 72.04 110.564 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -3.23 51.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.126 0.787 . . . . 73.31 113.126 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.1 -164.33 0.25 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.319 1.047 . . . . 52.53 113.183 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.51 163.66 13.13 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.669 -0.493 . . . . 74.23 109.669 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -88.03 149.65 23.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 73.42 109.684 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 71.4 167.26 0.12 Allowed Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 124.721 1.208 . . . . 75.41 112.406 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.94 100.22 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.114 1.209 . . . . 75.15 112.597 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.647 -0.706 . . . . 71.14 109.48 174.764 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 111.716 -0.554 . . . . 74.25 111.716 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.9 m 59.19 46.0 13.6 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.723 1.209 . . . . 63.3 113.624 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -74.93 134.95 41.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.121 -0.49 . . . . 71.14 111.728 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 58.4 mtt -122.4 108.25 12.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.334 -0.848 . . . . 75.11 110.152 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 66.1 m -137.98 154.24 49.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.44 -0.8 . . . . 74.43 110.228 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.01 -27.51 57.41 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.548 0.53 . . . . 73.14 110.264 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.9 119.39 19.02 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.234 -0.894 . . . . 62.24 110.653 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.81 106.83 18.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.192 0.52 . . . . 71.23 110.207 165.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.7 m -141.96 148.88 39.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.889 -1.152 . . . . 55.32 107.889 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.7 pt -122.69 141.24 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.722 0.692 . . . . 63.22 109.173 166.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.84 134.8 43.27 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -128.03 144.55 37.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.664 0.745 . . . . 74.41 112.637 178.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.04 147.11 50.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 113.988 -1.46 . . . . 75.31 109.773 -176.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.13 32.75 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 123.823 0.702 . . . . 63.02 112.644 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 72.21 0.81 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.967 -1.123 . . . . 63.12 107.967 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.31 157.33 27.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.271 -0.877 . . . . 42.2 112.868 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.66 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.642 . . . . 71.4 113.062 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.71 21.64 36.21 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.198 -0.91 . . . . 37.27 111.04 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.48 150.1 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.535 -0.543 . . . . 63.23 109.535 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 24.6 m -88.55 170.35 10.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.74 -0.663 . . . . 64.15 110.831 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -169.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.547 1.939 . . . . 73.43 113.37 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -43.91 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 127.028 2.131 . . . . 71.11 116.074 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -48.31 -23.19 0.83 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 126.511 1.924 . . . . 74.12 113.77 170.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -57.4 -29.78 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.834 0.453 . . . . 74.3 110.63 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.31 -38.04 94.01 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.714 -0.492 . . . . 72.1 113.37 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.95 -30.56 66.88 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.795 0.838 . . . . 71.2 111.389 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.8 t80 -56.62 -45.87 81.25 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.83 0.852 . . . . 64.51 111.186 171.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -77.61 -22.64 50.48 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 122.055 -0.403 . . . . 75.05 111.53 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.54 -10.63 59.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.527 1.131 . . . . 73.01 111.94 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.01 -16.72 62.26 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 121.807 -0.558 . . . . 64.34 111.523 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.1 mm -103.49 -48.19 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.458 0.703 . . . . 75.33 110.274 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -135.8 -159.51 8.55 Favored Glycine 0 C--O 1.22 -0.747 0 C-N-CA 120.769 -0.729 . . . . 73.31 113.428 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.9 mt -107.65 142.09 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.339 0.656 . . . . 73.14 111.754 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.7 mm -65.39 115.14 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 123.717 0.636 . . . . 75.5 110.142 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -98.08 140.11 32.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.453 -0.794 . . . . 65.12 111.369 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.0 m -85.52 117.75 24.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.106 -0.952 . . . . 72.24 108.478 168.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.1 125.79 29.9 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 109.062 -0.718 . . . . 72.42 109.062 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.8 -9.51 58.66 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.637 0.977 . . . . 54.11 113.637 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 -29.14 65.31 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 111.884 0.328 . . . . 73.33 111.884 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.6 t -124.16 -31.79 3.29 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.469 -0.332 . . . . 63.1 111.641 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.6 6.65 70.1 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 123.338 0.399 . . . . 64.12 112.679 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -97.17 151.87 37.95 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.093 0.405 . . . . 75.54 112.093 174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.93 154.06 75.55 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.523 2.815 . . . . 51.34 111.794 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.428 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.7 ptm -71.98 99.79 2.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.451 1.278 . . . . 65.22 114.451 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.4 mm -144.16 113.85 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.58 -1.266 . . . . 74.13 107.58 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -128.99 119.48 24.36 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.077 0.853 . . . . 72.14 110.57 161.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 113.07 25.18 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.376 0.422 . . . . 71.3 110.278 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.35 112.68 25.48 Favored 'General case' 0 C--O 1.262 1.761 0 CA-C-O 121.31 0.576 . . . . 75.21 110.627 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.9 p -144.8 121.16 10.94 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.809 -1.541 . . . . 74.04 109.455 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.8 113.01 22.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.407 0.623 . . . . 63.24 111.719 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -8.72 58.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.715 1.006 . . . . 71.53 113.715 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -30.41 64.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 51.44 112.08 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -90.66 -19.03 24.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 120.735 -0.386 . . . . 73.12 110.185 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.5 22.93 38.39 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.951 -0.568 . . . . 74.02 113.802 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -146.82 147.69 30.62 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.744 -0.465 . . . . 74.12 109.744 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.38 126.75 22.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.047 1.831 . . . . 73.55 113.594 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -62.19 -40.11 94.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.88 -1.055 . . . . 74.24 111.628 175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.95 25.15 15.24 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.812 -0.708 . . . . 63.42 111.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -119.03 143.75 46.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 73.13 109.609 -175.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 158.64 44.26 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.623 -0.262 . . . . 62.52 111.179 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 19.4 p -136.18 137.78 41.25 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.104 -0.332 . . . . 60.21 110.104 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.12 147.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 116.356 -0.384 . . . . 64.44 110.461 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.3 t -99.1 117.49 33.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.309 0.644 . . . . 64.03 112.664 -174.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 162.81 16.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 121.154 -0.219 . . . . 71.24 110.867 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.88 -48.63 17.75 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.307 0.484 . . . . 44.53 112.307 -172.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.44 137.18 21.52 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.695 -0.402 . . . . 74.03 110.904 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.08 -38.02 80.28 Favored 'Trans proline' 0 CA--C 1.566 2.086 0 C-N-CA 123.265 2.644 . . . . 63.22 116.234 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.65 -30.89 41.62 Favored 'Trans proline' 0 C--N 1.396 3.043 0 CA-C-N 123.314 2.219 . . . . 55.11 113.177 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 39.7 m -69.76 -29.4 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.477 -0.783 . . . . 65.51 111.115 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.03 -41.75 58.61 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 122.956 0.502 . . . . 70.11 111.347 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -33.43 66.83 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 112.009 0.374 . . . . 72.11 112.009 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.21 75.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.354 -0.384 . . . . 75.05 110.675 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.58 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.44 -25.28 64.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.977 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.75 -33.64 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.132 -0.355 . . . . 71.04 110.489 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.97 -58.82 3.05 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 113.865 1.061 . . . . 74.44 113.865 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.56 -29.69 18.73 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.219 1.933 . . . . 73.12 116.219 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.58 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 75.0 t80 -89.03 -8.25 54.35 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 118.345 0.521 . . . . 62.41 111.017 -168.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 165.23 11.34 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 108.217 -1.031 . . . . 73.31 108.217 170.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.17 13.43 52.4 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.76 -0.734 . . . . 65.24 112.363 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -122.31 -160.5 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.495 -1.298 . . . . 63.41 107.495 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.09 143.27 46.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.474 0.654 . . . . 72.5 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -113.81 113.93 25.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.196 -1.039 . . . . 75.21 108.196 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.17 28.46 14.06 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.809 1.244 . . . . 74.22 112.593 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.14 74.7 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.568 -0.349 . . . . 71.23 113.831 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.74 143.52 51.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.419 -0.956 . . . . 65.23 108.419 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.94 127.68 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.88 0.372 . . . . 74.42 111.079 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.7 tt -109.78 137.62 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.025 -0.534 . . . . 72.34 111.101 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -130.48 128.42 41.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.77 -0.65 . . . . 74.32 111.051 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.97 130.49 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 122.99 0.516 . . . . 74.52 110.759 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -129.42 175.78 8.49 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.626 1.17 . . . . 71.33 109.414 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.83 -3.13 59.03 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.884 1.068 . . . . 74.3 113.884 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.04 -164.12 0.25 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.084 0.954 . . . . 62.24 113.128 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.5 m -99.46 144.82 28.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.471 -0.566 . . . . 73.43 109.471 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 174.95 5.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.882 -0.599 . . . . 71.13 109.641 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 71.77 88.84 0.09 OUTLIER Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.851 1.261 . . . . 73.12 112.297 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.07 101.58 1.01 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.499 2.133 . . . . 70.43 114.046 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.179 -0.915 . . . . 73.44 109.742 174.127 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.922 0 N-CA-C 112.231 -0.348 . . . . 75.35 112.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 66.9 m -112.64 -176.04 2.81 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.663 0.268 . . . . 60.52 111.424 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -137.47 120.7 16.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.597 -0.274 . . . . 72.5 110.87 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.71 78.05 1.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.873 0.845 . . . . 75.02 110.008 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.9 p -160.62 131.3 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.037 -0.983 . . . . 64.1 110.759 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -83.83 -36.14 23.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.524 -0.546 . . . . 51.11 109.524 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -76.24 123.56 26.08 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.292 -0.867 . . . . 73.4 110.427 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.75 106.83 18.78 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.395 0.616 . . . . 74.34 110.466 165.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.6 m -142.16 149.19 39.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.135 -1.061 . . . . 70.3 108.135 166.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.96 140.57 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.614 0.643 . . . . 74.32 109.533 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.07 135.04 43.18 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.037 -0.727 . . . . 70.11 109.037 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -126.61 143.68 39.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.626 0.727 . . . . 53.44 112.538 177.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.78 148.06 50.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.272 -1.331 . . . . 73.25 110.849 -176.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.27 20.0 37.02 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 123.814 0.696 . . . . 71.45 113.186 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.09 74.14 0.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.684 -1.228 . . . . 75.11 107.684 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.22 -82.6 0.22 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.368 -0.92 . . . . 75.41 112.808 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 110.39 10.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.785 0.803 . . . . 74.03 111.532 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.73 19.88 33.18 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.079 -0.964 . . . . 73.2 111.566 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.95 151.94 4.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.719 -0.474 . . . . 63.05 109.719 -172.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.5 m -91.49 170.49 9.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.523 -0.762 . . . . 64.01 109.93 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.928 2.091 . . . . 72.32 113.971 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -43.85 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.606 1.962 . . . . 74.43 115.319 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.73 -21.47 0.2 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.636 1.975 . . . . 63.32 113.957 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -56.49 -31.53 34.04 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 CA-C-N 118.618 0.645 . . . . 75.41 109.818 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.92 -33.53 83.94 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 119.858 -0.412 . . . . 70.21 113.704 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -74.74 -30.47 61.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.907 0.883 . . . . 70.01 111.184 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 4.7 t80 -57.5 -46.82 83.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.541 0.736 . . . . 74.05 110.646 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.93 -23.59 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.432 0.158 . . . . 72.21 111.325 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -69.72 -20.0 63.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.586 0.754 . . . . 73.44 111.519 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -65.31 -20.01 66.21 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 122.187 -0.321 . . . . 71.4 111.325 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.1 63.04 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.823 -0.436 . . . . 75.2 109.823 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.11 178.37 23.22 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.209 -0.996 . . . . 74.15 115.044 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.08 138.35 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.5 0.72 . . . . 73.22 110.337 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.8 mm -71.23 111.9 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.271 0.557 . . . . 74.14 110.417 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -102.28 144.26 31.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 73.13 111.32 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.29 132.38 34.63 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.857 -0.794 . . . . 73.24 108.857 165.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.64 123.52 26.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.479 -0.934 . . . . 62.21 108.479 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.12 58.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.941 0.719 . . . . 55.32 112.941 -173.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -68.51 -34.22 75.5 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.579 0.352 . . . . 73.24 111.304 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 p -125.53 -32.0 2.93 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 111.863 0.32 . . . . 73.53 111.863 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.84 10.18 65.18 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.925 -0.58 . . . . 73.21 113.487 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -97.19 145.61 29.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 117.335 0.568 . . . . 74.24 111.224 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.8 153.45 77.79 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.975 2.45 . . . . 64.44 111.448 168.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.465 ' CB ' ' H ' ' A' ' 289' ' ' SER . 3.4 ptm -71.6 98.63 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.176 1.176 . . . . 73.35 114.176 -171.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -144.5 112.53 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.026 -1.472 . . . . 71.13 107.026 164.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -130.09 116.72 18.91 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.139 0.882 . . . . 72.43 109.786 159.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.01 110.55 19.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.786 -0.45 . . . . 72.15 109.786 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -102.88 112.87 25.88 Favored 'General case' 0 C--O 1.261 1.706 0 CA-C-O 121.247 0.546 . . . . 74.43 110.896 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.0 p -143.32 123.34 13.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.109 -1.405 . . . . 72.41 110.292 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.63 112.12 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.153 0.501 . . . . 70.34 111.974 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -11.04 51.07 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.187 0.81 . . . . 74.33 113.187 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.88 -28.59 58.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.604 0.24 . . . . 74.55 111.641 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 71.1 p -89.33 -22.22 22.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.146 -0.687 . . . . 64.12 109.146 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.35 57.25 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.191 -0.913 . . . . 35.95 112.679 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -109.45 139.59 21.27 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.957 -0.386 . . . . 61.14 109.957 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.02 136.99 78.57 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.152 2.568 . . . . 72.11 114.448 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -67.85 -35.62 78.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.938 -1.028 . . . . 52.45 112.053 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.25 22.23 25.34 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.03 -0.605 . . . . 51.53 112.992 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -116.22 142.67 46.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.682 -0.407 . . . . 71.42 109.929 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.73 153.65 34.77 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.596 0.56 . . . . 75.13 110.661 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 136.21 40.88 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.755 0.312 . . . . 64.44 110.446 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.27 148.13 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.933 -0.576 . . . . 74.04 110.139 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.465 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.8 t -105.34 120.26 41.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.65 0.78 . . . . 73.14 112.664 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -85.77 163.66 18.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.082 0.401 . . . . 73.4 112.082 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -78.81 -47.46 16.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.299 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -98.67 135.94 20.89 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.348 -0.387 . . . . 73.35 111.176 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.63 -40.51 29.54 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 122.559 2.173 . . . . 73.43 115.87 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 -29.74 47.99 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.759 2.021 . . . . 61.2 113.602 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 75.0 m -64.77 -26.26 68.28 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -74.08 -48.34 30.45 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.469 0.308 . . . . 72.34 111.664 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -33.72 71.69 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.261 0.553 . . . . 74.53 112.103 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.65 62.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.746 -0.661 . . . . 61.52 110.937 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.89 -28.7 65.85 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.468 0.175 . . . . 40.21 111.187 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.34 -33.75 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 O-C-N 122.225 -0.297 . . . . 72.4 110.468 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.11 -59.4 2.8 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 114.389 1.255 . . . . 61.54 114.389 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -90.05 -33.68 16.23 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.746 1.758 . . . . 70.45 115.746 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.4 t80 -85.65 -19.62 30.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.091 0.472 . . . . 73.32 109.984 -169.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -105.59 174.38 5.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.081 -0.963 . . . . 74.41 109.207 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.31 53.51 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.893 -0.67 . . . . 35.95 111.731 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -136.0 -154.52 0.57 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.64 -0.504 . . . . 71.3 109.64 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.51 145.54 51.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.77 0.795 . . . . 71.3 111.416 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -114.82 115.96 27.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.546 -1.206 . . . . 62.34 108.274 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.2 m170 64.44 28.93 13.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.607 1.163 . . . . 53.33 112.834 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.05 84.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.462 -0.399 . . . . 53.11 113.887 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -122.62 147.97 45.8 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.92 -0.77 . . . . 63.53 108.92 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.4 mm -69.97 129.74 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.721 0.408 . . . . 74.23 110.614 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.4 tt -108.41 147.08 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.206 -0.664 . . . . 74.43 109.206 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -137.2 123.82 21.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.408 -0.36 . . . . 63.43 111.279 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.74 135.83 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.22 0.608 . . . . 53.41 110.266 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.1 m -138.09 175.24 9.76 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.546 1.139 . . . . 73.34 109.591 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -85.7 2.0 47.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 71.24 113.975 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 61.01 -163.02 0.26 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.726 0.81 . . . . 64.54 112.173 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 9.5 t -89.15 141.5 28.46 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.288 -0.634 . . . . 74.54 109.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.15 85.13 2.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.585 0.707 . . . . 52.13 110.862 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -166.11 86.88 0.91 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.07 -0.968 . . . . 55.52 110.458 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -82.57 110.28 1.9 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.448 1.432 . . . . 71.15 113.031 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.539 -0.743 . . . . 70.21 109.717 -179.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.95 0 N-CA-C 111.925 -0.47 . . . . 54.44 111.925 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 62.5 m -138.64 167.46 21.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.85 0.325 . . . . 71.11 110.739 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -71.9 133.52 45.47 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.859 -0.609 . . . . 75.45 111.15 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.9 mmt -117.47 17.63 14.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.72 -0.673 . . . . 75.51 110.18 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 45.7 m 71.31 -178.63 0.22 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.779 1.632 . . . . 36.65 112.269 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 3.52 44.67 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.587 -0.733 . . . . 73.32 111.101 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -80.36 106.87 12.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.431 -0.804 . . . . 71.3 110.337 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.55 105.48 17.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.654 -0.818 . . . . 74.42 110.182 166.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.4 m -143.2 144.16 32.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.486 -1.301 . . . . 74.44 107.486 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.3 pt -120.58 136.62 56.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 119.233 0.924 . . . . 72.04 109.727 164.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.402 ' HA ' HG23 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.14 121.21 41.06 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.39 0.614 . . . . 70.31 109.526 -178.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -118.14 139.59 44.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.309 -0.859 . . . . 63.33 109.954 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.57 141.23 51.43 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.038 -0.727 . . . . 73.52 109.038 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 104.52 26.64 6.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.156 -0.545 . . . . 70.5 113.221 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 78.93 1.87 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.227 -0.657 . . . . 60.14 109.227 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -141.42 -79.63 0.05 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 120.058 -1.067 . . . . 74.33 112.946 -175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.26 110.48 10.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.902 0.382 . . . . 74.1 111.846 -173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.58 18.73 43.78 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.683 -0.77 . . . . 61.34 111.686 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.57 151.32 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.195 0.522 . . . . 71.43 109.764 -170.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.419 ' O ' HG12 ' A' ' 245' ' ' VAL . 24.7 m -86.24 169.76 12.73 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.774 -0.648 . . . . 72.24 109.949 171.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -168.45 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.694 1.998 . . . . 73.13 112.709 -177.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.63 -12.21 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.774 2.03 . . . . 52.44 115.873 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.8 OUTLIER -47.07 -23.89 0.56 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 126.901 2.081 . . . . 75.01 113.304 170.207 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -56.75 -31.45 35.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-N 118.171 0.442 . . . . 52.41 110.116 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.14 -32.51 76.39 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 121.645 -0.659 . . . . 75.35 113.659 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -75.71 -31.23 59.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.382 0.673 . . . . 71.25 110.98 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.7 t80 -54.67 -46.77 74.11 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.36 0.664 . . . . 64.03 110.874 170.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -77.74 -23.27 49.4 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.218 -0.301 . . . . 73.31 111.68 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -67.46 -19.27 65.33 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.579 0.752 . . . . 62.23 111.549 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.4 pt20 -63.01 -18.99 63.92 Favored 'General case' 0 CA--C 1.558 1.254 0 O-C-N 122.24 -0.287 . . . . 74.12 111.424 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 mm -120.75 54.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-O 121.211 0.529 . . . . 75.32 109.838 171.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.29 -169.6 27.56 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 118.268 -1.92 . . . . 61.42 115.214 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.35 137.66 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.282 -0.959 . . . . 75.22 109.761 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.5 mm -72.04 114.15 10.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.57 0.7 . . . . 61.52 110.438 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -98.53 144.3 28.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.65 -1.159 . . . . 75.12 110.393 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.8 m -84.29 118.92 24.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.631 -0.877 . . . . 62.32 108.631 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.59 128.4 35.45 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 109.354 -0.61 . . . . 71.55 109.354 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -79.29 -8.38 59.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.378 0.881 . . . . 71.42 113.378 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.15 -30.52 68.77 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.144 0.277 . . . . 74.44 111.132 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.0 t -125.46 -31.07 3.04 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.572 -0.285 . . . . 70.34 111.572 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.93 5.98 67.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.321 -0.4 . . . . 64.42 112.726 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -97.22 152.64 38.39 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 123.052 0.541 . . . . 74.35 111.721 173.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.59 153.31 75.8 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.318 2.678 . . . . 72.1 111.802 166.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -70.23 101.62 1.92 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.966 1.099 . . . . 72.42 113.966 -173.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.2 mm -143.59 112.9 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.624 -1.25 . . . . 73.3 107.624 163.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -128.33 116.72 20.24 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.381 0.991 . . . . 52.24 110.227 164.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 112.12 22.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.007 0.432 . . . . 74.23 110.426 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 112.34 25.03 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-N 115.852 -0.613 . . . . 73.43 110.243 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.4 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.4 p -142.28 122.03 13.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.249 -1.341 . . . . 73.13 110.488 -176.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.73 110.98 19.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.229 0.538 . . . . 72.22 111.217 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -10.8 49.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.53 0.937 . . . . 73.41 113.53 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.3 -29.27 53.61 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 62.22 109.718 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 60.9 p -89.1 -20.37 24.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.31 -0.859 . . . . 64.11 109.836 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.27 -34.65 5.25 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.301 -0.863 . . . . 74.43 113.061 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -101.35 143.77 27.26 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 109.804 -0.443 . . . . 73.44 109.804 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.22 141.03 88.52 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.275 2.65 . . . . 63.04 114.018 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 275' ' ' THR . 52.0 mttt -65.62 -33.14 75.21 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.774 -1.103 . . . . 74.4 111.606 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.77 23.31 23.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.517 -0.765 . . . . 71.0 112.237 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.82 143.0 47.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.308 -0.557 . . . . 73.31 110.702 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.03 143.18 24.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.626 -0.715 . . . . 70.3 109.496 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.402 HG23 ' HA ' ' A' ' 237' ' ' PHE . 68.9 p -126.88 137.86 53.22 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.609 -0.436 . . . . 70.02 110.023 173.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.49 145.43 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 121.043 0.449 . . . . 74.42 109.991 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.71 129.18 45.16 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.623 0.972 . . . . 72.51 113.623 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.64 165.61 15.29 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.702 0.63 . . . . 74.11 112.702 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.69 73.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.448 -0.796 . . . . 72.51 111.935 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.4 139.8 35.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.891 -0.781 . . . . 71.51 108.891 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -58.79 -40.09 75.74 Favored 'Trans proline' 0 CA--C 1.576 2.588 0 C-N-CA 122.488 2.125 . . . . 65.2 117.368 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 -30.34 14.13 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 123.614 2.326 . . . . 73.21 114.106 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 55.0 p -62.97 -29.82 71.11 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.131 0.572 . . . . 74.42 111.627 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.11 -37.17 78.24 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.627 1.204 . . . . 43.4 112.214 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -68.56 -38.79 81.06 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 123.55 0.531 . . . . 72.42 111.839 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.55 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.937 -0.574 . . . . 65.12 111.428 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -66.51 -26.88 67.37 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 123.316 0.647 . . . . 54.14 112.257 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 296' ' ' ALA . 72.7 mt -68.71 -32.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.843 -1.161 . . . . 74.23 111.377 172.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.27 -58.27 3.38 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 113.169 0.803 . . . . 63.22 113.169 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.95 -30.72 17.64 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.385 1.995 . . . . 73.54 116.385 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 66.0 t80 -88.53 -17.5 30.13 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.086 0.403 . . . . 73.42 110.742 -169.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.473 ' OD1' ' HA ' ' A' ' 314' ' ' LYS . 1.6 t70 -87.56 159.59 18.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.16 50.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.478 -0.391 . . . . 73.43 113.154 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 -162.04 0.84 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.414 -0.958 . . . . 73.4 108.414 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.66 143.69 51.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.715 0.769 . . . . 70.45 111.367 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -113.74 115.83 28.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.966 -1.016 . . . . 74.23 108.454 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 63.85 28.43 14.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.67 1.231 . . . . 75.31 112.406 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.12 11.54 80.86 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.113 0.405 . . . . 51.31 114.113 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.53 147.86 50.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.73 -0.841 . . . . 60.43 108.73 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.2 127.66 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.777 0.431 . . . . 73.11 111.369 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 14.8 tt -110.71 134.15 53.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.732 -0.667 . . . . 71.14 110.551 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.473 ' HA ' ' OD1' ' A' ' 304' ' ' ASP . 3.1 mttm -124.06 141.19 52.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.469 -0.787 . . . . 64.32 110.729 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 300' ' ' ILE . 0.3 OUTLIER -123.4 140.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.8 m -140.39 174.2 10.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.853 0.461 . . . . 72.1 110.86 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -2.63 55.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.609 0.966 . . . . 72.54 113.609 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.04 -160.39 0.3 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.264 1.026 . . . . 64.34 111.922 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.2 t -100.26 158.22 16.03 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.355 -0.609 . . . . 75.33 109.355 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -99.83 171.4 7.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 75.23 110.034 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 64.8 87.44 0.12 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.649 1.18 . . . . 75.4 112.745 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.5 86.12 0.72 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.805 2.337 . . . . 71.31 113.017 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.582 1.153 . . . . 74.42 112.142 -176.616 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 CA-C-O 119.546 -0.586 . . . . 64.44 112.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.3 m 58.58 64.06 1.54 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.46 1.104 . . . . 64.05 111.556 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 63.72 -178.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.374 1.47 . . . . 74.54 111.792 -173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -130.54 19.36 5.21 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.998 -0.439 . . . . 73.41 111.198 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 59.7 m 72.19 130.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.197 1.399 . . . . 74.44 112.421 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.18 -38.51 51.51 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.475 -0.784 . . . . 74.34 110.264 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -74.56 117.86 16.87 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 63.41 110.402 171.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.29 106.47 18.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 119.675 -0.81 . . . . 70.11 110.724 165.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.1 m -142.1 147.08 36.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.735 -1.209 . . . . 70.35 107.735 166.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.27 137.0 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.106 0.867 . . . . 75.03 109.959 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.54 124.51 44.78 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.207 -0.664 . . . . 53.11 109.207 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.79 140.7 44.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.718 -0.674 . . . . 71.02 109.556 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.69 141.56 51.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.599 . . . . 64.13 109.442 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.32 27.61 6.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.291 -0.481 . . . . 62.14 112.773 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.14 80.34 1.95 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.246 -0.65 . . . . 74.3 109.246 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -146.7 -69.6 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.396 -0.907 . . . . 60.13 113.126 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.7 107.2 11.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.741 0.781 . . . . 72.43 111.232 -171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.22 20.77 44.22 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.228 -0.897 . . . . 51.34 111.569 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 246' ' ' SER . 0.3 OUTLIER -79.97 152.33 4.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.104 0.478 . . . . 73.31 109.937 -172.176 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 245' ' ' VAL . 17.7 m -89.28 171.05 10.06 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.609 -0.723 . . . . 70.25 109.571 170.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.852 1.661 . . . . 54.33 113.887 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -43.44 -14.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 127.764 2.426 . . . . 71.0 115.257 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.62 -21.46 0.36 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.942 2.097 . . . . 74.24 114.429 171.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -55.37 -31.62 27.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 C-N-CA 122.951 0.5 . . . . 64.21 110.102 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.65 -33.56 82.76 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.684 -0.509 . . . . 42.51 114.018 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.2 -30.87 60.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.226 0.611 . . . . 75.12 110.946 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.547 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.6 t80 -54.39 -46.32 73.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 71.44 110.619 170.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.07 -23.31 48.1 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.906 0.336 . . . . 74.23 111.906 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -70.63 -15.21 62.72 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.145 0.978 . . . . 74.3 111.514 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.49 -14.53 57.61 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 122.036 -0.415 . . . . 72.33 112.021 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.0 -31.54 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.097 0.559 . . . . 63.22 111.157 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -156.86 -160.78 10.31 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 119.429 -1.367 . . . . 75.31 114.845 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.91 138.81 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.913 -0.643 . . . . 75.44 110.369 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 30.9 mm -68.94 115.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 123.77 0.669 . . . . 71.5 110.565 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -97.84 142.37 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.318 -0.855 . . . . 74.32 110.94 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 80.2 m -85.94 115.84 23.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.198 -1.038 . . . . 62.24 108.198 167.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 122.92 22.64 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.046 -0.724 . . . . 71.1 109.046 -177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -72.58 -8.92 57.64 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.238 1.199 . . . . 75.53 114.238 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -69.87 -29.85 67.17 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.334 0.254 . . . . 65.42 111.614 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.4 t -124.41 -31.9 3.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.641 -0.254 . . . . 71.24 111.121 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.68 66.41 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 116.382 -0.372 . . . . 71.44 112.321 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -97.62 153.19 38.39 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.246 0.618 . . . . 63.42 111.388 173.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.26 153.79 67.67 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 123.493 2.795 . . . . 74.11 112.048 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 1.1 ptm -75.2 100.73 4.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.704 0.764 . . . . 55.32 112.746 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.73 114.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.285 -1.376 . . . . 72.15 107.285 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -128.5 117.07 20.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.151 0.887 . . . . 73.43 109.957 161.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.09 111.78 22.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.177 0.513 . . . . 71.34 110.152 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -101.45 112.41 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.948 -0.569 . . . . 75.35 109.942 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.2 p -144.35 119.36 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.23 -1.35 . . . . 75.33 109.908 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -87.63 111.91 21.76 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.619 1.2 . . . . 63.42 112.274 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -7.92 58.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.185 -0.916 . . . . 71.23 112.525 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.73 -27.96 64.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.723 0.409 . . . . 74.24 111.94 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 44.0 p -89.64 -25.85 21.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.571 -0.529 . . . . 75.45 109.571 168.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.49 61.31 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.195 -0.911 . . . . 72.14 112.661 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 140.85 37.96 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.367 -0.975 . . . . 71.54 108.367 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.07 137.33 70.92 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.348 2.032 . . . . 62.25 114.285 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -61.13 -35.07 76.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.058 -1.428 . . . . 74.15 111.739 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.07 30.73 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.484 -0.78 . . . . 62.43 112.744 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -119.97 143.39 48.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.988 -0.685 . . . . 63.22 110.476 -172.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.62 24.15 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.941 -0.572 . . . . 71.35 110.018 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 60.3 p -127.0 137.85 53.16 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 110.148 -0.316 . . . . 71.11 110.148 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.93 147.88 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 110.034 -0.358 . . . . 74.12 110.034 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 14.5 m -108.48 123.95 49.68 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.531 0.567 . . . . 73.35 112.531 -170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.8 163.44 13.52 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.963 0.357 . . . . 74.22 111.963 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -76.25 -48.27 20.89 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.641 -0.254 . . . . 73.21 110.4 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.55 135.21 19.35 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 120.366 -0.533 . . . . 74.41 110.03 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.4 -39.34 29.53 Favored 'Trans proline' 0 CA--C 1.568 2.208 0 C-N-CA 122.572 2.181 . . . . 75.21 116.029 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.51 -31.05 61.45 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 122.978 2.099 . . . . 63.23 113.958 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.8 m -70.32 -30.3 67.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.897 -0.592 . . . . 73.22 110.794 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.64 64.18 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.795 -0.638 . . . . 73.23 111.08 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -71.82 -37.07 70.39 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 120.887 0.375 . . . . 71.22 111.967 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.41 78.12 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.339 -0.391 . . . . 73.4 110.842 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.575 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -65.25 -35.15 80.13 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 116.154 -0.476 . . . . 53.34 111.76 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.74 -32.57 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 O-C-N 122.052 -0.405 . . . . 70.24 111.106 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -72.34 -58.43 3.41 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.973 1.101 . . . . 63.21 113.973 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.55 -30.92 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.569 2.063 . . . . 71.33 116.569 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 85.4 t80 -83.94 -11.21 57.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.443 0.697 . . . . 74.43 111.107 -168.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.21 170.44 7.88 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.624 -0.88 . . . . 74.31 108.624 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.64 6.21 59.69 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.272 -0.49 . . . . 72.54 112.48 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 -157.55 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.393 -0.965 . . . . 61.33 108.393 174.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -129.87 147.15 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.428 0.632 . . . . 65.34 111.329 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -114.32 111.88 22.2 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.8 28.78 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.423 1.089 . . . . 73.34 112.253 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.06 -2.07 87.69 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 116.359 -0.382 . . . . 63.24 113.546 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -108.64 144.9 35.77 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 109.125 -0.694 . . . . 70.32 109.125 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.28 126.99 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.863 0.363 . . . . 75.1 111.126 -173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 20.3 tt -110.34 136.31 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.568 0.699 . . . . 64.22 111.191 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -130.64 131.74 45.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.052 -0.976 . . . . 72.14 110.545 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.24 139.06 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 110.006 -0.368 . . . . 54.14 110.006 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.4 m -137.88 174.71 10.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.195 0.998 . . . . 54.15 109.647 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.68 1.59 51.46 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.051 1.13 . . . . 74.23 114.051 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.76 -162.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.012 0.925 . . . . 73.13 113.178 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 6.8 m -97.15 131.71 43.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.059 -0.719 . . . . 74.23 109.059 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -91.53 177.02 6.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.981 -0.554 . . . . 63.33 110.325 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 67.94 86.77 0.12 Allowed Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.554 1.142 . . . . 71.32 111.831 173.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.3 175.6 8.12 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.58 2.186 . . . . 64.15 114.491 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.256 1.41 0 CA-C-N 114.846 -1.07 . . . . 74.43 109.545 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 CA-C-O 119.554 -0.581 . . . . 73.44 111.998 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 22.7 m 62.14 92.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.007 1.323 . . . . 73.34 113.233 176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -135.55 132.3 37.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 75.22 111.707 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.76 97.87 3.09 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.956 0.884 . . . . 74.3 110.009 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.1 m -141.47 134.57 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.957 -1.019 . . . . 74.2 109.299 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -84.19 -9.66 58.36 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.706 0.629 . . . . 74.13 110.932 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.27 104.34 13.37 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.808 -0.633 . . . . 72.11 109.47 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 107.02 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.329 -0.548 . . . . 65.44 109.819 168.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.9 m -142.9 149.01 37.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.584 -0.895 . . . . 71.12 108.584 169.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.7 pp -123.79 141.15 45.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 118.625 0.648 . . . . 75.22 109.58 161.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 315' ' ' VAL . 0.3 OUTLIER -102.31 130.2 48.95 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 177.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -121.38 144.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.636 0.731 . . . . 62.01 112.642 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 114.257 -1.338 . . . . 62.33 110.049 -178.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 95.45 7.89 58.91 Favored Glycine 0 CA--C 1.519 0.296 0 O-C-N 123.599 0.562 . . . . 60.25 113.688 174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.67 76.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.374 -0.973 . . . . 63.1 108.374 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -134.4 -87.65 0.28 Allowed Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 120.419 -0.896 . . . . 64.31 113.822 -171.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.96 112.91 9.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.753 0.311 . . . . 75.21 111.21 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.01 19.87 38.27 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.709 -0.678 . . . . 70.22 111.977 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.33 150.87 4.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.311 0.576 . . . . 72.25 109.674 -173.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.1 m -90.29 170.65 10.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.539 -0.755 . . . . 65.02 110.364 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -167.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 127.117 2.167 . . . . 70.44 113.36 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.2 -11.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.285 1.834 . . . . 74.21 115.673 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -45.87 -22.31 0.19 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 126.869 2.068 . . . . 74.1 113.756 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.54 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -32.28 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 118.815 0.734 . . . . 72.4 110.058 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -36.67 92.78 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.737 -0.479 . . . . 71.0 113.168 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.11 -34.27 76.06 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.502 0.721 . . . . 71.24 110.635 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.1 t80 -57.56 -43.18 84.27 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.252 -0.886 . . . . 72.05 111.486 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.64 -24.45 45.26 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.181 0.438 . . . . 72.32 112.181 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 23.4 tptm -66.66 -18.96 65.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.795 1.238 . . . . 64.35 112.189 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.23 -15.09 62.11 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 113.172 0.804 . . . . 64.24 113.172 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.2 -6.73 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 120.882 0.372 . . . . 72.51 110.792 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.508 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . -171.59 -160.44 20.13 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 118.95 -1.595 . . . . 75.34 114.721 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.59 139.44 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.443 0.697 . . . . 74.24 110.518 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.412 HG12 ' HD3' ' A' ' 255' ' ' LYS . 20.8 mm -66.38 116.31 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 123.643 0.589 . . . . 74.4 109.674 173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.11 133.24 42.03 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.447 -0.797 . . . . 72.35 110.454 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 50.3 m -84.8 117.09 23.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.299 -1.0 . . . . 73.24 108.299 167.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.29 136.67 42.63 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 112.196 0.443 . . . . 74.45 112.196 -174.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -80.07 -10.77 59.79 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.668 0.988 . . . . 73.11 113.668 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -70.12 -38.48 75.6 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 112.477 0.547 . . . . 72.42 112.477 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.37 -24.55 4.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.482 0.182 . . . . 75.4 111.279 174.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.85 16.52 54.39 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.121 0.408 . . . . 74.42 114.121 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -100.34 152.94 37.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.398 0.599 . . . . 72.43 111.496 177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.62 152.12 83.04 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.443 2.096 . . . . 73.33 111.572 166.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.472 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.09 97.9 4.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.764 1.024 . . . . 65.21 113.764 -172.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 35.7 mm -143.11 112.87 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.614 -1.254 . . . . 75.15 107.614 165.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -129.07 117.61 21.15 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.107 0.867 . . . . 63.4 109.852 161.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 111.04 20.61 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.595 -0.52 . . . . 75.05 109.595 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -101.92 112.29 24.86 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 121.259 0.552 . . . . 71.34 110.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 23.0 p -142.6 120.93 12.32 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.985 -1.461 . . . . 72.33 110.207 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 26.0 t70 -87.47 113.49 23.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.288 0.566 . . . . 72.31 111.147 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -9.9 55.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.662 -0.699 . . . . 63.34 112.797 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -29.95 61.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.652 0.263 . . . . 62.21 111.547 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.4 t -91.3 -15.41 29.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.417 0.627 . . . . 75.4 109.686 167.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.98 -37.4 3.46 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.71 -0.677 . . . . 53.31 113.237 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -96.73 141.85 23.69 Favored Pre-proline 0 N--CA 1.443 -0.814 0 O-C-N 123.635 0.256 . . . . 72.43 110.971 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.49 136.26 74.78 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.636 2.891 . . . . 74.22 114.129 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.427 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 56.2 mtpt -65.6 -37.82 87.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 75.14 111.604 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.97 25.05 13.57 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.862 -0.685 . . . . 61.2 113.021 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -115.82 142.24 47.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.711 -0.477 . . . . 70.01 109.711 -174.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 155.26 38.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.308 -0.405 . . . . 41.53 110.828 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 137.31 41.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.098 -0.334 . . . . 72.1 110.098 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.56 145.36 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.152 -0.684 . . . . 72.25 109.152 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.472 ' H ' ' CB ' ' A' ' 270' ' ' MET . 22.7 t -97.68 117.59 32.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.639 0.775 . . . . 75.11 111.645 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.4 164.09 13.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 121.139 -0.225 . . . . 72.02 111.442 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.53 -48.53 55.06 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.715 0.635 . . . . 74.2 112.715 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -119.57 136.16 24.53 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.33 -38.35 65.6 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 123.682 2.921 . . . . 54.1 117.699 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.68 -29.94 15.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 123.55 2.304 . . . . 64.45 112.487 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -64.27 -27.4 69.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.725 1.21 . . . . 72.23 112.181 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -67.7 -40.97 84.3 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.595 0.559 . . . . 62.41 112.23 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -72.79 -34.67 67.08 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.292 0.567 . . . . 75.0 110.713 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.27 -33.76 76.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.337 -0.847 . . . . 71.14 111.048 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.22 -28.69 67.47 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.91 -0.586 . . . . 55.31 111.707 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 296' ' ' ALA . 49.3 mt -69.88 -30.59 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 O-C-N 122.035 -0.416 . . . . 63.12 110.812 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.88 -60.67 2.29 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.959 1.096 . . . . 63.14 113.959 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -91.87 -29.58 16.63 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.438 2.014 . . . . 73.15 116.438 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 23.6 t80 -86.62 -24.12 25.46 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 -171.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . 0.432 ' HB2' HG13 ' A' ' 315' ' ' VAL . 7.5 t70 -82.87 -170.51 3.04 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.957 -1.02 . . . . 73.12 109.531 166.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 78.25 13.48 83.25 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.198 -0.525 . . . . 62.44 112.853 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -135.67 -161.88 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.883 0.373 . . . . 73.34 110.179 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -128.69 144.62 51.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.21 0.529 . . . . 45.44 110.467 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -113.12 112.04 23.14 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.21 -1.033 . . . . 74.42 108.21 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 65.03 29.25 12.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.764 1.29 . . . . 75.52 112.167 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.78 5.79 80.82 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 114.211 0.444 . . . . 72.54 114.211 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -124.21 148.42 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.778 -0.823 . . . . 55.12 108.778 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.59 129.27 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 123.303 0.377 . . . . 70.43 110.901 -171.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.1 tt -108.5 143.95 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.791 -0.641 . . . . 75.52 109.54 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 15.3 tptp -136.94 121.89 18.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.914 0.388 . . . . 73.52 110.361 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 237' ' ' PHE . 7.7 p -111.89 138.39 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.522 -0.763 . . . . 61.24 111.226 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -142.79 172.79 12.22 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.286 1.034 . . . . 72.2 109.837 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -5.25 48.48 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.942 1.09 . . . . 74.23 113.942 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.59 -169.74 0.2 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.508 1.123 . . . . 72.12 113.176 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.7 m -87.23 139.25 30.75 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.737 -0.665 . . . . 70.24 110.183 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -96.66 169.73 9.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.177 -0.305 . . . . 72.22 110.177 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 72.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 124.619 1.199 . . . . 74.31 112.072 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.2 -164.06 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.79 2.326 . . . . 73.23 114.257 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.636 -1.166 . . . . 74.43 111.939 -175.457 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.058 0 N-CA-C 111.487 -0.645 . . . . 73.0 111.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.1 t -84.71 -69.24 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.262 0.531 . . . . 53.01 111.456 -175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 54.25 71.35 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.556 1.142 . . . . 73.4 112.838 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 56.1 mtt -100.43 91.36 4.66 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.499 0.666 . . . . 74.14 110.29 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.7 t -112.18 141.8 45.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.837 -1.074 . . . . 73.21 109.609 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.27 -34.14 76.8 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.354 1.034 . . . . 73.22 110.479 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -82.37 110.5 17.57 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.875 -1.057 . . . . 74.4 111.541 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.79 104.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.821 -0.752 . . . . 73.44 110.276 160.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 21.9 m -143.0 147.19 34.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.212 -1.032 . . . . 61.34 108.212 165.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 288' ' ' VAL . 2.5 pp -121.7 141.9 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 118.754 0.706 . . . . 62.43 109.588 164.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.67 122.31 45.39 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.754 -0.657 . . . . 74.44 109.39 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -114.3 144.52 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.755 0.788 . . . . 73.45 112.756 176.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.29 151.28 47.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.768 -1.56 . . . . 73.54 110.124 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.12 15.3 54.33 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.266 -0.492 . . . . 72.32 113.539 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.36 76.86 1.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.083 -1.081 . . . . 75.11 108.083 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.18 -88.26 0.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.152 -1.023 . . . . 70.11 114.301 -169.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -78.55 109.3 12.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 75.24 111.225 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.95 21.2 21.6 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.27 -0.877 . . . . 62.15 111.783 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -85.41 151.42 3.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.752 -0.462 . . . . 72.03 109.752 -173.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.0 m -90.54 170.01 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.788 -0.642 . . . . 73.02 110.696 172.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.811 2.044 . . . . 75.01 113.555 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -43.19 -12.7 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 126.634 1.974 . . . . 73.2 115.749 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.22 -22.04 0.34 Allowed 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 126.473 1.909 . . . . 73.43 113.668 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -56.57 -31.55 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 118.482 0.583 . . . . 73.11 110.236 178.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.07 -32.02 82.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.707 -0.496 . . . . 72.4 114.267 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -72.73 -33.58 66.5 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.706 0.802 . . . . 74.34 110.758 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.7 t80 -57.22 -43.15 82.58 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.083 -0.962 . . . . 73.14 111.256 173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.02 -24.9 43.34 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 122.144 -0.347 . . . . 74.31 111.851 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.87 -22.32 66.97 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.402 1.081 . . . . 75.21 112.199 177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -13.79 53.12 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 112.963 0.727 . . . . 52.34 112.963 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 46.6 mm -111.49 -26.46 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 122.698 0.399 . . . . 75.44 110.589 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -160.9 -174.95 31.39 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 119.982 -1.104 . . . . 62.42 115.127 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.22 138.8 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 73.43 111.201 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 23.7 mm -70.98 115.54 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.818 -0.628 . . . . 75.13 110.785 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -98.28 138.11 36.03 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.579 0.704 . . . . 71.2 111.078 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 94.7 m -84.2 116.83 23.14 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.605 -1.18 . . . . 70.24 108.509 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 131.51 37.05 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 109.504 -0.554 . . . . 63.3 109.504 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -76.08 -5.65 47.48 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.704 1.002 . . . . 71.54 113.704 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -66.94 -34.83 78.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.636 0.255 . . . . 70.03 111.156 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 21.3 p -124.6 -31.45 3.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.854 0.462 . . . . 65.43 111.578 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.88 67.17 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.431 -0.804 . . . . 74.45 112.034 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.32 151.73 37.53 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.101 0.56 . . . . 74.11 111.677 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.45 153.92 76.01 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.066 2.51 . . . . 74.12 111.38 166.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.423 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -76.93 99.2 5.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.373 0.879 . . . . 73.41 113.373 -169.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.9 mm -143.07 112.87 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.59 -1.263 . . . . 54.42 107.59 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -128.69 116.2 19.19 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.953 0.797 . . . . 73.44 110.276 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.81 110.89 20.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.638 -0.504 . . . . 71.12 109.638 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 31.7 m-85 -103.03 112.94 26.02 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.088 0.471 . . . . 72.25 110.651 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 p -144.77 122.07 11.58 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.55 -1.205 . . . . 74.23 110.088 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.21 112.2 21.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.441 0.638 . . . . 73.42 112.618 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -85.75 -10.42 55.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.799 -0.637 . . . . 70.23 112.017 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.69 -31.36 66.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.407 0.623 . . . . 65.54 110.221 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 47.3 p -91.21 -21.92 20.88 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.212 -0.904 . . . . 75.4 109.57 173.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.11 -33.25 6.29 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.263 -0.88 . . . . 62.35 113.029 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -99.37 141.42 22.8 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 110.302 -0.259 . . . . 75.44 110.302 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.58 132.72 53.82 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.418 2.745 . . . . 74.33 114.385 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -59.54 -42.09 91.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 75.14 112.294 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.49 24.76 15.19 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.64 -0.791 . . . . 54.04 113.145 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.4 mt-10 -116.45 142.87 46.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.722 -0.473 . . . . 71.22 109.722 -174.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.18 32.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 74.23 110.966 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 p -131.31 136.74 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.88 0.372 . . . . 71.03 110.2 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 236' ' ' ILE . 6.1 m -135.56 146.22 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 109.221 -0.659 . . . . 75.45 109.221 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.423 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.6 m -110.21 117.81 34.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.25 165.23 13.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.918 0.71 . . . . 74.35 112.918 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.66 -47.16 76.45 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.852 0.861 . . . . 73.11 112.857 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -122.45 136.7 26.8 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.964 -0.384 . . . . 73.02 109.964 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -61.26 -38.5 65.27 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.229 2.619 . . . . 74.25 117.259 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -28.18 14.2 Favored 'Trans proline' 0 C--N 1.386 2.502 0 CA-C-N 123.682 2.351 . . . . 71.32 112.466 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.7 m -62.48 -27.9 69.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.056 0.942 . . . . 72.13 112.026 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.14 -39.38 78.87 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.267 0.627 . . . . 70.1 111.904 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -69.49 -37.88 77.42 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.87 0.367 . . . . 74.41 110.772 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.03 72.09 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.633 -0.712 . . . . 71.24 110.941 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.73 -29.56 66.97 Favored 'General case' 0 C--O 1.213 -0.852 0 O-C-N 123.395 0.434 . . . . 75.13 111.726 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 296' ' ' ALA . 56.6 mt -69.84 -32.06 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 121.716 -0.615 . . . . 65.43 110.428 173.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.71 -60.61 2.3 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 113.381 0.882 . . . . 72.24 113.381 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -93.52 -30.76 14.85 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.283 1.957 . . . . 73.44 116.283 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 37.5 t80 -84.57 -23.19 29.77 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.492 0.587 . . . . 73.51 109.69 -169.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -87.78 -164.65 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.459 -0.792 . . . . 62.32 110.649 168.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.06 7.21 87.39 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.528 -0.76 . . . . 73.14 113.061 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -137.78 -164.35 1.6 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.56 0.219 . . . . 71.51 110.634 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.77 144.62 45.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.719 0.771 . . . . 62.23 112.035 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -113.82 114.83 26.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.794 -1.187 . . . . 62.13 107.794 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.09 28.5 14.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 124.64 1.213 . . . . 75.22 112.211 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.18 -4.47 84.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 114.106 0.403 . . . . 71.04 114.106 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -113.11 145.51 40.8 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.699 -0.482 . . . . 64.33 109.699 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.11 132.0 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.203 0.314 . . . . 74.02 110.635 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.8 tt -107.28 145.19 14.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.747 -0.834 . . . . 64.42 108.747 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 7.0 tppt? -136.19 121.32 18.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.095 -0.706 . . . . 72.03 109.095 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.23 134.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.399 0.618 . . . . 74.44 110.153 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.8 m -133.72 173.45 11.51 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.191 -0.913 . . . . 62.2 109.495 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -3.35 45.58 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.948 0.721 . . . . 75.13 112.948 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.96 -164.87 0.24 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.508 1.123 . . . . 62.53 112.771 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.9 171.57 13.73 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.696 -0.683 . . . . 62.54 109.255 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 -79.11 -171.75 2.81 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.176 0.436 . . . . 73.02 112.176 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -62.97 149.29 90.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.022 0.529 . . . . 63.35 112.422 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.49 95.47 0.18 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.263 2.642 . . . . 64.52 113.35 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.488 1.467 0 C-N-CA 126.764 2.026 . . . . 53.35 114.459 179.644 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.415 -0.274 . . . . 61.24 112.415 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 80.0 p -140.94 170.95 14.77 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 110.081 -0.34 . . . . 54.44 110.081 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -86.0 140.98 29.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.396 -0.366 . . . . 73.23 110.676 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 21.7 mmt -128.23 55.98 1.64 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.35 0.595 . . . . 62.51 109.871 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.2 p 58.2 -171.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.116 1.767 . . . . 75.43 113.249 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -96.57 1.12 50.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.143 -0.481 . . . . 72.45 110.592 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.12 111.3 18.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.328 -0.396 . . . . 75.24 110.462 176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.74 105.03 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.936 -0.574 . . . . 74.41 110.159 167.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 m -144.01 148.81 35.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 74.43 108.564 163.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.1 pt -126.09 144.47 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 118.83 0.741 . . . . 75.14 109.329 161.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -99.95 133.0 44.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.756 -0.831 . . . . 74.22 108.756 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 t -124.76 137.76 56.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.011 -0.737 . . . . 72.42 109.011 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.47 140.58 52.36 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.741 -0.663 . . . . 72.24 111.214 -177.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.04 3.93 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.246 0.966 . . . . 63.42 112.316 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.21 79.13 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.906 -0.776 . . . . 70.43 108.906 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -123.97 -99.06 1.32 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.542 -0.754 . . . . 61.43 113.996 -171.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.48 119.39 17.64 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.019 0.438 . . . . 74.05 111.526 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.58 30.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.26 -0.882 . . . . 62.23 111.592 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.23 152.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.674 -0.491 . . . . 62.13 109.674 -172.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.0 m -88.29 169.28 11.99 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.681 -0.69 . . . . 73.54 109.935 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.177 1.791 . . . . 71.3 114.201 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -42.6 -14.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.726 2.01 . . . . 72.14 115.547 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -47.61 -22.06 0.44 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 126.374 1.87 . . . . 74.25 113.912 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.8 OUTLIER -56.11 -32.62 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.38 -0.6 . . . . 72.3 109.38 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.94 84.45 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.699 0.639 . . . . 73.44 114.699 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.77 -31.13 63.15 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.312 0.577 . . . . 53.22 111.231 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 3.9 t80 -56.48 -45.15 81.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.434 -0.803 . . . . 70.33 111.015 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -78.0 -23.45 48.33 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.033 -0.417 . . . . 73.41 111.651 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.26 -14.95 62.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.849 0.86 . . . . 71.21 111.806 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -64.65 -13.37 53.55 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 121.88 -0.512 . . . . 74.44 112.046 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.3 mm -104.19 -43.13 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.02 0.528 . . . . 75.25 110.563 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -147.08 -160.11 8.66 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 120.236 -0.983 . . . . 40.24 114.613 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.51 138.45 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.007 0.523 . . . . 55.42 111.452 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.76 116.81 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.688 -0.687 . . . . 75.21 110.689 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -97.93 140.75 31.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.436 0.636 . . . . 75.13 111.158 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.6 m -86.06 118.59 25.62 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.916 -1.038 . . . . 51.32 108.44 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.84 136.97 45.44 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.292 -0.413 . . . . 64.55 111.208 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.49 -9.83 59.68 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.61 0.596 . . . . 74.44 112.61 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -69.64 -39.57 77.04 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 22.4 p -123.19 -26.52 4.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.967 0.413 . . . . 75.41 111.181 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.87 9.86 65.52 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.427 -0.806 . . . . 72.1 112.813 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -97.96 150.74 37.07 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.416 0.525 . . . . 64.21 112.416 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 154.53 70.66 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 123.283 2.655 . . . . 61.41 111.993 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.417 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.8 ptm -68.31 102.48 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.118 1.155 . . . . 71.53 114.118 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 24.0 mm -144.44 112.45 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.139 -1.8 . . . . 72.4 106.139 161.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -128.72 114.5 16.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.091 0.86 . . . . 62.32 109.986 163.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.21 111.85 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.895 -0.409 . . . . 74.12 109.895 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -102.04 111.4 23.66 Favored 'General case' 0 C--O 1.265 1.884 0 CA-C-O 121.487 0.66 . . . . 73.15 109.866 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.0 p -144.4 120.5 10.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 113.86 -1.518 . . . . 72.41 109.694 -177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.81 112.92 22.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.43 0.634 . . . . 63.52 111.454 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -10.38 56.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.802 0.668 . . . . 53.13 112.802 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.21 66.34 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.965 0.357 . . . . 72.25 111.965 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.2 t -91.16 -18.26 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.702 -0.481 . . . . 65.43 109.702 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 100.22 -40.88 2.29 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.884 -0.598 . . . . 74.3 113.021 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -87.79 141.61 31.88 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-O 119.889 -0.101 . . . . 75.31 110.804 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.65 132.9 54.89 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.061 2.507 . . . . 62.45 114.102 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -56.53 -40.13 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.413 -1.267 . . . . 74.11 112.571 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.36 23.14 20.17 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.98 -0.554 . . . . 63.41 112.864 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -120.31 142.05 49.47 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.82 0.364 . . . . 74.25 110.562 -173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 148.68 28.13 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.62 -0.264 . . . . 60.25 110.875 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 67.6 p -128.76 138.57 52.17 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.571 -0.529 . . . . 74.52 109.571 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 8.1 m -138.38 152.02 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.272 -0.64 . . . . 75.41 109.272 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.417 ' H ' ' CB ' ' A' ' 270' ' ' MET . 34.0 t -113.67 131.19 56.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.813 1.042 . . . . 73.1 113.813 -171.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.0 163.42 13.66 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.434 0.531 . . . . 64.44 112.434 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.62 -46.2 80.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.5 -0.773 . . . . 73.43 111.896 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -119.91 136.15 24.73 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.684 -0.487 . . . . 72.2 109.684 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -61.41 -38.87 60.7 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.272 2.648 . . . . 60.41 117.4 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.04 -30.5 13.5 Favored 'Trans proline' 0 C--N 1.381 2.261 0 CA-C-N 123.37 2.239 . . . . 63.44 112.716 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 48.9 m -64.06 -27.92 69.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.384 -0.825 . . . . 72.41 111.394 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -72.05 -34.92 69.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.473 0.545 . . . . 54.44 112.473 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -71.86 -36.07 70.0 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.932 0.396 . . . . 64.21 110.695 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.31 88.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.784 -0.644 . . . . 71.11 111.093 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.559 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.12 -25.86 64.61 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.059 0.456 . . . . 74.5 111.586 176.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.31 -34.32 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 O-C-N 121.7 -0.625 . . . . 75.51 110.804 172.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.25 -56.89 4.17 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.378 0.881 . . . . 71.34 113.378 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -89.55 -29.1 19.15 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.245 1.943 . . . . 72.41 116.245 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 81.3 t80 -91.09 -9.26 46.33 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 122.01 -0.432 . . . . 73.42 111.402 -167.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.17 169.06 8.71 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.956 -0.757 . . . . 63.43 108.956 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.91 49.67 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 120.851 -0.69 . . . . 64.05 112.315 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -125.81 -162.72 1.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.244 -1.021 . . . . 73.1 108.244 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.78 145.93 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.621 0.724 . . . . 74.02 112.456 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -113.73 112.96 24.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.536 -1.211 . . . . 73.02 107.756 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.1 m170 64.88 28.95 12.67 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.132 . . . . 72.22 112.264 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.86 -1.38 85.15 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.465 -0.397 . . . . 63.12 113.97 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -115.22 143.51 45.13 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.202 -0.666 . . . . 72.13 109.202 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.24 129.22 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 122.632 0.373 . . . . 62.5 111.321 -171.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.8 tt -109.84 134.3 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.697 -0.683 . . . . 73.43 110.814 -174.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.42 131.22 53.5 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.522 -0.763 . . . . 63.53 110.197 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.01 126.77 67.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.965 0.412 . . . . 72.12 110.27 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -127.72 174.13 9.36 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 123.925 0.89 . . . . 75.54 109.119 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -1.72 57.31 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.954 1.094 . . . . 73.21 113.954 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.62 -159.31 0.31 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.11 0.964 . . . . 75.45 112.526 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 177.86 8.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.896 0.478 . . . . 62.12 109.945 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -161.8 0.69 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 111.651 0.241 . . . . 72.4 111.651 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -56.59 151.18 31.53 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.437 1.095 . . . . 74.42 112.645 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.0 174.54 12.22 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.09 2.527 . . . . 72.45 114.162 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 C--O 1.254 1.329 0 CA-C-N 115.054 -0.975 . . . . 61.3 110.829 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.262 -0.335 . . . . 54.01 112.262 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 34.7 p -118.48 -16.95 9.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.614 0.598 . . . . 70.35 112.614 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -68.96 153.5 43.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.508 0.323 . . . . 72.41 111.128 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.9 ttm 71.12 26.42 3.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 124.908 1.38 . . . . 72.21 111.379 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.0 t -135.5 120.92 19.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.529 -0.545 . . . . 73.34 109.529 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.95 -5.0 58.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.674 -0.694 . . . . 74.23 110.804 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.54 107.05 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 64.14 111.309 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.1 101.95 14.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.841 -0.743 . . . . 71.11 110.071 164.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 150.2 36.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.805 -1.183 . . . . 75.33 107.805 167.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.82 140.25 48.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.272 0.942 . . . . 63.24 110.013 163.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.02 128.71 45.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.601 -0.888 . . . . 74.52 108.601 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.81 138.61 52.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.775 -0.454 . . . . 72.13 109.775 -177.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -128.82 141.74 51.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 75.44 109.21 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 106.91 14.92 17.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.183 -0.532 . . . . 61.41 113.197 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 78.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.853 -0.795 . . . . 74.32 108.853 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.506 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.1 -89.19 0.39 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.317 -0.944 . . . . 51.21 113.984 -171.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.59 117.93 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.437 0.637 . . . . 71.42 111.133 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.85 20.96 37.92 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.514 -0.766 . . . . 52.41 111.583 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.05 150.45 4.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.438 -0.578 . . . . 74.15 109.438 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.5 t -91.38 170.23 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.433 -0.58 . . . . 53.12 109.433 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -169.05 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.332 1.853 . . . . 70.4 113.848 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -43.38 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.768 2.027 . . . . 71.42 114.985 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.06 -22.04 0.3 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.55 1.94 . . . . 71.22 113.995 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.574 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -55.28 -31.88 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.631 0.651 . . . . 62.3 110.556 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.78 85.66 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 121.935 -0.174 . . . . 53.42 113.504 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.67 -33.3 66.45 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.616 0.767 . . . . 75.13 110.152 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.574 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.9 t80 -56.57 -44.46 81.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.548 -0.751 . . . . 71.01 111.72 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -78.9 -22.2 46.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.002 0.429 . . . . 75.4 111.462 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -73.03 -13.01 61.13 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.357 0.663 . . . . 74.11 111.803 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.67 -14.48 52.39 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 120.662 0.268 . . . . 75.55 111.505 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.9 mm -104.57 -47.99 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 122.924 0.49 . . . . 55.44 111.313 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -140.41 -161.52 8.74 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.066 -0.588 . . . . 62.21 113.667 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.24 138.1 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.324 0.65 . . . . 52.45 110.836 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.01 116.05 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.709 -0.678 . . . . 64.13 110.911 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -98.57 142.89 29.59 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.323 -0.853 . . . . 74.34 111.111 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 51.0 m -84.75 117.29 23.73 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.25 -1.018 . . . . 64.33 108.25 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.68 133.11 43.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.328 -0.396 . . . . 75.11 110.211 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -80.0 -8.03 59.14 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.572 0.582 . . . . 75.14 112.572 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 266' ' ' THR . 21.8 pttt -67.24 -36.85 82.51 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.275 0.23 . . . . 74.12 111.529 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 265' ' ' LYS . 15.0 p -124.15 -30.19 3.49 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.654 0.382 . . . . 63.2 111.372 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.7 64.48 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 116.14 -0.482 . . . . 62.2 112.952 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -98.23 151.53 37.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.182 0.438 . . . . 60.45 112.182 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.57 155.34 69.45 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 123.464 2.776 . . . . 65.22 112.597 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.438 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.6 ptm -71.48 102.01 2.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.665 0.987 . . . . 72.13 113.665 -172.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.8 mm -143.06 113.02 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.618 -1.623 . . . . 61.43 106.618 163.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -128.12 115.9 19.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.016 0.825 . . . . 73.22 109.98 162.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.95 111.72 21.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.183 -0.303 . . . . 74.42 110.183 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 45.2 m-85 -102.92 112.25 24.98 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 121.222 0.534 . . . . 72.41 110.388 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -144.7 122.91 12.2 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.295 -1.321 . . . . 70.13 110.003 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -85.82 111.95 20.66 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.113 0.482 . . . . 74.35 111.36 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -10.52 54.48 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.884 0.698 . . . . 73.22 112.884 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.38 -32.82 68.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.046 0.45 . . . . 60.2 110.381 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 77.6 p -90.71 -18.94 24.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.667 -0.697 . . . . 73.13 109.547 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.78 -29.29 10.73 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.557 -0.747 . . . . 72.34 113.102 170.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -105.84 142.49 24.92 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 110.196 -0.298 . . . . 74.22 110.196 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.5 136.86 78.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.422 2.748 . . . . 75.4 114.594 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -64.33 -38.48 91.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.045 -0.979 . . . . 72.1 111.873 177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.67 17.38 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.459 -0.791 . . . . 72.13 113.057 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 43.6 mt-10 -116.55 142.2 47.18 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.333 -0.547 . . . . 62.33 110.454 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.27 143.86 23.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.751 -0.659 . . . . 74.13 109.948 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 77.1 p -127.25 138.71 53.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.181 0.515 . . . . 74.52 110.445 171.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.48 147.45 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.836 -0.62 . . . . 71.3 110.783 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.438 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.8 t -98.19 136.55 38.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.213 0.605 . . . . 75.24 112.526 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.72 164.35 11.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.596 0.221 . . . . 71.02 111.596 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.84 -46.46 68.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.914 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -123.49 136.55 27.31 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.49 -0.559 . . . . 75.32 109.49 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.41 -37.59 80.36 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.381 2.72 . . . . 74.32 117.076 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -29.12 12.68 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 123.3 2.214 . . . . 64.11 113.023 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.5 m -61.39 -27.96 68.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.732 -0.667 . . . . 72.52 111.517 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.06 -35.44 61.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.094 -0.503 . . . . 74.41 111.439 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 120.74 -0.384 . . . . 64.53 110.934 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.03 86.04 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 120.839 0.352 . . . . 72.11 110.869 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.42 -26.62 66.51 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.74 -0.664 . . . . 74.25 112.337 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.84 -33.97 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 121.731 -0.605 . . . . 74.02 110.214 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.4 -56.06 5.29 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.623 0.971 . . . . 63.52 113.623 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -31.78 17.31 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.809 1.781 . . . . 74.31 115.809 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.621 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.4 t80 -88.51 -8.82 54.2 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 118.535 0.607 . . . . 71.2 111.647 -167.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.53 9.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.66 -0.867 . . . . 75.13 108.66 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.84 51.33 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.207 -0.997 . . . . 73.25 112.369 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -126.9 -162.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.32 -0.622 . . . . 60.43 109.32 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.96 147.53 46.51 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.568 0.699 . . . . 61.4 112.197 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -115.46 112.4 22.22 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.836 -1.172 . . . . 74.42 107.836 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.14 29.43 14.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.695 1.198 . . . . 75.44 112.427 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.55 11.97 73.53 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.458 -0.401 . . . . 38.33 113.675 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -128.0 143.3 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.047 -0.723 . . . . 73.21 109.047 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.63 127.66 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.043 0.449 . . . . 71.43 111.457 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 19.4 tt -110.42 131.7 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.835 0.826 . . . . 74.01 111.133 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -123.54 139.18 54.27 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.877 -1.056 . . . . 72.13 109.643 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.8 t -122.29 137.43 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 121.058 0.456 . . . . 73.52 111.112 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -131.65 176.5 8.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.547 1.139 . . . . 72.41 110.164 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.45 -8.77 58.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.761 1.022 . . . . 75.43 113.761 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.86 -168.61 0.21 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.612 1.165 . . . . 70.2 113.494 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.7 m -82.63 134.52 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.855 . . . . 64.25 110.599 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.81 178.12 7.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.982 -0.554 . . . . 73.22 110.794 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 44.83 86.62 0.13 Allowed Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 125.952 1.701 . . . . 74.11 114.481 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.96 81.7 1.6 Allowed 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 122.626 2.218 . . . . 65.31 114.192 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 124.997 1.319 . . . . 72.3 112.1 178.494 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 N-CA-C 111.887 -0.485 . . . . 52.45 111.887 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 8.0 t -94.01 56.04 2.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 117.3 0.55 . . . . 52.41 111.483 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . 0.412 ' CE1' ' HB3' ' A' ' 294' ' ' PRO . 3.0 m-70 71.38 -77.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.706 1.602 . . . . 65.32 111.734 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.51 30.61 15.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.726 1.21 . . . . 52.33 112.247 171.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 32.9 t -156.4 133.36 10.44 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.904 -0.406 . . . . 70.53 109.904 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -93.71 8.67 40.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.129 0.49 . . . . 72.4 110.847 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -93.52 108.1 19.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.227 -0.442 . . . . 70.53 110.21 177.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.68 103.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.495 -0.882 . . . . 72.3 109.452 162.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.3 m -143.58 143.96 31.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.455 -1.313 . . . . 74.13 107.455 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.13 139.15 50.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.144 0.884 . . . . 70.41 110.652 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.42 134.16 42.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.52 -0.918 . . . . 74.35 108.52 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.77 140.14 47.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 109.39 -0.596 . . . . 72.52 109.39 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.59 143.34 50.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 124.256 0.972 . . . . 72.42 109.231 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 89.59 22.66 36.1 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.836 -0.697 . . . . 53.54 113.366 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.91 70.83 1.02 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.344 -0.984 . . . . 74.34 108.344 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.37 -176.86 22.18 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.13 -1.033 . . . . 72.44 112.779 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 42.15 86.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.686 1.994 . . . . 71.32 114.867 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.71 22.46 26.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.333 -0.849 . . . . 61.32 111.528 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.0 150.92 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.23 110.094 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.4 m -84.55 169.47 14.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.691 -0.686 . . . . 75.03 110.939 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -167.81 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.323 1.849 . . . . 62.32 113.592 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -44.24 -13.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 126.949 2.1 . . . . 72.0 115.671 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.93 -23.42 0.45 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 126.72 2.008 . . . . 62.05 114.348 172.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.5 OUTLIER -56.92 -32.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 CA-C-N 118.735 0.698 . . . . 74.05 109.767 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.06 -33.82 86.97 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.825 -0.431 . . . . 63.44 113.445 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.41 -29.14 59.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.206 0.602 . . . . 64.41 111.055 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.4 t80 -56.41 -42.52 78.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.512 . . . . 72.13 110.708 168.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -77.58 -24.1 49.82 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.067 0.395 . . . . 75.41 112.067 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.19 -16.25 62.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.638 0.775 . . . . 53.42 111.675 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -64.61 -15.09 60.62 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 121.572 -0.705 . . . . 63.31 112.012 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 mm -119.14 20.41 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-O 121.592 0.711 . . . . 74.44 110.327 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.5 34.15 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 119.386 -2.071 . . . . 36.55 116.009 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 23.2 mt -107.31 138.13 34.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.167 -1.017 . . . . 74.5 110.204 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 48.7 mm -73.17 114.7 12.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.576 0.547 . . . . 72.13 110.001 176.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -98.88 143.92 28.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.142 -0.936 . . . . 74.22 110.311 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.51 131.59 34.63 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.55 -0.908 . . . . 74.01 108.55 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 122.04 27.56 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 108.974 -0.751 . . . . 50.33 108.974 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -67.14 -8.57 32.01 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.275 1.213 . . . . 61.01 114.275 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.02 -30.39 68.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 117.679 0.218 . . . . 74.24 111.053 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.6 t -126.75 -29.06 2.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.735 0.302 . . . . 74.34 111.376 177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.73 7.49 68.71 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.104 -0.498 . . . . 73.44 112.387 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -98.91 149.13 35.46 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 122.81 0.444 . . . . 74.32 111.051 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.15 153.86 71.31 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.839 3.026 . . . . 73.42 112.76 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.433 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -69.28 97.51 0.95 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.758 1.021 . . . . 73.2 113.758 -175.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 mm -144.5 112.37 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.425 -1.324 . . . . 61.34 107.425 165.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.19 117.55 20.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.015 0.825 . . . . 71.41 109.836 162.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 112.03 22.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.802 -0.444 . . . . 64.42 109.802 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -101.87 112.92 25.71 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.8 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.3 p -141.56 122.02 14.09 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.497 -1.229 . . . . 64.25 109.993 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -86.22 111.83 20.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.405 1.097 . . . . 52.34 111.602 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -6.54 59.27 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.484 -0.78 . . . . 71.15 112.765 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.64 -28.1 65.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.136 -0.484 . . . . 64.25 111.186 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 46.6 p -90.63 -29.48 17.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.822 -0.436 . . . . 75.32 109.822 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.01 57.49 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.645 -0.707 . . . . 75.03 112.658 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -113.54 144.32 31.11 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.349 -0.612 . . . . 71.14 109.349 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.83 126.48 21.28 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.201 1.934 . . . . 74.45 113.507 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -57.28 -43.0 82.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.285 0.991 . . . . 75.31 110.757 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.77 19.43 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.024 -0.989 . . . . 55.43 112.706 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -116.78 148.44 41.16 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.599 -0.84 . . . . 65.02 109.929 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 160.35 43.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.14 111.669 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.21 137.11 42.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.905 -0.588 . . . . 73.21 109.878 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.411 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 27.4 m -134.09 143.33 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.663 -0.866 . . . . 63.3 108.663 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.433 ' H ' ' CB ' ' A' ' 270' ' ' MET . 1.1 p -101.06 121.35 41.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.238 0.615 . . . . 71.14 112.304 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.36 165.9 13.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.138 -0.483 . . . . 73.34 111.836 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.48 -49.31 69.56 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.029 0.831 . . . . 74.32 112.442 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.99 138.05 31.88 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 110.115 -0.328 . . . . 74.51 110.115 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -59.16 -38.02 88.68 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.686 2.924 . . . . 73.12 117.735 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . 0.412 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 51.0 Cg_endo -68.01 -30.29 32.59 Favored 'Trans proline' 0 C--N 1.386 2.509 0 CA-C-N 123.681 2.35 . . . . 74.24 112.992 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 19.7 m -62.88 -28.27 69.92 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.248 1.019 . . . . 72.33 112.21 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.85 -40.2 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.876 0.735 . . . . 42.13 112.434 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -71.16 -38.64 72.19 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.128 0.489 . . . . 75.02 111.08 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.66 81.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.446 -0.797 . . . . 74.52 111.041 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.76 -28.55 66.9 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.725 -0.67 . . . . 70.44 112.05 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 296' ' ' ALA . 45.7 mt -67.4 -32.83 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.996 -0.44 . . . . 75.44 110.647 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.87 -60.34 2.41 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.783 1.031 . . . . 61.43 113.783 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -91.09 -32.71 15.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.125 1.898 . . . . 75.32 116.125 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . 0.424 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 41.1 t80 -84.37 -25.27 29.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.243 0.474 . . . . 72.2 110.237 -170.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -94.89 177.05 6.03 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.968 -1.015 . . . . 62.13 110.127 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.97 13.49 59.02 Favored Glycine 0 CA--C 1.509 -0.326 0 C-N-CA 121.22 -0.514 . . . . 62.14 112.223 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 -153.75 0.59 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 73.32 108.814 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -131.61 142.18 49.82 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.569 0.699 . . . . 64.14 111.357 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -113.74 117.36 31.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.604 -1.258 . . . . 72.12 107.604 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.15 27.78 14.05 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.756 1.222 . . . . 75.32 112.51 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.21 -3.85 86.53 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.848 0.299 . . . . 61.42 113.848 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -108.77 146.11 34.1 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.723 -0.843 . . . . 75.53 108.723 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.78 131.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.99 0.424 . . . . 73.02 110.904 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 15.0 tt -108.54 140.0 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.91 -0.774 . . . . 74.13 108.91 -178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.18 125.0 22.51 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.591 -0.522 . . . . 64.33 109.591 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.23 139.98 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 107.733 -1.21 . . . . 65.33 107.733 -170.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 m -140.57 171.62 13.86 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 121.716 -0.615 . . . . 73.31 110.936 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.01 -3.13 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.881 0.697 . . . . 73.22 112.881 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 66.0 -166.22 0.22 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.766 1.227 . . . . 75.21 112.985 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.92 168.84 18.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.654 -0.703 . . . . 74.41 109.343 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -164.17 0.83 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.583 0.23 . . . . 74.11 111.408 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -63.52 148.94 93.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.591 0.756 . . . . 73.54 112.99 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.76 -170.21 0.51 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 123.899 3.066 . . . . 64.03 115.229 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.157 -0.929 . . . . 71.55 111.367 -179.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 111.92 -0.472 . . . . 70.12 111.92 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 21.1 m -96.89 102.9 14.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.167 0.508 . . . . 55.41 111.734 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -94.62 -179.23 4.81 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.884 -0.598 . . . . 75.05 110.204 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.43 43.56 6.31 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.197 1.799 . . . . 72.54 113.552 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 47.0 t -130.46 131.85 45.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.216 -0.902 . . . . 72.2 109.812 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -86.93 -6.58 58.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.579 0.55 . . . . 73.31 110.85 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.1 108.61 12.72 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 72.23 110.77 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.99 105.4 17.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.463 -0.495 . . . . 65.55 110.287 164.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.8 m -142.1 147.83 37.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.679 -1.23 . . . . 61.02 107.679 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.0 pt -125.46 138.45 54.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 119.279 0.945 . . . . 73.14 110.072 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.84 119.86 39.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.546 -0.539 . . . . 75.44 109.546 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.45 138.87 45.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.545 -0.752 . . . . 72.0 109.288 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -128.87 142.33 50.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.365 0.666 . . . . 75.31 109.226 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.51 8.49 Favored Glycine 0 C--N 1.332 0.358 0 O-C-N 123.331 0.394 . . . . 38.46 113.259 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 76.39 1.52 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.565 -0.902 . . . . 73.23 108.565 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.22 -77.13 0.06 OUTLIER Glycine 0 CA--C 1.499 -0.944 0 C-N-CA 120.237 -0.983 . . . . 60.45 112.999 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.54 109.18 11.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.638 0.732 . . . . 75.04 111.633 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.72 20.62 33.63 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.185 -0.916 . . . . 71.33 111.349 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.87 151.56 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.331 0.586 . . . . 72.43 109.901 -173.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.8 t -91.7 170.44 9.91 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 109.152 -0.684 . . . . 62.31 109.152 171.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 127.529 2.332 . . . . 74.24 113.829 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -44.86 -11.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 126.161 1.784 . . . . 73.52 115.513 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 252' ' ' GLU . 1.3 pp0? -46.79 -22.11 0.27 Allowed 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 126.72 2.008 . . . . 71.34 113.73 168.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.52 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -56.23 -30.66 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.384 -0.822 . . . . 73.03 109.33 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.26 91.7 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.964 -0.909 . . . . 38.46 114.718 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 249' ' ' GLN . 8.9 pt-20 -75.55 -27.65 58.72 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.367 1.084 . . . . 72.53 111.457 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.52 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.7 t80 -55.61 -45.06 77.56 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.046 0.841 . . . . 75.15 110.612 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -78.79 -23.77 45.02 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.12 0.415 . . . . 74.42 112.12 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -75.5 -11.22 59.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.45 0.7 . . . . 70.13 111.93 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.53 -16.16 63.4 Favored 'General case' 0 CA--C 1.555 1.137 0 O-C-N 121.883 -0.51 . . . . 62.41 111.827 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.06 -36.87 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.257 0.623 . . . . 54.31 111.133 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -148.04 -161.13 9.35 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 119.29 -1.433 . . . . 71.3 114.31 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.41 139.24 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 122.759 0.424 . . . . 74.34 110.959 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.0 mm -67.37 115.87 6.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.496 -0.774 . . . . 73.1 110.874 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -97.47 138.86 34.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.209 -0.905 . . . . 65.52 110.962 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -84.49 116.17 22.96 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.982 -1.118 . . . . 74.33 107.982 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.92 129.21 36.58 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 109.274 -0.639 . . . . 75.03 109.274 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -78.63 -7.1 57.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.417 0.895 . . . . 73.12 113.417 -173.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.54 -30.28 69.05 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.354 0.262 . . . . 71.23 111.439 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.5 t -125.94 -32.41 2.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.559 0.219 . . . . 74.34 111.579 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.76 11.23 64.02 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 112.232 -0.347 . . . . 53.23 112.232 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -98.52 151.29 37.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.438 0.695 . . . . 61.52 111.781 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.04 154.84 72.43 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.671 2.914 . . . . 38.46 112.459 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.417 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.4 ptm -73.56 100.81 3.4 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.713 1.005 . . . . 75.54 113.713 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.66 112.51 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.684 -1.599 . . . . 74.3 106.684 162.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -127.89 117.35 21.63 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.495 1.043 . . . . 61.44 110.363 162.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.43 113.2 24.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.087 0.47 . . . . 74.34 110.776 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 51.0 m-85 -101.96 110.72 22.76 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.596 -0.729 . . . . 73.33 109.285 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 37.8 p -143.11 122.04 12.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.64 -1.164 . . . . 65.12 109.676 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -86.45 112.44 21.5 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.399 0.619 . . . . 75.34 111.718 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -85.73 -10.56 55.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.664 0.616 . . . . 71.13 112.664 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.42 -33.96 67.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.031 0.382 . . . . 72.54 112.031 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 12.9 t -91.03 -16.21 28.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.43 0.633 . . . . 75.31 109.723 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.92 -48.87 1.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.585 -0.734 . . . . 52.52 112.607 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -74.34 138.52 74.95 Favored Pre-proline 0 N--CA 1.456 -0.172 0 N-CA-C 110.122 -0.325 . . . . 71.21 110.122 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.99 139.38 90.65 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.541 2.161 . . . . 64.55 113.238 171.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -59.4 -39.98 85.14 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.357 1.036 . . . . 75.14 111.874 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.91 24.78 12.41 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.612 -0.722 . . . . 62.1 112.969 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 2.1 mp0 -117.72 144.01 45.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.859 -0.736 . . . . 72.3 110.621 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -148.84 142.37 25.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 72.15 109.107 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 81.5 p -125.31 138.12 54.07 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.708 -0.478 . . . . 71.23 109.708 172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.68 148.22 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.066 0.46 . . . . 75.13 110.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.417 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.9 t -101.23 127.6 47.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.856 0.862 . . . . 75.24 112.505 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 164.33 12.26 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.177 -0.327 . . . . 74.02 111.606 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.03 -46.82 49.75 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.66 0.6 . . . . 71.21 110.76 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -109.41 135.36 20.3 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 120.795 -0.362 . . . . 73.52 110.302 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.61 -39.51 20.93 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 C-N-CA 122.775 2.317 . . . . 61.53 116.887 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.49 -29.92 52.83 Favored 'Trans proline' 0 C--N 1.39 2.752 0 CA-C-N 123.459 2.271 . . . . 54.42 113.721 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 47.8 m -63.72 -27.34 69.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.829 0.852 . . . . 73.44 112.174 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -71.59 -34.19 69.68 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.602 0.564 . . . . 73.15 112.204 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -71.82 -39.13 70.02 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.959 0.409 . . . . 71.32 110.338 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.99 74.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.359 -0.837 . . . . 45.32 111.013 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.47 -29.31 66.94 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 116.14 -0.482 . . . . 70.4 112.129 174.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 296' ' ' ALA . 52.7 mt -67.33 -31.48 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 122.229 -0.294 . . . . 73.31 110.49 172.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -78.52 -61.4 2.02 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.958 1.096 . . . . 63.24 113.958 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -92.07 -29.63 16.46 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.296 1.961 . . . . 73.44 116.296 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -87.6 -21.56 25.27 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.469 0.652 . . . . 73.22 109.914 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -93.31 175.33 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.975 -1.011 . . . . 70.11 109.672 171.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.54 12.4 61.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.305 -0.474 . . . . 62.15 112.047 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -126.14 -158.13 0.83 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.267 -0.642 . . . . 62.34 109.267 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.76 143.97 50.62 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.573 0.701 . . . . 74.42 110.601 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.1 114.03 25.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.716 -1.129 . . . . 74.31 108.155 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.0 m170 64.66 29.12 13.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.597 1.186 . . . . 65.14 112.611 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 10.11 80.61 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 113.923 0.329 . . . . 74.43 113.923 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.58 146.01 50.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.699 -0.852 . . . . 73.1 108.699 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.33 127.99 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.271 0.557 . . . . 74.3 111.02 -170.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.7 137.11 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.324 -0.853 . . . . 73.13 109.374 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.24 128.38 41.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.61 -0.723 . . . . 65.14 110.228 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.57 142.05 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 -174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -142.1 175.23 9.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.331 0.652 . . . . 70.23 110.492 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.33 -4.34 58.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.048 1.129 . . . . 70.03 114.048 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.5 -163.11 0.27 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.944 0.898 . . . . 64.11 112.865 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 14.4 t -98.51 165.35 11.87 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.027 -0.533 . . . . 60.31 109.887 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -88.54 137.95 31.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.25 110.418 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 73.79 163.42 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 124.786 1.304 . . . . 55.22 112.365 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -69.96 103.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 121.441 1.427 . . . . 74.33 113.424 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.255 1.381 0 CA-C-N 115.393 -0.821 . . . . 74.43 109.553 175.828 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.107 -0.397 . . . . 62.12 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 11.8 p -143.47 -64.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 119.446 -0.311 . . . . 73.23 111.567 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 61.54 39.89 14.25 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.315 1.446 . . . . 74.32 111.551 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 64.9 mtt -95.09 74.86 3.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.21 0.529 . . . . 74.32 110.803 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.4 p -162.85 122.75 2.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.11 -0.95 . . . . 61.52 110.801 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.39 -22.53 41.22 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.836 -0.62 . . . . 64.14 110.765 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -85.11 106.45 16.58 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.279 -0.873 . . . . 61.22 110.149 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.14 106.61 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 73.23 109.98 165.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 16.0 m -141.79 148.06 38.31 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.902 -1.148 . . . . 63.33 107.902 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.66 137.23 56.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 118.891 0.769 . . . . 52.15 110.051 164.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.46 119.0 37.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.243 -0.651 . . . . 75.23 109.243 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.63 141.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.496 -0.775 . . . . 64.24 109.44 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.01 149.17 50.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.831 -0.622 . . . . 72.44 110.461 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 94.74 18.47 34.87 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 123.63 0.581 . . . . 70.41 113.362 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.78 76.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.02 -91.76 0.53 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.333 -0.937 . . . . 73.15 113.873 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.05 114.42 16.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.024 0.44 . . . . 75.03 110.943 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.55 19.86 33.73 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.263 -0.88 . . . . 74.22 111.89 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -83.58 151.47 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.351 -0.611 . . . . 55.23 109.351 -173.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.3 m -90.35 170.36 10.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.162 -0.472 . . . . 74.11 109.944 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -167.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.108 2.163 . . . . 73.23 113.198 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.26 -13.66 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 127.44 2.296 . . . . 62.21 115.018 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.419 ' O ' ' HG3' ' A' ' 252' ' ' GLU . 0.7 OUTLIER -47.7 -21.3 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.751 2.021 . . . . 62.21 114.136 169.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.34 -31.25 26.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.975 0 CA-C-N 119.207 0.912 . . . . 65.23 109.363 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -56.74 -37.85 79.48 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.003 -0.887 . . . . 64.41 114.419 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 249' ' ' GLN . 0.0 OUTLIER -74.91 -28.6 60.69 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.046 0.923 . . . . 70.41 110.468 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.1 t80 -56.44 -45.7 80.67 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 123.805 0.69 . . . . 74.2 110.833 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.63 -24.5 45.24 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.228 0.455 . . . . 74.21 112.228 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -63.1 -24.97 68.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.186 0.994 . . . . 63.0 111.744 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.6 pt20 -62.95 -22.09 66.55 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.403 0.52 . . . . 72.33 112.403 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.6 mm -125.1 55.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 117.979 0.354 . . . . 73.34 110.114 171.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.41 -176.43 27.23 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 119.143 -1.503 . . . . 72.23 114.573 170.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.32 137.96 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.531 -0.334 . . . . 75.34 110.156 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.0 mm -73.77 114.24 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.723 -0.671 . . . . 71.31 110.121 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -98.59 140.24 33.12 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.67 0.748 . . . . 75.13 110.886 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.0 m -84.43 121.15 27.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.502 -1.226 . . . . 72.02 108.415 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.73 134.73 50.22 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.528 0.518 . . . . 61.1 111.246 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -81.98 -7.54 59.62 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.875 1.065 . . . . 75.34 113.875 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -68.38 -42.9 78.43 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.238 0.336 . . . . 64.31 111.485 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 24.6 p -124.4 -25.62 4.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.758 0.313 . . . . 75.13 111.337 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.26 16.46 57.37 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.905 -0.588 . . . . 38.2 113.601 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 152.13 38.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.794 0.297 . . . . 71.24 111.715 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.92 152.66 81.49 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.579 2.186 . . . . 71.51 111.361 165.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.428 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.1 ptm -72.82 99.48 2.65 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.808 1.04 . . . . 71.54 113.808 -174.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.4 mm -143.72 114.07 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.781 -1.563 . . . . 73.51 106.781 165.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -129.02 113.63 15.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.901 0.773 . . . . 73.43 109.425 162.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.08 111.34 21.45 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.828 0.347 . . . . 74.44 110.081 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . 0.425 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.8 m-85 -103.81 111.83 24.52 Favored 'General case' 0 C--O 1.263 1.767 0 CA-C-O 121.308 0.575 . . . . 75.53 110.555 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.422 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.2 p -143.26 121.97 12.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.196 -1.365 . . . . 74.14 110.165 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.52 113.97 22.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.649 0.738 . . . . 74.22 112.24 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.54 -9.78 56.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.021 0.749 . . . . 71.01 113.021 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.94 -33.94 66.23 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.963 0.411 . . . . 72.1 110.904 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -90.56 -14.99 31.44 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.443 0.64 . . . . 63.35 110.114 170.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 89.67 -12.19 67.87 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.704 -0.68 . . . . 53.12 113.907 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.11 142.02 27.9 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.618 -0.512 . . . . 63.51 109.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.18 133.01 55.7 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.108 2.539 . . . . 75.21 113.796 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.422 ' H ' ' HA ' ' A' ' 275' ' ' THR . 22.5 mttt -62.3 -33.93 75.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.493 -1.231 . . . . 73.1 112.116 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.38 23.78 20.79 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.495 -0.775 . . . . 65.33 112.782 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.9 mt-10 -119.75 141.86 49.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.072 -0.651 . . . . 53.23 109.822 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.94 143.46 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 72.15 109.665 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 70.8 p -128.6 140.35 51.82 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.924 -0.399 . . . . 73.45 109.924 173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.18 146.7 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.208 0.527 . . . . 60.31 109.993 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.428 ' H ' ' CB ' ' A' ' 270' ' ' MET . 25.6 t -98.95 119.96 38.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.566 0.747 . . . . 73.11 111.83 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.52 165.1 12.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.23 0.456 . . . . 74.55 112.23 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.34 -47.93 45.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 124.481 1.113 . . . . 71.13 111.988 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -124.12 137.23 28.64 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 109.558 -0.534 . . . . 75.31 109.558 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.43 -38.06 86.04 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 C-N-CA 123.58 2.853 . . . . 72.23 116.977 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.73 -29.27 29.57 Favored 'Trans proline' 0 C--N 1.397 3.082 0 CA-C-N 123.419 2.257 . . . . 71.2 113.373 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.7 m -65.84 -27.81 68.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.013 0.925 . . . . 72.52 112.208 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -74.89 -44.02 51.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.167 0.587 . . . . 51.4 112.086 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -74.77 -31.3 61.73 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.257 0.551 . . . . 75.33 111.916 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.14 73.52 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.635 -0.711 . . . . 71.45 110.601 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -67.56 -28.3 67.67 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.58 -0.736 . . . . 63.35 111.497 172.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 296' ' ' ALA . 43.7 mt -67.41 -32.34 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 122.171 -0.331 . . . . 72.32 111.08 172.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.24 -60.07 2.52 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.72 1.007 . . . . 73.11 113.72 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -35.52 15.32 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.032 1.864 . . . . 74.32 116.032 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.158 0.504 . . . . 71.33 110.325 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -98.3 -178.29 3.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.266 -0.879 . . . . 71.12 109.601 172.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.16 64.31 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.943 0.19 . . . . 38.2 112.717 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.29 -158.64 0.9 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.286 -0.457 . . . . 73.13 109.997 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.87 145.78 50.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.658 0.742 . . . . 50.34 111.257 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -115.86 116.07 27.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.35 -1.295 . . . . 74.02 107.828 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 23.3 m170 64.29 28.89 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.657 1.183 . . . . 74.54 112.631 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.66 7.0 84.97 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 114.126 0.41 . . . . 63.14 114.126 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.23 147.93 48.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.803 -0.814 . . . . 51.31 108.803 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.86 130.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.083 0.468 . . . . 75.51 111.269 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.4 tt -109.14 142.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.009 -0.996 . . . . 73.54 109.502 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -136.28 128.01 29.05 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.715 -0.675 . . . . 63.45 110.718 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.11 141.87 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 N-CA-C 108.478 -0.934 . . . . 70.44 108.478 -173.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.1 m -144.52 174.25 11.11 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 121.633 -0.667 . . . . 73.12 110.623 -173.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.2 -3.35 54.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.636 0.976 . . . . 75.01 113.636 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.54 -166.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.552 1.141 . . . . 70.42 112.991 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.9 t -91.42 154.21 19.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 52.33 109.395 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.26 172.55 6.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.459 -0.791 . . . . 74.22 109.139 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 68.9 89.03 0.1 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 124.614 1.196 . . . . 73.31 112.744 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.43 -162.26 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.87 2.38 . . . . 53.14 113.656 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.485 1.317 0 C-N-CA 126.043 1.737 . . . . 63.0 110.812 -179.355 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.087 0 N-CA-C 111.821 -0.512 . . . . 64.32 111.821 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.0 m -95.87 -172.75 2.66 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.844 -0.428 . . . . 71.33 109.844 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -63.79 -70.24 0.23 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.743 0.417 . . . . 74.21 111.382 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 23.5 ptp -154.43 9.74 0.35 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 60.22 110.283 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 66.9 m 63.31 111.41 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.955 1.302 . . . . 70.03 111.54 -166.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.29 -24.34 59.23 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.402 -0.817 . . . . 73.32 110.502 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -72.81 106.73 4.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.299 -0.864 . . . . 72.43 110.113 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 104.99 17.49 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.121 -0.632 . . . . 74.31 109.564 165.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.1 m -142.39 148.84 38.51 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.413 -0.958 . . . . 73.43 108.413 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.11 137.8 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.675 0.671 . . . . 54.34 111.061 164.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.43 130.55 45.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.018 -0.734 . . . . 71.03 109.018 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 141.01 44.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.356 -0.838 . . . . 63.12 109.41 -173.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.65 150.62 50.16 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.36 -179.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.58 14.17 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 124.067 0.854 . . . . 72.1 112.857 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.03 74.88 1.32 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.903 -1.147 . . . . 64.1 107.903 175.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -136.05 -77.24 0.08 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.249 -0.976 . . . . 73.53 112.957 -175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -78.26 102.86 7.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.964 0.888 . . . . 75.24 111.919 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.53 20.67 24.11 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.109 -0.951 . . . . 71.11 112.064 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -79.16 152.5 4.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.549 0.69 . . . . 64.43 110.492 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t -91.71 168.57 11.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.297 -0.865 . . . . 73.23 109.715 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.6 t -63.52 -168.26 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.274 2.23 . . . . 73.3 113.497 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -43.94 -12.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 126.625 1.97 . . . . 61.13 115.645 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.96 -22.35 0.32 Allowed 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 126.361 1.864 . . . . 63.11 114.319 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.55 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -55.91 -32.61 33.15 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 CA-C-N 118.899 0.772 . . . . 72.2 111.001 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.17 84.19 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.646 -0.312 . . . . 73.35 113.416 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -74.6 -30.43 61.68 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.675 0.79 . . . . 70.44 111.289 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.55 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.5 t80 -56.05 -45.19 79.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 70.23 111.232 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.52 -23.71 50.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.823 0.305 . . . . 74.5 111.823 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.98 -14.32 61.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.477 0.711 . . . . 70.43 112.382 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.2 -11.81 44.67 Favored 'General case' 0 CA--C 1.557 1.223 0 O-C-N 121.666 -0.646 . . . . 75.4 112.14 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mm -106.56 -42.18 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.972 0.509 . . . . 64.03 111.102 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.61 -158.97 7.78 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 120.898 -0.668 . . . . 65.21 113.942 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 14.5 mt -104.93 139.88 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.138 0.575 . . . . 62.3 110.589 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.6 mm -65.98 113.29 2.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 109.523 -0.547 . . . . 64.12 109.523 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.04 141.64 32.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.338 -0.847 . . . . 74.24 110.767 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 11.0 m -85.07 117.71 24.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.85 -1.068 . . . . 61.31 108.511 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.61 130.29 39.28 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.152 -0.684 . . . . 73.22 109.152 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -73.36 -9.15 58.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.674 0.99 . . . . 73.02 113.674 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -69.67 -34.35 73.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 111.997 0.369 . . . . 60.43 111.997 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.5 t -125.68 -30.24 3.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.478 0.311 . . . . 73.43 111.519 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.19 9.08 67.82 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.543 -0.298 . . . . 64.51 112.612 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -98.14 152.08 37.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.026 0.53 . . . . 71.42 112.196 172.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.09 156.24 63.88 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.892 3.061 . . . . 70.44 112.562 169.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.41 ' SD ' ' HB ' ' A' ' 288' ' ' VAL . 0.0 OUTLIER -72.04 98.52 2.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.841 1.052 . . . . 75.42 113.841 -172.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -143.43 112.38 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.266 -1.383 . . . . 63.43 107.266 164.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -128.71 113.74 15.73 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.957 0.798 . . . . 62.11 109.367 160.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -114.52 107.89 16.12 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.721 -0.844 . . . . 53.54 108.721 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -103.81 112.72 25.8 Favored 'General case' 0 C--O 1.26 1.634 0 CA-C-O 121.211 0.529 . . . . 73.21 110.935 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.6 p -144.42 122.92 12.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.468 -1.242 . . . . 63.41 110.308 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.99 113.39 22.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.427 0.632 . . . . 63.41 112.118 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 -8.95 57.48 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.517 -0.765 . . . . 73.22 112.715 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -35.4 71.33 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.753 0.279 . . . . 74.41 111.753 175.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.0 t -90.97 -14.26 31.83 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.204 0.526 . . . . 75.01 110.136 171.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.2 -46.32 1.7 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.579 -0.737 . . . . 60.41 113.043 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -86.19 142.84 36.2 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 110.547 -0.168 . . . . 72.35 110.547 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 139.13 83.2 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.563 2.842 . . . . 64.44 114.459 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -67.22 -34.21 76.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.179 -0.919 . . . . 61.52 112.146 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.76 27.75 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.093 -0.575 . . . . 62.43 112.772 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -115.92 143.12 45.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.812 -0.355 . . . . 75.4 110.429 -171.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.47 154.74 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.233 -0.44 . . . . 71.53 110.78 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.2 137.39 37.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.782 -0.451 . . . . 74.31 109.782 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.41 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 32.8 m -136.35 144.75 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.361 -0.607 . . . . 74.04 109.361 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.404 ' H ' ' CB ' ' A' ' 270' ' ' MET . 26.7 t -93.35 121.69 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.61 0.764 . . . . 72.34 111.789 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -94.15 164.14 13.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.664 -0.244 . . . . 74.42 111.596 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.5 -48.78 73.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.926 0.891 . . . . 65.51 112.852 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -127.11 137.89 31.56 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 109.512 -0.551 . . . . 73.51 109.512 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.27 -38.41 75.81 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 123.078 2.519 . . . . 71.22 117.137 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.18 -28.92 15.03 Favored 'Trans proline' 0 C--N 1.391 2.799 0 CA-C-N 124.139 2.514 . . . . 72.44 113.054 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 37.9 m -61.45 -28.31 69.19 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.381 1.072 . . . . 71.03 112.027 174.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.21 -37.13 77.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.644 0.778 . . . . 54.54 112.777 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.8 -35.14 62.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 120.981 0.419 . . . . 74.54 111.288 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.563 -0.744 . . . . 74.52 111.035 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.66 -28.12 65.61 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.809 -0.632 . . . . 71.3 112.08 174.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 296' ' ' ALA . 42.3 mt -67.84 -31.86 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 122.026 -0.421 . . . . 75.3 110.811 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.43 -59.76 2.63 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.863 1.061 . . . . 74.45 113.863 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -91.27 -34.97 14.74 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.48 2.03 . . . . 63.11 116.48 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.44 -25.28 31.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.177 0.513 . . . . 73.11 110.188 -169.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -93.46 176.38 6.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.801 -1.09 . . . . 71.44 109.95 173.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.53 12.95 57.74 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.275 -0.488 . . . . 61.25 112.31 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -128.99 -154.58 0.65 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.854 -0.424 . . . . 73.41 109.854 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.72 139.84 49.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.268 0.556 . . . . 75.41 110.868 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.52 112.74 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.716 -1.216 . . . . 70.43 107.716 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.9 m170 64.66 28.4 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.947 1.299 . . . . 75.04 112.205 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.98 88.19 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 121.629 -0.32 . . . . 43.04 113.428 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.03 143.29 33.41 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.28 -1.007 . . . . 60.33 108.28 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.82 126.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.655 0.264 . . . . 53.34 110.501 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.1 tt -107.9 140.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.976 -0.556 . . . . 60.45 109.636 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.89 126.23 28.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.863 -0.608 . . . . 75.1 109.654 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.52 138.69 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.76 -1.2 . . . . 71.14 107.76 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.0 m -144.56 171.7 14.0 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 123.0 0.52 . . . . 72.41 110.192 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.48 -4.49 42.89 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.229 1.196 . . . . 73.55 114.229 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.42 -168.56 0.21 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.403 1.081 . . . . 64.14 113.097 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.8 m -88.67 132.21 34.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.474 -0.784 . . . . 61.13 109.573 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.3 mpp_? -83.23 -176.0 6.11 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.318 -0.401 . . . . 71.31 109.982 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 13.8 ptt85 48.3 87.31 0.13 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.853 1.661 . . . . 74.14 114.663 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.33 -178.09 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.753 2.302 . . . . 72.11 114.308 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.062 1.745 . . . . 62.31 111.587 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 CA-C-O 118.668 -1.074 . . . . 63.43 113.217 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.9 m 53.4 87.32 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 64.2 113.474 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -91.26 -173.35 3.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.7 -0.682 . . . . 71.13 109.927 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 65.1 mtt 67.58 27.18 7.87 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.555 1.142 . . . . 61.22 111.772 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 29.2 m -125.26 103.19 7.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.45 110.084 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.54 -22.21 35.07 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.538 0.685 . . . . 72.44 110.809 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -90.92 117.7 29.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.94 -1.027 . . . . 61.14 110.878 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.33 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.424 0.631 . . . . 70.44 110.509 167.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.6 m -143.17 150.06 38.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.861 -1.162 . . . . 63.31 107.861 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.58 140.71 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.023 0.828 . . . . 62.31 111.223 164.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.67 136.18 41.95 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.791 -0.64 . . . . 65.55 109.433 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.36 142.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 122.028 0.918 . . . . 70.31 112.401 177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -127.25 141.34 51.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.594 -1.639 . . . . 62.14 108.151 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.68 29.25 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.044 -0.598 . . . . 63.1 112.193 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 9.2 mt -107.72 71.72 0.83 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.632 -0.877 . . . . 74.34 108.632 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.46 -79.91 0.07 OUTLIER Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 119.89 -1.148 . . . . 73.23 113.741 -174.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.99 106.76 7.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.106 0.955 . . . . 74.01 111.756 -171.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.7 20.02 32.86 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.83 -1.077 . . . . 72.43 111.58 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.38 151.34 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.13 0.491 . . . . 72.41 109.825 -171.464 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.7 m -92.01 170.85 9.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 72.12 110.072 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.814 2.046 . . . . 74.44 114.042 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -42.44 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 127.181 2.193 . . . . 74.35 115.854 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -21.92 0.41 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.56 1.944 . . . . 75.34 114.408 169.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.3 t -56.36 -32.03 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.114 0.87 . . . . 40.2 110.762 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.4 -31.56 81.26 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.878 -0.401 . . . . 71.44 113.559 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -75.51 -30.7 59.91 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.34 0.591 . . . . 73.11 110.251 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.5 t80 -59.21 -42.91 92.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.412 -0.813 . . . . 65.01 110.72 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.4 ' HD1' ' O ' ' A' ' 250' ' ' VAL . 78.8 m-85 -78.17 -24.04 47.41 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.894 0.378 . . . . 74.14 112.015 177.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.432 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 22.7 tptm -66.83 -21.88 66.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.475 1.11 . . . . 72.12 112.197 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.42 -20.54 65.64 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 112.119 0.414 . . . . 63.13 112.119 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.91 54.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 117.871 0.305 . . . . 72.34 110.191 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . 147.04 -168.72 28.19 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.178 -1.487 . . . . 37.38 115.011 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.55 138.42 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.407 0.683 . . . . 74.43 110.994 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.428 HG12 ' HD3' ' A' ' 255' ' ' LYS . 6.7 mm -74.12 116.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.306 0.379 . . . . 74.15 110.17 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -98.93 142.92 29.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.401 0.619 . . . . 53.53 111.11 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 12.7 m -84.62 115.66 22.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 166.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.76 136.07 48.63 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.789 0.292 . . . . 65.22 111.789 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -11.05 59.98 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.739 0.644 . . . . 64.2 112.739 -174.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -74.11 -26.94 60.63 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.452 0.168 . . . . 73.03 111.236 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 1.8 t -125.32 -31.54 3.03 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.096 0.406 . . . . 62.05 112.096 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.8 83.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 116.308 -0.405 . . . . 53.31 112.934 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -96.24 148.41 34.45 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.442 0.697 . . . . 73.22 111.325 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.0 153.58 74.79 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.787 2.325 . . . . 55.23 111.022 165.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.429 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.6 OUTLIER -76.32 101.24 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.263 0.838 . . . . 73.41 113.263 -170.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.2 mm -142.55 112.82 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.024 -1.473 . . . . 71.11 107.024 162.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -129.07 113.34 15.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.333 -0.617 . . . . 71.24 109.333 162.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.42 110.5 19.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.032 -0.729 . . . . 62.11 109.032 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -103.44 111.83 24.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.095 0.474 . . . . 72.12 110.897 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 17.1 p -145.39 120.81 10.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.56 -1.2 . . . . 74.42 109.815 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -87.76 113.87 23.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.411 1.1 . . . . 75.23 112.595 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -4.05 58.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.119 -0.946 . . . . 63.15 112.574 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.64 79.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 64.42 110.836 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -92.69 -21.43 20.0 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.691 -0.686 . . . . 73.43 109.801 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 103.67 -45.29 1.34 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.905 -0.588 . . . . 74.13 112.673 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -79.75 143.98 59.42 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 121.224 -0.19 . . . . 72.34 110.628 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -57.12 140.51 92.92 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.959 2.439 . . . . 74.23 114.378 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.52 -37.24 82.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.877 -1.056 . . . . 74.41 111.571 176.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.11 17.18 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.872 -0.604 . . . . 64.43 113.891 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.44 146.18 47.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.449 -0.5 . . . . 73.34 111.478 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.48 152.67 33.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.81 -0.632 . . . . 55.32 110.632 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.75 135.17 50.72 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.101 166.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.96 146.81 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' SER . . . . . 0.429 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.7 m -113.58 133.82 55.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.502 0.556 . . . . 65.14 112.502 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.71 165.23 11.49 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.661 0.615 . . . . 75.21 112.661 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.89 -47.95 60.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.339 -0.846 . . . . 64.23 111.949 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -117.79 135.78 23.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.351 -0.611 . . . . 71.23 109.351 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.13 -38.84 53.25 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 123.274 2.649 . . . . 71.43 117.238 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.19 -28.39 15.6 Favored 'Trans proline' 0 C--N 1.393 2.874 0 CA-C-N 123.426 2.259 . . . . 51.42 112.544 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.4 m -61.92 -27.44 68.82 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.301 1.04 . . . . 71.52 111.946 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . 0.451 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.26 -39.58 78.36 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.307 0.38 . . . . 71.45 111.712 175.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -41.07 87.74 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.744 0.307 . . . . 73.12 110.387 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.82 76.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.722 -0.672 . . . . 54.51 111.395 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.64 -31.18 71.7 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 122.806 0.443 . . . . 60.22 111.725 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.2 mt -68.86 -31.11 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 O-C-N 122.197 -0.315 . . . . 74.43 110.86 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.11 -59.74 2.65 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.385 0.883 . . . . 72.01 113.385 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . 0.253 1.7 p-90 -91.69 -34.26 14.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.534 2.049 . . . . 73.32 116.534 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -84.82 -22.48 29.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.376 0.607 . . . . 61.44 110.193 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -83.31 -176.02 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.009 -0.996 . . . . 61.41 109.435 171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 84.53 9.83 80.76 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 114.123 0.409 . . . . 64.52 114.123 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 -160.97 1.04 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.151 -0.685 . . . . 63.32 109.151 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.21 146.14 49.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.694 0.759 . . . . 74.34 111.401 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.88 114.28 26.72 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.749 -1.204 . . . . 73.31 107.749 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.7 m170 62.54 28.37 16.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.672 1.189 . . . . 62.54 111.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 88.89 -2.34 84.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.462 -0.399 . . . . 70.41 114.092 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -110.5 142.58 42.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.399 0.599 . . . . 55.54 109.597 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.82 126.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.177 0.513 . . . . 70.15 110.944 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 10.6 tt -108.78 139.42 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.65 -0.704 . . . . 74.13 109.963 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -136.4 123.79 22.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.55 111.075 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 p -109.29 138.85 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 CA-C-N 115.022 -0.99 . . . . 75.32 110.226 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 115.767 -0.652 . . . . 73.34 109.866 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -79.14 -3.63 46.49 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 114.618 1.34 . . . . 73.51 114.618 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.66 -169.22 0.2 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.402 1.081 . . . . 72.22 112.535 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.8 m -96.34 137.36 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.573 -0.528 . . . . 74.5 109.573 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.76 176.05 5.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.492 -0.322 . . . . 71.24 111.141 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 72.34 89.41 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 124.851 1.261 . . . . 75.52 111.517 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.84 -166.55 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.106 2.537 . . . . 73.33 113.48 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.866 1.266 . . . . 74.22 110.312 -177.783 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.558 0.218 . . . . 53.44 110.706 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 103.38 15.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.192 -0.603 . . . . 65.45 110.569 167.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.3 m -143.73 143.55 31.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.535 -0.913 . . . . 63.13 108.535 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.94 142.24 36.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 119.262 0.937 . . . . 70.05 109.915 163.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -100.09 130.51 46.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.23 -1.026 . . . . 71.33 108.23 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.48 141.56 43.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.565 -0.532 . . . . 73.04 109.565 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 12.3 mm-40 -126.33 150.63 48.4 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 63.42 110.423 -176.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.07 14.01 59.72 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 124.383 1.052 . . . . 63.21 112.782 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 286' ' ' ALA . 6.5 mt -103.48 74.56 1.27 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.984 -1.117 . . . . 73.31 107.984 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.91 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.513 -0.851 . . . . 73.3 113.55 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.21 112.4 12.64 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.432 0.634 . . . . 64.53 111.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.14 21.02 51.27 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.308 -0.86 . . . . 63.42 111.686 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.59 151.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.393 -0.595 . . . . 74.32 109.393 -172.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.8 t -91.81 170.78 9.61 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.05 -0.722 . . . . 71.35 109.05 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -167.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.535 2.334 . . . . 71.44 114.039 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -44.29 -12.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 126.24 1.816 . . . . 50.21 115.26 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -46.0 -22.58 0.22 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.605 1.962 . . . . 72.44 113.471 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.64 HG11 HD13 ' A' ' 241' ' ' LEU . 0.9 OUTLIER -56.3 -32.49 35.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 CA-C-N 118.914 0.779 . . . . 75.11 109.912 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.58 -32.58 83.78 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.281 -0.262 . . . . 73.35 113.197 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.12 -32.63 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.418 0.687 . . . . 73.54 110.481 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 7.5 t80 -56.76 -44.38 81.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.433 1.093 . . . . 74.11 110.806 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.24 -24.29 47.0 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 111.956 0.354 . . . . 74.21 111.956 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -66.87 -21.34 66.01 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.936 0.895 . . . . 72.44 111.46 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.55 -25.0 68.04 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 122.195 -0.316 . . . . 74.13 111.365 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.4 mm -124.59 70.86 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.024 -0.732 . . . . 43.15 109.024 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.36 -176.0 24.61 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 119.096 -1.526 . . . . 53.35 114.575 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.01 139.58 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.347 0.659 . . . . 74.1 109.727 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.68 116.53 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.119 0.485 . . . . 74.53 110.262 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' A' ' 290' ' ' PHE . 22.8 tttm -95.73 137.49 34.71 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.543 0.687 . . . . 72.4 111.048 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 26.7 m -85.2 117.85 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.666 -1.152 . . . . 64.01 108.471 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -75.24 137.98 41.59 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.147 -0.479 . . . . 71.02 110.554 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -80.01 -10.15 59.75 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.393 0.886 . . . . 73.22 113.393 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.85 -41.16 78.85 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.364 0.505 . . . . 62.4 112.364 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.6 t -125.36 -18.86 5.21 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.739 0.304 . . . . 52.22 111.089 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.67 57.11 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 116.292 -0.413 . . . . 61.44 113.165 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -98.13 153.3 38.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.016 0.376 . . . . 71.22 112.016 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.16 155.84 68.9 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.646 2.898 . . . . 65.35 112.353 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.493 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.55 98.11 2.25 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.175 0.988 . . . . 61.25 113.353 -174.669 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.2 mm -144.15 112.58 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.034 -1.469 . . . . 73.45 107.034 163.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.07 116.33 19.12 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.425 1.011 . . . . 64.24 109.865 162.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 111.25 21.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.51 110.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 32.4 m-85 -102.6 112.0 24.55 Favored 'General case' 0 C--O 1.26 1.625 0 CA-C-O 121.241 0.543 . . . . 72.11 110.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.1 p -143.46 120.43 11.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.317 -1.311 . . . . 75.45 109.807 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -87.9 113.14 23.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.804 1.288 . . . . 73.52 111.884 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -7.61 59.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.633 -1.167 . . . . 73.4 111.639 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.81 -29.51 66.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.246 0.618 . . . . 75.5 111.371 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -91.11 -29.41 17.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.412 -0.588 . . . . 72.4 109.412 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 107.18 -19.3 34.96 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.316 -0.856 . . . . 52.11 112.633 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -113.17 141.64 26.03 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.292 -0.262 . . . . 73.43 110.292 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.35 140.35 94.1 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 123.316 2.678 . . . . 71.04 114.958 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.444 ' H ' ' HA ' ' A' ' 275' ' ' THR . 16.2 mttt -64.18 -36.52 84.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.706 -1.134 . . . . 64.32 112.247 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.87 20.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.519 -0.764 . . . . 63.11 112.421 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 49.1 mt-10 -119.62 141.03 49.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 119.724 -0.79 . . . . 71.32 109.81 -174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -152.74 144.69 23.7 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.908 -0.587 . . . . 30.35 109.887 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 237' ' ' PHE . 76.3 p -127.7 140.22 52.21 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 122.017 -0.427 . . . . 53.52 109.964 173.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.405 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 19.6 m -134.58 146.78 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.006 0.432 . . . . 72.22 110.428 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.493 ' H ' ' CB ' ' A' ' 270' ' ' MET . 27.6 t -98.61 113.98 26.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.725 0.81 . . . . 63.42 112.49 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.422 ' O ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 m-85 -88.08 162.77 16.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.592 0.219 . . . . 65.13 111.592 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.47 -47.62 19.19 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.434 0.459 . . . . 70.41 111.199 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.76 135.44 22.19 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 120.967 -0.293 . . . . 62.32 110.277 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.67 -40.45 22.72 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.213 1.942 . . . . 65.1 116.376 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.66 -30.02 51.31 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 123.082 2.136 . . . . 74.32 113.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 67.9 m -63.82 -27.36 69.12 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.44 0.696 . . . . 61.31 112.709 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.97 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.24 0.616 . . . . 75.2 111.838 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.84 -40.76 88.06 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.079 0.552 . . . . 63.32 111.159 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.05 -32.94 74.71 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.438 -0.801 . . . . 62.24 111.583 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -70.59 -29.56 66.01 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.54 -33.81 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 110.384 -0.228 . . . . 74.44 110.384 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.21 -59.41 2.79 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 114.264 1.209 . . . . 70.31 114.264 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -91.37 -34.07 15.02 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.117 1.895 . . . . 74.24 116.117 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 67.7 t80 -86.74 -14.99 40.79 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.339 0.59 . . . . 74.31 110.558 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.38 175.77 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.81 14.49 46.27 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.903 -0.665 . . . . 71.03 112.809 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -133.72 -154.04 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.097 -0.705 . . . . 75.02 109.097 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 149.91 52.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.85 0.833 . . . . 75.12 111.264 174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -113.49 114.81 27.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.61 -1.177 . . . . 74.43 108.211 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.9 m170 64.52 28.35 13.4 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.606 1.163 . . . . 75.15 112.5 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.35 -2.75 86.68 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 119.891 -0.394 . . . . 61.3 113.905 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.69 141.93 47.17 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.927 -0.768 . . . . 64.13 108.927 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.14 131.23 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.127 0.489 . . . . 73.3 111.481 -169.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.86 142.68 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.597 -0.729 . . . . 73.24 109.569 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -137.11 129.1 29.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 75.0 111.359 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.66 134.64 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.811 -0.631 . . . . 64.21 110.188 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -136.12 173.49 11.65 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.149 0.98 . . . . 50.43 109.816 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.9 0.56 43.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.409 0.892 . . . . 74.24 113.409 175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 124.359 1.064 . . . . 54.04 112.88 176.539 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.239 0.511 0 N-CA-C 110.164 -0.309 . . . . 52.03 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.39 105.53 17.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.272 0.558 . . . . 64.05 110.407 165.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 14.0 m -142.29 145.21 33.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.047 -1.094 . . . . 55.25 108.047 165.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.46 HD13 HG13 ' A' ' 315' ' ' VAL . 1.7 pp -122.16 144.42 31.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 118.937 0.79 . . . . 73.41 109.117 166.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 136.62 43.26 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.279 -0.638 . . . . 75.24 109.279 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.02 143.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.58 0.705 . . . . 62.34 112.515 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 12.8 mm-40 -126.56 147.36 49.88 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.102 -1.408 . . . . 62.21 110.387 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.4 21.93 30.76 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.524 0.515 . . . . 62.24 113.373 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -114.96 75.48 0.94 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.566 -1.272 . . . . 74.21 107.566 176.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -131.32 -86.87 0.39 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.513 -0.851 . . . . 73.12 113.495 -170.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.31 113.21 12.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.179 0.514 . . . . 63.33 111.549 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.26 40.08 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.219 -0.9 . . . . 55.32 111.707 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.82 151.67 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.508 -0.552 . . . . 73.31 109.508 -174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.2 m -89.34 169.97 10.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.213 -0.903 . . . . 70.11 110.09 173.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.594 1.957 . . . . 64.23 113.868 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -42.64 -14.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 C-N-CA 126.36 1.864 . . . . 75.51 114.728 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.94 -20.78 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.748 2.019 . . . . 74.24 114.229 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.46 -31.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.81 0.732 . . . . 64.43 110.25 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.89 -35.82 91.02 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.548 -0.585 . . . . 61.22 113.964 172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.99 -35.46 80.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.943 0.897 . . . . 74.03 111.757 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.0 t80 -57.24 -44.35 83.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.005 0.922 . . . . 71.52 111.125 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.85 -24.34 44.41 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 111.821 0.304 . . . . 75.52 111.821 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 260' ' ' ILE . 15.3 tptm -63.93 -23.4 67.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.095 0.958 . . . . 73.13 111.905 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.79 -24.39 67.71 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 121.037 -0.265 . . . . 63.23 111.521 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -126.29 67.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 109.086 -0.709 . . . . 75.53 109.086 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.77 -177.01 24.44 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 119.38 -1.39 . . . . 74.55 114.574 171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.02 138.44 31.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.112 0.565 . . . . 54.24 109.669 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.8 mm -66.86 115.98 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.662 0.601 . . . . 62.11 110.066 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -95.97 139.2 32.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.241 -0.89 . . . . 72.4 111.135 -176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 29.4 m -86.92 117.57 25.74 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.101 -1.074 . . . . 71.23 108.101 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.68 132.02 36.86 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.854 -0.425 . . . . 75.24 109.854 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -10.11 59.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.098 1.147 . . . . 75.2 114.098 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.09 -31.22 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 111.772 0.286 . . . . 71.44 111.772 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.2 t -124.66 -31.7 3.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.772 0.32 . . . . 75.14 111.267 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.01 6.65 69.12 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.176 -0.466 . . . . 34.41 112.506 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.444 ' H ' HG23 ' A' ' 266' ' ' THR . 75.6 mttt -98.18 152.0 37.79 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.295 0.638 . . . . 75.54 112.217 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.01 154.42 74.09 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.662 2.908 . . . . 73.4 112.306 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.9 ptm -71.0 99.53 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.894 1.072 . . . . 64.42 113.894 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.6 mm -144.4 114.21 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.565 -1.272 . . . . 62.41 107.565 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -129.54 116.45 18.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.997 0.817 . . . . 74.02 110.41 161.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 111.32 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.836 -0.431 . . . . 73.25 109.836 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.7 m-85 -103.16 112.52 25.41 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-O 121.159 0.504 . . . . 73.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.466 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.1 p -141.99 122.99 14.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.524 -1.216 . . . . 65.45 110.336 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.62 112.22 20.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.118 0.485 . . . . 53.31 111.627 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -11.06 50.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.094 0.776 . . . . 75.21 113.094 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -28.79 57.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.487 . . . . 61.32 110.175 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 51.5 p -89.56 -21.8 22.7 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.742 -0.663 . . . . 70.21 109.624 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.46 -35.68 4.56 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.584 -0.734 . . . . 51.54 112.536 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -97.96 141.63 23.28 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 123.379 0.105 . . . . 74.31 111.163 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.57 135.44 70.4 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.493 2.795 . . . . 63.22 114.173 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.466 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.3 mttt -63.85 -36.68 84.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.607 -1.179 . . . . 64.4 112.082 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.55 23.95 19.81 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.777 -0.725 . . . . 62.41 112.682 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 26.8 mt-10 -117.78 142.96 46.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.793 -0.447 . . . . 74.13 109.793 -172.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.53 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.278 -0.419 . . . . 63.54 110.535 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 20.7 p -134.97 137.01 42.65 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.964 -0.384 . . . . 71.13 109.964 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.61 150.06 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.259 -0.428 . . . . 35.43 110.125 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 30.7 t -105.47 117.73 34.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.972 0.73 . . . . 55.42 112.972 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 159.93 20.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.097 -0.241 . . . . 71.33 111.227 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.29 -47.03 16.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.119 -0.491 . . . . 74.3 109.951 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.62 135.4 29.25 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 123.212 0.32 . . . . 73.42 110.468 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.32 -40.71 30.53 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.434 2.089 . . . . 73.1 116.133 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.33 -29.22 32.22 Favored 'Trans proline' 0 C--N 1.389 2.696 0 CA-C-N 122.682 1.994 . . . . 63.33 113.535 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 61.3 m -63.55 -25.78 68.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.175 0.59 . . . . 75.45 112.361 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -72.98 -45.68 56.59 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.037 0.384 . . . . 70.12 112.037 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -32.69 68.59 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.257 0.551 . . . . 62.22 111.415 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.74 -30.62 61.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.284 -0.871 . . . . 75.15 110.6 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.62 -31.23 71.11 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 122.252 0.221 . . . . 70.34 111.218 173.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 296' ' ' ALA . 67.2 mt -67.04 -34.57 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 120.484 0.183 . . . . 53.55 110.748 173.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.9 -59.86 2.61 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.393 1.257 . . . . 73.42 114.393 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.93 -35.33 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.509 1.67 . . . . 74.11 115.509 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.6 t80 -83.32 -18.66 38.2 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.101 0.477 . . . . 72.22 110.156 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.97 -174.08 2.46 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.043 -0.98 . . . . 62.22 109.219 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.08 65.35 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.121 -0.561 . . . . 75.42 112.322 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -135.98 -160.88 1.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.622 0.369 . . . . 70.41 110.137 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.17 145.68 47.97 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.784 0.802 . . . . 72.43 111.884 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -114.74 114.93 26.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.43 -1.259 . . . . 71.24 107.858 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.9 m170 64.37 28.66 13.68 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.915 1.286 . . . . 73.41 112.649 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.94 -2.97 85.96 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.148 0.419 . . . . 71.52 114.148 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -111.74 144.4 41.1 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 122.801 0.441 . . . . 71.12 110.05 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.66 129.66 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 123.331 0.394 . . . . 71.2 110.33 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.0 tt -108.41 145.8 14.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.9 -0.591 . . . . 74.41 109.514 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 42.5 tttp -135.4 127.94 30.66 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.071 -0.513 . . . . 54.24 111.256 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.46 HG13 HD13 ' A' ' 236' ' ' ILE . 25.2 t -103.61 133.76 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.37 0.605 . . . . 71.44 109.385 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -132.53 173.36 11.4 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.997 0.919 . . . . 74.41 109.313 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.26 -1.07 52.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 113.076 0.769 . . . . 75.12 113.076 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 124.404 1.082 . . . . 35.2 113.321 175.353 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.397 0.141 . . . . 72.14 111.359 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.42 104.21 16.75 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.45 -0.781 . . . . 74.03 110.676 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -144.12 149.51 36.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.467 0.707 . . . . 60.3 109.344 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.76 137.16 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.726 0.694 . . . . 61.42 110.512 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.55 125.51 48.21 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.556 -0.535 . . . . 75.03 109.556 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -120.05 143.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.745 0.784 . . . . 74.12 111.93 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 6.2 tp-100 -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.986 -1.461 . . . . 44.42 108.927 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.78 43.94 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.098 -0.573 . . . . 61.43 112.958 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -105.0 78.65 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.579 -0.896 . . . . 63.41 108.579 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.54 -81.44 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.491 -0.861 . . . . 71.14 113.486 -172.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.68 107.14 9.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 72.14 111.21 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.23 20.92 24.07 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.556 -0.747 . . . . 61.13 112.078 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.54 152.55 4.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.384 0.611 . . . . 73.32 110.572 -173.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -93.84 169.24 10.44 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.597 -0.729 . . . . 60.15 109.408 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -167.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 127.136 2.174 . . . . 71.11 114.208 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -44.14 -13.12 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 126.241 1.817 . . . . 75.41 115.528 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -22.96 0.38 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 126.499 1.92 . . . . 73.43 113.998 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -56.21 -30.59 30.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 O-C-N 122.001 -0.437 . . . . 74.41 110.287 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.38 -33.49 84.79 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 122.054 -0.403 . . . . 75.11 113.378 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.22 -32.13 64.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.527 0.731 . . . . 45.04 110.697 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 11.0 t80 -55.56 -45.85 77.24 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.162 -0.926 . . . . 74.33 111.182 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.82 -24.12 48.83 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.195 -0.315 . . . . 71.15 111.613 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -74.83 -11.11 60.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.661 0.785 . . . . 63.2 112.183 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -15.83 61.88 Favored 'General case' 0 CA--C 1.557 1.238 0 O-C-N 121.854 -0.529 . . . . 61.5 111.733 172.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 -44.41 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.909 0.484 . . . . 71.04 111.115 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -139.08 -162.09 8.99 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.365 -0.921 . . . . 64.24 114.72 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.0 138.2 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.832 0.453 . . . . 73.4 110.835 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.82 114.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 O-C-N 123.885 0.741 . . . . 64.3 110.947 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -100.96 144.16 30.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.763 -1.108 . . . . 53.42 111.308 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.8 m -83.39 118.1 23.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.369 -1.287 . . . . 74.53 108.114 168.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.94 133.96 45.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.605 0.565 . . . . 71.33 109.676 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -77.38 -11.55 59.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.474 0.546 . . . . 72.52 112.474 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.31 -31.21 68.43 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.106 0.41 . . . . 60.44 112.106 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.2 t -124.86 -31.68 3.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.625 0.232 . . . . 71.4 111.625 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.85 69.19 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 116.48 -0.327 . . . . 64.34 112.515 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 266' ' ' THR . 49.9 mttt -98.45 152.4 37.91 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 123.256 0.623 . . . . 64.44 112.247 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.02 154.35 74.38 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 123.178 2.585 . . . . 64.14 111.113 166.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.525 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.94 102.15 6.27 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.651 0.982 . . . . 64.52 113.651 -168.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.86 112.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.126 -1.435 . . . . 74.53 107.126 163.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -128.5 114.78 17.2 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.685 0.675 . . . . 72.51 109.367 161.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.56 110.24 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.363 -0.606 . . . . 73.05 109.363 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -103.06 112.22 24.96 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 121.356 0.598 . . . . 75.14 111.009 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.7 p -144.18 120.99 11.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.594 -1.185 . . . . 53.23 109.997 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.96 112.94 21.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.448 0.642 . . . . 64.21 111.864 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -7.9 58.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.407 -0.815 . . . . 73.35 112.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -33.0 69.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.021 0.438 . . . . 72.23 111.138 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 7.7 t -91.53 -14.53 30.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.776 -0.647 . . . . 74.31 109.886 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.59 -49.76 1.62 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.589 -0.732 . . . . 43.14 112.628 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.11 142.09 59.06 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.716 0.304 . . . . 71.02 110.54 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -57.15 134.56 64.97 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.314 2.676 . . . . 73.24 114.228 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -60.26 -42.46 95.37 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.928 -1.033 . . . . 74.45 111.889 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.77 14.59 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.796 -0.716 . . . . 52.31 113.565 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -118.27 145.86 44.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.086 0.443 . . . . 73.24 110.517 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.86 156.13 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 61.51 110.456 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.71 136.08 46.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.74 0.305 . . . . 74.43 110.211 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.68 148.05 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 116.176 -0.465 . . . . 72.31 109.747 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.525 ' H ' ' CB ' ' A' ' 270' ' ' MET . 47.4 t -97.66 141.74 30.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.227 1.011 . . . . 74.32 111.74 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.81 164.89 12.31 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.195 -0.315 . . . . 74.25 110.538 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.0 -47.51 65.35 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.442 0.464 . . . . 74.23 110.872 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.411 ' HB3' ' HD2' ' A' ' 294' ' ' PRO . 40.3 m-20 -115.11 138.18 23.36 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 116.481 -0.327 . . . . 72.1 110.232 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -61.88 -37.8 63.65 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 C-N-CA 123.137 2.558 . . . . 70.21 117.782 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 292' ' ' ASP . 33.3 Cg_endo -76.6 -27.3 7.63 Favored 'Trans proline' 0 C--N 1.392 2.824 0 CA-C-N 123.645 2.337 . . . . 71.21 112.999 -172.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.5 m -59.57 -27.94 66.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.258 1.023 . . . . 73.25 111.738 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.1 -39.28 82.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.506 0.723 . . . . 71.55 112.892 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -75.07 -32.77 61.57 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.821 0.343 . . . . 65.21 111.116 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.17 79.99 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.156 -0.475 . . . . 51.24 110.314 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.13 68.04 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.152 -0.476 . . . . 63.13 112.204 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.8 mt -67.41 -30.56 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 O-C-N 122.164 -0.335 . . . . 64.32 110.582 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -59.73 2.66 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 113.904 1.076 . . . . 60.45 113.904 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -90.73 -37.48 13.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.272 1.953 . . . . 73.43 116.272 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -82.42 -21.12 35.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.304 0.573 . . . . 75.24 110.436 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 315' ' ' VAL . 13.9 t70 -83.85 -172.52 4.2 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.083 -0.962 . . . . 62.22 109.971 168.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 80.86 11.8 83.44 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.854 -0.529 . . . . 42.21 113.106 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 -159.21 0.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.481 -0.563 . . . . 74.33 109.481 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.84 145.2 51.41 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.597 0.713 . . . . 74.45 110.784 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -112.35 113.57 25.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.485 -1.302 . . . . 72.12 107.485 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.1 m170 64.41 28.51 13.6 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 124.455 1.097 . . . . 74.24 112.663 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.77 3.37 88.14 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.408 -0.36 . . . . 73.52 113.458 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -112.87 141.47 46.65 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.739 -0.837 . . . . 63.4 108.739 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.21 127.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.966 0.413 . . . . 63.35 110.462 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.6 tt -108.5 144.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.764 -0.653 . . . . 55.13 109.629 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 39.1 tptt -136.5 121.12 18.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.993 -0.548 . . . . 72.23 109.95 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 304' ' ' ASP . 8.2 p -107.65 136.74 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.489 -0.778 . . . . 65.12 109.892 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 m -138.08 174.15 10.87 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 124.146 0.978 . . . . 71.13 110.13 -173.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -7.25 59.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.632 0.975 . . . . 74.34 113.632 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 114.593 1.331 . . . . 70.41 114.593 172.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 110.26 -0.274 . . . . 74.41 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 103.95 16.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.905 -0.718 . . . . 71.45 110.24 162.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.9 m -142.27 144.87 33.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.948 -1.501 . . . . 61.31 106.948 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 11.8 pt -123.59 141.26 44.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 119.406 1.003 . . . . 73.22 109.689 168.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.519 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.5 OUTLIER -101.53 122.53 43.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.677 -0.86 . . . . 72.42 108.677 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.9 141.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.087 -0.709 . . . . 71.0 109.087 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 13.1 mm-40 -128.15 151.03 49.71 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.489 0.716 . . . . 72.32 110.516 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 312' ' ' ILE . . . 90.9 21.48 36.12 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 124.158 0.911 . . . . 71.31 113.638 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 76.92 1.0 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.79 -1.189 . . . . 60.24 107.79 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.68 -90.93 0.42 Allowed Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.587 -0.816 . . . . 63.23 113.753 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.68 112.9 16.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.929 0.395 . . . . 70.21 110.791 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.59 20.15 25.41 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.321 -0.854 . . . . 74.43 111.996 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -87.29 151.83 3.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.681 -0.489 . . . . 75.33 109.681 -173.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.2 m -93.55 170.63 9.45 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.0 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -165.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.344 2.258 . . . . 73.11 114.233 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -42.89 -14.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 127.384 2.273 . . . . 73.32 114.819 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -46.93 -22.08 0.28 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.671 1.988 . . . . 64.3 114.723 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -57.46 -32.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 119.341 0.973 . . . . 63.4 110.699 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.86 85.93 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 120.065 -0.297 . . . . 62.24 113.463 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 37.4 tt0 -73.47 -31.47 63.78 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.39 0.676 . . . . 71.45 111.23 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.9 t80 -56.8 -43.44 80.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.144 0.578 . . . . 72.23 111.298 170.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -79.04 -24.46 43.6 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.471 0.545 . . . . 74.34 112.471 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 13.2 tptm -63.01 -23.17 67.33 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.356 1.062 . . . . 72.34 111.681 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.15 -20.38 65.95 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.63 0.604 . . . . 75.43 112.63 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.5 mm -123.61 41.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 121.419 0.628 . . . . 65.5 110.233 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 150.64 -168.81 30.49 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 118.835 -1.65 . . . . 65.54 115.02 172.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.29 136.56 37.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.372 -0.414 . . . . 63.2 110.573 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 38.3 mm -67.46 115.25 5.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.86 -1.064 . . . . 73.51 110.027 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -98.18 140.54 32.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.505 0.669 . . . . 73.22 111.3 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.7 m -84.35 116.71 23.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.688 -1.142 . . . . 73.14 108.074 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.67 126.64 31.19 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 109.132 -0.692 . . . . 72.21 109.132 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -74.98 -6.32 48.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.229 1.196 . . . . 75.42 114.229 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.97 -33.47 74.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.23 0.212 . . . . 72.53 111.147 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.38 -29.33 3.25 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.729 0.299 . . . . 72.21 111.511 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 91.5 11.02 61.3 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.194 -0.457 . . . . 62.13 112.811 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.46 ' H ' HG23 ' A' ' 266' ' ' THR . 73.9 mttt -98.62 151.53 37.49 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 122.933 0.493 . . . . 73.24 112.182 173.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.99 155.52 63.96 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 123.981 3.12 . . . . 64.11 112.837 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.466 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -70.35 98.91 1.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.03 1.122 . . . . 71.35 114.03 -173.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.5 mm -144.19 113.07 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.224 -1.398 . . . . 74.01 107.224 164.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -128.7 115.05 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 119.262 0.937 . . . . 71.24 109.891 161.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.69 111.21 21.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.957 0.408 . . . . 64.23 110.083 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 62.2 m-85 -103.54 111.53 24.02 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 121.356 0.598 . . . . 71.42 110.39 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.442 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.2 p -143.2 122.51 13.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.027 -1.442 . . . . 63.3 110.136 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.7 112.02 20.65 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.207 0.527 . . . . 62.15 111.497 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.21 -9.82 54.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.146 0.795 . . . . 54.11 113.146 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -28.65 56.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.566 0.222 . . . . 65.51 110.582 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 56.8 p -88.69 -21.04 24.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.375 0.607 . . . . 62.14 109.454 169.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.32 -12.14 70.29 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 114.932 -1.031 . . . . 75.11 112.944 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -121.08 140.26 30.72 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 110.184 -0.302 . . . . 72.22 110.184 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.47 133.5 55.06 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 123.187 2.591 . . . . 70.24 114.209 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.4 mttt -62.12 -34.37 76.23 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.798 -1.092 . . . . 65.41 112.357 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.34 24.46 18.89 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.94 -0.648 . . . . 43.05 112.723 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 35.9 mt-10 -119.35 142.1 48.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.764 -0.774 . . . . 74.31 109.901 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.59 143.04 23.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.264 -0.643 . . . . 40.52 109.264 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 237' ' ' PHE . 62.4 p -128.43 139.62 52.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.289 -0.634 . . . . 75.32 109.289 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.89 144.47 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 120.947 0.404 . . . . 52.35 110.17 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 270' ' ' MET . 43.3 t -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.49 0.716 . . . . 61.04 112.041 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.82 164.97 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.658 -0.246 . . . . 75.15 111.422 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.11 -48.05 63.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.117 0.567 . . . . 75.02 112.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -122.23 136.45 26.42 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.641 -0.874 . . . . 72.24 108.641 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.9 -37.9 62.68 Favored 'Trans proline' 0 CA--C 1.567 2.151 0 C-N-CA 123.099 2.532 . . . . 65.2 117.462 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 -29.01 18.08 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.762 2.379 . . . . 61.12 113.238 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.0 m -60.04 -29.02 68.23 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.306 1.043 . . . . 74.45 112.063 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.49 -38.61 81.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.639 0.775 . . . . 61.43 112.759 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -74.36 -36.01 63.57 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.258 0.551 . . . . 74.43 111.126 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.75 81.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.074 -0.967 . . . . 73.31 110.929 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.72 -29.66 68.13 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 123.583 0.552 . . . . 64.34 111.976 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 296' ' ' ALA . 78.9 mt -63.29 -34.72 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 117.772 0.26 . . . . 75.02 110.713 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.41 -60.05 2.52 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 114.19 1.181 . . . . 71.52 114.19 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.44 -34.05 15.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.194 1.924 . . . . 73.54 116.194 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.441 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 60.3 t80 -85.65 -18.47 33.14 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.191 0.52 . . . . 65.4 110.167 -171.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -107.59 -175.51 2.81 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.339 -0.986 . . . . 73.12 108.339 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.45 56.42 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.679 -0.296 . . . . 62.22 112.378 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.56 -153.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.939 -0.393 . . . . 75.53 109.939 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -120.68 146.24 46.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.82 0.448 . . . . 72.12 110.783 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -113.7 110.76 20.71 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.68 -1.23 . . . . 63.01 107.68 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 18.8 m170 64.96 29.64 12.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.638 1.175 . . . . 73.11 112.245 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.14 83.84 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.394 -0.366 . . . . 74.41 113.98 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -110.22 148.72 31.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 117.222 0.511 . . . . 64.43 110.159 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ILE . . . . . 0.406 ' O ' ' HA3' ' A' ' 240' ' ' GLY . 46.6 mm -68.78 126.0 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 123.467 0.48 . . . . 74.51 110.767 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.22 142.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.939 -0.573 . . . . 72.14 109.944 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -136.42 129.84 31.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 71.43 111.034 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.91 137.33 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.201 0.524 . . . . 62.44 109.75 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -136.38 172.94 12.28 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.102 0.961 . . . . 71.23 109.451 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.77 -4.66 55.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.193 0.812 . . . . 74.05 113.193 174.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 124.914 1.286 . . . . 73.34 112.883 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.9 0.381 . . . . 51.24 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.8 105.66 17.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.495 -0.482 . . . . 75.34 110.186 162.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -142.25 150.25 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.066 -1.457 . . . . 64.21 107.066 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.23 137.22 57.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 119.154 0.888 . . . . 65.45 109.837 165.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.666 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.91 116.94 33.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.789 -0.819 . . . . 73.24 108.789 -177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.02 139.7 36.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.42 -0.585 . . . . 71.01 109.42 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 6.2 tp-100 -128.9 142.71 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.761 -0.829 . . . . 65.11 108.761 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.8 20.75 11.09 Favored Glycine 0 N--CA 1.462 0.371 0 C-N-CA 121.139 -0.553 . . . . 53.32 112.464 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.72 73.06 0.8 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.55 -0.907 . . . . 70.44 108.55 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.86 -178.44 26.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.477 -0.783 . . . . 71.03 112.018 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 282' ' ' PRO 0.261 12.0 pt-20 40.84 87.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.833 2.053 . . . . 45.52 114.845 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.18 21.11 25.95 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.008 -0.837 . . . . 65.15 111.008 -173.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.94 151.59 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.242 -0.651 . . . . 71.23 109.242 -173.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.6 m -84.61 168.69 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.76 -0.655 . . . . 74.53 110.23 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -169.13 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.618 1.967 . . . . 74.44 113.07 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -44.11 -12.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 126.422 1.889 . . . . 75.44 115.468 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.09 -23.17 0.28 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.314 1.846 . . . . 71.15 113.701 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -57.78 -31.33 39.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 109.585 -0.524 . . . . 73.54 109.585 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.07 83.68 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-O 119.907 -0.385 . . . . 60.14 113.438 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -76.1 -29.65 57.99 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.243 0.617 . . . . 74.34 111.241 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.8 t80 -55.5 -44.56 76.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.498 0.719 . . . . 73.13 110.419 169.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -77.82 -24.54 48.68 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.685 0.254 . . . . 74.12 111.685 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 260' ' ' ILE . 10.9 tmtt? -68.98 -18.78 64.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.585 0.754 . . . . 74.32 111.292 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -62.86 -22.12 66.46 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 122.297 -0.252 . . . . 73.13 110.802 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -122.83 63.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.369 -0.604 . . . . 70.31 109.369 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.07 -172.84 26.59 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 118.803 -1.665 . . . . 33.54 115.366 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.48 138.48 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.165 -1.018 . . . . 73.14 109.62 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 255' ' ' LYS . 47.7 mm -70.35 116.05 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.272 0.558 . . . . 71.11 110.373 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -96.42 140.15 31.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 72.33 111.404 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 89.7 m -86.0 117.5 24.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.132 -0.94 . . . . 74.43 108.597 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -72.75 136.97 45.59 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.42 -0.354 . . . . 71.24 111.069 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -78.76 -9.39 59.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.003 0.742 . . . . 64.24 113.003 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.43 -39.56 77.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.011 0.374 . . . . 64.25 112.011 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 t -126.25 -19.4 4.71 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.532 0.206 . . . . 73.15 111.359 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.49 57.17 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.519 -0.309 . . . . 74.14 113.063 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -99.93 153.91 37.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.99 0.367 . . . . 74.41 111.99 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.41 153.06 76.89 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.056 2.504 . . . . 64.0 111.723 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.463 ' HE3' ' HB ' ' A' ' 288' ' ' VAL . 1.4 ptm -76.73 100.15 5.33 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.162 0.801 . . . . 71.53 113.162 -171.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.5 mm -143.14 113.92 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 165.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -128.13 117.61 21.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 119.177 0.898 . . . . 75.53 109.815 162.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.53 112.74 23.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 64.2 110.218 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 61.8 m-85 -101.62 111.68 24.01 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-N 115.907 -0.588 . . . . 54.53 109.663 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.2 p -143.74 122.07 12.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.317 -1.311 . . . . 73.34 109.231 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.49 110.7 18.87 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.256 0.55 . . . . 62.21 111.043 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -7.43 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.213 0.82 . . . . 63.22 113.213 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -32.43 70.09 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.252 0.345 . . . . 72.34 110.816 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -91.88 -19.18 22.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.149 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 102.27 -44.43 1.52 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.004 -0.543 . . . . 70.03 112.911 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -81.95 142.1 48.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.587 0.227 . . . . 54.14 111.187 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 243' ' ' GLU . 10.1 Cg_endo -58.69 130.86 39.06 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.909 2.406 . . . . 51.04 113.508 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -59.98 -39.12 84.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.926 -1.034 . . . . 70.14 112.165 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.9 25.23 15.24 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.668 -0.777 . . . . 62.21 113.076 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 37.3 mt-10 -118.81 143.56 46.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.101 0.451 . . . . 73.52 110.084 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.13 143.36 23.26 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.455 0.302 . . . . 61.43 110.341 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.6 p -125.53 138.86 53.98 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 122.074 -0.391 . . . . 71.44 110.296 173.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.463 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 7.4 m -136.86 148.06 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.992 -0.373 . . . . 75.21 109.992 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.432 ' H ' ' CB ' ' A' ' 270' ' ' MET . 49.8 m -108.44 117.48 34.27 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.978 0.733 . . . . 51.02 112.978 -172.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.44 163.94 19.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.759 0.424 . . . . 72.2 111.897 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.2 -48.42 20.47 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 116.536 -0.302 . . . . 61.01 110.686 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.01 135.61 23.41 Favored Pre-proline 0 C--O 1.239 0.548 0 O-C-N 123.203 0.314 . . . . 74.32 110.743 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.81 -41.16 19.08 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 122.802 2.334 . . . . 62.43 116.813 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.58 -29.74 52.15 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 122.946 2.088 . . . . 74.42 113.806 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 49.8 m -64.29 -27.42 69.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.099 0.96 . . . . 71.43 112.465 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.19 88.75 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 122.841 0.457 . . . . 71.14 111.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.62 -39.68 88.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.153 0.581 . . . . 63.31 110.349 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.86 76.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.521 -0.763 . . . . 75.21 111.448 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.92 -33.14 73.26 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.709 0.404 . . . . 71.12 111.623 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 75.2 mt -64.8 -33.41 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.849 0.357 . . . . 71.24 110.603 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.49 -60.33 2.4 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.766 1.024 . . . . 75.14 113.766 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -91.72 -31.84 15.65 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.867 1.803 . . . . 73.2 115.867 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 72.2 t80 -87.49 -14.79 39.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.371 0.605 . . . . 73.22 109.937 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -104.89 173.81 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.337 -0.986 . . . . 74.24 108.337 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.28 14.21 51.83 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.731 -0.747 . . . . 71.23 112.228 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -131.25 -156.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.699 -0.852 . . . . 71.42 108.699 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -132.84 148.77 52.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.618 0.723 . . . . 65.5 111.011 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -113.61 117.7 32.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.4 m170 64.69 28.47 13.08 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.722 1.209 . . . . 61.34 112.17 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.07 86.52 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.405 -0.361 . . . . 72.11 113.762 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.55 144.84 42.19 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 109.197 -0.668 . . . . 72.24 109.197 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.65 130.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.165 0.507 . . . . 64.42 111.673 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.5 tt -110.43 142.51 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.324 -0.853 . . . . 74.22 110.023 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -136.86 126.87 25.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.236 0.614 . . . . 61.53 111.341 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 31.6 t -108.7 138.83 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.276 -0.42 . . . . 74.01 110.877 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -134.95 176.61 8.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 63.55 110.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.77 -11.58 59.83 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.97 1.1 . . . . 71.32 113.97 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 237' ' ' PHE . . . . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 124.289 1.036 . . . . 65.55 113.319 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.7 t30 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.596 0.236 . . . . 71.11 110.382 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.47 103.96 15.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 118.623 -1.231 . . . . 74.4 110.477 160.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -143.03 149.0 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.241 -1.392 . . . . 52.31 107.241 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.0 pt -125.18 139.46 51.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 118.8 0.727 . . . . 53.15 109.605 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.663 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.51 120.52 39.78 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.987 -0.746 . . . . 73.43 108.987 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.81 138.19 45.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.962 -0.563 . . . . 74.32 109.973 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.54 144.32 51.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 72.0 110.984 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.17 20.78 11.76 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.878 0.736 . . . . 63.54 112.969 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.48 75.08 0.92 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.602 -0.888 . . . . 71.42 108.602 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -127.31 -97.16 0.96 Allowed Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.524 -0.846 . . . . 63.11 113.565 -170.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -76.74 117.07 17.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.853 0.358 . . . . 64.52 111.104 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.17 19.66 30.04 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.218 -0.901 . . . . 72.31 111.675 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.22 151.29 4.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.357 0.599 . . . . 41.32 109.494 -174.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.9 t -93.46 170.61 9.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.235 -0.654 . . . . 72.55 109.235 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -167.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.489 2.316 . . . . 70.03 113.379 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -44.44 -12.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 126.497 1.919 . . . . 73.34 115.253 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.3 -23.04 0.49 Allowed 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 126.692 1.997 . . . . 73.43 112.892 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -31.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-N 118.653 0.661 . . . . 70.1 109.523 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.29 -35.48 88.34 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.248 -0.751 . . . . 41.4 114.383 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -75.77 -28.21 58.33 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 117.961 0.881 . . . . 72.23 110.832 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.586 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 6.7 t80 -55.66 -47.35 76.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.013 0.925 . . . . 65.21 110.671 171.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.59 -23.36 46.03 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.057 0.391 . . . . 75.34 112.057 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 11.5 tptm -61.3 -26.21 67.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.387 1.075 . . . . 74.43 111.221 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.84 -19.73 64.39 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 111.905 0.335 . . . . 74.24 111.905 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.1 mm -124.23 62.62 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 109.598 -0.519 . . . . 73.1 109.598 170.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.76 -174.09 25.86 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 118.621 -1.752 . . . . 72.34 115.056 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.18 137.74 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.1 mm -71.48 113.22 7.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.298 0.571 . . . . 55.22 110.391 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -99.66 140.05 34.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.998 -1.001 . . . . 73.22 110.991 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 59.2 m -85.07 116.38 23.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.066 -0.97 . . . . 74.24 108.606 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.16 131.1 41.62 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.086 0.554 . . . . 75.12 110.213 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.7 -7.03 55.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.42 0.896 . . . . 54.34 113.42 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.25 -35.95 80.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.745 0.307 . . . . 72.15 111.108 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.8 p -125.25 -33.56 2.84 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.029 -0.532 . . . . 64.33 111.927 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.76 11.41 65.76 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.959 -0.564 . . . . 64.13 111.927 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -97.35 150.83 37.23 Favored Pre-proline 0 C--O 1.239 0.528 0 C-N-CA 123.238 0.615 . . . . 74.45 110.877 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.87 153.92 74.28 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.998 2.466 . . . . 72.32 111.241 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.471 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -73.22 101.19 3.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.645 0.979 . . . . 75.24 113.645 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -143.2 113.32 2.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.139 -1.391 . . . . 64.42 107.342 163.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -127.6 113.71 16.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 119.182 0.901 . . . . 64.1 109.768 163.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 110.53 20.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.205 -0.294 . . . . 72.33 110.205 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 36.3 m-85 -103.0 111.54 23.93 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 121.266 0.555 . . . . 72.42 110.156 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 20.9 p -145.0 120.98 10.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.984 -1.462 . . . . 54.13 109.624 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -87.47 112.67 22.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.462 0.648 . . . . 62.52 111.762 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -10.23 55.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.167 -0.47 . . . . 74.13 112.22 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.363 0.415 . . . . 61.22 111.191 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.2 p -90.81 -20.45 22.31 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.337 0.589 . . . . 70.51 109.892 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 85.62 7.73 81.39 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.077 -0.965 . . . . 62.45 112.697 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 139.99 25.95 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 110.338 -0.245 . . . . 71.12 110.338 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -58.97 130.75 38.04 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.185 2.59 . . . . 53.34 113.893 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.488 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 40.9 mtpt -63.16 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.874 -1.057 . . . . 75.21 111.992 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.78 14.86 Favored Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.436 -0.802 . . . . 74.01 112.671 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.7 mt-10 -115.48 140.65 48.96 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.212 -0.595 . . . . 74.43 110.239 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.96 143.16 22.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.106 -0.497 . . . . 73.31 109.893 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 237' ' ' PHE . 72.3 p -128.98 139.78 51.95 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.756 -0.377 . . . . 73.54 110.538 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.45 147.63 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 121.176 0.512 . . . . 45.34 110.433 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.471 ' H ' ' CB ' ' A' ' 270' ' ' MET . 44.3 t -94.29 128.03 40.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.729 0.812 . . . . 74.32 112.583 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.28 165.78 12.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.678 0.621 . . . . 75.13 112.678 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -42.37 59.61 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.573 0.546 . . . . 61.51 111.661 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 136.96 29.83 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 109.843 -0.429 . . . . 72.13 109.843 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -59.94 -37.19 87.11 Favored 'Trans proline' 0 CA--C 1.562 1.92 0 C-N-CA 123.53 2.82 . . . . 73.4 117.203 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 -29.75 10.71 Favored 'Trans proline' 0 C--N 1.392 2.825 0 CA-C-N 123.321 2.222 . . . . 64.24 112.691 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 33.6 m -62.97 -32.75 74.15 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.158 0.983 . . . . 64.0 111.315 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.74 83.71 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.011 0.819 . . . . 41.03 111.822 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -48.18 78.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.376 0.422 . . . . 75.23 111.268 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.78 97.53 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 123.714 0.634 . . . . 74.43 110.862 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.85 68.15 Favored 'General case' 0 C--O 1.184 -2.389 0 CA-C-N 115.283 -0.871 . . . . 64.32 111.156 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.19 -34.47 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.128 0.571 . . . . 73.33 112.428 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.28 -54.91 22.14 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.688 0.625 . . . . 72.34 112.688 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -27.26 19.22 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.248 2.314 . . . . 74.44 117.248 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.57 -20.39 39.98 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.175 0.99 . . . . 75.34 112.038 -170.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.8 166.65 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.213 -0.662 . . . . 75.2 109.213 175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.98 12.87 54.8 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.156 -0.545 . . . . 73.43 112.627 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -122.05 -159.37 0.82 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.29 -1.004 . . . . 74.42 108.29 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -130.56 143.02 50.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.555 0.693 . . . . 52.14 111.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -113.14 110.73 20.92 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.14 -1.059 . . . . 73.12 108.14 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.3 m170 64.33 30.11 13.43 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.516 1.135 . . . . 74.33 112.095 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.76 84.46 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 114.369 0.507 . . . . 62.53 114.369 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.2 147.39 37.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.548 -0.538 . . . . 70.53 109.548 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.69 124.92 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.177 0.513 . . . . 73.31 111.202 -172.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 134.83 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.403 -0.817 . . . . 73.22 110.65 -174.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -130.56 145.22 51.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.856 -0.611 . . . . 62.23 111.017 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.42 140.08 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.984 -0.553 . . . . 73.14 109.903 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -133.48 176.5 8.48 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.1 0.96 . . . . 64.52 109.984 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -83.13 -8.61 59.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.596 0.962 . . . . 73.34 113.596 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 124.332 1.053 . . . . 64.5 112.61 178.498 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.448 -0.575 . . . . 64.52 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.0 106.4 18.49 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.529 -0.868 . . . . 62.3 110.34 168.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.9 m -142.05 142.21 32.84 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.532 -0.914 . . . . 71.03 108.532 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 pt -121.83 138.97 50.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 119.897 -0.721 . . . . 72.04 110.241 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.7 120.66 40.95 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.818 -0.628 . . . . 63.51 109.928 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -112.82 142.82 23.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.87 0.843 . . . . 74.43 113.046 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 10.0 mm-40 -127.32 151.99 48.04 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.1 -1.864 . . . . 55.41 109.493 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.81 16.95 46.34 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.171 -0.537 . . . . 74.35 113.172 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 286' ' ' ALA . 0.5 OUTLIER -106.07 64.15 0.67 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.659 0.743 . . . . 61.21 109.273 172.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -106.03 -103.89 2.9 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 115.348 -0.842 . . . . 31.32 112.951 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.86 119.6 17.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.547 0.689 . . . . 74.51 112.415 -173.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.24 18.96 29.56 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.634 -1.166 . . . . 61.35 111.694 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.01 151.94 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.129 0.49 . . . . 72.21 109.804 -172.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.3 m -90.64 170.46 10.14 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.691 -0.686 . . . . 60.24 109.619 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -167.75 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.637 1.975 . . . . 73.1 114.239 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -43.38 -12.91 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 C-N-CA 126.148 1.779 . . . . 73.53 115.444 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -46.78 -20.99 0.16 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 126.26 1.824 . . . . 74.34 114.243 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -55.72 -32.7 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.454 0.57 . . . . 73.44 110.491 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.71 81.66 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 119.953 -0.359 . . . . 74.22 113.611 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.95 -31.52 64.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.023 0.929 . . . . 55.34 111.003 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.0 t80 -58.61 -44.79 90.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.873 0.869 . . . . 63.22 110.887 171.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -76.87 -24.37 52.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 121.196 -0.202 . . . . 73.54 111.32 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -73.05 -15.91 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.497 0.719 . . . . 71.1 111.342 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.82 -17.68 64.81 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.805 -0.559 . . . . 73.34 111.12 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.06 58.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 109.377 -0.601 . . . . 74.52 109.377 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.71 -179.05 26.81 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 119.903 -1.142 . . . . 70.03 114.692 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 11.8 mt -106.73 139.7 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.435 0.694 . . . . 64.44 110.326 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.85 114.76 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.958 -0.564 . . . . 75.23 110.437 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.87 138.36 35.33 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.423 -0.808 . . . . 61.31 110.342 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 57.7 m -84.45 116.12 22.91 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.836 -1.172 . . . . 75.41 107.836 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.48 128.35 35.33 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 109.323 -0.621 . . . . 63.43 109.323 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -78.57 -8.38 58.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.128 0.788 . . . . 72.51 113.128 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -68.97 -29.88 68.19 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.54 0.2 . . . . 62.0 111.54 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 268' ' ' LYS . 4.8 t -125.46 -30.07 3.15 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 111.643 0.238 . . . . 74.22 111.643 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.79 13.61 60.72 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.566 -0.288 . . . . 15.12 113.027 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.439 ' H ' HG23 ' A' ' 266' ' ' THR . 7.9 mptt -99.18 152.71 37.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 122.852 0.461 . . . . 73.44 112.093 173.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.46 154.78 66.38 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.579 2.853 . . . . 65.41 111.695 165.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.544 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -77.83 98.64 5.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.31 0.856 . . . . 75.1 113.31 -168.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 36.4 mm -143.43 113.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 75.54 107.253 165.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -129.36 114.45 16.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.836 0.743 . . . . 75.21 109.909 161.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.91 111.29 21.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.962 -0.385 . . . . 74.34 109.962 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 37.8 m-85 -103.63 113.23 26.59 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 115.972 -0.558 . . . . 71.41 110.774 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.451 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.3 p -142.4 123.79 14.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.469 -1.242 . . . . 55.45 110.337 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.85 112.52 21.21 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.272 0.558 . . . . 72.21 111.763 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -86.83 -10.93 52.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.622 0.971 . . . . 55.02 113.622 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.28 -34.55 61.33 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.998 0.428 . . . . 74.24 110.652 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -90.33 -15.25 31.5 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.705 -0.68 . . . . 70.13 109.716 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.16 -45.06 1.61 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.874 -0.603 . . . . 72.45 113.111 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -83.85 141.85 41.5 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 111.854 0.316 . . . . 73.43 111.854 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 136.96 72.28 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.345 2.697 . . . . 64.14 113.848 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 275' ' ' THR . 37.6 mttt -68.79 -33.4 73.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.027 -0.988 . . . . 73.12 111.621 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.85 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.729 -0.669 . . . . 33.53 113.081 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 47.7 mt-10 -115.5 143.21 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.944 -0.391 . . . . 65.31 109.944 -171.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -152.01 155.37 37.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.386 . . . . 75.52 111.05 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.3 p -131.12 135.42 47.47 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.76 -0.459 . . . . 73.34 109.76 165.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.491 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 11.4 m -137.06 148.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 109.055 -0.72 . . . . 74.34 109.055 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.544 ' H ' ' CB ' ' A' ' 270' ' ' MET . 17.4 m -114.15 119.41 36.99 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.038 0.755 . . . . 54.24 113.038 -168.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.95 165.14 17.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.269 0.84 . . . . 63.32 113.269 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.53 -47.24 34.03 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.811 -1.086 . . . . 74.21 111.087 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 137.66 21.53 Favored Pre-proline 0 C--O 1.237 0.402 0 O-C-N 123.523 0.515 . . . . 54.14 110.701 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.55 -38.75 60.23 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.192 2.594 . . . . 52.13 117.246 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.87 -29.79 22.81 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 123.185 2.173 . . . . 53.44 113.047 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -61.41 -28.37 69.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.336 1.054 . . . . 63.01 112.078 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -70.39 -43.49 69.97 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -73.73 -34.15 64.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.346 0.593 . . . . 75.11 111.054 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.53 -32.43 71.25 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.569 -0.741 . . . . 73.32 110.444 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.48 -27.71 65.45 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 122.297 0.239 . . . . 65.41 111.204 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 296' ' ' ALA . 44.9 mt -66.98 -32.3 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 121.881 -0.512 . . . . 64.03 110.702 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.06 -59.09 2.92 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.09 1.144 . . . . 71.42 114.09 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -36.35 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.606 1.706 . . . . 70.03 115.606 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -84.9 -22.99 29.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.437 0.295 . . . . 72.42 110.452 -168.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -85.59 -177.11 6.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.715 -0.675 . . . . 74.52 110.238 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.21 3.83 84.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 114.191 0.437 . . . . 61.11 114.191 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -123.48 -154.47 0.61 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.611 -0.514 . . . . 73.24 109.611 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.96 140.74 52.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.43 0.633 . . . . 64.53 110.958 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -114.22 111.28 21.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.136 -1.431 . . . . 73.5 107.136 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 20.6 m170 64.85 30.52 12.1 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.818 1.247 . . . . 73.15 112.672 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.2 10.54 77.76 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 116.298 -0.41 . . . . 74.31 113.875 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -126.72 148.62 49.86 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.269 -0.641 . . . . 74.5 109.269 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.62 130.76 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 123.523 0.515 . . . . 73.13 110.628 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.5 tt -107.75 143.32 18.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.824 -0.806 . . . . 73.11 108.824 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 4.3 tmtp? -135.95 122.55 20.89 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.292 -0.633 . . . . 63.22 109.292 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 238' ' ' VAL . 9.8 p -111.45 137.35 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.701 0.625 . . . . 74.23 109.608 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -138.21 173.5 11.55 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 123.177 0.591 . . . . 72.04 110.564 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -3.23 51.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.126 0.787 . . . . 71.42 113.126 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 C-N-CA 124.319 1.047 . . . . 52.53 113.183 174.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 C--O 1.238 0.491 0 CA-C-O 120.488 0.185 . . . . 62.24 110.653 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.81 106.83 18.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.192 0.52 . . . . 71.23 110.207 165.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.7 m -141.96 148.88 39.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.889 -1.152 . . . . 55.32 107.889 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.7 pt -122.69 141.24 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.722 0.692 . . . . 63.22 109.173 166.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.84 134.8 43.27 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -128.03 144.55 37.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.664 0.745 . . . . 74.41 112.637 178.213 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 11.9 mm-40 -127.04 147.11 50.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 113.988 -1.46 . . . . 75.31 109.773 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.13 32.75 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 123.823 0.702 . . . . 63.02 112.644 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 72.21 0.81 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.967 -1.123 . . . . 53.03 107.967 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.31 157.33 27.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.271 -0.877 . . . . 42.2 112.868 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.66 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.642 . . . . 71.4 113.062 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.71 21.64 36.21 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.198 -0.91 . . . . 14.45 111.04 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.48 150.1 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.535 -0.543 . . . . 63.23 109.535 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 24.6 m -88.55 170.35 10.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.74 -0.663 . . . . 64.15 110.831 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -169.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.547 1.939 . . . . 73.43 113.37 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -43.91 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 127.028 2.131 . . . . 71.11 116.074 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -48.31 -23.19 0.83 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 126.511 1.924 . . . . 74.12 113.77 170.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -57.4 -29.78 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.834 0.453 . . . . 72.1 110.63 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.31 -38.04 94.01 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.714 -0.492 . . . . 72.1 113.37 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.95 -30.56 66.88 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.795 0.838 . . . . 71.2 111.389 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.8 t80 -56.62 -45.87 81.25 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.83 0.852 . . . . 64.51 111.186 171.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -77.61 -22.64 50.48 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 122.055 -0.403 . . . . 75.05 111.53 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 260' ' ' ILE . 66.0 tttt -75.54 -10.63 59.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.527 1.131 . . . . 73.01 111.94 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.01 -16.72 62.26 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 121.807 -0.558 . . . . 62.23 111.523 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.1 mm -103.49 -48.19 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.458 0.703 . . . . 71.53 110.274 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -135.8 -159.51 8.55 Favored Glycine 0 C--O 1.22 -0.747 0 C-N-CA 120.769 -0.729 . . . . 73.31 113.428 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.9 mt -107.65 142.09 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.339 0.656 . . . . 73.14 111.754 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.7 mm -65.39 115.14 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 123.717 0.636 . . . . 75.5 110.142 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -98.08 140.11 32.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.453 -0.794 . . . . 65.12 111.369 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.0 m -85.52 117.75 24.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.106 -0.952 . . . . 72.24 108.478 168.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.1 125.79 29.9 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 109.062 -0.718 . . . . 72.42 109.062 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.8 -9.51 58.66 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.637 0.977 . . . . 54.11 113.637 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 -29.14 65.31 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 111.884 0.328 . . . . 65.13 111.884 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.6 t -124.16 -31.79 3.29 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.469 -0.332 . . . . 45.53 111.641 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.6 6.65 70.1 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 123.338 0.399 . . . . 64.12 112.679 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.432 ' H ' HG23 ' A' ' 266' ' ' THR . 52.8 mtpt -97.17 151.87 37.95 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.093 0.405 . . . . 75.54 112.093 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.93 154.06 75.55 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.523 2.815 . . . . 51.34 111.794 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.481 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.7 ptm -71.98 99.79 2.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.451 1.278 . . . . 65.22 114.451 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.4 mm -144.16 113.85 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.58 -1.266 . . . . 74.13 107.58 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -128.99 119.48 24.36 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.077 0.853 . . . . 63.53 110.57 161.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 113.07 25.18 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.376 0.422 . . . . 71.3 110.278 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.4 m-85 -102.35 112.68 25.48 Favored 'General case' 0 C--O 1.262 1.761 0 CA-C-O 121.31 0.576 . . . . 75.21 110.627 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.9 p -144.8 121.16 10.94 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.809 -1.541 . . . . 71.33 109.455 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.8 113.01 22.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.407 0.623 . . . . 63.24 111.719 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -8.72 58.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.715 1.006 . . . . 71.53 113.715 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -30.41 64.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 51.44 112.08 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -90.66 -19.03 24.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 120.735 -0.386 . . . . 73.12 110.185 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.5 22.93 38.39 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.951 -0.568 . . . . 74.02 113.802 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -146.82 147.69 30.62 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.744 -0.465 . . . . 74.12 109.744 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.38 126.75 22.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.047 1.831 . . . . 73.55 113.594 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 275' ' ' THR . 10.7 mttm -62.19 -40.11 94.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.88 -1.055 . . . . 74.24 111.628 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.95 25.15 15.24 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.812 -0.708 . . . . 63.42 111.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 78.2 mt-10 -119.03 143.75 46.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 64.21 109.609 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 158.64 44.26 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.623 -0.262 . . . . 62.52 111.179 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 19.4 p -136.18 137.78 41.25 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.104 -0.332 . . . . 60.21 110.104 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.12 147.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 116.356 -0.384 . . . . 64.44 110.461 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.481 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.3 t -99.1 117.49 33.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.309 0.644 . . . . 60.05 112.664 -174.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 162.81 16.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 121.154 -0.219 . . . . 71.24 110.867 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.88 -48.63 17.75 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.307 0.484 . . . . 44.53 112.307 -172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.44 137.18 21.52 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.695 -0.402 . . . . 74.03 110.904 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.08 -38.02 80.28 Favored 'Trans proline' 0 CA--C 1.566 2.086 0 C-N-CA 123.265 2.644 . . . . 63.22 116.234 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.65 -30.89 41.62 Favored 'Trans proline' 0 C--N 1.396 3.043 0 CA-C-N 123.314 2.219 . . . . 55.11 113.177 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 39.7 m -69.76 -29.4 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.477 -0.783 . . . . 65.51 111.115 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.03 -41.75 58.61 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 122.956 0.502 . . . . 45.13 111.347 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -33.43 66.83 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 112.009 0.374 . . . . 72.11 112.009 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.21 75.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.354 -0.384 . . . . 75.05 110.675 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.44 -25.28 64.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.977 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.75 -33.64 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.132 -0.355 . . . . 71.04 110.489 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.97 -58.82 3.05 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 113.865 1.061 . . . . 74.44 113.865 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.56 -29.69 18.73 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.219 1.933 . . . . 73.12 116.219 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 75.0 t80 -89.03 -8.25 54.35 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 118.345 0.521 . . . . 53.41 111.017 -168.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 165.23 11.34 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 108.217 -1.031 . . . . 73.31 108.217 170.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.17 13.43 52.4 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.76 -0.734 . . . . 65.24 112.363 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -122.31 -160.5 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.495 -1.298 . . . . 63.41 107.495 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.09 143.27 46.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.474 0.654 . . . . 72.5 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -113.81 113.93 25.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.196 -1.039 . . . . 75.21 108.196 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.17 28.46 14.06 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.809 1.244 . . . . 74.22 112.593 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.14 74.7 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.568 -0.349 . . . . 71.23 113.831 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.74 143.52 51.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.419 -0.956 . . . . 65.23 108.419 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.94 127.68 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.88 0.372 . . . . 71.4 111.079 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.7 tt -109.78 137.62 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.025 -0.534 . . . . 72.34 111.101 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -130.48 128.42 41.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.77 -0.65 . . . . 74.32 111.051 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.97 130.49 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 122.99 0.516 . . . . 74.52 110.759 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -129.42 175.78 8.49 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.626 1.17 . . . . 71.12 109.414 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.83 -3.13 59.03 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.884 1.068 . . . . 74.3 113.884 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 C-N-CA 124.084 0.954 . . . . 62.24 113.128 177.398 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 110.427 -0.212 . . . . 73.4 110.427 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.75 106.83 18.78 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.395 0.616 . . . . 74.34 110.466 165.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.6 m -142.16 149.19 39.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.135 -1.061 . . . . 70.3 108.135 166.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.96 140.57 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.614 0.643 . . . . 74.32 109.533 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.07 135.04 43.18 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.037 -0.727 . . . . 70.11 109.037 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.775 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -126.61 143.68 39.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.626 0.727 . . . . 51.42 112.538 177.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 14.1 mm-40 -127.78 148.06 50.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.272 -1.331 . . . . 73.25 110.849 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.27 20.0 37.02 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 123.814 0.696 . . . . 71.45 113.186 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.775 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -113.09 74.14 0.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.684 -1.228 . . . . 62.03 107.684 177.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.22 -82.6 0.22 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.368 -0.92 . . . . 75.41 112.808 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 110.39 10.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.785 0.803 . . . . 63.33 111.532 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.73 19.88 33.18 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.079 -0.964 . . . . 73.2 111.566 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.95 151.94 4.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.719 -0.474 . . . . 53.13 109.719 -172.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.5 m -91.49 170.49 9.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.523 -0.762 . . . . 51.32 109.93 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.928 2.091 . . . . 72.32 113.971 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -43.85 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.606 1.962 . . . . 74.43 115.319 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.73 -21.47 0.2 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.636 1.975 . . . . 63.32 113.957 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -56.49 -31.53 34.04 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 CA-C-N 118.618 0.645 . . . . 75.41 109.818 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.92 -33.53 83.94 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 119.858 -0.412 . . . . 70.21 113.704 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -74.74 -30.47 61.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.907 0.883 . . . . 70.01 111.184 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.512 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 4.7 t80 -57.5 -46.82 83.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.541 0.736 . . . . 74.05 110.646 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.93 -23.59 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.432 0.158 . . . . 64.5 111.325 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 260' ' ' ILE . 9.3 tmtt? -69.72 -20.0 63.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.586 0.754 . . . . 73.44 111.519 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -65.31 -20.01 66.21 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 122.187 -0.321 . . . . 71.4 111.325 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.1 63.04 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.823 -0.436 . . . . 75.2 109.823 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.11 178.37 23.22 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.209 -0.996 . . . . 74.15 115.044 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.08 138.35 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.5 0.72 . . . . 73.22 110.337 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 255' ' ' LYS . 34.8 mm -71.23 111.9 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.271 0.557 . . . . 74.14 110.417 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -102.28 144.26 31.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 73.13 111.32 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.29 132.38 34.63 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.857 -0.794 . . . . 71.43 108.857 165.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.64 123.52 26.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.479 -0.934 . . . . 62.21 108.479 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.12 58.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.941 0.719 . . . . 55.32 112.941 -173.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -68.51 -34.22 75.5 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.579 0.352 . . . . 73.24 111.304 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 p -125.53 -32.0 2.93 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 111.863 0.32 . . . . 73.53 111.863 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.84 10.18 65.18 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.925 -0.58 . . . . 73.21 113.487 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -97.19 145.61 29.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 117.335 0.568 . . . . 74.24 111.224 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.8 153.45 77.79 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.975 2.45 . . . . 64.44 111.448 168.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.517 ' CB ' ' H ' ' A' ' 289' ' ' SER . 3.4 ptm -71.6 98.63 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.176 1.176 . . . . 73.35 114.176 -171.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -144.5 112.53 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.026 -1.472 . . . . 54.32 107.026 164.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -130.09 116.72 18.91 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.139 0.882 . . . . 72.43 109.786 159.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.01 110.55 19.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.786 -0.45 . . . . 61.02 109.786 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 38.7 m-85 -102.88 112.87 25.88 Favored 'General case' 0 C--O 1.261 1.706 0 CA-C-O 121.247 0.546 . . . . 74.43 110.896 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 12.0 p -143.32 123.34 13.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.109 -1.405 . . . . 72.41 110.292 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.63 112.12 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.153 0.501 . . . . 70.34 111.974 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -11.04 51.07 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.187 0.81 . . . . 74.33 113.187 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.88 -28.59 58.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.604 0.24 . . . . 74.55 111.641 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 71.1 p -89.33 -22.22 22.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.146 -0.687 . . . . 64.12 109.146 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.35 57.25 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.191 -0.913 . . . . 24.32 112.679 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -109.45 139.59 21.27 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.957 -0.386 . . . . 61.14 109.957 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.02 136.99 78.57 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.152 2.568 . . . . 72.11 114.448 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 275' ' ' THR . 36.2 mttt -67.85 -35.62 78.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.938 -1.028 . . . . 52.45 112.053 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.25 22.23 25.34 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.03 -0.605 . . . . 51.53 112.992 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 34.8 mt-10 -116.22 142.67 46.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.682 -0.407 . . . . 71.42 109.929 -172.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.73 153.65 34.77 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.596 0.56 . . . . 75.13 110.661 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 136.21 40.88 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.755 0.312 . . . . 64.44 110.446 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.27 148.13 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.933 -0.576 . . . . 74.04 110.139 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.517 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.8 t -105.34 120.26 41.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.65 0.78 . . . . 45.21 112.664 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -85.77 163.66 18.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.082 0.401 . . . . 73.4 112.082 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -78.81 -47.46 16.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.299 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -98.67 135.94 20.89 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.348 -0.387 . . . . 73.35 111.176 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.63 -40.51 29.54 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 122.559 2.173 . . . . 73.43 115.87 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 -29.74 47.99 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.759 2.021 . . . . 61.2 113.602 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 75.0 m -64.77 -26.26 68.28 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -74.08 -48.34 30.45 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.469 0.308 . . . . 72.34 111.664 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -33.72 71.69 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.261 0.553 . . . . 74.53 112.103 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.65 62.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.746 -0.661 . . . . 61.52 110.937 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.89 -28.7 65.85 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.468 0.175 . . . . 40.21 111.187 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.34 -33.75 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 O-C-N 122.225 -0.297 . . . . 72.4 110.468 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.11 -59.4 2.8 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 114.389 1.255 . . . . 61.54 114.389 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -90.05 -33.68 16.23 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.746 1.758 . . . . 70.45 115.746 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.4 t80 -85.65 -19.62 30.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.091 0.472 . . . . 73.32 109.984 -169.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -105.59 174.38 5.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.081 -0.963 . . . . 74.41 109.207 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.31 53.51 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.893 -0.67 . . . . 24.22 111.731 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -136.0 -154.52 0.57 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.64 -0.504 . . . . 71.3 109.64 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.51 145.54 51.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.77 0.795 . . . . 71.3 111.416 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -114.82 115.96 27.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.546 -1.206 . . . . 62.34 108.274 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.2 m170 64.44 28.93 13.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.607 1.163 . . . . 53.2 112.834 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.05 84.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.462 -0.399 . . . . 53.11 113.887 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -122.62 147.97 45.8 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.92 -0.77 . . . . 61.32 108.92 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.4 mm -69.97 129.74 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.721 0.408 . . . . 74.23 110.614 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.4 tt -108.41 147.08 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.206 -0.664 . . . . 74.43 109.206 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -137.2 123.82 21.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.408 -0.36 . . . . 63.43 111.279 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.74 135.83 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.22 0.608 . . . . 51.35 110.266 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.1 m -138.09 175.24 9.76 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.546 1.139 . . . . 73.34 109.591 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -85.7 2.0 47.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 71.24 113.975 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 C-N-CA 123.726 0.81 . . . . 64.54 112.173 178.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.755 0.312 . . . . 71.3 110.337 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.55 105.48 17.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.654 -0.818 . . . . 74.42 110.182 166.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.4 m -143.2 144.16 32.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.486 -1.301 . . . . 74.44 107.486 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.3 pt -120.58 136.62 56.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 119.233 0.924 . . . . 72.04 109.727 164.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.508 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.14 121.21 41.06 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.39 0.614 . . . . 55.31 109.526 -178.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.415 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.2 t -118.14 139.59 44.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.309 -0.859 . . . . 60.25 109.954 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -128.57 141.23 51.43 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.038 -0.727 . . . . 73.13 109.038 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 104.52 26.64 6.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.156 -0.545 . . . . 70.5 113.221 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 78.93 1.87 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.227 -0.657 . . . . 60.14 109.227 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -141.42 -79.63 0.05 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 120.058 -1.067 . . . . 74.33 112.946 -175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.26 110.48 10.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.902 0.382 . . . . 71.32 111.846 -173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.58 18.73 43.78 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.683 -0.77 . . . . 61.34 111.686 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.57 151.32 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.195 0.522 . . . . 33.32 109.764 -170.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.405 ' O ' HG13 ' A' ' 245' ' ' VAL . 24.7 m -86.24 169.76 12.73 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.774 -0.648 . . . . 72.24 109.949 171.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -168.45 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.694 1.998 . . . . 73.13 112.709 -177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.63 -12.21 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.774 2.03 . . . . 52.44 115.873 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.8 OUTLIER -47.07 -23.89 0.56 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 126.901 2.081 . . . . 75.01 113.304 170.207 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -56.75 -31.45 35.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-N 118.171 0.442 . . . . 52.41 110.116 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.14 -32.51 76.39 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 121.645 -0.659 . . . . 75.35 113.659 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -75.71 -31.23 59.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.382 0.673 . . . . 71.25 110.98 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.7 t80 -54.67 -46.77 74.11 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.36 0.664 . . . . 64.03 110.874 170.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 92.1 m-85 -77.74 -23.27 49.4 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.218 -0.301 . . . . 73.31 111.68 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' A' ' 260' ' ' ILE . 2.5 tmtm? -67.46 -19.27 65.33 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.579 0.752 . . . . 62.23 111.549 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.4 pt20 -63.01 -18.99 63.92 Favored 'General case' 0 CA--C 1.558 1.254 0 O-C-N 122.24 -0.287 . . . . 63.34 111.424 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 mm -120.75 54.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-O 121.211 0.529 . . . . 64.11 109.838 171.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.29 -169.6 27.56 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 118.268 -1.92 . . . . 61.42 115.214 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.35 137.66 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.282 -0.959 . . . . 54.21 109.761 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.5 mm -72.04 114.15 10.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.57 0.7 . . . . 61.52 110.438 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -98.53 144.3 28.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.65 -1.159 . . . . 75.12 110.393 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.8 m -84.29 118.92 24.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.631 -0.877 . . . . 62.32 108.631 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.59 128.4 35.45 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 109.354 -0.61 . . . . 71.55 109.354 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -79.29 -8.38 59.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.378 0.881 . . . . 71.42 113.378 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.15 -30.52 68.77 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.144 0.277 . . . . 74.44 111.132 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.0 t -125.46 -31.07 3.04 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.572 -0.285 . . . . 42.41 111.572 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.93 5.98 67.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.321 -0.4 . . . . 64.42 112.726 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.452 ' H ' HG23 ' A' ' 266' ' ' THR . 9.4 mttp -97.22 152.64 38.39 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 123.052 0.541 . . . . 74.35 111.721 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.59 153.31 75.8 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.318 2.678 . . . . 72.1 111.802 166.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.45 ' HB3' ' H ' ' A' ' 289' ' ' SER . 1.0 OUTLIER -70.23 101.62 1.92 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.966 1.099 . . . . 61.24 113.966 -173.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.2 mm -143.59 112.9 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.624 -1.25 . . . . 73.3 107.624 163.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -128.33 116.72 20.24 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.381 0.991 . . . . 52.24 110.227 164.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 112.12 22.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.007 0.432 . . . . 74.23 110.426 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 75.2 m-85 -102.51 112.34 25.03 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-N 115.852 -0.613 . . . . 73.43 110.243 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.4 p -142.28 122.03 13.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.249 -1.341 . . . . 64.31 110.488 -176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.73 110.98 19.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.229 0.538 . . . . 72.22 111.217 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -10.8 49.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.53 0.937 . . . . 73.41 113.53 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.3 -29.27 53.61 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 62.22 109.718 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 60.9 p -89.1 -20.37 24.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.31 -0.859 . . . . 61.51 109.836 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.27 -34.65 5.25 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.301 -0.863 . . . . 74.43 113.061 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -101.35 143.77 27.26 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 109.804 -0.443 . . . . 73.44 109.804 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.22 141.03 88.52 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.275 2.65 . . . . 63.04 114.018 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 52.0 mttt -65.62 -33.14 75.21 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.774 -1.103 . . . . 74.4 111.606 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.77 23.31 23.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.517 -0.765 . . . . 71.0 112.237 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 45.1 mt-10 -118.82 143.0 47.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.308 -0.557 . . . . 73.31 110.702 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.03 143.18 24.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.626 -0.715 . . . . 70.1 109.496 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' PHE . 68.9 p -126.88 137.86 53.22 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.609 -0.436 . . . . 54.33 110.023 173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.49 145.43 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 121.043 0.449 . . . . 71.53 109.991 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 270' ' ' MET . 0.1 OUTLIER -98.71 129.18 45.16 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.623 0.972 . . . . 72.51 113.623 -176.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.64 165.61 15.29 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.702 0.63 . . . . 74.11 112.702 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.69 73.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.448 -0.796 . . . . 72.51 111.935 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.4 139.8 35.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.891 -0.781 . . . . 71.51 108.891 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -58.79 -40.09 75.74 Favored 'Trans proline' 0 CA--C 1.576 2.588 0 C-N-CA 122.488 2.125 . . . . 65.2 117.368 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 -30.34 14.13 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 123.614 2.326 . . . . 73.21 114.106 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 55.0 p -62.97 -29.82 71.11 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.131 0.572 . . . . 74.42 111.627 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.11 -37.17 78.24 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.627 1.204 . . . . 43.4 112.214 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -68.56 -38.79 81.06 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 123.55 0.531 . . . . 72.42 111.839 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.55 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.937 -0.574 . . . . 65.12 111.428 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -66.51 -26.88 67.37 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 123.316 0.647 . . . . 54.14 112.257 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 296' ' ' ALA . 72.7 mt -68.71 -32.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.843 -1.161 . . . . 74.23 111.377 172.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.27 -58.27 3.38 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 113.169 0.803 . . . . 63.22 113.169 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.95 -30.72 17.64 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.385 1.995 . . . . 73.54 116.385 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 66.0 t80 -88.53 -17.5 30.13 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.086 0.403 . . . . 73.15 110.742 -169.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.667 ' HB2' HG12 ' A' ' 315' ' ' VAL . 1.6 t70 -87.56 159.59 18.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.16 50.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.478 -0.391 . . . . 73.43 113.154 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 -162.04 0.84 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.414 -0.958 . . . . 71.13 108.414 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.66 143.69 51.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.715 0.769 . . . . 70.45 111.367 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -113.74 115.83 28.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.966 -1.016 . . . . 74.23 108.454 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 63.85 28.43 14.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.67 1.231 . . . . 75.31 112.406 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.12 11.54 80.86 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.113 0.405 . . . . 51.31 114.113 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.53 147.86 50.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.73 -0.841 . . . . 60.43 108.73 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.2 127.66 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.777 0.431 . . . . 73.11 111.369 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 14.8 tt -110.71 134.15 53.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.732 -0.667 . . . . 71.14 110.551 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.483 ' HA ' ' OD1' ' A' ' 304' ' ' ASP . 3.1 mttm -124.06 141.19 52.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.469 -0.787 . . . . 64.3 110.729 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.667 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.3 OUTLIER -123.4 140.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 108.449 -0.945 . . . . 72.15 108.449 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.8 m -140.39 174.2 10.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.853 0.461 . . . . 65.44 110.86 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -2.63 55.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.609 0.966 . . . . 64.12 113.609 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 C-N-CA 124.264 1.026 . . . . 64.34 111.922 -178.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.3 t30 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.402 -0.222 . . . . 63.41 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.29 106.47 18.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 119.675 -0.81 . . . . 70.11 110.724 165.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.1 m -142.1 147.08 36.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.735 -1.209 . . . . 52.13 107.735 166.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.27 137.0 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.106 0.867 . . . . 75.03 109.959 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -99.54 124.51 44.78 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.207 -0.664 . . . . 52.33 109.207 -178.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.79 140.7 44.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.718 -0.674 . . . . 62.23 109.556 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -128.69 141.56 51.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.599 . . . . 64.13 109.442 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.32 27.61 6.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.291 -0.481 . . . . 62.14 112.773 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.14 80.34 1.95 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.246 -0.65 . . . . 74.3 109.246 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -146.7 -69.6 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.396 -0.907 . . . . 60.13 113.126 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.7 107.2 11.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.741 0.781 . . . . 72.43 111.232 -171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.22 20.77 44.22 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.228 -0.897 . . . . 51.34 111.569 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 246' ' ' SER . 0.3 OUTLIER -79.97 152.33 4.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.104 0.478 . . . . 73.31 109.937 -172.176 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 245' ' ' VAL . 17.7 m -89.28 171.05 10.06 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.609 -0.723 . . . . 70.25 109.571 170.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.852 1.661 . . . . 54.33 113.887 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -43.44 -14.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 127.764 2.426 . . . . 71.0 115.257 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.62 -21.46 0.36 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.942 2.097 . . . . 74.24 114.429 171.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -55.37 -31.62 27.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 C-N-CA 122.951 0.5 . . . . 64.21 110.102 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.65 -33.56 82.76 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.684 -0.509 . . . . 42.51 114.018 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.2 -30.87 60.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.226 0.611 . . . . 75.12 110.946 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.6 t80 -54.39 -46.32 73.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 71.44 110.619 170.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.07 -23.31 48.1 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.906 0.336 . . . . 74.23 111.906 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -70.63 -15.21 62.72 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.145 0.978 . . . . 74.3 111.514 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.49 -14.53 57.61 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 122.036 -0.415 . . . . 72.33 112.021 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.0 -31.54 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.097 0.559 . . . . 63.22 111.157 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -156.86 -160.78 10.31 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 119.429 -1.367 . . . . 75.31 114.845 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.91 138.81 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.913 -0.643 . . . . 75.44 110.369 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 30.9 mm -68.94 115.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 123.77 0.669 . . . . 71.5 110.565 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -97.84 142.37 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.318 -0.855 . . . . 74.32 110.94 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 80.2 m -85.94 115.84 23.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.198 -1.038 . . . . 62.24 108.198 167.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -73.15 122.92 22.64 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.046 -0.724 . . . . 71.1 109.046 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -72.58 -8.92 57.64 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.238 1.199 . . . . 75.53 114.238 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -69.87 -29.85 67.17 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.334 0.254 . . . . 65.42 111.614 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.4 t -124.41 -31.9 3.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.641 -0.254 . . . . 71.24 111.121 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.68 66.41 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 116.382 -0.372 . . . . 71.44 112.321 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' H ' HG23 ' A' ' 266' ' ' THR . 27.3 mtpp -97.62 153.19 38.39 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.246 0.618 . . . . 63.42 111.388 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.26 153.79 67.67 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 123.493 2.795 . . . . 74.11 112.048 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.441 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.1 ptm -75.2 100.73 4.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.704 0.764 . . . . 55.32 112.746 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.73 114.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.285 -1.376 . . . . 72.15 107.285 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -128.5 117.07 20.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.151 0.887 . . . . 73.43 109.957 161.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.09 111.78 22.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.177 0.513 . . . . 71.34 110.152 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 57.8 m-85 -101.45 112.41 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.948 -0.569 . . . . 75.35 109.942 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.471 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.2 p -144.35 119.36 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.23 -1.35 . . . . 75.33 109.908 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -87.63 111.91 21.76 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.619 1.2 . . . . 63.42 112.274 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -7.92 58.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.185 -0.916 . . . . 71.21 112.525 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.73 -27.96 64.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.723 0.409 . . . . 74.24 111.94 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 44.0 p -89.64 -25.85 21.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.571 -0.529 . . . . 74.14 109.571 168.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.49 61.31 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.195 -0.911 . . . . 72.14 112.661 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 140.85 37.96 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.367 -0.975 . . . . 64.12 108.367 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.07 137.33 70.92 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.348 2.032 . . . . 62.25 114.285 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 275' ' ' THR . 1.6 tttm -61.13 -35.07 76.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.058 -1.428 . . . . 74.15 111.739 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.07 30.73 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.484 -0.78 . . . . 62.43 112.744 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.5 mt-10 -119.97 143.39 48.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.988 -0.685 . . . . 61.35 110.476 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.62 24.15 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.941 -0.572 . . . . 71.35 110.018 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 237' ' ' PHE . 60.3 p -127.0 137.85 53.16 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 110.148 -0.316 . . . . 71.11 110.148 172.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.93 147.88 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 110.034 -0.358 . . . . 74.12 110.034 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.441 ' H ' ' CB ' ' A' ' 270' ' ' MET . 14.5 m -108.48 123.95 49.68 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.531 0.567 . . . . 73.35 112.531 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.8 163.44 13.52 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.963 0.357 . . . . 74.22 111.963 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -76.25 -48.27 20.89 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.641 -0.254 . . . . 62.33 110.4 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.55 135.21 19.35 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 120.366 -0.533 . . . . 74.41 110.03 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.4 -39.34 29.53 Favored 'Trans proline' 0 CA--C 1.568 2.208 0 C-N-CA 122.572 2.181 . . . . 75.21 116.029 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.51 -31.05 61.45 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 122.978 2.099 . . . . 63.23 113.958 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.8 m -70.32 -30.3 67.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.897 -0.592 . . . . 72.04 110.794 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.64 64.18 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.795 -0.638 . . . . 52.1 111.08 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -71.82 -37.07 70.39 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 120.887 0.375 . . . . 71.22 111.967 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.41 78.12 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.339 -0.391 . . . . 73.4 110.842 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -65.25 -35.15 80.13 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 116.154 -0.476 . . . . 53.34 111.76 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.74 -32.57 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 O-C-N 122.052 -0.405 . . . . 70.24 111.106 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -72.34 -58.43 3.41 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.973 1.101 . . . . 63.21 113.973 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.55 -30.92 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.569 2.063 . . . . 71.33 116.569 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 85.4 t80 -83.94 -11.21 57.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.443 0.697 . . . . 62.34 111.107 -168.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.21 170.44 7.88 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.624 -0.88 . . . . 74.31 108.624 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.64 6.21 59.69 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.272 -0.49 . . . . 72.54 112.48 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 -157.55 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.393 -0.965 . . . . 61.33 108.393 174.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -129.87 147.15 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.428 0.632 . . . . 65.34 111.329 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -114.32 111.88 22.2 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.989 -1.115 . . . . 62.22 107.989 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.8 28.78 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.423 1.089 . . . . 73.34 112.253 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.06 -2.07 87.69 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 116.359 -0.382 . . . . 63.24 113.546 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -108.64 144.9 35.77 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 109.125 -0.694 . . . . 70.32 109.125 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.28 126.99 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.863 0.363 . . . . 75.1 111.126 -173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 20.3 tt -110.34 136.31 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.568 0.699 . . . . 64.22 111.191 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -130.64 131.74 45.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.052 -0.976 . . . . 72.14 110.545 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.24 139.06 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 110.006 -0.368 . . . . 54.14 110.006 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.4 m -137.88 174.71 10.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.195 0.998 . . . . 54.15 109.647 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.68 1.59 51.46 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.051 1.13 . . . . 74.23 114.051 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.012 0.925 . . . . 73.13 113.178 176.017 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.237 0.443 0 N-CA-C 109.47 -0.567 . . . . 72.11 109.47 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 107.02 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.329 -0.548 . . . . 65.44 109.819 168.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.9 m -142.9 149.01 37.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.584 -0.895 . . . . 71.12 108.584 169.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 315' ' ' VAL . 2.7 pp -123.79 141.15 45.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 118.625 0.648 . . . . 75.22 109.58 161.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 315' ' ' VAL . 0.3 OUTLIER -102.31 130.2 48.95 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.552 -0.907 . . . . 72.21 108.552 177.12 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -121.38 144.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.636 0.731 . . . . 62.01 112.642 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 10.0 mm-40 -126.91 151.11 48.88 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 114.257 -1.338 . . . . 62.33 110.049 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 95.45 7.89 58.91 Favored Glycine 0 CA--C 1.519 0.296 0 O-C-N 123.599 0.562 . . . . 60.25 113.688 174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -103.67 76.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.374 -0.973 . . . . 63.1 108.374 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -134.4 -87.65 0.28 Allowed Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 120.419 -0.896 . . . . 64.31 113.822 -171.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.96 112.91 9.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.753 0.311 . . . . 75.21 111.21 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.01 19.87 38.27 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.709 -0.678 . . . . 70.22 111.977 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.33 150.87 4.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.311 0.576 . . . . 72.25 109.674 -173.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.1 m -90.29 170.65 10.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.539 -0.755 . . . . 65.02 110.364 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -167.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 127.117 2.167 . . . . 61.21 113.36 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.2 -11.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.285 1.834 . . . . 74.21 115.673 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -45.87 -22.31 0.19 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 126.869 2.068 . . . . 73.43 113.756 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -32.28 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 118.815 0.734 . . . . 72.4 110.058 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -36.67 92.78 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.737 -0.479 . . . . 71.0 113.168 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.11 -34.27 76.06 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.502 0.721 . . . . 71.24 110.635 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.1 t80 -57.56 -43.18 84.27 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.252 -0.886 . . . . 72.05 111.486 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.64 -24.45 45.26 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.181 0.438 . . . . 72.32 112.181 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 23.4 tptm -66.66 -18.96 65.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.795 1.238 . . . . 64.35 112.189 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.23 -15.09 62.11 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 113.172 0.804 . . . . 64.24 113.172 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.2 -6.73 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 120.882 0.372 . . . . 72.51 110.792 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.522 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . -171.59 -160.44 20.13 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 118.95 -1.595 . . . . 75.34 114.721 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.59 139.44 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.443 0.697 . . . . 74.24 110.518 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.456 HG12 ' HD3' ' A' ' 255' ' ' LYS . 20.8 mm -66.38 116.31 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 123.643 0.589 . . . . 74.4 109.674 173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.11 133.24 42.03 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.447 -0.797 . . . . 72.35 110.454 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 50.3 m -84.8 117.09 23.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.299 -1.0 . . . . 71.12 108.299 167.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.29 136.67 42.63 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 112.196 0.443 . . . . 74.45 112.196 -174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -80.07 -10.77 59.79 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.668 0.988 . . . . 73.11 113.668 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -70.12 -38.48 75.6 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 112.477 0.547 . . . . 62.52 112.477 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -124.37 -24.55 4.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.482 0.182 . . . . 74.43 111.279 174.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.85 16.52 54.39 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.121 0.408 . . . . 74.42 114.121 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 266' ' ' THR . 19.6 ptpt -100.34 152.94 37.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.398 0.599 . . . . 63.44 111.496 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.62 152.12 83.04 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.443 2.096 . . . . 73.33 111.572 166.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.09 97.9 4.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.764 1.024 . . . . 65.21 113.764 -172.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 35.7 mm -143.11 112.87 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.614 -1.254 . . . . 75.15 107.614 165.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -129.07 117.61 21.15 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.107 0.867 . . . . 63.4 109.852 161.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 111.04 20.61 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.595 -0.52 . . . . 71.4 109.595 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 35.2 m-85 -101.92 112.29 24.86 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 121.259 0.552 . . . . 64.01 110.577 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.424 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.0 p -142.6 120.93 12.32 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.985 -1.461 . . . . 72.33 110.207 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ASP . . . . . 0.507 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 26.0 t70 -87.47 113.49 23.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.288 0.566 . . . . 72.31 111.147 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -9.9 55.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.662 -0.699 . . . . 63.34 112.797 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -29.95 61.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.652 0.263 . . . . 61.31 111.547 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.4 t -91.3 -15.41 29.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.417 0.627 . . . . 75.4 109.686 167.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.98 -37.4 3.46 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.71 -0.677 . . . . 53.31 113.237 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -96.73 141.85 23.69 Favored Pre-proline 0 N--CA 1.443 -0.814 0 O-C-N 123.635 0.256 . . . . 72.43 110.971 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.49 136.26 74.78 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.636 2.891 . . . . 74.22 114.129 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 56.2 mtpt -65.6 -37.82 87.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 75.14 111.604 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.97 25.05 13.57 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.862 -0.685 . . . . 61.2 113.021 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 40.6 mt-10 -115.82 142.24 47.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.711 -0.477 . . . . 70.01 109.711 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 155.26 38.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.308 -0.405 . . . . 41.53 110.828 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 137.31 41.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.098 -0.334 . . . . 72.1 110.098 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 236' ' ' ILE . 11.5 m -136.56 145.36 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.152 -0.684 . . . . 72.25 109.152 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 22.7 t -97.68 117.59 32.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.639 0.775 . . . . 75.11 111.645 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.4 164.09 13.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 121.139 -0.225 . . . . 71.03 111.442 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.53 -48.53 55.06 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.715 0.635 . . . . 74.2 112.715 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -119.57 136.16 24.53 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.33 -38.35 65.6 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 123.682 2.921 . . . . 54.1 117.699 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.68 -29.94 15.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 123.55 2.304 . . . . 64.45 112.487 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -64.27 -27.4 69.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.725 1.21 . . . . 72.23 112.181 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.455 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -67.7 -40.97 84.3 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.595 0.559 . . . . 62.41 112.23 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -72.79 -34.67 67.08 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.292 0.567 . . . . 75.0 110.713 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.27 -33.76 76.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.337 -0.847 . . . . 71.14 111.048 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.22 -28.69 67.47 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.91 -0.586 . . . . 52.15 111.707 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 296' ' ' ALA . 49.3 mt -69.88 -30.59 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 O-C-N 122.035 -0.416 . . . . 63.12 110.812 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.88 -60.67 2.29 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.959 1.096 . . . . 63.14 113.959 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -91.87 -29.58 16.63 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.438 2.014 . . . . 72.24 116.438 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 23.6 t80 -86.62 -24.12 25.46 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 -171.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 315' ' ' VAL . 7.5 t70 -82.87 -170.51 3.04 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.957 -1.02 . . . . 73.12 109.531 166.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 78.25 13.48 83.25 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.198 -0.525 . . . . 62.44 112.853 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -135.67 -161.88 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.883 0.373 . . . . 73.34 110.179 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -128.69 144.62 51.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.21 0.529 . . . . 32.24 110.467 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -113.12 112.04 23.14 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.21 -1.033 . . . . 74.42 108.21 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 65.03 29.25 12.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.764 1.29 . . . . 74.35 112.167 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.78 5.79 80.82 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 114.211 0.444 . . . . 72.54 114.211 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -124.21 148.42 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.778 -0.823 . . . . 55.12 108.778 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.59 129.27 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 123.303 0.377 . . . . 70.43 110.901 -171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.1 tt -108.5 143.95 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.791 -0.641 . . . . 75.52 109.54 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 15.3 tptp -136.94 121.89 18.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.914 0.388 . . . . 73.52 110.361 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 237' ' ' PHE . 7.7 p -111.89 138.39 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.522 -0.763 . . . . 61.24 111.226 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -142.79 172.79 12.22 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.286 1.034 . . . . 72.2 109.837 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -5.25 48.48 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.942 1.09 . . . . 74.04 113.942 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 124.508 1.123 . . . . 72.12 113.176 177.11 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--O 1.237 0.427 0 CA-C-O 120.64 0.257 . . . . 74.4 111.541 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.79 104.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.821 -0.752 . . . . 73.44 110.276 160.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 21.9 m -143.0 147.19 34.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.212 -1.032 . . . . 53.11 108.212 165.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 315' ' ' VAL . 2.5 pp -121.7 141.9 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 118.754 0.706 . . . . 62.43 109.588 164.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.67 122.31 45.39 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.754 -0.657 . . . . 74.44 109.39 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -114.3 144.52 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.755 0.788 . . . . 73.45 112.756 176.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 12.0 mm-40 -126.29 151.28 47.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.768 -1.56 . . . . 73.54 110.124 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.12 15.3 54.33 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.266 -0.492 . . . . 72.32 113.539 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.724 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -108.36 76.86 1.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.083 -1.081 . . . . 75.11 108.083 176.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.18 -88.26 0.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.152 -1.023 . . . . 70.11 114.301 -169.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -78.55 109.3 12.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 75.24 111.225 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.95 21.2 21.6 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.27 -0.877 . . . . 62.15 111.783 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -85.41 151.42 3.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.752 -0.462 . . . . 72.03 109.752 -173.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.0 m -90.54 170.01 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.788 -0.642 . . . . 73.02 110.696 172.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.811 2.044 . . . . 75.01 113.555 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -43.19 -12.7 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 126.634 1.974 . . . . 73.2 115.749 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.22 -22.04 0.34 Allowed 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 126.473 1.909 . . . . 73.43 113.668 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -56.57 -31.55 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 118.482 0.583 . . . . 73.11 110.236 178.49 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.07 -32.02 82.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.707 -0.496 . . . . 72.4 114.267 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 10.5 tp10 -72.73 -33.58 66.5 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.706 0.802 . . . . 74.34 110.758 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.7 t80 -57.22 -43.15 82.58 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.083 -0.962 . . . . 73.14 111.256 173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.02 -24.9 43.34 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 122.144 -0.347 . . . . 74.31 111.851 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.46 ' HB2' HD11 ' A' ' 260' ' ' ILE . 13.5 tptm -64.87 -22.32 66.97 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.402 1.081 . . . . 75.21 112.199 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -13.79 53.12 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 112.963 0.727 . . . . 52.34 112.963 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 46.6 mm -111.49 -26.46 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 122.698 0.399 . . . . 75.44 110.589 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -160.9 -174.95 31.39 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 119.982 -1.104 . . . . 62.42 115.127 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.22 138.8 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 73.43 111.201 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 255' ' ' LYS . 23.7 mm -70.98 115.54 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.818 -0.628 . . . . 75.13 110.785 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -98.28 138.11 36.03 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.579 0.704 . . . . 71.2 111.078 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 94.7 m -84.2 116.83 23.14 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.605 -1.18 . . . . 70.24 108.509 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -78.33 131.51 37.05 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 109.504 -0.554 . . . . 63.3 109.504 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -76.08 -5.65 47.48 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.704 1.002 . . . . 71.54 113.704 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -66.94 -34.83 78.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.636 0.255 . . . . 70.03 111.156 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 21.3 p -124.6 -31.45 3.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.854 0.462 . . . . 61.41 111.578 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.88 67.17 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.431 -0.804 . . . . 74.45 112.034 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.32 151.73 37.53 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.101 0.56 . . . . 74.11 111.677 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.45 153.92 76.01 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.066 2.51 . . . . 74.12 111.38 166.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.472 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -76.93 99.2 5.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.373 0.879 . . . . 73.41 113.373 -169.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.9 mm -143.07 112.87 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.59 -1.263 . . . . 54.42 107.59 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -128.69 116.2 19.19 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.953 0.797 . . . . 73.44 110.276 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.81 110.89 20.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.638 -0.504 . . . . 71.12 109.638 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 31.7 m-85 -103.03 112.94 26.02 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.088 0.471 . . . . 72.25 110.651 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 p -144.77 122.07 11.58 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.55 -1.205 . . . . 74.23 110.088 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.21 112.2 21.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.441 0.638 . . . . 73.42 112.618 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -85.75 -10.42 55.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.799 -0.637 . . . . 70.23 112.017 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.69 -31.36 66.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.407 0.623 . . . . 65.54 110.221 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 47.3 p -91.21 -21.92 20.88 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.212 -0.904 . . . . 75.4 109.57 173.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.11 -33.25 6.29 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.263 -0.88 . . . . 62.35 113.029 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -99.37 141.42 22.8 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 110.302 -0.259 . . . . 75.44 110.302 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.58 132.72 53.82 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.418 2.745 . . . . 74.04 114.385 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -59.54 -42.09 91.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 75.14 112.294 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.49 24.76 15.19 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.64 -0.791 . . . . 54.04 113.145 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.4 mt-10 -116.45 142.87 46.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.722 -0.473 . . . . 71.22 109.722 -174.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.18 32.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 74.23 110.966 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 p -131.31 136.74 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.88 0.372 . . . . 71.03 110.2 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.415 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 6.1 m -135.56 146.22 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 109.221 -0.659 . . . . 75.45 109.221 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.472 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.6 m -110.21 117.81 34.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.25 165.23 13.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.918 0.71 . . . . 53.11 112.918 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.66 -47.16 76.45 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.852 0.861 . . . . 73.11 112.857 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -122.45 136.7 26.8 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.964 -0.384 . . . . 73.02 109.964 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -61.26 -38.5 65.27 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.229 2.619 . . . . 74.25 117.259 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -28.18 14.2 Favored 'Trans proline' 0 C--N 1.386 2.502 0 CA-C-N 123.682 2.351 . . . . 71.32 112.466 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.7 m -62.48 -27.9 69.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.056 0.942 . . . . 72.13 112.026 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.14 -39.38 78.87 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.267 0.627 . . . . 70.1 111.904 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -69.49 -37.88 77.42 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.87 0.367 . . . . 74.41 110.772 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.03 72.09 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.633 -0.712 . . . . 13.24 110.941 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.73 -29.56 66.97 Favored 'General case' 0 C--O 1.213 -0.852 0 O-C-N 123.395 0.434 . . . . 75.13 111.726 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 296' ' ' ALA . 56.6 mt -69.84 -32.06 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 121.716 -0.615 . . . . 65.43 110.428 173.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.71 -60.61 2.3 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 113.381 0.882 . . . . 72.24 113.381 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -93.52 -30.76 14.85 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.283 1.957 . . . . 73.44 116.283 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 37.5 t80 -84.57 -23.19 29.77 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.492 0.587 . . . . 63.15 109.69 -169.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 315' ' ' VAL . 3.4 t0 -87.78 -164.65 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.459 -0.792 . . . . 62.32 110.649 168.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.06 7.21 87.39 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.528 -0.76 . . . . 73.14 113.061 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -137.78 -164.35 1.6 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.56 0.219 . . . . 71.51 110.634 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.77 144.62 45.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.719 0.771 . . . . 62.23 112.035 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -113.82 114.83 26.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.794 -1.187 . . . . 62.13 107.794 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.09 28.5 14.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 124.64 1.213 . . . . 75.22 112.211 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.18 -4.47 84.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 114.106 0.403 . . . . 71.04 114.106 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -113.11 145.51 40.8 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.699 -0.482 . . . . 64.33 109.699 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.11 132.0 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.203 0.314 . . . . 74.02 110.635 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.8 tt -107.28 145.19 14.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.747 -0.834 . . . . 64.42 108.747 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 7.0 tppt? -136.19 121.32 18.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.095 -0.706 . . . . 72.03 109.095 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 236' ' ' ILE . 13.3 p -112.23 134.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.399 0.618 . . . . 74.44 110.153 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.8 m -133.72 173.45 11.51 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.191 -0.913 . . . . 62.2 109.495 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -3.35 45.58 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.948 0.721 . . . . 73.11 112.948 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.508 1.123 . . . . 62.53 112.771 177.221 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.1 t30 . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.751 0.31 . . . . 75.24 110.462 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.74 105.03 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.936 -0.574 . . . . 74.41 110.159 167.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 m -144.01 148.81 35.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 74.43 108.564 163.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 288' ' ' VAL . 43.1 pt -126.09 144.47 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 118.83 0.741 . . . . 71.52 109.329 161.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.451 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -99.95 133.0 44.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.756 -0.831 . . . . 64.05 108.756 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.484 HG11 ' HZ ' ' A' ' 254' ' ' PHE . 1.5 t -124.76 137.76 56.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.011 -0.737 . . . . 72.42 109.011 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 14.5 mm-40 -126.47 140.58 52.36 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.741 -0.663 . . . . 72.24 111.214 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.04 3.93 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.246 0.966 . . . . 63.42 112.316 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.21 79.13 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.906 -0.776 . . . . 70.43 108.906 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -123.97 -99.06 1.32 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.542 -0.754 . . . . 61.43 113.996 -171.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.48 119.39 17.64 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.019 0.438 . . . . 71.22 111.526 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.58 30.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.26 -0.882 . . . . 62.23 111.592 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.23 152.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.674 -0.491 . . . . 62.13 109.674 -172.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.0 m -88.29 169.28 11.99 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.681 -0.69 . . . . 72.21 109.935 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.177 1.791 . . . . 71.3 114.201 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -42.6 -14.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.726 2.01 . . . . 72.14 115.547 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -47.61 -22.06 0.44 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 126.374 1.87 . . . . 74.25 113.912 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.8 OUTLIER -56.11 -32.62 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.38 -0.6 . . . . 63.43 109.38 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.94 84.45 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.699 0.639 . . . . 73.44 114.699 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.77 -31.13 63.15 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.312 0.577 . . . . 53.22 111.231 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 3.9 t80 -56.48 -45.15 81.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.434 -0.803 . . . . 70.33 111.015 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.484 ' HZ ' HG11 ' A' ' 238' ' ' VAL . 93.2 m-85 -78.0 -23.45 48.33 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.033 -0.417 . . . . 73.12 111.651 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.26 -14.95 62.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.849 0.86 . . . . 71.21 111.806 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -64.65 -13.37 53.55 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 121.88 -0.512 . . . . 74.44 112.046 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.3 mm -104.19 -43.13 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.02 0.528 . . . . 75.25 110.563 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -147.08 -160.11 8.66 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 120.236 -0.983 . . . . 40.24 114.613 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.51 138.45 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.007 0.523 . . . . 55.42 111.452 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.76 116.81 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.688 -0.687 . . . . 75.21 110.689 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -97.93 140.75 31.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.436 0.636 . . . . 75.13 111.158 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.6 m -86.06 118.59 25.62 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.916 -1.038 . . . . 51.32 108.44 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.84 136.97 45.44 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.292 -0.413 . . . . 64.55 111.208 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.49 -9.83 59.68 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.61 0.596 . . . . 74.44 112.61 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -69.64 -39.57 77.04 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 22.4 p -123.19 -26.52 4.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.967 0.413 . . . . 75.41 111.181 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.87 9.86 65.52 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.427 -0.806 . . . . 72.1 112.813 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -97.96 150.74 37.07 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.416 0.525 . . . . 64.21 112.416 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 154.53 70.66 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 123.283 2.655 . . . . 53.33 111.993 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.458 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.8 ptm -68.31 102.48 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.118 1.155 . . . . 71.53 114.118 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 24.0 mm -144.44 112.45 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.139 -1.8 . . . . 72.4 106.139 161.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -128.72 114.5 16.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.091 0.86 . . . . 62.32 109.986 163.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.21 111.85 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.895 -0.409 . . . . 74.12 109.895 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 49.0 m-85 -102.04 111.4 23.66 Favored 'General case' 0 C--O 1.265 1.884 0 CA-C-O 121.487 0.66 . . . . 64.11 109.866 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.449 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 16.0 p -144.4 120.5 10.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 113.86 -1.518 . . . . 54.2 109.694 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.81 112.92 22.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.43 0.634 . . . . 63.52 111.454 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -10.38 56.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.802 0.668 . . . . 53.13 112.802 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.21 66.34 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.965 0.357 . . . . 72.25 111.965 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.2 t -91.16 -18.26 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.702 -0.481 . . . . 65.43 109.702 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 100.22 -40.88 2.29 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.884 -0.598 . . . . 74.3 113.021 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -87.79 141.61 31.88 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-O 119.889 -0.101 . . . . 74.34 110.804 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.65 132.9 54.89 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.061 2.507 . . . . 62.45 114.102 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.449 ' H ' ' HA ' ' A' ' 275' ' ' THR . 13.6 mttm -56.53 -40.13 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.413 -1.267 . . . . 74.11 112.571 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.36 23.14 20.17 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.98 -0.554 . . . . 63.41 112.864 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 21.3 mt-10 -120.31 142.05 49.47 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.82 0.364 . . . . 74.25 110.562 -173.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 148.68 28.13 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.62 -0.264 . . . . 60.25 110.875 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 237' ' ' PHE . 67.6 p -128.76 138.57 52.17 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.571 -0.529 . . . . 74.52 109.571 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 236' ' ' ILE . 8.1 m -138.38 152.02 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.272 -0.64 . . . . 75.41 109.272 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.458 ' H ' ' CB ' ' A' ' 270' ' ' MET . 34.0 t -113.67 131.19 56.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.813 1.042 . . . . 73.1 113.813 -171.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.0 163.42 13.66 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.434 0.531 . . . . 64.44 112.434 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.62 -46.2 80.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.5 -0.773 . . . . 73.43 111.896 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -119.91 136.15 24.73 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.684 -0.487 . . . . 72.2 109.684 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -61.41 -38.87 60.7 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.272 2.648 . . . . 60.41 117.4 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.04 -30.5 13.5 Favored 'Trans proline' 0 C--N 1.381 2.261 0 CA-C-N 123.37 2.239 . . . . 63.44 112.716 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 48.9 m -64.06 -27.92 69.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.384 -0.825 . . . . 72.41 111.394 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -72.05 -34.92 69.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.473 0.545 . . . . 54.44 112.473 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -71.86 -36.07 70.0 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.932 0.396 . . . . 64.21 110.695 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.31 88.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.784 -0.644 . . . . 71.11 111.093 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.12 -25.86 64.61 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.059 0.456 . . . . 74.5 111.586 176.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.31 -34.32 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 O-C-N 121.7 -0.625 . . . . 75.51 110.804 172.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.25 -56.89 4.17 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.378 0.881 . . . . 71.34 113.378 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -89.55 -29.1 19.15 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.245 1.943 . . . . 72.41 116.245 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 81.3 t80 -91.09 -9.26 46.33 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 122.01 -0.432 . . . . 73.42 111.402 -167.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.17 169.06 8.71 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.956 -0.757 . . . . 63.43 108.956 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.91 49.67 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 120.851 -0.69 . . . . 64.05 112.315 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -125.81 -162.72 1.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.244 -1.021 . . . . 73.1 108.244 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.78 145.93 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.621 0.724 . . . . 74.02 112.456 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -113.73 112.96 24.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.536 -1.211 . . . . 73.02 107.756 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.1 m170 64.88 28.95 12.67 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.132 . . . . 72.02 112.264 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.86 -1.38 85.15 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.465 -0.397 . . . . 63.12 113.97 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -115.22 143.51 45.13 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.202 -0.666 . . . . 72.13 109.202 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.24 129.22 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 122.632 0.373 . . . . 62.5 111.321 -171.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.8 tt -109.84 134.3 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.697 -0.683 . . . . 64.55 110.814 -174.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.42 131.22 53.5 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.522 -0.763 . . . . 63.53 110.197 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.01 126.77 67.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.965 0.412 . . . . 52.35 110.27 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -127.72 174.13 9.36 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 123.925 0.89 . . . . 75.54 109.119 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -1.72 57.31 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.954 1.094 . . . . 73.21 113.954 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.11 0.964 . . . . 75.45 112.526 179.609 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.687 0.28 . . . . 64.14 111.309 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.1 101.95 14.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.841 -0.743 . . . . 71.11 110.071 164.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 150.2 36.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.805 -1.183 . . . . 74.44 107.805 167.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.82 140.25 48.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.272 0.942 . . . . 63.24 110.013 163.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.66 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.02 128.71 45.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.601 -0.888 . . . . 74.52 108.601 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.402 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.1 t -123.81 138.61 52.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.775 -0.454 . . . . 72.13 109.775 -177.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -128.82 141.74 51.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 75.44 109.21 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 106.91 14.92 17.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.183 -0.532 . . . . 61.41 113.197 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 78.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.853 -0.795 . . . . 74.32 108.853 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.1 -89.19 0.39 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.317 -0.944 . . . . 51.21 113.984 -171.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.59 117.93 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.437 0.637 . . . . 71.42 111.133 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.85 20.96 37.92 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.514 -0.766 . . . . 52.41 111.583 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.05 150.45 4.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.438 -0.578 . . . . 74.15 109.438 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.5 t -91.38 170.23 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.433 -0.58 . . . . 51.53 109.433 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -169.05 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.332 1.853 . . . . 70.4 113.848 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -43.38 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.768 2.027 . . . . 54.35 114.985 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.06 -22.04 0.3 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.55 1.94 . . . . 71.22 113.995 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -55.28 -31.88 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.631 0.651 . . . . 62.3 110.556 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.78 85.66 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 121.935 -0.174 . . . . 53.42 113.504 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.67 -33.3 66.45 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.616 0.767 . . . . 75.13 110.152 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.9 t80 -56.57 -44.46 81.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.548 -0.751 . . . . 71.01 111.72 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 98.8 m-85 -78.9 -22.2 46.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.002 0.429 . . . . 75.4 111.462 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -73.03 -13.01 61.13 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.357 0.663 . . . . 62.22 111.803 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.67 -14.48 52.39 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 120.662 0.268 . . . . 75.55 111.505 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.9 mm -104.57 -47.99 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 122.924 0.49 . . . . 55.44 111.313 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -140.41 -161.52 8.74 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.066 -0.588 . . . . 62.21 113.667 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.24 138.1 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.324 0.65 . . . . 52.45 110.836 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.01 116.05 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.709 -0.678 . . . . 64.13 110.911 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -98.57 142.89 29.59 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.323 -0.853 . . . . 74.34 111.111 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 51.0 m -84.75 117.29 23.73 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.25 -1.018 . . . . 64.33 108.25 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.68 133.11 43.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.328 -0.396 . . . . 75.11 110.211 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -80.0 -8.03 59.14 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.572 0.582 . . . . 75.14 112.572 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 266' ' ' THR . 21.8 pttt -67.24 -36.85 82.51 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.275 0.23 . . . . 74.12 111.529 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 265' ' ' LYS . 15.0 p -124.15 -30.19 3.49 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.654 0.382 . . . . 63.2 111.372 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.7 64.48 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 116.14 -0.482 . . . . 62.2 112.952 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -98.23 151.53 37.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.182 0.438 . . . . 60.45 112.182 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.57 155.34 69.45 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 123.464 2.776 . . . . 65.22 112.597 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.485 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.6 ptm -71.48 102.01 2.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.665 0.987 . . . . 71.41 113.665 -172.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.8 mm -143.06 113.02 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.618 -1.623 . . . . 61.43 106.618 163.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -128.12 115.9 19.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.016 0.825 . . . . 73.22 109.98 162.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.95 111.72 21.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.183 -0.303 . . . . 74.42 110.183 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.467 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 45.2 m-85 -102.92 112.25 24.98 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 121.222 0.534 . . . . 72.41 110.388 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.443 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.4 p -144.7 122.91 12.2 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.295 -1.321 . . . . 70.13 110.003 -177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -85.82 111.95 20.66 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.113 0.482 . . . . 74.35 111.36 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -10.52 54.48 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.884 0.698 . . . . 73.22 112.884 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.38 -32.82 68.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.046 0.45 . . . . 60.2 110.381 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 77.6 p -90.71 -18.94 24.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.667 -0.697 . . . . 73.13 109.547 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.78 -29.29 10.73 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.557 -0.747 . . . . 72.34 113.102 170.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -105.84 142.49 24.92 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 110.196 -0.298 . . . . 74.22 110.196 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.5 136.86 78.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.422 2.748 . . . . 75.4 114.594 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 275' ' ' THR . 45.8 mttt -64.33 -38.48 91.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.045 -0.979 . . . . 72.1 111.873 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.67 17.38 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.459 -0.791 . . . . 72.13 113.057 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 43.6 mt-10 -116.55 142.2 47.18 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.333 -0.547 . . . . 62.33 110.454 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.27 143.86 23.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.751 -0.659 . . . . 74.13 109.948 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 237' ' ' PHE . 77.1 p -127.25 138.71 53.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.181 0.515 . . . . 74.52 110.445 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.48 147.45 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.836 -0.62 . . . . 71.3 110.783 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.485 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.8 t -98.19 136.55 38.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.213 0.605 . . . . 65.35 112.526 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.72 164.35 11.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.596 0.221 . . . . 71.02 111.596 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.84 -46.46 68.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.914 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -123.49 136.55 27.31 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.49 -0.559 . . . . 75.32 109.49 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.41 -37.59 80.36 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.381 2.72 . . . . 74.32 117.076 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -29.12 12.68 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 123.3 2.214 . . . . 41.43 113.023 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.5 m -61.39 -27.96 68.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.732 -0.667 . . . . 72.52 111.517 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.06 -35.44 61.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.094 -0.503 . . . . 74.41 111.439 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 120.74 -0.384 . . . . 64.53 110.934 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.03 86.04 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 120.839 0.352 . . . . 72.11 110.869 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.626 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.42 -26.62 66.51 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.74 -0.664 . . . . 74.25 112.337 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.84 -33.97 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 121.731 -0.605 . . . . 54.01 110.214 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.4 -56.06 5.29 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.623 0.971 . . . . 63.52 113.623 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -31.78 17.31 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.809 1.781 . . . . 74.31 115.809 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.4 t80 -88.51 -8.82 54.2 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 118.535 0.607 . . . . 71.2 111.647 -167.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.53 9.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.66 -0.867 . . . . 75.13 108.66 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.84 51.33 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.207 -0.997 . . . . 73.25 112.369 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -126.9 -162.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.32 -0.622 . . . . 60.43 109.32 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.96 147.53 46.51 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.568 0.699 . . . . 61.4 112.197 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -115.46 112.4 22.22 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.836 -1.172 . . . . 71.34 107.836 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.14 29.43 14.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.695 1.198 . . . . 75.44 112.427 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.55 11.97 73.53 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.458 -0.401 . . . . 33.14 113.675 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -128.0 143.3 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.047 -0.723 . . . . 73.21 109.047 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.63 127.66 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.043 0.449 . . . . 71.43 111.457 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 19.4 tt -110.42 131.7 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.835 0.826 . . . . 71.11 111.133 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -123.54 139.18 54.27 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.877 -1.056 . . . . 72.13 109.643 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.8 t -122.29 137.43 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 121.058 0.456 . . . . 73.52 111.112 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -131.65 176.5 8.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.547 1.139 . . . . 72.41 110.164 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.45 -8.77 58.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.761 1.022 . . . . 73.25 113.761 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 124.612 1.165 . . . . 70.2 113.494 -178.632 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.21 -0.293 . . . . 70.53 110.21 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.68 103.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.495 -0.882 . . . . 72.3 109.452 162.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.3 m -143.58 143.96 31.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.455 -1.313 . . . . 72.14 107.455 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.13 139.15 50.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.144 0.884 . . . . 63.41 110.652 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.42 134.16 42.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.52 -0.918 . . . . 72.13 108.52 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.77 140.14 47.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 109.39 -0.596 . . . . 72.52 109.39 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 3.7 mm-40 -124.59 143.34 50.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 124.256 0.972 . . . . 72.42 109.231 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 89.59 22.66 36.1 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.836 -0.697 . . . . 53.54 113.366 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.567 HD13 HG11 ' A' ' 250' ' ' VAL . 11.2 mt -103.91 70.83 1.02 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.344 -0.984 . . . . 74.34 108.344 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.37 -176.86 22.18 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.13 -1.033 . . . . 72.44 112.779 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 42.15 86.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.686 1.994 . . . . 71.32 114.867 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.71 22.46 26.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.333 -0.849 . . . . 61.32 111.528 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.0 150.92 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.23 110.094 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.4 m -84.55 169.47 14.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.691 -0.686 . . . . 75.03 110.939 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -167.81 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.323 1.849 . . . . 60.32 113.592 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -44.24 -13.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 126.949 2.1 . . . . 72.0 115.671 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.93 -23.42 0.45 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 126.72 2.008 . . . . 62.05 114.348 172.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.567 HG11 HD13 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -56.92 -32.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 CA-C-N 118.735 0.698 . . . . 73.12 109.767 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.06 -33.82 86.97 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.825 -0.431 . . . . 63.44 113.445 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.41 -29.14 59.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.206 0.602 . . . . 64.41 111.055 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.4 t80 -56.41 -42.52 78.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.512 . . . . 72.13 110.708 168.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -77.58 -24.1 49.82 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.067 0.395 . . . . 71.1 112.067 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 260' ' ' ILE . 0.7 OUTLIER -71.19 -16.25 62.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.638 0.775 . . . . 53.42 111.675 178.309 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -64.61 -15.09 60.62 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 121.572 -0.705 . . . . 63.31 112.012 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 mm -119.14 20.41 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-O 121.592 0.711 . . . . 74.44 110.327 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.5 34.15 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 119.386 -2.071 . . . . 24.31 116.009 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 23.2 mt -107.31 138.13 34.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.167 -1.017 . . . . 74.5 110.204 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 255' ' ' LYS . 48.7 mm -73.17 114.7 12.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.576 0.547 . . . . 72.13 110.001 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -98.88 143.92 28.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.142 -0.936 . . . . 74.22 110.311 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.51 131.59 34.63 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.55 -0.908 . . . . 74.01 108.55 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -82.52 122.04 27.56 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 108.974 -0.751 . . . . 50.33 108.974 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -67.14 -8.57 32.01 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.275 1.213 . . . . 61.01 114.275 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.02 -30.39 68.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 117.679 0.218 . . . . 74.24 111.053 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.6 t -126.75 -29.06 2.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.735 0.302 . . . . 74.34 111.376 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.73 7.49 68.71 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.104 -0.498 . . . . 73.44 112.387 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.48 ' H ' HG23 ' A' ' 266' ' ' THR . 39.4 mtpt -98.91 149.13 35.46 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 122.81 0.444 . . . . 74.32 111.051 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.15 153.86 71.31 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.839 3.026 . . . . 73.42 112.76 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.474 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -69.28 97.51 0.95 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.758 1.021 . . . . 73.2 113.758 -175.31 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 mm -144.5 112.37 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.425 -1.324 . . . . 61.34 107.425 165.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.19 117.55 20.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.015 0.825 . . . . 71.41 109.836 162.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 112.03 22.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.802 -0.444 . . . . 64.42 109.802 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -101.87 112.92 25.71 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.8 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.3 p -141.56 122.02 14.09 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.497 -1.229 . . . . 53.22 109.993 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -86.22 111.83 20.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.405 1.097 . . . . 52.34 111.602 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -6.54 59.27 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.484 -0.78 . . . . 64.24 112.765 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.64 -28.1 65.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.136 -0.484 . . . . 64.25 111.186 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 46.6 p -90.63 -29.48 17.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.822 -0.436 . . . . 64.24 109.822 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.01 57.49 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.645 -0.707 . . . . 75.03 112.658 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -113.54 144.32 31.11 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.349 -0.612 . . . . 71.14 109.349 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.83 126.48 21.28 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.201 1.934 . . . . 74.45 113.507 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -57.28 -43.0 82.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.285 0.991 . . . . 75.31 110.757 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.77 19.43 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.024 -0.989 . . . . 55.43 112.706 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -116.78 148.44 41.16 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.599 -0.84 . . . . 65.02 109.929 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -151.81 160.35 43.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.14 111.669 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.21 137.11 42.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.905 -0.588 . . . . 73.21 109.878 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.402 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 27.4 m -134.09 143.33 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.663 -0.866 . . . . 63.3 108.663 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.474 ' H ' ' CB ' ' A' ' 270' ' ' MET . 1.1 p -101.06 121.35 41.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.238 0.615 . . . . 71.14 112.304 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.36 165.9 13.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.138 -0.483 . . . . 73.34 111.836 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.48 -49.31 69.56 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.029 0.831 . . . . 74.32 112.442 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.99 138.05 31.88 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 110.115 -0.328 . . . . 74.51 110.115 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -59.16 -38.02 88.68 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.686 2.924 . . . . 73.12 117.735 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 -30.29 32.59 Favored 'Trans proline' 0 C--N 1.386 2.509 0 CA-C-N 123.681 2.35 . . . . 74.24 112.992 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 19.7 m -62.88 -28.27 69.92 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.248 1.019 . . . . 72.33 112.21 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.85 -40.2 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.876 0.735 . . . . 42.13 112.434 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -71.16 -38.64 72.19 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.128 0.489 . . . . 75.02 111.08 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.66 81.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.446 -0.797 . . . . 74.52 111.041 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.76 -28.55 66.9 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.725 -0.67 . . . . 52.33 112.05 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 296' ' ' ALA . 45.7 mt -67.4 -32.83 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.996 -0.44 . . . . 75.44 110.647 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.87 -60.34 2.41 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.783 1.031 . . . . 61.43 113.783 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -91.09 -32.71 15.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.125 1.898 . . . . 75.32 116.125 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 41.1 t80 -84.37 -25.27 29.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.243 0.474 . . . . 72.2 110.237 -170.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -94.89 177.05 6.03 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.968 -1.015 . . . . 41.42 110.127 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.97 13.49 59.02 Favored Glycine 0 CA--C 1.509 -0.326 0 C-N-CA 121.22 -0.514 . . . . 62.14 112.223 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 -153.75 0.59 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 73.32 108.814 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -131.61 142.18 49.82 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.569 0.699 . . . . 64.14 111.357 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -113.74 117.36 31.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.604 -1.258 . . . . 72.12 107.604 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.15 27.78 14.05 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.756 1.222 . . . . 64.43 112.51 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.21 -3.85 86.53 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.848 0.299 . . . . 61.42 113.848 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -108.77 146.11 34.1 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.723 -0.843 . . . . 75.53 108.723 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.78 131.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.99 0.424 . . . . 73.02 110.904 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.0 tt -108.54 140.0 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.91 -0.774 . . . . 74.13 108.91 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.18 125.0 22.51 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.591 -0.522 . . . . 64.33 109.591 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -113.23 139.98 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 107.733 -1.21 . . . . 65.33 107.733 -170.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 m -140.57 171.62 13.86 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 121.716 -0.615 . . . . 72.45 110.936 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.01 -3.13 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.881 0.697 . . . . 71.0 112.881 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 124.766 1.227 . . . . 35.44 112.985 175.58 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.241 0.65 0 CA-C-O 120.74 0.305 . . . . 60.43 110.77 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.99 105.4 17.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.463 -0.495 . . . . 65.55 110.287 164.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.8 m -142.1 147.83 37.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.679 -1.23 . . . . 50.32 107.679 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.0 pt -125.46 138.45 54.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 119.279 0.945 . . . . 73.14 110.072 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.84 119.86 39.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.546 -0.539 . . . . 75.44 109.546 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.45 138.87 45.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.545 -0.752 . . . . 72.0 109.288 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -128.87 142.33 50.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.365 0.666 . . . . 75.31 109.226 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.51 8.49 Favored Glycine 0 C--N 1.332 0.358 0 O-C-N 123.331 0.394 . . . . 14.31 113.259 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 76.39 1.52 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.565 -0.902 . . . . 73.23 108.565 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.22 -77.13 0.06 OUTLIER Glycine 0 CA--C 1.499 -0.944 0 C-N-CA 120.237 -0.983 . . . . 60.45 112.999 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.54 109.18 11.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.638 0.732 . . . . 75.04 111.633 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.72 20.62 33.63 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.185 -0.916 . . . . 71.33 111.349 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.87 151.56 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.331 0.586 . . . . 72.43 109.901 -173.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.8 t -91.7 170.44 9.91 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 109.152 -0.684 . . . . 50.24 109.152 171.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 127.529 2.332 . . . . 72.24 113.829 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -44.86 -11.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 126.161 1.784 . . . . 73.52 115.513 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 252' ' ' GLU . 1.3 pp0? -46.79 -22.11 0.27 Allowed 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 126.72 2.008 . . . . 71.34 113.73 168.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -56.23 -30.66 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.384 -0.822 . . . . 73.03 109.33 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.26 91.7 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.964 -0.909 . . . . 32.03 114.718 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 249' ' ' GLN . 8.9 pt-20 -75.55 -27.65 58.72 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.367 1.084 . . . . 72.15 111.457 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.7 t80 -55.61 -45.06 77.56 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.046 0.841 . . . . 75.15 110.612 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -78.79 -23.77 45.02 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.12 0.415 . . . . 73.44 112.12 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -75.5 -11.22 59.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.45 0.7 . . . . 70.13 111.93 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.53 -16.16 63.4 Favored 'General case' 0 CA--C 1.555 1.137 0 O-C-N 121.883 -0.51 . . . . 62.41 111.827 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.06 -36.87 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.257 0.623 . . . . 54.31 111.133 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -148.04 -161.13 9.35 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 119.29 -1.433 . . . . 71.3 114.31 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.41 139.24 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 122.759 0.424 . . . . 74.34 110.959 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.0 mm -67.37 115.87 6.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.496 -0.774 . . . . 73.1 110.874 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -97.47 138.86 34.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.209 -0.905 . . . . 65.52 110.962 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -84.49 116.17 22.96 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.982 -1.118 . . . . 74.33 107.982 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.92 129.21 36.58 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 109.274 -0.639 . . . . 75.03 109.274 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -78.63 -7.1 57.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.417 0.895 . . . . 73.12 113.417 -173.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.54 -30.28 69.05 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.354 0.262 . . . . 71.23 111.439 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.5 t -125.94 -32.41 2.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.559 0.219 . . . . 62.31 111.579 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.76 11.23 64.02 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 112.232 -0.347 . . . . 53.23 112.232 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.472 ' H ' HG23 ' A' ' 266' ' ' THR . 8.8 mttp -98.52 151.29 37.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.438 0.695 . . . . 61.52 111.781 173.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.04 154.84 72.43 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.671 2.914 . . . . 35.43 112.459 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.469 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.4 ptm -73.56 100.81 3.4 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.713 1.005 . . . . 75.54 113.713 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.66 112.51 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.684 -1.599 . . . . 73.2 106.684 162.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -127.89 117.35 21.63 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.495 1.043 . . . . 61.44 110.363 162.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.43 113.2 24.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.087 0.47 . . . . 74.34 110.776 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 51.0 m-85 -101.96 110.72 22.76 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.596 -0.729 . . . . 73.33 109.285 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 37.8 p -143.11 122.04 12.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.64 -1.164 . . . . 63.0 109.676 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -86.45 112.44 21.5 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.399 0.619 . . . . 75.34 111.718 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -85.73 -10.56 55.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.664 0.616 . . . . 71.13 112.664 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.42 -33.96 67.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.031 0.382 . . . . 44.32 112.031 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 12.9 t -91.03 -16.21 28.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.43 0.633 . . . . 75.31 109.723 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.92 -48.87 1.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.585 -0.734 . . . . 52.52 112.607 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -74.34 138.52 74.95 Favored Pre-proline 0 N--CA 1.456 -0.172 0 N-CA-C 110.122 -0.325 . . . . 71.21 110.122 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.99 139.38 90.65 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.541 2.161 . . . . 64.55 113.238 171.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 72.1 mttt -59.4 -39.98 85.14 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.357 1.036 . . . . 75.14 111.874 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.91 24.78 12.41 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.612 -0.722 . . . . 62.1 112.969 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 2.1 mp0 -117.72 144.01 45.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.859 -0.736 . . . . 72.3 110.621 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -148.84 142.37 25.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 72.15 109.107 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 237' ' ' PHE . 81.5 p -125.31 138.12 54.07 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.708 -0.478 . . . . 71.23 109.708 172.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.68 148.22 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.066 0.46 . . . . 65.31 110.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.469 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.9 t -101.23 127.6 47.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.856 0.862 . . . . 65.14 112.505 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 164.33 12.26 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.177 -0.327 . . . . 65.44 111.606 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.03 -46.82 49.75 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.66 0.6 . . . . 64.14 110.76 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -109.41 135.36 20.3 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 120.795 -0.362 . . . . 73.52 110.302 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.61 -39.51 20.93 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 C-N-CA 122.775 2.317 . . . . 61.53 116.887 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.49 -29.92 52.83 Favored 'Trans proline' 0 C--N 1.39 2.752 0 CA-C-N 123.459 2.271 . . . . 54.42 113.721 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 47.8 m -63.72 -27.34 69.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.829 0.852 . . . . 73.44 112.174 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -71.59 -34.19 69.68 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.602 0.564 . . . . 73.15 112.204 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -71.82 -39.13 70.02 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.959 0.409 . . . . 71.32 110.338 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.99 74.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.359 -0.837 . . . . 45.32 111.013 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.47 -29.31 66.94 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 116.14 -0.482 . . . . 65.41 112.129 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 296' ' ' ALA . 52.7 mt -67.33 -31.48 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 122.229 -0.294 . . . . 73.31 110.49 172.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -78.52 -61.4 2.02 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.958 1.096 . . . . 63.24 113.958 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -92.07 -29.63 16.46 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.296 1.961 . . . . 73.44 116.296 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.0 t80 -87.6 -21.56 25.27 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.469 0.652 . . . . 64.44 109.914 -171.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.565 ' HB2' HG12 ' A' ' 315' ' ' VAL . 26.2 t0 -93.31 175.33 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.975 -1.011 . . . . 70.11 109.672 171.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.54 12.4 61.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.305 -0.474 . . . . 62.15 112.047 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -126.14 -158.13 0.83 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.267 -0.642 . . . . 62.34 109.267 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.76 143.97 50.62 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.573 0.701 . . . . 74.42 110.601 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.1 114.03 25.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.716 -1.129 . . . . 72.12 108.155 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.0 m170 64.66 29.12 13.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.597 1.186 . . . . 65.14 112.611 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 10.11 80.61 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 113.923 0.329 . . . . 74.43 113.923 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.58 146.01 50.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.699 -0.852 . . . . 73.1 108.699 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.33 127.99 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.271 0.557 . . . . 74.3 111.02 -170.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.7 137.11 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.324 -0.853 . . . . 73.13 109.374 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.24 128.38 41.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.61 -0.723 . . . . 65.14 110.228 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.4 OUTLIER -115.57 142.05 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 -174.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -142.1 175.23 9.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.331 0.652 . . . . 70.23 110.492 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.33 -4.34 58.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.048 1.129 . . . . 70.03 114.048 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 123.944 0.898 . . . . 64.11 112.865 -179.8 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--O 1.24 0.575 0 N-CA-C 110.149 -0.315 . . . . 61.22 110.149 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.14 106.61 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 62.22 109.98 165.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 16.0 m -141.79 148.06 38.31 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.902 -1.148 . . . . 63.33 107.902 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.66 137.23 56.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 118.891 0.769 . . . . 52.15 110.051 164.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.704 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -100.46 119.0 37.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.243 -0.651 . . . . 73.35 109.243 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.63 141.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.496 -0.775 . . . . 64.24 109.44 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 11.1 mm-40 -128.01 149.17 50.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.831 -0.622 . . . . 72.44 110.461 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 94.74 18.47 34.87 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 123.63 0.581 . . . . 70.41 113.362 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.78 76.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.526 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.02 -91.76 0.53 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.333 -0.937 . . . . 73.15 113.873 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.05 114.42 16.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.024 0.44 . . . . 75.03 110.943 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.55 19.86 33.73 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.263 -0.88 . . . . 74.22 111.89 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -83.58 151.47 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.351 -0.611 . . . . 55.23 109.351 -173.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.3 m -90.35 170.36 10.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.162 -0.472 . . . . 74.11 109.944 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -167.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.108 2.163 . . . . 73.23 113.198 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.26 -13.66 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 127.44 2.296 . . . . 62.21 115.018 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 252' ' ' GLU . 0.7 OUTLIER -47.7 -21.3 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.751 2.021 . . . . 61.1 114.136 169.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.34 -31.25 26.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.975 0 CA-C-N 119.207 0.912 . . . . 65.23 109.363 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -56.74 -37.85 79.48 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.003 -0.887 . . . . 64.41 114.419 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 249' ' ' GLN . 0.0 OUTLIER -74.91 -28.6 60.69 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.046 0.923 . . . . 70.41 110.468 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.1 t80 -56.44 -45.7 80.67 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 123.805 0.69 . . . . 74.2 110.833 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.63 -24.5 45.24 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.228 0.455 . . . . 74.21 112.228 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 12.3 tptm -63.1 -24.97 68.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.186 0.994 . . . . 63.0 111.744 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -62.95 -22.09 66.55 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.403 0.52 . . . . 72.33 112.403 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.6 mm -125.1 55.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 117.979 0.354 . . . . 73.34 110.114 171.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.41 -176.43 27.23 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 119.143 -1.503 . . . . 72.23 114.573 170.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.32 137.96 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.531 -0.334 . . . . 64.31 110.156 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.0 mm -73.77 114.24 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.723 -0.671 . . . . 71.31 110.121 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -98.59 140.24 33.12 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.67 0.748 . . . . 75.13 110.886 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.0 m -84.43 121.15 27.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.502 -1.226 . . . . 72.02 108.415 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.73 134.73 50.22 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.528 0.518 . . . . 61.1 111.246 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -81.98 -7.54 59.62 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.875 1.065 . . . . 75.34 113.875 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -68.38 -42.9 78.43 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.238 0.336 . . . . 55.13 111.485 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 24.6 p -124.4 -25.62 4.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.758 0.313 . . . . 75.13 111.337 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.26 16.46 57.37 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.905 -0.588 . . . . 22.31 113.601 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 152.13 38.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.794 0.297 . . . . 71.24 111.715 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.92 152.66 81.49 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.579 2.186 . . . . 71.51 111.361 165.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.478 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.1 ptm -72.82 99.48 2.65 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.808 1.04 . . . . 52.41 113.808 -174.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.4 mm -143.72 114.07 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.781 -1.563 . . . . 73.51 106.781 165.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -129.02 113.63 15.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.901 0.773 . . . . 73.43 109.425 162.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.08 111.34 21.45 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.828 0.347 . . . . 74.3 110.081 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.8 m-85 -103.81 111.83 24.52 Favored 'General case' 0 C--O 1.263 1.767 0 CA-C-O 121.308 0.575 . . . . 71.55 110.555 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.486 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.2 p -143.26 121.97 12.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.196 -1.365 . . . . 74.14 110.165 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.52 113.97 22.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.649 0.738 . . . . 74.22 112.24 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.54 -9.78 56.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.021 0.749 . . . . 71.01 113.021 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.94 -33.94 66.23 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.963 0.411 . . . . 72.1 110.904 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -90.56 -14.99 31.44 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.443 0.64 . . . . 63.12 110.114 170.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 89.67 -12.19 67.87 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.704 -0.68 . . . . 53.12 113.907 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.11 142.02 27.9 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.618 -0.512 . . . . 63.51 109.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.18 133.01 55.7 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.108 2.539 . . . . 75.21 113.796 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.486 ' H ' ' HA ' ' A' ' 275' ' ' THR . 22.5 mttt -62.3 -33.93 75.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.493 -1.231 . . . . 73.1 112.116 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.38 23.78 20.79 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.495 -0.775 . . . . 65.33 112.782 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.9 mt-10 -119.75 141.86 49.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.072 -0.651 . . . . 53.23 109.822 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.94 143.46 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 72.15 109.665 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.8 p -128.6 140.35 51.82 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.924 -0.399 . . . . 72.54 109.924 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.18 146.7 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.208 0.527 . . . . 51.4 109.993 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.478 ' H ' ' CB ' ' A' ' 270' ' ' MET . 25.6 t -98.95 119.96 38.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.566 0.747 . . . . 73.11 111.83 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.52 165.1 12.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.23 0.456 . . . . 60.3 112.23 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.34 -47.93 45.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 124.481 1.113 . . . . 71.13 111.988 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -124.12 137.23 28.64 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 109.558 -0.534 . . . . 75.31 109.558 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.43 -38.06 86.04 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 C-N-CA 123.58 2.853 . . . . 72.23 116.977 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.73 -29.27 29.57 Favored 'Trans proline' 0 C--N 1.397 3.082 0 CA-C-N 123.419 2.257 . . . . 71.2 113.373 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.7 m -65.84 -27.81 68.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.013 0.925 . . . . 63.51 112.208 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -74.89 -44.02 51.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.167 0.587 . . . . 51.4 112.086 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -74.77 -31.3 61.73 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.257 0.551 . . . . 75.33 111.916 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.14 73.52 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.635 -0.711 . . . . 71.45 110.601 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -67.56 -28.3 67.67 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.58 -0.736 . . . . 63.35 111.497 172.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 315' ' ' VAL . 43.7 mt -67.41 -32.34 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 122.171 -0.331 . . . . 72.32 111.08 172.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.24 -60.07 2.52 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.72 1.007 . . . . 73.11 113.72 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -35.52 15.32 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.032 1.864 . . . . 73.35 116.032 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.158 0.504 . . . . 52.54 110.325 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 315' ' ' VAL . 28.2 t0 -98.3 -178.29 3.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.266 -0.879 . . . . 71.12 109.601 172.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.16 64.31 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.943 0.19 . . . . 25.41 112.717 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.29 -158.64 0.9 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.286 -0.457 . . . . 73.13 109.997 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.87 145.78 50.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.658 0.742 . . . . 50.34 111.257 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -115.86 116.07 27.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.35 -1.295 . . . . 74.02 107.828 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 23.3 m170 64.29 28.89 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.657 1.183 . . . . 74.54 112.631 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.66 7.0 84.97 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 114.126 0.41 . . . . 63.14 114.126 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.23 147.93 48.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.803 -0.814 . . . . 51.31 108.803 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.86 130.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.083 0.468 . . . . 75.51 111.269 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.4 tt -109.14 142.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.009 -0.996 . . . . 73.54 109.502 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -136.28 128.01 29.05 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.715 -0.675 . . . . 63.45 110.718 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.11 141.87 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 N-CA-C 108.478 -0.934 . . . . 70.44 108.478 -173.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.1 m -144.52 174.25 11.11 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 121.633 -0.667 . . . . 73.12 110.623 -173.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.2 -3.35 54.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.636 0.976 . . . . 75.01 113.636 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 124.552 1.141 . . . . 70.42 112.991 176.792 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 110.113 -0.328 . . . . 72.43 110.113 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.11 104.99 17.49 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.121 -0.632 . . . . 74.31 109.564 165.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.1 m -142.39 148.84 38.51 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.413 -0.958 . . . . 71.01 108.413 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.11 137.8 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.675 0.671 . . . . 54.34 111.061 164.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.43 130.55 45.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.018 -0.734 . . . . 71.03 109.018 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 141.01 44.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.356 -0.838 . . . . 63.12 109.41 -173.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 13.0 mm-40 -128.65 150.62 50.16 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.36 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.58 14.17 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 124.067 0.854 . . . . 72.1 112.857 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.03 74.88 1.32 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.903 -1.147 . . . . 64.1 107.903 175.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -136.05 -77.24 0.08 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.249 -0.976 . . . . 73.53 112.957 -175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -78.26 102.86 7.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.964 0.888 . . . . 75.24 111.919 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.53 20.67 24.11 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.109 -0.951 . . . . 71.11 112.064 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -79.16 152.5 4.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.549 0.69 . . . . 64.43 110.492 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t -91.71 168.57 11.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.297 -0.865 . . . . 65.11 109.715 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.6 t -63.52 -168.26 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.274 2.23 . . . . 73.3 113.497 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -43.94 -12.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 126.625 1.97 . . . . 61.13 115.645 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.96 -22.35 0.32 Allowed 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 126.361 1.864 . . . . 63.11 114.319 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -55.91 -32.61 33.15 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 CA-C-N 118.899 0.772 . . . . 62.11 111.001 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.17 84.19 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.646 -0.312 . . . . 73.35 113.416 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -74.6 -30.43 61.68 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.675 0.79 . . . . 70.44 111.289 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.5 t80 -56.05 -45.19 79.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 70.23 111.232 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.52 -23.71 50.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.823 0.305 . . . . 73.12 111.823 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.98 -14.32 61.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.477 0.711 . . . . 70.43 112.382 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.2 -11.81 44.67 Favored 'General case' 0 CA--C 1.557 1.223 0 O-C-N 121.666 -0.646 . . . . 75.4 112.14 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mm -106.56 -42.18 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.972 0.509 . . . . 64.03 111.102 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.61 -158.97 7.78 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 120.898 -0.668 . . . . 65.21 113.942 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 14.5 mt -104.93 139.88 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.138 0.575 . . . . 62.3 110.589 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.6 mm -65.98 113.29 2.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 109.523 -0.547 . . . . 64.12 109.523 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.04 141.64 32.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.338 -0.847 . . . . 74.24 110.767 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 11.0 m -85.07 117.71 24.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.85 -1.068 . . . . 61.31 108.511 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -74.61 130.29 39.28 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.152 -0.684 . . . . 73.22 109.152 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -73.36 -9.15 58.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.674 0.99 . . . . 73.02 113.674 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -69.67 -34.35 73.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 111.997 0.369 . . . . 60.43 111.997 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.68 -30.24 3.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.478 0.311 . . . . 63.13 111.519 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.19 9.08 67.82 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.543 -0.298 . . . . 64.51 112.612 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.458 ' H ' HG23 ' A' ' 266' ' ' THR . 42.9 mttt -98.14 152.08 37.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.026 0.53 . . . . 71.42 112.196 172.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.09 156.24 63.88 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.892 3.061 . . . . 70.44 112.562 169.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.449 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.04 98.52 2.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.841 1.052 . . . . 74.1 113.841 -172.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -143.43 112.38 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.266 -1.383 . . . . 63.43 107.266 164.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -128.71 113.74 15.73 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.957 0.798 . . . . 62.11 109.367 160.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -114.52 107.89 16.12 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.721 -0.844 . . . . 52.4 108.721 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 26.1 m-85 -103.81 112.72 25.8 Favored 'General case' 0 C--O 1.26 1.634 0 CA-C-O 121.211 0.529 . . . . 73.21 110.935 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.464 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.6 p -144.42 122.92 12.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.468 -1.242 . . . . 63.41 110.308 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.99 113.39 22.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.427 0.632 . . . . 63.41 112.118 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 -8.95 57.48 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.517 -0.765 . . . . 73.22 112.715 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -35.4 71.33 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.753 0.279 . . . . 74.41 111.753 175.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.0 t -90.97 -14.26 31.83 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.204 0.526 . . . . 75.01 110.136 171.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.2 -46.32 1.7 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.579 -0.737 . . . . 60.41 113.043 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -86.19 142.84 36.2 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 110.547 -0.168 . . . . 72.35 110.547 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 139.13 83.2 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.563 2.842 . . . . 64.44 114.459 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 275' ' ' THR . 49.5 mttt -67.22 -34.21 76.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.179 -0.919 . . . . 61.52 112.146 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.76 27.75 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.093 -0.575 . . . . 62.43 112.772 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 41.7 mt-10 -115.92 143.12 45.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.812 -0.355 . . . . 75.4 110.429 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.47 154.74 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.233 -0.44 . . . . 70.43 110.78 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.2 137.39 37.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.782 -0.451 . . . . 74.31 109.782 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.35 144.75 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.361 -0.607 . . . . 45.14 109.361 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.449 ' H ' ' CB ' ' A' ' 270' ' ' MET . 26.7 t -93.35 121.69 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.61 0.764 . . . . 72.34 111.789 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -94.15 164.14 13.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.664 -0.244 . . . . 74.42 111.596 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.5 -48.78 73.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.926 0.891 . . . . 65.51 112.852 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -127.11 137.89 31.56 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 109.512 -0.551 . . . . 73.51 109.512 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.27 -38.41 75.81 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 123.078 2.519 . . . . 71.22 117.137 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.18 -28.92 15.03 Favored 'Trans proline' 0 C--N 1.391 2.799 0 CA-C-N 124.139 2.514 . . . . 72.44 113.054 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 37.9 m -61.45 -28.31 69.19 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.381 1.072 . . . . 64.44 112.027 174.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.21 -37.13 77.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.644 0.778 . . . . 54.54 112.777 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.8 -35.14 62.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 120.981 0.419 . . . . 74.54 111.288 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.563 -0.744 . . . . 74.52 111.035 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.66 -28.12 65.61 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.809 -0.632 . . . . 71.3 112.08 174.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 315' ' ' VAL . 42.3 mt -67.84 -31.86 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 122.026 -0.421 . . . . 75.3 110.811 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.43 -59.76 2.63 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.863 1.061 . . . . 74.32 113.863 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -91.27 -34.97 14.74 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.48 2.03 . . . . 62.45 116.48 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 44.3 t80 -83.44 -25.28 31.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.177 0.513 . . . . 73.11 110.188 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.5 ' HB2' HG12 ' A' ' 315' ' ' VAL . 16.7 t0 -93.46 176.38 6.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.801 -1.09 . . . . 71.44 109.95 173.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.53 12.95 57.74 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.275 -0.488 . . . . 61.25 112.31 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -128.99 -154.58 0.65 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.854 -0.424 . . . . 73.41 109.854 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.72 139.84 49.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.268 0.556 . . . . 75.41 110.868 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.52 112.74 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.716 -1.216 . . . . 70.43 107.716 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.9 m170 64.66 28.4 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.947 1.299 . . . . 75.04 112.205 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.98 88.19 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 121.629 -0.32 . . . . 43.04 113.428 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.03 143.29 33.41 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.28 -1.007 . . . . 60.33 108.28 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.82 126.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.655 0.264 . . . . 53.34 110.501 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.1 tt -107.9 140.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.976 -0.556 . . . . 60.45 109.636 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.89 126.23 28.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.863 -0.608 . . . . 75.1 109.654 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.52 138.69 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.76 -1.2 . . . . 71.14 107.76 -175.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.0 m -144.56 171.7 14.0 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 123.0 0.52 . . . . 72.41 110.192 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.48 -4.49 42.89 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.229 1.196 . . . . 71.53 114.229 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 124.403 1.081 . . . . 64.14 113.097 177.272 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 C--O 1.236 0.363 0 CA-C-O 120.733 0.301 . . . . 61.14 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.33 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.424 0.631 . . . . 70.44 110.509 167.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.6 m -143.17 150.06 38.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.861 -1.162 . . . . 55.52 107.861 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 288' ' ' VAL . 2.8 pp -124.58 140.71 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.023 0.828 . . . . 62.31 111.223 164.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.67 136.18 41.95 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.791 -0.64 . . . . 65.55 109.433 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 315' ' ' VAL . 0.0 OUTLIER -128.36 142.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 122.028 0.918 . . . . 70.31 112.401 177.212 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -127.25 141.34 51.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.594 -1.639 . . . . 62.14 108.151 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.68 29.25 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.044 -0.598 . . . . 63.1 112.193 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.513 HD13 HG11 ' A' ' 250' ' ' VAL . 9.2 mt -107.72 71.72 0.83 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.632 -0.877 . . . . 74.34 108.632 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.46 -79.91 0.07 OUTLIER Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 119.89 -1.148 . . . . 73.23 113.741 -174.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.99 106.76 7.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.106 0.955 . . . . 74.01 111.756 -171.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.7 20.02 32.86 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.83 -1.077 . . . . 72.43 111.58 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.38 151.34 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.13 0.491 . . . . 72.41 109.825 -171.464 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.7 m -92.01 170.85 9.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 72.12 110.072 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.814 2.046 . . . . 74.44 114.042 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -42.44 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 127.181 2.193 . . . . 74.35 115.854 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -21.92 0.41 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.56 1.944 . . . . 75.34 114.408 169.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 241' ' ' LEU . 1.3 t -56.36 -32.03 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.114 0.87 . . . . 40.2 110.762 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.4 -31.56 81.26 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.878 -0.401 . . . . 71.44 113.559 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -75.51 -30.7 59.91 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.34 0.591 . . . . 73.11 110.251 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.5 t80 -59.21 -42.91 92.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.412 -0.813 . . . . 62.41 110.72 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -78.17 -24.04 47.41 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.894 0.378 . . . . 65.41 112.015 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 260' ' ' ILE . 22.7 tptm -66.83 -21.88 66.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.475 1.11 . . . . 72.12 112.197 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.42 -20.54 65.64 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 112.119 0.414 . . . . 63.13 112.119 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.91 54.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 117.871 0.305 . . . . 72.34 110.191 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . 147.04 -168.72 28.19 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.178 -1.487 . . . . 30.3 115.011 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.55 138.42 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.407 0.683 . . . . 74.43 110.994 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 255' ' ' LYS . 6.7 mm -74.12 116.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.306 0.379 . . . . 74.15 110.17 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -98.93 142.92 29.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.401 0.619 . . . . 53.53 111.11 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 12.7 m -84.62 115.66 22.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 166.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.76 136.07 48.63 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.789 0.292 . . . . 65.22 111.789 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -11.05 59.98 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.739 0.644 . . . . 63.33 112.739 -174.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -74.11 -26.94 60.63 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.452 0.168 . . . . 73.03 111.236 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.8 t -125.32 -31.54 3.03 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.096 0.406 . . . . 62.05 112.096 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.8 83.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 116.308 -0.405 . . . . 53.31 112.934 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 266' ' ' THR . 53.3 mmtt -96.24 148.41 34.45 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.442 0.697 . . . . 73.22 111.325 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.0 153.58 74.79 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.787 2.325 . . . . 41.13 111.022 165.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.477 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.6 OUTLIER -76.32 101.24 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.263 0.838 . . . . 73.41 113.263 -170.256 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.2 mm -142.55 112.82 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.024 -1.473 . . . . 71.11 107.024 162.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -129.07 113.34 15.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.333 -0.617 . . . . 71.24 109.333 162.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 273' ' ' LEU . 0.8 OUTLIER -114.42 110.5 19.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.032 -0.729 . . . . 62.11 109.032 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -103.44 111.83 24.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.095 0.474 . . . . 72.12 110.897 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.426 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.1 p -145.39 120.81 10.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.56 -1.2 . . . . 74.42 109.815 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -87.76 113.87 23.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.411 1.1 . . . . 75.23 112.595 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -4.05 58.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.119 -0.946 . . . . 63.15 112.574 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.64 79.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 64.42 110.836 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -92.69 -21.43 20.0 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.691 -0.686 . . . . 64.52 109.801 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 103.67 -45.29 1.34 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.905 -0.588 . . . . 74.13 112.673 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -79.75 143.98 59.42 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 121.224 -0.19 . . . . 72.34 110.628 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -57.12 140.51 92.92 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.959 2.439 . . . . 74.23 114.378 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 275' ' ' THR . 9.3 tttt -67.52 -37.24 82.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.877 -1.056 . . . . 64.1 111.571 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.11 17.18 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.872 -0.604 . . . . 64.43 113.891 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.44 146.18 47.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.449 -0.5 . . . . 73.34 111.478 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.48 152.67 33.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.81 -0.632 . . . . 55.32 110.632 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.75 135.17 50.72 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.101 166.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.435 HG22 HD11 ' A' ' 236' ' ' ILE . 3.3 m -134.96 146.81 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' SER . . . . . 0.477 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.7 m -113.58 133.82 55.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.502 0.556 . . . . 62.52 112.502 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.71 165.23 11.49 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.661 0.615 . . . . 75.21 112.661 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.89 -47.95 60.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.339 -0.846 . . . . 64.23 111.949 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -117.79 135.78 23.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.351 -0.611 . . . . 71.23 109.351 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.13 -38.84 53.25 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 123.274 2.649 . . . . 54.15 117.238 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.19 -28.39 15.6 Favored 'Trans proline' 0 C--N 1.393 2.874 0 CA-C-N 123.426 2.259 . . . . 51.42 112.544 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.4 m -61.92 -27.44 68.82 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.301 1.04 . . . . 71.52 111.946 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.26 -39.58 78.36 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.307 0.38 . . . . 71.45 111.712 175.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -41.07 87.74 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.744 0.307 . . . . 73.12 110.387 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.82 76.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.722 -0.672 . . . . 54.51 111.395 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.64 -31.18 71.7 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 122.806 0.443 . . . . 60.22 111.725 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 315' ' ' VAL . 57.2 mt -68.86 -31.11 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 O-C-N 122.197 -0.315 . . . . 72.32 110.86 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.11 -59.74 2.65 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.385 0.883 . . . . 71.21 113.385 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . 0.253 1.7 p-90 -91.69 -34.26 14.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.534 2.049 . . . . 72.23 116.534 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -84.82 -22.48 29.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.376 0.607 . . . . 61.44 110.193 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 315' ' ' VAL . 21.9 t0 -83.31 -176.02 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.009 -0.996 . . . . 61.41 109.435 171.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 84.53 9.83 80.76 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 114.123 0.409 . . . . 64.52 114.123 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 -160.97 1.04 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.151 -0.685 . . . . 63.32 109.151 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.21 146.14 49.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.694 0.759 . . . . 74.34 111.401 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.88 114.28 26.72 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.749 -1.204 . . . . 73.31 107.749 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.7 m170 62.54 28.37 16.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.672 1.189 . . . . 62.54 111.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 88.89 -2.34 84.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.462 -0.399 . . . . 70.41 114.092 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -110.5 142.58 42.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.399 0.599 . . . . 55.54 109.597 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.82 126.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.177 0.513 . . . . 70.15 110.944 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 10.6 tt -108.78 139.42 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.65 -0.704 . . . . 74.13 109.963 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -136.4 123.79 22.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.55 111.075 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.541 HG23 HG13 ' A' ' 238' ' ' VAL . 4.7 p -109.29 138.85 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 CA-C-N 115.022 -0.99 . . . . 75.32 110.226 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 115.767 -0.652 . . . . 73.34 109.866 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -79.14 -3.63 46.49 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 114.618 1.34 . . . . 73.42 114.618 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 124.402 1.081 . . . . 72.22 112.535 179.218 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.055 0 N-CA-C 111.358 -0.697 . . . . 24.1 111.358 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.8 t 68.4 -171.7 0.18 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.959 1.304 . . . . 43.3 112.111 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -90.89 118.88 30.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.95 0.5 . . . . 62.22 111.001 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 67.5 mtt -123.29 88.59 2.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.685 0.278 . . . . 63.32 110.542 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m 69.6 177.56 0.26 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.292 1.437 . . . . 61.11 113.186 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -100.38 7.42 44.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.374 -0.83 . . . . 62.03 110.474 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -84.96 110.61 19.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.59 -0.732 . . . . 53.44 110.706 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 103.38 15.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.192 -0.603 . . . . 65.45 110.569 167.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.3 m -143.73 143.55 31.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.535 -0.913 . . . . 63.13 108.535 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.94 142.24 36.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 119.262 0.937 . . . . 70.05 109.915 163.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -100.09 130.51 46.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.23 -1.026 . . . . 71.33 108.23 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.48 141.56 43.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.565 -0.532 . . . . 73.04 109.565 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 12.3 mm-40 -126.33 150.63 48.4 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 63.42 110.423 -176.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.07 14.01 59.72 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 124.383 1.052 . . . . 63.21 112.782 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 286' ' ' ALA . 6.5 mt -103.48 74.56 1.27 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.984 -1.117 . . . . 73.31 107.984 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.91 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.513 -0.851 . . . . 73.3 113.55 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.21 112.4 12.64 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.432 0.634 . . . . 64.53 111.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.14 21.02 51.27 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.308 -0.86 . . . . 63.42 111.686 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.59 151.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.393 -0.595 . . . . 74.32 109.393 -172.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.8 t -91.81 170.78 9.61 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.05 -0.722 . . . . 71.35 109.05 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -167.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.535 2.334 . . . . 71.44 114.039 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -44.29 -12.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 126.24 1.816 . . . . 50.21 115.26 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -46.0 -22.58 0.22 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.605 1.962 . . . . 72.44 113.471 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.64 HG11 HD13 ' A' ' 241' ' ' LEU . 0.9 OUTLIER -56.3 -32.49 35.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 CA-C-N 118.914 0.779 . . . . 75.11 109.912 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.58 -32.58 83.78 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.281 -0.262 . . . . 73.35 113.197 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.12 -32.63 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.418 0.687 . . . . 73.54 110.481 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 7.5 t80 -56.76 -44.38 81.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.433 1.093 . . . . 74.11 110.806 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.24 -24.29 47.0 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 111.956 0.354 . . . . 74.21 111.956 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -66.87 -21.34 66.01 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.936 0.895 . . . . 72.44 111.46 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.55 -25.0 68.04 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 122.195 -0.316 . . . . 74.13 111.365 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.4 mm -124.59 70.86 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.024 -0.732 . . . . 43.15 109.024 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.36 -176.0 24.61 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 119.096 -1.526 . . . . 53.35 114.575 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.01 139.58 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.347 0.659 . . . . 74.1 109.727 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.68 116.53 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.119 0.485 . . . . 74.53 110.262 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' A' ' 290' ' ' PHE . 22.8 tttm -95.73 137.49 34.71 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.543 0.687 . . . . 72.4 111.048 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 26.7 m -85.2 117.85 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.666 -1.152 . . . . 64.01 108.471 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -75.24 137.98 41.59 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.147 -0.479 . . . . 71.02 110.554 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -80.01 -10.15 59.75 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.393 0.886 . . . . 73.22 113.393 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.85 -41.16 78.85 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.364 0.505 . . . . 62.4 112.364 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.6 t -125.36 -18.86 5.21 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.739 0.304 . . . . 52.22 111.089 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.67 57.11 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 116.292 -0.413 . . . . 61.44 113.165 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -98.13 153.3 38.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.016 0.376 . . . . 71.22 112.016 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.16 155.84 68.9 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.646 2.898 . . . . 65.35 112.353 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.493 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.55 98.11 2.25 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.175 0.988 . . . . 61.25 113.353 -174.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.2 mm -144.15 112.58 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.034 -1.469 . . . . 73.45 107.034 163.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.07 116.33 19.12 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.425 1.011 . . . . 64.24 109.865 162.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 111.25 21.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.51 110.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 32.4 m-85 -102.6 112.0 24.55 Favored 'General case' 0 C--O 1.26 1.625 0 CA-C-O 121.241 0.543 . . . . 72.11 110.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.1 p -143.46 120.43 11.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.317 -1.311 . . . . 75.45 109.807 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -87.9 113.14 23.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.804 1.288 . . . . 73.52 111.884 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -7.61 59.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.633 -1.167 . . . . 73.4 111.639 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.81 -29.51 66.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.246 0.618 . . . . 75.5 111.371 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -91.11 -29.41 17.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.412 -0.588 . . . . 72.4 109.412 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 107.18 -19.3 34.96 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.316 -0.856 . . . . 52.11 112.633 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -113.17 141.64 26.03 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.292 -0.262 . . . . 73.43 110.292 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.35 140.35 94.1 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 123.316 2.678 . . . . 71.04 114.958 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.444 ' H ' ' HA ' ' A' ' 275' ' ' THR . 16.2 mttt -64.18 -36.52 84.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.706 -1.134 . . . . 64.32 112.247 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.87 20.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.519 -0.764 . . . . 63.11 112.421 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 49.1 mt-10 -119.62 141.03 49.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 119.724 -0.79 . . . . 71.32 109.81 -174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -152.74 144.69 23.7 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.908 -0.587 . . . . 30.35 109.887 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 237' ' ' PHE . 76.3 p -127.7 140.22 52.21 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 122.017 -0.427 . . . . 53.52 109.964 173.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.405 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 19.6 m -134.58 146.78 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.006 0.432 . . . . 72.22 110.428 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.493 ' H ' ' CB ' ' A' ' 270' ' ' MET . 27.6 t -98.61 113.98 26.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.725 0.81 . . . . 63.42 112.49 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.422 ' O ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 m-85 -88.08 162.77 16.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.592 0.219 . . . . 65.13 111.592 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.47 -47.62 19.19 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.434 0.459 . . . . 70.41 111.199 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.76 135.44 22.19 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 120.967 -0.293 . . . . 62.32 110.277 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.67 -40.45 22.72 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.213 1.942 . . . . 65.1 116.376 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.66 -30.02 51.31 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 123.082 2.136 . . . . 74.32 113.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 67.9 m -63.82 -27.36 69.12 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.44 0.696 . . . . 61.31 112.709 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.97 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.24 0.616 . . . . 75.2 111.838 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.84 -40.76 88.06 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.079 0.552 . . . . 63.32 111.159 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.05 -32.94 74.71 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.438 -0.801 . . . . 62.24 111.583 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -70.59 -29.56 66.01 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.07 0.396 . . . . 74.31 112.07 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.54 -33.81 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 110.384 -0.228 . . . . 74.44 110.384 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.21 -59.41 2.79 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 114.264 1.209 . . . . 70.31 114.264 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -91.37 -34.07 15.02 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.117 1.895 . . . . 74.24 116.117 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 67.7 t80 -86.74 -14.99 40.79 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.339 0.59 . . . . 74.31 110.558 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.38 175.77 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.81 14.49 46.27 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.903 -0.665 . . . . 71.03 112.809 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -133.72 -154.04 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.097 -0.705 . . . . 75.02 109.097 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 149.91 52.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.85 0.833 . . . . 75.12 111.264 174.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -113.49 114.81 27.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.61 -1.177 . . . . 74.43 108.211 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.9 m170 64.52 28.35 13.4 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.606 1.163 . . . . 75.15 112.5 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.35 -2.75 86.68 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 119.891 -0.394 . . . . 61.3 113.905 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.69 141.93 47.17 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.927 -0.768 . . . . 64.13 108.927 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.14 131.23 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.127 0.489 . . . . 73.3 111.481 -169.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.86 142.68 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.597 -0.729 . . . . 73.24 109.569 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -137.11 129.1 29.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 75.0 111.359 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.66 134.64 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.811 -0.631 . . . . 64.21 110.188 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -136.12 173.49 11.65 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.149 0.98 . . . . 50.43 109.816 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.9 0.56 43.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.409 0.892 . . . . 74.24 113.409 175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.08 -158.3 0.32 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.359 1.064 . . . . 54.04 112.88 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 4.9 m -103.89 145.55 29.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.792 -0.447 . . . . 63.4 109.792 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -92.16 173.56 7.76 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.244 -0.28 . . . . 60.11 110.244 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 65.29 86.89 0.13 Allowed Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.462 1.105 . . . . 73.43 112.045 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.83 111.83 3.42 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.241 1.961 . . . . 71.21 112.845 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.227 -0.892 . . . . 72.23 110.375 -178.358 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 111.418 -0.673 . . . . 72.15 111.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 37.2 m 63.72 29.32 14.93 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.457 1.28 . . . . 61.32 114.457 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 60.32 81.68 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.611 1.164 . . . . 75.43 111.714 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 13.0 mmt -109.0 -3.83 17.15 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.549 -0.75 . . . . 75.0 112.358 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -140.76 140.58 34.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.926 0.393 . . . . 71.41 111.62 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 -11.77 46.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.365 -0.834 . . . . 61.02 109.953 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.77 110.2 14.91 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.556 -0.747 . . . . 52.03 110.164 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.39 105.53 17.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.272 0.558 . . . . 64.05 110.407 165.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 14.0 m -142.29 145.21 33.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.047 -1.094 . . . . 55.25 108.047 165.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.46 HD13 HG13 ' A' ' 315' ' ' VAL . 1.7 pp -122.16 144.42 31.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 118.937 0.79 . . . . 73.41 109.117 166.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 136.62 43.26 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.279 -0.638 . . . . 75.24 109.279 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.02 143.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.58 0.705 . . . . 62.34 112.515 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 12.8 mm-40 -126.56 147.36 49.88 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.102 -1.408 . . . . 62.21 110.387 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.4 21.93 30.76 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.524 0.515 . . . . 62.24 113.373 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -114.96 75.48 0.94 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.566 -1.272 . . . . 74.21 107.566 176.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -131.32 -86.87 0.39 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.513 -0.851 . . . . 73.12 113.495 -170.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.31 113.21 12.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.179 0.514 . . . . 63.33 111.549 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.26 40.08 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.219 -0.9 . . . . 55.32 111.707 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.82 151.67 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.508 -0.552 . . . . 73.31 109.508 -174.281 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.2 m -89.34 169.97 10.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.213 -0.903 . . . . 70.11 110.09 173.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.594 1.957 . . . . 64.23 113.868 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -42.64 -14.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 C-N-CA 126.36 1.864 . . . . 75.51 114.728 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.94 -20.78 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.748 2.019 . . . . 74.24 114.229 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.46 -31.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.81 0.732 . . . . 64.43 110.25 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.89 -35.82 91.02 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.548 -0.585 . . . . 61.22 113.964 172.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.99 -35.46 80.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.943 0.897 . . . . 74.03 111.757 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.0 t80 -57.24 -44.35 83.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.005 0.922 . . . . 71.52 111.125 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.85 -24.34 44.41 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 111.821 0.304 . . . . 75.52 111.821 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 260' ' ' ILE . 15.3 tptm -63.93 -23.4 67.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.095 0.958 . . . . 73.13 111.905 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.79 -24.39 67.71 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 121.037 -0.265 . . . . 63.23 111.521 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -126.29 67.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 109.086 -0.709 . . . . 75.53 109.086 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.77 -177.01 24.44 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 119.38 -1.39 . . . . 74.55 114.574 171.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.02 138.44 31.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.112 0.565 . . . . 54.24 109.669 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.8 mm -66.86 115.98 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.662 0.601 . . . . 62.11 110.066 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -95.97 139.2 32.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.241 -0.89 . . . . 72.4 111.135 -176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 29.4 m -86.92 117.57 25.74 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.101 -1.074 . . . . 71.23 108.101 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.68 132.02 36.86 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.854 -0.425 . . . . 75.24 109.854 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -10.11 59.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.098 1.147 . . . . 75.2 114.098 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.09 -31.22 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 111.772 0.286 . . . . 71.44 111.772 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.2 t -124.66 -31.7 3.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.772 0.32 . . . . 75.14 111.267 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.01 6.65 69.12 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.176 -0.466 . . . . 34.41 112.506 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' H ' HG23 ' A' ' 266' ' ' THR . 75.6 mttt -98.18 152.0 37.79 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.295 0.638 . . . . 75.54 112.217 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.01 154.42 74.09 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.662 2.908 . . . . 73.4 112.306 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.9 ptm -71.0 99.53 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.894 1.072 . . . . 64.42 113.894 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.6 mm -144.4 114.21 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.565 -1.272 . . . . 62.41 107.565 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -129.54 116.45 18.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.997 0.817 . . . . 74.02 110.41 161.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 111.32 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.836 -0.431 . . . . 73.25 109.836 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.7 m-85 -103.16 112.52 25.41 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-O 121.159 0.504 . . . . 73.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.466 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.1 p -141.99 122.99 14.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.524 -1.216 . . . . 65.45 110.336 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.62 112.22 20.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.118 0.485 . . . . 53.31 111.627 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -11.06 50.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.094 0.776 . . . . 75.21 113.094 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -28.79 57.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.487 . . . . 61.32 110.175 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 51.5 p -89.56 -21.8 22.7 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.742 -0.663 . . . . 70.21 109.624 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.46 -35.68 4.56 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.584 -0.734 . . . . 51.54 112.536 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -97.96 141.63 23.28 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 123.379 0.105 . . . . 74.31 111.163 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.57 135.44 70.4 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.493 2.795 . . . . 63.22 114.173 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.466 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.3 mttt -63.85 -36.68 84.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.607 -1.179 . . . . 64.4 112.082 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.55 23.95 19.81 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.777 -0.725 . . . . 62.41 112.682 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 26.8 mt-10 -117.78 142.96 46.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.793 -0.447 . . . . 74.13 109.793 -172.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.53 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.278 -0.419 . . . . 63.54 110.535 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 20.7 p -134.97 137.01 42.65 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.964 -0.384 . . . . 71.13 109.964 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.61 150.06 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.259 -0.428 . . . . 35.43 110.125 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 30.7 t -105.47 117.73 34.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.972 0.73 . . . . 55.42 112.972 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 159.93 20.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.097 -0.241 . . . . 71.33 111.227 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.29 -47.03 16.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.119 -0.491 . . . . 74.3 109.951 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.62 135.4 29.25 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 123.212 0.32 . . . . 73.42 110.468 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.32 -40.71 30.53 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.434 2.089 . . . . 73.1 116.133 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.33 -29.22 32.22 Favored 'Trans proline' 0 C--N 1.389 2.696 0 CA-C-N 122.682 1.994 . . . . 63.33 113.535 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 61.3 m -63.55 -25.78 68.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.175 0.59 . . . . 75.45 112.361 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -72.98 -45.68 56.59 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.037 0.384 . . . . 70.12 112.037 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -32.69 68.59 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.257 0.551 . . . . 62.22 111.415 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.74 -30.62 61.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.284 -0.871 . . . . 75.15 110.6 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.62 -31.23 71.11 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 122.252 0.221 . . . . 70.34 111.218 173.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 296' ' ' ALA . 67.2 mt -67.04 -34.57 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 120.484 0.183 . . . . 53.55 110.748 173.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.9 -59.86 2.61 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.393 1.257 . . . . 73.42 114.393 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.93 -35.33 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.509 1.67 . . . . 74.11 115.509 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.6 t80 -83.32 -18.66 38.2 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.101 0.477 . . . . 72.22 110.156 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.97 -174.08 2.46 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.043 -0.98 . . . . 62.22 109.219 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.08 65.35 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.121 -0.561 . . . . 75.42 112.322 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -135.98 -160.88 1.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.622 0.369 . . . . 70.41 110.137 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.17 145.68 47.97 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.784 0.802 . . . . 72.43 111.884 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -114.74 114.93 26.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.43 -1.259 . . . . 71.24 107.858 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.9 m170 64.37 28.66 13.68 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.915 1.286 . . . . 73.41 112.649 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.94 -2.97 85.96 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.148 0.419 . . . . 71.52 114.148 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -111.74 144.4 41.1 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 122.801 0.441 . . . . 71.12 110.05 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.66 129.66 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 123.331 0.394 . . . . 71.2 110.33 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.0 tt -108.41 145.8 14.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.9 -0.591 . . . . 74.41 109.514 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 42.5 tttp -135.4 127.94 30.66 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.071 -0.513 . . . . 54.24 111.256 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.46 HG13 HD13 ' A' ' 236' ' ' ILE . 25.2 t -103.61 133.76 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.37 0.605 . . . . 71.44 109.385 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -132.53 173.36 11.4 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.997 0.919 . . . . 74.41 109.313 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.26 -1.07 52.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 113.076 0.769 . . . . 75.12 113.076 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 62.75 -165.92 0.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.404 1.082 . . . . 35.2 113.321 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.3 m -89.05 146.48 24.81 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.614 -0.721 . . . . 73.21 109.401 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -164.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.783 -0.821 . . . . 72.53 108.783 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 43.91 84.34 0.19 Allowed Pre-proline 0 N--CA 1.502 2.143 0 C-N-CA 125.274 1.43 . . . . 73.24 114.501 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.44 111.79 3.23 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 121.936 1.757 . . . . 73.23 112.578 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.129 -0.938 . . . . 55.11 110.882 -174.57 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 CA-C-O 119.575 -0.569 . . . . 60.24 112.347 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.9 m 73.71 -60.3 0.53 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.575 1.55 . . . . 73.34 112.584 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -111.53 149.7 31.01 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.934 -0.765 . . . . 62.33 108.934 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 70.1 mmm -113.23 12.04 18.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.265 0.555 . . . . 63.14 110.886 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.4 p -151.19 139.33 20.16 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.534 -0.757 . . . . 64.32 110.956 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -123.35 69.28 1.01 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.517 1.151 . . . . 65.12 110.063 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -90.13 121.76 32.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.976 -1.465 . . . . 72.14 111.359 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.42 104.21 16.75 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.45 -0.781 . . . . 74.03 110.676 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -144.12 149.51 36.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.467 0.707 . . . . 60.3 109.344 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.76 137.16 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.726 0.694 . . . . 61.42 110.512 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.55 125.51 48.21 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.556 -0.535 . . . . 75.03 109.556 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -120.05 143.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.745 0.784 . . . . 74.12 111.93 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 6.2 tp-100 -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.986 -1.461 . . . . 44.42 108.927 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.78 43.94 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.098 -0.573 . . . . 61.43 112.958 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -105.0 78.65 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.579 -0.896 . . . . 63.41 108.579 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.54 -81.44 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.491 -0.861 . . . . 71.14 113.486 -172.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.68 107.14 9.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 72.14 111.21 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.23 20.92 24.07 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.556 -0.747 . . . . 61.13 112.078 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.54 152.55 4.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.384 0.611 . . . . 73.32 110.572 -173.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -93.84 169.24 10.44 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.597 -0.729 . . . . 60.15 109.408 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -167.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 127.136 2.174 . . . . 71.11 114.208 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -44.14 -13.12 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 126.241 1.817 . . . . 75.41 115.528 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -22.96 0.38 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 126.499 1.92 . . . . 73.43 113.998 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -56.21 -30.59 30.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 O-C-N 122.001 -0.437 . . . . 74.41 110.287 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.38 -33.49 84.79 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 122.054 -0.403 . . . . 75.11 113.378 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.22 -32.13 64.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.527 0.731 . . . . 45.04 110.697 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 11.0 t80 -55.56 -45.85 77.24 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.162 -0.926 . . . . 74.33 111.182 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.82 -24.12 48.83 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.195 -0.315 . . . . 71.15 111.613 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -74.83 -11.11 60.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.661 0.785 . . . . 63.2 112.183 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -15.83 61.88 Favored 'General case' 0 CA--C 1.557 1.238 0 O-C-N 121.854 -0.529 . . . . 61.5 111.733 172.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 -44.41 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.909 0.484 . . . . 71.04 111.115 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -139.08 -162.09 8.99 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.365 -0.921 . . . . 64.24 114.72 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.0 138.2 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.832 0.453 . . . . 73.4 110.835 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.82 114.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 O-C-N 123.885 0.741 . . . . 64.3 110.947 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -100.96 144.16 30.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.763 -1.108 . . . . 53.42 111.308 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.8 m -83.39 118.1 23.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.369 -1.287 . . . . 74.53 108.114 168.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.94 133.96 45.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.605 0.565 . . . . 71.33 109.676 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -77.38 -11.55 59.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.474 0.546 . . . . 72.52 112.474 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.31 -31.21 68.43 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.106 0.41 . . . . 60.44 112.106 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.2 t -124.86 -31.68 3.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.625 0.232 . . . . 71.4 111.625 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.85 69.19 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 116.48 -0.327 . . . . 64.34 112.515 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 266' ' ' THR . 49.9 mttt -98.45 152.4 37.91 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 123.256 0.623 . . . . 64.44 112.247 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.02 154.35 74.38 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 123.178 2.585 . . . . 64.14 111.113 166.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.525 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.94 102.15 6.27 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.651 0.982 . . . . 64.52 113.651 -168.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.86 112.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.126 -1.435 . . . . 74.53 107.126 163.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -128.5 114.78 17.2 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.685 0.675 . . . . 72.51 109.367 161.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.56 110.24 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.363 -0.606 . . . . 73.05 109.363 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -103.06 112.22 24.96 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 121.356 0.598 . . . . 75.14 111.009 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.7 p -144.18 120.99 11.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.594 -1.185 . . . . 53.23 109.997 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.96 112.94 21.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.448 0.642 . . . . 64.21 111.864 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -7.9 58.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.407 -0.815 . . . . 73.35 112.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -33.0 69.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.021 0.438 . . . . 72.23 111.138 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 7.7 t -91.53 -14.53 30.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.776 -0.647 . . . . 74.31 109.886 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.59 -49.76 1.62 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.589 -0.732 . . . . 43.14 112.628 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.11 142.09 59.06 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.716 0.304 . . . . 71.02 110.54 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -57.15 134.56 64.97 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.314 2.676 . . . . 73.24 114.228 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -60.26 -42.46 95.37 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.928 -1.033 . . . . 74.45 111.889 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.77 14.59 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.796 -0.716 . . . . 52.31 113.565 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -118.27 145.86 44.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.086 0.443 . . . . 73.24 110.517 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.86 156.13 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 61.51 110.456 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.71 136.08 46.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.74 0.305 . . . . 74.43 110.211 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.68 148.05 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 116.176 -0.465 . . . . 72.31 109.747 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.525 ' H ' ' CB ' ' A' ' 270' ' ' MET . 47.4 t -97.66 141.74 30.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.227 1.011 . . . . 74.32 111.74 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.81 164.89 12.31 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.195 -0.315 . . . . 74.25 110.538 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.0 -47.51 65.35 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.442 0.464 . . . . 74.23 110.872 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.411 ' HB3' ' HD2' ' A' ' 294' ' ' PRO . 40.3 m-20 -115.11 138.18 23.36 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 116.481 -0.327 . . . . 72.1 110.232 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -61.88 -37.8 63.65 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 C-N-CA 123.137 2.558 . . . . 70.21 117.782 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 292' ' ' ASP . 33.3 Cg_endo -76.6 -27.3 7.63 Favored 'Trans proline' 0 C--N 1.392 2.824 0 CA-C-N 123.645 2.337 . . . . 71.21 112.999 -172.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.5 m -59.57 -27.94 66.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.258 1.023 . . . . 73.25 111.738 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.1 -39.28 82.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.506 0.723 . . . . 71.55 112.892 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -75.07 -32.77 61.57 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.821 0.343 . . . . 65.21 111.116 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.17 79.99 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.156 -0.475 . . . . 51.24 110.314 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.13 68.04 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.152 -0.476 . . . . 63.13 112.204 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.8 mt -67.41 -30.56 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 O-C-N 122.164 -0.335 . . . . 64.32 110.582 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -59.73 2.66 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 113.904 1.076 . . . . 60.45 113.904 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -90.73 -37.48 13.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.272 1.953 . . . . 73.43 116.272 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -82.42 -21.12 35.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.304 0.573 . . . . 75.24 110.436 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 315' ' ' VAL . 13.9 t70 -83.85 -172.52 4.2 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.083 -0.962 . . . . 62.22 109.971 168.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 80.86 11.8 83.44 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.854 -0.529 . . . . 42.21 113.106 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 -159.21 0.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.481 -0.563 . . . . 74.33 109.481 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.84 145.2 51.41 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.597 0.713 . . . . 74.45 110.784 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -112.35 113.57 25.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.485 -1.302 . . . . 72.12 107.485 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.1 m170 64.41 28.51 13.6 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 124.455 1.097 . . . . 74.24 112.663 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.77 3.37 88.14 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.408 -0.36 . . . . 73.52 113.458 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -112.87 141.47 46.65 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.739 -0.837 . . . . 63.4 108.739 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.21 127.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.966 0.413 . . . . 63.35 110.462 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.6 tt -108.5 144.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.764 -0.653 . . . . 55.13 109.629 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 39.1 tptt -136.5 121.12 18.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.993 -0.548 . . . . 72.23 109.95 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 304' ' ' ASP . 8.2 p -107.65 136.74 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.489 -0.778 . . . . 65.12 109.892 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 m -138.08 174.15 10.87 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 124.146 0.978 . . . . 71.13 110.13 -173.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -7.25 59.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.632 0.975 . . . . 74.34 113.632 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 69.73 8.53 6.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.593 1.331 . . . . 70.41 114.593 172.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m 65.83 121.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.858 1.263 . . . . 64.43 111.724 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -84.86 93.77 8.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.661 -0.7 . . . . 74.14 111.056 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -166.56 88.86 0.82 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.568 0.747 . . . . 64.43 111.545 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -80.97 94.34 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.195 1.264 . . . . 64.34 113.326 171.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.351 -0.84 . . . . 63.34 109.875 177.925 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.964 0 N-CA-C 112.317 -0.313 . . . . 60.54 112.317 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.5 m -129.7 -49.53 1.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.465 0.174 . . . . 64.32 111.374 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -125.55 125.54 43.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.544 0.211 . . . . 52.31 110.556 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.5 mtt -143.86 30.76 1.31 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.424 -0.353 . . . . 73.22 111.894 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 151.66 38.17 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.895 -0.409 . . . . 54.02 109.895 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.3 -5.7 55.97 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.577 0.548 . . . . 73.34 109.807 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -76.39 107.51 8.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.458 -0.792 . . . . 74.41 110.26 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 103.95 16.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.905 -0.718 . . . . 71.45 110.24 162.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.9 m -142.27 144.87 33.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.948 -1.501 . . . . 61.31 106.948 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 11.8 pt -123.59 141.26 44.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 119.406 1.003 . . . . 73.22 109.689 168.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.519 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.5 OUTLIER -101.53 122.53 43.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.677 -0.86 . . . . 72.42 108.677 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.9 141.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.087 -0.709 . . . . 71.0 109.087 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 13.1 mm-40 -128.15 151.03 49.71 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.489 0.716 . . . . 72.32 110.516 -177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 312' ' ' ILE . . . 90.9 21.48 36.12 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 124.158 0.911 . . . . 71.31 113.638 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 76.92 1.0 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.79 -1.189 . . . . 60.24 107.79 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.68 -90.93 0.42 Allowed Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.587 -0.816 . . . . 63.23 113.753 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.68 112.9 16.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.929 0.395 . . . . 70.21 110.791 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.59 20.15 25.41 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.321 -0.854 . . . . 74.43 111.996 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -87.29 151.83 3.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.681 -0.489 . . . . 75.33 109.681 -173.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.2 m -93.55 170.63 9.45 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.0 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -165.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.344 2.258 . . . . 73.11 114.233 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -42.89 -14.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 127.384 2.273 . . . . 73.32 114.819 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -46.93 -22.08 0.28 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.671 1.988 . . . . 64.3 114.723 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -57.46 -32.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 119.341 0.973 . . . . 63.4 110.699 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.86 85.93 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 120.065 -0.297 . . . . 62.24 113.463 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 37.4 tt0 -73.47 -31.47 63.78 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.39 0.676 . . . . 71.45 111.23 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.9 t80 -56.8 -43.44 80.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.144 0.578 . . . . 72.23 111.298 170.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -79.04 -24.46 43.6 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.471 0.545 . . . . 74.34 112.471 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 13.2 tptm -63.01 -23.17 67.33 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.356 1.062 . . . . 72.34 111.681 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.15 -20.38 65.95 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.63 0.604 . . . . 75.43 112.63 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.5 mm -123.61 41.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 121.419 0.628 . . . . 65.5 110.233 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 150.64 -168.81 30.49 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 118.835 -1.65 . . . . 65.54 115.02 172.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.29 136.56 37.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.372 -0.414 . . . . 63.2 110.573 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 38.3 mm -67.46 115.25 5.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.86 -1.064 . . . . 73.51 110.027 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -98.18 140.54 32.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.505 0.669 . . . . 73.22 111.3 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.7 m -84.35 116.71 23.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.688 -1.142 . . . . 73.14 108.074 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.67 126.64 31.19 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 109.132 -0.692 . . . . 72.21 109.132 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -74.98 -6.32 48.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.229 1.196 . . . . 75.42 114.229 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.97 -33.47 74.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.23 0.212 . . . . 72.53 111.147 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.38 -29.33 3.25 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.729 0.299 . . . . 72.21 111.511 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 91.5 11.02 61.3 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.194 -0.457 . . . . 62.13 112.811 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.46 ' H ' HG23 ' A' ' 266' ' ' THR . 73.9 mttt -98.62 151.53 37.49 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 122.933 0.493 . . . . 73.24 112.182 173.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.99 155.52 63.96 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 123.981 3.12 . . . . 64.11 112.837 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.466 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -70.35 98.91 1.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.03 1.122 . . . . 71.35 114.03 -173.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.5 mm -144.19 113.07 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.224 -1.398 . . . . 74.01 107.224 164.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -128.7 115.05 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 119.262 0.937 . . . . 71.24 109.891 161.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.69 111.21 21.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.957 0.408 . . . . 64.23 110.083 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 62.2 m-85 -103.54 111.53 24.02 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 121.356 0.598 . . . . 71.42 110.39 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.442 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.2 p -143.2 122.51 13.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.027 -1.442 . . . . 63.3 110.136 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.7 112.02 20.65 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.207 0.527 . . . . 62.15 111.497 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.21 -9.82 54.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.146 0.795 . . . . 54.11 113.146 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -28.65 56.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.566 0.222 . . . . 65.51 110.582 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 56.8 p -88.69 -21.04 24.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.375 0.607 . . . . 62.14 109.454 169.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.32 -12.14 70.29 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 114.932 -1.031 . . . . 75.11 112.944 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -121.08 140.26 30.72 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 110.184 -0.302 . . . . 72.22 110.184 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.47 133.5 55.06 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 123.187 2.591 . . . . 70.24 114.209 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.4 mttt -62.12 -34.37 76.23 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.798 -1.092 . . . . 65.41 112.357 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.34 24.46 18.89 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.94 -0.648 . . . . 43.05 112.723 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 35.9 mt-10 -119.35 142.1 48.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.764 -0.774 . . . . 74.31 109.901 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.59 143.04 23.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.264 -0.643 . . . . 40.52 109.264 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 237' ' ' PHE . 62.4 p -128.43 139.62 52.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.289 -0.634 . . . . 75.32 109.289 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.89 144.47 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 120.947 0.404 . . . . 52.35 110.17 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 270' ' ' MET . 43.3 t -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.49 0.716 . . . . 61.04 112.041 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.82 164.97 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.658 -0.246 . . . . 75.15 111.422 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.11 -48.05 63.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.117 0.567 . . . . 75.02 112.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -122.23 136.45 26.42 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.641 -0.874 . . . . 72.24 108.641 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.9 -37.9 62.68 Favored 'Trans proline' 0 CA--C 1.567 2.151 0 C-N-CA 123.099 2.532 . . . . 65.2 117.462 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 -29.01 18.08 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.762 2.379 . . . . 61.12 113.238 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.0 m -60.04 -29.02 68.23 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.306 1.043 . . . . 74.45 112.063 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.49 -38.61 81.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.639 0.775 . . . . 61.43 112.759 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -74.36 -36.01 63.57 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.258 0.551 . . . . 74.43 111.126 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.75 81.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.074 -0.967 . . . . 73.31 110.929 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.72 -29.66 68.13 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 123.583 0.552 . . . . 64.34 111.976 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 296' ' ' ALA . 78.9 mt -63.29 -34.72 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 117.772 0.26 . . . . 75.02 110.713 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.41 -60.05 2.52 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 114.19 1.181 . . . . 71.52 114.19 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.44 -34.05 15.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.194 1.924 . . . . 73.54 116.194 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.441 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 60.3 t80 -85.65 -18.47 33.14 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.191 0.52 . . . . 65.4 110.167 -171.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -107.59 -175.51 2.81 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.339 -0.986 . . . . 73.12 108.339 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.45 56.42 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.679 -0.296 . . . . 62.22 112.378 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.56 -153.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.939 -0.393 . . . . 75.53 109.939 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -120.68 146.24 46.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.82 0.448 . . . . 72.12 110.783 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -113.7 110.76 20.71 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.68 -1.23 . . . . 63.01 107.68 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 18.8 m170 64.96 29.64 12.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.638 1.175 . . . . 73.11 112.245 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.14 83.84 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.394 -0.366 . . . . 74.41 113.98 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -110.22 148.72 31.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 117.222 0.511 . . . . 64.43 110.159 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ILE . . . . . 0.406 ' O ' ' HA3' ' A' ' 240' ' ' GLY . 46.6 mm -68.78 126.0 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 123.467 0.48 . . . . 74.51 110.767 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.22 142.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.939 -0.573 . . . . 72.14 109.944 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -136.42 129.84 31.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 71.43 111.034 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.91 137.33 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.201 0.524 . . . . 62.44 109.75 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -136.38 172.94 12.28 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.102 0.961 . . . . 71.23 109.451 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.77 -4.66 55.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.193 0.812 . . . . 74.05 113.193 174.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.56 -165.22 0.24 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.914 1.286 . . . . 73.34 112.883 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 171.84 12.18 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.677 -0.692 . . . . 63.34 109.377 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -75.53 -170.72 1.32 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.676 0.621 . . . . 75.41 112.676 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -60.09 151.09 67.78 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.247 1.019 . . . . 73.42 112.501 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.14 90.37 0.26 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.423 2.748 . . . . 74.42 112.706 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 125.481 1.512 . . . . 72.3 111.989 -175.897 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 119.612 -0.549 . . . . 71.11 113.007 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.0 p 55.41 19.9 3.35 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 126.144 1.778 . . . . 64.13 115.303 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 63.65 174.21 0.17 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.442 1.497 . . . . 74.23 113.062 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 8.5 ptm -152.43 83.02 1.24 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.983 -0.553 . . . . 63.34 111.209 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.2 p -166.47 127.23 1.69 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.605 -0.725 . . . . 70.21 111.443 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.71 -15.62 53.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.523 -0.762 . . . . 73.42 110.06 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.9 106.78 2.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.359 -0.837 . . . . 51.24 111.201 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.8 105.66 17.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.495 -0.482 . . . . 75.34 110.186 162.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -142.25 150.25 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.066 -1.457 . . . . 64.21 107.066 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.23 137.22 57.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 119.154 0.888 . . . . 65.45 109.837 165.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.666 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.91 116.94 33.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.789 -0.819 . . . . 73.24 108.789 -177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.02 139.7 36.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.42 -0.585 . . . . 71.01 109.42 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 6.2 tp-100 -128.9 142.71 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.761 -0.829 . . . . 65.11 108.761 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.8 20.75 11.09 Favored Glycine 0 N--CA 1.462 0.371 0 C-N-CA 121.139 -0.553 . . . . 53.32 112.464 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.72 73.06 0.8 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.55 -0.907 . . . . 70.44 108.55 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.86 -178.44 26.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.477 -0.783 . . . . 71.03 112.018 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 282' ' ' PRO 0.261 12.0 pt-20 40.84 87.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.833 2.053 . . . . 45.52 114.845 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.18 21.11 25.95 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.008 -0.837 . . . . 65.15 111.008 -173.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.94 151.59 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.242 -0.651 . . . . 71.23 109.242 -173.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.6 m -84.61 168.69 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.76 -0.655 . . . . 74.53 110.23 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -169.13 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.618 1.967 . . . . 74.44 113.07 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -44.11 -12.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 126.422 1.889 . . . . 75.44 115.468 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.09 -23.17 0.28 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.314 1.846 . . . . 71.15 113.701 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -57.78 -31.33 39.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 109.585 -0.524 . . . . 73.54 109.585 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.07 83.68 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-O 119.907 -0.385 . . . . 60.14 113.438 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -76.1 -29.65 57.99 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.243 0.617 . . . . 74.34 111.241 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.8 t80 -55.5 -44.56 76.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.498 0.719 . . . . 73.13 110.419 169.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -77.82 -24.54 48.68 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.685 0.254 . . . . 74.12 111.685 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 260' ' ' ILE . 10.9 tmtt? -68.98 -18.78 64.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.585 0.754 . . . . 74.32 111.292 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -62.86 -22.12 66.46 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 122.297 -0.252 . . . . 73.13 110.802 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -122.83 63.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.369 -0.604 . . . . 70.31 109.369 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.07 -172.84 26.59 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 118.803 -1.665 . . . . 33.54 115.366 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.48 138.48 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.165 -1.018 . . . . 73.14 109.62 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 255' ' ' LYS . 47.7 mm -70.35 116.05 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.272 0.558 . . . . 71.11 110.373 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -96.42 140.15 31.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 72.33 111.404 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 89.7 m -86.0 117.5 24.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.132 -0.94 . . . . 74.43 108.597 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -72.75 136.97 45.59 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.42 -0.354 . . . . 71.24 111.069 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -78.76 -9.39 59.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.003 0.742 . . . . 64.24 113.003 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.43 -39.56 77.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.011 0.374 . . . . 64.25 112.011 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 t -126.25 -19.4 4.71 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.532 0.206 . . . . 73.15 111.359 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.49 57.17 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.519 -0.309 . . . . 74.14 113.063 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -99.93 153.91 37.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.99 0.367 . . . . 74.41 111.99 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.41 153.06 76.89 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.056 2.504 . . . . 64.0 111.723 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.463 ' HE3' ' HB ' ' A' ' 288' ' ' VAL . 1.4 ptm -76.73 100.15 5.33 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.162 0.801 . . . . 71.53 113.162 -171.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.5 mm -143.14 113.92 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.129 -1.434 . . . . 74.34 107.129 165.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -128.13 117.61 21.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 119.177 0.898 . . . . 75.53 109.815 162.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.53 112.74 23.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 64.2 110.218 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 61.8 m-85 -101.62 111.68 24.01 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-N 115.907 -0.588 . . . . 54.53 109.663 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.2 p -143.74 122.07 12.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.317 -1.311 . . . . 73.34 109.231 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.49 110.7 18.87 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.256 0.55 . . . . 62.21 111.043 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -7.43 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.213 0.82 . . . . 63.22 113.213 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -32.43 70.09 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.252 0.345 . . . . 72.34 110.816 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -91.88 -19.18 22.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.984 -0.553 . . . . 74.44 110.149 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 102.27 -44.43 1.52 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.004 -0.543 . . . . 70.03 112.911 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -81.95 142.1 48.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.587 0.227 . . . . 54.14 111.187 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 243' ' ' GLU . 10.1 Cg_endo -58.69 130.86 39.06 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.909 2.406 . . . . 51.04 113.508 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -59.98 -39.12 84.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.926 -1.034 . . . . 70.14 112.165 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.9 25.23 15.24 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.668 -0.777 . . . . 62.21 113.076 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 37.3 mt-10 -118.81 143.56 46.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.101 0.451 . . . . 73.52 110.084 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.13 143.36 23.26 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.455 0.302 . . . . 61.43 110.341 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.6 p -125.53 138.86 53.98 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 122.074 -0.391 . . . . 71.44 110.296 173.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.463 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 7.4 m -136.86 148.06 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.992 -0.373 . . . . 75.21 109.992 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.432 ' H ' ' CB ' ' A' ' 270' ' ' MET . 49.8 m -108.44 117.48 34.27 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.978 0.733 . . . . 51.02 112.978 -172.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.44 163.94 19.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.759 0.424 . . . . 72.2 111.897 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.2 -48.42 20.47 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 116.536 -0.302 . . . . 61.01 110.686 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.01 135.61 23.41 Favored Pre-proline 0 C--O 1.239 0.548 0 O-C-N 123.203 0.314 . . . . 74.32 110.743 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.81 -41.16 19.08 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 122.802 2.334 . . . . 62.43 116.813 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.58 -29.74 52.15 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 122.946 2.088 . . . . 74.42 113.806 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 49.8 m -64.29 -27.42 69.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.099 0.96 . . . . 71.43 112.465 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.19 88.75 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 122.841 0.457 . . . . 71.14 111.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.62 -39.68 88.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.153 0.581 . . . . 63.31 110.349 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.86 76.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.521 -0.763 . . . . 75.21 111.448 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.92 -33.14 73.26 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.709 0.404 . . . . 71.12 111.623 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 75.2 mt -64.8 -33.41 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.849 0.357 . . . . 71.24 110.603 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.49 -60.33 2.4 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.766 1.024 . . . . 75.14 113.766 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -91.72 -31.84 15.65 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.867 1.803 . . . . 73.2 115.867 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 72.2 t80 -87.49 -14.79 39.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.371 0.605 . . . . 73.22 109.937 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -104.89 173.81 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.337 -0.986 . . . . 74.24 108.337 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.28 14.21 51.83 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.731 -0.747 . . . . 71.23 112.228 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -131.25 -156.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.699 -0.852 . . . . 71.42 108.699 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -132.84 148.77 52.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.618 0.723 . . . . 65.5 111.011 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -113.61 117.7 32.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.4 m170 64.69 28.47 13.08 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.722 1.209 . . . . 61.34 112.17 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.07 86.52 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.405 -0.361 . . . . 72.11 113.762 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.55 144.84 42.19 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 109.197 -0.668 . . . . 72.24 109.197 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.65 130.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.165 0.507 . . . . 64.42 111.673 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.5 tt -110.43 142.51 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.324 -0.853 . . . . 74.22 110.023 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -136.86 126.87 25.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.236 0.614 . . . . 61.53 111.341 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 31.6 t -108.7 138.83 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.276 -0.42 . . . . 74.01 110.877 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -134.95 176.61 8.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 63.55 110.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.77 -11.58 59.83 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.97 1.1 . . . . 71.32 113.97 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 237' ' ' PHE . . . 67.32 -170.08 0.19 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.289 1.036 . . . . 65.55 113.319 176.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.85 158.94 19.83 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.103 -0.953 . . . . 74.24 110.136 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -91.36 147.92 22.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.101 -0.5 . . . . 72.24 109.867 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 74.32 165.28 0.13 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 124.622 1.201 . . . . 72.53 113.669 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.52 -170.87 0.8 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.381 2.054 . . . . 65.04 113.515 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.786 -1.097 . . . . 51.52 110.976 -177.069 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 111.831 -0.508 . . . . 61.12 111.831 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 14.3 m -116.88 48.57 1.28 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.739 0.304 . . . . 64.45 110.826 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 62.95 23.02 13.78 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.715 1.206 . . . . 75.2 112.088 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 19.5 mmt 54.68 69.33 0.74 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.228 1.411 . . . . 45.55 112.127 -174.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 24.1 p -88.67 120.49 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.21 -0.905 . . . . 71.53 111.551 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.06 -19.73 61.78 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.143 -0.935 . . . . 62.23 110.605 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.11 101.72 4.66 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.222 -0.899 . . . . 71.11 110.382 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.47 103.96 15.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 118.623 -1.231 . . . . 74.4 110.477 160.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -143.03 149.0 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.241 -1.392 . . . . 52.31 107.241 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.0 pt -125.18 139.46 51.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 118.8 0.727 . . . . 53.15 109.605 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.663 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.51 120.52 39.78 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.987 -0.746 . . . . 73.43 108.987 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.81 138.19 45.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.962 -0.563 . . . . 74.32 109.973 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -128.54 144.32 51.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 72.0 110.984 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.17 20.78 11.76 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.878 0.736 . . . . 63.54 112.969 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.48 75.08 0.92 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.602 -0.888 . . . . 71.42 108.602 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -127.31 -97.16 0.96 Allowed Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.524 -0.846 . . . . 63.11 113.565 -170.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -76.74 117.07 17.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.853 0.358 . . . . 64.52 111.104 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.17 19.66 30.04 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.218 -0.901 . . . . 72.31 111.675 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.22 151.29 4.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.357 0.599 . . . . 41.32 109.494 -174.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.9 t -93.46 170.61 9.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.235 -0.654 . . . . 72.55 109.235 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -167.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.489 2.316 . . . . 70.03 113.379 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -44.44 -12.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 126.497 1.919 . . . . 73.34 115.253 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.3 -23.04 0.49 Allowed 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 126.692 1.997 . . . . 73.43 112.892 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -31.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-N 118.653 0.661 . . . . 70.1 109.523 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.29 -35.48 88.34 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.248 -0.751 . . . . 41.4 114.383 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -75.77 -28.21 58.33 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 117.961 0.881 . . . . 72.23 110.832 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.586 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 6.7 t80 -55.66 -47.35 76.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.013 0.925 . . . . 65.21 110.671 171.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.59 -23.36 46.03 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.057 0.391 . . . . 75.34 112.057 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 11.5 tptm -61.3 -26.21 67.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.387 1.075 . . . . 74.43 111.221 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.84 -19.73 64.39 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 111.905 0.335 . . . . 74.24 111.905 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.1 mm -124.23 62.62 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 109.598 -0.519 . . . . 73.1 109.598 170.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.76 -174.09 25.86 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 118.621 -1.752 . . . . 72.34 115.056 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.18 137.74 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.121 -0.696 . . . . 73.31 109.121 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.1 mm -71.48 113.22 7.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.298 0.571 . . . . 55.22 110.391 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -99.66 140.05 34.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.998 -1.001 . . . . 73.22 110.991 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 59.2 m -85.07 116.38 23.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.066 -0.97 . . . . 74.24 108.606 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.16 131.1 41.62 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.086 0.554 . . . . 75.12 110.213 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.7 -7.03 55.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.42 0.896 . . . . 54.34 113.42 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.25 -35.95 80.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.745 0.307 . . . . 72.15 111.108 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.8 p -125.25 -33.56 2.84 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.029 -0.532 . . . . 64.33 111.927 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.76 11.41 65.76 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.959 -0.564 . . . . 64.13 111.927 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -97.35 150.83 37.23 Favored Pre-proline 0 C--O 1.239 0.528 0 C-N-CA 123.238 0.615 . . . . 74.45 110.877 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.87 153.92 74.28 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.998 2.466 . . . . 72.32 111.241 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.471 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -73.22 101.19 3.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.645 0.979 . . . . 75.24 113.645 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -143.2 113.32 2.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.139 -1.391 . . . . 64.42 107.342 163.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -127.6 113.71 16.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 119.182 0.901 . . . . 64.1 109.768 163.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 110.53 20.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.205 -0.294 . . . . 72.33 110.205 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 36.3 m-85 -103.0 111.54 23.93 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 121.266 0.555 . . . . 72.42 110.156 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 20.9 p -145.0 120.98 10.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.984 -1.462 . . . . 54.13 109.624 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -87.47 112.67 22.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.462 0.648 . . . . 62.52 111.762 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -10.23 55.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.167 -0.47 . . . . 74.13 112.22 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.363 0.415 . . . . 61.22 111.191 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.2 p -90.81 -20.45 22.31 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.337 0.589 . . . . 70.51 109.892 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 85.62 7.73 81.39 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.077 -0.965 . . . . 62.45 112.697 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 139.99 25.95 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 110.338 -0.245 . . . . 71.12 110.338 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -58.97 130.75 38.04 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.185 2.59 . . . . 53.34 113.893 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.488 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 40.9 mtpt -63.16 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.874 -1.057 . . . . 75.21 111.992 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.78 14.86 Favored Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.436 -0.802 . . . . 74.01 112.671 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.7 mt-10 -115.48 140.65 48.96 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.212 -0.595 . . . . 74.43 110.239 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.96 143.16 22.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.106 -0.497 . . . . 73.31 109.893 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 237' ' ' PHE . 72.3 p -128.98 139.78 51.95 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.756 -0.377 . . . . 73.54 110.538 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.45 147.63 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 121.176 0.512 . . . . 45.34 110.433 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.471 ' H ' ' CB ' ' A' ' 270' ' ' MET . 44.3 t -94.29 128.03 40.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.729 0.812 . . . . 74.32 112.583 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.28 165.78 12.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.678 0.621 . . . . 75.13 112.678 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -42.37 59.61 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.573 0.546 . . . . 61.51 111.661 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 136.96 29.83 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 109.843 -0.429 . . . . 72.13 109.843 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -59.94 -37.19 87.11 Favored 'Trans proline' 0 CA--C 1.562 1.92 0 C-N-CA 123.53 2.82 . . . . 73.4 117.203 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 -29.75 10.71 Favored 'Trans proline' 0 C--N 1.392 2.825 0 CA-C-N 123.321 2.222 . . . . 64.24 112.691 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 33.6 m -62.97 -32.75 74.15 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.158 0.983 . . . . 64.0 111.315 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.74 83.71 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.011 0.819 . . . . 41.03 111.822 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -48.18 78.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.376 0.422 . . . . 75.23 111.268 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.78 97.53 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 123.714 0.634 . . . . 74.43 110.862 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.85 68.15 Favored 'General case' 0 C--O 1.184 -2.389 0 CA-C-N 115.283 -0.871 . . . . 64.32 111.156 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.19 -34.47 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.128 0.571 . . . . 73.33 112.428 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.28 -54.91 22.14 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.688 0.625 . . . . 72.34 112.688 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -27.26 19.22 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.248 2.314 . . . . 74.44 117.248 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.57 -20.39 39.98 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.175 0.99 . . . . 75.34 112.038 -170.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.8 166.65 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.213 -0.662 . . . . 75.2 109.213 175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.98 12.87 54.8 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.156 -0.545 . . . . 73.43 112.627 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -122.05 -159.37 0.82 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.29 -1.004 . . . . 74.42 108.29 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -130.56 143.02 50.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.555 0.693 . . . . 52.14 111.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -113.14 110.73 20.92 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.14 -1.059 . . . . 73.12 108.14 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.3 m170 64.33 30.11 13.43 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.516 1.135 . . . . 74.33 112.095 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.76 84.46 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 114.369 0.507 . . . . 62.53 114.369 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.2 147.39 37.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.548 -0.538 . . . . 70.53 109.548 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.69 124.92 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.177 0.513 . . . . 73.31 111.202 -172.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 134.83 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.403 -0.817 . . . . 73.22 110.65 -174.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -130.56 145.22 51.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.856 -0.611 . . . . 62.23 111.017 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.42 140.08 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.984 -0.553 . . . . 73.14 109.903 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -133.48 176.5 8.48 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.1 0.96 . . . . 64.52 109.984 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -83.13 -8.61 59.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.596 0.962 . . . . 73.34 113.596 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 66.93 -162.35 0.23 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.332 1.053 . . . . 64.5 112.61 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 14.5 t -90.33 172.95 8.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.59 -0.522 . . . . 63.42 109.59 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -81.48 -175.07 5.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 70.45 112.087 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.32 149.0 84.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.138 -0.937 . . . . 75.42 112.844 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.91 115.55 2.7 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.603 2.869 . . . . 73.03 113.381 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.037 -0.983 . . . . 63.41 110.225 -175.3 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.442 -0.263 . . . . 60.11 112.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.0 t -156.27 164.08 38.77 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.025 -0.361 . . . . 74.34 110.025 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -114.7 145.16 42.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.266 -0.424 . . . . 74.24 110.683 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.455 ' SD ' ' HB2' ' A' ' 293' ' ' PRO . 2.5 ptp -136.83 28.84 2.9 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.133 -0.485 . . . . 74.22 110.184 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 54.8 m 75.44 144.74 0.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.021 1.728 . . . . 73.23 111.519 -171.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.99 -2.28 58.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.203 0.525 . . . . 74.13 111.079 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.96 106.84 13.28 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.885 -0.598 . . . . 64.52 109.448 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.0 106.4 18.49 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.529 -0.868 . . . . 62.3 110.34 168.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.9 m -142.05 142.21 32.84 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.532 -0.914 . . . . 71.03 108.532 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 pt -121.83 138.97 50.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 119.897 -0.721 . . . . 72.04 110.241 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.7 120.66 40.95 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.818 -0.628 . . . . 63.51 109.928 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -112.82 142.82 23.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.87 0.843 . . . . 74.43 113.046 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 10.0 mm-40 -127.32 151.99 48.04 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.1 -1.864 . . . . 55.41 109.493 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.81 16.95 46.34 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.171 -0.537 . . . . 74.35 113.172 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 286' ' ' ALA . 0.5 OUTLIER -106.07 64.15 0.67 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.659 0.743 . . . . 61.21 109.273 172.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -106.03 -103.89 2.9 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 115.348 -0.842 . . . . 31.32 112.951 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.86 119.6 17.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.547 0.689 . . . . 74.51 112.415 -173.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.24 18.96 29.56 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.634 -1.166 . . . . 61.35 111.694 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.01 151.94 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.129 0.49 . . . . 72.21 109.804 -172.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.3 m -90.64 170.46 10.14 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.691 -0.686 . . . . 60.24 109.619 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -167.75 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.637 1.975 . . . . 73.1 114.239 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -43.38 -12.91 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 C-N-CA 126.148 1.779 . . . . 73.53 115.444 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -46.78 -20.99 0.16 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 126.26 1.824 . . . . 74.34 114.243 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -55.72 -32.7 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.454 0.57 . . . . 73.44 110.491 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.71 81.66 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 119.953 -0.359 . . . . 74.22 113.611 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.95 -31.52 64.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.023 0.929 . . . . 55.34 111.003 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.0 t80 -58.61 -44.79 90.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.873 0.869 . . . . 63.22 110.887 171.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -76.87 -24.37 52.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 121.196 -0.202 . . . . 73.54 111.32 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -73.05 -15.91 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.497 0.719 . . . . 71.1 111.342 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.82 -17.68 64.81 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.805 -0.559 . . . . 73.34 111.12 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.06 58.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 109.377 -0.601 . . . . 74.52 109.377 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.71 -179.05 26.81 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 119.903 -1.142 . . . . 70.03 114.692 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 11.8 mt -106.73 139.7 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.435 0.694 . . . . 64.44 110.326 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.85 114.76 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.958 -0.564 . . . . 75.23 110.437 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.87 138.36 35.33 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.423 -0.808 . . . . 61.31 110.342 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 57.7 m -84.45 116.12 22.91 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.836 -1.172 . . . . 75.41 107.836 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.48 128.35 35.33 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 109.323 -0.621 . . . . 63.43 109.323 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -78.57 -8.38 58.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.128 0.788 . . . . 72.51 113.128 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -68.97 -29.88 68.19 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.54 0.2 . . . . 62.0 111.54 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 268' ' ' LYS . 4.8 t -125.46 -30.07 3.15 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 111.643 0.238 . . . . 74.22 111.643 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.79 13.61 60.72 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.566 -0.288 . . . . 15.12 113.027 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.439 ' H ' HG23 ' A' ' 266' ' ' THR . 7.9 mptt -99.18 152.71 37.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 122.852 0.461 . . . . 73.44 112.093 173.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.46 154.78 66.38 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.579 2.853 . . . . 65.41 111.695 165.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.544 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -77.83 98.64 5.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.31 0.856 . . . . 75.1 113.31 -168.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 36.4 mm -143.43 113.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 75.54 107.253 165.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -129.36 114.45 16.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.836 0.743 . . . . 75.21 109.909 161.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.91 111.29 21.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.962 -0.385 . . . . 74.34 109.962 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 37.8 m-85 -103.63 113.23 26.59 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 115.972 -0.558 . . . . 71.41 110.774 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.451 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.3 p -142.4 123.79 14.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.469 -1.242 . . . . 55.45 110.337 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.85 112.52 21.21 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.272 0.558 . . . . 72.21 111.763 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -86.83 -10.93 52.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.622 0.971 . . . . 55.02 113.622 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.28 -34.55 61.33 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.998 0.428 . . . . 74.24 110.652 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -90.33 -15.25 31.5 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.705 -0.68 . . . . 70.13 109.716 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.16 -45.06 1.61 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.874 -0.603 . . . . 72.45 113.111 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -83.85 141.85 41.5 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 111.854 0.316 . . . . 73.43 111.854 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 136.96 72.28 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.345 2.697 . . . . 64.14 113.848 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 275' ' ' THR . 37.6 mttt -68.79 -33.4 73.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.027 -0.988 . . . . 73.12 111.621 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.85 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.729 -0.669 . . . . 33.53 113.081 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 47.7 mt-10 -115.5 143.21 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.944 -0.391 . . . . 65.31 109.944 -171.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -152.01 155.37 37.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.386 . . . . 75.52 111.05 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.3 p -131.12 135.42 47.47 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.76 -0.459 . . . . 73.34 109.76 165.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.491 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 11.4 m -137.06 148.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 109.055 -0.72 . . . . 74.34 109.055 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.544 ' H ' ' CB ' ' A' ' 270' ' ' MET . 17.4 m -114.15 119.41 36.99 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.038 0.755 . . . . 54.24 113.038 -168.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.95 165.14 17.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.269 0.84 . . . . 63.32 113.269 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.53 -47.24 34.03 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.811 -1.086 . . . . 74.21 111.087 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 137.66 21.53 Favored Pre-proline 0 C--O 1.237 0.402 0 O-C-N 123.523 0.515 . . . . 54.14 110.701 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.455 ' HB2' ' SD ' ' A' ' 230' ' ' MET . 10.2 Cg_endo -61.55 -38.75 60.23 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.192 2.594 . . . . 52.13 117.246 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.87 -29.79 22.81 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 123.185 2.173 . . . . 53.44 113.047 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -61.41 -28.37 69.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.336 1.054 . . . . 63.01 112.078 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -70.39 -43.49 69.97 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -73.73 -34.15 64.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.346 0.593 . . . . 75.11 111.054 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.53 -32.43 71.25 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.569 -0.741 . . . . 73.32 110.444 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.48 -27.71 65.45 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 122.297 0.239 . . . . 65.41 111.204 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 296' ' ' ALA . 44.9 mt -66.98 -32.3 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 121.881 -0.512 . . . . 64.03 110.702 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.06 -59.09 2.92 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.09 1.144 . . . . 71.42 114.09 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -36.35 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.606 1.706 . . . . 70.03 115.606 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -84.9 -22.99 29.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.437 0.295 . . . . 72.42 110.452 -168.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -85.59 -177.11 6.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.715 -0.675 . . . . 74.52 110.238 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.21 3.83 84.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 114.191 0.437 . . . . 61.11 114.191 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -123.48 -154.47 0.61 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.611 -0.514 . . . . 73.24 109.611 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.96 140.74 52.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.43 0.633 . . . . 64.53 110.958 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -114.22 111.28 21.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.136 -1.431 . . . . 73.5 107.136 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 20.6 m170 64.85 30.52 12.1 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.818 1.247 . . . . 73.15 112.672 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.2 10.54 77.76 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 116.298 -0.41 . . . . 74.31 113.875 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -126.72 148.62 49.86 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.269 -0.641 . . . . 74.5 109.269 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.62 130.76 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 123.523 0.515 . . . . 73.13 110.628 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.5 tt -107.75 143.32 18.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.824 -0.806 . . . . 73.11 108.824 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 4.3 tmtp? -135.95 122.55 20.89 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.292 -0.633 . . . . 63.22 109.292 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 238' ' ' VAL . 9.8 p -111.45 137.35 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.701 0.625 . . . . 74.23 109.608 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -138.21 173.5 11.55 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 123.177 0.591 . . . . 72.04 110.564 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -3.23 51.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.126 0.787 . . . . 71.42 113.126 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.1 -164.33 0.25 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.319 1.047 . . . . 52.53 113.183 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.51 163.66 13.13 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.669 -0.493 . . . . 74.23 109.669 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -88.03 149.65 23.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 73.42 109.684 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 71.4 167.26 0.12 Allowed Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 124.721 1.208 . . . . 75.41 112.406 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.94 100.22 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.114 1.209 . . . . 75.15 112.597 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.647 -0.706 . . . . 70.43 109.48 174.764 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 111.716 -0.554 . . . . 74.25 111.716 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.9 m 59.19 46.0 13.6 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.723 1.209 . . . . 61.34 113.624 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -74.93 134.95 41.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.121 -0.49 . . . . 71.14 111.728 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 58.4 mtt -122.4 108.25 12.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.334 -0.848 . . . . 75.11 110.152 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 66.1 m -137.98 154.24 49.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.44 -0.8 . . . . 55.35 110.228 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.01 -27.51 57.41 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.548 0.53 . . . . 73.14 110.264 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.9 119.39 19.02 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.234 -0.894 . . . . 62.24 110.653 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.81 106.83 18.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.192 0.52 . . . . 71.23 110.207 165.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.7 m -141.96 148.88 39.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.889 -1.152 . . . . 55.32 107.889 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.7 pt -122.69 141.24 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.722 0.692 . . . . 63.22 109.173 166.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.84 134.8 43.27 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -128.03 144.55 37.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.664 0.745 . . . . 74.41 112.637 178.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 11.9 mm-40 -127.04 147.11 50.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 113.988 -1.46 . . . . 75.31 109.773 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.13 32.75 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 123.823 0.702 . . . . 63.02 112.644 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 72.21 0.81 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.967 -1.123 . . . . 53.03 107.967 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.31 157.33 27.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.271 -0.877 . . . . 42.2 112.868 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.66 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.642 . . . . 71.4 113.062 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.71 21.64 36.21 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.198 -0.91 . . . . 14.45 111.04 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.48 150.1 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.535 -0.543 . . . . 63.23 109.535 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 24.6 m -88.55 170.35 10.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.74 -0.663 . . . . 64.15 110.831 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -169.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.547 1.939 . . . . 73.43 113.37 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -43.91 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 127.028 2.131 . . . . 71.11 116.074 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -48.31 -23.19 0.83 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 126.511 1.924 . . . . 74.12 113.77 170.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -57.4 -29.78 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.834 0.453 . . . . 72.1 110.63 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.31 -38.04 94.01 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.714 -0.492 . . . . 72.1 113.37 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.95 -30.56 66.88 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.795 0.838 . . . . 71.2 111.389 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.8 t80 -56.62 -45.87 81.25 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.83 0.852 . . . . 64.51 111.186 171.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -77.61 -22.64 50.48 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 122.055 -0.403 . . . . 75.05 111.53 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 260' ' ' ILE . 66.0 tttt -75.54 -10.63 59.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.527 1.131 . . . . 73.01 111.94 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.01 -16.72 62.26 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 121.807 -0.558 . . . . 62.23 111.523 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.1 mm -103.49 -48.19 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.458 0.703 . . . . 71.53 110.274 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -135.8 -159.51 8.55 Favored Glycine 0 C--O 1.22 -0.747 0 C-N-CA 120.769 -0.729 . . . . 73.31 113.428 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.9 mt -107.65 142.09 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.339 0.656 . . . . 73.14 111.754 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.7 mm -65.39 115.14 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 123.717 0.636 . . . . 75.5 110.142 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -98.08 140.11 32.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.453 -0.794 . . . . 65.12 111.369 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.0 m -85.52 117.75 24.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.106 -0.952 . . . . 72.24 108.478 168.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.1 125.79 29.9 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 109.062 -0.718 . . . . 72.42 109.062 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.8 -9.51 58.66 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.637 0.977 . . . . 54.11 113.637 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 -29.14 65.31 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 111.884 0.328 . . . . 65.13 111.884 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.6 t -124.16 -31.79 3.29 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.469 -0.332 . . . . 45.53 111.641 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.6 6.65 70.1 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 123.338 0.399 . . . . 64.12 112.679 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.432 ' H ' HG23 ' A' ' 266' ' ' THR . 52.8 mtpt -97.17 151.87 37.95 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.093 0.405 . . . . 75.54 112.093 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.93 154.06 75.55 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.523 2.815 . . . . 51.34 111.794 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.481 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.7 ptm -71.98 99.79 2.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.451 1.278 . . . . 65.22 114.451 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.4 mm -144.16 113.85 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.58 -1.266 . . . . 74.13 107.58 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -128.99 119.48 24.36 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.077 0.853 . . . . 63.53 110.57 161.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 113.07 25.18 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.376 0.422 . . . . 71.3 110.278 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.4 m-85 -102.35 112.68 25.48 Favored 'General case' 0 C--O 1.262 1.761 0 CA-C-O 121.31 0.576 . . . . 75.21 110.627 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.9 p -144.8 121.16 10.94 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.809 -1.541 . . . . 71.33 109.455 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.8 113.01 22.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.407 0.623 . . . . 63.24 111.719 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -8.72 58.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.715 1.006 . . . . 71.53 113.715 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -30.41 64.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 51.44 112.08 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -90.66 -19.03 24.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 120.735 -0.386 . . . . 73.12 110.185 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.5 22.93 38.39 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.951 -0.568 . . . . 74.02 113.802 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -146.82 147.69 30.62 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.744 -0.465 . . . . 74.12 109.744 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.38 126.75 22.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.047 1.831 . . . . 73.55 113.594 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 275' ' ' THR . 10.7 mttm -62.19 -40.11 94.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.88 -1.055 . . . . 74.24 111.628 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.95 25.15 15.24 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.812 -0.708 . . . . 63.42 111.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 78.2 mt-10 -119.03 143.75 46.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 64.21 109.609 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 158.64 44.26 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.623 -0.262 . . . . 62.52 111.179 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 19.4 p -136.18 137.78 41.25 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.104 -0.332 . . . . 60.21 110.104 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.12 147.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 116.356 -0.384 . . . . 64.44 110.461 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.481 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.3 t -99.1 117.49 33.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.309 0.644 . . . . 60.05 112.664 -174.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 162.81 16.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 121.154 -0.219 . . . . 71.24 110.867 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.88 -48.63 17.75 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.307 0.484 . . . . 44.53 112.307 -172.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.44 137.18 21.52 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.695 -0.402 . . . . 74.03 110.904 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.08 -38.02 80.28 Favored 'Trans proline' 0 CA--C 1.566 2.086 0 C-N-CA 123.265 2.644 . . . . 63.22 116.234 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.65 -30.89 41.62 Favored 'Trans proline' 0 C--N 1.396 3.043 0 CA-C-N 123.314 2.219 . . . . 55.11 113.177 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 39.7 m -69.76 -29.4 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.477 -0.783 . . . . 65.51 111.115 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.03 -41.75 58.61 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 122.956 0.502 . . . . 45.13 111.347 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -33.43 66.83 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 112.009 0.374 . . . . 72.11 112.009 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.21 75.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.354 -0.384 . . . . 75.05 110.675 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.44 -25.28 64.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.977 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.75 -33.64 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.132 -0.355 . . . . 71.04 110.489 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.97 -58.82 3.05 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 113.865 1.061 . . . . 74.44 113.865 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.56 -29.69 18.73 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.219 1.933 . . . . 73.12 116.219 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 75.0 t80 -89.03 -8.25 54.35 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 118.345 0.521 . . . . 53.41 111.017 -168.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 165.23 11.34 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 108.217 -1.031 . . . . 73.31 108.217 170.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.17 13.43 52.4 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.76 -0.734 . . . . 65.24 112.363 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -122.31 -160.5 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.495 -1.298 . . . . 63.41 107.495 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.09 143.27 46.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.474 0.654 . . . . 72.5 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -113.81 113.93 25.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.196 -1.039 . . . . 75.21 108.196 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.17 28.46 14.06 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.809 1.244 . . . . 74.22 112.593 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.14 74.7 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.568 -0.349 . . . . 71.23 113.831 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.74 143.52 51.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.419 -0.956 . . . . 65.23 108.419 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.94 127.68 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.88 0.372 . . . . 71.4 111.079 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.7 tt -109.78 137.62 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.025 -0.534 . . . . 72.34 111.101 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -130.48 128.42 41.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.77 -0.65 . . . . 74.32 111.051 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.97 130.49 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 122.99 0.516 . . . . 74.52 110.759 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -129.42 175.78 8.49 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.626 1.17 . . . . 71.12 109.414 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.83 -3.13 59.03 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.884 1.068 . . . . 74.3 113.884 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.04 -164.12 0.25 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.084 0.954 . . . . 62.24 113.128 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.5 m -99.46 144.82 28.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.471 -0.566 . . . . 71.21 109.471 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 174.95 5.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.882 -0.599 . . . . 71.13 109.641 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 71.77 88.84 0.09 OUTLIER Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.851 1.261 . . . . 73.12 112.297 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.07 101.58 1.01 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.499 2.133 . . . . 70.43 114.046 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.179 -0.915 . . . . 73.44 109.742 174.127 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.922 0 N-CA-C 112.231 -0.348 . . . . 75.35 112.231 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 66.9 m -112.64 -176.04 2.81 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.663 0.268 . . . . 60.52 111.424 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -137.47 120.7 16.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.597 -0.274 . . . . 72.5 110.87 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.71 78.05 1.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.873 0.845 . . . . 75.02 110.008 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.9 p -160.62 131.3 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.037 -0.983 . . . . 61.24 110.759 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -83.83 -36.14 23.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.524 -0.546 . . . . 51.11 109.524 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -76.24 123.56 26.08 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.292 -0.867 . . . . 73.4 110.427 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.75 106.83 18.78 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.395 0.616 . . . . 74.34 110.466 165.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.6 m -142.16 149.19 39.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.135 -1.061 . . . . 70.3 108.135 166.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.96 140.57 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.614 0.643 . . . . 74.32 109.533 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.07 135.04 43.18 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.037 -0.727 . . . . 70.11 109.037 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.775 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -126.61 143.68 39.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.626 0.727 . . . . 51.42 112.538 177.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 14.1 mm-40 -127.78 148.06 50.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.272 -1.331 . . . . 73.25 110.849 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.27 20.0 37.02 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 123.814 0.696 . . . . 71.45 113.186 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.775 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -113.09 74.14 0.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.684 -1.228 . . . . 62.03 107.684 177.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.22 -82.6 0.22 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.368 -0.92 . . . . 75.41 112.808 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 110.39 10.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.785 0.803 . . . . 63.33 111.532 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.73 19.88 33.18 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.079 -0.964 . . . . 73.2 111.566 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.95 151.94 4.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.719 -0.474 . . . . 53.13 109.719 -172.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.5 m -91.49 170.49 9.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.523 -0.762 . . . . 51.32 109.93 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.928 2.091 . . . . 72.32 113.971 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -43.85 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.606 1.962 . . . . 74.43 115.319 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.73 -21.47 0.2 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.636 1.975 . . . . 63.32 113.957 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -56.49 -31.53 34.04 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 CA-C-N 118.618 0.645 . . . . 75.41 109.818 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.92 -33.53 83.94 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 119.858 -0.412 . . . . 70.21 113.704 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -74.74 -30.47 61.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.907 0.883 . . . . 70.01 111.184 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.512 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 4.7 t80 -57.5 -46.82 83.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.541 0.736 . . . . 74.05 110.646 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.93 -23.59 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.432 0.158 . . . . 64.5 111.325 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 260' ' ' ILE . 9.3 tmtt? -69.72 -20.0 63.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.586 0.754 . . . . 73.44 111.519 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -65.31 -20.01 66.21 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 122.187 -0.321 . . . . 71.4 111.325 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.1 63.04 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.823 -0.436 . . . . 75.2 109.823 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.11 178.37 23.22 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.209 -0.996 . . . . 74.15 115.044 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.08 138.35 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.5 0.72 . . . . 73.22 110.337 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 255' ' ' LYS . 34.8 mm -71.23 111.9 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.271 0.557 . . . . 74.14 110.417 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -102.28 144.26 31.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 73.13 111.32 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.29 132.38 34.63 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.857 -0.794 . . . . 71.43 108.857 165.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.64 123.52 26.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.479 -0.934 . . . . 62.21 108.479 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.12 58.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.941 0.719 . . . . 55.32 112.941 -173.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -68.51 -34.22 75.5 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.579 0.352 . . . . 73.24 111.304 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 p -125.53 -32.0 2.93 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 111.863 0.32 . . . . 73.53 111.863 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.84 10.18 65.18 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.925 -0.58 . . . . 73.21 113.487 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -97.19 145.61 29.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 117.335 0.568 . . . . 74.24 111.224 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.8 153.45 77.79 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.975 2.45 . . . . 64.44 111.448 168.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.517 ' CB ' ' H ' ' A' ' 289' ' ' SER . 3.4 ptm -71.6 98.63 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.176 1.176 . . . . 73.35 114.176 -171.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -144.5 112.53 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.026 -1.472 . . . . 54.32 107.026 164.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -130.09 116.72 18.91 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.139 0.882 . . . . 72.43 109.786 159.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.01 110.55 19.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.786 -0.45 . . . . 61.02 109.786 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 38.7 m-85 -102.88 112.87 25.88 Favored 'General case' 0 C--O 1.261 1.706 0 CA-C-O 121.247 0.546 . . . . 74.43 110.896 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 12.0 p -143.32 123.34 13.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.109 -1.405 . . . . 72.41 110.292 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.63 112.12 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.153 0.501 . . . . 70.34 111.974 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -11.04 51.07 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.187 0.81 . . . . 74.33 113.187 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.88 -28.59 58.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.604 0.24 . . . . 74.55 111.641 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 71.1 p -89.33 -22.22 22.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.146 -0.687 . . . . 64.12 109.146 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.35 57.25 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.191 -0.913 . . . . 24.32 112.679 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -109.45 139.59 21.27 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.957 -0.386 . . . . 61.14 109.957 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.02 136.99 78.57 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.152 2.568 . . . . 72.11 114.448 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 275' ' ' THR . 36.2 mttt -67.85 -35.62 78.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.938 -1.028 . . . . 52.45 112.053 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.25 22.23 25.34 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.03 -0.605 . . . . 51.53 112.992 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 34.8 mt-10 -116.22 142.67 46.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.682 -0.407 . . . . 71.42 109.929 -172.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.73 153.65 34.77 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.596 0.56 . . . . 75.13 110.661 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 136.21 40.88 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.755 0.312 . . . . 64.44 110.446 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.27 148.13 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.933 -0.576 . . . . 74.04 110.139 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.517 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.8 t -105.34 120.26 41.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.65 0.78 . . . . 45.21 112.664 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -85.77 163.66 18.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.082 0.401 . . . . 73.4 112.082 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -78.81 -47.46 16.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.299 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -98.67 135.94 20.89 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.348 -0.387 . . . . 73.35 111.176 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.63 -40.51 29.54 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 122.559 2.173 . . . . 73.43 115.87 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 -29.74 47.99 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.759 2.021 . . . . 61.2 113.602 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 75.0 m -64.77 -26.26 68.28 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 73.22 112.626 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -74.08 -48.34 30.45 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.469 0.308 . . . . 72.34 111.664 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -33.72 71.69 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.261 0.553 . . . . 74.53 112.103 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.65 62.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.746 -0.661 . . . . 61.52 110.937 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.89 -28.7 65.85 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.468 0.175 . . . . 40.21 111.187 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.34 -33.75 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 O-C-N 122.225 -0.297 . . . . 72.4 110.468 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.11 -59.4 2.8 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 114.389 1.255 . . . . 61.54 114.389 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -90.05 -33.68 16.23 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.746 1.758 . . . . 70.45 115.746 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.4 t80 -85.65 -19.62 30.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.091 0.472 . . . . 73.32 109.984 -169.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -105.59 174.38 5.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.081 -0.963 . . . . 74.41 109.207 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.31 53.51 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.893 -0.67 . . . . 24.22 111.731 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -136.0 -154.52 0.57 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.64 -0.504 . . . . 71.3 109.64 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.51 145.54 51.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.77 0.795 . . . . 71.3 111.416 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -114.82 115.96 27.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.546 -1.206 . . . . 62.34 108.274 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.2 m170 64.44 28.93 13.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.607 1.163 . . . . 53.2 112.834 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.05 84.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.462 -0.399 . . . . 53.11 113.887 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -122.62 147.97 45.8 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.92 -0.77 . . . . 61.32 108.92 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.4 mm -69.97 129.74 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.721 0.408 . . . . 74.23 110.614 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.4 tt -108.41 147.08 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.206 -0.664 . . . . 74.43 109.206 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -137.2 123.82 21.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.408 -0.36 . . . . 63.43 111.279 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.74 135.83 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.22 0.608 . . . . 51.35 110.266 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.1 m -138.09 175.24 9.76 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.546 1.139 . . . . 73.34 109.591 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -85.7 2.0 47.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 71.24 113.975 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 61.01 -163.02 0.26 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.726 0.81 . . . . 64.54 112.173 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 9.5 t -89.15 141.5 28.46 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.288 -0.634 . . . . 74.54 109.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.15 85.13 2.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.585 0.707 . . . . 52.13 110.862 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -166.11 86.88 0.91 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.07 -0.968 . . . . 54.31 110.458 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -82.57 110.28 1.9 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.448 1.432 . . . . 71.15 113.031 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.539 -0.743 . . . . 70.21 109.717 -179.66 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.95 0 N-CA-C 111.925 -0.47 . . . . 54.44 111.925 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 62.5 m -138.64 167.46 21.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.85 0.325 . . . . 71.11 110.739 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -71.9 133.52 45.47 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.859 -0.609 . . . . 75.45 111.15 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.9 mmt -117.47 17.63 14.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.72 -0.673 . . . . 75.51 110.18 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 45.7 m 71.31 -178.63 0.22 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.779 1.632 . . . . 31.41 112.269 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 3.52 44.67 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.587 -0.733 . . . . 73.32 111.101 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -80.36 106.87 12.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.431 -0.804 . . . . 71.3 110.337 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.55 105.48 17.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.654 -0.818 . . . . 74.42 110.182 166.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.4 m -143.2 144.16 32.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.486 -1.301 . . . . 74.44 107.486 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.3 pt -120.58 136.62 56.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 119.233 0.924 . . . . 72.04 109.727 164.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.508 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.14 121.21 41.06 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.39 0.614 . . . . 55.31 109.526 -178.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.415 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.2 t -118.14 139.59 44.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.309 -0.859 . . . . 60.25 109.954 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -128.57 141.23 51.43 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.038 -0.727 . . . . 73.13 109.038 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 104.52 26.64 6.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.156 -0.545 . . . . 70.5 113.221 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 78.93 1.87 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.227 -0.657 . . . . 60.14 109.227 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -141.42 -79.63 0.05 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 120.058 -1.067 . . . . 74.33 112.946 -175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.26 110.48 10.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.902 0.382 . . . . 71.32 111.846 -173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.58 18.73 43.78 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.683 -0.77 . . . . 61.34 111.686 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.57 151.32 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.195 0.522 . . . . 33.32 109.764 -170.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.405 ' O ' HG13 ' A' ' 245' ' ' VAL . 24.7 m -86.24 169.76 12.73 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.774 -0.648 . . . . 72.24 109.949 171.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -168.45 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.694 1.998 . . . . 73.13 112.709 -177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.63 -12.21 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.774 2.03 . . . . 52.44 115.873 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.8 OUTLIER -47.07 -23.89 0.56 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 126.901 2.081 . . . . 75.01 113.304 170.207 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -56.75 -31.45 35.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-N 118.171 0.442 . . . . 52.41 110.116 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.14 -32.51 76.39 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 121.645 -0.659 . . . . 75.35 113.659 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -75.71 -31.23 59.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.382 0.673 . . . . 71.25 110.98 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.7 t80 -54.67 -46.77 74.11 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.36 0.664 . . . . 64.03 110.874 170.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 92.1 m-85 -77.74 -23.27 49.4 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.218 -0.301 . . . . 73.31 111.68 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' A' ' 260' ' ' ILE . 2.5 tmtm? -67.46 -19.27 65.33 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.579 0.752 . . . . 62.23 111.549 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.4 pt20 -63.01 -18.99 63.92 Favored 'General case' 0 CA--C 1.558 1.254 0 O-C-N 122.24 -0.287 . . . . 63.34 111.424 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 mm -120.75 54.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-O 121.211 0.529 . . . . 64.11 109.838 171.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.29 -169.6 27.56 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 118.268 -1.92 . . . . 61.42 115.214 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.35 137.66 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.282 -0.959 . . . . 54.21 109.761 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.5 mm -72.04 114.15 10.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.57 0.7 . . . . 61.52 110.438 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -98.53 144.3 28.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.65 -1.159 . . . . 75.12 110.393 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.8 m -84.29 118.92 24.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.631 -0.877 . . . . 62.32 108.631 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.59 128.4 35.45 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 109.354 -0.61 . . . . 71.55 109.354 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -79.29 -8.38 59.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.378 0.881 . . . . 71.42 113.378 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.15 -30.52 68.77 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.144 0.277 . . . . 74.44 111.132 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.0 t -125.46 -31.07 3.04 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.572 -0.285 . . . . 42.41 111.572 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.93 5.98 67.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.321 -0.4 . . . . 64.42 112.726 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.452 ' H ' HG23 ' A' ' 266' ' ' THR . 9.4 mttp -97.22 152.64 38.39 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 123.052 0.541 . . . . 74.35 111.721 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.59 153.31 75.8 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.318 2.678 . . . . 72.1 111.802 166.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.45 ' HB3' ' H ' ' A' ' 289' ' ' SER . 1.0 OUTLIER -70.23 101.62 1.92 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.966 1.099 . . . . 61.24 113.966 -173.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.2 mm -143.59 112.9 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.624 -1.25 . . . . 73.3 107.624 163.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -128.33 116.72 20.24 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.381 0.991 . . . . 52.24 110.227 164.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 112.12 22.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.007 0.432 . . . . 74.23 110.426 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 75.2 m-85 -102.51 112.34 25.03 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-N 115.852 -0.613 . . . . 73.43 110.243 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.4 p -142.28 122.03 13.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.249 -1.341 . . . . 64.31 110.488 -176.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.73 110.98 19.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.229 0.538 . . . . 72.22 111.217 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -10.8 49.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.53 0.937 . . . . 73.41 113.53 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.3 -29.27 53.61 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 62.22 109.718 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 60.9 p -89.1 -20.37 24.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.31 -0.859 . . . . 61.51 109.836 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.27 -34.65 5.25 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.301 -0.863 . . . . 74.43 113.061 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -101.35 143.77 27.26 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 109.804 -0.443 . . . . 73.44 109.804 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.22 141.03 88.52 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.275 2.65 . . . . 63.04 114.018 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 52.0 mttt -65.62 -33.14 75.21 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.774 -1.103 . . . . 74.4 111.606 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.77 23.31 23.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.517 -0.765 . . . . 71.0 112.237 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 45.1 mt-10 -118.82 143.0 47.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.308 -0.557 . . . . 73.31 110.702 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.03 143.18 24.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.626 -0.715 . . . . 70.1 109.496 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' PHE . 68.9 p -126.88 137.86 53.22 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.609 -0.436 . . . . 54.33 110.023 173.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.49 145.43 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 121.043 0.449 . . . . 71.53 109.991 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 270' ' ' MET . 0.1 OUTLIER -98.71 129.18 45.16 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.623 0.972 . . . . 72.51 113.623 -176.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.64 165.61 15.29 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.702 0.63 . . . . 74.11 112.702 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.69 73.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.448 -0.796 . . . . 72.51 111.935 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.4 139.8 35.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.891 -0.781 . . . . 71.51 108.891 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -58.79 -40.09 75.74 Favored 'Trans proline' 0 CA--C 1.576 2.588 0 C-N-CA 122.488 2.125 . . . . 65.2 117.368 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 -30.34 14.13 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 123.614 2.326 . . . . 73.21 114.106 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 55.0 p -62.97 -29.82 71.11 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.131 0.572 . . . . 74.42 111.627 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.11 -37.17 78.24 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.627 1.204 . . . . 43.4 112.214 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -68.56 -38.79 81.06 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 123.55 0.531 . . . . 72.42 111.839 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.55 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.937 -0.574 . . . . 65.12 111.428 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -66.51 -26.88 67.37 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 123.316 0.647 . . . . 54.14 112.257 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 296' ' ' ALA . 72.7 mt -68.71 -32.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.843 -1.161 . . . . 74.23 111.377 172.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.27 -58.27 3.38 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 113.169 0.803 . . . . 63.22 113.169 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.95 -30.72 17.64 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.385 1.995 . . . . 73.54 116.385 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 66.0 t80 -88.53 -17.5 30.13 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.086 0.403 . . . . 73.15 110.742 -169.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.667 ' HB2' HG12 ' A' ' 315' ' ' VAL . 1.6 t70 -87.56 159.59 18.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.16 50.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.478 -0.391 . . . . 73.43 113.154 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 -162.04 0.84 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.414 -0.958 . . . . 71.13 108.414 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.66 143.69 51.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.715 0.769 . . . . 70.45 111.367 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -113.74 115.83 28.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.966 -1.016 . . . . 74.23 108.454 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 63.85 28.43 14.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.67 1.231 . . . . 75.31 112.406 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.12 11.54 80.86 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.113 0.405 . . . . 51.31 114.113 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.53 147.86 50.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.73 -0.841 . . . . 60.43 108.73 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.2 127.66 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.777 0.431 . . . . 73.11 111.369 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 14.8 tt -110.71 134.15 53.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.732 -0.667 . . . . 71.14 110.551 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.483 ' HA ' ' OD1' ' A' ' 304' ' ' ASP . 3.1 mttm -124.06 141.19 52.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.469 -0.787 . . . . 64.3 110.729 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.667 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.3 OUTLIER -123.4 140.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 108.449 -0.945 . . . . 72.15 108.449 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.8 m -140.39 174.2 10.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.853 0.461 . . . . 65.44 110.86 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -2.63 55.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.609 0.966 . . . . 64.12 113.609 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.04 -160.39 0.3 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.264 1.026 . . . . 64.34 111.922 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.2 t -100.26 158.22 16.03 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.355 -0.609 . . . . 75.33 109.355 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -99.83 171.4 7.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 75.23 110.034 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 64.8 87.44 0.12 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.649 1.18 . . . . 75.4 112.745 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.5 86.12 0.72 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.805 2.337 . . . . 71.31 113.017 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.582 1.153 . . . . 74.42 112.142 -176.616 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 CA-C-O 119.546 -0.586 . . . . 64.44 112.152 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.3 m 58.58 64.06 1.54 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.46 1.104 . . . . 64.05 111.556 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 63.72 -178.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.374 1.47 . . . . 74.54 111.792 -173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -130.54 19.36 5.21 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.998 -0.439 . . . . 73.41 111.198 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 59.7 m 72.19 130.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.197 1.399 . . . . 74.44 112.421 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.18 -38.51 51.51 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.475 -0.784 . . . . 74.34 110.264 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -74.56 117.86 16.87 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 63.41 110.402 171.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.29 106.47 18.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 119.675 -0.81 . . . . 70.11 110.724 165.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.1 m -142.1 147.08 36.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.735 -1.209 . . . . 52.13 107.735 166.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.27 137.0 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.106 0.867 . . . . 75.03 109.959 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -99.54 124.51 44.78 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.207 -0.664 . . . . 52.33 109.207 -178.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.79 140.7 44.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.718 -0.674 . . . . 62.23 109.556 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -128.69 141.56 51.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.599 . . . . 64.13 109.442 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.32 27.61 6.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.291 -0.481 . . . . 62.14 112.773 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.14 80.34 1.95 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.246 -0.65 . . . . 74.3 109.246 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -146.7 -69.6 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.396 -0.907 . . . . 60.13 113.126 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.7 107.2 11.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.741 0.781 . . . . 72.43 111.232 -171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.22 20.77 44.22 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.228 -0.897 . . . . 51.34 111.569 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 246' ' ' SER . 0.3 OUTLIER -79.97 152.33 4.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.104 0.478 . . . . 73.31 109.937 -172.176 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 245' ' ' VAL . 17.7 m -89.28 171.05 10.06 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.609 -0.723 . . . . 70.25 109.571 170.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.852 1.661 . . . . 54.33 113.887 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -43.44 -14.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 127.764 2.426 . . . . 71.0 115.257 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.62 -21.46 0.36 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.942 2.097 . . . . 74.24 114.429 171.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -55.37 -31.62 27.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 C-N-CA 122.951 0.5 . . . . 64.21 110.102 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.65 -33.56 82.76 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.684 -0.509 . . . . 42.51 114.018 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.2 -30.87 60.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.226 0.611 . . . . 75.12 110.946 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.6 t80 -54.39 -46.32 73.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 71.44 110.619 170.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.07 -23.31 48.1 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.906 0.336 . . . . 74.23 111.906 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -70.63 -15.21 62.72 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.145 0.978 . . . . 74.3 111.514 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.49 -14.53 57.61 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 122.036 -0.415 . . . . 72.33 112.021 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.0 -31.54 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.097 0.559 . . . . 63.22 111.157 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -156.86 -160.78 10.31 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 119.429 -1.367 . . . . 75.31 114.845 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.91 138.81 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.913 -0.643 . . . . 75.44 110.369 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 30.9 mm -68.94 115.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 123.77 0.669 . . . . 71.5 110.565 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -97.84 142.37 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.318 -0.855 . . . . 74.32 110.94 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 80.2 m -85.94 115.84 23.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.198 -1.038 . . . . 62.24 108.198 167.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -73.15 122.92 22.64 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.046 -0.724 . . . . 71.1 109.046 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -72.58 -8.92 57.64 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.238 1.199 . . . . 75.53 114.238 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -69.87 -29.85 67.17 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.334 0.254 . . . . 65.42 111.614 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.4 t -124.41 -31.9 3.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.641 -0.254 . . . . 71.24 111.121 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.68 66.41 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 116.382 -0.372 . . . . 71.44 112.321 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' H ' HG23 ' A' ' 266' ' ' THR . 27.3 mtpp -97.62 153.19 38.39 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.246 0.618 . . . . 63.42 111.388 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.26 153.79 67.67 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 123.493 2.795 . . . . 74.11 112.048 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.441 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.1 ptm -75.2 100.73 4.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.704 0.764 . . . . 55.32 112.746 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.73 114.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.285 -1.376 . . . . 72.15 107.285 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -128.5 117.07 20.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.151 0.887 . . . . 73.43 109.957 161.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.09 111.78 22.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.177 0.513 . . . . 71.34 110.152 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 57.8 m-85 -101.45 112.41 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.948 -0.569 . . . . 75.35 109.942 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.471 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.2 p -144.35 119.36 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.23 -1.35 . . . . 75.33 109.908 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -87.63 111.91 21.76 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.619 1.2 . . . . 63.42 112.274 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -7.92 58.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.185 -0.916 . . . . 71.21 112.525 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.73 -27.96 64.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.723 0.409 . . . . 74.24 111.94 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 44.0 p -89.64 -25.85 21.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.571 -0.529 . . . . 74.14 109.571 168.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.49 61.31 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.195 -0.911 . . . . 72.14 112.661 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 140.85 37.96 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.367 -0.975 . . . . 64.12 108.367 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.07 137.33 70.92 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.348 2.032 . . . . 62.25 114.285 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 275' ' ' THR . 1.6 tttm -61.13 -35.07 76.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.058 -1.428 . . . . 74.15 111.739 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.07 30.73 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.484 -0.78 . . . . 62.43 112.744 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.5 mt-10 -119.97 143.39 48.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.988 -0.685 . . . . 61.35 110.476 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.62 24.15 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.941 -0.572 . . . . 71.35 110.018 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 237' ' ' PHE . 60.3 p -127.0 137.85 53.16 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 110.148 -0.316 . . . . 71.11 110.148 172.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.93 147.88 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 110.034 -0.358 . . . . 74.12 110.034 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.441 ' H ' ' CB ' ' A' ' 270' ' ' MET . 14.5 m -108.48 123.95 49.68 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.531 0.567 . . . . 73.35 112.531 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.8 163.44 13.52 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.963 0.357 . . . . 74.22 111.963 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -76.25 -48.27 20.89 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.641 -0.254 . . . . 62.33 110.4 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.55 135.21 19.35 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 120.366 -0.533 . . . . 74.41 110.03 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.4 -39.34 29.53 Favored 'Trans proline' 0 CA--C 1.568 2.208 0 C-N-CA 122.572 2.181 . . . . 75.21 116.029 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.51 -31.05 61.45 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 122.978 2.099 . . . . 63.23 113.958 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.8 m -70.32 -30.3 67.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.897 -0.592 . . . . 72.04 110.794 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.64 64.18 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.795 -0.638 . . . . 52.1 111.08 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -71.82 -37.07 70.39 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 120.887 0.375 . . . . 71.22 111.967 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.41 78.12 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.339 -0.391 . . . . 73.4 110.842 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -65.25 -35.15 80.13 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 116.154 -0.476 . . . . 53.34 111.76 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.74 -32.57 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 O-C-N 122.052 -0.405 . . . . 70.24 111.106 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -72.34 -58.43 3.41 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.973 1.101 . . . . 63.21 113.973 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.55 -30.92 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.569 2.063 . . . . 71.33 116.569 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 85.4 t80 -83.94 -11.21 57.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.443 0.697 . . . . 62.34 111.107 -168.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.21 170.44 7.88 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.624 -0.88 . . . . 74.31 108.624 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.64 6.21 59.69 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.272 -0.49 . . . . 72.54 112.48 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 -157.55 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.393 -0.965 . . . . 61.33 108.393 174.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -129.87 147.15 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.428 0.632 . . . . 65.34 111.329 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -114.32 111.88 22.2 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.989 -1.115 . . . . 62.22 107.989 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.8 28.78 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.423 1.089 . . . . 73.34 112.253 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.06 -2.07 87.69 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 116.359 -0.382 . . . . 63.24 113.546 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -108.64 144.9 35.77 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 109.125 -0.694 . . . . 70.32 109.125 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.28 126.99 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.863 0.363 . . . . 75.1 111.126 -173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 20.3 tt -110.34 136.31 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.568 0.699 . . . . 64.22 111.191 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -130.64 131.74 45.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.052 -0.976 . . . . 72.14 110.545 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.24 139.06 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 110.006 -0.368 . . . . 54.14 110.006 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.4 m -137.88 174.71 10.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.195 0.998 . . . . 54.15 109.647 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.68 1.59 51.46 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.051 1.13 . . . . 74.23 114.051 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.76 -162.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.012 0.925 . . . . 73.13 113.178 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 6.8 m -97.15 131.71 43.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.059 -0.719 . . . . 71.51 109.059 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -91.53 177.02 6.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.981 -0.554 . . . . 63.33 110.325 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 67.94 86.77 0.12 Allowed Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.554 1.142 . . . . 71.32 111.831 173.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.3 175.6 8.12 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.58 2.186 . . . . 64.15 114.491 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.256 1.41 0 CA-C-N 114.846 -1.07 . . . . 74.43 109.545 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 CA-C-O 119.554 -0.581 . . . . 73.44 111.998 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 22.7 m 62.14 92.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.007 1.323 . . . . 73.34 113.233 176.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -135.55 132.3 37.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 75.22 111.707 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.76 97.87 3.09 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.956 0.884 . . . . 74.3 110.009 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.1 m -141.47 134.57 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.957 -1.019 . . . . 74.2 109.299 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -84.19 -9.66 58.36 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.706 0.629 . . . . 74.13 110.932 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.27 104.34 13.37 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.808 -0.633 . . . . 72.11 109.47 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 107.02 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.329 -0.548 . . . . 65.44 109.819 168.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.9 m -142.9 149.01 37.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.584 -0.895 . . . . 71.12 108.584 169.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 315' ' ' VAL . 2.7 pp -123.79 141.15 45.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 118.625 0.648 . . . . 75.22 109.58 161.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 315' ' ' VAL . 0.3 OUTLIER -102.31 130.2 48.95 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.552 -0.907 . . . . 72.21 108.552 177.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -121.38 144.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.636 0.731 . . . . 62.01 112.642 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 10.0 mm-40 -126.91 151.11 48.88 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 114.257 -1.338 . . . . 62.33 110.049 -178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 95.45 7.89 58.91 Favored Glycine 0 CA--C 1.519 0.296 0 O-C-N 123.599 0.562 . . . . 60.25 113.688 174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -103.67 76.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.374 -0.973 . . . . 63.1 108.374 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -134.4 -87.65 0.28 Allowed Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 120.419 -0.896 . . . . 64.31 113.822 -171.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.96 112.91 9.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.753 0.311 . . . . 75.21 111.21 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.01 19.87 38.27 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.709 -0.678 . . . . 70.22 111.977 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.33 150.87 4.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.311 0.576 . . . . 72.25 109.674 -173.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.1 m -90.29 170.65 10.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.539 -0.755 . . . . 65.02 110.364 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -167.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 127.117 2.167 . . . . 61.21 113.36 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.2 -11.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.285 1.834 . . . . 74.21 115.673 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -45.87 -22.31 0.19 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 126.869 2.068 . . . . 73.43 113.756 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -32.28 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 118.815 0.734 . . . . 72.4 110.058 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -36.67 92.78 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.737 -0.479 . . . . 71.0 113.168 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.11 -34.27 76.06 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.502 0.721 . . . . 71.24 110.635 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.1 t80 -57.56 -43.18 84.27 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.252 -0.886 . . . . 72.05 111.486 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.64 -24.45 45.26 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.181 0.438 . . . . 72.32 112.181 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 23.4 tptm -66.66 -18.96 65.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.795 1.238 . . . . 64.35 112.189 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.23 -15.09 62.11 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 113.172 0.804 . . . . 64.24 113.172 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.2 -6.73 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 120.882 0.372 . . . . 72.51 110.792 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.522 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . -171.59 -160.44 20.13 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 118.95 -1.595 . . . . 75.34 114.721 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.59 139.44 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.443 0.697 . . . . 74.24 110.518 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.456 HG12 ' HD3' ' A' ' 255' ' ' LYS . 20.8 mm -66.38 116.31 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 123.643 0.589 . . . . 74.4 109.674 173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.11 133.24 42.03 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.447 -0.797 . . . . 72.35 110.454 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 50.3 m -84.8 117.09 23.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.299 -1.0 . . . . 71.12 108.299 167.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.29 136.67 42.63 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 112.196 0.443 . . . . 74.45 112.196 -174.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -80.07 -10.77 59.79 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.668 0.988 . . . . 73.11 113.668 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -70.12 -38.48 75.6 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 112.477 0.547 . . . . 62.52 112.477 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -124.37 -24.55 4.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.482 0.182 . . . . 74.43 111.279 174.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.85 16.52 54.39 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.121 0.408 . . . . 74.42 114.121 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 266' ' ' THR . 19.6 ptpt -100.34 152.94 37.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.398 0.599 . . . . 63.44 111.496 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.62 152.12 83.04 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.443 2.096 . . . . 73.33 111.572 166.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.09 97.9 4.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.764 1.024 . . . . 65.21 113.764 -172.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 35.7 mm -143.11 112.87 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.614 -1.254 . . . . 75.15 107.614 165.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -129.07 117.61 21.15 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.107 0.867 . . . . 63.4 109.852 161.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 111.04 20.61 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.595 -0.52 . . . . 71.4 109.595 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 35.2 m-85 -101.92 112.29 24.86 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 121.259 0.552 . . . . 64.01 110.577 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.424 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.0 p -142.6 120.93 12.32 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.985 -1.461 . . . . 72.33 110.207 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ASP . . . . . 0.507 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 26.0 t70 -87.47 113.49 23.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.288 0.566 . . . . 72.31 111.147 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -9.9 55.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.662 -0.699 . . . . 63.34 112.797 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -29.95 61.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.652 0.263 . . . . 61.31 111.547 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.4 t -91.3 -15.41 29.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.417 0.627 . . . . 75.4 109.686 167.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.98 -37.4 3.46 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.71 -0.677 . . . . 53.31 113.237 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -96.73 141.85 23.69 Favored Pre-proline 0 N--CA 1.443 -0.814 0 O-C-N 123.635 0.256 . . . . 72.43 110.971 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.49 136.26 74.78 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.636 2.891 . . . . 74.22 114.129 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 56.2 mtpt -65.6 -37.82 87.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 75.14 111.604 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.97 25.05 13.57 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.862 -0.685 . . . . 61.2 113.021 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 40.6 mt-10 -115.82 142.24 47.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.711 -0.477 . . . . 70.01 109.711 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 155.26 38.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.308 -0.405 . . . . 41.53 110.828 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 137.31 41.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.098 -0.334 . . . . 72.1 110.098 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 236' ' ' ILE . 11.5 m -136.56 145.36 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.152 -0.684 . . . . 72.25 109.152 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 22.7 t -97.68 117.59 32.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.639 0.775 . . . . 75.11 111.645 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.4 164.09 13.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 121.139 -0.225 . . . . 71.03 111.442 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.53 -48.53 55.06 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.715 0.635 . . . . 74.2 112.715 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -119.57 136.16 24.53 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 109.726 -0.472 . . . . 73.12 109.726 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.33 -38.35 65.6 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 123.682 2.921 . . . . 54.1 117.699 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.68 -29.94 15.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 123.55 2.304 . . . . 64.45 112.487 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -64.27 -27.4 69.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.725 1.21 . . . . 72.23 112.181 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.455 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -67.7 -40.97 84.3 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.595 0.559 . . . . 62.41 112.23 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -72.79 -34.67 67.08 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.292 0.567 . . . . 75.0 110.713 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.27 -33.76 76.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.337 -0.847 . . . . 71.14 111.048 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.22 -28.69 67.47 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.91 -0.586 . . . . 52.15 111.707 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 296' ' ' ALA . 49.3 mt -69.88 -30.59 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 O-C-N 122.035 -0.416 . . . . 63.12 110.812 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.88 -60.67 2.29 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.959 1.096 . . . . 63.14 113.959 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -91.87 -29.58 16.63 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.438 2.014 . . . . 72.24 116.438 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 23.6 t80 -86.62 -24.12 25.46 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 -171.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 315' ' ' VAL . 7.5 t70 -82.87 -170.51 3.04 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.957 -1.02 . . . . 73.12 109.531 166.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 78.25 13.48 83.25 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.198 -0.525 . . . . 62.44 112.853 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -135.67 -161.88 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.883 0.373 . . . . 73.34 110.179 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -128.69 144.62 51.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.21 0.529 . . . . 32.24 110.467 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -113.12 112.04 23.14 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.21 -1.033 . . . . 74.42 108.21 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 65.03 29.25 12.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.764 1.29 . . . . 74.35 112.167 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.78 5.79 80.82 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 114.211 0.444 . . . . 72.54 114.211 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -124.21 148.42 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.778 -0.823 . . . . 55.12 108.778 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.59 129.27 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 123.303 0.377 . . . . 70.43 110.901 -171.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.1 tt -108.5 143.95 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.791 -0.641 . . . . 75.52 109.54 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 15.3 tptp -136.94 121.89 18.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.914 0.388 . . . . 73.52 110.361 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 237' ' ' PHE . 7.7 p -111.89 138.39 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.522 -0.763 . . . . 61.24 111.226 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -142.79 172.79 12.22 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.286 1.034 . . . . 72.2 109.837 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -5.25 48.48 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.942 1.09 . . . . 74.04 113.942 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.59 -169.74 0.2 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.508 1.123 . . . . 72.12 113.176 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.7 m -87.23 139.25 30.75 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.737 -0.665 . . . . 70.24 110.183 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -96.66 169.73 9.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.177 -0.305 . . . . 72.22 110.177 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 72.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 124.619 1.199 . . . . 74.31 112.072 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.2 -164.06 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.79 2.326 . . . . 73.23 114.257 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.636 -1.166 . . . . 74.43 111.939 -175.457 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.058 0 N-CA-C 111.487 -0.645 . . . . 73.0 111.487 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.1 t -84.71 -69.24 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.262 0.531 . . . . 42.13 111.456 -175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 54.25 71.35 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.556 1.142 . . . . 73.4 112.838 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 56.1 mtt -100.43 91.36 4.66 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.499 0.666 . . . . 54.52 110.29 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.7 t -112.18 141.8 45.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.837 -1.074 . . . . 73.21 109.609 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.27 -34.14 76.8 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.354 1.034 . . . . 73.22 110.479 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -82.37 110.5 17.57 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.875 -1.057 . . . . 74.4 111.541 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.79 104.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.821 -0.752 . . . . 73.44 110.276 160.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 21.9 m -143.0 147.19 34.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.212 -1.032 . . . . 53.11 108.212 165.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 315' ' ' VAL . 2.5 pp -121.7 141.9 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 118.754 0.706 . . . . 62.43 109.588 164.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.67 122.31 45.39 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.754 -0.657 . . . . 74.44 109.39 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -114.3 144.52 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.755 0.788 . . . . 73.45 112.756 176.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 12.0 mm-40 -126.29 151.28 47.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.768 -1.56 . . . . 73.54 110.124 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.12 15.3 54.33 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.266 -0.492 . . . . 72.32 113.539 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.724 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -108.36 76.86 1.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.083 -1.081 . . . . 75.11 108.083 176.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.18 -88.26 0.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.152 -1.023 . . . . 70.11 114.301 -169.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -78.55 109.3 12.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 75.24 111.225 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.95 21.2 21.6 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.27 -0.877 . . . . 62.15 111.783 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -85.41 151.42 3.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.752 -0.462 . . . . 72.03 109.752 -173.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.0 m -90.54 170.01 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.788 -0.642 . . . . 73.02 110.696 172.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.811 2.044 . . . . 75.01 113.555 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -43.19 -12.7 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 126.634 1.974 . . . . 73.2 115.749 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.22 -22.04 0.34 Allowed 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 126.473 1.909 . . . . 73.43 113.668 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -56.57 -31.55 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 118.482 0.583 . . . . 73.11 110.236 178.49 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.07 -32.02 82.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.707 -0.496 . . . . 72.4 114.267 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 10.5 tp10 -72.73 -33.58 66.5 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.706 0.802 . . . . 74.34 110.758 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.7 t80 -57.22 -43.15 82.58 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.083 -0.962 . . . . 73.14 111.256 173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.02 -24.9 43.34 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 122.144 -0.347 . . . . 74.31 111.851 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.46 ' HB2' HD11 ' A' ' 260' ' ' ILE . 13.5 tptm -64.87 -22.32 66.97 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.402 1.081 . . . . 75.21 112.199 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -13.79 53.12 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 112.963 0.727 . . . . 52.34 112.963 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 46.6 mm -111.49 -26.46 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 122.698 0.399 . . . . 75.44 110.589 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -160.9 -174.95 31.39 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 119.982 -1.104 . . . . 62.42 115.127 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.22 138.8 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 73.43 111.201 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 255' ' ' LYS . 23.7 mm -70.98 115.54 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.818 -0.628 . . . . 75.13 110.785 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -98.28 138.11 36.03 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.579 0.704 . . . . 71.2 111.078 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 94.7 m -84.2 116.83 23.14 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.605 -1.18 . . . . 70.24 108.509 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -78.33 131.51 37.05 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 109.504 -0.554 . . . . 63.3 109.504 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -76.08 -5.65 47.48 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.704 1.002 . . . . 71.54 113.704 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -66.94 -34.83 78.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.636 0.255 . . . . 70.03 111.156 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 21.3 p -124.6 -31.45 3.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.854 0.462 . . . . 61.41 111.578 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.88 67.17 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.431 -0.804 . . . . 74.45 112.034 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.32 151.73 37.53 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.101 0.56 . . . . 74.11 111.677 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.45 153.92 76.01 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.066 2.51 . . . . 74.12 111.38 166.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.472 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -76.93 99.2 5.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.373 0.879 . . . . 73.41 113.373 -169.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.9 mm -143.07 112.87 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.59 -1.263 . . . . 54.42 107.59 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -128.69 116.2 19.19 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.953 0.797 . . . . 73.44 110.276 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.81 110.89 20.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.638 -0.504 . . . . 71.12 109.638 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 31.7 m-85 -103.03 112.94 26.02 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.088 0.471 . . . . 72.25 110.651 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 p -144.77 122.07 11.58 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.55 -1.205 . . . . 74.23 110.088 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.21 112.2 21.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.441 0.638 . . . . 73.42 112.618 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -85.75 -10.42 55.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.799 -0.637 . . . . 70.23 112.017 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.69 -31.36 66.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.407 0.623 . . . . 65.54 110.221 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 47.3 p -91.21 -21.92 20.88 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.212 -0.904 . . . . 75.4 109.57 173.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.11 -33.25 6.29 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.263 -0.88 . . . . 62.35 113.029 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -99.37 141.42 22.8 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 110.302 -0.259 . . . . 75.44 110.302 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.58 132.72 53.82 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.418 2.745 . . . . 74.04 114.385 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -59.54 -42.09 91.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 75.14 112.294 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.49 24.76 15.19 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.64 -0.791 . . . . 54.04 113.145 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.4 mt-10 -116.45 142.87 46.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.722 -0.473 . . . . 71.22 109.722 -174.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.18 32.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 74.23 110.966 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 p -131.31 136.74 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.88 0.372 . . . . 71.03 110.2 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.415 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 6.1 m -135.56 146.22 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 109.221 -0.659 . . . . 75.45 109.221 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.472 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.6 m -110.21 117.81 34.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.087 0.403 . . . . 74.14 112.087 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.25 165.23 13.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.918 0.71 . . . . 53.11 112.918 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.66 -47.16 76.45 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.852 0.861 . . . . 73.11 112.857 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -122.45 136.7 26.8 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.964 -0.384 . . . . 73.02 109.964 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -61.26 -38.5 65.27 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.229 2.619 . . . . 74.25 117.259 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -28.18 14.2 Favored 'Trans proline' 0 C--N 1.386 2.502 0 CA-C-N 123.682 2.351 . . . . 71.32 112.466 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.7 m -62.48 -27.9 69.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.056 0.942 . . . . 72.13 112.026 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.14 -39.38 78.87 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.267 0.627 . . . . 70.1 111.904 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -69.49 -37.88 77.42 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.87 0.367 . . . . 74.41 110.772 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.03 72.09 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.633 -0.712 . . . . 13.24 110.941 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.73 -29.56 66.97 Favored 'General case' 0 C--O 1.213 -0.852 0 O-C-N 123.395 0.434 . . . . 75.13 111.726 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 296' ' ' ALA . 56.6 mt -69.84 -32.06 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 121.716 -0.615 . . . . 65.43 110.428 173.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.71 -60.61 2.3 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 113.381 0.882 . . . . 72.24 113.381 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -93.52 -30.76 14.85 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.283 1.957 . . . . 73.44 116.283 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 37.5 t80 -84.57 -23.19 29.77 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.492 0.587 . . . . 63.15 109.69 -169.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 315' ' ' VAL . 3.4 t0 -87.78 -164.65 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.459 -0.792 . . . . 62.32 110.649 168.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.06 7.21 87.39 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.528 -0.76 . . . . 73.14 113.061 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -137.78 -164.35 1.6 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.56 0.219 . . . . 71.51 110.634 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.77 144.62 45.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.719 0.771 . . . . 62.23 112.035 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -113.82 114.83 26.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.794 -1.187 . . . . 62.13 107.794 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.09 28.5 14.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 124.64 1.213 . . . . 75.22 112.211 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.18 -4.47 84.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 114.106 0.403 . . . . 71.04 114.106 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -113.11 145.51 40.8 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.699 -0.482 . . . . 64.33 109.699 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.11 132.0 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.203 0.314 . . . . 74.02 110.635 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.8 tt -107.28 145.19 14.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.747 -0.834 . . . . 64.42 108.747 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 7.0 tppt? -136.19 121.32 18.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.095 -0.706 . . . . 72.03 109.095 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 236' ' ' ILE . 13.3 p -112.23 134.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.399 0.618 . . . . 74.44 110.153 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.8 m -133.72 173.45 11.51 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.191 -0.913 . . . . 62.2 109.495 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -3.35 45.58 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.948 0.721 . . . . 73.11 112.948 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.96 -164.87 0.24 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.508 1.123 . . . . 62.53 112.771 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.9 171.57 13.73 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.696 -0.683 . . . . 62.54 109.255 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 -79.11 -171.75 2.81 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.176 0.436 . . . . 61.22 112.176 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -62.97 149.29 90.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.022 0.529 . . . . 62.3 112.422 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.49 95.47 0.18 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.263 2.642 . . . . 64.52 113.35 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.488 1.467 0 C-N-CA 126.764 2.026 . . . . 53.35 114.459 179.644 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.415 -0.274 . . . . 61.24 112.415 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 80.0 p -140.94 170.95 14.77 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 110.081 -0.34 . . . . 54.44 110.081 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -86.0 140.98 29.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.396 -0.366 . . . . 73.23 110.676 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 21.7 mmt -128.23 55.98 1.64 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.35 0.595 . . . . 62.33 109.871 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.2 p 58.2 -171.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.116 1.767 . . . . 61.11 113.249 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -96.57 1.12 50.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.143 -0.481 . . . . 72.45 110.592 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.12 111.3 18.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.328 -0.396 . . . . 75.24 110.462 176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.74 105.03 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.936 -0.574 . . . . 74.41 110.159 167.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 m -144.01 148.81 35.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 74.43 108.564 163.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 288' ' ' VAL . 43.1 pt -126.09 144.47 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 118.83 0.741 . . . . 71.52 109.329 161.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.451 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -99.95 133.0 44.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.756 -0.831 . . . . 64.05 108.756 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.484 HG11 ' HZ ' ' A' ' 254' ' ' PHE . 1.5 t -124.76 137.76 56.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.011 -0.737 . . . . 72.42 109.011 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 14.5 mm-40 -126.47 140.58 52.36 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.741 -0.663 . . . . 72.24 111.214 -177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.04 3.93 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.246 0.966 . . . . 63.42 112.316 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.21 79.13 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.906 -0.776 . . . . 70.43 108.906 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -123.97 -99.06 1.32 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.542 -0.754 . . . . 61.43 113.996 -171.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.48 119.39 17.64 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.019 0.438 . . . . 71.22 111.526 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.58 30.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.26 -0.882 . . . . 62.23 111.592 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.23 152.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.674 -0.491 . . . . 62.13 109.674 -172.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.0 m -88.29 169.28 11.99 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.681 -0.69 . . . . 72.21 109.935 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.177 1.791 . . . . 71.3 114.201 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -42.6 -14.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.726 2.01 . . . . 72.14 115.547 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -47.61 -22.06 0.44 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 126.374 1.87 . . . . 74.25 113.912 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.8 OUTLIER -56.11 -32.62 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.38 -0.6 . . . . 63.43 109.38 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.94 84.45 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.699 0.639 . . . . 73.44 114.699 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.77 -31.13 63.15 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.312 0.577 . . . . 53.22 111.231 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 3.9 t80 -56.48 -45.15 81.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.434 -0.803 . . . . 70.33 111.015 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.484 ' HZ ' HG11 ' A' ' 238' ' ' VAL . 93.2 m-85 -78.0 -23.45 48.33 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.033 -0.417 . . . . 73.12 111.651 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.26 -14.95 62.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.849 0.86 . . . . 71.21 111.806 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -64.65 -13.37 53.55 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 121.88 -0.512 . . . . 74.44 112.046 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.3 mm -104.19 -43.13 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.02 0.528 . . . . 75.25 110.563 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -147.08 -160.11 8.66 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 120.236 -0.983 . . . . 40.24 114.613 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.51 138.45 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.007 0.523 . . . . 55.42 111.452 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.76 116.81 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.688 -0.687 . . . . 75.21 110.689 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -97.93 140.75 31.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.436 0.636 . . . . 75.13 111.158 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.6 m -86.06 118.59 25.62 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.916 -1.038 . . . . 51.32 108.44 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.84 136.97 45.44 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.292 -0.413 . . . . 64.55 111.208 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.49 -9.83 59.68 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.61 0.596 . . . . 74.44 112.61 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -69.64 -39.57 77.04 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.028 0.381 . . . . 74.41 112.028 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 22.4 p -123.19 -26.52 4.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.967 0.413 . . . . 75.41 111.181 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.87 9.86 65.52 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.427 -0.806 . . . . 72.1 112.813 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -97.96 150.74 37.07 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.416 0.525 . . . . 64.21 112.416 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 154.53 70.66 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 123.283 2.655 . . . . 53.33 111.993 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.458 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.8 ptm -68.31 102.48 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.118 1.155 . . . . 71.53 114.118 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 24.0 mm -144.44 112.45 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.139 -1.8 . . . . 72.4 106.139 161.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -128.72 114.5 16.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.091 0.86 . . . . 62.32 109.986 163.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.21 111.85 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.895 -0.409 . . . . 74.12 109.895 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 49.0 m-85 -102.04 111.4 23.66 Favored 'General case' 0 C--O 1.265 1.884 0 CA-C-O 121.487 0.66 . . . . 64.11 109.866 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.449 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 16.0 p -144.4 120.5 10.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 113.86 -1.518 . . . . 54.2 109.694 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.81 112.92 22.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.43 0.634 . . . . 63.52 111.454 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -10.38 56.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.802 0.668 . . . . 53.13 112.802 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.21 66.34 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.965 0.357 . . . . 72.25 111.965 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.2 t -91.16 -18.26 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.702 -0.481 . . . . 65.43 109.702 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 100.22 -40.88 2.29 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.884 -0.598 . . . . 74.3 113.021 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -87.79 141.61 31.88 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-O 119.889 -0.101 . . . . 74.34 110.804 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.65 132.9 54.89 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.061 2.507 . . . . 62.45 114.102 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.449 ' H ' ' HA ' ' A' ' 275' ' ' THR . 13.6 mttm -56.53 -40.13 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.413 -1.267 . . . . 74.11 112.571 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.36 23.14 20.17 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.98 -0.554 . . . . 63.41 112.864 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 21.3 mt-10 -120.31 142.05 49.47 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.82 0.364 . . . . 74.25 110.562 -173.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 148.68 28.13 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.62 -0.264 . . . . 60.25 110.875 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 237' ' ' PHE . 67.6 p -128.76 138.57 52.17 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.571 -0.529 . . . . 74.52 109.571 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 236' ' ' ILE . 8.1 m -138.38 152.02 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.272 -0.64 . . . . 75.41 109.272 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.458 ' H ' ' CB ' ' A' ' 270' ' ' MET . 34.0 t -113.67 131.19 56.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.813 1.042 . . . . 73.1 113.813 -171.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.0 163.42 13.66 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.434 0.531 . . . . 64.44 112.434 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.62 -46.2 80.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.5 -0.773 . . . . 73.43 111.896 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -119.91 136.15 24.73 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.684 -0.487 . . . . 72.2 109.684 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -61.41 -38.87 60.7 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.272 2.648 . . . . 60.41 117.4 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.04 -30.5 13.5 Favored 'Trans proline' 0 C--N 1.381 2.261 0 CA-C-N 123.37 2.239 . . . . 63.44 112.716 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 48.9 m -64.06 -27.92 69.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.384 -0.825 . . . . 72.41 111.394 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -72.05 -34.92 69.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.473 0.545 . . . . 54.44 112.473 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -71.86 -36.07 70.0 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.932 0.396 . . . . 64.21 110.695 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.31 88.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.784 -0.644 . . . . 71.11 111.093 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.12 -25.86 64.61 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.059 0.456 . . . . 74.5 111.586 176.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.31 -34.32 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 O-C-N 121.7 -0.625 . . . . 75.51 110.804 172.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.25 -56.89 4.17 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.378 0.881 . . . . 71.34 113.378 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -89.55 -29.1 19.15 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.245 1.943 . . . . 72.41 116.245 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 81.3 t80 -91.09 -9.26 46.33 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 122.01 -0.432 . . . . 73.42 111.402 -167.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.17 169.06 8.71 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.956 -0.757 . . . . 63.43 108.956 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.91 49.67 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 120.851 -0.69 . . . . 64.05 112.315 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -125.81 -162.72 1.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.244 -1.021 . . . . 73.1 108.244 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.78 145.93 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.621 0.724 . . . . 74.02 112.456 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -113.73 112.96 24.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.536 -1.211 . . . . 73.02 107.756 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.1 m170 64.88 28.95 12.67 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.132 . . . . 72.02 112.264 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.86 -1.38 85.15 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.465 -0.397 . . . . 63.12 113.97 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -115.22 143.51 45.13 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.202 -0.666 . . . . 72.13 109.202 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.24 129.22 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 122.632 0.373 . . . . 62.5 111.321 -171.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.8 tt -109.84 134.3 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.697 -0.683 . . . . 64.55 110.814 -174.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.42 131.22 53.5 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.522 -0.763 . . . . 63.53 110.197 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.01 126.77 67.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.965 0.412 . . . . 52.35 110.27 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -127.72 174.13 9.36 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 123.925 0.89 . . . . 75.54 109.119 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -1.72 57.31 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.954 1.094 . . . . 73.21 113.954 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.62 -159.31 0.31 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.11 0.964 . . . . 75.45 112.526 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 177.86 8.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.896 0.478 . . . . 54.51 109.945 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -161.8 0.69 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 111.651 0.241 . . . . 72.4 111.651 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -56.59 151.18 31.53 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.437 1.095 . . . . 73.35 112.645 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.0 174.54 12.22 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.09 2.527 . . . . 72.45 114.162 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 C--O 1.254 1.329 0 CA-C-N 115.054 -0.975 . . . . 61.3 110.829 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.262 -0.335 . . . . 54.01 112.262 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 34.7 p -118.48 -16.95 9.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.614 0.598 . . . . 70.35 112.614 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -68.96 153.5 43.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.508 0.323 . . . . 70.11 111.128 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.9 ttm 71.12 26.42 3.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 124.908 1.38 . . . . 72.21 111.379 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.0 t -135.5 120.92 19.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.529 -0.545 . . . . 73.34 109.529 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.95 -5.0 58.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.674 -0.694 . . . . 74.23 110.804 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.54 107.05 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 64.14 111.309 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.1 101.95 14.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.841 -0.743 . . . . 71.11 110.071 164.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 150.2 36.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.805 -1.183 . . . . 74.44 107.805 167.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.82 140.25 48.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.272 0.942 . . . . 63.24 110.013 163.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.66 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.02 128.71 45.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.601 -0.888 . . . . 74.52 108.601 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.402 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.1 t -123.81 138.61 52.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.775 -0.454 . . . . 72.13 109.775 -177.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -128.82 141.74 51.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 75.44 109.21 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 106.91 14.92 17.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.183 -0.532 . . . . 61.41 113.197 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 78.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.853 -0.795 . . . . 74.32 108.853 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.1 -89.19 0.39 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.317 -0.944 . . . . 51.21 113.984 -171.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.59 117.93 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.437 0.637 . . . . 71.42 111.133 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.85 20.96 37.92 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.514 -0.766 . . . . 52.41 111.583 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.05 150.45 4.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.438 -0.578 . . . . 74.15 109.438 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.5 t -91.38 170.23 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.433 -0.58 . . . . 51.53 109.433 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -169.05 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.332 1.853 . . . . 70.4 113.848 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -43.38 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.768 2.027 . . . . 54.35 114.985 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.06 -22.04 0.3 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.55 1.94 . . . . 71.22 113.995 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -55.28 -31.88 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.631 0.651 . . . . 62.3 110.556 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.78 85.66 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 121.935 -0.174 . . . . 53.42 113.504 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.67 -33.3 66.45 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.616 0.767 . . . . 75.13 110.152 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.9 t80 -56.57 -44.46 81.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.548 -0.751 . . . . 71.01 111.72 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 98.8 m-85 -78.9 -22.2 46.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.002 0.429 . . . . 75.4 111.462 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -73.03 -13.01 61.13 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.357 0.663 . . . . 62.22 111.803 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.67 -14.48 52.39 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 120.662 0.268 . . . . 75.55 111.505 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.9 mm -104.57 -47.99 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 122.924 0.49 . . . . 55.44 111.313 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -140.41 -161.52 8.74 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.066 -0.588 . . . . 62.21 113.667 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.24 138.1 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.324 0.65 . . . . 52.45 110.836 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.01 116.05 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.709 -0.678 . . . . 64.13 110.911 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -98.57 142.89 29.59 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.323 -0.853 . . . . 74.34 111.111 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 51.0 m -84.75 117.29 23.73 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.25 -1.018 . . . . 64.33 108.25 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.68 133.11 43.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.328 -0.396 . . . . 75.11 110.211 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -80.0 -8.03 59.14 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.572 0.582 . . . . 75.14 112.572 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 266' ' ' THR . 21.8 pttt -67.24 -36.85 82.51 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.275 0.23 . . . . 74.12 111.529 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 265' ' ' LYS . 15.0 p -124.15 -30.19 3.49 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.654 0.382 . . . . 63.2 111.372 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.7 64.48 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 116.14 -0.482 . . . . 62.2 112.952 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -98.23 151.53 37.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.182 0.438 . . . . 60.45 112.182 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.57 155.34 69.45 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 123.464 2.776 . . . . 65.22 112.597 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.485 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.6 ptm -71.48 102.01 2.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.665 0.987 . . . . 71.41 113.665 -172.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.8 mm -143.06 113.02 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.618 -1.623 . . . . 61.43 106.618 163.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -128.12 115.9 19.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.016 0.825 . . . . 73.22 109.98 162.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.95 111.72 21.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.183 -0.303 . . . . 74.42 110.183 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.467 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 45.2 m-85 -102.92 112.25 24.98 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 121.222 0.534 . . . . 72.41 110.388 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.443 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.4 p -144.7 122.91 12.2 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.295 -1.321 . . . . 70.13 110.003 -177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -85.82 111.95 20.66 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.113 0.482 . . . . 74.35 111.36 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -10.52 54.48 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.884 0.698 . . . . 73.22 112.884 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.38 -32.82 68.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.046 0.45 . . . . 60.2 110.381 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 77.6 p -90.71 -18.94 24.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.667 -0.697 . . . . 73.13 109.547 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.78 -29.29 10.73 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.557 -0.747 . . . . 72.34 113.102 170.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -105.84 142.49 24.92 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 110.196 -0.298 . . . . 74.22 110.196 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.5 136.86 78.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.422 2.748 . . . . 75.4 114.594 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 275' ' ' THR . 45.8 mttt -64.33 -38.48 91.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.045 -0.979 . . . . 72.1 111.873 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.67 17.38 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.459 -0.791 . . . . 72.13 113.057 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 43.6 mt-10 -116.55 142.2 47.18 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.333 -0.547 . . . . 62.33 110.454 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.27 143.86 23.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.751 -0.659 . . . . 74.13 109.948 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 237' ' ' PHE . 77.1 p -127.25 138.71 53.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.181 0.515 . . . . 74.52 110.445 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.48 147.45 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.836 -0.62 . . . . 71.3 110.783 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.485 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.8 t -98.19 136.55 38.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.213 0.605 . . . . 65.35 112.526 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.72 164.35 11.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.596 0.221 . . . . 71.02 111.596 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.84 -46.46 68.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.914 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -123.49 136.55 27.31 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.49 -0.559 . . . . 75.32 109.49 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.41 -37.59 80.36 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.381 2.72 . . . . 74.32 117.076 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -29.12 12.68 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 123.3 2.214 . . . . 41.43 113.023 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.5 m -61.39 -27.96 68.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.732 -0.667 . . . . 72.52 111.517 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.06 -35.44 61.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.094 -0.503 . . . . 74.41 111.439 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 120.74 -0.384 . . . . 64.53 110.934 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.03 86.04 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 120.839 0.352 . . . . 72.11 110.869 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.626 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.42 -26.62 66.51 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.74 -0.664 . . . . 74.25 112.337 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.84 -33.97 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 121.731 -0.605 . . . . 54.01 110.214 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.4 -56.06 5.29 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.623 0.971 . . . . 63.52 113.623 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -31.78 17.31 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.809 1.781 . . . . 74.31 115.809 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.4 t80 -88.51 -8.82 54.2 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 118.535 0.607 . . . . 71.2 111.647 -167.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.53 9.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.66 -0.867 . . . . 75.13 108.66 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.84 51.33 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.207 -0.997 . . . . 73.25 112.369 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -126.9 -162.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.32 -0.622 . . . . 60.43 109.32 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.96 147.53 46.51 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.568 0.699 . . . . 61.4 112.197 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -115.46 112.4 22.22 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.836 -1.172 . . . . 71.34 107.836 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.14 29.43 14.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.695 1.198 . . . . 75.44 112.427 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.55 11.97 73.53 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.458 -0.401 . . . . 33.14 113.675 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -128.0 143.3 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.047 -0.723 . . . . 73.21 109.047 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.63 127.66 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.043 0.449 . . . . 71.43 111.457 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 19.4 tt -110.42 131.7 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.835 0.826 . . . . 71.11 111.133 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -123.54 139.18 54.27 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.877 -1.056 . . . . 72.13 109.643 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.8 t -122.29 137.43 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 121.058 0.456 . . . . 73.52 111.112 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -131.65 176.5 8.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.547 1.139 . . . . 72.41 110.164 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.45 -8.77 58.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.761 1.022 . . . . 73.25 113.761 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.86 -168.61 0.21 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.612 1.165 . . . . 70.2 113.494 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.7 m -82.63 134.52 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.855 . . . . 64.25 110.599 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.81 178.12 7.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.982 -0.554 . . . . 73.22 110.794 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 44.83 86.62 0.13 Allowed Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 125.952 1.701 . . . . 74.11 114.481 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.96 81.7 1.6 Allowed 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 122.626 2.218 . . . . 65.31 114.192 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 124.997 1.319 . . . . 72.3 112.1 178.494 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 N-CA-C 111.887 -0.485 . . . . 52.45 111.887 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 8.0 t -94.01 56.04 2.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 117.3 0.55 . . . . 51.52 111.483 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 9.9 m170 71.38 -77.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.706 1.602 . . . . 64.41 111.734 174.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.51 30.61 15.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.726 1.21 . . . . 52.33 112.247 171.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 32.9 t -156.4 133.36 10.44 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.904 -0.406 . . . . 64.44 109.904 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -93.71 8.67 40.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.129 0.49 . . . . 63.13 110.847 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -93.52 108.1 19.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.227 -0.442 . . . . 70.53 110.21 177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.68 103.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.495 -0.882 . . . . 72.3 109.452 162.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.3 m -143.58 143.96 31.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.455 -1.313 . . . . 72.14 107.455 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.13 139.15 50.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.144 0.884 . . . . 63.41 110.652 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.42 134.16 42.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.52 -0.918 . . . . 72.13 108.52 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.77 140.14 47.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 109.39 -0.596 . . . . 72.52 109.39 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 3.7 mm-40 -124.59 143.34 50.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 124.256 0.972 . . . . 72.42 109.231 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 89.59 22.66 36.1 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.836 -0.697 . . . . 53.54 113.366 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.567 HD13 HG11 ' A' ' 250' ' ' VAL . 11.2 mt -103.91 70.83 1.02 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.344 -0.984 . . . . 74.34 108.344 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.37 -176.86 22.18 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.13 -1.033 . . . . 72.44 112.779 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 42.15 86.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.686 1.994 . . . . 71.32 114.867 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.71 22.46 26.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.333 -0.849 . . . . 61.32 111.528 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.0 150.92 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.23 110.094 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.4 m -84.55 169.47 14.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.691 -0.686 . . . . 75.03 110.939 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -167.81 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.323 1.849 . . . . 60.32 113.592 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -44.24 -13.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 126.949 2.1 . . . . 72.0 115.671 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.93 -23.42 0.45 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 126.72 2.008 . . . . 62.05 114.348 172.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.567 HG11 HD13 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -56.92 -32.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 CA-C-N 118.735 0.698 . . . . 73.12 109.767 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.06 -33.82 86.97 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.825 -0.431 . . . . 63.44 113.445 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.41 -29.14 59.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.206 0.602 . . . . 64.41 111.055 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.4 t80 -56.41 -42.52 78.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.512 . . . . 72.13 110.708 168.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -77.58 -24.1 49.82 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.067 0.395 . . . . 71.1 112.067 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 260' ' ' ILE . 0.7 OUTLIER -71.19 -16.25 62.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.638 0.775 . . . . 53.42 111.675 178.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -64.61 -15.09 60.62 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 121.572 -0.705 . . . . 63.31 112.012 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 mm -119.14 20.41 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-O 121.592 0.711 . . . . 74.44 110.327 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.5 34.15 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 119.386 -2.071 . . . . 24.31 116.009 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 23.2 mt -107.31 138.13 34.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.167 -1.017 . . . . 74.5 110.204 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 255' ' ' LYS . 48.7 mm -73.17 114.7 12.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.576 0.547 . . . . 72.13 110.001 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -98.88 143.92 28.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.142 -0.936 . . . . 74.22 110.311 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.51 131.59 34.63 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.55 -0.908 . . . . 74.01 108.55 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -82.52 122.04 27.56 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 108.974 -0.751 . . . . 50.33 108.974 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -67.14 -8.57 32.01 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.275 1.213 . . . . 61.01 114.275 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.02 -30.39 68.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 117.679 0.218 . . . . 74.24 111.053 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.6 t -126.75 -29.06 2.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.735 0.302 . . . . 74.34 111.376 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.73 7.49 68.71 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.104 -0.498 . . . . 73.44 112.387 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.48 ' H ' HG23 ' A' ' 266' ' ' THR . 39.4 mtpt -98.91 149.13 35.46 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 122.81 0.444 . . . . 74.32 111.051 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.15 153.86 71.31 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.839 3.026 . . . . 73.42 112.76 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.474 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -69.28 97.51 0.95 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.758 1.021 . . . . 73.2 113.758 -175.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 mm -144.5 112.37 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.425 -1.324 . . . . 61.34 107.425 165.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.19 117.55 20.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.015 0.825 . . . . 71.41 109.836 162.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 112.03 22.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.802 -0.444 . . . . 64.42 109.802 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -101.87 112.92 25.71 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.8 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.3 p -141.56 122.02 14.09 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.497 -1.229 . . . . 53.22 109.993 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -86.22 111.83 20.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.405 1.097 . . . . 52.34 111.602 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -6.54 59.27 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.484 -0.78 . . . . 64.24 112.765 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.64 -28.1 65.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.136 -0.484 . . . . 64.25 111.186 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 46.6 p -90.63 -29.48 17.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.822 -0.436 . . . . 64.24 109.822 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.01 57.49 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.645 -0.707 . . . . 75.03 112.658 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -113.54 144.32 31.11 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.349 -0.612 . . . . 71.14 109.349 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.83 126.48 21.28 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.201 1.934 . . . . 74.45 113.507 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -57.28 -43.0 82.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.285 0.991 . . . . 75.31 110.757 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.77 19.43 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.024 -0.989 . . . . 55.43 112.706 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -116.78 148.44 41.16 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.599 -0.84 . . . . 65.02 109.929 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -151.81 160.35 43.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.14 111.669 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.21 137.11 42.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.905 -0.588 . . . . 73.21 109.878 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.402 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 27.4 m -134.09 143.33 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.663 -0.866 . . . . 63.3 108.663 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.474 ' H ' ' CB ' ' A' ' 270' ' ' MET . 1.1 p -101.06 121.35 41.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.238 0.615 . . . . 71.14 112.304 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.36 165.9 13.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.138 -0.483 . . . . 73.34 111.836 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.48 -49.31 69.56 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.029 0.831 . . . . 74.32 112.442 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.99 138.05 31.88 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 110.115 -0.328 . . . . 74.51 110.115 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -59.16 -38.02 88.68 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.686 2.924 . . . . 73.12 117.735 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 -30.29 32.59 Favored 'Trans proline' 0 C--N 1.386 2.509 0 CA-C-N 123.681 2.35 . . . . 74.24 112.992 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 19.7 m -62.88 -28.27 69.92 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.248 1.019 . . . . 72.33 112.21 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.85 -40.2 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.876 0.735 . . . . 42.13 112.434 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -71.16 -38.64 72.19 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.128 0.489 . . . . 75.02 111.08 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.66 81.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.446 -0.797 . . . . 74.52 111.041 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.76 -28.55 66.9 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.725 -0.67 . . . . 52.33 112.05 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 296' ' ' ALA . 45.7 mt -67.4 -32.83 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.996 -0.44 . . . . 75.44 110.647 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.87 -60.34 2.41 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.783 1.031 . . . . 61.43 113.783 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -91.09 -32.71 15.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.125 1.898 . . . . 75.32 116.125 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 41.1 t80 -84.37 -25.27 29.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.243 0.474 . . . . 72.2 110.237 -170.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -94.89 177.05 6.03 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.968 -1.015 . . . . 41.42 110.127 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.97 13.49 59.02 Favored Glycine 0 CA--C 1.509 -0.326 0 C-N-CA 121.22 -0.514 . . . . 62.14 112.223 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 -153.75 0.59 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 73.32 108.814 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -131.61 142.18 49.82 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.569 0.699 . . . . 64.14 111.357 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -113.74 117.36 31.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.604 -1.258 . . . . 72.12 107.604 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.15 27.78 14.05 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.756 1.222 . . . . 64.43 112.51 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.21 -3.85 86.53 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.848 0.299 . . . . 61.42 113.848 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -108.77 146.11 34.1 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.723 -0.843 . . . . 75.53 108.723 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.78 131.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.99 0.424 . . . . 73.02 110.904 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.0 tt -108.54 140.0 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.91 -0.774 . . . . 74.13 108.91 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.18 125.0 22.51 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.591 -0.522 . . . . 64.33 109.591 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -113.23 139.98 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 107.733 -1.21 . . . . 65.33 107.733 -170.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 m -140.57 171.62 13.86 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 121.716 -0.615 . . . . 72.45 110.936 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.01 -3.13 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.881 0.697 . . . . 71.0 112.881 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 66.0 -166.22 0.22 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.766 1.227 . . . . 35.44 112.985 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.92 168.84 18.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.654 -0.703 . . . . 74.41 109.343 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -164.17 0.83 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.583 0.23 . . . . 74.11 111.408 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -63.52 148.94 93.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.591 0.756 . . . . 72.04 112.99 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.76 -170.21 0.51 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 123.899 3.066 . . . . 64.03 115.229 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.157 -0.929 . . . . 71.55 111.367 -179.58 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 111.92 -0.472 . . . . 70.12 111.92 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 21.1 m -96.89 102.9 14.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.167 0.508 . . . . 55.41 111.734 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -94.62 -179.23 4.81 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.884 -0.598 . . . . 75.05 110.204 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.43 43.56 6.31 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.197 1.799 . . . . 72.54 113.552 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 47.0 t -130.46 131.85 45.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.216 -0.902 . . . . 72.2 109.812 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -86.93 -6.58 58.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.579 0.55 . . . . 73.31 110.85 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.1 108.61 12.72 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 60.43 110.77 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.99 105.4 17.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.463 -0.495 . . . . 65.55 110.287 164.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.8 m -142.1 147.83 37.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.679 -1.23 . . . . 50.32 107.679 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.0 pt -125.46 138.45 54.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 119.279 0.945 . . . . 73.14 110.072 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.84 119.86 39.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.546 -0.539 . . . . 75.44 109.546 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.45 138.87 45.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.545 -0.752 . . . . 72.0 109.288 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -128.87 142.33 50.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.365 0.666 . . . . 75.31 109.226 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.51 8.49 Favored Glycine 0 C--N 1.332 0.358 0 O-C-N 123.331 0.394 . . . . 14.31 113.259 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 76.39 1.52 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.565 -0.902 . . . . 73.23 108.565 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.22 -77.13 0.06 OUTLIER Glycine 0 CA--C 1.499 -0.944 0 C-N-CA 120.237 -0.983 . . . . 60.45 112.999 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.54 109.18 11.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.638 0.732 . . . . 75.04 111.633 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.72 20.62 33.63 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.185 -0.916 . . . . 71.33 111.349 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.87 151.56 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.331 0.586 . . . . 72.43 109.901 -173.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.8 t -91.7 170.44 9.91 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 109.152 -0.684 . . . . 50.24 109.152 171.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 127.529 2.332 . . . . 72.24 113.829 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -44.86 -11.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 126.161 1.784 . . . . 73.52 115.513 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 252' ' ' GLU . 1.3 pp0? -46.79 -22.11 0.27 Allowed 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 126.72 2.008 . . . . 71.34 113.73 168.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -56.23 -30.66 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.384 -0.822 . . . . 73.03 109.33 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.26 91.7 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.964 -0.909 . . . . 32.03 114.718 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 249' ' ' GLN . 8.9 pt-20 -75.55 -27.65 58.72 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.367 1.084 . . . . 72.15 111.457 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.7 t80 -55.61 -45.06 77.56 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.046 0.841 . . . . 75.15 110.612 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -78.79 -23.77 45.02 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.12 0.415 . . . . 73.44 112.12 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -75.5 -11.22 59.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.45 0.7 . . . . 70.13 111.93 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.53 -16.16 63.4 Favored 'General case' 0 CA--C 1.555 1.137 0 O-C-N 121.883 -0.51 . . . . 62.41 111.827 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.06 -36.87 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.257 0.623 . . . . 54.31 111.133 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -148.04 -161.13 9.35 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 119.29 -1.433 . . . . 71.3 114.31 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.41 139.24 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 122.759 0.424 . . . . 74.34 110.959 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.0 mm -67.37 115.87 6.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.496 -0.774 . . . . 73.1 110.874 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -97.47 138.86 34.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.209 -0.905 . . . . 65.52 110.962 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -84.49 116.17 22.96 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.982 -1.118 . . . . 74.33 107.982 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.92 129.21 36.58 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 109.274 -0.639 . . . . 75.03 109.274 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -78.63 -7.1 57.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.417 0.895 . . . . 73.12 113.417 -173.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.54 -30.28 69.05 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.354 0.262 . . . . 71.23 111.439 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.5 t -125.94 -32.41 2.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.559 0.219 . . . . 62.31 111.579 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.76 11.23 64.02 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 112.232 -0.347 . . . . 53.23 112.232 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.472 ' H ' HG23 ' A' ' 266' ' ' THR . 8.8 mttp -98.52 151.29 37.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.438 0.695 . . . . 61.52 111.781 173.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.04 154.84 72.43 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.671 2.914 . . . . 35.43 112.459 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.469 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.4 ptm -73.56 100.81 3.4 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.713 1.005 . . . . 75.54 113.713 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.66 112.51 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.684 -1.599 . . . . 73.2 106.684 162.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -127.89 117.35 21.63 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.495 1.043 . . . . 61.44 110.363 162.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.43 113.2 24.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.087 0.47 . . . . 74.34 110.776 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 51.0 m-85 -101.96 110.72 22.76 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.596 -0.729 . . . . 73.33 109.285 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 37.8 p -143.11 122.04 12.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.64 -1.164 . . . . 63.0 109.676 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -86.45 112.44 21.5 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.399 0.619 . . . . 75.34 111.718 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -85.73 -10.56 55.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.664 0.616 . . . . 71.13 112.664 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.42 -33.96 67.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.031 0.382 . . . . 44.32 112.031 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 12.9 t -91.03 -16.21 28.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.43 0.633 . . . . 75.31 109.723 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.92 -48.87 1.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.585 -0.734 . . . . 52.52 112.607 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -74.34 138.52 74.95 Favored Pre-proline 0 N--CA 1.456 -0.172 0 N-CA-C 110.122 -0.325 . . . . 71.21 110.122 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.99 139.38 90.65 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.541 2.161 . . . . 64.55 113.238 171.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 72.1 mttt -59.4 -39.98 85.14 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.357 1.036 . . . . 75.14 111.874 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.91 24.78 12.41 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.612 -0.722 . . . . 62.1 112.969 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 2.1 mp0 -117.72 144.01 45.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.859 -0.736 . . . . 72.3 110.621 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -148.84 142.37 25.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 72.15 109.107 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 237' ' ' PHE . 81.5 p -125.31 138.12 54.07 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.708 -0.478 . . . . 71.23 109.708 172.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.68 148.22 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.066 0.46 . . . . 65.31 110.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.469 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.9 t -101.23 127.6 47.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.856 0.862 . . . . 65.14 112.505 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 164.33 12.26 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.177 -0.327 . . . . 65.44 111.606 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.03 -46.82 49.75 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.66 0.6 . . . . 64.14 110.76 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -109.41 135.36 20.3 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 120.795 -0.362 . . . . 73.52 110.302 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.61 -39.51 20.93 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 C-N-CA 122.775 2.317 . . . . 61.53 116.887 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.49 -29.92 52.83 Favored 'Trans proline' 0 C--N 1.39 2.752 0 CA-C-N 123.459 2.271 . . . . 54.42 113.721 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 47.8 m -63.72 -27.34 69.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.829 0.852 . . . . 73.44 112.174 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -71.59 -34.19 69.68 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.602 0.564 . . . . 73.15 112.204 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -71.82 -39.13 70.02 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.959 0.409 . . . . 71.32 110.338 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.99 74.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.359 -0.837 . . . . 45.32 111.013 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.47 -29.31 66.94 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 116.14 -0.482 . . . . 65.41 112.129 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 296' ' ' ALA . 52.7 mt -67.33 -31.48 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 122.229 -0.294 . . . . 73.31 110.49 172.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -78.52 -61.4 2.02 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.958 1.096 . . . . 63.24 113.958 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -92.07 -29.63 16.46 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.296 1.961 . . . . 73.44 116.296 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.0 t80 -87.6 -21.56 25.27 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.469 0.652 . . . . 64.44 109.914 -171.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.565 ' HB2' HG12 ' A' ' 315' ' ' VAL . 26.2 t0 -93.31 175.33 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.975 -1.011 . . . . 70.11 109.672 171.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.54 12.4 61.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.305 -0.474 . . . . 62.15 112.047 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -126.14 -158.13 0.83 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.267 -0.642 . . . . 62.34 109.267 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.76 143.97 50.62 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.573 0.701 . . . . 74.42 110.601 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.1 114.03 25.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.716 -1.129 . . . . 72.12 108.155 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.0 m170 64.66 29.12 13.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.597 1.186 . . . . 65.14 112.611 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 10.11 80.61 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 113.923 0.329 . . . . 74.43 113.923 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.58 146.01 50.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.699 -0.852 . . . . 73.1 108.699 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.33 127.99 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.271 0.557 . . . . 74.3 111.02 -170.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.7 137.11 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.324 -0.853 . . . . 73.13 109.374 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.24 128.38 41.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.61 -0.723 . . . . 65.14 110.228 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.4 OUTLIER -115.57 142.05 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 -174.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -142.1 175.23 9.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.331 0.652 . . . . 70.23 110.492 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.33 -4.34 58.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.048 1.129 . . . . 70.03 114.048 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.5 -163.11 0.27 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.944 0.898 . . . . 64.11 112.865 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 14.4 t -98.51 165.35 11.87 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.027 -0.533 . . . . 60.31 109.887 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -88.54 137.95 31.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.25 110.418 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 73.79 163.42 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 124.786 1.304 . . . . 55.22 112.365 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -69.96 103.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 121.441 1.427 . . . . 74.33 113.424 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.255 1.381 0 CA-C-N 115.393 -0.821 . . . . 74.43 109.553 175.828 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.107 -0.397 . . . . 62.12 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 11.8 p -143.47 -64.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 119.446 -0.311 . . . . 73.23 111.567 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 61.54 39.89 14.25 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.315 1.446 . . . . 74.11 111.551 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 64.9 mtt -95.09 74.86 3.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.21 0.529 . . . . 73.14 110.803 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.4 p -162.85 122.75 2.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.11 -0.95 . . . . 61.52 110.801 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.39 -22.53 41.22 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.836 -0.62 . . . . 64.14 110.765 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -85.11 106.45 16.58 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.279 -0.873 . . . . 61.22 110.149 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.14 106.61 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 62.22 109.98 165.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 16.0 m -141.79 148.06 38.31 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.902 -1.148 . . . . 63.33 107.902 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.66 137.23 56.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 118.891 0.769 . . . . 52.15 110.051 164.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.704 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -100.46 119.0 37.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.243 -0.651 . . . . 73.35 109.243 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.63 141.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.496 -0.775 . . . . 64.24 109.44 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 11.1 mm-40 -128.01 149.17 50.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.831 -0.622 . . . . 72.44 110.461 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 94.74 18.47 34.87 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 123.63 0.581 . . . . 70.41 113.362 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.78 76.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.526 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.02 -91.76 0.53 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.333 -0.937 . . . . 73.15 113.873 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.05 114.42 16.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.024 0.44 . . . . 75.03 110.943 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.55 19.86 33.73 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.263 -0.88 . . . . 74.22 111.89 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -83.58 151.47 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.351 -0.611 . . . . 55.23 109.351 -173.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.3 m -90.35 170.36 10.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.162 -0.472 . . . . 74.11 109.944 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -167.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.108 2.163 . . . . 73.23 113.198 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.26 -13.66 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 127.44 2.296 . . . . 62.21 115.018 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 252' ' ' GLU . 0.7 OUTLIER -47.7 -21.3 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.751 2.021 . . . . 61.1 114.136 169.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.34 -31.25 26.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.975 0 CA-C-N 119.207 0.912 . . . . 65.23 109.363 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -56.74 -37.85 79.48 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.003 -0.887 . . . . 64.41 114.419 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 249' ' ' GLN . 0.0 OUTLIER -74.91 -28.6 60.69 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.046 0.923 . . . . 70.41 110.468 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.1 t80 -56.44 -45.7 80.67 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 123.805 0.69 . . . . 74.2 110.833 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.63 -24.5 45.24 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.228 0.455 . . . . 74.21 112.228 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 12.3 tptm -63.1 -24.97 68.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.186 0.994 . . . . 63.0 111.744 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -62.95 -22.09 66.55 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.403 0.52 . . . . 72.33 112.403 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.6 mm -125.1 55.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 117.979 0.354 . . . . 73.34 110.114 171.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.41 -176.43 27.23 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 119.143 -1.503 . . . . 72.23 114.573 170.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.32 137.96 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.531 -0.334 . . . . 64.31 110.156 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.0 mm -73.77 114.24 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.723 -0.671 . . . . 71.31 110.121 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -98.59 140.24 33.12 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.67 0.748 . . . . 75.13 110.886 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.0 m -84.43 121.15 27.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.502 -1.226 . . . . 72.02 108.415 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.73 134.73 50.22 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.528 0.518 . . . . 61.1 111.246 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -81.98 -7.54 59.62 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.875 1.065 . . . . 75.34 113.875 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -68.38 -42.9 78.43 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.238 0.336 . . . . 55.13 111.485 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 24.6 p -124.4 -25.62 4.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.758 0.313 . . . . 75.13 111.337 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.26 16.46 57.37 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.905 -0.588 . . . . 22.31 113.601 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 152.13 38.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.794 0.297 . . . . 71.24 111.715 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.92 152.66 81.49 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.579 2.186 . . . . 71.51 111.361 165.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.478 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.1 ptm -72.82 99.48 2.65 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.808 1.04 . . . . 52.41 113.808 -174.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.4 mm -143.72 114.07 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.781 -1.563 . . . . 73.51 106.781 165.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -129.02 113.63 15.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.901 0.773 . . . . 73.43 109.425 162.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.08 111.34 21.45 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.828 0.347 . . . . 74.3 110.081 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.8 m-85 -103.81 111.83 24.52 Favored 'General case' 0 C--O 1.263 1.767 0 CA-C-O 121.308 0.575 . . . . 71.55 110.555 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.486 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.2 p -143.26 121.97 12.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.196 -1.365 . . . . 74.14 110.165 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.52 113.97 22.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.649 0.738 . . . . 74.22 112.24 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.54 -9.78 56.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.021 0.749 . . . . 71.01 113.021 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.94 -33.94 66.23 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.963 0.411 . . . . 72.1 110.904 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -90.56 -14.99 31.44 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.443 0.64 . . . . 63.12 110.114 170.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 89.67 -12.19 67.87 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.704 -0.68 . . . . 53.12 113.907 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.11 142.02 27.9 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.618 -0.512 . . . . 63.51 109.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.18 133.01 55.7 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.108 2.539 . . . . 75.21 113.796 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.486 ' H ' ' HA ' ' A' ' 275' ' ' THR . 22.5 mttt -62.3 -33.93 75.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.493 -1.231 . . . . 73.1 112.116 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.38 23.78 20.79 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.495 -0.775 . . . . 65.33 112.782 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.9 mt-10 -119.75 141.86 49.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.072 -0.651 . . . . 53.23 109.822 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.94 143.46 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 72.15 109.665 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.8 p -128.6 140.35 51.82 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.924 -0.399 . . . . 72.54 109.924 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.18 146.7 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.208 0.527 . . . . 51.4 109.993 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.478 ' H ' ' CB ' ' A' ' 270' ' ' MET . 25.6 t -98.95 119.96 38.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.566 0.747 . . . . 73.11 111.83 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.52 165.1 12.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.23 0.456 . . . . 60.3 112.23 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.34 -47.93 45.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 124.481 1.113 . . . . 71.13 111.988 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -124.12 137.23 28.64 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 109.558 -0.534 . . . . 75.31 109.558 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.43 -38.06 86.04 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 C-N-CA 123.58 2.853 . . . . 72.23 116.977 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.73 -29.27 29.57 Favored 'Trans proline' 0 C--N 1.397 3.082 0 CA-C-N 123.419 2.257 . . . . 71.2 113.373 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.7 m -65.84 -27.81 68.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.013 0.925 . . . . 63.51 112.208 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -74.89 -44.02 51.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.167 0.587 . . . . 51.4 112.086 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -74.77 -31.3 61.73 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.257 0.551 . . . . 75.33 111.916 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.14 73.52 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.635 -0.711 . . . . 71.45 110.601 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -67.56 -28.3 67.67 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.58 -0.736 . . . . 63.35 111.497 172.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 315' ' ' VAL . 43.7 mt -67.41 -32.34 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 122.171 -0.331 . . . . 72.32 111.08 172.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.24 -60.07 2.52 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.72 1.007 . . . . 73.11 113.72 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -35.52 15.32 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.032 1.864 . . . . 73.35 116.032 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.158 0.504 . . . . 52.54 110.325 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 315' ' ' VAL . 28.2 t0 -98.3 -178.29 3.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.266 -0.879 . . . . 71.12 109.601 172.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.16 64.31 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.943 0.19 . . . . 25.41 112.717 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.29 -158.64 0.9 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.286 -0.457 . . . . 73.13 109.997 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.87 145.78 50.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.658 0.742 . . . . 50.34 111.257 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -115.86 116.07 27.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.35 -1.295 . . . . 74.02 107.828 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 23.3 m170 64.29 28.89 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.657 1.183 . . . . 74.54 112.631 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.66 7.0 84.97 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 114.126 0.41 . . . . 63.14 114.126 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.23 147.93 48.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.803 -0.814 . . . . 51.31 108.803 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.86 130.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.083 0.468 . . . . 75.51 111.269 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.4 tt -109.14 142.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.009 -0.996 . . . . 73.54 109.502 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -136.28 128.01 29.05 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.715 -0.675 . . . . 63.45 110.718 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.11 141.87 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 N-CA-C 108.478 -0.934 . . . . 70.44 108.478 -173.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.1 m -144.52 174.25 11.11 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 121.633 -0.667 . . . . 73.12 110.623 -173.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.2 -3.35 54.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.636 0.976 . . . . 75.01 113.636 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.54 -166.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.552 1.141 . . . . 70.42 112.991 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.9 t -91.42 154.21 19.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 52.33 109.395 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.26 172.55 6.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.459 -0.791 . . . . 74.22 109.139 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 68.9 89.03 0.1 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 124.614 1.196 . . . . 73.31 112.744 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.43 -162.26 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.87 2.38 . . . . 53.14 113.656 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.485 1.317 0 C-N-CA 126.043 1.737 . . . . 63.0 110.812 -179.355 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.087 0 N-CA-C 111.821 -0.512 . . . . 64.32 111.821 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.0 m -95.87 -172.75 2.66 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.844 -0.428 . . . . 71.33 109.844 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -63.79 -70.24 0.23 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.743 0.417 . . . . 74.21 111.382 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 23.5 ptp -154.43 9.74 0.35 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 60.22 110.283 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 66.9 m 63.31 111.41 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.955 1.302 . . . . 70.03 111.54 -166.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.29 -24.34 59.23 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.402 -0.817 . . . . 73.32 110.502 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -72.81 106.73 4.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.299 -0.864 . . . . 72.43 110.113 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.11 104.99 17.49 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.121 -0.632 . . . . 74.31 109.564 165.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.1 m -142.39 148.84 38.51 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.413 -0.958 . . . . 71.01 108.413 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.11 137.8 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.675 0.671 . . . . 54.34 111.061 164.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.43 130.55 45.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.018 -0.734 . . . . 71.03 109.018 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 141.01 44.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.356 -0.838 . . . . 63.12 109.41 -173.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 13.0 mm-40 -128.65 150.62 50.16 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.959 -0.564 . . . . 73.11 110.36 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.58 14.17 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 124.067 0.854 . . . . 72.1 112.857 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.03 74.88 1.32 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.903 -1.147 . . . . 64.1 107.903 175.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -136.05 -77.24 0.08 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.249 -0.976 . . . . 73.53 112.957 -175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -78.26 102.86 7.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.964 0.888 . . . . 75.24 111.919 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.53 20.67 24.11 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.109 -0.951 . . . . 71.11 112.064 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -79.16 152.5 4.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.549 0.69 . . . . 64.43 110.492 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t -91.71 168.57 11.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.297 -0.865 . . . . 65.11 109.715 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.6 t -63.52 -168.26 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.274 2.23 . . . . 73.3 113.497 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -43.94 -12.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 126.625 1.97 . . . . 61.13 115.645 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.96 -22.35 0.32 Allowed 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 126.361 1.864 . . . . 63.11 114.319 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -55.91 -32.61 33.15 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 CA-C-N 118.899 0.772 . . . . 62.11 111.001 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.17 84.19 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.646 -0.312 . . . . 73.35 113.416 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -74.6 -30.43 61.68 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.675 0.79 . . . . 70.44 111.289 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.5 t80 -56.05 -45.19 79.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 70.23 111.232 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.52 -23.71 50.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.823 0.305 . . . . 73.12 111.823 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.98 -14.32 61.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.477 0.711 . . . . 70.43 112.382 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.2 -11.81 44.67 Favored 'General case' 0 CA--C 1.557 1.223 0 O-C-N 121.666 -0.646 . . . . 75.4 112.14 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mm -106.56 -42.18 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.972 0.509 . . . . 64.03 111.102 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.61 -158.97 7.78 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 120.898 -0.668 . . . . 65.21 113.942 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 14.5 mt -104.93 139.88 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.138 0.575 . . . . 62.3 110.589 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.6 mm -65.98 113.29 2.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 109.523 -0.547 . . . . 64.12 109.523 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.04 141.64 32.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.338 -0.847 . . . . 74.24 110.767 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 11.0 m -85.07 117.71 24.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.85 -1.068 . . . . 61.31 108.511 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -74.61 130.29 39.28 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.152 -0.684 . . . . 73.22 109.152 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -73.36 -9.15 58.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.674 0.99 . . . . 73.02 113.674 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -69.67 -34.35 73.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 111.997 0.369 . . . . 60.43 111.997 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.68 -30.24 3.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.478 0.311 . . . . 63.13 111.519 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.19 9.08 67.82 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.543 -0.298 . . . . 64.51 112.612 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.458 ' H ' HG23 ' A' ' 266' ' ' THR . 42.9 mttt -98.14 152.08 37.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.026 0.53 . . . . 71.42 112.196 172.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.09 156.24 63.88 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.892 3.061 . . . . 70.44 112.562 169.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.449 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.04 98.52 2.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.841 1.052 . . . . 74.1 113.841 -172.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -143.43 112.38 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.266 -1.383 . . . . 63.43 107.266 164.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -128.71 113.74 15.73 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.957 0.798 . . . . 62.11 109.367 160.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -114.52 107.89 16.12 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.721 -0.844 . . . . 52.4 108.721 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 26.1 m-85 -103.81 112.72 25.8 Favored 'General case' 0 C--O 1.26 1.634 0 CA-C-O 121.211 0.529 . . . . 73.21 110.935 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.464 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.6 p -144.42 122.92 12.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.468 -1.242 . . . . 63.41 110.308 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.99 113.39 22.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.427 0.632 . . . . 63.41 112.118 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 -8.95 57.48 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.517 -0.765 . . . . 73.22 112.715 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -35.4 71.33 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.753 0.279 . . . . 74.41 111.753 175.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.0 t -90.97 -14.26 31.83 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.204 0.526 . . . . 75.01 110.136 171.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.2 -46.32 1.7 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.579 -0.737 . . . . 60.41 113.043 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -86.19 142.84 36.2 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 110.547 -0.168 . . . . 72.35 110.547 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 139.13 83.2 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.563 2.842 . . . . 64.44 114.459 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 275' ' ' THR . 49.5 mttt -67.22 -34.21 76.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.179 -0.919 . . . . 61.52 112.146 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.76 27.75 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.093 -0.575 . . . . 62.43 112.772 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 41.7 mt-10 -115.92 143.12 45.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.812 -0.355 . . . . 75.4 110.429 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.47 154.74 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.233 -0.44 . . . . 70.43 110.78 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.2 137.39 37.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.782 -0.451 . . . . 74.31 109.782 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.35 144.75 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.361 -0.607 . . . . 45.14 109.361 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.449 ' H ' ' CB ' ' A' ' 270' ' ' MET . 26.7 t -93.35 121.69 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.61 0.764 . . . . 72.34 111.789 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -94.15 164.14 13.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.664 -0.244 . . . . 74.42 111.596 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.5 -48.78 73.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.926 0.891 . . . . 65.51 112.852 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -127.11 137.89 31.56 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 109.512 -0.551 . . . . 73.51 109.512 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.27 -38.41 75.81 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 123.078 2.519 . . . . 71.22 117.137 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.18 -28.92 15.03 Favored 'Trans proline' 0 C--N 1.391 2.799 0 CA-C-N 124.139 2.514 . . . . 72.44 113.054 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 37.9 m -61.45 -28.31 69.19 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.381 1.072 . . . . 64.44 112.027 174.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.21 -37.13 77.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.644 0.778 . . . . 54.54 112.777 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.8 -35.14 62.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 120.981 0.419 . . . . 74.54 111.288 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.563 -0.744 . . . . 74.52 111.035 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.66 -28.12 65.61 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.809 -0.632 . . . . 71.3 112.08 174.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 315' ' ' VAL . 42.3 mt -67.84 -31.86 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 122.026 -0.421 . . . . 75.3 110.811 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.43 -59.76 2.63 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.863 1.061 . . . . 74.32 113.863 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -91.27 -34.97 14.74 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.48 2.03 . . . . 62.45 116.48 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 44.3 t80 -83.44 -25.28 31.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.177 0.513 . . . . 73.11 110.188 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.5 ' HB2' HG12 ' A' ' 315' ' ' VAL . 16.7 t0 -93.46 176.38 6.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.801 -1.09 . . . . 71.44 109.95 173.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.53 12.95 57.74 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.275 -0.488 . . . . 61.25 112.31 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -128.99 -154.58 0.65 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.854 -0.424 . . . . 73.41 109.854 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.72 139.84 49.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.268 0.556 . . . . 75.41 110.868 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.52 112.74 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.716 -1.216 . . . . 70.43 107.716 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.9 m170 64.66 28.4 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.947 1.299 . . . . 75.04 112.205 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.98 88.19 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 121.629 -0.32 . . . . 43.04 113.428 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.03 143.29 33.41 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.28 -1.007 . . . . 60.33 108.28 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.82 126.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.655 0.264 . . . . 53.34 110.501 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.1 tt -107.9 140.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.976 -0.556 . . . . 60.45 109.636 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.89 126.23 28.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.863 -0.608 . . . . 75.1 109.654 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.52 138.69 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.76 -1.2 . . . . 71.14 107.76 -175.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.0 m -144.56 171.7 14.0 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 123.0 0.52 . . . . 72.41 110.192 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.48 -4.49 42.89 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.229 1.196 . . . . 71.53 114.229 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.42 -168.56 0.21 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.403 1.081 . . . . 64.14 113.097 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.8 m -88.67 132.21 34.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.474 -0.784 . . . . 44.41 109.573 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.3 mpp_? -83.23 -176.0 6.11 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.318 -0.401 . . . . 71.31 109.982 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 13.8 ptt85 48.3 87.31 0.13 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.853 1.661 . . . . 74.14 114.663 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.33 -178.09 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.753 2.302 . . . . 70.23 114.308 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.062 1.745 . . . . 51.0 111.587 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 CA-C-O 118.668 -1.074 . . . . 63.43 113.217 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.9 m 53.4 87.32 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 64.2 113.474 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -91.26 -173.35 3.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.7 -0.682 . . . . 54.13 109.927 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 65.1 mtt 67.58 27.18 7.87 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.555 1.142 . . . . 61.22 111.772 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 29.2 m -125.26 103.19 7.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.229 -0.441 . . . . 70.25 110.084 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.54 -22.21 35.07 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.538 0.685 . . . . 44.44 110.809 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -90.92 117.7 29.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.94 -1.027 . . . . 61.14 110.878 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.33 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.424 0.631 . . . . 70.44 110.509 167.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.6 m -143.17 150.06 38.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.861 -1.162 . . . . 55.52 107.861 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 288' ' ' VAL . 2.8 pp -124.58 140.71 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.023 0.828 . . . . 62.31 111.223 164.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.67 136.18 41.95 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.791 -0.64 . . . . 65.55 109.433 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 315' ' ' VAL . 0.0 OUTLIER -128.36 142.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 122.028 0.918 . . . . 70.31 112.401 177.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -127.25 141.34 51.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.594 -1.639 . . . . 62.14 108.151 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.68 29.25 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.044 -0.598 . . . . 63.1 112.193 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.513 HD13 HG11 ' A' ' 250' ' ' VAL . 9.2 mt -107.72 71.72 0.83 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.632 -0.877 . . . . 74.34 108.632 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.46 -79.91 0.07 OUTLIER Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 119.89 -1.148 . . . . 73.23 113.741 -174.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.99 106.76 7.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.106 0.955 . . . . 74.01 111.756 -171.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.7 20.02 32.86 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.83 -1.077 . . . . 72.43 111.58 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.38 151.34 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.13 0.491 . . . . 72.41 109.825 -171.464 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.7 m -92.01 170.85 9.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 72.12 110.072 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.814 2.046 . . . . 74.44 114.042 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -42.44 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 127.181 2.193 . . . . 74.35 115.854 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -21.92 0.41 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.56 1.944 . . . . 75.34 114.408 169.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 241' ' ' LEU . 1.3 t -56.36 -32.03 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.114 0.87 . . . . 40.2 110.762 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.4 -31.56 81.26 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.878 -0.401 . . . . 71.44 113.559 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -75.51 -30.7 59.91 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.34 0.591 . . . . 73.11 110.251 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.5 t80 -59.21 -42.91 92.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.412 -0.813 . . . . 62.41 110.72 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -78.17 -24.04 47.41 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.894 0.378 . . . . 65.41 112.015 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 260' ' ' ILE . 22.7 tptm -66.83 -21.88 66.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.475 1.11 . . . . 72.12 112.197 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.42 -20.54 65.64 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 112.119 0.414 . . . . 63.13 112.119 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.91 54.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 117.871 0.305 . . . . 72.34 110.191 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . 147.04 -168.72 28.19 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.178 -1.487 . . . . 30.3 115.011 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.55 138.42 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.407 0.683 . . . . 74.43 110.994 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 255' ' ' LYS . 6.7 mm -74.12 116.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.306 0.379 . . . . 74.15 110.17 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -98.93 142.92 29.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.401 0.619 . . . . 53.53 111.11 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 12.7 m -84.62 115.66 22.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 166.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.76 136.07 48.63 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.789 0.292 . . . . 65.22 111.789 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -11.05 59.98 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.739 0.644 . . . . 63.33 112.739 -174.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -74.11 -26.94 60.63 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.452 0.168 . . . . 73.03 111.236 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.8 t -125.32 -31.54 3.03 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.096 0.406 . . . . 62.05 112.096 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.8 83.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 116.308 -0.405 . . . . 53.31 112.934 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 266' ' ' THR . 53.3 mmtt -96.24 148.41 34.45 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.442 0.697 . . . . 73.22 111.325 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.0 153.58 74.79 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.787 2.325 . . . . 41.13 111.022 165.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.477 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.6 OUTLIER -76.32 101.24 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.263 0.838 . . . . 73.41 113.263 -170.256 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.2 mm -142.55 112.82 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.024 -1.473 . . . . 71.11 107.024 162.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -129.07 113.34 15.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.333 -0.617 . . . . 71.24 109.333 162.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 273' ' ' LEU . 0.8 OUTLIER -114.42 110.5 19.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.032 -0.729 . . . . 62.11 109.032 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -103.44 111.83 24.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.095 0.474 . . . . 72.12 110.897 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.426 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.1 p -145.39 120.81 10.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.56 -1.2 . . . . 74.42 109.815 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -87.76 113.87 23.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.411 1.1 . . . . 75.23 112.595 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -4.05 58.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.119 -0.946 . . . . 63.15 112.574 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.64 79.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 64.42 110.836 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -92.69 -21.43 20.0 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.691 -0.686 . . . . 64.52 109.801 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 103.67 -45.29 1.34 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.905 -0.588 . . . . 74.13 112.673 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -79.75 143.98 59.42 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 121.224 -0.19 . . . . 72.34 110.628 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -57.12 140.51 92.92 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.959 2.439 . . . . 74.23 114.378 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 275' ' ' THR . 9.3 tttt -67.52 -37.24 82.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.877 -1.056 . . . . 64.1 111.571 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.11 17.18 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.872 -0.604 . . . . 64.43 113.891 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.44 146.18 47.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.449 -0.5 . . . . 73.34 111.478 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.48 152.67 33.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.81 -0.632 . . . . 55.32 110.632 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.75 135.17 50.72 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.101 166.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.435 HG22 HD11 ' A' ' 236' ' ' ILE . 3.3 m -134.96 146.81 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' SER . . . . . 0.477 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.7 m -113.58 133.82 55.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.502 0.556 . . . . 62.52 112.502 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.71 165.23 11.49 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.661 0.615 . . . . 75.21 112.661 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.89 -47.95 60.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.339 -0.846 . . . . 64.23 111.949 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -117.79 135.78 23.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.351 -0.611 . . . . 71.23 109.351 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.13 -38.84 53.25 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 123.274 2.649 . . . . 54.15 117.238 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.19 -28.39 15.6 Favored 'Trans proline' 0 C--N 1.393 2.874 0 CA-C-N 123.426 2.259 . . . . 51.42 112.544 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.4 m -61.92 -27.44 68.82 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.301 1.04 . . . . 71.52 111.946 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.26 -39.58 78.36 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.307 0.38 . . . . 71.45 111.712 175.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -41.07 87.74 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.744 0.307 . . . . 73.12 110.387 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.82 76.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.722 -0.672 . . . . 54.51 111.395 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.64 -31.18 71.7 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 122.806 0.443 . . . . 60.22 111.725 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 315' ' ' VAL . 57.2 mt -68.86 -31.11 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 O-C-N 122.197 -0.315 . . . . 72.32 110.86 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.11 -59.74 2.65 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.385 0.883 . . . . 71.21 113.385 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . 0.253 1.7 p-90 -91.69 -34.26 14.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.534 2.049 . . . . 72.23 116.534 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -84.82 -22.48 29.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.376 0.607 . . . . 61.44 110.193 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 315' ' ' VAL . 21.9 t0 -83.31 -176.02 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.009 -0.996 . . . . 61.41 109.435 171.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 84.53 9.83 80.76 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 114.123 0.409 . . . . 64.52 114.123 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 -160.97 1.04 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.151 -0.685 . . . . 63.32 109.151 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.21 146.14 49.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.694 0.759 . . . . 74.34 111.401 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.88 114.28 26.72 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.749 -1.204 . . . . 73.31 107.749 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.7 m170 62.54 28.37 16.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.672 1.189 . . . . 62.54 111.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 88.89 -2.34 84.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.462 -0.399 . . . . 70.41 114.092 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -110.5 142.58 42.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.399 0.599 . . . . 55.54 109.597 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.82 126.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.177 0.513 . . . . 70.15 110.944 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 10.6 tt -108.78 139.42 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.65 -0.704 . . . . 74.13 109.963 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -136.4 123.79 22.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.55 111.075 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.541 HG23 HG13 ' A' ' 238' ' ' VAL . 4.7 p -109.29 138.85 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 CA-C-N 115.022 -0.99 . . . . 75.32 110.226 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 115.767 -0.652 . . . . 73.34 109.866 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -79.14 -3.63 46.49 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 114.618 1.34 . . . . 73.42 114.618 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.66 -169.22 0.2 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.402 1.081 . . . . 72.22 112.535 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.8 m -96.34 137.36 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.76 176.05 5.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.492 -0.322 . . . . 71.24 111.141 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 72.34 89.41 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 124.851 1.261 . . . . 75.52 111.517 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.84 -166.55 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.106 2.537 . . . . 73.33 113.48 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.866 1.266 . . . . 74.22 110.312 -177.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.0 t30 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.558 0.218 . . . . 53.439999999999998 110.706 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 103.38 15.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.192 -0.603 . . . . 65.450000000000003 110.569 167.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.3 m -143.73 143.55 31.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.535 -0.913 . . . . 63.130000000000003 108.535 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.94 142.24 36.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 119.262 0.937 . . . . 70.049999999999997 109.915 163.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -100.09 130.51 46.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.23 -1.026 . . . . 71.329999999999998 108.23 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.48 141.56 43.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.565 -0.532 . . . . 73.040000000000006 109.565 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.33 150.63 48.4 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 63.420000000000002 110.423 -176.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.07 14.01 59.72 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 124.383 1.052 . . . . 63.210000000000001 112.782 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 286' ' ' ALA . 6.5 mt -103.48 74.56 1.27 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.984 -1.117 . . . . 73.310000000000002 107.984 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.91 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.513 -0.851 . . . . 73.299999999999997 113.55 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.21 112.4 12.64 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.432 0.634 . . . . 64.530000000000001 111.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.14 21.02 51.27 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.308 -0.86 . . . . 63.420000000000002 111.686 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.59 151.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.393 -0.595 . . . . 74.319999999999993 109.393 -172.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.8 t -91.81 170.78 9.61 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.05 -0.722 . . . . 71.349999999999994 109.05 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -167.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.535 2.334 . . . . 71.439999999999998 114.039 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -44.29 -12.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 126.24 1.816 . . . . 50.210000000000001 115.26 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -46.0 -22.58 0.22 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.605 1.962 . . . . 72.439999999999998 113.471 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.64 HG11 HD13 ' A' ' 241' ' ' LEU . 0.9 OUTLIER -56.3 -32.49 35.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 CA-C-N 118.914 0.779 . . . . 75.109999999999999 109.912 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.58 -32.58 83.78 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.281 -0.262 . . . . 73.349999999999994 113.197 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.12 -32.63 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.418 0.687 . . . . 73.540000000000006 110.481 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 7.5 t80 -56.76 -44.38 81.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.433 1.093 . . . . 74.109999999999999 110.806 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.24 -24.29 47.0 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 111.956 0.354 . . . . 74.209999999999994 111.956 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -66.87 -21.34 66.01 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.936 0.895 . . . . 72.439999999999998 111.46 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.55 -25.0 68.04 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 122.195 -0.316 . . . . 74.129999999999995 111.365 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.4 mm -124.59 70.86 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.024 -0.732 . . . . 43.149999999999999 109.024 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.36 -176.0 24.61 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 119.096 -1.526 . . . . 53.350000000000001 114.575 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.01 139.58 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.347 0.659 . . . . 74.099999999999994 109.727 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.68 116.53 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.119 0.485 . . . . 74.530000000000001 110.262 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' A' ' 290' ' ' PHE . 22.8 tttm -95.73 137.49 34.71 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.543 0.687 . . . . 72.400000000000006 111.048 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 26.7 m -85.2 117.85 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.666 -1.152 . . . . 64.010000000000005 108.471 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -75.24 137.98 41.59 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.147 -0.479 . . . . 71.019999999999996 110.554 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -80.01 -10.15 59.75 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.393 0.886 . . . . 73.219999999999999 113.393 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.85 -41.16 78.85 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.364 0.505 . . . . 62.399999999999999 112.364 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.6 t -125.36 -18.86 5.21 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.739 0.304 . . . . 52.219999999999999 111.089 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.67 57.11 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 116.292 -0.413 . . . . 61.439999999999998 113.165 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -98.13 153.3 38.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.016 0.376 . . . . 71.219999999999999 112.016 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.16 155.84 68.9 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.646 2.898 . . . . 65.349999999999994 112.353 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.493 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.55 98.11 2.25 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.175 0.988 . . . . 61.25 113.353 -174.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.2 mm -144.15 112.58 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.034 -1.469 . . . . 73.450000000000003 107.034 163.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.07 116.33 19.12 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.425 1.011 . . . . 64.239999999999995 109.865 162.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 111.25 21.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.510000000000005 110.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 32.4 m-85 -102.6 112.0 24.55 Favored 'General case' 0 C--O 1.26 1.625 0 CA-C-O 121.241 0.543 . . . . 72.109999999999999 110.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.1 p -143.46 120.43 11.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.317 -1.311 . . . . 75.450000000000003 109.807 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -87.9 113.14 23.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.804 1.288 . . . . 73.519999999999996 111.884 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -7.61 59.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.633 -1.167 . . . . 73.400000000000006 111.639 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.81 -29.51 66.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.246 0.618 . . . . 75.5 111.371 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -91.11 -29.41 17.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.412 -0.588 . . . . 72.400000000000006 109.412 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 107.18 -19.3 34.96 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.316 -0.856 . . . . 52.109999999999999 112.633 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -113.17 141.64 26.03 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.292 -0.262 . . . . 73.430000000000007 110.292 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.35 140.35 94.1 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 123.316 2.678 . . . . 71.040000000000006 114.958 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.444 ' H ' ' HA ' ' A' ' 275' ' ' THR . 16.2 mttt -64.18 -36.52 84.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.706 -1.134 . . . . 64.319999999999993 112.247 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.87 20.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.519 -0.764 . . . . 63.109999999999999 112.421 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 49.1 mt-10 -119.62 141.03 49.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 119.724 -0.79 . . . . 71.319999999999993 109.81 -174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -152.74 144.69 23.7 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.908 -0.587 . . . . 30.350000000000001 109.887 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 237' ' ' PHE . 76.3 p -127.7 140.22 52.21 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 122.017 -0.427 . . . . 53.520000000000003 109.964 173.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.405 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 19.6 m -134.58 146.78 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.006 0.432 . . . . 72.219999999999999 110.428 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.493 ' H ' ' CB ' ' A' ' 270' ' ' MET . 27.6 t -98.61 113.98 26.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.725 0.81 . . . . 63.420000000000002 112.49 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.422 ' O ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 m-85 -88.08 162.77 16.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.592 0.219 . . . . 65.129999999999995 111.592 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.47 -47.62 19.19 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.434 0.459 . . . . 70.409999999999997 111.199 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.76 135.44 22.19 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 120.967 -0.293 . . . . 62.32 110.277 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.67 -40.45 22.72 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.213 1.942 . . . . 65.099999999999994 116.376 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.66 -30.02 51.31 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 123.082 2.136 . . . . 74.319999999999993 113.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 67.9 m -63.82 -27.36 69.12 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.44 0.696 . . . . 61.310000000000002 112.709 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.97 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.24 0.616 . . . . 75.200000000000003 111.838 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.84 -40.76 88.06 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.079 0.552 . . . . 63.32 111.159 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.05 -32.94 74.71 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.438 -0.801 . . . . 62.240000000000002 111.583 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -70.59 -29.56 66.01 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.07 0.396 . . . . 74.310000000000002 112.07 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.54 -33.81 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 110.384 -0.228 . . . . 74.439999999999998 110.384 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.21 -59.41 2.79 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 114.264 1.209 . . . . 70.310000000000002 114.264 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -91.37 -34.07 15.02 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.117 1.895 . . . . 74.239999999999995 116.117 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 67.7 t80 -86.74 -14.99 40.79 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.339 0.59 . . . . 74.310000000000002 110.558 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.38 175.77 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.588 -0.893 . . . . 71.409999999999997 108.588 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.81 14.49 46.27 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.903 -0.665 . . . . 71.030000000000001 112.809 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -133.72 -154.04 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.097 -0.705 . . . . 75.019999999999996 109.097 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 149.91 52.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.85 0.833 . . . . 75.120000000000005 111.264 174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -113.49 114.81 27.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.61 -1.177 . . . . 74.430000000000007 108.211 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.9 m170 64.52 28.35 13.4 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.606 1.163 . . . . 75.150000000000006 112.5 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.35 -2.75 86.68 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 119.891 -0.394 . . . . 61.299999999999997 113.905 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.69 141.93 47.17 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.927 -0.768 . . . . 64.129999999999995 108.927 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.14 131.23 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.127 0.489 . . . . 73.299999999999997 111.481 -169.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.86 142.68 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.597 -0.729 . . . . 73.239999999999995 109.569 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -137.11 129.1 29.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 75.0 111.359 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.66 134.64 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.811 -0.631 . . . . 64.209999999999994 110.188 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -136.12 173.49 11.65 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.149 0.98 . . . . 50.43 109.816 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.9 0.56 43.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.409 0.892 . . . . 74.239999999999995 113.409 175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 124.359 1.064 . . . . 54.039999999999999 112.88 176.539 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.239 0.511 0 N-CA-C 110.164 -0.309 . . . . 52.030000000000001 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.39 105.53 17.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.272 0.558 . . . . 64.049999999999997 110.407 165.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 14.0 m -142.29 145.21 33.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.047 -1.094 . . . . 55.25 108.047 165.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.46 HD13 HG13 ' A' ' 315' ' ' VAL . 1.7 pp -122.16 144.42 31.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 118.937 0.79 . . . . 73.409999999999997 109.117 166.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 136.62 43.26 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.279 -0.638 . . . . 75.239999999999995 109.279 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.02 143.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.58 0.705 . . . . 62.340000000000003 112.515 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.56 147.36 49.88 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.102 -1.408 . . . . 62.210000000000001 110.387 -176.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.4 21.93 30.76 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.524 0.515 . . . . 62.240000000000002 113.373 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -114.96 75.48 0.94 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.566 -1.272 . . . . 74.209999999999994 107.566 176.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -131.32 -86.87 0.39 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.513 -0.851 . . . . 73.120000000000005 113.495 -170.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.31 113.21 12.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 111.549 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.26 40.08 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.219 -0.9 . . . . 55.32 111.707 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.82 151.67 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.508 -0.552 . . . . 73.310000000000002 109.508 -174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.2 m -89.34 169.97 10.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.213 -0.903 . . . . 70.109999999999999 110.09 173.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.594 1.957 . . . . 64.230000000000004 113.868 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -42.64 -14.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 C-N-CA 126.36 1.864 . . . . 75.510000000000005 114.728 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.94 -20.78 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.748 2.019 . . . . 74.239999999999995 114.229 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.46 -31.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.81 0.732 . . . . 64.430000000000007 110.25 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.89 -35.82 91.02 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.548 -0.585 . . . . 61.219999999999999 113.964 172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.99 -35.46 80.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.943 0.897 . . . . 74.030000000000001 111.757 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.0 t80 -57.24 -44.35 83.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.005 0.922 . . . . 71.519999999999996 111.125 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.85 -24.34 44.41 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 111.821 0.304 . . . . 75.519999999999996 111.821 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 260' ' ' ILE . 15.3 tptm -63.93 -23.4 67.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.095 0.958 . . . . 73.129999999999995 111.905 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.79 -24.39 67.71 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 121.037 -0.265 . . . . 63.229999999999997 111.521 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -126.29 67.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 109.086 -0.709 . . . . 75.530000000000001 109.086 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.77 -177.01 24.44 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 119.38 -1.39 . . . . 74.549999999999997 114.574 171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.02 138.44 31.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.112 0.565 . . . . 54.240000000000002 109.669 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.8 mm -66.86 115.98 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.662 0.601 . . . . 62.109999999999999 110.066 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -95.97 139.2 32.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.241 -0.89 . . . . 72.400000000000006 111.135 -176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 29.4 m -86.92 117.57 25.74 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.101 -1.074 . . . . 71.230000000000004 108.101 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.68 132.02 36.86 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.854 -0.425 . . . . 75.239999999999995 109.854 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -10.11 59.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.098 1.147 . . . . 75.200000000000003 114.098 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.09 -31.22 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 111.772 0.286 . . . . 71.439999999999998 111.772 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.2 t -124.66 -31.7 3.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 111.267 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.01 6.65 69.12 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.176 -0.466 . . . . 34.409999999999997 112.506 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.444 ' H ' HG23 ' A' ' 266' ' ' THR . 75.6 mttt -98.18 152.0 37.79 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.295 0.638 . . . . 75.540000000000006 112.217 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.01 154.42 74.09 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.662 2.908 . . . . 73.400000000000006 112.306 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.9 ptm -71.0 99.53 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.894 1.072 . . . . 64.420000000000002 113.894 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.6 mm -144.4 114.21 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.565 -1.272 . . . . 62.409999999999997 107.565 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -129.54 116.45 18.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.997 0.817 . . . . 74.019999999999996 110.41 161.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 111.32 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.836 -0.431 . . . . 73.25 109.836 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.7 m-85 -103.16 112.52 25.41 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-O 121.159 0.504 . . . . 73.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.466 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.1 p -141.99 122.99 14.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.524 -1.216 . . . . 65.450000000000003 110.336 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.62 112.22 20.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.118 0.485 . . . . 53.310000000000002 111.627 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -11.06 50.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.094 0.776 . . . . 75.209999999999994 113.094 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -28.79 57.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.487 . . . . 61.32 110.175 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 51.5 p -89.56 -21.8 22.7 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.742 -0.663 . . . . 70.209999999999994 109.624 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.46 -35.68 4.56 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.584 -0.734 . . . . 51.539999999999999 112.536 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -97.96 141.63 23.28 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 123.379 0.105 . . . . 74.310000000000002 111.163 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.57 135.44 70.4 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.493 2.795 . . . . 63.219999999999999 114.173 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.466 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.3 mttt -63.85 -36.68 84.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.607 -1.179 . . . . 64.400000000000006 112.082 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.55 23.95 19.81 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.777 -0.725 . . . . 62.409999999999997 112.682 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 26.8 mt-10 -117.78 142.96 46.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.793 -0.447 . . . . 74.129999999999995 109.793 -172.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.53 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.278 -0.419 . . . . 63.539999999999999 110.535 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 20.7 p -134.97 137.01 42.65 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.964 -0.384 . . . . 71.129999999999995 109.964 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.61 150.06 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.259 -0.428 . . . . 35.43 110.125 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 30.7 t -105.47 117.73 34.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.972 0.73 . . . . 55.420000000000002 112.972 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 159.93 20.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.097 -0.241 . . . . 71.329999999999998 111.227 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.29 -47.03 16.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.119 -0.491 . . . . 74.299999999999997 109.951 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.62 135.4 29.25 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 123.212 0.32 . . . . 73.420000000000002 110.468 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.32 -40.71 30.53 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.434 2.089 . . . . 73.099999999999994 116.133 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.33 -29.22 32.22 Favored 'Trans proline' 0 C--N 1.389 2.696 0 CA-C-N 122.682 1.994 . . . . 63.329999999999998 113.535 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 61.3 m -63.55 -25.78 68.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.175 0.59 . . . . 75.450000000000003 112.361 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -72.98 -45.68 56.59 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.037 0.384 . . . . 70.120000000000005 112.037 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -32.69 68.59 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.257 0.551 . . . . 62.219999999999999 111.415 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.74 -30.62 61.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.284 -0.871 . . . . 75.150000000000006 110.6 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.62 -31.23 71.11 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 122.252 0.221 . . . . 70.340000000000003 111.218 173.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 296' ' ' ALA . 67.2 mt -67.04 -34.57 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 120.484 0.183 . . . . 53.549999999999997 110.748 173.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.9 -59.86 2.61 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.393 1.257 . . . . 73.420000000000002 114.393 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.93 -35.33 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.509 1.67 . . . . 74.109999999999999 115.509 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.6 t80 -83.32 -18.66 38.2 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.101 0.477 . . . . 72.219999999999999 110.156 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.97 -174.08 2.46 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.043 -0.98 . . . . 62.219999999999999 109.219 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.08 65.35 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.121 -0.561 . . . . 75.420000000000002 112.322 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -135.98 -160.88 1.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.622 0.369 . . . . 70.409999999999997 110.137 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.17 145.68 47.97 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.784 0.802 . . . . 72.430000000000007 111.884 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -114.74 114.93 26.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.43 -1.259 . . . . 71.239999999999995 107.858 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.9 m170 64.37 28.66 13.68 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.915 1.286 . . . . 73.409999999999997 112.649 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.94 -2.97 85.96 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.148 0.419 . . . . 71.519999999999996 114.148 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.74 144.4 41.1 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 122.801 0.441 . . . . 71.120000000000005 110.05 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.66 129.66 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 123.331 0.394 . . . . 71.200000000000003 110.33 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.0 tt -108.41 145.8 14.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.9 -0.591 . . . . 74.409999999999997 109.514 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 42.5 tttp -135.4 127.94 30.66 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.071 -0.513 . . . . 54.240000000000002 111.256 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.46 HG13 HD13 ' A' ' 236' ' ' ILE . 25.2 t -103.61 133.76 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.37 0.605 . . . . 71.439999999999998 109.385 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -132.53 173.36 11.4 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.997 0.919 . . . . 74.409999999999997 109.313 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.26 -1.07 52.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 113.076 0.769 . . . . 75.120000000000005 113.076 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 124.404 1.082 . . . . 35.200000000000003 113.321 175.353 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.397 0.141 . . . . 72.140000000000001 111.359 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.42 104.21 16.75 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.45 -0.781 . . . . 74.030000000000001 110.676 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -144.12 149.51 36.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.467 0.707 . . . . 60.299999999999997 109.344 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.76 137.16 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.726 0.694 . . . . 61.420000000000002 110.512 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.55 125.51 48.21 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.556 -0.535 . . . . 75.030000000000001 109.556 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -120.05 143.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.745 0.784 . . . . 74.120000000000005 111.93 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 26.1 tp60 -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.986 -1.461 . . . . 44.420000000000002 108.927 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.78 43.94 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.098 -0.573 . . . . 61.43 112.958 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -105.0 78.65 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.579 -0.896 . . . . 63.409999999999997 108.579 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.54 -81.44 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.491 -0.861 . . . . 71.140000000000001 113.486 -172.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.68 107.14 9.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 72.140000000000001 111.21 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.23 20.92 24.07 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.556 -0.747 . . . . 61.130000000000003 112.078 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.54 152.55 4.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.384 0.611 . . . . 73.319999999999993 110.572 -173.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -93.84 169.24 10.44 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.597 -0.729 . . . . 60.149999999999999 109.408 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -167.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 127.136 2.174 . . . . 71.109999999999999 114.208 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -44.14 -13.12 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 126.241 1.817 . . . . 75.409999999999997 115.528 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -22.96 0.38 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 126.499 1.92 . . . . 73.430000000000007 113.998 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -56.21 -30.59 30.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 O-C-N 122.001 -0.437 . . . . 74.409999999999997 110.287 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.38 -33.49 84.79 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 122.054 -0.403 . . . . 75.109999999999999 113.378 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.22 -32.13 64.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.527 0.731 . . . . 45.039999999999999 110.697 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 11.0 t80 -55.56 -45.85 77.24 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.162 -0.926 . . . . 74.329999999999998 111.182 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.82 -24.12 48.83 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.195 -0.315 . . . . 71.150000000000006 111.613 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -74.83 -11.11 60.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.661 0.785 . . . . 63.200000000000003 112.183 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -15.83 61.88 Favored 'General case' 0 CA--C 1.557 1.238 0 O-C-N 121.854 -0.529 . . . . 61.5 111.733 172.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 -44.41 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.909 0.484 . . . . 71.040000000000006 111.115 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -139.08 -162.09 8.99 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.365 -0.921 . . . . 64.239999999999995 114.72 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.0 138.2 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.832 0.453 . . . . 73.400000000000006 110.835 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.82 114.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 O-C-N 123.885 0.741 . . . . 64.299999999999997 110.947 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -100.96 144.16 30.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.763 -1.108 . . . . 53.420000000000002 111.308 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.8 m -83.39 118.1 23.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.369 -1.287 . . . . 74.530000000000001 108.114 168.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.94 133.96 45.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.605 0.565 . . . . 71.329999999999998 109.676 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -77.38 -11.55 59.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.474 0.546 . . . . 72.519999999999996 112.474 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.31 -31.21 68.43 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.106 0.41 . . . . 60.439999999999998 112.106 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.2 t -124.86 -31.68 3.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.625 0.232 . . . . 71.400000000000006 111.625 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.85 69.19 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 116.48 -0.327 . . . . 64.340000000000003 112.515 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 266' ' ' THR . 49.9 mttt -98.45 152.4 37.91 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 123.256 0.623 . . . . 64.439999999999998 112.247 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.02 154.35 74.38 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 123.178 2.585 . . . . 64.140000000000001 111.113 166.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.525 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.94 102.15 6.27 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.651 0.982 . . . . 64.519999999999996 113.651 -168.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.86 112.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.126 -1.435 . . . . 74.530000000000001 107.126 163.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -128.5 114.78 17.2 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.685 0.675 . . . . 72.510000000000005 109.367 161.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.56 110.24 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.363 -0.606 . . . . 73.049999999999997 109.363 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -103.06 112.22 24.96 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 121.356 0.598 . . . . 75.140000000000001 111.009 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.7 p -144.18 120.99 11.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.594 -1.185 . . . . 53.229999999999997 109.997 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.96 112.94 21.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.448 0.642 . . . . 64.209999999999994 111.864 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -7.9 58.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.407 -0.815 . . . . 73.349999999999994 112.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -33.0 69.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.021 0.438 . . . . 72.230000000000004 111.138 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 7.7 t -91.53 -14.53 30.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.776 -0.647 . . . . 74.310000000000002 109.886 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.59 -49.76 1.62 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.589 -0.732 . . . . 43.140000000000001 112.628 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.11 142.09 59.06 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.716 0.304 . . . . 71.019999999999996 110.54 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -57.15 134.56 64.97 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.314 2.676 . . . . 73.239999999999995 114.228 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -60.26 -42.46 95.37 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.928 -1.033 . . . . 74.450000000000003 111.889 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.77 14.59 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.796 -0.716 . . . . 52.310000000000002 113.565 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -118.27 145.86 44.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.086 0.443 . . . . 73.239999999999995 110.517 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.86 156.13 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 61.509999999999998 110.456 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.71 136.08 46.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.74 0.305 . . . . 74.430000000000007 110.211 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.68 148.05 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 116.176 -0.465 . . . . 72.310000000000002 109.747 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.525 ' H ' ' CB ' ' A' ' 270' ' ' MET . 47.4 t -97.66 141.74 30.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.227 1.011 . . . . 74.319999999999993 111.74 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.81 164.89 12.31 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.195 -0.315 . . . . 74.25 110.538 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.0 -47.51 65.35 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.442 0.464 . . . . 74.230000000000004 110.872 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.411 ' HB3' ' HD2' ' A' ' 294' ' ' PRO . 40.3 m-20 -115.11 138.18 23.36 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 116.481 -0.327 . . . . 72.099999999999994 110.232 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -61.88 -37.8 63.65 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 117.782 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 292' ' ' ASP . 33.3 Cg_endo -76.6 -27.3 7.63 Favored 'Trans proline' 0 C--N 1.392 2.824 0 CA-C-N 123.645 2.337 . . . . 71.209999999999994 112.999 -172.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.5 m -59.57 -27.94 66.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.258 1.023 . . . . 73.25 111.738 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.1 -39.28 82.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.506 0.723 . . . . 71.549999999999997 112.892 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -75.07 -32.77 61.57 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.821 0.343 . . . . 65.209999999999994 111.116 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.17 79.99 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.156 -0.475 . . . . 51.240000000000002 110.314 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.13 68.04 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.152 -0.476 . . . . 63.130000000000003 112.204 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.8 mt -67.41 -30.56 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 O-C-N 122.164 -0.335 . . . . 64.319999999999993 110.582 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -59.73 2.66 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 113.904 1.076 . . . . 60.450000000000003 113.904 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -90.73 -37.48 13.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.272 1.953 . . . . 73.430000000000007 116.272 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -82.42 -21.12 35.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.304 0.573 . . . . 75.239999999999995 110.436 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 315' ' ' VAL . 13.9 t70 -83.85 -172.52 4.2 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.083 -0.962 . . . . 62.219999999999999 109.971 168.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 80.86 11.8 83.44 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.854 -0.529 . . . . 42.210000000000001 113.106 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 -159.21 0.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.481 -0.563 . . . . 74.329999999999998 109.481 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.84 145.2 51.41 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.597 0.713 . . . . 74.450000000000003 110.784 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -112.35 113.57 25.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.485 -1.302 . . . . 72.120000000000005 107.485 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.1 m170 64.41 28.51 13.6 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 112.663 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.77 3.37 88.14 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.408 -0.36 . . . . 73.519999999999996 113.458 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -112.87 141.47 46.65 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.739 -0.837 . . . . 63.399999999999999 108.739 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.21 127.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.966 0.413 . . . . 63.350000000000001 110.462 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.6 tt -108.5 144.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.764 -0.653 . . . . 55.130000000000003 109.629 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 39.1 tptt -136.5 121.12 18.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.993 -0.548 . . . . 72.230000000000004 109.95 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 304' ' ' ASP . 8.2 p -107.65 136.74 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.489 -0.778 . . . . 65.120000000000005 109.892 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 m -138.08 174.15 10.87 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 124.146 0.978 . . . . 71.129999999999995 110.13 -173.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -7.25 59.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.632 0.975 . . . . 74.340000000000003 113.632 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 114.593 1.331 . . . . 70.409999999999997 114.593 172.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 . . . . . 0 N--CA 1.449 -0.519 0 N-CA-C 110.26 -0.274 . . . . 74.409999999999997 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 103.95 16.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.905 -0.718 . . . . 71.450000000000003 110.24 162.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.9 m -142.27 144.87 33.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.948 -1.501 . . . . 61.310000000000002 106.948 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 11.8 pt -123.59 141.26 44.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 119.406 1.003 . . . . 73.219999999999999 109.689 168.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.519 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.5 OUTLIER -101.53 122.53 43.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.677 -0.86 . . . . 72.420000000000002 108.677 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.9 141.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.087 -0.709 . . . . 71.0 109.087 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.15 151.03 49.71 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.489 0.716 . . . . 72.319999999999993 110.516 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 312' ' ' ILE . . . 90.9 21.48 36.12 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 124.158 0.911 . . . . 71.310000000000002 113.638 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 76.92 1.0 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.79 -1.189 . . . . 60.240000000000002 107.79 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.68 -90.93 0.42 Allowed Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.587 -0.816 . . . . 63.229999999999997 113.753 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.68 112.9 16.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.929 0.395 . . . . 70.209999999999994 110.791 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.59 20.15 25.41 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.321 -0.854 . . . . 74.430000000000007 111.996 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -87.29 151.83 3.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.681 -0.489 . . . . 75.329999999999998 109.681 -173.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.2 m -93.55 170.63 9.45 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.17 -0.468 . . . . 73.200000000000003 110.0 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -165.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.344 2.258 . . . . 73.109999999999999 114.233 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -42.89 -14.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 127.384 2.273 . . . . 73.319999999999993 114.819 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -46.93 -22.08 0.28 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.671 1.988 . . . . 64.299999999999997 114.723 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -57.46 -32.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 119.341 0.973 . . . . 63.399999999999999 110.699 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.86 85.93 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 120.065 -0.297 . . . . 62.240000000000002 113.463 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 37.4 tt0 -73.47 -31.47 63.78 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.39 0.676 . . . . 71.450000000000003 111.23 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.9 t80 -56.8 -43.44 80.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.144 0.578 . . . . 72.230000000000004 111.298 170.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -79.04 -24.46 43.6 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.471 0.545 . . . . 74.340000000000003 112.471 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 13.2 tptm -63.01 -23.17 67.33 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.356 1.062 . . . . 72.340000000000003 111.681 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.15 -20.38 65.95 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.63 0.604 . . . . 75.430000000000007 112.63 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.5 mm -123.61 41.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 121.419 0.628 . . . . 65.5 110.233 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 150.64 -168.81 30.49 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 118.835 -1.65 . . . . 65.540000000000006 115.02 172.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.29 136.56 37.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.372 -0.414 . . . . 63.200000000000003 110.573 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 38.3 mm -67.46 115.25 5.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.86 -1.064 . . . . 73.510000000000005 110.027 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -98.18 140.54 32.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.505 0.669 . . . . 73.219999999999999 111.3 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.7 m -84.35 116.71 23.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.688 -1.142 . . . . 73.140000000000001 108.074 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.67 126.64 31.19 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 109.132 -0.692 . . . . 72.209999999999994 109.132 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -74.98 -6.32 48.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.229 1.196 . . . . 75.420000000000002 114.229 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.97 -33.47 74.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.23 0.212 . . . . 72.530000000000001 111.147 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.38 -29.33 3.25 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.729 0.299 . . . . 72.209999999999994 111.511 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 91.5 11.02 61.3 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.194 -0.457 . . . . 62.130000000000003 112.811 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.46 ' H ' HG23 ' A' ' 266' ' ' THR . 73.9 mttt -98.62 151.53 37.49 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 122.933 0.493 . . . . 73.239999999999995 112.182 173.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.99 155.52 63.96 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 123.981 3.12 . . . . 64.109999999999999 112.837 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.466 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -70.35 98.91 1.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.03 1.122 . . . . 71.349999999999994 114.03 -173.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.5 mm -144.19 113.07 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.224 -1.398 . . . . 74.010000000000005 107.224 164.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -128.7 115.05 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 119.262 0.937 . . . . 71.239999999999995 109.891 161.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.69 111.21 21.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.957 0.408 . . . . 64.230000000000004 110.083 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 62.2 m-85 -103.54 111.53 24.02 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 121.356 0.598 . . . . 71.420000000000002 110.39 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.442 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.2 p -143.2 122.51 13.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.027 -1.442 . . . . 63.299999999999997 110.136 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.7 112.02 20.65 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.207 0.527 . . . . 62.149999999999999 111.497 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.21 -9.82 54.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.146 0.795 . . . . 54.109999999999999 113.146 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -28.65 56.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.566 0.222 . . . . 65.510000000000005 110.582 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 56.8 p -88.69 -21.04 24.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.375 0.607 . . . . 62.140000000000001 109.454 169.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.32 -12.14 70.29 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 114.932 -1.031 . . . . 75.109999999999999 112.944 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -121.08 140.26 30.72 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 110.184 -0.302 . . . . 72.219999999999999 110.184 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.47 133.5 55.06 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 123.187 2.591 . . . . 70.239999999999995 114.209 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.4 mttt -62.12 -34.37 76.23 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.798 -1.092 . . . . 65.409999999999997 112.357 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.34 24.46 18.89 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.94 -0.648 . . . . 43.049999999999997 112.723 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 35.9 mt-10 -119.35 142.1 48.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.764 -0.774 . . . . 74.310000000000002 109.901 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.59 143.04 23.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.264 -0.643 . . . . 40.520000000000003 109.264 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 237' ' ' PHE . 62.4 p -128.43 139.62 52.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.289 -0.634 . . . . 75.319999999999993 109.289 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.89 144.47 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 120.947 0.404 . . . . 52.350000000000001 110.17 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 270' ' ' MET . 43.3 t -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.49 0.716 . . . . 61.039999999999999 112.041 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.82 164.97 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.658 -0.246 . . . . 75.150000000000006 111.422 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.11 -48.05 63.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.117 0.567 . . . . 75.019999999999996 112.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -122.23 136.45 26.42 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.641 -0.874 . . . . 72.239999999999995 108.641 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.9 -37.9 62.68 Favored 'Trans proline' 0 CA--C 1.567 2.151 0 C-N-CA 123.099 2.532 . . . . 65.200000000000003 117.462 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 -29.01 18.08 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.762 2.379 . . . . 61.119999999999997 113.238 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.0 m -60.04 -29.02 68.23 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.306 1.043 . . . . 74.450000000000003 112.063 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.49 -38.61 81.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.639 0.775 . . . . 61.43 112.759 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -74.36 -36.01 63.57 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.258 0.551 . . . . 74.430000000000007 111.126 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.75 81.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.074 -0.967 . . . . 73.310000000000002 110.929 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.72 -29.66 68.13 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 123.583 0.552 . . . . 64.340000000000003 111.976 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 296' ' ' ALA . 78.9 mt -63.29 -34.72 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 117.772 0.26 . . . . 75.019999999999996 110.713 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.41 -60.05 2.52 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 114.19 1.181 . . . . 71.519999999999996 114.19 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.44 -34.05 15.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.194 1.924 . . . . 73.540000000000006 116.194 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.441 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 60.3 t80 -85.65 -18.47 33.14 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.191 0.52 . . . . 65.400000000000006 110.167 -171.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -107.59 -175.51 2.81 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.339 -0.986 . . . . 73.120000000000005 108.339 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.45 56.42 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.679 -0.296 . . . . 62.219999999999999 112.378 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.56 -153.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.939 -0.393 . . . . 75.530000000000001 109.939 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -120.68 146.24 46.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.82 0.448 . . . . 72.120000000000005 110.783 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -113.7 110.76 20.71 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.68 -1.23 . . . . 63.009999999999998 107.68 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 18.8 m170 64.96 29.64 12.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.638 1.175 . . . . 73.109999999999999 112.245 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.14 83.84 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.394 -0.366 . . . . 74.409999999999997 113.98 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -110.22 148.72 31.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 117.222 0.511 . . . . 64.430000000000007 110.159 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . 0.406 ' O ' ' HA3' ' A' ' 240' ' ' GLY . 46.6 mm -68.78 126.0 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 123.467 0.48 . . . . 74.510000000000005 110.767 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.22 142.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.939 -0.573 . . . . 72.140000000000001 109.944 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -136.42 129.84 31.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 71.430000000000007 111.034 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.91 137.33 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.201 0.524 . . . . 62.439999999999998 109.75 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -136.38 172.94 12.28 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.102 0.961 . . . . 71.230000000000004 109.451 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.77 -4.66 55.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.193 0.812 . . . . 74.049999999999997 113.193 174.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 124.914 1.286 . . . . 73.340000000000003 112.883 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.9 0.381 . . . . 51.240000000000002 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.8 105.66 17.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.495 -0.482 . . . . 75.340000000000003 110.186 162.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -142.25 150.25 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.066 -1.457 . . . . 64.209999999999994 107.066 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.23 137.22 57.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 119.154 0.888 . . . . 65.450000000000003 109.837 165.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.666 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.91 116.94 33.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.789 -0.819 . . . . 73.239999999999995 108.789 -177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.02 139.7 36.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.42 -0.585 . . . . 71.010000000000005 109.42 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 25.6 tp60 -128.9 142.71 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.761 -0.829 . . . . 65.109999999999999 108.761 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.8 20.75 11.09 Favored Glycine 0 N--CA 1.462 0.371 0 C-N-CA 121.139 -0.553 . . . . 53.32 112.464 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.72 73.06 0.8 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.55 -0.907 . . . . 70.439999999999998 108.55 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.86 -178.44 26.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.477 -0.783 . . . . 71.030000000000001 112.018 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 282' ' ' PRO 0.261 12.0 pt-20 40.84 87.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.833 2.053 . . . . 45.520000000000003 114.845 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.18 21.11 25.95 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.008 -0.837 . . . . 65.150000000000006 111.008 -173.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.94 151.59 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.242 -0.651 . . . . 71.230000000000004 109.242 -173.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.6 m -84.61 168.69 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.76 -0.655 . . . . 74.530000000000001 110.23 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -169.13 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.618 1.967 . . . . 74.439999999999998 113.07 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -44.11 -12.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 126.422 1.889 . . . . 75.439999999999998 115.468 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.09 -23.17 0.28 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.314 1.846 . . . . 71.150000000000006 113.701 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -57.78 -31.33 39.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 109.585 -0.524 . . . . 73.540000000000006 109.585 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.07 83.68 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-O 119.907 -0.385 . . . . 60.140000000000001 113.438 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -76.1 -29.65 57.99 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.243 0.617 . . . . 74.340000000000003 111.241 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.8 t80 -55.5 -44.56 76.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.498 0.719 . . . . 73.129999999999995 110.419 169.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -77.82 -24.54 48.68 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.685 0.254 . . . . 74.120000000000005 111.685 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 260' ' ' ILE . 10.9 tmtt? -68.98 -18.78 64.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.585 0.754 . . . . 74.319999999999993 111.292 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -62.86 -22.12 66.46 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 122.297 -0.252 . . . . 73.129999999999995 110.802 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -122.83 63.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.369 -0.604 . . . . 70.310000000000002 109.369 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.07 -172.84 26.59 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 118.803 -1.665 . . . . 33.539999999999999 115.366 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.48 138.48 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.165 -1.018 . . . . 73.140000000000001 109.62 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 255' ' ' LYS . 47.7 mm -70.35 116.05 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.272 0.558 . . . . 71.109999999999999 110.373 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -96.42 140.15 31.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 72.329999999999998 111.404 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 89.7 m -86.0 117.5 24.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.132 -0.94 . . . . 74.430000000000007 108.597 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -72.75 136.97 45.59 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.42 -0.354 . . . . 71.239999999999995 111.069 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -78.76 -9.39 59.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.003 0.742 . . . . 64.239999999999995 113.003 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.43 -39.56 77.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.011 0.374 . . . . 64.25 112.011 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 t -126.25 -19.4 4.71 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.532 0.206 . . . . 73.150000000000006 111.359 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.49 57.17 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.519 -0.309 . . . . 74.140000000000001 113.063 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -99.93 153.91 37.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.99 0.367 . . . . 74.409999999999997 111.99 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.41 153.06 76.89 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.056 2.504 . . . . 64.0 111.723 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.463 ' HE3' ' HB ' ' A' ' 288' ' ' VAL . 1.4 ptm -76.73 100.15 5.33 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.162 0.801 . . . . 71.530000000000001 113.162 -171.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.5 mm -143.14 113.92 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.129 -1.434 . . . . 74.340000000000003 107.129 165.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -128.13 117.61 21.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 119.177 0.898 . . . . 75.530000000000001 109.815 162.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.53 112.74 23.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 64.200000000000003 110.218 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 61.8 m-85 -101.62 111.68 24.01 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-N 115.907 -0.588 . . . . 54.530000000000001 109.663 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.2 p -143.74 122.07 12.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.317 -1.311 . . . . 73.340000000000003 109.231 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.49 110.7 18.87 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.256 0.55 . . . . 62.210000000000001 111.043 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -7.43 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.213 0.82 . . . . 63.219999999999999 113.213 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -32.43 70.09 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.252 0.345 . . . . 72.340000000000003 110.816 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -91.88 -19.18 22.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.149 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 102.27 -44.43 1.52 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.004 -0.543 . . . . 70.030000000000001 112.911 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -81.95 142.1 48.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.587 0.227 . . . . 54.140000000000001 111.187 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 243' ' ' GLU . 10.1 Cg_endo -58.69 130.86 39.06 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.909 2.406 . . . . 51.039999999999999 113.508 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -59.98 -39.12 84.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.926 -1.034 . . . . 70.140000000000001 112.165 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.9 25.23 15.24 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.668 -0.777 . . . . 62.210000000000001 113.076 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 37.3 mt-10 -118.81 143.56 46.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.101 0.451 . . . . 73.519999999999996 110.084 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.13 143.36 23.26 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.455 0.302 . . . . 61.43 110.341 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.6 p -125.53 138.86 53.98 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 122.074 -0.391 . . . . 71.439999999999998 110.296 173.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.463 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 7.4 m -136.86 148.06 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.992 -0.373 . . . . 75.209999999999994 109.992 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.432 ' H ' ' CB ' ' A' ' 270' ' ' MET . 49.8 m -108.44 117.48 34.27 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.978 0.733 . . . . 51.020000000000003 112.978 -172.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.44 163.94 19.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.759 0.424 . . . . 72.200000000000003 111.897 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.2 -48.42 20.47 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 116.536 -0.302 . . . . 61.009999999999998 110.686 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.01 135.61 23.41 Favored Pre-proline 0 C--O 1.239 0.548 0 O-C-N 123.203 0.314 . . . . 74.319999999999993 110.743 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.81 -41.16 19.08 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 122.802 2.334 . . . . 62.43 116.813 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.58 -29.74 52.15 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 122.946 2.088 . . . . 74.420000000000002 113.806 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 49.8 m -64.29 -27.42 69.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.099 0.96 . . . . 71.430000000000007 112.465 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.19 88.75 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 122.841 0.457 . . . . 71.140000000000001 111.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.62 -39.68 88.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.153 0.581 . . . . 63.310000000000002 110.349 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.86 76.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.521 -0.763 . . . . 75.209999999999994 111.448 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.92 -33.14 73.26 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.709 0.404 . . . . 71.120000000000005 111.623 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 75.2 mt -64.8 -33.41 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.849 0.357 . . . . 71.239999999999995 110.603 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.49 -60.33 2.4 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.766 1.024 . . . . 75.140000000000001 113.766 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -91.72 -31.84 15.65 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.867 1.803 . . . . 73.200000000000003 115.867 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 72.2 t80 -87.49 -14.79 39.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.371 0.605 . . . . 73.219999999999999 109.937 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -104.89 173.81 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.337 -0.986 . . . . 74.239999999999995 108.337 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.28 14.21 51.83 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.731 -0.747 . . . . 71.230000000000004 112.228 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -131.25 -156.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.699 -0.852 . . . . 71.420000000000002 108.699 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -132.84 148.77 52.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.618 0.723 . . . . 65.5 111.011 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -113.61 117.7 32.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.4 m170 64.69 28.47 13.08 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.722 1.209 . . . . 61.340000000000003 112.17 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.07 86.52 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.405 -0.361 . . . . 72.109999999999999 113.762 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.55 144.84 42.19 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 109.197 -0.668 . . . . 72.239999999999995 109.197 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.65 130.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.165 0.507 . . . . 64.420000000000002 111.673 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.5 tt -110.43 142.51 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.324 -0.853 . . . . 74.219999999999999 110.023 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -136.86 126.87 25.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.236 0.614 . . . . 61.530000000000001 111.341 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 31.6 t -108.7 138.83 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.276 -0.42 . . . . 74.010000000000005 110.877 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -134.95 176.61 8.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 63.549999999999997 110.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.77 -11.58 59.83 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.97 1.1 . . . . 71.319999999999993 113.97 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 237' ' ' PHE . . . . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 124.289 1.036 . . . . 65.549999999999997 113.319 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.7 t30 . . . . . 0 C--O 1.233 0.222 0 CA-C-O 120.596 0.236 . . . . 71.109999999999999 110.382 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.47 103.96 15.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 118.623 -1.231 . . . . 74.400000000000006 110.477 160.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -143.03 149.0 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.241 -1.392 . . . . 52.310000000000002 107.241 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.0 pt -125.18 139.46 51.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 118.8 0.727 . . . . 53.149999999999999 109.605 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.663 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.51 120.52 39.78 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.987 -0.746 . . . . 73.430000000000007 108.987 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.81 138.19 45.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.962 -0.563 . . . . 74.319999999999993 109.973 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.54 144.32 51.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 72.0 110.984 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.17 20.78 11.76 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.878 0.736 . . . . 63.539999999999999 112.969 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.48 75.08 0.92 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.602 -0.888 . . . . 71.420000000000002 108.602 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -127.31 -97.16 0.96 Allowed Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.524 -0.846 . . . . 63.109999999999999 113.565 -170.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -76.74 117.07 17.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.853 0.358 . . . . 64.519999999999996 111.104 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.17 19.66 30.04 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.218 -0.901 . . . . 72.310000000000002 111.675 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.22 151.29 4.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.357 0.599 . . . . 41.32 109.494 -174.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.9 t -93.46 170.61 9.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.235 -0.654 . . . . 72.549999999999997 109.235 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -167.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.489 2.316 . . . . 70.030000000000001 113.379 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -44.44 -12.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 126.497 1.919 . . . . 73.340000000000003 115.253 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.3 -23.04 0.49 Allowed 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 126.692 1.997 . . . . 73.430000000000007 112.892 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -31.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-N 118.653 0.661 . . . . 70.099999999999994 109.523 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.29 -35.48 88.34 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.248 -0.751 . . . . 41.399999999999999 114.383 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -75.77 -28.21 58.33 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 117.961 0.881 . . . . 72.230000000000004 110.832 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.586 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 6.7 t80 -55.66 -47.35 76.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.013 0.925 . . . . 65.209999999999994 110.671 171.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.59 -23.36 46.03 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.057 0.391 . . . . 75.340000000000003 112.057 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 11.5 tptm -61.3 -26.21 67.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.387 1.075 . . . . 74.430000000000007 111.221 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.84 -19.73 64.39 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 111.905 0.335 . . . . 74.239999999999995 111.905 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.1 mm -124.23 62.62 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 109.598 -0.519 . . . . 73.099999999999994 109.598 170.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.76 -174.09 25.86 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 118.621 -1.752 . . . . 72.340000000000003 115.056 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.18 137.74 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.121 -0.696 . . . . 73.310000000000002 109.121 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.1 mm -71.48 113.22 7.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.298 0.571 . . . . 55.219999999999999 110.391 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -99.66 140.05 34.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.998 -1.001 . . . . 73.219999999999999 110.991 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 59.2 m -85.07 116.38 23.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.066 -0.97 . . . . 74.239999999999995 108.606 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.16 131.1 41.62 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.086 0.554 . . . . 75.120000000000005 110.213 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.7 -7.03 55.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.42 0.896 . . . . 54.340000000000003 113.42 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.25 -35.95 80.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.745 0.307 . . . . 72.150000000000006 111.108 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.8 p -125.25 -33.56 2.84 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.029 -0.532 . . . . 64.329999999999998 111.927 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.76 11.41 65.76 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.959 -0.564 . . . . 64.129999999999995 111.927 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -97.35 150.83 37.23 Favored Pre-proline 0 C--O 1.239 0.528 0 C-N-CA 123.238 0.615 . . . . 74.450000000000003 110.877 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.87 153.92 74.28 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.998 2.466 . . . . 72.319999999999993 111.241 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.471 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -73.22 101.19 3.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.645 0.979 . . . . 75.239999999999995 113.645 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -143.2 113.32 2.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.139 -1.391 . . . . 64.420000000000002 107.342 163.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -127.6 113.71 16.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 119.182 0.901 . . . . 64.099999999999994 109.768 163.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 110.53 20.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.205 -0.294 . . . . 72.329999999999998 110.205 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 36.3 m-85 -103.0 111.54 23.93 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 121.266 0.555 . . . . 72.420000000000002 110.156 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 20.9 p -145.0 120.98 10.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.984 -1.462 . . . . 54.130000000000003 109.624 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -87.47 112.67 22.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.462 0.648 . . . . 62.520000000000003 111.762 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -10.23 55.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 112.22 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.363 0.415 . . . . 61.219999999999999 111.191 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.2 p -90.81 -20.45 22.31 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.337 0.589 . . . . 70.510000000000005 109.892 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 85.62 7.73 81.39 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.077 -0.965 . . . . 62.450000000000003 112.697 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 139.99 25.95 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 110.338 -0.245 . . . . 71.120000000000005 110.338 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -58.97 130.75 38.04 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.185 2.59 . . . . 53.340000000000003 113.893 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.488 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 40.9 mtpt -63.16 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.874 -1.057 . . . . 75.209999999999994 111.992 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.78 14.86 Favored Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.436 -0.802 . . . . 74.010000000000005 112.671 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.7 mt-10 -115.48 140.65 48.96 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.212 -0.595 . . . . 74.430000000000007 110.239 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.96 143.16 22.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.106 -0.497 . . . . 73.310000000000002 109.893 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 237' ' ' PHE . 72.3 p -128.98 139.78 51.95 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.756 -0.377 . . . . 73.540000000000006 110.538 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.45 147.63 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 121.176 0.512 . . . . 45.340000000000003 110.433 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.471 ' H ' ' CB ' ' A' ' 270' ' ' MET . 44.3 t -94.29 128.03 40.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.729 0.812 . . . . 74.319999999999993 112.583 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.28 165.78 12.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.678 0.621 . . . . 75.129999999999995 112.678 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -42.37 59.61 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.573 0.546 . . . . 61.509999999999998 111.661 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 136.96 29.83 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 109.843 -0.429 . . . . 72.129999999999995 109.843 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -59.94 -37.19 87.11 Favored 'Trans proline' 0 CA--C 1.562 1.92 0 C-N-CA 123.53 2.82 . . . . 73.400000000000006 117.203 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 -29.75 10.71 Favored 'Trans proline' 0 C--N 1.392 2.825 0 CA-C-N 123.321 2.222 . . . . 64.239999999999995 112.691 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 33.6 m -62.97 -32.75 74.15 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.158 0.983 . . . . 64.0 111.315 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.74 83.71 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.011 0.819 . . . . 41.030000000000001 111.822 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -48.18 78.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.376 0.422 . . . . 75.230000000000004 111.268 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.78 97.53 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 123.714 0.634 . . . . 74.430000000000007 110.862 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.85 68.15 Favored 'General case' 0 C--O 1.184 -2.389 0 CA-C-N 115.283 -0.871 . . . . 64.319999999999993 111.156 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.19 -34.47 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.128 0.571 . . . . 73.329999999999998 112.428 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.28 -54.91 22.14 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.688 0.625 . . . . 72.340000000000003 112.688 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -27.26 19.22 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.248 2.314 . . . . 74.439999999999998 117.248 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.57 -20.39 39.98 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.175 0.99 . . . . 75.340000000000003 112.038 -170.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.8 166.65 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.213 -0.662 . . . . 75.200000000000003 109.213 175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.98 12.87 54.8 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.156 -0.545 . . . . 73.430000000000007 112.627 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -122.05 -159.37 0.82 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.29 -1.004 . . . . 74.420000000000002 108.29 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -130.56 143.02 50.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.555 0.693 . . . . 52.140000000000001 111.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -113.14 110.73 20.92 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.14 -1.059 . . . . 73.120000000000005 108.14 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.3 m170 64.33 30.11 13.43 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.516 1.135 . . . . 74.329999999999998 112.095 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.76 84.46 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 114.369 0.507 . . . . 62.530000000000001 114.369 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.2 147.39 37.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.548 -0.538 . . . . 70.530000000000001 109.548 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.69 124.92 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.177 0.513 . . . . 73.310000000000002 111.202 -172.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 134.83 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.403 -0.817 . . . . 73.219999999999999 110.65 -174.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -130.56 145.22 51.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.856 -0.611 . . . . 62.229999999999997 111.017 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.42 140.08 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.984 -0.553 . . . . 73.140000000000001 109.903 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -133.48 176.5 8.48 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.1 0.96 . . . . 64.519999999999996 109.984 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -83.13 -8.61 59.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.596 0.962 . . . . 73.340000000000003 113.596 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 C-N-CA 124.332 1.053 . . . . 64.5 112.61 178.498 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.238 0.493 0 N-CA-C 109.448 -0.575 . . . . 64.519999999999996 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.0 106.4 18.49 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.529 -0.868 . . . . 62.299999999999997 110.34 168.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.9 m -142.05 142.21 32.84 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.532 -0.914 . . . . 71.030000000000001 108.532 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 pt -121.83 138.97 50.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 119.897 -0.721 . . . . 72.040000000000006 110.241 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.7 120.66 40.95 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.818 -0.628 . . . . 63.509999999999998 109.928 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -112.82 142.82 23.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.87 0.843 . . . . 74.430000000000007 113.046 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.32 151.99 48.04 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.1 -1.864 . . . . 55.409999999999997 109.493 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.81 16.95 46.34 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.171 -0.537 . . . . 74.349999999999994 113.172 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 286' ' ' ALA . 0.5 OUTLIER -106.07 64.15 0.67 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.659 0.743 . . . . 61.210000000000001 109.273 172.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -106.03 -103.89 2.9 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 115.348 -0.842 . . . . 31.32 112.951 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.86 119.6 17.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.547 0.689 . . . . 74.510000000000005 112.415 -173.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.24 18.96 29.56 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.634 -1.166 . . . . 61.350000000000001 111.694 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.01 151.94 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.129 0.49 . . . . 72.209999999999994 109.804 -172.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.3 m -90.64 170.46 10.14 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.691 -0.686 . . . . 60.240000000000002 109.619 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -167.75 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.637 1.975 . . . . 73.099999999999994 114.239 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -43.38 -12.91 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 C-N-CA 126.148 1.779 . . . . 73.530000000000001 115.444 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -46.78 -20.99 0.16 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 126.26 1.824 . . . . 74.340000000000003 114.243 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -55.72 -32.7 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.454 0.57 . . . . 73.439999999999998 110.491 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.71 81.66 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 119.953 -0.359 . . . . 74.219999999999999 113.611 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.95 -31.52 64.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.023 0.929 . . . . 55.340000000000003 111.003 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.0 t80 -58.61 -44.79 90.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.873 0.869 . . . . 63.219999999999999 110.887 171.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -76.87 -24.37 52.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 121.196 -0.202 . . . . 73.540000000000006 111.32 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -73.05 -15.91 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.497 0.719 . . . . 71.099999999999994 111.342 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.82 -17.68 64.81 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.805 -0.559 . . . . 73.340000000000003 111.12 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.06 58.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 109.377 -0.601 . . . . 74.519999999999996 109.377 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.71 -179.05 26.81 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 119.903 -1.142 . . . . 70.030000000000001 114.692 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 11.8 mt -106.73 139.7 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.435 0.694 . . . . 64.439999999999998 110.326 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.85 114.76 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.958 -0.564 . . . . 75.230000000000004 110.437 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.87 138.36 35.33 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.423 -0.808 . . . . 61.310000000000002 110.342 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 57.7 m -84.45 116.12 22.91 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.836 -1.172 . . . . 75.409999999999997 107.836 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.48 128.35 35.33 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 109.323 -0.621 . . . . 63.43 109.323 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -78.57 -8.38 58.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.128 0.788 . . . . 72.510000000000005 113.128 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -68.97 -29.88 68.19 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.54 0.2 . . . . 62.0 111.54 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 268' ' ' LYS . 4.8 t -125.46 -30.07 3.15 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 111.643 0.238 . . . . 74.219999999999999 111.643 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.79 13.61 60.72 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.566 -0.288 . . . . 15.119999999999999 113.027 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.439 ' H ' HG23 ' A' ' 266' ' ' THR . 7.9 mptt -99.18 152.71 37.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 122.852 0.461 . . . . 73.439999999999998 112.093 173.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.46 154.78 66.38 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.579 2.853 . . . . 65.409999999999997 111.695 165.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.544 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -77.83 98.64 5.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.31 0.856 . . . . 75.099999999999994 113.31 -168.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 36.4 mm -143.43 113.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 75.540000000000006 107.253 165.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -129.36 114.45 16.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.836 0.743 . . . . 75.209999999999994 109.909 161.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.91 111.29 21.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.962 -0.385 . . . . 74.340000000000003 109.962 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 37.8 m-85 -103.63 113.23 26.59 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 115.972 -0.558 . . . . 71.409999999999997 110.774 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.451 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.3 p -142.4 123.79 14.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.469 -1.242 . . . . 55.450000000000003 110.337 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.85 112.52 21.21 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.272 0.558 . . . . 72.209999999999994 111.763 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -86.83 -10.93 52.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.622 0.971 . . . . 55.020000000000003 113.622 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.28 -34.55 61.33 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.998 0.428 . . . . 74.239999999999995 110.652 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -90.33 -15.25 31.5 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.705 -0.68 . . . . 70.129999999999995 109.716 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.16 -45.06 1.61 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.874 -0.603 . . . . 72.450000000000003 113.111 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -83.85 141.85 41.5 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 111.854 0.316 . . . . 73.430000000000007 111.854 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 136.96 72.28 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.345 2.697 . . . . 64.140000000000001 113.848 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 275' ' ' THR . 37.6 mttt -68.79 -33.4 73.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.027 -0.988 . . . . 73.120000000000005 111.621 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.85 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.729 -0.669 . . . . 33.530000000000001 113.081 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 47.7 mt-10 -115.5 143.21 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.944 -0.391 . . . . 65.310000000000002 109.944 -171.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -152.01 155.37 37.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.386 . . . . 75.519999999999996 111.05 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.3 p -131.12 135.42 47.47 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.76 -0.459 . . . . 73.340000000000003 109.76 165.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.491 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 11.4 m -137.06 148.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 109.055 -0.72 . . . . 74.340000000000003 109.055 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.544 ' H ' ' CB ' ' A' ' 270' ' ' MET . 17.4 m -114.15 119.41 36.99 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.038 0.755 . . . . 54.240000000000002 113.038 -168.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.95 165.14 17.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.269 0.84 . . . . 63.32 113.269 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.53 -47.24 34.03 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.811 -1.086 . . . . 74.209999999999994 111.087 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 137.66 21.53 Favored Pre-proline 0 C--O 1.237 0.402 0 O-C-N 123.523 0.515 . . . . 54.140000000000001 110.701 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.55 -38.75 60.23 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.192 2.594 . . . . 52.130000000000003 117.246 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.87 -29.79 22.81 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 123.185 2.173 . . . . 53.439999999999998 113.047 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -61.41 -28.37 69.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.336 1.054 . . . . 63.009999999999998 112.078 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -70.39 -43.49 69.97 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.425 0.528 . . . . 75.120000000000005 112.425 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -73.73 -34.15 64.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.346 0.593 . . . . 75.109999999999999 111.054 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.53 -32.43 71.25 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.569 -0.741 . . . . 73.319999999999993 110.444 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.48 -27.71 65.45 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 122.297 0.239 . . . . 65.409999999999997 111.204 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 296' ' ' ALA . 44.9 mt -66.98 -32.3 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 121.881 -0.512 . . . . 64.030000000000001 110.702 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.06 -59.09 2.92 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.09 1.144 . . . . 71.420000000000002 114.09 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -36.35 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.606 1.706 . . . . 70.030000000000001 115.606 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -84.9 -22.99 29.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.437 0.295 . . . . 72.420000000000002 110.452 -168.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -85.59 -177.11 6.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.715 -0.675 . . . . 74.519999999999996 110.238 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.21 3.83 84.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 114.191 0.437 . . . . 61.109999999999999 114.191 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -123.48 -154.47 0.61 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.611 -0.514 . . . . 73.239999999999995 109.611 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.96 140.74 52.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.43 0.633 . . . . 64.530000000000001 110.958 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -114.22 111.28 21.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.136 -1.431 . . . . 73.5 107.136 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 20.6 m170 64.85 30.52 12.1 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.818 1.247 . . . . 73.150000000000006 112.672 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.2 10.54 77.76 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 116.298 -0.41 . . . . 74.310000000000002 113.875 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -126.72 148.62 49.86 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.269 -0.641 . . . . 74.5 109.269 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.62 130.76 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 123.523 0.515 . . . . 73.129999999999995 110.628 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.5 tt -107.75 143.32 18.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.824 -0.806 . . . . 73.109999999999999 108.824 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 4.3 tmtp? -135.95 122.55 20.89 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.292 -0.633 . . . . 63.219999999999999 109.292 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 238' ' ' VAL . 9.8 p -111.45 137.35 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.701 0.625 . . . . 74.230000000000004 109.608 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -138.21 173.5 11.55 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 123.177 0.591 . . . . 72.040000000000006 110.564 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -3.23 51.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.126 0.787 . . . . 71.420000000000002 113.126 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 C-N-CA 124.319 1.047 . . . . 52.530000000000001 113.183 174.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 t30 . . . . . 0 C--O 1.238 0.491 0 CA-C-O 120.488 0.185 . . . . 62.240000000000002 110.653 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.81 106.83 18.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.192 0.52 . . . . 71.230000000000004 110.207 165.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.7 m -141.96 148.88 39.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.889 -1.152 . . . . 55.32 107.889 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.7 pt -122.69 141.24 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.722 0.692 . . . . 63.219999999999999 109.173 166.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.84 134.8 43.27 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.154 -0.684 . . . . 75.310000000000002 109.154 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -128.03 144.55 37.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.664 0.745 . . . . 74.409999999999997 112.637 178.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.04 147.11 50.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 113.988 -1.46 . . . . 75.310000000000002 109.773 -176.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.13 32.75 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 123.823 0.702 . . . . 63.020000000000003 112.644 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 72.21 0.81 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.967 -1.123 . . . . 53.030000000000001 107.967 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.31 157.33 27.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.271 -0.877 . . . . 42.200000000000003 112.868 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.66 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.642 . . . . 71.400000000000006 113.062 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.71 21.64 36.21 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.198 -0.91 . . . . 14.449999999999999 111.04 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.48 150.1 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.535 -0.543 . . . . 63.229999999999997 109.535 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 24.6 m -88.55 170.35 10.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.74 -0.663 . . . . 64.150000000000006 110.831 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -169.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.547 1.939 . . . . 73.430000000000007 113.37 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -43.91 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 127.028 2.131 . . . . 71.109999999999999 116.074 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -48.31 -23.19 0.83 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 126.511 1.924 . . . . 74.120000000000005 113.77 170.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -57.4 -29.78 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.834 0.453 . . . . 72.099999999999994 110.63 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.31 -38.04 94.01 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.714 -0.492 . . . . 72.099999999999994 113.37 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.95 -30.56 66.88 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.795 0.838 . . . . 71.200000000000003 111.389 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.8 t80 -56.62 -45.87 81.25 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.83 0.852 . . . . 64.510000000000005 111.186 171.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -77.61 -22.64 50.48 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 122.055 -0.403 . . . . 75.049999999999997 111.53 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 260' ' ' ILE . 66.0 tttt -75.54 -10.63 59.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.527 1.131 . . . . 73.010000000000005 111.94 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.01 -16.72 62.26 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 121.807 -0.558 . . . . 62.229999999999997 111.523 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.1 mm -103.49 -48.19 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.458 0.703 . . . . 71.530000000000001 110.274 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -135.8 -159.51 8.55 Favored Glycine 0 C--O 1.22 -0.747 0 C-N-CA 120.769 -0.729 . . . . 73.310000000000002 113.428 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.9 mt -107.65 142.09 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.339 0.656 . . . . 73.140000000000001 111.754 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.7 mm -65.39 115.14 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 123.717 0.636 . . . . 75.5 110.142 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -98.08 140.11 32.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.453 -0.794 . . . . 65.120000000000005 111.369 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.0 m -85.52 117.75 24.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.106 -0.952 . . . . 72.239999999999995 108.478 168.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.1 125.79 29.9 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 109.062 -0.718 . . . . 72.420000000000002 109.062 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.8 -9.51 58.66 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.637 0.977 . . . . 54.109999999999999 113.637 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 -29.14 65.31 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 111.884 0.328 . . . . 65.129999999999995 111.884 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.6 t -124.16 -31.79 3.29 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.469 -0.332 . . . . 45.530000000000001 111.641 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.6 6.65 70.1 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 123.338 0.399 . . . . 64.120000000000005 112.679 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.432 ' H ' HG23 ' A' ' 266' ' ' THR . 52.8 mtpt -97.17 151.87 37.95 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.093 0.405 . . . . 75.540000000000006 112.093 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.93 154.06 75.55 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.523 2.815 . . . . 51.340000000000003 111.794 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.481 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.7 ptm -71.98 99.79 2.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.451 1.278 . . . . 65.219999999999999 114.451 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.4 mm -144.16 113.85 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.58 -1.266 . . . . 74.129999999999995 107.58 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -128.99 119.48 24.36 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.077 0.853 . . . . 63.530000000000001 110.57 161.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 113.07 25.18 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.376 0.422 . . . . 71.299999999999997 110.278 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.4 m-85 -102.35 112.68 25.48 Favored 'General case' 0 C--O 1.262 1.761 0 CA-C-O 121.31 0.576 . . . . 75.209999999999994 110.627 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.9 p -144.8 121.16 10.94 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.809 -1.541 . . . . 71.329999999999998 109.455 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.8 113.01 22.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.407 0.623 . . . . 63.240000000000002 111.719 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -8.72 58.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.715 1.006 . . . . 71.530000000000001 113.715 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -30.41 64.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 51.439999999999998 112.08 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -90.66 -19.03 24.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 120.735 -0.386 . . . . 73.120000000000005 110.185 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.5 22.93 38.39 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.951 -0.568 . . . . 74.019999999999996 113.802 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -146.82 147.69 30.62 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.744 -0.465 . . . . 74.120000000000005 109.744 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.38 126.75 22.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.047 1.831 . . . . 73.549999999999997 113.594 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 275' ' ' THR . 10.7 mttm -62.19 -40.11 94.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.88 -1.055 . . . . 74.239999999999995 111.628 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.95 25.15 15.24 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.812 -0.708 . . . . 63.420000000000002 111.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 78.2 mt-10 -119.03 143.75 46.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 64.209999999999994 109.609 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 158.64 44.26 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.623 -0.262 . . . . 62.520000000000003 111.179 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 19.4 p -136.18 137.78 41.25 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.104 -0.332 . . . . 60.210000000000001 110.104 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.12 147.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 116.356 -0.384 . . . . 64.439999999999998 110.461 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.481 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.3 t -99.1 117.49 33.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.309 0.644 . . . . 60.049999999999997 112.664 -174.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 162.81 16.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 121.154 -0.219 . . . . 71.239999999999995 110.867 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.88 -48.63 17.75 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.307 0.484 . . . . 44.530000000000001 112.307 -172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.44 137.18 21.52 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.695 -0.402 . . . . 74.030000000000001 110.904 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.08 -38.02 80.28 Favored 'Trans proline' 0 CA--C 1.566 2.086 0 C-N-CA 123.265 2.644 . . . . 63.219999999999999 116.234 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.65 -30.89 41.62 Favored 'Trans proline' 0 C--N 1.396 3.043 0 CA-C-N 123.314 2.219 . . . . 55.109999999999999 113.177 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 39.7 m -69.76 -29.4 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.477 -0.783 . . . . 65.510000000000005 111.115 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.03 -41.75 58.61 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 122.956 0.502 . . . . 45.130000000000003 111.347 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -33.43 66.83 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 112.009 0.374 . . . . 72.109999999999999 112.009 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.21 75.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.354 -0.384 . . . . 75.049999999999997 110.675 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.44 -25.28 64.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 111.977 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.75 -33.64 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.132 -0.355 . . . . 71.040000000000006 110.489 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.97 -58.82 3.05 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 113.865 1.061 . . . . 74.439999999999998 113.865 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.56 -29.69 18.73 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.219 1.933 . . . . 73.120000000000005 116.219 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 75.0 t80 -89.03 -8.25 54.35 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 118.345 0.521 . . . . 53.409999999999997 111.017 -168.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 165.23 11.34 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 108.217 -1.031 . . . . 73.310000000000002 108.217 170.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.17 13.43 52.4 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.76 -0.734 . . . . 65.239999999999995 112.363 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -122.31 -160.5 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.495 -1.298 . . . . 63.409999999999997 107.495 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.09 143.27 46.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.474 0.654 . . . . 72.5 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -113.81 113.93 25.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.196 -1.039 . . . . 75.209999999999994 108.196 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.17 28.46 14.06 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.809 1.244 . . . . 74.219999999999999 112.593 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.14 74.7 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.568 -0.349 . . . . 71.230000000000004 113.831 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.74 143.52 51.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.419 -0.956 . . . . 65.230000000000004 108.419 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.94 127.68 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.88 0.372 . . . . 71.400000000000006 111.079 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.7 tt -109.78 137.62 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 111.101 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -130.48 128.42 41.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 111.051 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.97 130.49 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 122.99 0.516 . . . . 74.519999999999996 110.759 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -129.42 175.78 8.49 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.626 1.17 . . . . 71.120000000000005 109.414 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.83 -3.13 59.03 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.884 1.068 . . . . 74.299999999999997 113.884 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.314 0 C-N-CA 124.084 0.954 . . . . 62.240000000000002 113.128 177.398 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 110.427 -0.212 . . . . 73.400000000000006 110.427 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.75 106.83 18.78 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.395 0.616 . . . . 74.340000000000003 110.466 165.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.6 m -142.16 149.19 39.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.135 -1.061 . . . . 70.299999999999997 108.135 166.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.96 140.57 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.614 0.643 . . . . 74.319999999999993 109.533 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.07 135.04 43.18 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.037 -0.727 . . . . 70.109999999999999 109.037 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.775 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -126.61 143.68 39.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.626 0.727 . . . . 51.420000000000002 112.538 177.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.78 148.06 50.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.272 -1.331 . . . . 73.25 110.849 -176.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.27 20.0 37.02 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 123.814 0.696 . . . . 71.450000000000003 113.186 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.775 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -113.09 74.14 0.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.684 -1.228 . . . . 62.030000000000001 107.684 177.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.22 -82.6 0.22 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.368 -0.92 . . . . 75.409999999999997 112.808 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 110.39 10.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.785 0.803 . . . . 63.329999999999998 111.532 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.73 19.88 33.18 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.079 -0.964 . . . . 73.200000000000003 111.566 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.95 151.94 4.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.719 -0.474 . . . . 53.130000000000003 109.719 -172.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.5 m -91.49 170.49 9.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.523 -0.762 . . . . 51.32 109.93 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.928 2.091 . . . . 72.319999999999993 113.971 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -43.85 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.606 1.962 . . . . 74.430000000000007 115.319 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.73 -21.47 0.2 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.636 1.975 . . . . 63.32 113.957 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -56.49 -31.53 34.04 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 CA-C-N 118.618 0.645 . . . . 75.409999999999997 109.818 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.92 -33.53 83.94 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 119.858 -0.412 . . . . 70.209999999999994 113.704 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -74.74 -30.47 61.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.907 0.883 . . . . 70.010000000000005 111.184 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.512 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 4.7 t80 -57.5 -46.82 83.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.541 0.736 . . . . 74.049999999999997 110.646 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.93 -23.59 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.432 0.158 . . . . 64.5 111.325 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 260' ' ' ILE . 9.3 tmtt? -69.72 -20.0 63.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.586 0.754 . . . . 73.439999999999998 111.519 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -65.31 -20.01 66.21 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 122.187 -0.321 . . . . 71.400000000000006 111.325 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.1 63.04 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.823 -0.436 . . . . 75.200000000000003 109.823 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.11 178.37 23.22 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.209 -0.996 . . . . 74.150000000000006 115.044 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.08 138.35 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.5 0.72 . . . . 73.219999999999999 110.337 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 255' ' ' LYS . 34.8 mm -71.23 111.9 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.271 0.557 . . . . 74.140000000000001 110.417 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -102.28 144.26 31.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 73.129999999999995 111.32 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.29 132.38 34.63 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.857 -0.794 . . . . 71.430000000000007 108.857 165.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.64 123.52 26.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.479 -0.934 . . . . 62.210000000000001 108.479 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.12 58.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.941 0.719 . . . . 55.32 112.941 -173.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -68.51 -34.22 75.5 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.579 0.352 . . . . 73.239999999999995 111.304 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 p -125.53 -32.0 2.93 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 111.863 0.32 . . . . 73.530000000000001 111.863 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.84 10.18 65.18 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.925 -0.58 . . . . 73.209999999999994 113.487 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -97.19 145.61 29.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 117.335 0.568 . . . . 74.239999999999995 111.224 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.8 153.45 77.79 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.975 2.45 . . . . 64.439999999999998 111.448 168.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.517 ' CB ' ' H ' ' A' ' 289' ' ' SER . 3.4 ptm -71.6 98.63 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.176 1.176 . . . . 73.349999999999994 114.176 -171.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -144.5 112.53 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.026 -1.472 . . . . 54.32 107.026 164.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -130.09 116.72 18.91 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.139 0.882 . . . . 72.430000000000007 109.786 159.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.01 110.55 19.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.786 -0.45 . . . . 61.020000000000003 109.786 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 38.7 m-85 -102.88 112.87 25.88 Favored 'General case' 0 C--O 1.261 1.706 0 CA-C-O 121.247 0.546 . . . . 74.430000000000007 110.896 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 12.0 p -143.32 123.34 13.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.109 -1.405 . . . . 72.409999999999997 110.292 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.63 112.12 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.153 0.501 . . . . 70.340000000000003 111.974 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -11.04 51.07 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.187 0.81 . . . . 74.329999999999998 113.187 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.88 -28.59 58.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.604 0.24 . . . . 74.549999999999997 111.641 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 71.1 p -89.33 -22.22 22.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.146 -0.687 . . . . 64.120000000000005 109.146 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.35 57.25 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.191 -0.913 . . . . 24.32 112.679 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -109.45 139.59 21.27 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.957 -0.386 . . . . 61.140000000000001 109.957 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.02 136.99 78.57 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.152 2.568 . . . . 72.109999999999999 114.448 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 275' ' ' THR . 36.2 mttt -67.85 -35.62 78.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.938 -1.028 . . . . 52.450000000000003 112.053 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.25 22.23 25.34 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.03 -0.605 . . . . 51.530000000000001 112.992 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 34.8 mt-10 -116.22 142.67 46.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.682 -0.407 . . . . 71.420000000000002 109.929 -172.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.73 153.65 34.77 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.596 0.56 . . . . 75.129999999999995 110.661 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 136.21 40.88 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.755 0.312 . . . . 64.439999999999998 110.446 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.27 148.13 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.933 -0.576 . . . . 74.040000000000006 110.139 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.517 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.8 t -105.34 120.26 41.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.65 0.78 . . . . 45.210000000000001 112.664 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -85.77 163.66 18.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.082 0.401 . . . . 73.400000000000006 112.082 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -78.81 -47.46 16.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.299 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -98.67 135.94 20.89 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.348 -0.387 . . . . 73.349999999999994 111.176 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.63 -40.51 29.54 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 122.559 2.173 . . . . 73.430000000000007 115.87 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 -29.74 47.99 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.759 2.021 . . . . 61.200000000000003 113.602 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 75.0 m -64.77 -26.26 68.28 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 73.219999999999999 112.626 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -74.08 -48.34 30.45 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.469 0.308 . . . . 72.340000000000003 111.664 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -33.72 71.69 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.261 0.553 . . . . 74.530000000000001 112.103 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.65 62.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.746 -0.661 . . . . 61.520000000000003 110.937 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.89 -28.7 65.85 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.468 0.175 . . . . 40.210000000000001 111.187 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.34 -33.75 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 O-C-N 122.225 -0.297 . . . . 72.400000000000006 110.468 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.11 -59.4 2.8 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 114.389 1.255 . . . . 61.539999999999999 114.389 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -90.05 -33.68 16.23 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.746 1.758 . . . . 70.450000000000003 115.746 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.4 t80 -85.65 -19.62 30.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.091 0.472 . . . . 73.319999999999993 109.984 -169.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -105.59 174.38 5.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.081 -0.963 . . . . 74.409999999999997 109.207 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.31 53.51 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.893 -0.67 . . . . 24.219999999999999 111.731 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -136.0 -154.52 0.57 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.64 -0.504 . . . . 71.299999999999997 109.64 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.51 145.54 51.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.77 0.795 . . . . 71.299999999999997 111.416 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -114.82 115.96 27.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.546 -1.206 . . . . 62.340000000000003 108.274 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.2 m170 64.44 28.93 13.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.607 1.163 . . . . 53.200000000000003 112.834 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.05 84.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.462 -0.399 . . . . 53.109999999999999 113.887 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -122.62 147.97 45.8 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.92 -0.77 . . . . 61.32 108.92 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.4 mm -69.97 129.74 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.721 0.408 . . . . 74.230000000000004 110.614 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.4 tt -108.41 147.08 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.206 -0.664 . . . . 74.430000000000007 109.206 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -137.2 123.82 21.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.408 -0.36 . . . . 63.43 111.279 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.74 135.83 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.22 0.608 . . . . 51.350000000000001 110.266 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.1 m -138.09 175.24 9.76 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.546 1.139 . . . . 73.340000000000003 109.591 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -85.7 2.0 47.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 71.239999999999995 113.975 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 C-N-CA 123.726 0.81 . . . . 64.540000000000006 112.173 178.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.2 t30 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.755 0.312 . . . . 71.299999999999997 110.337 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.55 105.48 17.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.654 -0.818 . . . . 74.420000000000002 110.182 166.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.4 m -143.2 144.16 32.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.3 pt -120.58 136.62 56.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 119.233 0.924 . . . . 72.040000000000006 109.727 164.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.508 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.14 121.21 41.06 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.39 0.614 . . . . 55.310000000000002 109.526 -178.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.415 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.2 t -118.14 139.59 44.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.309 -0.859 . . . . 60.25 109.954 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.57 141.23 51.43 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.038 -0.727 . . . . 73.129999999999995 109.038 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 104.52 26.64 6.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.156 -0.545 . . . . 70.5 113.221 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 78.93 1.87 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.227 -0.657 . . . . 60.140000000000001 109.227 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -141.42 -79.63 0.05 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 120.058 -1.067 . . . . 74.329999999999998 112.946 -175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.26 110.48 10.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.902 0.382 . . . . 71.319999999999993 111.846 -173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.58 18.73 43.78 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.683 -0.77 . . . . 61.340000000000003 111.686 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.57 151.32 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.195 0.522 . . . . 33.32 109.764 -170.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.405 ' O ' HG13 ' A' ' 245' ' ' VAL . 24.7 m -86.24 169.76 12.73 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.774 -0.648 . . . . 72.239999999999995 109.949 171.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -168.45 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.694 1.998 . . . . 73.129999999999995 112.709 -177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.63 -12.21 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.774 2.03 . . . . 52.439999999999998 115.873 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.8 OUTLIER -47.07 -23.89 0.56 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 126.901 2.081 . . . . 75.010000000000005 113.304 170.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -56.75 -31.45 35.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-N 118.171 0.442 . . . . 52.409999999999997 110.116 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.14 -32.51 76.39 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 121.645 -0.659 . . . . 75.349999999999994 113.659 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -75.71 -31.23 59.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.382 0.673 . . . . 71.25 110.98 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.7 t80 -54.67 -46.77 74.11 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.36 0.664 . . . . 64.030000000000001 110.874 170.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 92.1 m-85 -77.74 -23.27 49.4 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.218 -0.301 . . . . 73.310000000000002 111.68 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' A' ' 260' ' ' ILE . 2.5 tmtm? -67.46 -19.27 65.33 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.579 0.752 . . . . 62.229999999999997 111.549 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.4 pt20 -63.01 -18.99 63.92 Favored 'General case' 0 CA--C 1.558 1.254 0 O-C-N 122.24 -0.287 . . . . 63.340000000000003 111.424 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 mm -120.75 54.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-O 121.211 0.529 . . . . 64.109999999999999 109.838 171.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.29 -169.6 27.56 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 118.268 -1.92 . . . . 61.420000000000002 115.214 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.35 137.66 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.282 -0.959 . . . . 54.210000000000001 109.761 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.5 mm -72.04 114.15 10.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.57 0.7 . . . . 61.520000000000003 110.438 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -98.53 144.3 28.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.65 -1.159 . . . . 75.120000000000005 110.393 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.8 m -84.29 118.92 24.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.631 -0.877 . . . . 62.32 108.631 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.59 128.4 35.45 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 109.354 -0.61 . . . . 71.549999999999997 109.354 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -79.29 -8.38 59.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.378 0.881 . . . . 71.420000000000002 113.378 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.15 -30.52 68.77 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.144 0.277 . . . . 74.439999999999998 111.132 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.0 t -125.46 -31.07 3.04 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.572 -0.285 . . . . 42.409999999999997 111.572 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.93 5.98 67.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.321 -0.4 . . . . 64.420000000000002 112.726 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.452 ' H ' HG23 ' A' ' 266' ' ' THR . 9.4 mttp -97.22 152.64 38.39 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 123.052 0.541 . . . . 74.349999999999994 111.721 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.59 153.31 75.8 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.318 2.678 . . . . 72.099999999999994 111.802 166.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.45 ' HB3' ' H ' ' A' ' 289' ' ' SER . 1.0 OUTLIER -70.23 101.62 1.92 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.966 1.099 . . . . 61.240000000000002 113.966 -173.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.2 mm -143.59 112.9 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.624 -1.25 . . . . 73.299999999999997 107.624 163.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -128.33 116.72 20.24 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.381 0.991 . . . . 52.240000000000002 110.227 164.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 112.12 22.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.007 0.432 . . . . 74.230000000000004 110.426 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 75.2 m-85 -102.51 112.34 25.03 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-N 115.852 -0.613 . . . . 73.430000000000007 110.243 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.4 p -142.28 122.03 13.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.249 -1.341 . . . . 64.310000000000002 110.488 -176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.73 110.98 19.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.229 0.538 . . . . 72.219999999999999 111.217 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -10.8 49.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.53 0.937 . . . . 73.409999999999997 113.53 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.3 -29.27 53.61 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 62.219999999999999 109.718 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 60.9 p -89.1 -20.37 24.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.31 -0.859 . . . . 61.509999999999998 109.836 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.27 -34.65 5.25 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.301 -0.863 . . . . 74.430000000000007 113.061 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -101.35 143.77 27.26 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 109.804 -0.443 . . . . 73.439999999999998 109.804 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.22 141.03 88.52 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.275 2.65 . . . . 63.039999999999999 114.018 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 52.0 mttt -65.62 -33.14 75.21 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.774 -1.103 . . . . 74.400000000000006 111.606 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.77 23.31 23.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.517 -0.765 . . . . 71.0 112.237 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 45.1 mt-10 -118.82 143.0 47.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.308 -0.557 . . . . 73.310000000000002 110.702 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.03 143.18 24.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.626 -0.715 . . . . 70.099999999999994 109.496 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' PHE . 68.9 p -126.88 137.86 53.22 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.609 -0.436 . . . . 54.329999999999998 110.023 173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.49 145.43 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 121.043 0.449 . . . . 71.530000000000001 109.991 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 270' ' ' MET . 0.1 OUTLIER -98.71 129.18 45.16 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.623 0.972 . . . . 72.510000000000005 113.623 -176.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.64 165.61 15.29 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.702 0.63 . . . . 74.109999999999999 112.702 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.69 73.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.448 -0.796 . . . . 72.510000000000005 111.935 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.4 139.8 35.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.891 -0.781 . . . . 71.510000000000005 108.891 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -58.79 -40.09 75.74 Favored 'Trans proline' 0 CA--C 1.576 2.588 0 C-N-CA 122.488 2.125 . . . . 65.200000000000003 117.368 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 -30.34 14.13 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 123.614 2.326 . . . . 73.209999999999994 114.106 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 55.0 p -62.97 -29.82 71.11 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.131 0.572 . . . . 74.420000000000002 111.627 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.11 -37.17 78.24 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.627 1.204 . . . . 43.399999999999999 112.214 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -68.56 -38.79 81.06 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 123.55 0.531 . . . . 72.420000000000002 111.839 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.55 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.937 -0.574 . . . . 65.120000000000005 111.428 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -66.51 -26.88 67.37 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 123.316 0.647 . . . . 54.140000000000001 112.257 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 296' ' ' ALA . 72.7 mt -68.71 -32.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.843 -1.161 . . . . 74.230000000000004 111.377 172.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.27 -58.27 3.38 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 113.169 0.803 . . . . 63.219999999999999 113.169 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.95 -30.72 17.64 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.385 1.995 . . . . 73.540000000000006 116.385 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 66.0 t80 -88.53 -17.5 30.13 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.086 0.403 . . . . 73.150000000000006 110.742 -169.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.667 ' HB2' HG12 ' A' ' 315' ' ' VAL . 1.6 t70 -87.56 159.59 18.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.247 -0.649 . . . . 73.109999999999999 109.247 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.16 50.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.478 -0.391 . . . . 73.430000000000007 113.154 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 -162.04 0.84 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.414 -0.958 . . . . 71.129999999999995 108.414 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.66 143.69 51.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.715 0.769 . . . . 70.450000000000003 111.367 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -113.74 115.83 28.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.966 -1.016 . . . . 74.230000000000004 108.454 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 63.85 28.43 14.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.67 1.231 . . . . 75.310000000000002 112.406 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.12 11.54 80.86 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.113 0.405 . . . . 51.310000000000002 114.113 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.53 147.86 50.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.73 -0.841 . . . . 60.43 108.73 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.2 127.66 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.777 0.431 . . . . 73.109999999999999 111.369 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 14.8 tt -110.71 134.15 53.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.732 -0.667 . . . . 71.140000000000001 110.551 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.483 ' HA ' ' OD1' ' A' ' 304' ' ' ASP . 3.1 mttm -124.06 141.19 52.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.469 -0.787 . . . . 64.299999999999997 110.729 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.667 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.3 OUTLIER -123.4 140.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 108.449 -0.945 . . . . 72.150000000000006 108.449 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.8 m -140.39 174.2 10.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.853 0.461 . . . . 65.439999999999998 110.86 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -2.63 55.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.609 0.966 . . . . 64.120000000000005 113.609 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.253 0 C-N-CA 124.264 1.026 . . . . 64.340000000000003 111.922 -178.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.3 t30 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 110.402 -0.222 . . . . 63.409999999999997 110.402 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.29 106.47 18.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 119.675 -0.81 . . . . 70.109999999999999 110.724 165.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.1 m -142.1 147.08 36.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.735 -1.209 . . . . 52.130000000000003 107.735 166.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.27 137.0 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.106 0.867 . . . . 75.030000000000001 109.959 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -99.54 124.51 44.78 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.207 -0.664 . . . . 52.329999999999998 109.207 -178.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.79 140.7 44.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.718 -0.674 . . . . 62.229999999999997 109.556 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.69 141.56 51.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.599 . . . . 64.129999999999995 109.442 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.32 27.61 6.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.291 -0.481 . . . . 62.140000000000001 112.773 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.14 80.34 1.95 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.246 -0.65 . . . . 74.299999999999997 109.246 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -146.7 -69.6 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.396 -0.907 . . . . 60.130000000000003 113.126 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.7 107.2 11.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.741 0.781 . . . . 72.430000000000007 111.232 -171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.22 20.77 44.22 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.228 -0.897 . . . . 51.340000000000003 111.569 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 246' ' ' SER . 0.3 OUTLIER -79.97 152.33 4.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.104 0.478 . . . . 73.310000000000002 109.937 -172.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 245' ' ' VAL . 17.7 m -89.28 171.05 10.06 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.609 -0.723 . . . . 70.25 109.571 170.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.852 1.661 . . . . 54.329999999999998 113.887 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -43.44 -14.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 127.764 2.426 . . . . 71.0 115.257 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.62 -21.46 0.36 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.942 2.097 . . . . 74.239999999999995 114.429 171.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -55.37 -31.62 27.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 C-N-CA 122.951 0.5 . . . . 64.209999999999994 110.102 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.65 -33.56 82.76 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.684 -0.509 . . . . 42.509999999999998 114.018 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.2 -30.87 60.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.226 0.611 . . . . 75.120000000000005 110.946 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.6 t80 -54.39 -46.32 73.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 71.439999999999998 110.619 170.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.07 -23.31 48.1 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.906 0.336 . . . . 74.230000000000004 111.906 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -70.63 -15.21 62.72 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.145 0.978 . . . . 74.299999999999997 111.514 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.49 -14.53 57.61 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 122.036 -0.415 . . . . 72.329999999999998 112.021 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.0 -31.54 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.097 0.559 . . . . 63.219999999999999 111.157 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -156.86 -160.78 10.31 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 119.429 -1.367 . . . . 75.310000000000002 114.845 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.91 138.81 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.913 -0.643 . . . . 75.439999999999998 110.369 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 30.9 mm -68.94 115.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 123.77 0.669 . . . . 71.5 110.565 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -97.84 142.37 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.318 -0.855 . . . . 74.319999999999993 110.94 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 80.2 m -85.94 115.84 23.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.198 -1.038 . . . . 62.240000000000002 108.198 167.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 122.92 22.64 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.046 -0.724 . . . . 71.099999999999994 109.046 -177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -72.58 -8.92 57.64 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.238 1.199 . . . . 75.530000000000001 114.238 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -69.87 -29.85 67.17 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.334 0.254 . . . . 65.420000000000002 111.614 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.4 t -124.41 -31.9 3.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.641 -0.254 . . . . 71.239999999999995 111.121 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.68 66.41 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 116.382 -0.372 . . . . 71.439999999999998 112.321 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.434 ' H ' HG23 ' A' ' 266' ' ' THR . 27.3 mtpp -97.62 153.19 38.39 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.246 0.618 . . . . 63.420000000000002 111.388 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.26 153.79 67.67 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 123.493 2.795 . . . . 74.109999999999999 112.048 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.441 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.1 ptm -75.2 100.73 4.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.704 0.764 . . . . 55.32 112.746 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.73 114.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.285 -1.376 . . . . 72.150000000000006 107.285 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -128.5 117.07 20.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.151 0.887 . . . . 73.430000000000007 109.957 161.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.09 111.78 22.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.177 0.513 . . . . 71.340000000000003 110.152 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 57.8 m-85 -101.45 112.41 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.948 -0.569 . . . . 75.349999999999994 109.942 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.471 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.2 p -144.35 119.36 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.23 -1.35 . . . . 75.329999999999998 109.908 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -87.63 111.91 21.76 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.619 1.2 . . . . 63.420000000000002 112.274 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -7.92 58.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.185 -0.916 . . . . 71.209999999999994 112.525 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.73 -27.96 64.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.723 0.409 . . . . 74.239999999999995 111.94 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 44.0 p -89.64 -25.85 21.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.571 -0.529 . . . . 74.140000000000001 109.571 168.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.49 61.31 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.195 -0.911 . . . . 72.140000000000001 112.661 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 140.85 37.96 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.367 -0.975 . . . . 64.120000000000005 108.367 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.07 137.33 70.92 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.348 2.032 . . . . 62.25 114.285 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 275' ' ' THR . 1.6 tttm -61.13 -35.07 76.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.058 -1.428 . . . . 74.150000000000006 111.739 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.07 30.73 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.484 -0.78 . . . . 62.43 112.744 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.5 mt-10 -119.97 143.39 48.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.988 -0.685 . . . . 61.350000000000001 110.476 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.62 24.15 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.941 -0.572 . . . . 71.349999999999994 110.018 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 237' ' ' PHE . 60.3 p -127.0 137.85 53.16 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 110.148 -0.316 . . . . 71.109999999999999 110.148 172.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.93 147.88 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 110.034 -0.358 . . . . 74.120000000000005 110.034 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.441 ' H ' ' CB ' ' A' ' 270' ' ' MET . 14.5 m -108.48 123.95 49.68 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.531 0.567 . . . . 73.349999999999994 112.531 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.8 163.44 13.52 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.963 0.357 . . . . 74.219999999999999 111.963 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -76.25 -48.27 20.89 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.641 -0.254 . . . . 62.329999999999998 110.4 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.55 135.21 19.35 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 120.366 -0.533 . . . . 74.409999999999997 110.03 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.4 -39.34 29.53 Favored 'Trans proline' 0 CA--C 1.568 2.208 0 C-N-CA 122.572 2.181 . . . . 75.209999999999994 116.029 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.51 -31.05 61.45 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 122.978 2.099 . . . . 63.229999999999997 113.958 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.8 m -70.32 -30.3 67.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.897 -0.592 . . . . 72.040000000000006 110.794 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.64 64.18 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.795 -0.638 . . . . 52.100000000000001 111.08 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -71.82 -37.07 70.39 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 120.887 0.375 . . . . 71.219999999999999 111.967 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.41 78.12 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.339 -0.391 . . . . 73.400000000000006 110.842 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -65.25 -35.15 80.13 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 116.154 -0.476 . . . . 53.340000000000003 111.76 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.74 -32.57 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 O-C-N 122.052 -0.405 . . . . 70.239999999999995 111.106 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -72.34 -58.43 3.41 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.973 1.101 . . . . 63.210000000000001 113.973 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.55 -30.92 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.569 2.063 . . . . 71.329999999999998 116.569 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 85.4 t80 -83.94 -11.21 57.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.443 0.697 . . . . 62.340000000000003 111.107 -168.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.21 170.44 7.88 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.64 6.21 59.69 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.272 -0.49 . . . . 72.540000000000006 112.48 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 -157.55 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.393 -0.965 . . . . 61.329999999999998 108.393 174.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -129.87 147.15 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.428 0.632 . . . . 65.340000000000003 111.329 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -114.32 111.88 22.2 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.989 -1.115 . . . . 62.219999999999999 107.989 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.8 28.78 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.423 1.089 . . . . 73.340000000000003 112.253 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.06 -2.07 87.69 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 116.359 -0.382 . . . . 63.240000000000002 113.546 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -108.64 144.9 35.77 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 109.125 -0.694 . . . . 70.319999999999993 109.125 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.28 126.99 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.863 0.363 . . . . 75.099999999999994 111.126 -173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 20.3 tt -110.34 136.31 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.568 0.699 . . . . 64.219999999999999 111.191 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -130.64 131.74 45.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.052 -0.976 . . . . 72.140000000000001 110.545 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.24 139.06 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 110.006 -0.368 . . . . 54.140000000000001 110.006 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.4 m -137.88 174.71 10.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.195 0.998 . . . . 54.149999999999999 109.647 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.68 1.59 51.46 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.051 1.13 . . . . 74.230000000000004 114.051 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.012 0.925 . . . . 73.129999999999995 113.178 176.017 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.5 t30 . . . . . 0 C--O 1.237 0.443 0 N-CA-C 109.47 -0.567 . . . . 72.109999999999999 109.47 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 107.02 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.329 -0.548 . . . . 65.439999999999998 109.819 168.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.9 m -142.9 149.01 37.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.584 -0.895 . . . . 71.120000000000005 108.584 169.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 315' ' ' VAL . 2.7 pp -123.79 141.15 45.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 118.625 0.648 . . . . 75.219999999999999 109.58 161.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 315' ' ' VAL . 0.3 OUTLIER -102.31 130.2 48.95 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.552 -0.907 . . . . 72.209999999999994 108.552 177.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -121.38 144.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.636 0.731 . . . . 62.009999999999998 112.642 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 114.257 -1.338 . . . . 62.329999999999998 110.049 -178.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 95.45 7.89 58.91 Favored Glycine 0 CA--C 1.519 0.296 0 O-C-N 123.599 0.562 . . . . 60.25 113.688 174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -103.67 76.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.374 -0.973 . . . . 63.100000000000001 108.374 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -134.4 -87.65 0.28 Allowed Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 120.419 -0.896 . . . . 64.310000000000002 113.822 -171.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.96 112.91 9.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.753 0.311 . . . . 75.209999999999994 111.21 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.01 19.87 38.27 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.709 -0.678 . . . . 70.219999999999999 111.977 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.33 150.87 4.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.311 0.576 . . . . 72.25 109.674 -173.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.1 m -90.29 170.65 10.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.539 -0.755 . . . . 65.019999999999996 110.364 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -167.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 127.117 2.167 . . . . 61.210000000000001 113.36 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.2 -11.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.285 1.834 . . . . 74.209999999999994 115.673 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -45.87 -22.31 0.19 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 126.869 2.068 . . . . 73.430000000000007 113.756 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -32.28 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 118.815 0.734 . . . . 72.400000000000006 110.058 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -36.67 92.78 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.737 -0.479 . . . . 71.0 113.168 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.11 -34.27 76.06 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.502 0.721 . . . . 71.239999999999995 110.635 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.1 t80 -57.56 -43.18 84.27 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.252 -0.886 . . . . 72.049999999999997 111.486 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.64 -24.45 45.26 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.181 0.438 . . . . 72.319999999999993 112.181 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 23.4 tptm -66.66 -18.96 65.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.795 1.238 . . . . 64.349999999999994 112.189 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.23 -15.09 62.11 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 113.172 0.804 . . . . 64.239999999999995 113.172 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.2 -6.73 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 120.882 0.372 . . . . 72.510000000000005 110.792 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.522 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . -171.59 -160.44 20.13 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 118.95 -1.595 . . . . 75.340000000000003 114.721 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.59 139.44 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.443 0.697 . . . . 74.239999999999995 110.518 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.456 HG12 ' HD3' ' A' ' 255' ' ' LYS . 20.8 mm -66.38 116.31 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 123.643 0.589 . . . . 74.400000000000006 109.674 173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.11 133.24 42.03 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.447 -0.797 . . . . 72.349999999999994 110.454 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 50.3 m -84.8 117.09 23.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.299 -1.0 . . . . 71.120000000000005 108.299 167.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.29 136.67 42.63 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 112.196 0.443 . . . . 74.450000000000003 112.196 -174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -80.07 -10.77 59.79 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.668 0.988 . . . . 73.109999999999999 113.668 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -70.12 -38.48 75.6 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 112.477 0.547 . . . . 62.520000000000003 112.477 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -124.37 -24.55 4.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.482 0.182 . . . . 74.430000000000007 111.279 174.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.85 16.52 54.39 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.121 0.408 . . . . 74.420000000000002 114.121 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 266' ' ' THR . 19.6 ptpt -100.34 152.94 37.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.398 0.599 . . . . 63.439999999999998 111.496 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.62 152.12 83.04 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.443 2.096 . . . . 73.329999999999998 111.572 166.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.09 97.9 4.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.764 1.024 . . . . 65.209999999999994 113.764 -172.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 35.7 mm -143.11 112.87 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.614 -1.254 . . . . 75.150000000000006 107.614 165.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -129.07 117.61 21.15 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.107 0.867 . . . . 63.399999999999999 109.852 161.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 111.04 20.61 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.595 -0.52 . . . . 71.400000000000006 109.595 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 35.2 m-85 -101.92 112.29 24.86 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 121.259 0.552 . . . . 64.010000000000005 110.577 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.424 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.0 p -142.6 120.93 12.32 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.985 -1.461 . . . . 72.329999999999998 110.207 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . 0.507 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 26.0 t70 -87.47 113.49 23.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.288 0.566 . . . . 72.310000000000002 111.147 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -9.9 55.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.662 -0.699 . . . . 63.340000000000003 112.797 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -29.95 61.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.652 0.263 . . . . 61.310000000000002 111.547 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.4 t -91.3 -15.41 29.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.417 0.627 . . . . 75.400000000000006 109.686 167.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.98 -37.4 3.46 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.71 -0.677 . . . . 53.310000000000002 113.237 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -96.73 141.85 23.69 Favored Pre-proline 0 N--CA 1.443 -0.814 0 O-C-N 123.635 0.256 . . . . 72.430000000000007 110.971 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.49 136.26 74.78 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.636 2.891 . . . . 74.219999999999999 114.129 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 56.2 mtpt -65.6 -37.82 87.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 75.140000000000001 111.604 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.97 25.05 13.57 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.862 -0.685 . . . . 61.200000000000003 113.021 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 40.6 mt-10 -115.82 142.24 47.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.711 -0.477 . . . . 70.010000000000005 109.711 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 155.26 38.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.308 -0.405 . . . . 41.530000000000001 110.828 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 137.31 41.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.098 -0.334 . . . . 72.099999999999994 110.098 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 236' ' ' ILE . 11.5 m -136.56 145.36 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.152 -0.684 . . . . 72.25 109.152 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 22.7 t -97.68 117.59 32.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.639 0.775 . . . . 75.109999999999999 111.645 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.4 164.09 13.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 121.139 -0.225 . . . . 71.030000000000001 111.442 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.53 -48.53 55.06 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.715 0.635 . . . . 74.200000000000003 112.715 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -119.57 136.16 24.53 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 109.726 -0.472 . . . . 73.120000000000005 109.726 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.33 -38.35 65.6 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 123.682 2.921 . . . . 54.100000000000001 117.699 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.68 -29.94 15.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 123.55 2.304 . . . . 64.450000000000003 112.487 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -64.27 -27.4 69.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.725 1.21 . . . . 72.230000000000004 112.181 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.455 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -67.7 -40.97 84.3 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.595 0.559 . . . . 62.409999999999997 112.23 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -72.79 -34.67 67.08 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.292 0.567 . . . . 75.0 110.713 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.27 -33.76 76.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.337 -0.847 . . . . 71.140000000000001 111.048 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.22 -28.69 67.47 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.91 -0.586 . . . . 52.149999999999999 111.707 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 296' ' ' ALA . 49.3 mt -69.88 -30.59 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 O-C-N 122.035 -0.416 . . . . 63.119999999999997 110.812 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.88 -60.67 2.29 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.959 1.096 . . . . 63.140000000000001 113.959 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -91.87 -29.58 16.63 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.438 2.014 . . . . 72.239999999999995 116.438 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 23.6 t80 -86.62 -24.12 25.46 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 -171.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 315' ' ' VAL . 7.5 t70 -82.87 -170.51 3.04 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.957 -1.02 . . . . 73.120000000000005 109.531 166.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 78.25 13.48 83.25 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.198 -0.525 . . . . 62.439999999999998 112.853 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -135.67 -161.88 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.883 0.373 . . . . 73.340000000000003 110.179 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -128.69 144.62 51.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.21 0.529 . . . . 32.240000000000002 110.467 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -113.12 112.04 23.14 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.21 -1.033 . . . . 74.420000000000002 108.21 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 65.03 29.25 12.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.764 1.29 . . . . 74.349999999999994 112.167 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.78 5.79 80.82 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 114.211 0.444 . . . . 72.540000000000006 114.211 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -124.21 148.42 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.778 -0.823 . . . . 55.119999999999997 108.778 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.59 129.27 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 123.303 0.377 . . . . 70.430000000000007 110.901 -171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.1 tt -108.5 143.95 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.791 -0.641 . . . . 75.519999999999996 109.54 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 15.3 tptp -136.94 121.89 18.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.914 0.388 . . . . 73.519999999999996 110.361 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 237' ' ' PHE . 7.7 p -111.89 138.39 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.522 -0.763 . . . . 61.240000000000002 111.226 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -142.79 172.79 12.22 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.286 1.034 . . . . 72.200000000000003 109.837 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -5.25 48.48 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.942 1.09 . . . . 74.040000000000006 113.942 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.206 0 C-N-CA 124.508 1.123 . . . . 72.120000000000005 113.176 177.11 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.6 t30 . . . . . 0 C--O 1.237 0.427 0 CA-C-O 120.64 0.257 . . . . 74.400000000000006 111.541 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.79 104.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.821 -0.752 . . . . 73.439999999999998 110.276 160.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 21.9 m -143.0 147.19 34.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.212 -1.032 . . . . 53.109999999999999 108.212 165.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 315' ' ' VAL . 2.5 pp -121.7 141.9 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 118.754 0.706 . . . . 62.43 109.588 164.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.67 122.31 45.39 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.754 -0.657 . . . . 74.439999999999998 109.39 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -114.3 144.52 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.755 0.788 . . . . 73.450000000000003 112.756 176.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.29 151.28 47.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.768 -1.56 . . . . 73.540000000000006 110.124 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.12 15.3 54.33 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.266 -0.492 . . . . 72.319999999999993 113.539 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.724 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -108.36 76.86 1.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.083 -1.081 . . . . 75.109999999999999 108.083 176.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.18 -88.26 0.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.152 -1.023 . . . . 70.109999999999999 114.301 -169.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -78.55 109.3 12.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 75.239999999999995 111.225 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.95 21.2 21.6 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.27 -0.877 . . . . 62.149999999999999 111.783 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -85.41 151.42 3.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.752 -0.462 . . . . 72.030000000000001 109.752 -173.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.0 m -90.54 170.01 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.788 -0.642 . . . . 73.019999999999996 110.696 172.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.811 2.044 . . . . 75.010000000000005 113.555 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -43.19 -12.7 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 126.634 1.974 . . . . 73.200000000000003 115.749 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.22 -22.04 0.34 Allowed 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 126.473 1.909 . . . . 73.430000000000007 113.668 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -56.57 -31.55 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 118.482 0.583 . . . . 73.109999999999999 110.236 178.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.07 -32.02 82.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.707 -0.496 . . . . 72.400000000000006 114.267 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 10.5 tp10 -72.73 -33.58 66.5 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.706 0.802 . . . . 74.340000000000003 110.758 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.7 t80 -57.22 -43.15 82.58 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.083 -0.962 . . . . 73.140000000000001 111.256 173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.02 -24.9 43.34 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 122.144 -0.347 . . . . 74.310000000000002 111.851 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.46 ' HB2' HD11 ' A' ' 260' ' ' ILE . 13.5 tptm -64.87 -22.32 66.97 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.402 1.081 . . . . 75.209999999999994 112.199 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -13.79 53.12 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 112.963 0.727 . . . . 52.340000000000003 112.963 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 46.6 mm -111.49 -26.46 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 122.698 0.399 . . . . 75.439999999999998 110.589 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -160.9 -174.95 31.39 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 119.982 -1.104 . . . . 62.420000000000002 115.127 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.22 138.8 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 73.430000000000007 111.201 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 255' ' ' LYS . 23.7 mm -70.98 115.54 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.818 -0.628 . . . . 75.129999999999995 110.785 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -98.28 138.11 36.03 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.579 0.704 . . . . 71.200000000000003 111.078 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 94.7 m -84.2 116.83 23.14 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.605 -1.18 . . . . 70.239999999999995 108.509 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 131.51 37.05 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 109.504 -0.554 . . . . 63.299999999999997 109.504 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -76.08 -5.65 47.48 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.704 1.002 . . . . 71.540000000000006 113.704 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -66.94 -34.83 78.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.636 0.255 . . . . 70.030000000000001 111.156 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 21.3 p -124.6 -31.45 3.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.854 0.462 . . . . 61.409999999999997 111.578 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.88 67.17 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.431 -0.804 . . . . 74.450000000000003 112.034 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.32 151.73 37.53 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.101 0.56 . . . . 74.109999999999999 111.677 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.45 153.92 76.01 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.066 2.51 . . . . 74.120000000000005 111.38 166.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.472 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -76.93 99.2 5.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.373 0.879 . . . . 73.409999999999997 113.373 -169.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.9 mm -143.07 112.87 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.59 -1.263 . . . . 54.420000000000002 107.59 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -128.69 116.2 19.19 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.953 0.797 . . . . 73.439999999999998 110.276 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.81 110.89 20.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.638 -0.504 . . . . 71.120000000000005 109.638 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 31.7 m-85 -103.03 112.94 26.02 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.088 0.471 . . . . 72.25 110.651 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 p -144.77 122.07 11.58 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.55 -1.205 . . . . 74.230000000000004 110.088 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.21 112.2 21.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.441 0.638 . . . . 73.420000000000002 112.618 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -85.75 -10.42 55.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.799 -0.637 . . . . 70.230000000000004 112.017 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.69 -31.36 66.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.407 0.623 . . . . 65.540000000000006 110.221 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 47.3 p -91.21 -21.92 20.88 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.212 -0.904 . . . . 75.400000000000006 109.57 173.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.11 -33.25 6.29 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.263 -0.88 . . . . 62.350000000000001 113.029 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -99.37 141.42 22.8 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 110.302 -0.259 . . . . 75.439999999999998 110.302 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.58 132.72 53.82 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.418 2.745 . . . . 74.040000000000006 114.385 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -59.54 -42.09 91.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 75.140000000000001 112.294 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.49 24.76 15.19 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.64 -0.791 . . . . 54.039999999999999 113.145 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.4 mt-10 -116.45 142.87 46.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.722 -0.473 . . . . 71.219999999999999 109.722 -174.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.18 32.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 74.230000000000004 110.966 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 p -131.31 136.74 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.88 0.372 . . . . 71.030000000000001 110.2 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.415 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 6.1 m -135.56 146.22 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 109.221 -0.659 . . . . 75.450000000000003 109.221 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.472 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.6 m -110.21 117.81 34.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.087 0.403 . . . . 74.140000000000001 112.087 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.25 165.23 13.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.918 0.71 . . . . 53.109999999999999 112.918 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.66 -47.16 76.45 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.852 0.861 . . . . 73.109999999999999 112.857 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -122.45 136.7 26.8 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.964 -0.384 . . . . 73.019999999999996 109.964 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -61.26 -38.5 65.27 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.229 2.619 . . . . 74.25 117.259 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -28.18 14.2 Favored 'Trans proline' 0 C--N 1.386 2.502 0 CA-C-N 123.682 2.351 . . . . 71.319999999999993 112.466 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.7 m -62.48 -27.9 69.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.056 0.942 . . . . 72.129999999999995 112.026 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.14 -39.38 78.87 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.267 0.627 . . . . 70.099999999999994 111.904 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -69.49 -37.88 77.42 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.87 0.367 . . . . 74.409999999999997 110.772 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.03 72.09 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.633 -0.712 . . . . 13.24 110.941 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.73 -29.56 66.97 Favored 'General case' 0 C--O 1.213 -0.852 0 O-C-N 123.395 0.434 . . . . 75.129999999999995 111.726 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 296' ' ' ALA . 56.6 mt -69.84 -32.06 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 121.716 -0.615 . . . . 65.430000000000007 110.428 173.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.71 -60.61 2.3 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 113.381 0.882 . . . . 72.239999999999995 113.381 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -93.52 -30.76 14.85 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.283 1.957 . . . . 73.439999999999998 116.283 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 37.5 t80 -84.57 -23.19 29.77 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.492 0.587 . . . . 63.149999999999999 109.69 -169.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 315' ' ' VAL . 3.4 t0 -87.78 -164.65 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.459 -0.792 . . . . 62.32 110.649 168.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.06 7.21 87.39 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.528 -0.76 . . . . 73.140000000000001 113.061 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -137.78 -164.35 1.6 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.56 0.219 . . . . 71.510000000000005 110.634 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.77 144.62 45.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.719 0.771 . . . . 62.229999999999997 112.035 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -113.82 114.83 26.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.794 -1.187 . . . . 62.130000000000003 107.794 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.09 28.5 14.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 124.64 1.213 . . . . 75.219999999999999 112.211 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.18 -4.47 84.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 114.106 0.403 . . . . 71.040000000000006 114.106 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -113.11 145.51 40.8 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.699 -0.482 . . . . 64.329999999999998 109.699 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.11 132.0 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.203 0.314 . . . . 74.019999999999996 110.635 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.8 tt -107.28 145.19 14.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.747 -0.834 . . . . 64.420000000000002 108.747 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 7.0 tppt? -136.19 121.32 18.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.095 -0.706 . . . . 72.030000000000001 109.095 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 236' ' ' ILE . 13.3 p -112.23 134.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.399 0.618 . . . . 74.439999999999998 110.153 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.8 m -133.72 173.45 11.51 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.191 -0.913 . . . . 62.200000000000003 109.495 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -3.35 45.58 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.948 0.721 . . . . 73.109999999999999 112.948 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 C-N-CA 124.508 1.123 . . . . 62.530000000000001 112.771 177.221 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.1 t30 . . . . . 0 C--O 1.236 0.366 0 CA-C-O 120.751 0.31 . . . . 75.239999999999995 110.462 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.74 105.03 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.936 -0.574 . . . . 74.409999999999997 110.159 167.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 m -144.01 148.81 35.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 74.430000000000007 108.564 163.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 288' ' ' VAL . 43.1 pt -126.09 144.47 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 118.83 0.741 . . . . 71.519999999999996 109.329 161.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.451 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -99.95 133.0 44.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.756 -0.831 . . . . 64.049999999999997 108.756 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.484 HG11 ' HZ ' ' A' ' 254' ' ' PHE . 1.5 t -124.76 137.76 56.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.011 -0.737 . . . . 72.420000000000002 109.011 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.47 140.58 52.36 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.741 -0.663 . . . . 72.239999999999995 111.214 -177.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.04 3.93 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.246 0.966 . . . . 63.420000000000002 112.316 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.21 79.13 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.906 -0.776 . . . . 70.430000000000007 108.906 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -123.97 -99.06 1.32 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.542 -0.754 . . . . 61.43 113.996 -171.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.48 119.39 17.64 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.019 0.438 . . . . 71.219999999999999 111.526 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.58 30.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.26 -0.882 . . . . 62.229999999999997 111.592 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.23 152.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.674 -0.491 . . . . 62.130000000000003 109.674 -172.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.0 m -88.29 169.28 11.99 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.681 -0.69 . . . . 72.209999999999994 109.935 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.177 1.791 . . . . 71.299999999999997 114.201 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -42.6 -14.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.726 2.01 . . . . 72.140000000000001 115.547 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -47.61 -22.06 0.44 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 126.374 1.87 . . . . 74.25 113.912 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.8 OUTLIER -56.11 -32.62 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.38 -0.6 . . . . 63.43 109.38 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.94 84.45 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.699 0.639 . . . . 73.439999999999998 114.699 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.77 -31.13 63.15 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.312 0.577 . . . . 53.219999999999999 111.231 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 3.9 t80 -56.48 -45.15 81.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.434 -0.803 . . . . 70.329999999999998 111.015 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.484 ' HZ ' HG11 ' A' ' 238' ' ' VAL . 93.2 m-85 -78.0 -23.45 48.33 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.033 -0.417 . . . . 73.120000000000005 111.651 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.26 -14.95 62.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.849 0.86 . . . . 71.209999999999994 111.806 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -64.65 -13.37 53.55 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 121.88 -0.512 . . . . 74.439999999999998 112.046 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.3 mm -104.19 -43.13 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.02 0.528 . . . . 75.25 110.563 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -147.08 -160.11 8.66 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 120.236 -0.983 . . . . 40.240000000000002 114.613 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.51 138.45 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.007 0.523 . . . . 55.420000000000002 111.452 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.76 116.81 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.688 -0.687 . . . . 75.209999999999994 110.689 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -97.93 140.75 31.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.436 0.636 . . . . 75.129999999999995 111.158 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.6 m -86.06 118.59 25.62 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.916 -1.038 . . . . 51.32 108.44 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.84 136.97 45.44 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.292 -0.413 . . . . 64.549999999999997 111.208 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.49 -9.83 59.68 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.61 0.596 . . . . 74.439999999999998 112.61 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -69.64 -39.57 77.04 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.028 0.381 . . . . 74.409999999999997 112.028 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 22.4 p -123.19 -26.52 4.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.967 0.413 . . . . 75.409999999999997 111.181 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.87 9.86 65.52 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.427 -0.806 . . . . 72.099999999999994 112.813 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -97.96 150.74 37.07 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.416 0.525 . . . . 64.209999999999994 112.416 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 154.53 70.66 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 123.283 2.655 . . . . 53.329999999999998 111.993 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.458 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.8 ptm -68.31 102.48 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.118 1.155 . . . . 71.530000000000001 114.118 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 24.0 mm -144.44 112.45 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.139 -1.8 . . . . 72.400000000000006 106.139 161.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -128.72 114.5 16.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.091 0.86 . . . . 62.32 109.986 163.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.21 111.85 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.895 -0.409 . . . . 74.120000000000005 109.895 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 49.0 m-85 -102.04 111.4 23.66 Favored 'General case' 0 C--O 1.265 1.884 0 CA-C-O 121.487 0.66 . . . . 64.109999999999999 109.866 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.449 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 16.0 p -144.4 120.5 10.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 113.86 -1.518 . . . . 54.200000000000003 109.694 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.81 112.92 22.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.43 0.634 . . . . 63.520000000000003 111.454 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -10.38 56.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.802 0.668 . . . . 53.130000000000003 112.802 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.21 66.34 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.965 0.357 . . . . 72.25 111.965 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.2 t -91.16 -18.26 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.702 -0.481 . . . . 65.430000000000007 109.702 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 100.22 -40.88 2.29 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.884 -0.598 . . . . 74.299999999999997 113.021 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -87.79 141.61 31.88 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-O 119.889 -0.101 . . . . 74.340000000000003 110.804 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.65 132.9 54.89 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.061 2.507 . . . . 62.450000000000003 114.102 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.449 ' H ' ' HA ' ' A' ' 275' ' ' THR . 13.6 mttm -56.53 -40.13 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.413 -1.267 . . . . 74.109999999999999 112.571 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.36 23.14 20.17 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.98 -0.554 . . . . 63.409999999999997 112.864 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 21.3 mt-10 -120.31 142.05 49.47 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.82 0.364 . . . . 74.25 110.562 -173.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 148.68 28.13 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.62 -0.264 . . . . 60.25 110.875 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 237' ' ' PHE . 67.6 p -128.76 138.57 52.17 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.571 -0.529 . . . . 74.519999999999996 109.571 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 236' ' ' ILE . 8.1 m -138.38 152.02 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.272 -0.64 . . . . 75.409999999999997 109.272 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.458 ' H ' ' CB ' ' A' ' 270' ' ' MET . 34.0 t -113.67 131.19 56.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.813 1.042 . . . . 73.099999999999994 113.813 -171.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.0 163.42 13.66 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.434 0.531 . . . . 64.439999999999998 112.434 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.62 -46.2 80.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.5 -0.773 . . . . 73.430000000000007 111.896 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -119.91 136.15 24.73 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.684 -0.487 . . . . 72.200000000000003 109.684 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -61.41 -38.87 60.7 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.272 2.648 . . . . 60.409999999999997 117.4 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.04 -30.5 13.5 Favored 'Trans proline' 0 C--N 1.381 2.261 0 CA-C-N 123.37 2.239 . . . . 63.439999999999998 112.716 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 48.9 m -64.06 -27.92 69.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.384 -0.825 . . . . 72.409999999999997 111.394 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -72.05 -34.92 69.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.473 0.545 . . . . 54.439999999999998 112.473 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -71.86 -36.07 70.0 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.932 0.396 . . . . 64.209999999999994 110.695 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.31 88.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.784 -0.644 . . . . 71.109999999999999 111.093 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.12 -25.86 64.61 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.059 0.456 . . . . 74.5 111.586 176.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.31 -34.32 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 O-C-N 121.7 -0.625 . . . . 75.510000000000005 110.804 172.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.25 -56.89 4.17 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.378 0.881 . . . . 71.340000000000003 113.378 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -89.55 -29.1 19.15 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.245 1.943 . . . . 72.409999999999997 116.245 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 81.3 t80 -91.09 -9.26 46.33 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 122.01 -0.432 . . . . 73.420000000000002 111.402 -167.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.17 169.06 8.71 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.956 -0.757 . . . . 63.43 108.956 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.91 49.67 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 120.851 -0.69 . . . . 64.049999999999997 112.315 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -125.81 -162.72 1.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.244 -1.021 . . . . 73.099999999999994 108.244 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.78 145.93 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.621 0.724 . . . . 74.019999999999996 112.456 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -113.73 112.96 24.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.536 -1.211 . . . . 73.019999999999996 107.756 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.1 m170 64.88 28.95 12.67 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.132 . . . . 72.019999999999996 112.264 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.86 -1.38 85.15 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.465 -0.397 . . . . 63.119999999999997 113.97 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -115.22 143.51 45.13 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.202 -0.666 . . . . 72.129999999999995 109.202 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.24 129.22 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 122.632 0.373 . . . . 62.5 111.321 -171.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.8 tt -109.84 134.3 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.697 -0.683 . . . . 64.549999999999997 110.814 -174.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.42 131.22 53.5 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.522 -0.763 . . . . 63.530000000000001 110.197 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.01 126.77 67.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.965 0.412 . . . . 52.350000000000001 110.27 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -127.72 174.13 9.36 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 123.925 0.89 . . . . 75.540000000000006 109.119 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -1.72 57.31 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.954 1.094 . . . . 73.209999999999994 113.954 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.11 0.964 . . . . 75.450000000000003 112.526 179.609 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.0 t30 . . . . . 0 C--O 1.235 0.339 0 CA-C-O 120.687 0.28 . . . . 64.140000000000001 111.309 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.1 101.95 14.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.841 -0.743 . . . . 71.109999999999999 110.071 164.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 150.2 36.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.805 -1.183 . . . . 74.439999999999998 107.805 167.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.82 140.25 48.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.272 0.942 . . . . 63.240000000000002 110.013 163.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.66 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.02 128.71 45.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.601 -0.888 . . . . 74.519999999999996 108.601 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.402 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.1 t -123.81 138.61 52.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.775 -0.454 . . . . 72.129999999999995 109.775 -177.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -128.82 141.74 51.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 75.439999999999998 109.21 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 106.91 14.92 17.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.183 -0.532 . . . . 61.409999999999997 113.197 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 78.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.853 -0.795 . . . . 74.319999999999993 108.853 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.1 -89.19 0.39 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.317 -0.944 . . . . 51.210000000000001 113.984 -171.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.59 117.93 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.437 0.637 . . . . 71.420000000000002 111.133 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.85 20.96 37.92 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.514 -0.766 . . . . 52.409999999999997 111.583 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.05 150.45 4.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.438 -0.578 . . . . 74.150000000000006 109.438 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.5 t -91.38 170.23 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.433 -0.58 . . . . 51.530000000000001 109.433 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -169.05 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.332 1.853 . . . . 70.400000000000006 113.848 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -43.38 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.768 2.027 . . . . 54.350000000000001 114.985 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.06 -22.04 0.3 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.55 1.94 . . . . 71.219999999999999 113.995 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -55.28 -31.88 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.631 0.651 . . . . 62.299999999999997 110.556 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.78 85.66 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 121.935 -0.174 . . . . 53.420000000000002 113.504 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.67 -33.3 66.45 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.616 0.767 . . . . 75.129999999999995 110.152 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.9 t80 -56.57 -44.46 81.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.548 -0.751 . . . . 71.010000000000005 111.72 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 98.8 m-85 -78.9 -22.2 46.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.002 0.429 . . . . 75.400000000000006 111.462 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -73.03 -13.01 61.13 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.357 0.663 . . . . 62.219999999999999 111.803 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.67 -14.48 52.39 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 120.662 0.268 . . . . 75.549999999999997 111.505 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.9 mm -104.57 -47.99 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 122.924 0.49 . . . . 55.439999999999998 111.313 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -140.41 -161.52 8.74 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.066 -0.588 . . . . 62.210000000000001 113.667 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.24 138.1 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.324 0.65 . . . . 52.450000000000003 110.836 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.01 116.05 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.709 -0.678 . . . . 64.129999999999995 110.911 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -98.57 142.89 29.59 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.323 -0.853 . . . . 74.340000000000003 111.111 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 51.0 m -84.75 117.29 23.73 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.25 -1.018 . . . . 64.329999999999998 108.25 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.68 133.11 43.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.328 -0.396 . . . . 75.109999999999999 110.211 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -80.0 -8.03 59.14 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.572 0.582 . . . . 75.140000000000001 112.572 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 266' ' ' THR . 21.8 pttt -67.24 -36.85 82.51 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.275 0.23 . . . . 74.120000000000005 111.529 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 265' ' ' LYS . 15.0 p -124.15 -30.19 3.49 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.654 0.382 . . . . 63.200000000000003 111.372 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.7 64.48 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 116.14 -0.482 . . . . 62.200000000000003 112.952 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -98.23 151.53 37.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.182 0.438 . . . . 60.450000000000003 112.182 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.57 155.34 69.45 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 123.464 2.776 . . . . 65.219999999999999 112.597 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.485 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.6 ptm -71.48 102.01 2.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.665 0.987 . . . . 71.409999999999997 113.665 -172.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.8 mm -143.06 113.02 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.618 -1.623 . . . . 61.43 106.618 163.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -128.12 115.9 19.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.016 0.825 . . . . 73.219999999999999 109.98 162.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.95 111.72 21.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.183 -0.303 . . . . 74.420000000000002 110.183 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.467 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 45.2 m-85 -102.92 112.25 24.98 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 121.222 0.534 . . . . 72.409999999999997 110.388 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.443 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.4 p -144.7 122.91 12.2 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.295 -1.321 . . . . 70.129999999999995 110.003 -177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -85.82 111.95 20.66 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.113 0.482 . . . . 74.349999999999994 111.36 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -10.52 54.48 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.884 0.698 . . . . 73.219999999999999 112.884 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.38 -32.82 68.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.046 0.45 . . . . 60.200000000000003 110.381 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 77.6 p -90.71 -18.94 24.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.667 -0.697 . . . . 73.129999999999995 109.547 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.78 -29.29 10.73 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.557 -0.747 . . . . 72.340000000000003 113.102 170.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -105.84 142.49 24.92 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 110.196 -0.298 . . . . 74.219999999999999 110.196 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.5 136.86 78.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.422 2.748 . . . . 75.400000000000006 114.594 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 275' ' ' THR . 45.8 mttt -64.33 -38.48 91.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.045 -0.979 . . . . 72.099999999999994 111.873 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.67 17.38 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.459 -0.791 . . . . 72.129999999999995 113.057 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 43.6 mt-10 -116.55 142.2 47.18 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.333 -0.547 . . . . 62.329999999999998 110.454 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.27 143.86 23.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.751 -0.659 . . . . 74.129999999999995 109.948 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 237' ' ' PHE . 77.1 p -127.25 138.71 53.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.181 0.515 . . . . 74.519999999999996 110.445 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.48 147.45 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.836 -0.62 . . . . 71.299999999999997 110.783 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.485 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.8 t -98.19 136.55 38.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.213 0.605 . . . . 65.349999999999994 112.526 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.72 164.35 11.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.596 0.221 . . . . 71.019999999999996 111.596 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.84 -46.46 68.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.914 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -123.49 136.55 27.31 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.49 -0.559 . . . . 75.319999999999993 109.49 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.41 -37.59 80.36 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.381 2.72 . . . . 74.319999999999993 117.076 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -29.12 12.68 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 123.3 2.214 . . . . 41.43 113.023 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.5 m -61.39 -27.96 68.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.732 -0.667 . . . . 72.519999999999996 111.517 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.06 -35.44 61.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.094 -0.503 . . . . 74.409999999999997 111.439 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 120.74 -0.384 . . . . 64.530000000000001 110.934 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.03 86.04 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 110.869 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.626 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.42 -26.62 66.51 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.74 -0.664 . . . . 74.25 112.337 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.84 -33.97 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 121.731 -0.605 . . . . 54.009999999999998 110.214 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.4 -56.06 5.29 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.623 0.971 . . . . 63.520000000000003 113.623 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -31.78 17.31 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.809 1.781 . . . . 74.310000000000002 115.809 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.4 t80 -88.51 -8.82 54.2 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 118.535 0.607 . . . . 71.200000000000003 111.647 -167.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.53 9.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.66 -0.867 . . . . 75.129999999999995 108.66 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.84 51.33 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.207 -0.997 . . . . 73.25 112.369 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -126.9 -162.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.32 -0.622 . . . . 60.43 109.32 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.96 147.53 46.51 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.568 0.699 . . . . 61.399999999999999 112.197 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -115.46 112.4 22.22 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.836 -1.172 . . . . 71.340000000000003 107.836 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.14 29.43 14.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.695 1.198 . . . . 75.439999999999998 112.427 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.55 11.97 73.53 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.458 -0.401 . . . . 33.140000000000001 113.675 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -128.0 143.3 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.047 -0.723 . . . . 73.209999999999994 109.047 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.63 127.66 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.043 0.449 . . . . 71.430000000000007 111.457 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 19.4 tt -110.42 131.7 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.835 0.826 . . . . 71.109999999999999 111.133 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -123.54 139.18 54.27 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.877 -1.056 . . . . 72.129999999999995 109.643 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.8 t -122.29 137.43 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 121.058 0.456 . . . . 73.519999999999996 111.112 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -131.65 176.5 8.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.547 1.139 . . . . 72.409999999999997 110.164 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.45 -8.77 58.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.761 1.022 . . . . 73.25 113.761 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 124.612 1.165 . . . . 70.200000000000003 113.494 -178.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.6 t30 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.21 -0.293 . . . . 70.530000000000001 110.21 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.68 103.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.495 -0.882 . . . . 72.299999999999997 109.452 162.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.3 m -143.58 143.96 31.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.455 -1.313 . . . . 72.140000000000001 107.455 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.13 139.15 50.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.144 0.884 . . . . 63.409999999999997 110.652 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.42 134.16 42.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.52 -0.918 . . . . 72.129999999999995 108.52 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.77 140.14 47.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 109.39 -0.596 . . . . 72.519999999999996 109.39 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -124.59 143.34 50.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 124.256 0.972 . . . . 72.420000000000002 109.231 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 89.59 22.66 36.1 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.836 -0.697 . . . . 53.539999999999999 113.366 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.567 HD13 HG11 ' A' ' 250' ' ' VAL . 11.2 mt -103.91 70.83 1.02 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.344 -0.984 . . . . 74.340000000000003 108.344 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.37 -176.86 22.18 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.13 -1.033 . . . . 72.439999999999998 112.779 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 42.15 86.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.686 1.994 . . . . 71.319999999999993 114.867 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.71 22.46 26.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.333 -0.849 . . . . 61.32 111.528 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.0 150.92 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.230000000000004 110.094 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.4 m -84.55 169.47 14.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.691 -0.686 . . . . 75.030000000000001 110.939 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -167.81 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.323 1.849 . . . . 60.32 113.592 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -44.24 -13.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 126.949 2.1 . . . . 72.0 115.671 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.93 -23.42 0.45 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 126.72 2.008 . . . . 62.049999999999997 114.348 172.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.567 HG11 HD13 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -56.92 -32.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 CA-C-N 118.735 0.698 . . . . 73.120000000000005 109.767 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.06 -33.82 86.97 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.825 -0.431 . . . . 63.439999999999998 113.445 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.41 -29.14 59.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.206 0.602 . . . . 64.409999999999997 111.055 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.4 t80 -56.41 -42.52 78.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.512 . . . . 72.129999999999995 110.708 168.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -77.58 -24.1 49.82 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.067 0.395 . . . . 71.099999999999994 112.067 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 260' ' ' ILE . 0.7 OUTLIER -71.19 -16.25 62.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.638 0.775 . . . . 53.420000000000002 111.675 178.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -64.61 -15.09 60.62 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 121.572 -0.705 . . . . 63.310000000000002 112.012 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 mm -119.14 20.41 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-O 121.592 0.711 . . . . 74.439999999999998 110.327 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.5 34.15 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 119.386 -2.071 . . . . 24.309999999999999 116.009 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 23.2 mt -107.31 138.13 34.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.167 -1.017 . . . . 74.5 110.204 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 255' ' ' LYS . 48.7 mm -73.17 114.7 12.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.576 0.547 . . . . 72.129999999999995 110.001 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -98.88 143.92 28.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.142 -0.936 . . . . 74.219999999999999 110.311 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.51 131.59 34.63 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.55 -0.908 . . . . 74.010000000000005 108.55 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 122.04 27.56 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 108.974 -0.751 . . . . 50.329999999999998 108.974 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -67.14 -8.57 32.01 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.275 1.213 . . . . 61.009999999999998 114.275 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.02 -30.39 68.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 117.679 0.218 . . . . 74.239999999999995 111.053 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.6 t -126.75 -29.06 2.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.735 0.302 . . . . 74.340000000000003 111.376 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.73 7.49 68.71 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.104 -0.498 . . . . 73.439999999999998 112.387 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.48 ' H ' HG23 ' A' ' 266' ' ' THR . 39.4 mtpt -98.91 149.13 35.46 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 122.81 0.444 . . . . 74.319999999999993 111.051 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.15 153.86 71.31 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.839 3.026 . . . . 73.420000000000002 112.76 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.474 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -69.28 97.51 0.95 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.758 1.021 . . . . 73.200000000000003 113.758 -175.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 mm -144.5 112.37 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.425 -1.324 . . . . 61.340000000000003 107.425 165.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.19 117.55 20.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.015 0.825 . . . . 71.409999999999997 109.836 162.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 112.03 22.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.802 -0.444 . . . . 64.420000000000002 109.802 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -101.87 112.92 25.71 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.8 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.3 p -141.56 122.02 14.09 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.497 -1.229 . . . . 53.219999999999999 109.993 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -86.22 111.83 20.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.405 1.097 . . . . 52.340000000000003 111.602 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -6.54 59.27 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.484 -0.78 . . . . 64.239999999999995 112.765 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.64 -28.1 65.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.136 -0.484 . . . . 64.25 111.186 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 46.6 p -90.63 -29.48 17.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.822 -0.436 . . . . 64.239999999999995 109.822 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.01 57.49 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.645 -0.707 . . . . 75.030000000000001 112.658 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -113.54 144.32 31.11 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.349 -0.612 . . . . 71.140000000000001 109.349 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.83 126.48 21.28 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.201 1.934 . . . . 74.450000000000003 113.507 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -57.28 -43.0 82.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.285 0.991 . . . . 75.310000000000002 110.757 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.77 19.43 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.024 -0.989 . . . . 55.43 112.706 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -116.78 148.44 41.16 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.599 -0.84 . . . . 65.019999999999996 109.929 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -151.81 160.35 43.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.140000000000001 111.669 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.21 137.11 42.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.905 -0.588 . . . . 73.209999999999994 109.878 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.402 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 27.4 m -134.09 143.33 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.663 -0.866 . . . . 63.299999999999997 108.663 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.474 ' H ' ' CB ' ' A' ' 270' ' ' MET . 1.1 p -101.06 121.35 41.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.238 0.615 . . . . 71.140000000000001 112.304 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.36 165.9 13.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 111.836 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.48 -49.31 69.56 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.029 0.831 . . . . 74.319999999999993 112.442 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.99 138.05 31.88 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 110.115 -0.328 . . . . 74.510000000000005 110.115 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -59.16 -38.02 88.68 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.686 2.924 . . . . 73.120000000000005 117.735 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.01 -30.29 32.59 Favored 'Trans proline' 0 C--N 1.386 2.509 0 CA-C-N 123.681 2.35 . . . . 74.239999999999995 112.992 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 19.7 m -62.88 -28.27 69.92 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.248 1.019 . . . . 72.329999999999998 112.21 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.85 -40.2 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.876 0.735 . . . . 42.130000000000003 112.434 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -71.16 -38.64 72.19 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.128 0.489 . . . . 75.019999999999996 111.08 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.66 81.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.446 -0.797 . . . . 74.519999999999996 111.041 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.76 -28.55 66.9 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.725 -0.67 . . . . 52.329999999999998 112.05 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 296' ' ' ALA . 45.7 mt -67.4 -32.83 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.996 -0.44 . . . . 75.439999999999998 110.647 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.87 -60.34 2.41 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.783 1.031 . . . . 61.43 113.783 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -91.09 -32.71 15.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.125 1.898 . . . . 75.319999999999993 116.125 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 41.1 t80 -84.37 -25.27 29.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.243 0.474 . . . . 72.200000000000003 110.237 -170.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -94.89 177.05 6.03 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.968 -1.015 . . . . 41.420000000000002 110.127 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.97 13.49 59.02 Favored Glycine 0 CA--C 1.509 -0.326 0 C-N-CA 121.22 -0.514 . . . . 62.140000000000001 112.223 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 -153.75 0.59 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 73.319999999999993 108.814 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -131.61 142.18 49.82 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.569 0.699 . . . . 64.140000000000001 111.357 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -113.74 117.36 31.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.604 -1.258 . . . . 72.120000000000005 107.604 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.15 27.78 14.05 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.756 1.222 . . . . 64.430000000000007 112.51 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.21 -3.85 86.53 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.848 0.299 . . . . 61.420000000000002 113.848 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -108.77 146.11 34.1 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.723 -0.843 . . . . 75.530000000000001 108.723 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.78 131.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.99 0.424 . . . . 73.019999999999996 110.904 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.0 tt -108.54 140.0 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.91 -0.774 . . . . 74.129999999999995 108.91 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.18 125.0 22.51 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.591 -0.522 . . . . 64.329999999999998 109.591 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -113.23 139.98 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 107.733 -1.21 . . . . 65.329999999999998 107.733 -170.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 m -140.57 171.62 13.86 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 121.716 -0.615 . . . . 72.450000000000003 110.936 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.01 -3.13 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.881 0.697 . . . . 71.0 112.881 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 124.766 1.227 . . . . 35.439999999999998 112.985 175.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 . . . . . 0 C--O 1.241 0.65 0 CA-C-O 120.74 0.305 . . . . 60.43 110.77 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.99 105.4 17.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.463 -0.495 . . . . 65.549999999999997 110.287 164.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.8 m -142.1 147.83 37.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.679 -1.23 . . . . 50.32 107.679 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.0 pt -125.46 138.45 54.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 119.279 0.945 . . . . 73.140000000000001 110.072 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.84 119.86 39.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.546 -0.539 . . . . 75.439999999999998 109.546 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.45 138.87 45.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.545 -0.752 . . . . 72.0 109.288 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -128.87 142.33 50.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.365 0.666 . . . . 75.310000000000002 109.226 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.51 8.49 Favored Glycine 0 C--N 1.332 0.358 0 O-C-N 123.331 0.394 . . . . 14.31 113.259 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 76.39 1.52 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.565 -0.902 . . . . 73.230000000000004 108.565 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.22 -77.13 0.06 OUTLIER Glycine 0 CA--C 1.499 -0.944 0 C-N-CA 120.237 -0.983 . . . . 60.450000000000003 112.999 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.54 109.18 11.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.638 0.732 . . . . 75.040000000000006 111.633 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.72 20.62 33.63 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.185 -0.916 . . . . 71.329999999999998 111.349 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.87 151.56 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.331 0.586 . . . . 72.430000000000007 109.901 -173.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.8 t -91.7 170.44 9.91 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 109.152 -0.684 . . . . 50.240000000000002 109.152 171.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 127.529 2.332 . . . . 72.239999999999995 113.829 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -44.86 -11.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 126.161 1.784 . . . . 73.519999999999996 115.513 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 252' ' ' GLU . 1.3 pp0? -46.79 -22.11 0.27 Allowed 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 126.72 2.008 . . . . 71.340000000000003 113.73 168.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -56.23 -30.66 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.384 -0.822 . . . . 73.030000000000001 109.33 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.26 91.7 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.964 -0.909 . . . . 32.030000000000001 114.718 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 249' ' ' GLN . 8.9 pt-20 -75.55 -27.65 58.72 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.367 1.084 . . . . 72.150000000000006 111.457 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.7 t80 -55.61 -45.06 77.56 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.046 0.841 . . . . 75.150000000000006 110.612 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -78.79 -23.77 45.02 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.12 0.415 . . . . 73.439999999999998 112.12 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -75.5 -11.22 59.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.45 0.7 . . . . 70.129999999999995 111.93 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.53 -16.16 63.4 Favored 'General case' 0 CA--C 1.555 1.137 0 O-C-N 121.883 -0.51 . . . . 62.409999999999997 111.827 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.06 -36.87 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.257 0.623 . . . . 54.310000000000002 111.133 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -148.04 -161.13 9.35 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 119.29 -1.433 . . . . 71.299999999999997 114.31 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.41 139.24 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 122.759 0.424 . . . . 74.340000000000003 110.959 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.0 mm -67.37 115.87 6.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.496 -0.774 . . . . 73.099999999999994 110.874 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -97.47 138.86 34.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.209 -0.905 . . . . 65.519999999999996 110.962 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -84.49 116.17 22.96 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.982 -1.118 . . . . 74.329999999999998 107.982 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.92 129.21 36.58 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 109.274 -0.639 . . . . 75.030000000000001 109.274 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -78.63 -7.1 57.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.417 0.895 . . . . 73.120000000000005 113.417 -173.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.54 -30.28 69.05 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.354 0.262 . . . . 71.230000000000004 111.439 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.5 t -125.94 -32.41 2.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.559 0.219 . . . . 62.310000000000002 111.579 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.76 11.23 64.02 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 112.232 -0.347 . . . . 53.229999999999997 112.232 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.472 ' H ' HG23 ' A' ' 266' ' ' THR . 8.8 mttp -98.52 151.29 37.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.438 0.695 . . . . 61.520000000000003 111.781 173.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.04 154.84 72.43 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.671 2.914 . . . . 35.43 112.459 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.469 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.4 ptm -73.56 100.81 3.4 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.713 1.005 . . . . 75.540000000000006 113.713 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.66 112.51 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.684 -1.599 . . . . 73.200000000000003 106.684 162.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -127.89 117.35 21.63 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.495 1.043 . . . . 61.439999999999998 110.363 162.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.43 113.2 24.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.087 0.47 . . . . 74.340000000000003 110.776 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 51.0 m-85 -101.96 110.72 22.76 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.596 -0.729 . . . . 73.329999999999998 109.285 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 37.8 p -143.11 122.04 12.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.64 -1.164 . . . . 63.0 109.676 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -86.45 112.44 21.5 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.399 0.619 . . . . 75.340000000000003 111.718 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -85.73 -10.56 55.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.664 0.616 . . . . 71.129999999999995 112.664 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.42 -33.96 67.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.031 0.382 . . . . 44.32 112.031 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 12.9 t -91.03 -16.21 28.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.43 0.633 . . . . 75.310000000000002 109.723 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.92 -48.87 1.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.585 -0.734 . . . . 52.520000000000003 112.607 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -74.34 138.52 74.95 Favored Pre-proline 0 N--CA 1.456 -0.172 0 N-CA-C 110.122 -0.325 . . . . 71.209999999999994 110.122 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.99 139.38 90.65 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.541 2.161 . . . . 64.549999999999997 113.238 171.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 72.1 mttt -59.4 -39.98 85.14 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.357 1.036 . . . . 75.140000000000001 111.874 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.91 24.78 12.41 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.612 -0.722 . . . . 62.100000000000001 112.969 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 2.1 mp0 -117.72 144.01 45.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.859 -0.736 . . . . 72.299999999999997 110.621 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -148.84 142.37 25.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 72.150000000000006 109.107 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 237' ' ' PHE . 81.5 p -125.31 138.12 54.07 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.708 -0.478 . . . . 71.230000000000004 109.708 172.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.68 148.22 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.066 0.46 . . . . 65.310000000000002 110.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.469 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.9 t -101.23 127.6 47.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.856 0.862 . . . . 65.140000000000001 112.505 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 164.33 12.26 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.177 -0.327 . . . . 65.439999999999998 111.606 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.03 -46.82 49.75 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.66 0.6 . . . . 64.140000000000001 110.76 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -109.41 135.36 20.3 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 120.795 -0.362 . . . . 73.519999999999996 110.302 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.61 -39.51 20.93 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 C-N-CA 122.775 2.317 . . . . 61.530000000000001 116.887 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.49 -29.92 52.83 Favored 'Trans proline' 0 C--N 1.39 2.752 0 CA-C-N 123.459 2.271 . . . . 54.420000000000002 113.721 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 47.8 m -63.72 -27.34 69.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.829 0.852 . . . . 73.439999999999998 112.174 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -71.59 -34.19 69.68 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.602 0.564 . . . . 73.150000000000006 112.204 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -71.82 -39.13 70.02 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.959 0.409 . . . . 71.319999999999993 110.338 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.99 74.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.359 -0.837 . . . . 45.32 111.013 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.47 -29.31 66.94 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 116.14 -0.482 . . . . 65.409999999999997 112.129 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 296' ' ' ALA . 52.7 mt -67.33 -31.48 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 122.229 -0.294 . . . . 73.310000000000002 110.49 172.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -78.52 -61.4 2.02 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.958 1.096 . . . . 63.240000000000002 113.958 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -92.07 -29.63 16.46 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.296 1.961 . . . . 73.439999999999998 116.296 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.0 t80 -87.6 -21.56 25.27 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.469 0.652 . . . . 64.439999999999998 109.914 -171.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.565 ' HB2' HG12 ' A' ' 315' ' ' VAL . 26.2 t0 -93.31 175.33 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.975 -1.011 . . . . 70.109999999999999 109.672 171.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.54 12.4 61.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.305 -0.474 . . . . 62.149999999999999 112.047 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -126.14 -158.13 0.83 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.267 -0.642 . . . . 62.340000000000003 109.267 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.76 143.97 50.62 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.573 0.701 . . . . 74.420000000000002 110.601 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.1 114.03 25.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.716 -1.129 . . . . 72.120000000000005 108.155 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.0 m170 64.66 29.12 13.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.597 1.186 . . . . 65.140000000000001 112.611 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 10.11 80.61 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 113.923 0.329 . . . . 74.430000000000007 113.923 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.58 146.01 50.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.699 -0.852 . . . . 73.099999999999994 108.699 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.33 127.99 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.271 0.557 . . . . 74.299999999999997 111.02 -170.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.7 137.11 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.324 -0.853 . . . . 73.129999999999995 109.374 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.24 128.38 41.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.61 -0.723 . . . . 65.140000000000001 110.228 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.4 OUTLIER -115.57 142.05 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 108.658 -0.867 . . . . 73.420000000000002 108.658 -174.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -142.1 175.23 9.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.331 0.652 . . . . 70.230000000000004 110.492 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.33 -4.34 58.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.048 1.129 . . . . 70.030000000000001 114.048 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.285 0 C-N-CA 123.944 0.898 . . . . 64.109999999999999 112.865 -179.8 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 C--O 1.24 0.575 0 N-CA-C 110.149 -0.315 . . . . 61.219999999999999 110.149 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.14 106.61 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 62.219999999999999 109.98 165.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 16.0 m -141.79 148.06 38.31 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.902 -1.148 . . . . 63.329999999999998 107.902 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.66 137.23 56.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 118.891 0.769 . . . . 52.149999999999999 110.051 164.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.704 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -100.46 119.0 37.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.243 -0.651 . . . . 73.349999999999994 109.243 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.63 141.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.496 -0.775 . . . . 64.239999999999995 109.44 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.01 149.17 50.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.831 -0.622 . . . . 72.439999999999998 110.461 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 94.74 18.47 34.87 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 123.63 0.581 . . . . 70.409999999999997 113.362 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.78 76.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 73.209999999999994 108.551 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.526 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.02 -91.76 0.53 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.333 -0.937 . . . . 73.150000000000006 113.873 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.05 114.42 16.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.024 0.44 . . . . 75.030000000000001 110.943 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.55 19.86 33.73 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.263 -0.88 . . . . 74.219999999999999 111.89 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -83.58 151.47 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.351 -0.611 . . . . 55.229999999999997 109.351 -173.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.3 m -90.35 170.36 10.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.162 -0.472 . . . . 74.109999999999999 109.944 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -167.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.108 2.163 . . . . 73.230000000000004 113.198 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.26 -13.66 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 127.44 2.296 . . . . 62.210000000000001 115.018 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 252' ' ' GLU . 0.7 OUTLIER -47.7 -21.3 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.751 2.021 . . . . 61.100000000000001 114.136 169.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.34 -31.25 26.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.975 0 CA-C-N 119.207 0.912 . . . . 65.230000000000004 109.363 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -56.74 -37.85 79.48 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.003 -0.887 . . . . 64.409999999999997 114.419 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 249' ' ' GLN . 0.0 OUTLIER -74.91 -28.6 60.69 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.046 0.923 . . . . 70.409999999999997 110.468 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.1 t80 -56.44 -45.7 80.67 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 123.805 0.69 . . . . 74.200000000000003 110.833 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.63 -24.5 45.24 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.228 0.455 . . . . 74.209999999999994 112.228 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 12.3 tptm -63.1 -24.97 68.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.186 0.994 . . . . 63.0 111.744 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -62.95 -22.09 66.55 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.403 0.52 . . . . 72.329999999999998 112.403 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.6 mm -125.1 55.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 117.979 0.354 . . . . 73.340000000000003 110.114 171.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.41 -176.43 27.23 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 119.143 -1.503 . . . . 72.230000000000004 114.573 170.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.32 137.96 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.531 -0.334 . . . . 64.310000000000002 110.156 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.0 mm -73.77 114.24 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.723 -0.671 . . . . 71.310000000000002 110.121 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -98.59 140.24 33.12 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.67 0.748 . . . . 75.129999999999995 110.886 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.0 m -84.43 121.15 27.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.502 -1.226 . . . . 72.019999999999996 108.415 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.73 134.73 50.22 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.528 0.518 . . . . 61.100000000000001 111.246 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -81.98 -7.54 59.62 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.875 1.065 . . . . 75.340000000000003 113.875 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -68.38 -42.9 78.43 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.238 0.336 . . . . 55.130000000000003 111.485 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 24.6 p -124.4 -25.62 4.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.758 0.313 . . . . 75.129999999999995 111.337 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.26 16.46 57.37 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.905 -0.588 . . . . 22.309999999999999 113.601 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 152.13 38.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.794 0.297 . . . . 71.239999999999995 111.715 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.92 152.66 81.49 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.579 2.186 . . . . 71.510000000000005 111.361 165.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.478 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.1 ptm -72.82 99.48 2.65 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.808 1.04 . . . . 52.409999999999997 113.808 -174.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.4 mm -143.72 114.07 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.781 -1.563 . . . . 73.510000000000005 106.781 165.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -129.02 113.63 15.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.901 0.773 . . . . 73.430000000000007 109.425 162.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.08 111.34 21.45 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.828 0.347 . . . . 74.299999999999997 110.081 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.8 m-85 -103.81 111.83 24.52 Favored 'General case' 0 C--O 1.263 1.767 0 CA-C-O 121.308 0.575 . . . . 71.549999999999997 110.555 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.486 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.2 p -143.26 121.97 12.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.196 -1.365 . . . . 74.140000000000001 110.165 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.52 113.97 22.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.649 0.738 . . . . 74.219999999999999 112.24 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.54 -9.78 56.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.021 0.749 . . . . 71.010000000000005 113.021 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.94 -33.94 66.23 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.963 0.411 . . . . 72.099999999999994 110.904 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -90.56 -14.99 31.44 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.443 0.64 . . . . 63.119999999999997 110.114 170.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 89.67 -12.19 67.87 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.704 -0.68 . . . . 53.119999999999997 113.907 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.11 142.02 27.9 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.618 -0.512 . . . . 63.509999999999998 109.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.18 133.01 55.7 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.108 2.539 . . . . 75.209999999999994 113.796 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.486 ' H ' ' HA ' ' A' ' 275' ' ' THR . 22.5 mttt -62.3 -33.93 75.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.493 -1.231 . . . . 73.099999999999994 112.116 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.38 23.78 20.79 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.495 -0.775 . . . . 65.329999999999998 112.782 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.9 mt-10 -119.75 141.86 49.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.072 -0.651 . . . . 53.229999999999997 109.822 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.94 143.46 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 72.150000000000006 109.665 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.8 p -128.6 140.35 51.82 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.924 -0.399 . . . . 72.540000000000006 109.924 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.18 146.7 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.208 0.527 . . . . 51.399999999999999 109.993 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.478 ' H ' ' CB ' ' A' ' 270' ' ' MET . 25.6 t -98.95 119.96 38.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.566 0.747 . . . . 73.109999999999999 111.83 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.52 165.1 12.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.23 0.456 . . . . 60.299999999999997 112.23 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.34 -47.93 45.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 124.481 1.113 . . . . 71.129999999999995 111.988 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -124.12 137.23 28.64 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 109.558 -0.534 . . . . 75.310000000000002 109.558 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.43 -38.06 86.04 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 C-N-CA 123.58 2.853 . . . . 72.230000000000004 116.977 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.73 -29.27 29.57 Favored 'Trans proline' 0 C--N 1.397 3.082 0 CA-C-N 123.419 2.257 . . . . 71.200000000000003 113.373 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.7 m -65.84 -27.81 68.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.013 0.925 . . . . 63.509999999999998 112.208 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -74.89 -44.02 51.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.167 0.587 . . . . 51.399999999999999 112.086 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -74.77 -31.3 61.73 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.257 0.551 . . . . 75.329999999999998 111.916 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.14 73.52 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.635 -0.711 . . . . 71.450000000000003 110.601 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -67.56 -28.3 67.67 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.58 -0.736 . . . . 63.350000000000001 111.497 172.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 315' ' ' VAL . 43.7 mt -67.41 -32.34 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 122.171 -0.331 . . . . 72.319999999999993 111.08 172.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.24 -60.07 2.52 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.72 1.007 . . . . 73.109999999999999 113.72 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -35.52 15.32 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.032 1.864 . . . . 73.349999999999994 116.032 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.158 0.504 . . . . 52.539999999999999 110.325 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 315' ' ' VAL . 28.2 t0 -98.3 -178.29 3.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.266 -0.879 . . . . 71.120000000000005 109.601 172.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.16 64.31 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.943 0.19 . . . . 25.41 112.717 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.29 -158.64 0.9 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.286 -0.457 . . . . 73.129999999999995 109.997 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.87 145.78 50.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.658 0.742 . . . . 50.340000000000003 111.257 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -115.86 116.07 27.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.35 -1.295 . . . . 74.019999999999996 107.828 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 23.3 m170 64.29 28.89 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.657 1.183 . . . . 74.540000000000006 112.631 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.66 7.0 84.97 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 114.126 0.41 . . . . 63.140000000000001 114.126 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.23 147.93 48.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.803 -0.814 . . . . 51.310000000000002 108.803 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.86 130.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.083 0.468 . . . . 75.510000000000005 111.269 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.4 tt -109.14 142.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.009 -0.996 . . . . 73.540000000000006 109.502 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -136.28 128.01 29.05 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.715 -0.675 . . . . 63.450000000000003 110.718 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.11 141.87 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 N-CA-C 108.478 -0.934 . . . . 70.439999999999998 108.478 -173.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.1 m -144.52 174.25 11.11 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 121.633 -0.667 . . . . 73.120000000000005 110.623 -173.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.2 -3.35 54.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.636 0.976 . . . . 75.010000000000005 113.636 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 C-N-CA 124.552 1.141 . . . . 70.420000000000002 112.991 176.792 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 . . . . . 0 CA--C 1.539 0.531 0 N-CA-C 110.113 -0.328 . . . . 72.430000000000007 110.113 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 104.99 17.49 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.121 -0.632 . . . . 74.310000000000002 109.564 165.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.1 m -142.39 148.84 38.51 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.413 -0.958 . . . . 71.010000000000005 108.413 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.11 137.8 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.675 0.671 . . . . 54.340000000000003 111.061 164.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.43 130.55 45.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.018 -0.734 . . . . 71.030000000000001 109.018 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 141.01 44.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.356 -0.838 . . . . 63.119999999999997 109.41 -173.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.65 150.62 50.16 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.959 -0.564 . . . . 73.109999999999999 110.36 -179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.58 14.17 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 124.067 0.854 . . . . 72.099999999999994 112.857 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.03 74.88 1.32 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.903 -1.147 . . . . 64.099999999999994 107.903 175.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -136.05 -77.24 0.08 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.249 -0.976 . . . . 73.530000000000001 112.957 -175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -78.26 102.86 7.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.964 0.888 . . . . 75.239999999999995 111.919 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.53 20.67 24.11 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.109 -0.951 . . . . 71.109999999999999 112.064 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -79.16 152.5 4.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.549 0.69 . . . . 64.430000000000007 110.492 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t -91.71 168.57 11.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.297 -0.865 . . . . 65.109999999999999 109.715 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.6 t -63.52 -168.26 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.274 2.23 . . . . 73.299999999999997 113.497 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -43.94 -12.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 126.625 1.97 . . . . 61.130000000000003 115.645 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.96 -22.35 0.32 Allowed 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 126.361 1.864 . . . . 63.109999999999999 114.319 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -55.91 -32.61 33.15 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 CA-C-N 118.899 0.772 . . . . 62.109999999999999 111.001 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.17 84.19 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.646 -0.312 . . . . 73.349999999999994 113.416 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -74.6 -30.43 61.68 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.675 0.79 . . . . 70.439999999999998 111.289 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.5 t80 -56.05 -45.19 79.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 70.230000000000004 111.232 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.52 -23.71 50.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.823 0.305 . . . . 73.120000000000005 111.823 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.98 -14.32 61.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.477 0.711 . . . . 70.430000000000007 112.382 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.2 -11.81 44.67 Favored 'General case' 0 CA--C 1.557 1.223 0 O-C-N 121.666 -0.646 . . . . 75.400000000000006 112.14 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mm -106.56 -42.18 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.972 0.509 . . . . 64.030000000000001 111.102 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.61 -158.97 7.78 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 120.898 -0.668 . . . . 65.209999999999994 113.942 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 14.5 mt -104.93 139.88 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.138 0.575 . . . . 62.299999999999997 110.589 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.6 mm -65.98 113.29 2.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 109.523 -0.547 . . . . 64.120000000000005 109.523 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.04 141.64 32.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.338 -0.847 . . . . 74.239999999999995 110.767 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 11.0 m -85.07 117.71 24.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.85 -1.068 . . . . 61.310000000000002 108.511 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.61 130.29 39.28 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.152 -0.684 . . . . 73.219999999999999 109.152 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -73.36 -9.15 58.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.674 0.99 . . . . 73.019999999999996 113.674 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -69.67 -34.35 73.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 111.997 0.369 . . . . 60.43 111.997 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.68 -30.24 3.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.478 0.311 . . . . 63.130000000000003 111.519 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.19 9.08 67.82 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.543 -0.298 . . . . 64.510000000000005 112.612 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.458 ' H ' HG23 ' A' ' 266' ' ' THR . 42.9 mttt -98.14 152.08 37.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 112.196 172.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.09 156.24 63.88 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.892 3.061 . . . . 70.439999999999998 112.562 169.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.449 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.04 98.52 2.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.841 1.052 . . . . 74.099999999999994 113.841 -172.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -143.43 112.38 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.266 -1.383 . . . . 63.43 107.266 164.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -128.71 113.74 15.73 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.957 0.798 . . . . 62.109999999999999 109.367 160.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -114.52 107.89 16.12 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.721 -0.844 . . . . 52.399999999999999 108.721 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 26.1 m-85 -103.81 112.72 25.8 Favored 'General case' 0 C--O 1.26 1.634 0 CA-C-O 121.211 0.529 . . . . 73.209999999999994 110.935 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.464 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.6 p -144.42 122.92 12.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.468 -1.242 . . . . 63.409999999999997 110.308 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.99 113.39 22.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.427 0.632 . . . . 63.409999999999997 112.118 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 -8.95 57.48 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.517 -0.765 . . . . 73.219999999999999 112.715 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -35.4 71.33 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.753 0.279 . . . . 74.409999999999997 111.753 175.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.0 t -90.97 -14.26 31.83 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.204 0.526 . . . . 75.010000000000005 110.136 171.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.2 -46.32 1.7 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.579 -0.737 . . . . 60.409999999999997 113.043 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -86.19 142.84 36.2 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 110.547 -0.168 . . . . 72.349999999999994 110.547 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 139.13 83.2 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.563 2.842 . . . . 64.439999999999998 114.459 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 275' ' ' THR . 49.5 mttt -67.22 -34.21 76.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.179 -0.919 . . . . 61.520000000000003 112.146 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.76 27.75 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.093 -0.575 . . . . 62.43 112.772 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 41.7 mt-10 -115.92 143.12 45.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.812 -0.355 . . . . 75.400000000000006 110.429 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.47 154.74 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.233 -0.44 . . . . 70.430000000000007 110.78 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.2 137.39 37.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.782 -0.451 . . . . 74.310000000000002 109.782 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.35 144.75 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.361 -0.607 . . . . 45.140000000000001 109.361 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.449 ' H ' ' CB ' ' A' ' 270' ' ' MET . 26.7 t -93.35 121.69 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.61 0.764 . . . . 72.340000000000003 111.789 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -94.15 164.14 13.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.664 -0.244 . . . . 74.420000000000002 111.596 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.5 -48.78 73.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.926 0.891 . . . . 65.510000000000005 112.852 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -127.11 137.89 31.56 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 109.512 -0.551 . . . . 73.510000000000005 109.512 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.27 -38.41 75.81 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 123.078 2.519 . . . . 71.219999999999999 117.137 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.18 -28.92 15.03 Favored 'Trans proline' 0 C--N 1.391 2.799 0 CA-C-N 124.139 2.514 . . . . 72.439999999999998 113.054 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 37.9 m -61.45 -28.31 69.19 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.381 1.072 . . . . 64.439999999999998 112.027 174.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.21 -37.13 77.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.644 0.778 . . . . 54.539999999999999 112.777 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.8 -35.14 62.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 120.981 0.419 . . . . 74.540000000000006 111.288 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.563 -0.744 . . . . 74.519999999999996 111.035 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.66 -28.12 65.61 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.809 -0.632 . . . . 71.299999999999997 112.08 174.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 315' ' ' VAL . 42.3 mt -67.84 -31.86 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 122.026 -0.421 . . . . 75.299999999999997 110.811 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.43 -59.76 2.63 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.863 1.061 . . . . 74.319999999999993 113.863 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -91.27 -34.97 14.74 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.48 2.03 . . . . 62.450000000000003 116.48 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 44.3 t80 -83.44 -25.28 31.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.177 0.513 . . . . 73.109999999999999 110.188 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.5 ' HB2' HG12 ' A' ' 315' ' ' VAL . 16.7 t0 -93.46 176.38 6.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.801 -1.09 . . . . 71.439999999999998 109.95 173.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.53 12.95 57.74 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.275 -0.488 . . . . 61.25 112.31 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -128.99 -154.58 0.65 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.854 -0.424 . . . . 73.409999999999997 109.854 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.72 139.84 49.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.268 0.556 . . . . 75.409999999999997 110.868 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.52 112.74 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.716 -1.216 . . . . 70.430000000000007 107.716 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.9 m170 64.66 28.4 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.947 1.299 . . . . 75.040000000000006 112.205 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.98 88.19 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 121.629 -0.32 . . . . 43.039999999999999 113.428 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.03 143.29 33.41 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.28 -1.007 . . . . 60.329999999999998 108.28 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.82 126.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.655 0.264 . . . . 53.340000000000003 110.501 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.1 tt -107.9 140.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.976 -0.556 . . . . 60.450000000000003 109.636 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.89 126.23 28.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.863 -0.608 . . . . 75.099999999999994 109.654 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.52 138.69 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.76 -1.2 . . . . 71.140000000000001 107.76 -175.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.0 m -144.56 171.7 14.0 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 123.0 0.52 . . . . 72.409999999999997 110.192 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.48 -4.49 42.89 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.229 1.196 . . . . 71.530000000000001 114.229 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.056 0 C-N-CA 124.403 1.081 . . . . 64.140000000000001 113.097 177.272 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 C--O 1.236 0.363 0 CA-C-O 120.733 0.301 . . . . 61.140000000000001 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.33 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.424 0.631 . . . . 70.439999999999998 110.509 167.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.6 m -143.17 150.06 38.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.861 -1.162 . . . . 55.520000000000003 107.861 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 288' ' ' VAL . 2.8 pp -124.58 140.71 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.023 0.828 . . . . 62.310000000000002 111.223 164.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.67 136.18 41.95 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.791 -0.64 . . . . 65.549999999999997 109.433 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 315' ' ' VAL . 0.0 OUTLIER -128.36 142.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 122.028 0.918 . . . . 70.310000000000002 112.401 177.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -127.25 141.34 51.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.594 -1.639 . . . . 62.140000000000001 108.151 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.68 29.25 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.044 -0.598 . . . . 63.100000000000001 112.193 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.513 HD13 HG11 ' A' ' 250' ' ' VAL . 9.2 mt -107.72 71.72 0.83 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.632 -0.877 . . . . 74.340000000000003 108.632 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.46 -79.91 0.07 OUTLIER Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 119.89 -1.148 . . . . 73.230000000000004 113.741 -174.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.99 106.76 7.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.106 0.955 . . . . 74.010000000000005 111.756 -171.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.7 20.02 32.86 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.83 -1.077 . . . . 72.430000000000007 111.58 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.38 151.34 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.13 0.491 . . . . 72.409999999999997 109.825 -171.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.7 m -92.01 170.85 9.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 72.120000000000005 110.072 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.814 2.046 . . . . 74.439999999999998 114.042 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -42.44 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 127.181 2.193 . . . . 74.349999999999994 115.854 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -21.92 0.41 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.56 1.944 . . . . 75.340000000000003 114.408 169.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 241' ' ' LEU . 1.3 t -56.36 -32.03 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.114 0.87 . . . . 40.200000000000003 110.762 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.4 -31.56 81.26 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.878 -0.401 . . . . 71.439999999999998 113.559 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -75.51 -30.7 59.91 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.34 0.591 . . . . 73.109999999999999 110.251 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.5 t80 -59.21 -42.91 92.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.412 -0.813 . . . . 62.409999999999997 110.72 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -78.17 -24.04 47.41 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.894 0.378 . . . . 65.409999999999997 112.015 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 260' ' ' ILE . 22.7 tptm -66.83 -21.88 66.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.475 1.11 . . . . 72.120000000000005 112.197 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.42 -20.54 65.64 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 112.119 0.414 . . . . 63.130000000000003 112.119 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.91 54.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 117.871 0.305 . . . . 72.340000000000003 110.191 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . 147.04 -168.72 28.19 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.178 -1.487 . . . . 30.300000000000001 115.011 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.55 138.42 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.407 0.683 . . . . 74.430000000000007 110.994 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 255' ' ' LYS . 6.7 mm -74.12 116.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.306 0.379 . . . . 74.150000000000006 110.17 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -98.93 142.92 29.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.401 0.619 . . . . 53.530000000000001 111.11 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 12.7 m -84.62 115.66 22.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.334 -0.988 . . . . 74.319999999999993 108.334 166.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.76 136.07 48.63 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.789 0.292 . . . . 65.219999999999999 111.789 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -11.05 59.98 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.739 0.644 . . . . 63.329999999999998 112.739 -174.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -74.11 -26.94 60.63 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.452 0.168 . . . . 73.030000000000001 111.236 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.8 t -125.32 -31.54 3.03 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.096 0.406 . . . . 62.049999999999997 112.096 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.8 83.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 116.308 -0.405 . . . . 53.310000000000002 112.934 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 266' ' ' THR . 53.3 mmtt -96.24 148.41 34.45 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.442 0.697 . . . . 73.219999999999999 111.325 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.0 153.58 74.79 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.787 2.325 . . . . 41.130000000000003 111.022 165.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.477 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.6 OUTLIER -76.32 101.24 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.263 0.838 . . . . 73.409999999999997 113.263 -170.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.2 mm -142.55 112.82 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.024 -1.473 . . . . 71.109999999999999 107.024 162.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -129.07 113.34 15.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.333 -0.617 . . . . 71.239999999999995 109.333 162.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 273' ' ' LEU . 0.8 OUTLIER -114.42 110.5 19.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.032 -0.729 . . . . 62.109999999999999 109.032 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -103.44 111.83 24.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.095 0.474 . . . . 72.120000000000005 110.897 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.426 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.1 p -145.39 120.81 10.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.56 -1.2 . . . . 74.420000000000002 109.815 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -87.76 113.87 23.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.411 1.1 . . . . 75.230000000000004 112.595 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -4.05 58.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.119 -0.946 . . . . 63.149999999999999 112.574 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.64 79.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 64.420000000000002 110.836 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -92.69 -21.43 20.0 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.691 -0.686 . . . . 64.519999999999996 109.801 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 103.67 -45.29 1.34 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.905 -0.588 . . . . 74.129999999999995 112.673 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -79.75 143.98 59.42 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 121.224 -0.19 . . . . 72.340000000000003 110.628 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -57.12 140.51 92.92 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.959 2.439 . . . . 74.230000000000004 114.378 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 275' ' ' THR . 9.3 tttt -67.52 -37.24 82.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.877 -1.056 . . . . 64.099999999999994 111.571 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.11 17.18 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.872 -0.604 . . . . 64.430000000000007 113.891 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.44 146.18 47.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.449 -0.5 . . . . 73.340000000000003 111.478 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.48 152.67 33.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.81 -0.632 . . . . 55.32 110.632 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.75 135.17 50.72 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.101 166.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.435 HG22 HD11 ' A' ' 236' ' ' ILE . 3.3 m -134.96 146.81 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.848 -1.168 . . . . 73.019999999999996 107.848 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' SER . . . . . 0.477 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.7 m -113.58 133.82 55.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.502 0.556 . . . . 62.520000000000003 112.502 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.71 165.23 11.49 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.661 0.615 . . . . 75.209999999999994 112.661 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.89 -47.95 60.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.339 -0.846 . . . . 64.230000000000004 111.949 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -117.79 135.78 23.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.351 -0.611 . . . . 71.230000000000004 109.351 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.13 -38.84 53.25 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 123.274 2.649 . . . . 54.149999999999999 117.238 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.19 -28.39 15.6 Favored 'Trans proline' 0 C--N 1.393 2.874 0 CA-C-N 123.426 2.259 . . . . 51.420000000000002 112.544 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.4 m -61.92 -27.44 68.82 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.301 1.04 . . . . 71.519999999999996 111.946 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.26 -39.58 78.36 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.307 0.38 . . . . 71.450000000000003 111.712 175.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -41.07 87.74 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.744 0.307 . . . . 73.120000000000005 110.387 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.82 76.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.722 -0.672 . . . . 54.509999999999998 111.395 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.64 -31.18 71.7 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 122.806 0.443 . . . . 60.219999999999999 111.725 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 315' ' ' VAL . 57.2 mt -68.86 -31.11 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 O-C-N 122.197 -0.315 . . . . 72.319999999999993 110.86 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.11 -59.74 2.65 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.385 0.883 . . . . 71.209999999999994 113.385 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' TRP . . . . . . . . . . . . 0.253 1.7 p-90 -91.69 -34.26 14.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.534 2.049 . . . . 72.230000000000004 116.534 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -84.82 -22.48 29.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.376 0.607 . . . . 61.439999999999998 110.193 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 315' ' ' VAL . 21.9 t0 -83.31 -176.02 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.009 -0.996 . . . . 61.409999999999997 109.435 171.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 84.53 9.83 80.76 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 114.123 0.409 . . . . 64.519999999999996 114.123 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 -160.97 1.04 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.151 -0.685 . . . . 63.32 109.151 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.21 146.14 49.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.694 0.759 . . . . 74.340000000000003 111.401 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.88 114.28 26.72 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.749 -1.204 . . . . 73.310000000000002 107.749 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.7 m170 62.54 28.37 16.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.672 1.189 . . . . 62.539999999999999 111.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 88.89 -2.34 84.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.462 -0.399 . . . . 70.409999999999997 114.092 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -110.5 142.58 42.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.399 0.599 . . . . 55.539999999999999 109.597 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.82 126.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.177 0.513 . . . . 70.150000000000006 110.944 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 10.6 tt -108.78 139.42 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.65 -0.704 . . . . 74.129999999999995 109.963 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -136.4 123.79 22.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.549999999999997 111.075 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.541 HG23 HG13 ' A' ' 238' ' ' VAL . 4.7 p -109.29 138.85 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 CA-C-N 115.022 -0.99 . . . . 75.319999999999993 110.226 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 115.767 -0.652 . . . . 73.340000000000003 109.866 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -79.14 -3.63 46.49 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 114.618 1.34 . . . . 73.420000000000002 114.618 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.209 0 C-N-CA 124.402 1.081 . . . . 72.219999999999999 112.535 179.218 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.055 0 N-CA-C 111.358 -0.697 . . . . 24.100000000000001 111.358 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 3.8 t 68.4 -171.7 0.18 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.959 1.304 . . . . 43.299999999999997 112.111 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -90.89 118.88 30.64 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.95 0.5 . . . . 62.219999999999999 111.001 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 67.5 mtt -123.29 88.59 2.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 120.685 0.278 . . . . 63.32 110.542 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.3 m 69.6 177.56 0.26 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 125.292 1.437 . . . . 61.109999999999999 113.186 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -100.38 7.42 44.29 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.374 -0.83 . . . . 62.030000000000001 110.474 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -84.96 110.61 19.02 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.59 -0.732 . . . . 53.439999999999998 110.706 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.81 103.38 15.94 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.192 -0.603 . . . . 65.450000000000003 110.569 167.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 10.3 m -143.73 143.55 31.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.535 -0.913 . . . . 63.130000000000003 108.535 166.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 43.5 pt -119.94 142.24 36.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 119.262 0.937 . . . . 70.049999999999997 109.915 163.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.646 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -100.09 130.51 46.25 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.23 -1.026 . . . . 71.329999999999998 108.23 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -123.48 141.56 43.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 109.565 -0.532 . . . . 73.040000000000006 109.565 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.33 150.63 48.4 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 115.797 -0.638 . . . . 63.420000000000002 110.423 -176.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 90.07 14.01 59.72 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 124.383 1.052 . . . . 63.210000000000001 112.782 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.664 HD12 ' HB3' ' A' ' 286' ' ' ALA . 6.5 mt -103.48 74.56 1.27 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.984 -1.117 . . . . 73.310000000000002 107.984 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.91 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.513 -0.851 . . . . 73.299999999999997 113.55 -172.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.21 112.4 12.64 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.432 0.634 . . . . 64.530000000000001 111.705 -171.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 87.14 21.02 51.27 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.308 -0.86 . . . . 63.420000000000002 111.686 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.59 151.43 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 109.393 -0.595 . . . . 74.319999999999993 109.393 -172.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.8 t -91.81 170.78 9.61 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.05 -0.722 . . . . 71.349999999999994 109.05 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -167.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 127.535 2.334 . . . . 71.439999999999998 114.039 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -44.29 -12.83 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 126.24 1.816 . . . . 50.210000000000001 115.26 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -46.0 -22.58 0.22 Allowed 'General case' 0 CA--C 1.561 1.378 0 C-N-CA 126.605 1.962 . . . . 72.439999999999998 113.471 168.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.64 HG11 HD13 ' A' ' 241' ' ' LEU . 0.9 OUTLIER -56.3 -32.49 35.34 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 CA-C-N 118.914 0.779 . . . . 75.109999999999999 109.912 178.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.58 -32.58 83.78 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 122.281 -0.262 . . . . 73.349999999999994 113.197 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -73.12 -32.63 65.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.418 0.687 . . . . 73.540000000000006 110.481 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.565 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 7.5 t80 -56.76 -44.38 81.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.433 1.093 . . . . 74.109999999999999 110.806 171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -78.24 -24.29 47.0 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 111.956 0.354 . . . . 74.209999999999994 111.956 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -66.87 -21.34 66.01 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.936 0.895 . . . . 72.439999999999998 111.46 175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -63.55 -25.0 68.04 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 122.195 -0.316 . . . . 74.129999999999995 111.365 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.4 mm -124.59 70.86 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 109.024 -0.732 . . . . 43.149999999999999 109.024 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.36 -176.0 24.61 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 119.096 -1.526 . . . . 53.350000000000001 114.575 170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.01 139.58 28.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 123.347 0.659 . . . . 74.099999999999994 109.727 174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 41.1 mm -66.68 116.53 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.119 0.485 . . . . 74.530000000000001 110.262 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.422 ' HD2' ' O ' ' A' ' 290' ' ' PHE . 22.8 tttm -95.73 137.49 34.71 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-O 121.543 0.687 . . . . 72.400000000000006 111.048 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 26.7 m -85.2 117.85 24.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.666 -1.152 . . . . 64.010000000000005 108.471 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -75.24 137.98 41.59 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 116.147 -0.479 . . . . 71.019999999999996 110.554 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -80.01 -10.15 59.75 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.393 0.886 . . . . 73.219999999999999 113.393 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.85 -41.16 78.85 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.364 0.505 . . . . 62.399999999999999 112.364 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.6 t -125.36 -18.86 5.21 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.739 0.304 . . . . 52.219999999999999 111.089 175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.23 16.67 57.11 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 116.292 -0.413 . . . . 61.439999999999998 113.165 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 20.9 mtpt -98.13 153.3 38.17 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 112.016 0.376 . . . . 71.219999999999999 112.016 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.16 155.84 68.9 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.646 2.898 . . . . 65.349999999999994 112.353 170.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.493 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.55 98.11 2.25 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.175 0.988 . . . . 61.25 113.353 -174.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.2 mm -144.15 112.58 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 107.034 -1.469 . . . . 73.450000000000003 107.034 163.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -129.07 116.33 19.12 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.425 1.011 . . . . 64.239999999999995 109.865 162.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.65 111.25 21.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.807 0.337 . . . . 74.510000000000005 110.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 32.4 m-85 -102.6 112.0 24.55 Favored 'General case' 0 C--O 1.26 1.625 0 CA-C-O 121.241 0.543 . . . . 72.109999999999999 110.025 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.1 p -143.46 120.43 11.35 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.317 -1.311 . . . . 75.450000000000003 109.807 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -87.9 113.14 23.27 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.804 1.288 . . . . 73.519999999999996 111.884 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -7.61 59.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.633 -1.167 . . . . 73.400000000000006 111.639 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.81 -29.51 66.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.246 0.618 . . . . 75.5 111.371 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -91.11 -29.41 17.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.412 -0.588 . . . . 72.400000000000006 109.412 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 107.18 -19.3 34.96 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.316 -0.856 . . . . 52.109999999999999 112.633 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -113.17 141.64 26.03 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.292 -0.262 . . . . 73.430000000000007 110.292 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -58.35 140.35 94.1 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 123.316 2.678 . . . . 71.040000000000006 114.958 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.444 ' H ' ' HA ' ' A' ' 275' ' ' THR . 16.2 mttt -64.18 -36.52 84.31 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.706 -1.134 . . . . 64.319999999999993 112.247 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.42 23.87 20.41 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.519 -0.764 . . . . 63.109999999999999 112.421 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 49.1 mt-10 -119.62 141.03 49.67 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 119.724 -0.79 . . . . 71.319999999999993 109.81 -174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . 0.664 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -152.74 144.69 23.7 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.908 -0.587 . . . . 30.350000000000001 109.887 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 237' ' ' PHE . 76.3 p -127.7 140.22 52.21 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 122.017 -0.427 . . . . 53.520000000000003 109.964 173.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.405 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 19.6 m -134.58 146.78 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 CA-C-O 121.006 0.432 . . . . 72.219999999999999 110.428 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.493 ' H ' ' CB ' ' A' ' 270' ' ' MET . 27.6 t -98.61 113.98 26.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.725 0.81 . . . . 63.420000000000002 112.49 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.422 ' O ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 m-85 -88.08 162.77 16.59 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 111.592 0.219 . . . . 65.129999999999995 111.592 174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -77.47 -47.62 19.19 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.434 0.459 . . . . 70.409999999999997 111.199 -175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -96.76 135.44 22.19 Favored Pre-proline 0 C--O 1.242 0.705 0 C-N-CA 120.967 -0.293 . . . . 62.32 110.277 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.67 -40.45 22.72 Favored 'Trans proline' 0 CA--C 1.564 1.981 0 C-N-CA 122.213 1.942 . . . . 65.099999999999994 116.376 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.66 -30.02 51.31 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 123.082 2.136 . . . . 74.319999999999993 113.907 177.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 67.9 m -63.82 -27.36 69.12 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.44 0.696 . . . . 61.310000000000002 112.709 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.97 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.24 0.616 . . . . 75.200000000000003 111.838 175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.84 -40.76 88.06 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 123.079 0.552 . . . . 63.32 111.159 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.05 -32.94 74.71 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.438 -0.801 . . . . 62.240000000000002 111.583 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -70.59 -29.56 66.01 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.07 0.396 . . . . 74.310000000000002 112.07 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 67.9 mt -66.54 -33.81 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 110.384 -0.228 . . . . 74.439999999999998 110.384 172.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.21 -59.41 2.79 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 114.264 1.209 . . . . 70.310000000000002 114.264 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -91.37 -34.07 15.02 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 116.117 1.895 . . . . 74.239999999999995 116.117 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.446 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 67.7 t80 -86.74 -14.99 40.79 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.339 0.59 . . . . 74.310000000000002 110.558 -169.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.38 175.77 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.588 -0.893 . . . . 71.409999999999997 108.588 174.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.81 14.49 46.27 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.903 -0.665 . . . . 71.030000000000001 112.809 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -133.72 -154.04 0.57 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.097 -0.705 . . . . 75.019999999999996 109.097 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.48 149.91 52.35 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.85 0.833 . . . . 75.120000000000005 111.264 174.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -113.49 114.81 27.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.61 -1.177 . . . . 74.430000000000007 108.211 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.9 m170 64.52 28.35 13.4 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.606 1.163 . . . . 75.150000000000006 112.5 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.35 -2.75 86.68 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-O 119.891 -0.394 . . . . 61.299999999999997 113.905 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.69 141.93 47.17 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.927 -0.768 . . . . 64.129999999999995 108.927 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.14 131.23 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.127 0.489 . . . . 73.299999999999997 111.481 -169.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.86 142.68 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 115.597 -0.729 . . . . 73.239999999999995 109.569 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -137.11 129.1 29.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.798 0.332 . . . . 75.0 111.359 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.66 134.64 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 115.811 -0.631 . . . . 64.209999999999994 110.188 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -136.12 173.49 11.65 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.149 0.98 . . . . 50.43 109.816 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.9 0.56 43.73 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.409 0.892 . . . . 74.239999999999995 113.409 175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.08 -158.3 0.32 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.359 1.064 . . . . 54.039999999999999 112.88 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 4.9 m -103.89 145.55 29.96 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.792 -0.447 . . . . 63.399999999999999 109.792 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -92.16 173.56 7.76 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.244 -0.28 . . . . 60.109999999999999 110.244 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 65.29 86.89 0.13 Allowed Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 124.462 1.105 . . . . 73.430000000000007 112.045 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -74.83 111.83 3.42 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.241 1.961 . . . . 71.209999999999994 112.845 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.227 -0.892 . . . . 72.230000000000004 110.375 -178.358 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 111.418 -0.673 . . . . 72.150000000000006 111.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 37.2 m 63.72 29.32 14.93 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.457 1.28 . . . . 61.32 114.457 169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 60.32 81.68 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.611 1.164 . . . . 75.430000000000007 111.714 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 13.0 mmt -109.0 -3.83 17.15 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.549 -0.75 . . . . 75.0 112.358 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 70.9 m -140.76 140.58 34.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 120.926 0.393 . . . . 71.409999999999997 111.62 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 -11.77 46.47 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.365 -0.834 . . . . 61.020000000000003 109.953 173.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.77 110.2 14.91 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.556 -0.747 . . . . 52.030000000000001 110.164 173.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.39 105.53 17.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.272 0.558 . . . . 64.049999999999997 110.407 165.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 14.0 m -142.29 145.21 33.75 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.047 -1.094 . . . . 55.25 108.047 165.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.46 HD13 HG13 ' A' ' 315' ' ' VAL . 1.7 pp -122.16 144.42 31.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 118.937 0.79 . . . . 73.409999999999997 109.117 166.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.93 136.62 43.26 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.279 -0.638 . . . . 75.239999999999995 109.279 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.795 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.02 143.91 38.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 121.58 0.705 . . . . 62.340000000000003 112.515 175.715 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.537 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.56 147.36 49.88 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 114.102 -1.408 . . . . 62.210000000000001 110.387 -176.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.4 21.93 30.76 Favored Glycine 0 CA--C 1.521 0.423 0 O-C-N 123.524 0.515 . . . . 62.240000000000002 113.373 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.795 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.4 OUTLIER -114.96 75.48 0.94 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.566 -1.272 . . . . 74.209999999999994 107.566 176.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -131.32 -86.87 0.39 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.513 -0.851 . . . . 73.120000000000005 113.495 -170.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.31 113.21 12.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.179 0.514 . . . . 63.329999999999998 111.549 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.98 20.26 40.08 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.219 -0.9 . . . . 55.32 111.707 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.82 151.67 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 109.508 -0.552 . . . . 73.310000000000002 109.508 -174.281 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.2 m -89.34 169.97 10.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.213 -0.903 . . . . 70.109999999999999 110.09 173.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -166.04 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 126.594 1.957 . . . . 64.230000000000004 113.868 -176.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -42.64 -14.16 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.641 0 C-N-CA 126.36 1.864 . . . . 75.510000000000005 114.728 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.94 -20.78 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 126.748 2.019 . . . . 74.239999999999995 114.229 171.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.9 OUTLIER -56.46 -31.35 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 118.81 0.732 . . . . 64.430000000000007 110.25 178.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.89 -35.82 91.02 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.548 -0.585 . . . . 61.219999999999999 113.964 172.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.99 -35.46 80.01 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.943 0.897 . . . . 74.030000000000001 111.757 173.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.0 t80 -57.24 -44.35 83.77 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.005 0.922 . . . . 71.519999999999996 111.125 173.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -78.85 -24.34 44.41 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 111.821 0.304 . . . . 75.519999999999996 111.821 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.462 ' HB2' HD11 ' A' ' 260' ' ' ILE . 15.3 tptm -63.93 -23.4 67.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.095 0.958 . . . . 73.129999999999995 111.905 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -62.79 -24.39 67.71 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 121.037 -0.265 . . . . 63.229999999999997 111.521 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -126.29 67.5 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 109.086 -0.709 . . . . 75.530000000000001 109.086 169.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.77 -177.01 24.44 Favored Glycine 0 C--O 1.226 -0.388 0 C-N-CA 119.38 -1.39 . . . . 74.549999999999997 114.574 171.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.02 138.44 31.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 123.112 0.565 . . . . 54.240000000000002 109.669 176.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.8 mm -66.86 115.98 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 O-C-N 123.662 0.601 . . . . 62.109999999999999 110.066 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -95.97 139.2 32.51 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.241 -0.89 . . . . 72.400000000000006 111.135 -176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 29.4 m -86.92 117.57 25.74 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.101 -1.074 . . . . 71.230000000000004 108.101 166.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -78.68 132.02 36.86 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 109.854 -0.425 . . . . 75.239999999999995 109.854 -177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.42 -10.11 59.27 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.098 1.147 . . . . 75.200000000000003 114.098 -175.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -70.09 -31.22 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 111.772 0.286 . . . . 71.439999999999998 111.772 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.444 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.2 t -124.66 -31.7 3.18 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 111.267 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.01 6.65 69.12 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.176 -0.466 . . . . 34.409999999999997 112.506 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.444 ' H ' HG23 ' A' ' 266' ' ' THR . 75.6 mttt -98.18 152.0 37.79 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.295 0.638 . . . . 75.540000000000006 112.217 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.01 154.42 74.09 Favored 'Trans proline' 0 C--N 1.365 1.41 0 C-N-CA 123.662 2.908 . . . . 73.400000000000006 112.306 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.9 ptm -71.0 99.53 1.81 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.894 1.072 . . . . 64.420000000000002 113.894 -172.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.6 mm -144.4 114.21 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.565 -1.272 . . . . 62.409999999999997 107.565 164.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -129.54 116.45 18.95 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.997 0.817 . . . . 74.019999999999996 110.41 161.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 111.32 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.836 -0.431 . . . . 73.25 109.836 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.7 m-85 -103.16 112.52 25.41 Favored 'General case' 0 C--O 1.262 1.724 0 CA-C-O 121.159 0.504 . . . . 73.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.466 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.1 p -141.99 122.99 14.53 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.524 -1.216 . . . . 65.450000000000003 110.336 -177.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.62 112.22 20.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.118 0.485 . . . . 53.310000000000002 111.627 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.29 -11.06 50.69 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.094 0.776 . . . . 75.209999999999994 113.094 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 -28.79 57.59 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.124 0.487 . . . . 61.32 110.175 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 51.5 p -89.56 -21.8 22.7 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.742 -0.663 . . . . 70.209999999999994 109.624 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.46 -35.68 4.56 Favored Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.584 -0.734 . . . . 51.539999999999999 112.536 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -97.96 141.63 23.28 Favored Pre-proline 0 N--CA 1.45 -0.432 0 O-C-N 123.379 0.105 . . . . 74.310000000000002 111.163 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.57 135.44 70.4 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 123.493 2.795 . . . . 63.219999999999999 114.173 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.466 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.3 mttt -63.85 -36.68 84.72 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.607 -1.179 . . . . 64.400000000000006 112.082 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.55 23.95 19.81 Favored Glycine 0 CA--C 1.503 -0.705 0 C-N-CA 120.777 -0.725 . . . . 62.409999999999997 112.682 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 26.8 mt-10 -117.78 142.96 46.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.793 -0.447 . . . . 74.129999999999995 109.793 -172.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.49 153.53 34.79 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.278 -0.419 . . . . 63.539999999999999 110.535 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 20.7 p -134.97 137.01 42.65 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.964 -0.384 . . . . 71.129999999999995 109.964 168.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.9 m -138.61 150.06 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 116.259 -0.428 . . . . 35.43 110.125 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 30.7 t -105.47 117.73 34.75 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.972 0.73 . . . . 55.420000000000002 112.972 -174.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 159.93 20.13 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 121.097 -0.241 . . . . 71.329999999999998 111.227 172.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.29 -47.03 16.59 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 116.119 -0.491 . . . . 74.299999999999997 109.951 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.62 135.4 29.25 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 123.212 0.32 . . . . 73.420000000000002 110.468 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.32 -40.71 30.53 Favored 'Trans proline' 0 CA--C 1.564 1.991 0 C-N-CA 122.434 2.089 . . . . 73.099999999999994 116.133 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.33 -29.22 32.22 Favored 'Trans proline' 0 C--N 1.389 2.696 0 CA-C-N 122.682 1.994 . . . . 63.329999999999998 113.535 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 61.3 m -63.55 -25.78 68.4 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.175 0.59 . . . . 75.450000000000003 112.361 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.406 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -72.98 -45.68 56.59 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.037 0.384 . . . . 70.120000000000005 112.037 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -32.69 68.59 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.257 0.551 . . . . 62.219999999999999 111.415 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -74.74 -30.62 61.56 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.284 -0.871 . . . . 75.150000000000006 110.6 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.62 -31.23 71.11 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 122.252 0.221 . . . . 70.340000000000003 111.218 173.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 296' ' ' ALA . 67.2 mt -67.04 -34.57 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-O 120.484 0.183 . . . . 53.549999999999997 110.748 173.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -77.9 -59.86 2.61 Favored 'General case' 0 CA--C 1.558 1.262 0 N-CA-C 114.393 1.257 . . . . 73.420000000000002 114.393 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.93 -35.33 14.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.509 1.67 . . . . 74.109999999999999 115.509 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.6 t80 -83.32 -18.66 38.2 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.101 0.477 . . . . 72.219999999999999 110.156 -169.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -103.97 -174.08 2.46 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 115.043 -0.98 . . . . 62.219999999999999 109.219 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 87.81 13.08 65.35 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 121.121 -0.561 . . . . 75.420000000000002 112.322 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -135.98 -160.88 1.1 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.622 0.369 . . . . 70.409999999999997 110.137 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -122.17 145.68 47.97 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.784 0.802 . . . . 72.430000000000007 111.884 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -114.74 114.93 26.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.43 -1.259 . . . . 71.239999999999995 107.858 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.9 m170 64.37 28.66 13.68 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.915 1.286 . . . . 73.409999999999997 112.649 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.94 -2.97 85.96 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.148 0.419 . . . . 71.519999999999996 114.148 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -111.74 144.4 41.1 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 122.801 0.441 . . . . 71.120000000000005 110.05 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.4 mm -69.66 129.66 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 123.331 0.394 . . . . 71.200000000000003 110.33 -175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.0 tt -108.41 145.8 14.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.9 -0.591 . . . . 74.409999999999997 109.514 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 42.5 tttp -135.4 127.94 30.66 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.071 -0.513 . . . . 54.240000000000002 111.256 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.46 HG13 HD13 ' A' ' 236' ' ' ILE . 25.2 t -103.61 133.76 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.37 0.605 . . . . 71.439999999999998 109.385 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.9 m -132.53 173.36 11.4 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.997 0.919 . . . . 74.409999999999997 109.313 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.26 -1.07 52.25 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 113.076 0.769 . . . . 75.120000000000005 113.076 174.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 62.75 -165.92 0.23 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.404 1.082 . . . . 35.200000000000003 113.321 175.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.3 m -89.05 146.48 24.81 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.614 -0.721 . . . . 73.209999999999994 109.401 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -164.59 1.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.783 -0.821 . . . . 72.530000000000001 108.783 175.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 43.91 84.34 0.19 Allowed Pre-proline 0 N--CA 1.502 2.143 0 C-N-CA 125.274 1.43 . . . . 73.239999999999995 114.501 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -77.44 111.79 3.23 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 121.936 1.757 . . . . 73.230000000000004 112.578 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.129 -0.938 . . . . 55.109999999999999 110.882 -174.57 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.053 0 CA-C-O 119.575 -0.569 . . . . 60.240000000000002 112.347 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 24.9 m 73.71 -60.3 0.53 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.575 1.55 . . . . 73.340000000000003 112.584 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -111.53 149.7 31.01 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.934 -0.765 . . . . 62.329999999999998 108.934 173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 70.1 mmm -113.23 12.04 18.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.265 0.555 . . . . 63.140000000000001 110.886 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 11.4 p -151.19 139.33 20.16 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.534 -0.757 . . . . 64.319999999999993 110.956 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -123.35 69.28 1.01 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.517 1.151 . . . . 65.120000000000005 110.063 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -90.13 121.76 32.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.976 -1.465 . . . . 72.140000000000001 111.359 174.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.42 104.21 16.75 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.45 -0.781 . . . . 74.030000000000001 110.676 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 7.4 m -144.12 149.51 36.64 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.467 0.707 . . . . 60.299999999999997 109.344 168.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.76 137.16 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 118.726 0.694 . . . . 61.420000000000002 110.512 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.55 125.51 48.21 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 109.556 -0.535 . . . . 75.030000000000001 109.556 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER -120.05 143.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.745 0.784 . . . . 74.120000000000005 111.93 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 26.1 tp60 -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 113.986 -1.461 . . . . 44.420000000000002 108.927 -176.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.89 5.78 43.94 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.098 -0.573 . . . . 61.43 112.958 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.462 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -105.0 78.65 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.579 -0.896 . . . . 63.409999999999997 108.579 178.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.54 -81.44 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.491 -0.861 . . . . 71.140000000000001 113.486 -172.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -77.68 107.14 9.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 72.140000000000001 111.21 -172.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.23 20.92 24.07 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.556 -0.747 . . . . 61.130000000000003 112.078 -174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.54 152.55 4.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.384 0.611 . . . . 73.319999999999993 110.572 -173.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.4 t -93.84 169.24 10.44 Favored 'General case' 0 CA--C 1.557 1.25 0 CA-C-N 115.597 -0.729 . . . . 60.149999999999999 109.408 169.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -167.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 127.136 2.174 . . . . 71.109999999999999 114.208 -174.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -44.14 -13.12 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 126.241 1.817 . . . . 75.409999999999997 115.528 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.94 -22.96 0.38 Allowed 'General case' 0 CA--C 1.567 1.613 0 C-N-CA 126.499 1.92 . . . . 73.430000000000007 113.998 169.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -56.21 -30.59 30.17 Favored 'Isoleucine or valine' 0 C--N 1.361 1.099 0 O-C-N 122.001 -0.437 . . . . 74.409999999999997 110.287 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.38 -33.49 84.79 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 122.054 -0.403 . . . . 75.109999999999999 113.378 174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -73.22 -32.13 64.58 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.527 0.731 . . . . 45.039999999999999 110.697 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 11.0 t80 -55.56 -45.85 77.24 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.162 -0.926 . . . . 74.329999999999998 111.182 172.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.82 -24.12 48.83 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 122.195 -0.315 . . . . 71.150000000000006 111.613 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttt -74.83 -11.11 60.07 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.661 0.785 . . . . 63.200000000000003 112.183 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -15.83 61.88 Favored 'General case' 0 CA--C 1.557 1.238 0 O-C-N 121.854 -0.529 . . . . 61.5 111.733 172.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.3 mm -105.14 -44.41 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.909 0.484 . . . . 71.040000000000006 111.115 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -139.08 -162.09 8.99 Favored Glycine 0 C--N 1.341 0.853 0 C-N-CA 120.365 -0.921 . . . . 64.239999999999995 114.72 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.0 138.2 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.832 0.453 . . . . 73.400000000000006 110.835 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.82 114.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 O-C-N 123.885 0.741 . . . . 64.299999999999997 110.947 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -100.96 144.16 30.24 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.763 -1.108 . . . . 53.420000000000002 111.308 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 95.8 m -83.39 118.1 23.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.369 -1.287 . . . . 74.530000000000001 108.114 168.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -71.94 133.96 45.7 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 123.605 0.565 . . . . 71.329999999999998 109.676 -176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -77.38 -11.55 59.85 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.474 0.546 . . . . 72.519999999999996 112.474 -175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -70.31 -31.21 68.43 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.106 0.41 . . . . 60.439999999999998 112.106 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.2 t -124.86 -31.68 3.13 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.625 0.232 . . . . 71.400000000000006 111.625 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.79 8.85 69.19 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 116.48 -0.327 . . . . 64.340000000000003 112.515 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.433 ' H ' HG23 ' A' ' 266' ' ' THR . 49.9 mttt -98.45 152.4 37.91 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 123.256 0.623 . . . . 64.439999999999998 112.247 173.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -66.02 154.35 74.38 Favored 'Trans proline' 0 C--N 1.367 1.553 0 C-N-CA 123.178 2.585 . . . . 64.140000000000001 111.113 166.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.525 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.94 102.15 6.27 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.651 0.982 . . . . 64.519999999999996 113.651 -168.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.6 mm -142.86 112.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 107.126 -1.435 . . . . 74.530000000000001 107.126 163.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -128.5 114.78 17.2 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 118.685 0.675 . . . . 72.510000000000005 109.367 161.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -115.56 110.24 18.95 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.363 -0.606 . . . . 73.049999999999997 109.363 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -103.06 112.22 24.96 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 121.356 0.598 . . . . 75.140000000000001 111.009 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.7 p -144.18 120.99 11.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.594 -1.185 . . . . 53.229999999999997 109.997 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.96 112.94 21.66 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.448 0.642 . . . . 64.209999999999994 111.864 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.86 -7.9 58.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.407 -0.815 . . . . 73.349999999999994 112.774 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.06 -33.0 69.84 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.021 0.438 . . . . 72.230000000000004 111.138 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 7.7 t -91.53 -14.53 30.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.776 -0.647 . . . . 74.310000000000002 109.886 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.59 -49.76 1.62 Allowed Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.589 -0.732 . . . . 43.140000000000001 112.628 174.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -79.11 142.09 59.06 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.716 0.304 . . . . 71.019999999999996 110.54 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -57.15 134.56 64.97 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.314 2.676 . . . . 73.239999999999995 114.228 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -60.26 -42.46 95.37 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.928 -1.033 . . . . 74.450000000000003 111.889 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.79 24.77 14.59 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.796 -0.716 . . . . 52.310000000000002 113.565 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -118.27 145.86 44.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 117.086 0.443 . . . . 73.239999999999995 110.517 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.86 156.13 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 61.509999999999998 110.456 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.71 136.08 46.17 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.74 0.305 . . . . 74.430000000000007 110.211 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.4 m -137.68 148.05 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 CA-C-N 116.176 -0.465 . . . . 72.310000000000002 109.747 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.525 ' H ' ' CB ' ' A' ' 270' ' ' MET . 47.4 t -97.66 141.74 30.31 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.227 1.011 . . . . 74.319999999999993 111.74 -174.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.81 164.89 12.31 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 122.195 -0.315 . . . . 74.25 110.538 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.0 -47.51 65.35 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.442 0.464 . . . . 74.230000000000004 110.872 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.411 ' HB3' ' HD2' ' A' ' 294' ' ' PRO . 40.3 m-20 -115.11 138.18 23.36 Favored Pre-proline 0 C--O 1.24 0.575 0 CA-C-N 116.481 -0.327 . . . . 72.099999999999994 110.232 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -61.88 -37.8 63.65 Favored 'Trans proline' 0 CA--C 1.57 2.294 0 C-N-CA 123.137 2.558 . . . . 70.209999999999994 117.782 175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 292' ' ' ASP . 33.3 Cg_endo -76.6 -27.3 7.63 Favored 'Trans proline' 0 C--N 1.392 2.824 0 CA-C-N 123.645 2.337 . . . . 71.209999999999994 112.999 -172.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 1.5 m -59.57 -27.94 66.69 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.258 1.023 . . . . 73.25 111.738 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.1 -39.28 82.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.506 0.723 . . . . 71.549999999999997 112.892 177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -75.07 -32.77 61.57 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 120.821 0.343 . . . . 65.209999999999994 111.116 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.7 -35.17 79.99 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.156 -0.475 . . . . 51.240000000000002 110.314 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -68.03 -29.13 68.04 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 116.152 -0.476 . . . . 63.130000000000003 112.204 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 296' ' ' ALA . 57.8 mt -67.41 -30.56 49.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 O-C-N 122.164 -0.335 . . . . 64.319999999999993 110.582 171.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.01 -59.73 2.66 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 113.904 1.076 . . . . 60.450000000000003 113.904 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -90.73 -37.48 13.67 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 116.272 1.953 . . . . 73.430000000000007 116.272 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -82.42 -21.12 35.89 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.304 0.573 . . . . 75.239999999999995 110.436 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 315' ' ' VAL . 13.9 t70 -83.85 -172.52 4.2 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.083 -0.962 . . . . 62.219999999999999 109.971 168.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 80.86 11.8 83.44 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.854 -0.529 . . . . 42.210000000000001 113.106 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 -159.21 0.95 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.481 -0.563 . . . . 74.329999999999998 109.481 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -131.84 145.2 51.41 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.597 0.713 . . . . 74.450000000000003 110.784 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -112.35 113.57 25.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.485 -1.302 . . . . 72.120000000000005 107.485 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.1 m170 64.41 28.51 13.6 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 124.455 1.097 . . . . 74.239999999999995 112.663 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.77 3.37 88.14 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.408 -0.36 . . . . 73.519999999999996 113.458 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -112.87 141.47 46.65 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.739 -0.837 . . . . 63.399999999999999 108.739 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.21 127.15 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.966 0.413 . . . . 63.350000000000001 110.462 -174.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.6 tt -108.5 144.75 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.764 -0.653 . . . . 55.130000000000003 109.629 -176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 39.1 tptt -136.5 121.12 18.37 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.993 -0.548 . . . . 72.230000000000004 109.95 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.414 HG12 ' HB2' ' A' ' 304' ' ' ASP . 8.2 p -107.65 136.74 41.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.489 -0.778 . . . . 65.120000000000005 109.892 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.2 m -138.08 174.15 10.87 Favored 'General case' 0 C--O 1.215 -0.762 0 C-N-CA 124.146 0.978 . . . . 71.129999999999995 110.13 -173.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.7 -7.25 59.28 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.632 0.975 . . . . 74.340000000000003 113.632 175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 69.73 8.53 6.77 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 114.593 1.331 . . . . 70.409999999999997 114.593 172.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 7.5 m 65.83 121.93 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.858 1.263 . . . . 64.430000000000007 111.724 -173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -84.86 93.77 8.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.661 -0.7 . . . . 74.140000000000001 111.056 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -166.56 88.86 0.82 Allowed Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 123.568 0.747 . . . . 64.430000000000007 111.545 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -80.97 94.34 0.98 Allowed 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.195 1.264 . . . . 64.340000000000003 113.326 171.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.246 0.906 0 CA-C-N 115.351 -0.84 . . . . 63.340000000000003 109.875 177.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.964 0 N-CA-C 112.317 -0.313 . . . . 60.539999999999999 112.317 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.5 m -129.7 -49.53 1.15 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.465 0.174 . . . . 64.319999999999993 111.374 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -125.55 125.54 43.38 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.544 0.211 . . . . 52.310000000000002 110.556 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.5 mtt -143.86 30.76 1.31 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.424 -0.353 . . . . 73.219999999999999 111.894 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 7.9 t -145.96 151.66 38.17 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.895 -0.409 . . . . 54.020000000000003 109.895 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -90.3 -5.7 55.97 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 123.577 0.548 . . . . 73.340000000000003 109.807 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -76.39 107.51 8.7 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.458 -0.792 . . . . 74.409999999999997 110.26 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.67 103.95 16.08 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.905 -0.718 . . . . 71.450000000000003 110.24 162.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.9 m -142.27 144.87 33.49 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.948 -1.501 . . . . 61.310000000000002 106.948 164.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 11.8 pt -123.59 141.26 44.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 119.406 1.003 . . . . 73.219999999999999 109.689 168.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.519 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.5 OUTLIER -101.53 122.53 43.99 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 108.677 -0.86 . . . . 72.420000000000002 108.677 -178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.9 141.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.087 -0.709 . . . . 71.0 109.087 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.15 151.03 49.71 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 123.489 0.716 . . . . 72.319999999999993 110.516 -177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 312' ' ' ILE . . . 90.9 21.48 36.12 Favored Glycine 0 C--N 1.334 0.442 0 O-C-N 124.158 0.911 . . . . 71.310000000000002 113.638 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.02 76.92 1.0 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.79 -1.189 . . . . 60.240000000000002 107.79 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.68 -90.93 0.42 Allowed Glycine 0 CA--C 1.502 -0.728 0 C-N-CA 120.587 -0.816 . . . . 63.229999999999997 113.753 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.68 112.9 16.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.929 0.395 . . . . 70.209999999999994 110.791 -174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.59 20.15 25.41 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.321 -0.854 . . . . 74.430000000000007 111.996 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -87.29 151.83 3.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 109.681 -0.489 . . . . 75.329999999999998 109.681 -173.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 37.2 m -93.55 170.63 9.45 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.17 -0.468 . . . . 73.200000000000003 110.0 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.58 -165.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.344 2.258 . . . . 73.109999999999999 114.233 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -42.89 -14.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 127.384 2.273 . . . . 73.319999999999993 114.819 174.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -46.93 -22.08 0.28 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.671 1.988 . . . . 64.299999999999997 114.723 169.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -57.46 -32.2 40.87 Favored 'Isoleucine or valine' 0 C--N 1.367 1.338 0 CA-C-N 119.341 0.973 . . . . 63.399999999999999 110.699 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.15 -34.86 85.93 Favored Glycine 0 C--N 1.357 1.723 0 CA-C-O 120.065 -0.297 . . . . 62.240000000000002 113.463 174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 37.4 tt0 -73.47 -31.47 63.78 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.39 0.676 . . . . 71.450000000000003 111.23 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.9 t80 -56.8 -43.44 80.95 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.144 0.578 . . . . 72.230000000000004 111.298 170.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -79.04 -24.46 43.6 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.471 0.545 . . . . 74.340000000000003 112.471 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 13.2 tptm -63.01 -23.17 67.33 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.356 1.062 . . . . 72.340000000000003 111.681 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -64.15 -20.38 65.95 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.63 0.604 . . . . 75.430000000000007 112.63 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.5 mm -123.61 41.57 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 121.419 0.628 . . . . 65.5 110.233 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 150.64 -168.81 30.49 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 118.835 -1.65 . . . . 65.540000000000006 115.02 172.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.29 136.56 37.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 115.372 -0.414 . . . . 63.200000000000003 110.573 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 38.3 mm -67.46 115.25 5.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.86 -1.064 . . . . 73.510000000000005 110.027 175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -98.18 140.54 32.32 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.505 0.669 . . . . 73.219999999999999 111.3 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 2.7 m -84.35 116.71 23.17 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.688 -1.142 . . . . 73.140000000000001 108.074 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.67 126.64 31.19 Favored 'General case' 0 C--O 1.213 -0.856 0 N-CA-C 109.132 -0.692 . . . . 72.209999999999994 109.132 -176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -74.98 -6.32 48.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.229 1.196 . . . . 75.420000000000002 114.229 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -67.97 -33.47 74.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.23 0.212 . . . . 72.530000000000001 111.147 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.38 -29.33 3.25 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.729 0.299 . . . . 72.209999999999994 111.511 176.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 91.5 11.02 61.3 Favored Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.194 -0.457 . . . . 62.130000000000003 112.811 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.46 ' H ' HG23 ' A' ' 266' ' ' THR . 73.9 mttt -98.62 151.53 37.49 Favored Pre-proline 0 C--O 1.241 0.646 0 C-N-CA 122.933 0.493 . . . . 73.239999999999995 112.182 173.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.99 155.52 63.96 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 123.981 3.12 . . . . 64.109999999999999 112.837 169.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.466 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -70.35 98.91 1.48 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.03 1.122 . . . . 71.349999999999994 114.03 -173.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.5 mm -144.19 113.07 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 107.224 -1.398 . . . . 74.010000000000005 107.224 164.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -128.7 115.05 17.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 119.262 0.937 . . . . 71.239999999999995 109.891 161.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.69 111.21 21.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.957 0.408 . . . . 64.230000000000004 110.083 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 62.2 m-85 -103.54 111.53 24.02 Favored 'General case' 0 C--O 1.26 1.64 0 CA-C-O 121.356 0.598 . . . . 71.420000000000002 110.39 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.442 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.2 p -143.2 122.51 13.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.027 -1.442 . . . . 63.299999999999997 110.136 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.7 112.02 20.65 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 121.207 0.527 . . . . 62.149999999999999 111.497 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.21 -9.82 54.15 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.146 0.795 . . . . 54.109999999999999 113.146 175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.61 -28.65 56.2 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.566 0.222 . . . . 65.510000000000005 110.582 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 56.8 p -88.69 -21.04 24.11 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.375 0.607 . . . . 62.140000000000001 109.454 169.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.32 -12.14 70.29 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 114.932 -1.031 . . . . 75.109999999999999 112.944 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -121.08 140.26 30.72 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 110.184 -0.302 . . . . 72.219999999999999 110.184 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.47 133.5 55.06 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 123.187 2.591 . . . . 70.239999999999995 114.209 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 275' ' ' THR . 32.4 mttt -62.12 -34.37 76.23 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.798 -1.092 . . . . 65.409999999999997 112.357 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.34 24.46 18.89 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.94 -0.648 . . . . 43.049999999999997 112.723 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 35.9 mt-10 -119.35 142.1 48.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.764 -0.774 . . . . 74.310000000000002 109.901 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.59 143.04 23.5 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.264 -0.643 . . . . 40.520000000000003 109.264 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 237' ' ' PHE . 62.4 p -128.43 139.62 52.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.289 -0.634 . . . . 75.319999999999993 109.289 173.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 33.0 m -135.89 144.47 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 120.947 0.404 . . . . 52.350000000000001 110.17 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.466 ' H ' ' CB ' ' A' ' 270' ' ' MET . 43.3 t -93.45 123.02 36.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.49 0.716 . . . . 61.039999999999999 112.041 -177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.82 164.97 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.658 -0.246 . . . . 75.150000000000006 111.422 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.11 -48.05 63.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.117 0.567 . . . . 75.019999999999996 112.206 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -122.23 136.45 26.42 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.641 -0.874 . . . . 72.239999999999995 108.641 -177.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -61.9 -37.9 62.68 Favored 'Trans proline' 0 CA--C 1.567 2.151 0 C-N-CA 123.099 2.532 . . . . 65.200000000000003 117.462 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.16 -29.01 18.08 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.762 2.379 . . . . 61.119999999999997 113.238 -175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 8.0 m -60.04 -29.02 68.23 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.306 1.043 . . . . 74.450000000000003 112.063 175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -68.49 -38.61 81.13 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 123.639 0.775 . . . . 61.43 112.759 177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 6.6 ttpp -74.36 -36.01 63.57 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.258 0.551 . . . . 74.430000000000007 111.126 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.75 81.68 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.074 -0.967 . . . . 73.310000000000002 110.929 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.72 -29.66 68.13 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 123.583 0.552 . . . . 64.340000000000003 111.976 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 296' ' ' ALA . 78.9 mt -63.29 -34.72 68.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-N 117.772 0.26 . . . . 75.019999999999996 110.713 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.41 -60.05 2.52 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 114.19 1.181 . . . . 71.519999999999996 114.19 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.44 -34.05 15.76 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 116.194 1.924 . . . . 73.540000000000006 116.194 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.441 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 60.3 t80 -85.65 -18.47 33.14 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.191 0.52 . . . . 65.400000000000006 110.167 -171.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -107.59 -175.51 2.81 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.339 -0.986 . . . . 73.120000000000005 108.339 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.45 56.42 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.679 -0.296 . . . . 62.219999999999999 112.378 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -140.56 -153.2 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.939 -0.393 . . . . 75.530000000000001 109.939 -175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -120.68 146.24 46.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.82 0.448 . . . . 72.120000000000005 110.783 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -113.7 110.76 20.71 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.68 -1.23 . . . . 63.009999999999998 107.68 171.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 18.8 m170 64.96 29.64 12.23 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.638 1.175 . . . . 73.109999999999999 112.245 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.51 -4.14 83.84 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.394 -0.366 . . . . 74.409999999999997 113.98 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -110.22 148.72 31.29 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 117.222 0.511 . . . . 64.430000000000007 110.159 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . 0.406 ' O ' ' HA3' ' A' ' 240' ' ' GLY . 46.6 mm -68.78 126.0 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 123.467 0.48 . . . . 74.510000000000005 110.767 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.2 tt -108.22 142.52 20.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 115.939 -0.573 . . . . 72.140000000000001 109.944 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -136.42 129.84 31.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.27 -0.423 . . . . 71.430000000000007 111.034 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.91 137.33 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.201 0.524 . . . . 62.439999999999998 109.75 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -136.38 172.94 12.28 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.102 0.961 . . . . 71.230000000000004 109.451 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.77 -4.66 55.35 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.193 0.812 . . . . 74.049999999999997 113.193 174.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.56 -165.22 0.24 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.914 1.286 . . . . 73.340000000000003 112.883 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.51 171.84 12.18 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.677 -0.692 . . . . 63.340000000000003 109.377 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 24.4 mtp180 -75.53 -170.72 1.32 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.676 0.621 . . . . 75.409999999999997 112.676 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 1.3 mtp-105 -60.09 151.09 67.78 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 124.247 1.019 . . . . 73.420000000000002 112.501 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.14 90.37 0.26 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.423 2.748 . . . . 74.420000000000002 112.706 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 . . . . . 0 C--O 1.253 1.268 0 C-N-CA 125.481 1.512 . . . . 72.299999999999997 111.989 -175.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 CA-C-O 119.612 -0.549 . . . . 71.109999999999999 113.007 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 92.0 p 55.41 19.9 3.35 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 126.144 1.778 . . . . 64.129999999999995 115.303 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 63.65 174.21 0.17 Allowed 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 125.442 1.497 . . . . 74.230000000000004 113.062 -176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 8.5 ptm -152.43 83.02 1.24 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.983 -0.553 . . . . 63.340000000000003 111.209 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 33.2 p -166.47 127.23 1.69 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.605 -0.725 . . . . 70.209999999999994 111.443 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -81.71 -15.62 53.83 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.523 -0.762 . . . . 73.420000000000002 110.06 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -67.9 106.78 2.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.359 -0.837 . . . . 51.240000000000002 111.201 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.8 105.66 17.76 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.495 -0.482 . . . . 75.340000000000003 110.186 162.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -142.25 150.25 40.67 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.066 -1.457 . . . . 64.209999999999994 107.066 166.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.23 137.22 57.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 119.154 0.888 . . . . 65.450000000000003 109.837 165.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.666 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.91 116.94 33.15 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.789 -0.819 . . . . 73.239999999999995 108.789 -177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.02 139.7 36.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.42 -0.585 . . . . 71.010000000000005 109.42 -176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 25.6 tp60 -128.9 142.71 50.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.761 -0.829 . . . . 65.109999999999999 108.761 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.8 20.75 11.09 Favored Glycine 0 N--CA 1.462 0.371 0 C-N-CA 121.139 -0.553 . . . . 53.32 112.464 175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.72 73.06 0.8 Allowed 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.55 -0.907 . . . . 70.439999999999998 108.55 177.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -151.86 -178.44 26.59 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.477 -0.783 . . . . 71.030000000000001 112.018 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 282' ' ' PRO 0.261 12.0 pt-20 40.84 87.19 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.833 2.053 . . . . 45.520000000000003 114.845 178.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.18 21.11 25.95 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.008 -0.837 . . . . 65.150000000000006 111.008 -173.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.94 151.59 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 109.242 -0.651 . . . . 71.230000000000004 109.242 -173.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 17.6 m -84.61 168.69 15.1 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.76 -0.655 . . . . 74.530000000000001 110.23 173.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.69 -169.13 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.618 1.967 . . . . 74.439999999999998 113.07 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -44.11 -12.48 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 C-N-CA 126.422 1.889 . . . . 75.439999999999998 115.468 174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.09 -23.17 0.28 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 126.314 1.846 . . . . 71.150000000000006 113.701 170.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -57.78 -31.33 39.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.2 0 N-CA-C 109.585 -0.524 . . . . 73.540000000000006 109.585 -178.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.62 -33.07 83.68 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-O 119.907 -0.385 . . . . 60.140000000000001 113.438 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -76.1 -29.65 57.99 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.243 0.617 . . . . 74.340000000000003 111.241 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.8 t80 -55.5 -44.56 76.69 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.498 0.719 . . . . 73.129999999999995 110.419 169.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -77.82 -24.54 48.68 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 111.685 0.254 . . . . 74.120000000000005 111.685 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.496 ' HB2' HD11 ' A' ' 260' ' ' ILE . 10.9 tmtt? -68.98 -18.78 64.11 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.585 0.754 . . . . 74.319999999999993 111.292 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -62.86 -22.12 66.46 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 122.297 -0.252 . . . . 73.129999999999995 110.802 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 6.1 mm -122.83 63.82 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.369 -0.604 . . . . 70.310000000000002 109.369 168.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.07 -172.84 26.59 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 118.803 -1.665 . . . . 33.539999999999999 115.366 169.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 45.9 mt -107.48 138.48 33.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.165 -1.018 . . . . 73.140000000000001 109.62 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 255' ' ' LYS . 47.7 mm -70.35 116.05 10.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.272 0.558 . . . . 71.109999999999999 110.373 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -96.42 140.15 31.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.081 -0.963 . . . . 72.329999999999998 111.404 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 89.7 m -86.0 117.5 24.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.132 -0.94 . . . . 74.430000000000007 108.597 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -72.75 136.97 45.59 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 116.42 -0.354 . . . . 71.239999999999995 111.069 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -78.76 -9.39 59.42 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 113.003 0.742 . . . . 64.239999999999995 113.003 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.43 -39.56 77.79 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 112.011 0.374 . . . . 64.25 112.011 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 7.9 t -126.25 -19.4 4.71 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 120.532 0.206 . . . . 73.150000000000006 111.359 174.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.49 57.17 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 116.519 -0.309 . . . . 74.140000000000001 113.063 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -99.93 153.91 37.51 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 111.99 0.367 . . . . 74.409999999999997 111.99 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.41 153.06 76.89 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.056 2.504 . . . . 64.0 111.723 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.463 ' HE3' ' HB ' ' A' ' 288' ' ' VAL . 1.4 ptm -76.73 100.15 5.33 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.162 0.801 . . . . 71.530000000000001 113.162 -171.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.5 mm -143.14 113.92 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.129 -1.434 . . . . 74.340000000000003 107.129 165.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -128.13 117.61 21.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 119.177 0.898 . . . . 75.530000000000001 109.815 162.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.53 112.74 23.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.08 0.467 . . . . 64.200000000000003 110.218 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 61.8 m-85 -101.62 111.68 24.01 Favored 'General case' 0 C--O 1.256 1.399 0 CA-C-N 115.907 -0.588 . . . . 54.530000000000001 109.663 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 12.2 p -143.74 122.07 12.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.317 -1.311 . . . . 73.340000000000003 109.231 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.49 110.7 18.87 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.256 0.55 . . . . 62.210000000000001 111.043 177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -7.43 58.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 113.213 0.82 . . . . 63.219999999999999 113.213 176.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.38 -32.43 70.09 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.252 0.345 . . . . 72.340000000000003 110.816 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -91.88 -19.18 22.76 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.984 -0.553 . . . . 74.439999999999998 110.149 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 102.27 -44.43 1.52 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.004 -0.543 . . . . 70.030000000000001 112.911 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -81.95 142.1 48.01 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 123.587 0.227 . . . . 54.140000000000001 111.187 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 243' ' ' GLU . 10.1 Cg_endo -58.69 130.86 39.06 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.909 2.406 . . . . 51.039999999999999 113.508 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -59.98 -39.12 84.6 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.926 -1.034 . . . . 70.140000000000001 112.165 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.9 25.23 15.24 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.668 -0.777 . . . . 62.210000000000001 113.076 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 37.3 mt-10 -118.81 143.56 46.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.101 0.451 . . . . 73.519999999999996 110.084 -176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.13 143.36 23.26 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 122.455 0.302 . . . . 61.43 110.341 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.666 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.6 p -125.53 138.86 53.98 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 122.074 -0.391 . . . . 71.439999999999998 110.296 173.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.463 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 7.4 m -136.86 148.06 26.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 N-CA-C 109.992 -0.373 . . . . 75.209999999999994 109.992 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.432 ' H ' ' CB ' ' A' ' 270' ' ' MET . 49.8 m -108.44 117.48 34.27 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.978 0.733 . . . . 51.020000000000003 112.978 -172.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -84.44 163.94 19.17 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.759 0.424 . . . . 72.200000000000003 111.897 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -76.2 -48.42 20.47 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 116.536 -0.302 . . . . 61.009999999999998 110.686 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.01 135.61 23.41 Favored Pre-proline 0 C--O 1.239 0.548 0 O-C-N 123.203 0.314 . . . . 74.319999999999993 110.743 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.81 -41.16 19.08 Favored 'Trans proline' 0 CA--C 1.564 1.99 0 C-N-CA 122.802 2.334 . . . . 62.43 116.813 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.58 -29.74 52.15 Favored 'Trans proline' 0 C--N 1.391 2.788 0 CA-C-N 122.946 2.088 . . . . 74.420000000000002 113.806 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 49.8 m -64.29 -27.42 69.02 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.099 0.96 . . . . 71.430000000000007 112.465 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -65.29 -44.19 88.75 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 122.841 0.457 . . . . 71.140000000000001 111.546 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -66.62 -39.68 88.44 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.153 0.581 . . . . 63.310000000000002 110.349 178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.37 -33.86 76.66 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.521 -0.763 . . . . 75.209999999999994 111.448 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.501 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.92 -33.14 73.26 Favored 'General case' 0 C--O 1.216 -0.709 0 C-N-CA 122.709 0.404 . . . . 71.120000000000005 111.623 174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 75.2 mt -64.8 -33.41 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-O 120.849 0.357 . . . . 71.239999999999995 110.603 172.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.49 -60.33 2.4 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 113.766 1.024 . . . . 75.140000000000001 113.766 -175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -91.72 -31.84 15.65 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.867 1.803 . . . . 73.200000000000003 115.867 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 72.2 t80 -87.49 -14.79 39.43 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.371 0.605 . . . . 73.219999999999999 109.937 -169.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -104.89 173.81 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.337 -0.986 . . . . 74.239999999999995 108.337 172.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.28 14.21 51.83 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.731 -0.747 . . . . 71.230000000000004 112.228 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -131.25 -156.54 0.76 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.699 -0.852 . . . . 71.420000000000002 108.699 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -132.84 148.77 52.3 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.618 0.723 . . . . 65.5 111.011 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -113.61 117.7 32.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.4 m170 64.69 28.47 13.08 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.722 1.209 . . . . 61.340000000000003 112.17 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.81 -3.07 86.52 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.405 -0.361 . . . . 72.109999999999999 113.762 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -113.55 144.84 42.19 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 109.197 -0.668 . . . . 72.239999999999995 109.197 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 49.2 mm -68.65 130.28 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.165 0.507 . . . . 64.420000000000002 111.673 -167.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.5 tt -110.43 142.51 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.324 -0.853 . . . . 74.219999999999999 110.023 -175.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -136.86 126.87 25.96 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.236 0.614 . . . . 61.530000000000001 111.341 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 31.6 t -108.7 138.83 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-N 116.276 -0.42 . . . . 74.010000000000005 110.877 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -134.95 176.61 8.5 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 63.549999999999997 110.489 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.77 -11.58 59.83 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.97 1.1 . . . . 71.319999999999993 113.97 171.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 237' ' ' PHE . . . 67.32 -170.08 0.19 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.289 1.036 . . . . 65.549999999999997 113.319 176.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.85 158.94 19.83 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.103 -0.953 . . . . 74.239999999999995 110.136 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -91.36 147.92 22.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.101 -0.5 . . . . 72.239999999999995 109.867 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.5 mtt180 74.32 165.28 0.13 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 124.622 1.201 . . . . 72.530000000000001 113.669 176.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.52 -170.87 0.8 Allowed 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.381 2.054 . . . . 65.040000000000006 113.515 170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 C--O 1.249 1.031 0 CA-C-N 114.786 -1.097 . . . . 51.520000000000003 110.976 -177.069 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 111.831 -0.508 . . . . 61.119999999999997 111.831 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 14.3 m -116.88 48.57 1.28 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.739 0.304 . . . . 64.450000000000003 110.826 -177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 62.95 23.02 13.78 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.715 1.206 . . . . 75.200000000000003 112.088 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 19.5 mmt 54.68 69.33 0.74 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.228 1.411 . . . . 45.549999999999997 112.127 -174.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 24.1 p -88.67 120.49 30.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.21 -0.905 . . . . 71.530000000000001 111.551 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -72.06 -19.73 61.78 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.143 -0.935 . . . . 62.229999999999997 110.605 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -75.11 101.72 4.66 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.222 -0.899 . . . . 71.109999999999999 110.382 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.47 103.96 15.92 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 118.623 -1.231 . . . . 74.400000000000006 110.477 160.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 9.0 m -143.03 149.0 37.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.241 -1.392 . . . . 52.310000000000002 107.241 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.0 pt -125.18 139.46 51.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 118.8 0.727 . . . . 53.149999999999999 109.605 165.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.663 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.51 120.52 39.78 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 108.987 -0.746 . . . . 73.430000000000007 108.987 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.81 138.19 45.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 115.962 -0.563 . . . . 74.319999999999993 109.973 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.54 144.32 51.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 72.0 110.984 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.17 20.78 11.76 Favored Glycine 0 C--N 1.335 0.478 0 O-C-N 123.878 0.736 . . . . 63.539999999999999 112.969 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.48 75.08 0.92 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.602 -0.888 . . . . 71.420000000000002 108.602 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -127.31 -97.16 0.96 Allowed Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.524 -0.846 . . . . 63.109999999999999 113.565 -170.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -76.74 117.07 17.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.853 0.358 . . . . 64.519999999999996 111.104 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 95.17 19.66 30.04 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.218 -0.901 . . . . 72.310000000000002 111.675 -176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.22 151.29 4.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-O 121.357 0.599 . . . . 41.32 109.494 -174.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.9 t -93.46 170.61 9.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.235 -0.654 . . . . 72.549999999999997 109.235 170.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -167.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.489 2.316 . . . . 70.030000000000001 113.379 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -44.44 -12.1 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 C-N-CA 126.497 1.919 . . . . 73.340000000000003 115.253 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.3 -23.04 0.49 Allowed 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 126.692 1.997 . . . . 73.430000000000007 112.892 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -31.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 CA-C-N 118.653 0.661 . . . . 70.099999999999994 109.523 176.33 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.29 -35.48 88.34 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.248 -0.751 . . . . 41.399999999999999 114.383 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -75.77 -28.21 58.33 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 117.961 0.881 . . . . 72.230000000000004 110.832 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.586 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 6.7 t80 -55.66 -47.35 76.85 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.013 0.925 . . . . 65.209999999999994 110.671 171.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -78.59 -23.36 46.03 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.057 0.391 . . . . 75.340000000000003 112.057 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 11.5 tptm -61.3 -26.21 67.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.387 1.075 . . . . 74.430000000000007 111.221 175.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -62.84 -19.73 64.39 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 111.905 0.335 . . . . 74.239999999999995 111.905 177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.1 mm -124.23 62.62 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 109.598 -0.519 . . . . 73.099999999999994 109.598 170.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 145.76 -174.09 25.86 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 118.621 -1.752 . . . . 72.340000000000003 115.056 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.18 137.74 34.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 109.121 -0.696 . . . . 73.310000000000002 109.121 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.1 mm -71.48 113.22 7.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 CA-C-O 121.298 0.571 . . . . 55.219999999999999 110.391 178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -99.66 140.05 34.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.998 -1.001 . . . . 73.219999999999999 110.991 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 59.2 m -85.07 116.38 23.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.066 -0.97 . . . . 74.239999999999995 108.606 170.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.16 131.1 41.62 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.086 0.554 . . . . 75.120000000000005 110.213 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -77.7 -7.03 55.91 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.42 0.896 . . . . 54.340000000000003 113.42 -174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -67.25 -35.95 80.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.745 0.307 . . . . 72.150000000000006 111.108 175.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 10.8 p -125.25 -33.56 2.84 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.029 -0.532 . . . . 64.329999999999998 111.927 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.76 11.41 65.76 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.959 -0.564 . . . . 64.129999999999995 111.927 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -97.35 150.83 37.23 Favored Pre-proline 0 C--O 1.239 0.528 0 C-N-CA 123.238 0.615 . . . . 74.450000000000003 110.877 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.87 153.92 74.28 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 122.998 2.466 . . . . 72.319999999999993 111.241 165.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.471 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -73.22 101.19 3.3 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.645 0.979 . . . . 75.239999999999995 113.645 -172.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.9 mm -143.2 113.32 2.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.139 -1.391 . . . . 64.420000000000002 107.342 163.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -127.6 113.71 16.44 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 119.182 0.901 . . . . 64.099999999999994 109.768 163.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.19 110.53 20.11 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.205 -0.294 . . . . 72.329999999999998 110.205 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 36.3 m-85 -103.0 111.54 23.93 Favored 'General case' 0 C--O 1.263 1.795 0 CA-C-O 121.266 0.555 . . . . 72.420000000000002 110.156 -179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 20.9 p -145.0 120.98 10.69 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 113.984 -1.462 . . . . 54.130000000000003 109.624 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.488 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 0.2 OUTLIER -87.47 112.67 22.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.462 0.648 . . . . 62.520000000000003 111.762 -178.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -10.23 55.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 112.22 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.09 -29.03 63.7 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.363 0.415 . . . . 61.219999999999999 111.191 175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.2 p -90.81 -20.45 22.31 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.337 0.589 . . . . 70.510000000000005 109.892 171.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 85.62 7.73 81.39 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.077 -0.965 . . . . 62.450000000000003 112.697 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 139.99 25.95 Favored Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 110.338 -0.245 . . . . 71.120000000000005 110.338 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -58.97 130.75 38.04 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 123.185 2.59 . . . . 53.340000000000003 113.893 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.488 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 40.9 mtpt -63.16 -32.22 73.56 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 114.874 -1.057 . . . . 75.209999999999994 111.992 177.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.63 24.78 14.86 Favored Glycine 0 N--CA 1.436 -1.363 0 CA-C-N 115.436 -0.802 . . . . 74.010000000000005 112.671 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.7 mt-10 -115.48 140.65 48.96 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.212 -0.595 . . . . 74.430000000000007 110.239 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.96 143.16 22.41 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.106 -0.497 . . . . 73.310000000000002 109.893 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.663 HG22 ' HA ' ' A' ' 237' ' ' PHE . 72.3 p -128.98 139.78 51.95 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 120.756 -0.377 . . . . 73.540000000000006 110.538 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 10.7 m -135.45 147.63 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.284 0 CA-C-O 121.176 0.512 . . . . 45.340000000000003 110.433 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.471 ' H ' ' CB ' ' A' ' 270' ' ' MET . 44.3 t -94.29 128.03 40.52 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.729 0.812 . . . . 74.319999999999993 112.583 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -92.28 165.78 12.93 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.678 0.621 . . . . 75.129999999999995 112.678 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -42.37 59.61 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.573 0.546 . . . . 61.509999999999998 111.661 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.13 136.96 29.83 Favored Pre-proline 0 C--O 1.241 0.651 0 N-CA-C 109.843 -0.429 . . . . 72.129999999999995 109.843 178.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -59.94 -37.19 87.11 Favored 'Trans proline' 0 CA--C 1.562 1.92 0 C-N-CA 123.53 2.82 . . . . 73.400000000000006 117.203 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.49 -29.75 10.71 Favored 'Trans proline' 0 C--N 1.392 2.825 0 CA-C-N 123.321 2.222 . . . . 64.239999999999995 112.691 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 33.6 m -62.97 -32.75 74.15 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.158 0.983 . . . . 64.0 111.315 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.74 83.71 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.011 0.819 . . . . 41.030000000000001 111.822 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.54 -48.18 78.57 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.376 0.422 . . . . 75.230000000000004 111.268 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.78 97.53 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 123.714 0.634 . . . . 74.430000000000007 110.862 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -58.52 -51.85 68.15 Favored 'General case' 0 C--O 1.184 -2.389 0 CA-C-N 115.283 -0.871 . . . . 64.319999999999993 111.156 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 90.4 mt -56.19 -34.47 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.128 0.571 . . . . 73.329999999999998 112.428 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -65.28 -54.91 22.14 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 112.688 0.625 . . . . 72.340000000000003 112.688 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -27.26 19.22 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 117.248 2.314 . . . . 74.439999999999998 117.248 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.57 -20.39 39.98 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 124.175 0.99 . . . . 75.340000000000003 112.038 -170.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.8 166.65 11.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.213 -0.662 . . . . 75.200000000000003 109.213 175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.98 12.87 54.8 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.156 -0.545 . . . . 73.430000000000007 112.627 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -122.05 -159.37 0.82 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.29 -1.004 . . . . 74.420000000000002 108.29 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -130.56 143.02 50.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.555 0.693 . . . . 52.140000000000001 111.637 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -113.14 110.73 20.92 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.14 -1.059 . . . . 73.120000000000005 108.14 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.3 m170 64.33 30.11 13.43 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.516 1.135 . . . . 74.329999999999998 112.095 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.12 -3.76 84.46 Favored Glycine 0 C--N 1.345 1.051 0 N-CA-C 114.369 0.507 . . . . 62.530000000000001 114.369 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -113.2 147.39 37.55 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.548 -0.538 . . . . 70.530000000000001 109.548 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -69.69 124.92 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.177 0.513 . . . . 73.310000000000002 111.202 -172.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.87 134.83 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.403 -0.817 . . . . 73.219999999999999 110.65 -174.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -130.56 145.22 51.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.856 -0.611 . . . . 62.229999999999997 111.017 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 4.7 t -119.42 140.08 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 115.984 -0.553 . . . . 73.140000000000001 109.903 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -133.48 176.5 8.48 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 124.1 0.96 . . . . 64.519999999999996 109.984 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -83.13 -8.61 59.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 113.596 0.962 . . . . 73.340000000000003 113.596 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 66.93 -162.35 0.23 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.332 1.053 . . . . 64.5 112.61 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 14.5 t -90.33 172.95 8.39 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.59 -0.522 . . . . 63.420000000000002 109.59 175.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -81.48 -175.07 5.31 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.116 0.484 . . . . 70.450000000000003 112.087 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.32 149.0 84.4 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.138 -0.937 . . . . 75.420000000000002 112.844 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.91 115.55 2.7 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.603 2.869 . . . . 73.030000000000001 113.381 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 . . . . . 0 C--O 1.25 1.118 0 CA-C-N 115.037 -0.983 . . . . 63.409999999999997 110.225 -175.3 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.442 -0.263 . . . . 60.109999999999999 112.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 10.0 t -156.27 164.08 38.77 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.025 -0.361 . . . . 74.340000000000003 110.025 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -114.7 145.16 42.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.266 -0.424 . . . . 74.239999999999995 110.683 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.455 ' SD ' ' HB2' ' A' ' 293' ' ' PRO . 2.5 ptp -136.83 28.84 2.9 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.133 -0.485 . . . . 74.219999999999999 110.184 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 54.8 m 75.44 144.74 0.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.021 1.728 . . . . 73.230000000000004 111.519 -171.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -85.99 -2.28 58.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.203 0.525 . . . . 74.129999999999995 111.079 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.96 106.84 13.28 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.885 -0.598 . . . . 64.519999999999996 109.448 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.0 106.4 18.49 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.529 -0.868 . . . . 62.299999999999997 110.34 168.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 11.9 m -142.05 142.21 32.84 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.532 -0.914 . . . . 71.030000000000001 108.532 171.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 pt -121.83 138.97 50.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 119.897 -0.721 . . . . 72.040000000000006 110.241 166.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.7 120.66 40.95 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.818 -0.628 . . . . 63.509999999999998 109.928 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -112.82 142.82 23.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.87 0.843 . . . . 74.430000000000007 113.046 177.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.441 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.32 151.99 48.04 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.1 -1.864 . . . . 55.409999999999997 109.493 -178.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.81 16.95 46.34 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.171 -0.537 . . . . 74.349999999999994 113.172 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 286' ' ' ALA . 0.5 OUTLIER -106.07 64.15 0.67 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.659 0.743 . . . . 61.210000000000001 109.273 172.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -106.03 -103.89 2.9 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 115.348 -0.842 . . . . 31.32 112.951 -171.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -72.86 119.6 17.32 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.547 0.689 . . . . 74.510000000000005 112.415 -173.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.24 18.96 29.56 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.634 -1.166 . . . . 61.350000000000001 111.694 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.01 151.94 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-O 121.129 0.49 . . . . 72.209999999999994 109.804 -172.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.3 m -90.64 170.46 10.14 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.691 -0.686 . . . . 60.240000000000002 109.619 169.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -167.75 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.637 1.975 . . . . 73.099999999999994 114.239 -175.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -43.38 -12.91 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.564 0 C-N-CA 126.148 1.779 . . . . 73.530000000000001 115.444 173.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -46.78 -20.99 0.16 Allowed 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 126.26 1.824 . . . . 74.340000000000003 114.243 169.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -55.72 -32.7 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.454 0.57 . . . . 73.439999999999998 110.491 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.24 -31.71 81.66 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 119.953 -0.359 . . . . 74.219999999999999 113.611 175.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -72.95 -31.52 64.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.023 0.929 . . . . 55.340000000000003 111.003 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.49 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.0 t80 -58.61 -44.79 90.06 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.873 0.869 . . . . 63.219999999999999 110.887 171.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -76.87 -24.37 52.59 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 121.196 -0.202 . . . . 73.540000000000006 111.32 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -73.05 -15.91 61.5 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.497 0.719 . . . . 71.099999999999994 111.342 178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -65.82 -17.68 64.81 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 121.805 -0.559 . . . . 73.340000000000003 111.12 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.06 58.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 109.377 -0.601 . . . . 74.519999999999996 109.377 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 149.71 -179.05 26.81 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 119.903 -1.142 . . . . 70.030000000000001 114.692 172.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 11.8 mt -106.73 139.7 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 123.435 0.694 . . . . 64.439999999999998 110.326 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.85 114.76 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.958 -0.564 . . . . 75.230000000000004 110.437 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.87 138.36 35.33 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.423 -0.808 . . . . 61.310000000000002 110.342 174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 57.7 m -84.45 116.12 22.91 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.836 -1.172 . . . . 75.409999999999997 107.836 170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -74.48 128.35 35.33 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 109.323 -0.621 . . . . 63.43 109.323 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -78.57 -8.38 58.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 113.128 0.788 . . . . 72.510000000000005 113.128 -173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -68.97 -29.88 68.19 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 111.54 0.2 . . . . 62.0 111.54 177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 268' ' ' LYS . 4.8 t -125.46 -30.07 3.15 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 111.643 0.238 . . . . 74.219999999999999 111.643 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.79 13.61 60.72 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.566 -0.288 . . . . 15.119999999999999 113.027 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.439 ' H ' HG23 ' A' ' 266' ' ' THR . 7.9 mptt -99.18 152.71 37.89 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 122.852 0.461 . . . . 73.439999999999998 112.093 173.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.46 154.78 66.38 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.579 2.853 . . . . 65.409999999999997 111.695 165.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.544 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -77.83 98.64 5.65 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.31 0.856 . . . . 75.099999999999994 113.31 -168.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 36.4 mm -143.43 113.19 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.253 -1.388 . . . . 75.540000000000006 107.253 165.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -129.36 114.45 16.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.836 0.743 . . . . 75.209999999999994 109.909 161.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.91 111.29 21.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.962 -0.385 . . . . 74.340000000000003 109.962 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.434 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 37.8 m-85 -103.63 113.23 26.59 Favored 'General case' 0 C--O 1.258 1.503 0 CA-C-N 115.972 -0.558 . . . . 71.409999999999997 110.774 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.451 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.3 p -142.4 123.79 14.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.469 -1.242 . . . . 55.450000000000003 110.337 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -85.85 112.52 21.21 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.272 0.558 . . . . 72.209999999999994 111.763 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -86.83 -10.93 52.31 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.622 0.971 . . . . 55.020000000000003 113.622 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.28 -34.55 61.33 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 120.998 0.428 . . . . 74.239999999999995 110.652 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.2 t -90.33 -15.25 31.5 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.705 -0.68 . . . . 70.129999999999995 109.716 170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.16 -45.06 1.61 Allowed Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.874 -0.603 . . . . 72.450000000000003 113.111 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 56.5 mttt -83.85 141.85 41.5 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 111.854 0.316 . . . . 73.430000000000007 111.854 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.56 136.96 72.28 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 123.345 2.697 . . . . 64.140000000000001 113.848 172.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 275' ' ' THR . 37.6 mttt -68.79 -33.4 73.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.027 -0.988 . . . . 73.120000000000005 111.621 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 91.04 23.85 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.729 -0.669 . . . . 33.530000000000001 113.081 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 47.7 mt-10 -115.5 143.21 45.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.944 -0.391 . . . . 65.310000000000002 109.944 -171.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 241' ' ' LEU . . . -152.01 155.37 37.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.352 -0.386 . . . . 75.519999999999996 111.05 175.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.3 p -131.12 135.42 47.47 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.76 -0.459 . . . . 73.340000000000003 109.76 165.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.491 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 11.4 m -137.06 148.49 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 109.055 -0.72 . . . . 74.340000000000003 109.055 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.544 ' H ' ' CB ' ' A' ' 270' ' ' MET . 17.4 m -114.15 119.41 36.99 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.038 0.755 . . . . 54.240000000000002 113.038 -168.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -84.95 165.14 17.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.269 0.84 . . . . 63.32 113.269 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.53 -47.24 34.03 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.811 -1.086 . . . . 74.209999999999994 111.087 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 137.66 21.53 Favored Pre-proline 0 C--O 1.237 0.402 0 O-C-N 123.523 0.515 . . . . 54.140000000000001 110.701 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.455 ' HB2' ' SD ' ' A' ' 230' ' ' MET . 10.2 Cg_endo -61.55 -38.75 60.23 Favored 'Trans proline' 0 CA--C 1.562 1.881 0 C-N-CA 123.192 2.594 . . . . 52.130000000000003 117.246 174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.87 -29.79 22.81 Favored 'Trans proline' 0 C--N 1.392 2.845 0 CA-C-N 123.185 2.173 . . . . 53.439999999999998 113.047 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -61.41 -28.37 69.2 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.336 1.054 . . . . 63.009999999999998 112.078 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.437 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -70.39 -43.49 69.97 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.425 0.528 . . . . 75.120000000000005 112.425 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -73.73 -34.15 64.64 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.346 0.593 . . . . 75.109999999999999 111.054 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.53 -32.43 71.25 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.569 -0.741 . . . . 73.319999999999993 110.444 177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -69.48 -27.71 65.45 Favored 'General case' 0 C--O 1.212 -0.877 0 C-N-CA 122.297 0.239 . . . . 65.409999999999997 111.204 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 296' ' ' ALA . 44.9 mt -66.98 -32.3 57.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 O-C-N 121.881 -0.512 . . . . 64.030000000000001 110.702 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -78.06 -59.09 2.92 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 114.09 1.144 . . . . 71.420000000000002 114.09 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -36.35 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.606 1.706 . . . . 70.030000000000001 115.606 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -84.9 -22.99 29.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.437 0.295 . . . . 72.420000000000002 110.452 -168.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -85.59 -177.11 6.33 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 115.715 -0.675 . . . . 74.519999999999996 110.238 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 86.21 3.83 84.48 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 114.191 0.437 . . . . 61.109999999999999 114.191 170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -123.48 -154.47 0.61 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.611 -0.514 . . . . 73.239999999999995 109.611 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -121.96 140.74 52.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.43 0.633 . . . . 64.530000000000001 110.958 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -114.22 111.28 21.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.136 -1.431 . . . . 73.5 107.136 169.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 20.6 m170 64.85 30.52 12.1 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.818 1.247 . . . . 73.150000000000006 112.672 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.2 10.54 77.76 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 116.298 -0.41 . . . . 74.310000000000002 113.875 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -126.72 148.62 49.86 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.269 -0.641 . . . . 74.5 109.269 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 35.7 mm -68.62 130.76 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 123.523 0.515 . . . . 73.129999999999995 110.628 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.5 tt -107.75 143.32 18.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 108.824 -0.806 . . . . 73.109999999999999 108.824 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 4.3 tmtp? -135.95 122.55 20.89 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 109.292 -0.633 . . . . 63.219999999999999 109.292 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.403 HG23 HG13 ' A' ' 238' ' ' VAL . 9.8 p -111.45 137.35 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.701 0.625 . . . . 74.230000000000004 109.608 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.0 m -138.21 173.5 11.55 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 123.177 0.591 . . . . 72.040000000000006 110.564 -173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.17 -3.23 51.52 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.126 0.787 . . . . 71.420000000000002 113.126 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.1 -164.33 0.25 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.319 1.047 . . . . 52.530000000000001 113.183 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.51 163.66 13.13 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.669 -0.493 . . . . 74.230000000000004 109.669 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -88.03 149.65 23.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 73.420000000000002 109.684 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 71.4 167.26 0.12 Allowed Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 124.721 1.208 . . . . 75.409999999999997 112.406 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -75.94 100.22 1.36 Allowed 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 121.114 1.209 . . . . 75.150000000000006 112.597 171.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.251 1.133 0 CA-C-N 115.647 -0.706 . . . . 70.430000000000007 109.48 174.764 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 111.716 -0.554 . . . . 74.25 111.716 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.9 m 59.19 46.0 13.6 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.723 1.209 . . . . 61.340000000000003 113.624 174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -74.93 134.95 41.46 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.121 -0.49 . . . . 71.140000000000001 111.728 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 58.4 mtt -122.4 108.25 12.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.334 -0.848 . . . . 75.109999999999999 110.152 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 66.1 m -137.98 154.24 49.37 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.44 -0.8 . . . . 55.350000000000001 110.228 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -76.01 -27.51 57.41 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.548 0.53 . . . . 73.140000000000001 110.264 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -74.9 119.39 19.02 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.234 -0.894 . . . . 62.240000000000002 110.653 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.81 106.83 18.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.192 0.52 . . . . 71.230000000000004 110.207 165.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 20.7 m -141.96 148.88 39.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.889 -1.152 . . . . 55.32 107.889 165.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.7 pt -122.69 141.24 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 118.722 0.692 . . . . 63.219999999999999 109.173 166.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.84 134.8 43.27 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.154 -0.684 . . . . 75.310000000000002 109.154 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 314' ' ' LYS . 0.0 OUTLIER -128.03 144.55 37.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.664 0.745 . . . . 74.409999999999997 112.637 178.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.04 147.11 50.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 113.988 -1.46 . . . . 75.310000000000002 109.773 -176.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 93.62 20.13 32.75 Favored Glycine 0 C--N 1.333 0.367 0 O-C-N 123.823 0.702 . . . . 63.020000000000003 112.644 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.73 72.21 0.81 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.967 -1.123 . . . . 53.030000000000001 107.967 175.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -156.31 157.33 27.8 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.271 -0.877 . . . . 42.200000000000003 112.868 -175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 59.66 95.7 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.806 1.642 . . . . 71.400000000000006 113.062 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.71 21.64 36.21 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.198 -0.91 . . . . 14.449999999999999 111.04 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -85.48 150.1 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.535 -0.543 . . . . 63.229999999999997 109.535 -171.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 24.6 m -88.55 170.35 10.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.74 -0.663 . . . . 64.150000000000006 110.831 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -169.01 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 126.547 1.939 . . . . 73.430000000000007 113.37 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -43.91 -13.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 127.028 2.131 . . . . 71.109999999999999 116.074 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -48.31 -23.19 0.83 Allowed 'General case' 0 CA--C 1.567 1.634 0 C-N-CA 126.511 1.924 . . . . 74.120000000000005 113.77 170.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -57.4 -29.78 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 122.834 0.453 . . . . 72.099999999999994 110.63 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.31 -38.04 94.01 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.714 -0.492 . . . . 72.099999999999994 113.37 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -70.95 -30.56 66.88 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.795 0.838 . . . . 71.200000000000003 111.389 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.8 t80 -56.62 -45.87 81.25 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.83 0.852 . . . . 64.510000000000005 111.186 171.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -77.61 -22.64 50.48 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 122.055 -0.403 . . . . 75.049999999999997 111.53 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.416 ' HB2' HD11 ' A' ' 260' ' ' ILE . 66.0 tttt -75.54 -10.63 59.61 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.527 1.131 . . . . 73.010000000000005 111.94 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -64.01 -16.72 62.26 Favored 'General case' 0 CA--C 1.557 1.239 0 O-C-N 121.807 -0.558 . . . . 62.229999999999997 111.523 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 48.1 mm -103.49 -48.19 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 123.458 0.703 . . . . 71.530000000000001 110.274 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -135.8 -159.51 8.55 Favored Glycine 0 C--O 1.22 -0.747 0 C-N-CA 120.769 -0.729 . . . . 73.310000000000002 113.428 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.9 mt -107.65 142.09 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.339 0.656 . . . . 73.140000000000001 111.754 -177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.7 mm -65.39 115.14 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 123.717 0.636 . . . . 75.5 110.142 176.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -98.08 140.11 32.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.453 -0.794 . . . . 65.120000000000005 111.369 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 31.0 m -85.52 117.75 24.62 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.106 -0.952 . . . . 72.239999999999995 108.478 168.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.1 125.79 29.9 Favored 'General case' 0 C--O 1.212 -0.916 0 N-CA-C 109.062 -0.718 . . . . 72.420000000000002 109.062 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -75.8 -9.51 58.66 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.637 0.977 . . . . 54.109999999999999 113.637 -173.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 -29.14 65.31 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 111.884 0.328 . . . . 65.129999999999995 111.884 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.6 t -124.16 -31.79 3.29 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.469 -0.332 . . . . 45.530000000000001 111.641 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.6 6.65 70.1 Favored Glycine 0 C--N 1.339 0.731 0 O-C-N 123.338 0.399 . . . . 64.120000000000005 112.679 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.432 ' H ' HG23 ' A' ' 266' ' ' THR . 52.8 mtpt -97.17 151.87 37.95 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 112.093 0.405 . . . . 75.540000000000006 112.093 174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.93 154.06 75.55 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 123.523 2.815 . . . . 51.340000000000003 111.794 167.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.481 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.7 ptm -71.98 99.79 2.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 114.451 1.278 . . . . 65.219999999999999 114.451 -172.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 28.4 mm -144.16 113.85 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.58 -1.266 . . . . 74.129999999999995 107.58 164.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -128.99 119.48 24.36 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.077 0.853 . . . . 63.530000000000001 110.57 161.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 113.07 25.18 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.376 0.422 . . . . 71.299999999999997 110.278 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.4 m-85 -102.35 112.68 25.48 Favored 'General case' 0 C--O 1.262 1.761 0 CA-C-O 121.31 0.576 . . . . 75.209999999999994 110.627 177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.9 p -144.8 121.16 10.94 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.809 -1.541 . . . . 71.329999999999998 109.455 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.8 113.01 22.27 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.407 0.623 . . . . 63.240000000000002 111.719 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.72 -8.72 58.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.715 1.006 . . . . 71.530000000000001 113.715 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.27 -30.41 64.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.08 0.4 . . . . 51.439999999999998 112.08 174.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.9 t -90.66 -19.03 24.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 120.735 -0.386 . . . . 73.120000000000005 110.185 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 88.5 22.93 38.39 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.951 -0.568 . . . . 74.019999999999996 113.802 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -146.82 147.69 30.62 Favored Pre-proline 0 CA--C 1.534 0.333 0 N-CA-C 109.744 -0.465 . . . . 74.120000000000005 109.744 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.38 126.75 22.34 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.047 1.831 . . . . 73.549999999999997 113.594 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.457 ' H ' ' HA ' ' A' ' 275' ' ' THR . 10.7 mttm -62.19 -40.11 94.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.88 -1.055 . . . . 74.239999999999995 111.628 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.95 25.15 15.24 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.812 -0.708 . . . . 63.420000000000002 111.998 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 78.2 mt-10 -119.03 143.75 46.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.609 -0.515 . . . . 64.209999999999994 109.609 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 158.64 44.26 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.623 -0.262 . . . . 62.520000000000003 111.179 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 19.4 p -136.18 137.78 41.25 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.104 -0.332 . . . . 60.210000000000001 110.104 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 21.4 m -139.12 147.66 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.085 0 CA-C-N 116.356 -0.384 . . . . 64.439999999999998 110.461 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.481 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.3 t -99.1 117.49 33.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.309 0.644 . . . . 60.049999999999997 112.664 -174.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 162.81 16.69 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 121.154 -0.219 . . . . 71.239999999999995 110.867 176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -76.88 -48.63 17.75 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.307 0.484 . . . . 44.530000000000001 112.307 -172.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.44 137.18 21.52 Favored Pre-proline 0 C--N 1.327 -0.404 0 C-N-CA 120.695 -0.402 . . . . 74.030000000000001 110.904 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.08 -38.02 80.28 Favored 'Trans proline' 0 CA--C 1.566 2.086 0 C-N-CA 123.265 2.644 . . . . 63.219999999999999 116.234 172.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.65 -30.89 41.62 Favored 'Trans proline' 0 C--N 1.396 3.043 0 CA-C-N 123.314 2.219 . . . . 55.109999999999999 113.177 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 39.7 m -69.76 -29.4 66.74 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.477 -0.783 . . . . 65.510000000000005 111.115 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.03 -41.75 58.61 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 122.956 0.502 . . . . 45.130000000000003 111.347 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.54 -33.43 66.83 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 112.009 0.374 . . . . 72.109999999999999 112.009 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -69.39 -35.21 75.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.354 -0.384 . . . . 75.049999999999997 110.675 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.44 -25.28 64.03 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 111.977 175.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.75 -33.64 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 122.132 -0.355 . . . . 71.040000000000006 110.489 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -74.97 -58.82 3.05 Favored 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 113.865 1.061 . . . . 74.439999999999998 113.865 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.56 -29.69 18.73 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.219 1.933 . . . . 73.120000000000005 116.219 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.591 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 75.0 t80 -89.03 -8.25 54.35 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-N 118.345 0.521 . . . . 53.409999999999997 111.017 -168.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.6 165.23 11.34 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 108.217 -1.031 . . . . 73.310000000000002 108.217 170.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.17 13.43 52.4 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 120.76 -0.734 . . . . 65.239999999999995 112.363 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -122.31 -160.5 0.88 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.495 -1.298 . . . . 63.409999999999997 107.495 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -135.09 143.27 46.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.474 0.654 . . . . 72.5 111.574 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -113.81 113.93 25.6 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.196 -1.039 . . . . 75.209999999999994 108.196 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.17 28.46 14.06 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.809 1.244 . . . . 74.219999999999999 112.593 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.14 74.7 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.568 -0.349 . . . . 71.230000000000004 113.831 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -127.74 143.52 51.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 108.419 -0.956 . . . . 65.230000000000004 108.419 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.5 mm -69.94 127.68 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.88 0.372 . . . . 71.400000000000006 111.079 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.7 tt -109.78 137.62 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 116.025 -0.534 . . . . 72.340000000000003 111.101 -175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -130.48 128.42 41.19 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 111.051 179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 5.7 t -106.97 130.49 58.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 122.99 0.516 . . . . 74.519999999999996 110.759 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -129.42 175.78 8.49 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.626 1.17 . . . . 71.120000000000005 109.414 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -86.83 -3.13 59.03 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.884 1.068 . . . . 74.299999999999997 113.884 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.04 -164.12 0.25 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.084 0.954 . . . . 62.240000000000002 113.128 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.5 m -99.46 144.82 28.12 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.471 -0.566 . . . . 71.209999999999994 109.471 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.52 174.95 5.64 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.882 -0.599 . . . . 71.129999999999995 109.641 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 71.77 88.84 0.09 OUTLIER Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.851 1.261 . . . . 73.120000000000005 112.297 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.07 101.58 1.01 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.499 2.133 . . . . 70.430000000000007 114.046 -175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.179 -0.915 . . . . 73.439999999999998 109.742 174.127 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.922 0 N-CA-C 112.231 -0.348 . . . . 75.349999999999994 112.231 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 66.9 m -112.64 -176.04 2.81 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.663 0.268 . . . . 60.520000000000003 111.424 -175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -137.47 120.7 16.84 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.597 -0.274 . . . . 72.5 110.87 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.71 78.05 1.35 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.873 0.845 . . . . 75.019999999999996 110.008 178.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 17.9 p -160.62 131.3 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.037 -0.983 . . . . 61.240000000000002 110.759 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -83.83 -36.14 23.7 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.524 -0.546 . . . . 51.109999999999999 109.524 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -76.24 123.56 26.08 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.292 -0.867 . . . . 73.400000000000006 110.427 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.75 106.83 18.78 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.395 0.616 . . . . 74.340000000000003 110.466 165.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 25.6 m -142.16 149.19 39.44 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.135 -1.061 . . . . 70.299999999999997 108.135 166.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.96 140.57 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.614 0.643 . . . . 74.319999999999993 109.533 166.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.07 135.04 43.18 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 109.037 -0.727 . . . . 70.109999999999999 109.037 177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.775 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -126.61 143.68 39.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.626 0.727 . . . . 51.420000000000002 112.538 177.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -127.78 148.06 50.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.272 -1.331 . . . . 73.25 110.849 -176.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.27 20.0 37.02 Favored Glycine 0 CA--C 1.519 0.327 0 O-C-N 123.814 0.696 . . . . 71.450000000000003 113.186 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.775 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -113.09 74.14 0.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.684 -1.228 . . . . 62.030000000000001 107.684 177.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.22 -82.6 0.22 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 120.368 -0.92 . . . . 75.409999999999997 112.808 -172.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -76.3 110.39 10.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.785 0.803 . . . . 63.329999999999998 111.532 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.73 19.88 33.18 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.079 -0.964 . . . . 73.200000000000003 111.566 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -80.95 151.94 4.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.719 -0.474 . . . . 53.130000000000003 109.719 -172.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.5 m -91.49 170.49 9.91 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.523 -0.762 . . . . 51.32 109.93 171.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.81 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.928 2.091 . . . . 72.319999999999993 113.971 -175.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -43.85 -13.14 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.606 1.962 . . . . 74.430000000000007 115.319 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -46.73 -21.47 0.2 Allowed 'General case' 0 CA--C 1.56 1.327 0 C-N-CA 126.636 1.975 . . . . 63.32 113.957 169.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.512 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -56.49 -31.53 34.04 Favored 'Isoleucine or valine' 0 C--N 1.362 1.15 0 CA-C-N 118.618 0.645 . . . . 75.409999999999997 109.818 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.92 -33.53 83.94 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-O 119.858 -0.412 . . . . 70.209999999999994 113.704 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -74.74 -30.47 61.5 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.907 0.883 . . . . 70.010000000000005 111.184 176.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.512 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 4.7 t80 -57.5 -46.82 83.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.541 0.736 . . . . 74.049999999999997 110.646 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -76.93 -23.59 52.44 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.432 0.158 . . . . 64.5 111.325 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.435 ' HB2' HD11 ' A' ' 260' ' ' ILE . 9.3 tmtt? -69.72 -20.0 63.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.586 0.754 . . . . 73.439999999999998 111.519 177.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -65.31 -20.01 66.21 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 122.187 -0.321 . . . . 71.400000000000006 111.325 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.1 63.04 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 N-CA-C 109.823 -0.436 . . . . 75.200000000000003 109.823 168.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.11 178.37 23.22 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.209 -0.996 . . . . 74.150000000000006 115.044 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 92.4 mt -105.08 138.35 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.5 0.72 . . . . 73.219999999999999 110.337 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 255' ' ' LYS . 34.8 mm -71.23 111.9 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 121.271 0.557 . . . . 74.140000000000001 110.417 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.7 tptm -102.28 144.26 31.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.266 -0.879 . . . . 73.129999999999995 111.32 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.29 132.38 34.63 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.857 -0.794 . . . . 71.430000000000007 108.857 165.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.64 123.52 26.25 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.479 -0.934 . . . . 62.210000000000001 108.479 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.12 58.01 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.941 0.719 . . . . 55.32 112.941 -173.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -68.51 -34.22 75.5 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 122.579 0.352 . . . . 73.239999999999995 111.304 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 3.1 p -125.53 -32.0 2.93 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 111.863 0.32 . . . . 73.530000000000001 111.863 -172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.84 10.18 65.18 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.925 -0.58 . . . . 73.209999999999994 113.487 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -97.19 145.61 29.93 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 117.335 0.568 . . . . 74.239999999999995 111.224 173.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.8 153.45 77.79 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 122.975 2.45 . . . . 64.439999999999998 111.448 168.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.517 ' CB ' ' H ' ' A' ' 289' ' ' SER . 3.4 ptm -71.6 98.63 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.176 1.176 . . . . 73.349999999999994 114.176 -171.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -144.5 112.53 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.026 -1.472 . . . . 54.32 107.026 164.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -130.09 116.72 18.91 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.139 0.882 . . . . 72.430000000000007 109.786 159.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.01 110.55 19.77 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.786 -0.45 . . . . 61.020000000000003 109.786 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.437 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 38.7 m-85 -102.88 112.87 25.88 Favored 'General case' 0 C--O 1.261 1.706 0 CA-C-O 121.247 0.546 . . . . 74.430000000000007 110.896 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 12.0 p -143.32 123.34 13.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.109 -1.405 . . . . 72.409999999999997 110.292 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -85.63 112.12 20.7 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.153 0.501 . . . . 70.340000000000003 111.974 -178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -11.04 51.07 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.187 0.81 . . . . 74.329999999999998 113.187 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.88 -28.59 58.19 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.604 0.24 . . . . 74.549999999999997 111.641 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 71.1 p -89.33 -22.22 22.74 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.146 -0.687 . . . . 64.120000000000005 109.146 169.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 94.55 -18.35 57.25 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.191 -0.913 . . . . 24.32 112.679 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -109.45 139.59 21.27 Favored Pre-proline 0 N--CA 1.449 -0.517 0 N-CA-C 109.957 -0.386 . . . . 61.140000000000001 109.957 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.02 136.99 78.57 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.152 2.568 . . . . 72.109999999999999 114.448 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 275' ' ' THR . 36.2 mttt -67.85 -35.62 78.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 114.938 -1.028 . . . . 52.450000000000003 112.053 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.25 22.23 25.34 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.03 -0.605 . . . . 51.530000000000001 112.992 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 34.8 mt-10 -116.22 142.67 46.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.682 -0.407 . . . . 71.420000000000002 109.929 -172.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.73 153.65 34.77 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.596 0.56 . . . . 75.129999999999995 110.661 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.3 p -135.6 136.21 40.88 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 120.755 0.312 . . . . 64.439999999999998 110.446 169.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.27 148.13 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 CA-C-N 115.933 -0.576 . . . . 74.040000000000006 110.139 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.517 ' H ' ' CB ' ' A' ' 270' ' ' MET . 35.8 t -105.34 120.26 41.13 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.65 0.78 . . . . 45.210000000000001 112.664 -173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -85.77 163.66 18.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.082 0.401 . . . . 73.400000000000006 112.082 176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -78.81 -47.46 16.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.33 -0.85 . . . . 72.25 110.299 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -98.67 135.94 20.89 Favored Pre-proline 0 C--O 1.238 0.479 0 CA-C-N 116.348 -0.387 . . . . 73.349999999999994 111.176 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.63 -40.51 29.54 Favored 'Trans proline' 0 CA--C 1.561 1.826 0 C-N-CA 122.559 2.173 . . . . 73.430000000000007 115.87 168.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.07 -29.74 47.99 Favored 'Trans proline' 0 C--N 1.387 2.56 0 CA-C-N 122.759 2.021 . . . . 61.200000000000003 113.602 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 75.0 m -64.77 -26.26 68.28 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 73.219999999999999 112.626 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -74.08 -48.34 30.45 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.469 0.308 . . . . 72.340000000000003 111.664 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -33.72 71.69 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.261 0.553 . . . . 74.530000000000001 112.103 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -73.8 -30.65 62.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.746 -0.661 . . . . 61.520000000000003 110.937 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.89 -28.7 65.85 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 120.468 0.175 . . . . 40.210000000000001 111.187 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 72.9 mt -66.34 -33.75 65.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 O-C-N 122.225 -0.297 . . . . 72.400000000000006 110.468 170.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.11 -59.4 2.8 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 114.389 1.255 . . . . 61.539999999999999 114.389 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -90.05 -33.68 16.23 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 115.746 1.758 . . . . 70.450000000000003 115.746 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.4 t80 -85.65 -19.62 30.68 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.091 0.472 . . . . 73.319999999999993 109.984 -169.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -105.59 174.38 5.91 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.081 -0.963 . . . . 74.409999999999997 109.207 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.31 53.51 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.893 -0.67 . . . . 24.219999999999999 111.731 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -136.0 -154.52 0.57 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 109.64 -0.504 . . . . 71.299999999999997 109.64 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -131.51 145.54 51.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.77 0.795 . . . . 71.299999999999997 111.416 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -114.82 115.96 27.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.546 -1.206 . . . . 62.340000000000003 108.274 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 27.2 m170 64.44 28.93 13.54 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.607 1.163 . . . . 53.200000000000003 112.834 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.9 5.05 84.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 121.462 -0.399 . . . . 53.109999999999999 113.887 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -122.62 147.97 45.8 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.92 -0.77 . . . . 61.32 108.92 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 46.4 mm -69.97 129.74 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 122.721 0.408 . . . . 74.230000000000004 110.614 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.4 tt -108.41 147.08 13.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 109.206 -0.664 . . . . 74.430000000000007 109.206 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -137.2 123.82 21.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.408 -0.36 . . . . 63.43 111.279 178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.74 135.83 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.22 0.608 . . . . 51.350000000000001 110.266 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.1 m -138.09 175.24 9.76 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 124.546 1.139 . . . . 73.340000000000003 109.591 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -85.7 2.0 47.13 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.975 1.102 . . . . 71.239999999999995 113.975 172.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 61.01 -163.02 0.26 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.726 0.81 . . . . 64.540000000000006 112.173 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 9.5 t -89.15 141.5 28.46 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.288 -0.634 . . . . 74.540000000000006 109.288 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.15 85.13 2.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.585 0.707 . . . . 52.130000000000003 110.862 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -166.11 86.88 0.91 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.07 -0.968 . . . . 54.310000000000002 110.458 -173.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -82.57 110.28 1.9 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.448 1.432 . . . . 71.150000000000006 113.031 174.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.539 -0.743 . . . . 70.209999999999994 109.717 -179.66 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.95 0 N-CA-C 111.925 -0.47 . . . . 54.439999999999998 111.925 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 62.5 m -138.64 167.46 21.91 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.85 0.325 . . . . 71.109999999999999 110.739 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -71.9 133.52 45.47 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.859 -0.609 . . . . 75.450000000000003 111.15 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.9 mmt -117.47 17.63 14.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.72 -0.673 . . . . 75.510000000000005 110.18 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 45.7 m 71.31 -178.63 0.22 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.779 1.632 . . . . 31.41 112.269 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -86.75 3.52 44.67 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.587 -0.733 . . . . 73.319999999999993 111.101 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -80.36 106.87 12.7 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.431 -0.804 . . . . 71.299999999999997 110.337 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -90.55 105.48 17.85 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 119.654 -0.818 . . . . 74.420000000000002 110.182 166.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 15.4 m -143.2 144.16 32.06 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.3 pt -120.58 136.62 56.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 119.233 0.924 . . . . 72.040000000000006 109.727 164.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.508 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.14 121.21 41.06 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.39 0.614 . . . . 55.310000000000002 109.526 -178.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.415 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.2 t -118.14 139.59 44.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.309 -0.859 . . . . 60.25 109.954 -174.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.57 141.23 51.43 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.038 -0.727 . . . . 73.129999999999995 109.038 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 104.52 26.64 6.41 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.156 -0.545 . . . . 70.5 113.221 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.21 78.93 1.87 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.227 -0.657 . . . . 60.140000000000001 109.227 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -141.42 -79.63 0.05 OUTLIER Glycine 0 CA--C 1.488 -1.596 0 C-N-CA 120.058 -1.067 . . . . 74.329999999999998 112.946 -175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.26 110.48 10.8 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.902 0.382 . . . . 71.319999999999993 111.846 -173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 91.58 18.73 43.78 Favored Glycine 0 C--N 1.342 0.874 0 C-N-CA 120.683 -0.77 . . . . 61.340000000000003 111.686 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.57 151.32 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.195 0.522 . . . . 33.32 109.764 -170.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.405 ' O ' HG13 ' A' ' 245' ' ' VAL . 24.7 m -86.24 169.76 12.73 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.774 -0.648 . . . . 72.239999999999995 109.949 171.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.98 -168.45 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.694 1.998 . . . . 73.129999999999995 112.709 -177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.63 -12.21 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 126.774 2.03 . . . . 52.439999999999998 115.873 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 250' ' ' VAL . 0.8 OUTLIER -47.07 -23.89 0.56 Allowed 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 126.901 2.081 . . . . 75.010000000000005 113.304 170.207 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.548 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.4 t -56.75 -31.45 35.34 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-N 118.171 0.442 . . . . 52.409999999999997 110.116 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.14 -32.51 76.39 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 121.645 -0.659 . . . . 75.349999999999994 113.659 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -75.71 -31.23 59.58 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.382 0.673 . . . . 71.25 110.98 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.7 t80 -54.67 -46.77 74.11 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.36 0.664 . . . . 64.030000000000001 110.874 170.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 92.1 m-85 -77.74 -23.27 49.4 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.218 -0.301 . . . . 73.310000000000002 111.68 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.431 ' HB2' HD11 ' A' ' 260' ' ' ILE . 2.5 tmtm? -67.46 -19.27 65.33 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.579 0.752 . . . . 62.229999999999997 111.549 178.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 253' ' ' PHE . 6.4 pt20 -63.01 -18.99 63.92 Favored 'General case' 0 CA--C 1.558 1.254 0 O-C-N 122.24 -0.287 . . . . 63.340000000000003 111.424 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 13.4 mm -120.75 54.81 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-O 121.211 0.529 . . . . 64.109999999999999 109.838 171.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 146.29 -169.6 27.56 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 118.268 -1.92 . . . . 61.420000000000002 115.214 169.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 82.0 mt -107.35 137.66 37.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.282 -0.959 . . . . 54.210000000000001 109.761 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 255' ' ' LYS . 33.5 mm -72.04 114.15 10.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.57 0.7 . . . . 61.520000000000003 110.438 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -98.53 144.3 28.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.65 -1.159 . . . . 75.120000000000005 110.393 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 40.8 m -84.29 118.92 24.5 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.631 -0.877 . . . . 62.32 108.631 169.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.59 128.4 35.45 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 109.354 -0.61 . . . . 71.549999999999997 109.354 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 18.5 mmtm -79.29 -8.38 59.01 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.378 0.881 . . . . 71.420000000000002 113.378 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -69.15 -30.52 68.77 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 123.144 0.277 . . . . 74.439999999999998 111.132 177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.0 t -125.46 -31.07 3.04 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.572 -0.285 . . . . 42.409999999999997 111.572 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.93 5.98 67.63 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.321 -0.4 . . . . 64.420000000000002 112.726 -177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.452 ' H ' HG23 ' A' ' 266' ' ' THR . 9.4 mttp -97.22 152.64 38.39 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 123.052 0.541 . . . . 74.349999999999994 111.721 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.59 153.31 75.8 Favored 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.318 2.678 . . . . 72.099999999999994 111.802 166.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.45 ' HB3' ' H ' ' A' ' 289' ' ' SER . 1.0 OUTLIER -70.23 101.62 1.92 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.966 1.099 . . . . 61.240000000000002 113.966 -173.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 27.2 mm -143.59 112.9 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.624 -1.25 . . . . 73.299999999999997 107.624 163.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -128.33 116.72 20.24 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.381 0.991 . . . . 52.240000000000002 110.227 164.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 112.12 22.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.007 0.432 . . . . 74.230000000000004 110.426 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.451 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 75.2 m-85 -102.51 112.34 25.03 Favored 'General case' 0 C--O 1.259 1.589 0 CA-C-N 115.852 -0.613 . . . . 73.430000000000007 110.243 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.4 p -142.28 122.03 13.47 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.249 -1.341 . . . . 64.310000000000002 110.488 -176.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -85.73 110.98 19.71 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.229 0.538 . . . . 72.219999999999999 111.217 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.04 -10.8 49.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.53 0.937 . . . . 73.409999999999997 113.53 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -77.3 -29.27 53.61 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.37 0.605 . . . . 62.219999999999999 109.718 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 60.9 p -89.1 -20.37 24.39 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.31 -0.859 . . . . 61.509999999999998 109.836 170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.27 -34.65 5.25 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.301 -0.863 . . . . 74.430000000000007 113.061 172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -101.35 143.77 27.26 Favored Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 109.804 -0.443 . . . . 73.439999999999998 109.804 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.22 141.03 88.52 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 123.275 2.65 . . . . 63.039999999999999 114.018 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 52.0 mttt -65.62 -33.14 75.21 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.774 -1.103 . . . . 74.400000000000006 111.606 176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.77 23.31 23.63 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.517 -0.765 . . . . 71.0 112.237 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 45.1 mt-10 -118.82 143.0 47.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 120.308 -0.557 . . . . 73.310000000000002 110.702 -173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.03 143.18 24.07 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.626 -0.715 . . . . 70.099999999999994 109.496 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 237' ' ' PHE . 68.9 p -126.88 137.86 53.22 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.609 -0.436 . . . . 54.329999999999998 110.023 173.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 13.6 m -136.49 145.43 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 121.043 0.449 . . . . 71.530000000000001 109.991 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 270' ' ' MET . 0.1 OUTLIER -98.71 129.18 45.16 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.623 0.972 . . . . 72.510000000000005 113.623 -176.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -87.64 165.61 15.29 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.702 0.63 . . . . 74.109999999999999 112.702 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -40.69 73.1 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.448 -0.796 . . . . 72.510000000000005 111.935 -177.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -126.4 139.8 35.57 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.891 -0.781 . . . . 71.510000000000005 108.891 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -58.79 -40.09 75.74 Favored 'Trans proline' 0 CA--C 1.576 2.588 0 C-N-CA 122.488 2.125 . . . . 65.200000000000003 117.368 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.89 -30.34 14.13 Favored 'Trans proline' 0 C--N 1.391 2.768 0 CA-C-N 123.614 2.326 . . . . 73.209999999999994 114.106 -175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 55.0 p -62.97 -29.82 71.11 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 123.131 0.572 . . . . 74.420000000000002 111.627 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.11 -37.17 78.24 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 124.627 1.204 . . . . 43.399999999999999 112.214 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -68.56 -38.79 81.06 Favored 'General case' 0 C--O 1.247 0.929 0 O-C-N 123.55 0.531 . . . . 72.420000000000002 111.839 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.55 96.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.937 -0.574 . . . . 65.120000000000005 111.428 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -66.51 -26.88 67.37 Favored 'General case' 0 C--O 1.207 -1.172 0 C-N-CA 123.316 0.647 . . . . 54.140000000000001 112.257 174.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 296' ' ' ALA . 72.7 mt -68.71 -32.84 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.843 -1.161 . . . . 74.230000000000004 111.377 172.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.27 -58.27 3.38 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 113.169 0.803 . . . . 63.219999999999999 113.169 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -89.95 -30.72 17.64 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 116.385 1.995 . . . . 73.540000000000006 116.385 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 66.0 t80 -88.53 -17.5 30.13 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 118.086 0.403 . . . . 73.150000000000006 110.742 -169.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.667 ' HB2' HG12 ' A' ' 315' ' ' VAL . 1.6 t70 -87.56 159.59 18.54 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.247 -0.649 . . . . 73.109999999999999 109.247 166.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.16 50.41 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.478 -0.391 . . . . 73.430000000000007 113.154 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 -162.04 0.84 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.414 -0.958 . . . . 71.129999999999995 108.414 174.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.66 143.69 51.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.715 0.769 . . . . 70.450000000000003 111.367 175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -113.74 115.83 28.44 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.966 -1.016 . . . . 74.230000000000004 108.454 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 63.85 28.43 14.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 124.67 1.231 . . . . 75.310000000000002 112.406 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 83.12 11.54 80.86 Favored Glycine 0 C--N 1.341 0.84 0 N-CA-C 114.113 0.405 . . . . 51.310000000000002 114.113 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -127.53 147.86 50.33 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.73 -0.841 . . . . 60.43 108.73 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.2 127.66 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.777 0.431 . . . . 73.109999999999999 111.369 -169.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 14.8 tt -110.71 134.15 53.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-N 115.732 -0.667 . . . . 71.140000000000001 110.551 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.483 ' HA ' ' OD1' ' A' ' 304' ' ' ASP . 3.1 mttm -124.06 141.19 52.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.469 -0.787 . . . . 64.299999999999997 110.729 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.667 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.3 OUTLIER -123.4 140.98 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 N-CA-C 108.449 -0.945 . . . . 72.150000000000006 108.449 -177.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.8 m -140.39 174.2 10.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.853 0.461 . . . . 65.439999999999998 110.86 -174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.02 -2.63 55.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.609 0.966 . . . . 64.120000000000005 113.609 173.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.04 -160.39 0.3 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.264 1.026 . . . . 64.340000000000003 111.922 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.2 t -100.26 158.22 16.03 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.355 -0.609 . . . . 75.329999999999998 109.355 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -99.83 171.4 7.9 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.034 -0.358 . . . . 75.230000000000004 110.034 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 64.8 87.44 0.12 Allowed Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 124.649 1.18 . . . . 75.400000000000006 112.745 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.5 86.12 0.72 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.805 2.337 . . . . 71.310000000000002 113.017 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 124.582 1.153 . . . . 74.420000000000002 112.142 -176.616 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 CA-C-O 119.546 -0.586 . . . . 64.439999999999998 112.152 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.3 m 58.58 64.06 1.54 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.46 1.104 . . . . 64.049999999999997 111.556 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 63.72 -178.18 0.16 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.374 1.47 . . . . 74.540000000000006 111.792 -173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -130.54 19.36 5.21 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.998 -0.439 . . . . 73.409999999999997 111.198 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 59.7 m 72.19 130.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.197 1.399 . . . . 74.439999999999998 112.421 -174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.18 -38.51 51.51 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.475 -0.784 . . . . 74.340000000000003 110.264 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -74.56 117.86 16.87 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.853 -0.612 . . . . 63.409999999999997 110.402 171.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.29 106.47 18.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 119.675 -0.81 . . . . 70.109999999999999 110.724 165.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 31.1 m -142.1 147.08 36.15 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.735 -1.209 . . . . 52.130000000000003 107.735 166.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 32.9 pt -121.27 137.0 56.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.106 0.867 . . . . 75.030000000000001 109.959 166.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.655 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -99.54 124.51 44.78 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 109.207 -0.664 . . . . 52.329999999999998 109.207 -178.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.0 t -120.79 140.7 44.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.718 -0.674 . . . . 62.229999999999997 109.556 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -128.69 141.56 51.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.881 -0.599 . . . . 64.129999999999995 109.442 -177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 103.32 27.61 6.43 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.291 -0.481 . . . . 62.140000000000001 112.773 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.14 80.34 1.95 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.246 -0.65 . . . . 74.299999999999997 109.246 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -146.7 -69.6 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.396 -0.907 . . . . 60.130000000000003 113.126 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.7 107.2 11.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.741 0.781 . . . . 72.430000000000007 111.232 -171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 89.22 20.77 44.22 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.228 -0.897 . . . . 51.340000000000003 111.569 -176.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 246' ' ' SER . 0.3 OUTLIER -79.97 152.33 4.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 121.104 0.478 . . . . 73.310000000000002 109.937 -172.176 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . 0.433 ' O ' HG13 ' A' ' 245' ' ' VAL . 17.7 m -89.28 171.05 10.06 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.609 -0.723 . . . . 70.25 109.571 170.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -170.26 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.852 1.661 . . . . 54.329999999999998 113.887 -179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -43.44 -14.12 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 127.764 2.426 . . . . 71.0 115.257 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -47.62 -21.46 0.36 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.942 2.097 . . . . 74.239999999999995 114.429 171.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.1 t -55.37 -31.62 27.62 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 C-N-CA 122.951 0.5 . . . . 64.209999999999994 110.102 177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.65 -33.56 82.76 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 119.684 -0.509 . . . . 42.509999999999998 114.018 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.2 -30.87 60.76 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.226 0.611 . . . . 75.120000000000005 110.946 176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.552 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.6 t80 -54.39 -46.32 73.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.396 0.678 . . . . 71.439999999999998 110.619 170.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -78.07 -23.31 48.1 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.906 0.336 . . . . 74.230000000000004 111.906 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -70.63 -15.21 62.72 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.145 0.978 . . . . 74.299999999999997 111.514 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -64.49 -14.53 57.61 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 122.036 -0.415 . . . . 72.329999999999998 112.021 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 43.3 mm -105.0 -31.54 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 123.097 0.559 . . . . 63.219999999999999 111.157 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -156.86 -160.78 10.31 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 119.429 -1.367 . . . . 75.310000000000002 114.845 -174.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 4.6 mt -103.91 138.81 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.913 -0.643 . . . . 75.439999999999998 110.369 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 30.9 mm -68.94 115.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 123.77 0.669 . . . . 71.5 110.565 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -97.84 142.37 29.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.318 -0.855 . . . . 74.319999999999993 110.94 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 80.2 m -85.94 115.84 23.8 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.198 -1.038 . . . . 62.240000000000002 108.198 167.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.15 122.92 22.64 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.046 -0.724 . . . . 71.099999999999994 109.046 -177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 12.5 mmtm -72.58 -8.92 57.64 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.238 1.199 . . . . 75.530000000000001 114.238 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -69.87 -29.85 67.17 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.334 0.254 . . . . 65.420000000000002 111.614 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.4 t -124.41 -31.9 3.22 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.641 -0.254 . . . . 71.239999999999995 111.121 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 88.32 11.68 66.41 Favored Glycine 0 C--N 1.337 0.622 0 CA-C-N 116.382 -0.372 . . . . 71.439999999999998 112.321 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' H ' HG23 ' A' ' 266' ' ' THR . 27.3 mtpp -97.62 153.19 38.39 Favored Pre-proline 0 C--O 1.24 0.589 0 C-N-CA 123.246 0.618 . . . . 63.420000000000002 111.388 173.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.26 153.79 67.67 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 123.493 2.795 . . . . 74.109999999999999 112.048 166.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.441 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.1 ptm -75.2 100.73 4.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.704 0.764 . . . . 55.32 112.746 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.73 114.34 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 107.285 -1.376 . . . . 72.150000000000006 107.285 164.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -128.5 117.07 20.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 119.151 0.887 . . . . 73.430000000000007 109.957 161.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.09 111.78 22.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.177 0.513 . . . . 71.340000000000003 110.152 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 57.8 m-85 -101.45 112.41 24.93 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-N 115.948 -0.569 . . . . 75.349999999999994 109.942 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.471 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.2 p -144.35 119.36 10.02 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 114.23 -1.35 . . . . 75.329999999999998 109.908 -177.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -87.63 111.91 21.76 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.619 1.2 . . . . 63.420000000000002 112.274 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -7.92 58.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.185 -0.916 . . . . 71.209999999999994 112.525 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.73 -27.96 64.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 122.723 0.409 . . . . 74.239999999999995 111.94 176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 44.0 p -89.64 -25.85 21.05 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.571 -0.529 . . . . 74.140000000000001 109.571 168.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 93.84 7.49 61.31 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.195 -0.911 . . . . 72.140000000000001 112.661 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.7 140.85 37.96 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 108.367 -0.975 . . . . 64.120000000000005 108.367 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.07 137.33 70.92 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.348 2.032 . . . . 62.25 114.285 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 275' ' ' THR . 1.6 tttm -61.13 -35.07 76.07 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.058 -1.428 . . . . 74.150000000000006 111.739 177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.26 22.07 30.73 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 115.484 -0.78 . . . . 62.43 112.744 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.5 mt-10 -119.97 143.39 48.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.988 -0.685 . . . . 61.350000000000001 110.476 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.11 144.62 24.15 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.941 -0.572 . . . . 71.349999999999994 110.018 177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 237' ' ' PHE . 60.3 p -127.0 137.85 53.16 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 110.148 -0.316 . . . . 71.109999999999999 110.148 172.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 4.7 m -134.93 147.88 29.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 N-CA-C 110.034 -0.358 . . . . 74.120000000000005 110.034 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.441 ' H ' ' CB ' ' A' ' 270' ' ' MET . 14.5 m -108.48 123.95 49.68 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.531 0.567 . . . . 73.349999999999994 112.531 -170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.8 163.44 13.52 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.963 0.357 . . . . 74.219999999999999 111.963 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -76.25 -48.27 20.89 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 116.641 -0.254 . . . . 62.329999999999998 110.4 -176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -104.55 135.21 19.35 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 120.366 -0.533 . . . . 74.409999999999997 110.03 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.4 -39.34 29.53 Favored 'Trans proline' 0 CA--C 1.568 2.208 0 C-N-CA 122.572 2.181 . . . . 75.209999999999994 116.029 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.51 -31.05 61.45 Favored 'Trans proline' 0 C--N 1.393 2.906 0 CA-C-N 122.978 2.099 . . . . 63.229999999999997 113.958 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 52.8 m -70.32 -30.3 67.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.897 -0.592 . . . . 72.040000000000006 110.794 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -73.38 -40.64 64.18 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 115.795 -0.638 . . . . 52.100000000000001 111.08 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -71.82 -37.07 70.39 Favored 'General case' 0 C--O 1.252 1.22 0 CA-C-O 120.887 0.375 . . . . 71.219999999999999 111.967 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.41 78.12 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 116.339 -0.391 . . . . 73.400000000000006 110.842 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -65.25 -35.15 80.13 Favored 'General case' 0 C--O 1.208 -1.091 0 CA-C-N 116.154 -0.476 . . . . 53.340000000000003 111.76 175.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.3 mt -63.74 -32.57 57.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 O-C-N 122.052 -0.405 . . . . 70.239999999999995 111.106 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -72.34 -58.43 3.41 Favored 'General case' 0 CA--C 1.563 1.465 0 N-CA-C 113.973 1.101 . . . . 63.210000000000001 113.973 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.55 -30.92 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.569 2.063 . . . . 71.329999999999998 116.569 -176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 85.4 t80 -83.94 -11.21 57.21 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.443 0.697 . . . . 62.340000000000003 111.107 -168.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.21 170.44 7.88 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 108.624 -0.88 . . . . 74.310000000000002 108.624 174.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.64 6.21 59.69 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 121.272 -0.49 . . . . 72.540000000000006 112.48 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 -157.55 0.63 Allowed 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.393 -0.965 . . . . 61.329999999999998 108.393 174.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -129.87 147.15 51.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.428 0.632 . . . . 65.340000000000003 111.329 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -114.32 111.88 22.2 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.989 -1.115 . . . . 62.219999999999999 107.989 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 19.8 m170 64.8 28.78 12.84 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.423 1.089 . . . . 73.340000000000003 112.253 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.06 -2.07 87.69 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 116.359 -0.382 . . . . 63.240000000000002 113.546 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -108.64 144.9 35.77 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 109.125 -0.694 . . . . 70.319999999999993 109.125 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.28 126.99 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.863 0.363 . . . . 75.099999999999994 111.126 -173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 20.3 tt -110.34 136.31 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.568 0.699 . . . . 64.219999999999999 111.191 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -130.64 131.74 45.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.052 -0.976 . . . . 72.140000000000001 110.545 178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.8 t -114.24 139.06 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 110.006 -0.368 . . . . 54.140000000000001 110.006 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.4 m -137.88 174.71 10.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.195 0.998 . . . . 54.149999999999999 109.647 -179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -86.68 1.59 51.46 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.051 1.13 . . . . 74.230000000000004 114.051 174.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.76 -162.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.012 0.925 . . . . 73.129999999999995 113.178 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 6.8 m -97.15 131.71 43.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.059 -0.719 . . . . 71.510000000000005 109.059 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -91.53 177.02 6.34 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.981 -0.554 . . . . 63.329999999999998 110.325 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 67.94 86.77 0.12 Allowed Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 124.554 1.142 . . . . 71.319999999999993 111.831 173.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -83.3 175.6 8.12 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.58 2.186 . . . . 64.150000000000006 114.491 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.256 1.41 0 CA-C-N 114.846 -1.07 . . . . 74.430000000000007 109.545 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.107 0 CA-C-O 119.554 -0.581 . . . . 73.439999999999998 111.998 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 22.7 m 62.14 92.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.007 1.323 . . . . 73.340000000000003 113.233 176.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -135.55 132.3 37.04 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.742 -0.663 . . . . 75.219999999999999 111.707 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.76 97.87 3.09 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.956 0.884 . . . . 74.299999999999997 110.009 168.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 69.1 m -141.47 134.57 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.957 -1.019 . . . . 74.200000000000003 109.299 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -84.19 -9.66 58.36 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 123.706 0.629 . . . . 74.129999999999995 110.932 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -83.27 104.34 13.37 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.808 -0.633 . . . . 72.109999999999999 109.47 172.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 107.02 18.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.329 -0.548 . . . . 65.439999999999998 109.819 168.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 3.9 m -142.9 149.01 37.91 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.584 -0.895 . . . . 71.120000000000005 108.584 169.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 315' ' ' VAL . 2.7 pp -123.79 141.15 45.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-N 118.625 0.648 . . . . 75.219999999999999 109.58 161.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 315' ' ' VAL . 0.3 OUTLIER -102.31 130.2 48.95 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 108.552 -0.907 . . . . 72.209999999999994 108.552 177.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.754 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -121.38 144.71 29.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.636 0.731 . . . . 62.009999999999998 112.642 176.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.91 151.11 48.88 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 114.257 -1.338 . . . . 62.329999999999998 110.049 -178.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 95.45 7.89 58.91 Favored Glycine 0 CA--C 1.519 0.296 0 O-C-N 123.599 0.562 . . . . 60.25 113.688 174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.754 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -103.67 76.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.374 -0.973 . . . . 63.100000000000001 108.374 179.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -134.4 -87.65 0.28 Allowed Glycine 0 CA--C 1.504 -0.652 0 C-N-CA 120.419 -0.896 . . . . 64.310000000000002 113.822 -171.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -72.96 112.91 9.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.753 0.311 . . . . 75.209999999999994 111.21 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.01 19.87 38.27 Favored Glycine 0 C--N 1.337 0.597 0 CA-C-N 115.709 -0.678 . . . . 70.219999999999999 111.977 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.33 150.87 4.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.311 0.576 . . . . 72.25 109.674 -173.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.1 m -90.29 170.65 10.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.539 -0.755 . . . . 65.019999999999996 110.364 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.71 -167.7 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 127.117 2.167 . . . . 61.210000000000001 113.36 -175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -44.2 -11.53 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.285 1.834 . . . . 74.209999999999994 115.673 173.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -45.87 -22.31 0.19 Allowed 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 126.869 2.068 . . . . 73.430000000000007 113.756 168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.78 -32.28 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 118.815 0.734 . . . . 72.400000000000006 110.058 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -36.67 92.78 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-O 119.737 -0.479 . . . . 71.0 113.168 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -68.11 -34.27 76.06 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.502 0.721 . . . . 71.239999999999995 110.635 175.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.1 t80 -57.56 -43.18 84.27 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.252 -0.886 . . . . 72.049999999999997 111.486 173.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.64 -24.45 45.26 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 112.181 0.438 . . . . 72.319999999999993 112.181 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.522 ' HD2' ' O ' ' A' ' 258' ' ' GLY . 23.4 tptm -66.66 -18.96 65.64 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.795 1.238 . . . . 64.349999999999994 112.189 177.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -65.23 -15.09 62.11 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 113.172 0.804 . . . . 64.239999999999995 113.172 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 24.6 mm -116.2 -6.73 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.398 0 CA-C-O 120.882 0.372 . . . . 72.510000000000005 110.792 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.522 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . -171.59 -160.44 20.13 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 118.95 -1.595 . . . . 75.340000000000003 114.721 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.59 139.44 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.443 0.697 . . . . 74.239999999999995 110.518 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.456 HG12 ' HD3' ' A' ' 255' ' ' LYS . 20.8 mm -66.38 116.31 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 O-C-N 123.643 0.589 . . . . 74.400000000000006 109.674 173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -97.11 133.24 42.03 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.447 -0.797 . . . . 72.349999999999994 110.454 178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 50.3 m -84.8 117.09 23.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.299 -1.0 . . . . 71.120000000000005 108.299 167.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.29 136.67 42.63 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 112.196 0.443 . . . . 74.450000000000003 112.196 -174.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -80.07 -10.77 59.79 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.668 0.988 . . . . 73.109999999999999 113.668 -176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -70.12 -38.48 75.6 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 112.477 0.547 . . . . 62.520000000000003 112.477 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.42 HG23 ' HG2' ' A' ' 268' ' ' LYS . 0.4 OUTLIER -124.37 -24.55 4.25 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 120.482 0.182 . . . . 74.430000000000007 111.279 174.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 90.85 16.52 54.39 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 114.121 0.408 . . . . 74.420000000000002 114.121 176.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.42 ' HG2' HG23 ' A' ' 266' ' ' THR . 19.6 ptpt -100.34 152.94 37.97 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.398 0.599 . . . . 63.439999999999998 111.496 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.62 152.12 83.04 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.443 2.096 . . . . 73.329999999999998 111.572 166.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.519 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -76.09 97.9 4.2 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.764 1.024 . . . . 65.209999999999994 113.764 -172.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 35.7 mm -143.11 112.87 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.614 -1.254 . . . . 75.150000000000006 107.614 165.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -129.07 117.61 21.15 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 119.107 0.867 . . . . 63.399999999999999 109.852 161.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.83 111.04 20.61 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.595 -0.52 . . . . 71.400000000000006 109.595 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.423 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 35.2 m-85 -101.92 112.29 24.86 Favored 'General case' 0 C--O 1.262 1.713 0 CA-C-O 121.259 0.552 . . . . 64.010000000000005 110.577 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.424 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 23.0 p -142.6 120.93 12.32 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 113.985 -1.461 . . . . 72.329999999999998 110.207 -177.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . 0.507 ' H ' ' HG3' ' A' ' 283' ' ' LYS . 26.0 t70 -87.47 113.49 23.21 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.288 0.566 . . . . 72.310000000000002 111.147 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.33 -9.9 55.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.662 -0.699 . . . . 63.340000000000003 112.797 179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -29.95 61.19 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.652 0.263 . . . . 61.310000000000002 111.547 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.4 t -91.3 -15.41 29.16 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.417 0.627 . . . . 75.400000000000006 109.686 167.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.98 -37.4 3.46 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.71 -0.677 . . . . 53.310000000000002 113.237 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -96.73 141.85 23.69 Favored Pre-proline 0 N--CA 1.443 -0.814 0 O-C-N 123.635 0.256 . . . . 72.430000000000007 110.971 -177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.49 136.26 74.78 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 123.636 2.891 . . . . 74.219999999999999 114.129 177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 276' ' ' ASP . 56.2 mtpt -65.6 -37.82 87.7 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.082 -0.963 . . . . 75.140000000000001 111.604 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.97 25.05 13.57 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.862 -0.685 . . . . 61.200000000000003 113.021 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 40.6 mt-10 -115.82 142.24 47.03 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.711 -0.477 . . . . 70.010000000000005 109.711 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.13 155.26 38.55 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.308 -0.405 . . . . 41.530000000000001 110.828 176.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 1.1 p -135.83 137.31 41.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 110.098 -0.334 . . . . 72.099999999999994 110.098 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 236' ' ' ILE . 11.5 m -136.56 145.36 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.152 -0.684 . . . . 72.25 109.152 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.519 ' H ' ' CB ' ' A' ' 270' ' ' MET . 22.7 t -97.68 117.59 32.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.639 0.775 . . . . 75.109999999999999 111.645 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.4 164.09 13.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 121.139 -0.225 . . . . 71.030000000000001 111.442 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -70.53 -48.53 55.06 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.715 0.635 . . . . 74.200000000000003 112.715 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -119.57 136.16 24.53 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 109.726 -0.472 . . . . 73.120000000000005 109.726 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -61.33 -38.35 65.6 Favored 'Trans proline' 0 CA--C 1.565 2.043 0 C-N-CA 123.682 2.921 . . . . 54.100000000000001 117.699 177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.68 -29.94 15.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 CA-C-N 123.55 2.304 . . . . 64.450000000000003 112.487 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 45.1 m -64.27 -27.4 69.02 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.725 1.21 . . . . 72.230000000000004 112.181 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.455 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -67.7 -40.97 84.3 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 123.595 0.559 . . . . 62.409999999999997 112.23 175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.2 ttpp -72.79 -34.67 67.08 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.292 0.567 . . . . 75.0 110.713 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.27 -33.76 76.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.337 -0.847 . . . . 71.140000000000001 111.048 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.22 -28.69 67.47 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 115.91 -0.586 . . . . 52.149999999999999 111.707 173.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 296' ' ' ALA . 49.3 mt -69.88 -30.59 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 O-C-N 122.035 -0.416 . . . . 63.119999999999997 110.812 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.88 -60.67 2.29 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.959 1.096 . . . . 63.140000000000001 113.959 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -91.87 -29.58 16.63 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 116.438 2.014 . . . . 72.239999999999995 116.438 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 23.6 t80 -86.62 -24.12 25.46 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.517 -0.549 . . . . 74.0 109.517 -171.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.43 ' HB2' HG12 ' A' ' 315' ' ' VAL . 7.5 t70 -82.87 -170.51 3.04 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.957 -1.02 . . . . 73.120000000000005 109.531 166.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 78.25 13.48 83.25 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.198 -0.525 . . . . 62.439999999999998 112.853 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -135.67 -161.88 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.883 0.373 . . . . 73.340000000000003 110.179 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -128.69 144.62 51.2 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.21 0.529 . . . . 32.240000000000002 110.467 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -113.12 112.04 23.14 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.21 -1.033 . . . . 74.420000000000002 108.21 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.2 m170 65.03 29.25 12.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 124.764 1.29 . . . . 74.349999999999994 112.167 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 86.78 5.79 80.82 Favored Glycine 0 C--N 1.341 0.834 0 N-CA-C 114.211 0.444 . . . . 72.540000000000006 114.211 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -124.21 148.42 47.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.778 -0.823 . . . . 55.119999999999997 108.778 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.59 129.27 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 O-C-N 123.303 0.377 . . . . 70.430000000000007 110.901 -171.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.1 tt -108.5 143.95 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.791 -0.641 . . . . 75.519999999999996 109.54 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 15.3 tptp -136.94 121.89 18.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.914 0.388 . . . . 73.519999999999996 110.361 178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 237' ' ' PHE . 7.7 p -111.89 138.39 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 115.522 -0.763 . . . . 61.240000000000002 111.226 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.3 m -142.79 172.79 12.22 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.286 1.034 . . . . 72.200000000000003 109.837 -175.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -77.19 -5.25 48.48 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.942 1.09 . . . . 74.040000000000006 113.942 176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.59 -169.74 0.2 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.508 1.123 . . . . 72.120000000000005 113.176 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 1.7 m -87.23 139.25 30.75 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.737 -0.665 . . . . 70.239999999999995 110.183 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -96.66 169.73 9.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.177 -0.305 . . . . 72.219999999999999 110.177 177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 72.9 90.32 0.07 OUTLIER Pre-proline 0 N--CA 1.484 1.272 0 O-C-N 124.619 1.199 . . . . 74.310000000000002 112.072 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.2 -164.06 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 122.79 2.326 . . . . 73.230000000000004 114.257 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 . . . . . 0 C--O 1.249 1.064 0 CA-C-N 114.636 -1.166 . . . . 74.430000000000007 111.939 -175.457 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.058 0 N-CA-C 111.487 -0.645 . . . . 73.0 111.487 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.1 t -84.71 -69.24 0.66 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.262 0.531 . . . . 42.130000000000003 111.456 -175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 54.25 71.35 0.53 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.556 1.142 . . . . 73.400000000000006 112.838 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 56.1 mtt -100.43 91.36 4.66 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.499 0.666 . . . . 54.520000000000003 110.29 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 22.7 t -112.18 141.8 45.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.837 -1.074 . . . . 73.209999999999994 109.609 175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.27 -34.14 76.8 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.354 1.034 . . . . 73.219999999999999 110.479 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -82.37 110.5 17.57 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.875 -1.057 . . . . 74.400000000000006 111.541 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.79 104.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 119.821 -0.752 . . . . 73.439999999999998 110.276 160.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 21.9 m -143.0 147.19 34.71 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.212 -1.032 . . . . 53.109999999999999 108.212 165.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.518 HD13 HG23 ' A' ' 315' ' ' VAL . 2.5 pp -121.7 141.9 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 CA-C-N 118.754 0.706 . . . . 62.43 109.588 164.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.67 122.31 45.39 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.754 -0.657 . . . . 74.439999999999998 109.39 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.724 ' HB ' HD11 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -114.3 144.52 21.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.755 0.788 . . . . 73.450000000000003 112.756 176.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.29 151.28 47.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 113.768 -1.56 . . . . 73.540000000000006 110.124 -178.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 92.12 15.3 54.33 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.266 -0.492 . . . . 72.319999999999993 113.539 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.724 HD11 ' HB ' ' A' ' 238' ' ' VAL . 0.0 OUTLIER -108.36 76.86 1.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.083 -1.081 . . . . 75.109999999999999 108.083 176.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.18 -88.26 0.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.152 -1.023 . . . . 70.109999999999999 114.301 -169.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -78.55 109.3 12.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.264 0.554 . . . . 75.239999999999995 111.225 -170.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.95 21.2 21.6 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.27 -0.877 . . . . 62.149999999999999 111.783 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -85.41 151.42 3.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 N-CA-C 109.752 -0.462 . . . . 72.030000000000001 109.752 -173.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.0 m -90.54 170.01 10.55 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.788 -0.642 . . . . 73.019999999999996 110.696 172.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -166.96 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.811 2.044 . . . . 75.010000000000005 113.555 -176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -43.19 -12.7 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 126.634 1.974 . . . . 73.200000000000003 115.749 176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.22 -22.04 0.34 Allowed 'General case' 0 CA--C 1.569 1.677 0 C-N-CA 126.473 1.909 . . . . 73.430000000000007 113.668 169.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.516 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -56.57 -31.55 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 118.482 0.583 . . . . 73.109999999999999 110.236 178.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.07 -32.02 82.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.707 -0.496 . . . . 72.400000000000006 114.267 174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 255' ' ' LYS . 10.5 tp10 -72.73 -33.58 66.5 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.706 0.802 . . . . 74.340000000000003 110.758 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.7 t80 -57.22 -43.15 82.58 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.083 -0.962 . . . . 73.140000000000001 111.256 173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.02 -24.9 43.34 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 122.144 -0.347 . . . . 74.310000000000002 111.851 176.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.46 ' HB2' HD11 ' A' ' 260' ' ' ILE . 13.5 tptm -64.87 -22.32 66.97 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.402 1.081 . . . . 75.209999999999994 112.199 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -64.41 -13.79 53.12 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 112.963 0.727 . . . . 52.340000000000003 112.963 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 46.6 mm -111.49 -26.46 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.234 0 C-N-CA 122.698 0.399 . . . . 75.439999999999998 110.589 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -160.9 -174.95 31.39 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 119.982 -1.104 . . . . 62.420000000000002 115.127 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.22 138.8 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.952 0.501 . . . . 73.430000000000007 111.201 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 255' ' ' LYS . 23.7 mm -70.98 115.54 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.818 -0.628 . . . . 75.129999999999995 110.785 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -98.28 138.11 36.03 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.579 0.704 . . . . 71.200000000000003 111.078 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 94.7 m -84.2 116.83 23.14 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.605 -1.18 . . . . 70.239999999999995 108.509 168.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.33 131.51 37.05 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 109.504 -0.554 . . . . 63.299999999999997 109.504 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -76.08 -5.65 47.48 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.704 1.002 . . . . 71.540000000000006 113.704 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -66.94 -34.83 78.63 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.636 0.255 . . . . 70.030000000000001 111.156 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 21.3 p -124.6 -31.45 3.22 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.854 0.462 . . . . 61.409999999999997 111.578 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.0 9.88 67.17 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-N 115.431 -0.804 . . . . 74.450000000000003 112.034 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -99.32 151.73 37.53 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 123.101 0.56 . . . . 74.109999999999999 111.677 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.45 153.92 76.01 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 123.066 2.51 . . . . 74.120000000000005 111.38 166.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.472 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.5 ptm -76.93 99.2 5.15 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.373 0.879 . . . . 73.409999999999997 113.373 -169.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.9 mm -143.07 112.87 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 107.59 -1.263 . . . . 54.420000000000002 107.59 165.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -128.69 116.2 19.19 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.953 0.797 . . . . 73.439999999999998 110.276 162.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.81 110.89 20.85 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.638 -0.504 . . . . 71.120000000000005 109.638 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 31.7 m-85 -103.03 112.94 26.02 Favored 'General case' 0 C--O 1.257 1.488 0 CA-C-O 121.088 0.471 . . . . 72.25 110.651 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 p -144.77 122.07 11.58 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.55 -1.205 . . . . 74.230000000000004 110.088 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.21 112.2 21.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.441 0.638 . . . . 73.420000000000002 112.618 178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -85.75 -10.42 55.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.799 -0.637 . . . . 70.230000000000004 112.017 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.69 -31.36 66.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.407 0.623 . . . . 65.540000000000006 110.221 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 47.3 p -91.21 -21.92 20.88 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.212 -0.904 . . . . 75.400000000000006 109.57 173.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 99.11 -33.25 6.29 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.263 -0.88 . . . . 62.350000000000001 113.029 174.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -99.37 141.42 22.8 Favored Pre-proline 0 N--CA 1.448 -0.547 0 N-CA-C 110.302 -0.259 . . . . 75.439999999999998 110.302 178.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -55.58 132.72 53.82 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 123.418 2.745 . . . . 74.040000000000006 114.385 175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -59.54 -42.09 91.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 75.140000000000001 112.294 175.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.49 24.76 15.19 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.64 -0.791 . . . . 54.039999999999999 113.145 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 51.4 mt-10 -116.45 142.87 46.3 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.722 -0.473 . . . . 71.219999999999999 109.722 -174.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.15 152.18 32.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.478 -0.328 . . . . 74.230000000000004 110.966 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 7.5 p -131.31 136.74 48.39 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.88 0.372 . . . . 71.030000000000001 110.2 168.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.415 ' HB ' ' HE3' ' A' ' 270' ' ' MET . 6.1 m -135.56 146.22 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 109.221 -0.659 . . . . 75.450000000000003 109.221 175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.472 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.6 m -110.21 117.81 34.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.087 0.403 . . . . 74.140000000000001 112.087 -172.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.25 165.23 13.56 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.918 0.71 . . . . 53.109999999999999 112.918 -170.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.66 -47.16 76.45 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.852 0.861 . . . . 73.109999999999999 112.857 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -122.45 136.7 26.8 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.964 -0.384 . . . . 73.019999999999996 109.964 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -61.26 -38.5 65.27 Favored 'Trans proline' 0 CA--C 1.562 1.913 0 C-N-CA 123.229 2.619 . . . . 74.25 117.259 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -28.18 14.2 Favored 'Trans proline' 0 C--N 1.386 2.502 0 CA-C-N 123.682 2.351 . . . . 71.319999999999993 112.466 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 56.7 m -62.48 -27.9 69.45 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.056 0.942 . . . . 72.129999999999995 112.026 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.14 -39.38 78.87 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.267 0.627 . . . . 70.099999999999994 111.904 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -69.49 -37.88 77.42 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 120.87 0.367 . . . . 74.409999999999997 110.772 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.03 72.09 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.633 -0.712 . . . . 13.24 110.941 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.73 -29.56 66.97 Favored 'General case' 0 C--O 1.213 -0.852 0 O-C-N 123.395 0.434 . . . . 75.129999999999995 111.726 174.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 296' ' ' ALA . 56.6 mt -69.84 -32.06 50.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 121.716 -0.615 . . . . 65.430000000000007 110.428 173.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -77.71 -60.61 2.3 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 113.381 0.882 . . . . 72.239999999999995 113.381 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -93.52 -30.76 14.85 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.283 1.957 . . . . 73.439999999999998 116.283 178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.461 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 37.5 t80 -84.57 -23.19 29.77 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 118.492 0.587 . . . . 63.149999999999999 109.69 -169.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 315' ' ' VAL . 3.4 t0 -87.78 -164.65 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.459 -0.792 . . . . 62.32 110.649 168.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 83.06 7.21 87.39 Favored Glycine 0 C--N 1.341 0.809 0 CA-C-N 115.528 -0.76 . . . . 73.140000000000001 113.061 175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -137.78 -164.35 1.6 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.56 0.219 . . . . 71.510000000000005 110.634 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.77 144.62 45.15 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 121.719 0.771 . . . . 62.229999999999997 112.035 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -113.82 114.83 26.83 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.794 -1.187 . . . . 62.130000000000003 107.794 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.2 m170 64.09 28.5 14.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 124.64 1.213 . . . . 75.219999999999999 112.211 -177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 89.18 -4.47 84.51 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 114.106 0.403 . . . . 71.040000000000006 114.106 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -113.11 145.51 40.8 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 109.699 -0.482 . . . . 64.329999999999998 109.699 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.1 mm -69.11 132.0 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 123.203 0.314 . . . . 74.019999999999996 110.635 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 16.8 tt -107.28 145.19 14.99 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 N-CA-C 108.747 -0.834 . . . . 64.420000000000002 108.747 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 238' ' ' VAL . 7.0 tppt? -136.19 121.32 18.98 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 109.095 -0.706 . . . . 72.030000000000001 109.095 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.518 HG23 HD13 ' A' ' 236' ' ' ILE . 13.3 p -112.23 134.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.399 0.618 . . . . 74.439999999999998 110.153 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.8 m -133.72 173.45 11.51 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 115.191 -0.913 . . . . 62.200000000000003 109.495 -175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.27 -3.35 45.58 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.948 0.721 . . . . 73.109999999999999 112.948 174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.96 -164.87 0.24 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.508 1.123 . . . . 62.530000000000001 112.771 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.9 171.57 13.73 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.696 -0.683 . . . . 62.539999999999999 109.255 172.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 51.2 mtt-85 -79.11 -171.75 2.81 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.176 0.436 . . . . 61.219999999999999 112.176 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.9 ptt180 -62.97 149.29 90.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.022 0.529 . . . . 62.299999999999997 112.422 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.49 95.47 0.18 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.263 2.642 . . . . 64.519999999999996 113.35 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 . . . . . 0 N--CA 1.488 1.467 0 C-N-CA 126.764 2.026 . . . . 53.350000000000001 114.459 179.644 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.415 -0.274 . . . . 61.240000000000002 112.415 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 80.0 p -140.94 170.95 14.77 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 110.081 -0.34 . . . . 54.439999999999998 110.081 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -86.0 140.98 29.82 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.396 -0.366 . . . . 73.230000000000004 110.676 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 21.7 mmt -128.23 55.98 1.64 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.35 0.595 . . . . 62.329999999999998 109.871 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 75.2 p 58.2 -171.1 0.11 Allowed 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.116 1.767 . . . . 61.109999999999999 113.249 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -96.57 1.12 50.99 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.143 -0.481 . . . . 72.450000000000003 110.592 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -83.12 111.3 18.78 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.328 -0.396 . . . . 75.239999999999995 110.462 176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.74 105.03 17.42 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.936 -0.574 . . . . 74.409999999999997 110.159 167.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 4.6 m -144.01 148.81 35.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 74.430000000000007 108.564 163.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.408 HG12 ' O ' ' A' ' 288' ' ' VAL . 43.1 pt -126.09 144.47 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 118.83 0.741 . . . . 71.519999999999996 109.329 161.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.451 ' HA ' HG22 ' A' ' 287' ' ' THR . 1.1 t80 -99.95 133.0 44.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.756 -0.831 . . . . 64.049999999999997 108.756 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.484 HG11 ' HZ ' ' A' ' 254' ' ' PHE . 1.5 t -124.76 137.76 56.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 109.011 -0.737 . . . . 72.420000000000002 109.011 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -126.47 140.58 52.36 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.741 -0.663 . . . . 72.239999999999995 111.214 -177.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 107.22 31.04 3.93 Favored Glycine 0 N--CA 1.447 -0.579 0 O-C-N 124.246 0.966 . . . . 63.420000000000002 112.316 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 241' ' ' LEU . 0.0 OUTLIER -127.21 79.13 1.86 Allowed 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.906 -0.776 . . . . 70.430000000000007 108.906 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -123.97 -99.06 1.32 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.542 -0.754 . . . . 61.43 113.996 -171.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -73.48 119.39 17.64 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.019 0.438 . . . . 71.219999999999999 111.526 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.78 20.58 30.96 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.26 -0.882 . . . . 62.229999999999997 111.592 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.23 152.03 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.674 -0.491 . . . . 62.130000000000003 109.674 -172.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 19.0 m -88.29 169.28 11.99 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.681 -0.69 . . . . 72.209999999999994 109.935 171.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -167.75 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.177 1.791 . . . . 71.299999999999997 114.201 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -42.6 -14.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.726 2.01 . . . . 72.140000000000001 115.547 174.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -47.61 -22.06 0.44 Allowed 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 126.374 1.87 . . . . 74.25 113.912 171.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.8 OUTLIER -56.11 -32.62 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.38 -0.6 . . . . 63.43 109.38 177.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.26 -32.94 84.45 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.699 0.639 . . . . 73.439999999999998 114.699 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -73.77 -31.13 63.15 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.312 0.577 . . . . 53.219999999999999 111.231 174.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 3.9 t80 -56.48 -45.15 81.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.434 -0.803 . . . . 70.329999999999998 111.015 171.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.484 ' HZ ' HG11 ' A' ' 238' ' ' VAL . 93.2 m-85 -78.0 -23.45 48.33 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.033 -0.417 . . . . 73.120000000000005 111.651 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.26 -14.95 62.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.849 0.86 . . . . 71.209999999999994 111.806 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -64.65 -13.37 53.55 Favored 'General case' 0 CA--C 1.555 1.156 0 O-C-N 121.88 -0.512 . . . . 74.439999999999998 112.046 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 51.3 mm -104.19 -43.13 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 123.02 0.528 . . . . 75.25 110.563 177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -147.08 -160.11 8.66 Favored Glycine 0 C--N 1.343 0.965 0 C-N-CA 120.236 -0.983 . . . . 40.240000000000002 114.613 -174.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 5.6 mt -103.51 138.45 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.007 0.523 . . . . 55.420000000000002 111.452 -173.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.76 116.81 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.688 -0.687 . . . . 75.209999999999994 110.689 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -97.93 140.75 31.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.436 0.636 . . . . 75.129999999999995 111.158 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 25.6 m -86.06 118.59 25.62 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.916 -1.038 . . . . 51.32 108.44 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -72.84 136.97 45.44 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 116.292 -0.413 . . . . 64.549999999999997 111.208 -174.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.49 -9.83 59.68 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.61 0.596 . . . . 74.439999999999998 112.61 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -69.64 -39.57 77.04 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.028 0.381 . . . . 74.409999999999997 112.028 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 22.4 p -123.19 -26.52 4.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.967 0.413 . . . . 75.409999999999997 111.181 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.87 9.86 65.52 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.427 -0.806 . . . . 72.099999999999994 112.813 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -97.96 150.74 37.07 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 112.416 0.525 . . . . 64.209999999999994 112.416 174.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 154.53 70.66 Favored 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 123.283 2.655 . . . . 53.329999999999998 111.993 166.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.458 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.8 ptm -68.31 102.48 1.4 Allowed 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.118 1.155 . . . . 71.530000000000001 114.118 -175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 24.0 mm -144.44 112.45 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.139 -1.8 . . . . 72.400000000000006 106.139 161.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -128.72 114.5 16.68 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.091 0.86 . . . . 62.32 109.986 163.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.21 111.85 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.895 -0.409 . . . . 74.120000000000005 109.895 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 49.0 m-85 -102.04 111.4 23.66 Favored 'General case' 0 C--O 1.265 1.884 0 CA-C-O 121.487 0.66 . . . . 64.109999999999999 109.866 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.449 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 16.0 p -144.4 120.5 10.76 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 113.86 -1.518 . . . . 54.200000000000003 109.694 -177.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -86.81 112.92 22.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.43 0.634 . . . . 63.520000000000003 111.454 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 -10.38 56.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.802 0.668 . . . . 53.130000000000003 112.802 176.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -32.21 66.34 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 111.965 0.357 . . . . 72.25 111.965 176.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 11.2 t -91.16 -18.26 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 109.702 -0.481 . . . . 65.430000000000007 109.702 169.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 100.22 -40.88 2.29 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.884 -0.598 . . . . 74.299999999999997 113.021 172.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -87.79 141.61 31.88 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-O 119.889 -0.101 . . . . 74.340000000000003 110.804 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -55.65 132.9 54.89 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.061 2.507 . . . . 62.450000000000003 114.102 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.449 ' H ' ' HA ' ' A' ' 275' ' ' THR . 13.6 mttm -56.53 -40.13 74.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.413 -1.267 . . . . 74.109999999999999 112.571 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.36 23.14 20.17 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.98 -0.554 . . . . 63.409999999999997 112.864 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 21.3 mt-10 -120.31 142.05 49.47 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 123.82 0.364 . . . . 74.25 110.562 -173.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.81 148.68 28.13 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 116.62 -0.264 . . . . 60.25 110.875 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 237' ' ' PHE . 67.6 p -128.76 138.57 52.17 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 109.571 -0.529 . . . . 74.519999999999996 109.571 169.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 236' ' ' ILE . 8.1 m -138.38 152.02 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.272 -0.64 . . . . 75.409999999999997 109.272 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.458 ' H ' ' CB ' ' A' ' 270' ' ' MET . 34.0 t -113.67 131.19 56.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.813 1.042 . . . . 73.099999999999994 113.813 -171.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.0 163.42 13.66 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.434 0.531 . . . . 64.439999999999998 112.434 177.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.62 -46.2 80.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.5 -0.773 . . . . 73.430000000000007 111.896 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -119.91 136.15 24.73 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 109.684 -0.487 . . . . 72.200000000000003 109.684 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -61.41 -38.87 60.7 Favored 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 123.272 2.648 . . . . 60.409999999999997 117.4 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.04 -30.5 13.5 Favored 'Trans proline' 0 C--N 1.381 2.261 0 CA-C-N 123.37 2.239 . . . . 63.439999999999998 112.716 -178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 48.9 m -64.06 -27.92 69.43 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.384 -0.825 . . . . 72.409999999999997 111.394 175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -72.05 -34.92 69.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.473 0.545 . . . . 54.439999999999998 112.473 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -71.86 -36.07 70.0 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 120.932 0.396 . . . . 64.209999999999994 110.695 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -65.75 -38.31 88.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.784 -0.644 . . . . 71.109999999999999 111.093 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.12 -25.86 64.61 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.059 0.456 . . . . 74.5 111.586 176.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 96.5 mt -68.31 -34.32 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 O-C-N 121.7 -0.625 . . . . 75.510000000000005 110.804 172.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -77.25 -56.89 4.17 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 113.378 0.881 . . . . 71.340000000000003 113.378 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -89.55 -29.1 19.15 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.245 1.943 . . . . 72.409999999999997 116.245 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.566 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 81.3 t80 -91.09 -9.26 46.33 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 122.01 -0.432 . . . . 73.420000000000002 111.402 -167.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.17 169.06 8.71 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.956 -0.757 . . . . 63.43 108.956 171.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.91 49.67 Favored Glycine 0 C--N 1.341 0.834 0 C-N-CA 120.851 -0.69 . . . . 64.049999999999997 112.315 -176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -125.81 -162.72 1.15 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.244 -1.021 . . . . 73.099999999999994 108.244 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.78 145.93 50.76 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.621 0.724 . . . . 74.019999999999996 112.456 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -113.73 112.96 24.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.536 -1.211 . . . . 73.019999999999996 107.756 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.1 m170 64.88 28.95 12.67 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.531 1.132 . . . . 72.019999999999996 112.264 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 87.86 -1.38 85.15 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 121.465 -0.397 . . . . 63.119999999999997 113.97 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -115.22 143.51 45.13 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.202 -0.666 . . . . 72.129999999999995 109.202 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.2 mm -69.24 129.22 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 122.632 0.373 . . . . 62.5 111.321 -171.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 18.8 tt -109.84 134.3 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.697 -0.683 . . . . 64.549999999999997 110.814 -174.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.42 131.22 53.5 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.522 -0.763 . . . . 63.530000000000001 110.197 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.01 126.77 67.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.965 0.412 . . . . 52.350000000000001 110.27 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.6 m -127.72 174.13 9.36 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 123.925 0.89 . . . . 75.540000000000006 109.119 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -85.35 -1.72 57.31 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.954 1.094 . . . . 73.209999999999994 113.954 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.62 -159.31 0.31 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.11 0.964 . . . . 75.450000000000003 112.526 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 177.86 8.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.896 0.478 . . . . 54.509999999999998 109.945 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -161.8 0.69 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 111.651 0.241 . . . . 72.400000000000006 111.651 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -56.59 151.18 31.53 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.437 1.095 . . . . 73.349999999999994 112.645 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.0 174.54 12.22 Favored 'Trans proline' 0 C--N 1.367 1.513 0 C-N-CA 123.09 2.527 . . . . 72.450000000000003 114.162 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 C--O 1.254 1.329 0 CA-C-N 115.054 -0.975 . . . . 61.299999999999997 110.829 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.262 -0.335 . . . . 54.009999999999998 112.262 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 34.7 p -118.48 -16.95 9.48 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.614 0.598 . . . . 70.349999999999994 112.614 -177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -68.96 153.5 43.69 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.508 0.323 . . . . 70.109999999999999 111.128 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 25.9 ttm 71.12 26.42 3.47 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 124.908 1.38 . . . . 72.209999999999994 111.379 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 15.0 t -135.5 120.92 19.2 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.529 -0.545 . . . . 73.340000000000003 109.529 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.95 -5.0 58.28 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.674 -0.694 . . . . 74.230000000000004 110.804 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.54 107.05 17.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.676 -0.693 . . . . 64.140000000000001 111.309 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -92.1 101.95 14.48 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.841 -0.743 . . . . 71.109999999999999 110.071 164.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 6.1 m -144.72 150.2 36.89 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.805 -1.183 . . . . 74.439999999999998 107.805 167.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 36.3 pt -124.82 140.25 48.55 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.272 0.942 . . . . 63.240000000000002 110.013 163.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.66 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.2 OUTLIER -99.02 128.71 45.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.601 -0.888 . . . . 74.519999999999996 108.601 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.402 HG21 ' CZ ' ' A' ' 254' ' ' PHE . 2.1 t -123.81 138.61 52.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.775 -0.454 . . . . 72.129999999999995 109.775 -177.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -128.82 141.74 51.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.638 -0.71 . . . . 75.439999999999998 109.21 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 106.91 14.92 17.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.183 -0.532 . . . . 61.409999999999997 113.197 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 78.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.853 -0.795 . . . . 74.319999999999993 108.853 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -133.1 -89.19 0.39 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.317 -0.944 . . . . 51.210000000000001 113.984 -171.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.59 117.93 19.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.437 0.637 . . . . 71.420000000000002 111.133 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 90.85 20.96 37.92 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.514 -0.766 . . . . 52.409999999999997 111.583 -177.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.05 150.45 4.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 109.438 -0.578 . . . . 74.150000000000006 109.438 -172.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 9.5 t -91.38 170.23 10.14 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.433 -0.58 . . . . 51.530000000000001 109.433 171.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -169.05 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.332 1.853 . . . . 70.400000000000006 113.848 -175.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -43.38 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.768 2.027 . . . . 54.350000000000001 114.985 175.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -47.06 -22.04 0.3 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 126.55 1.94 . . . . 71.219999999999999 113.995 169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.2 t -55.28 -31.88 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-N 118.631 0.651 . . . . 62.299999999999997 110.556 177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -61.26 -33.78 85.66 Favored Glycine 0 C--N 1.347 1.168 0 C-N-CA 121.935 -0.174 . . . . 53.420000000000002 113.504 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -72.67 -33.3 66.45 Favored 'General case' 0 C--O 1.246 0.889 0 C-N-CA 123.616 0.767 . . . . 75.129999999999995 110.152 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.573 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.9 t80 -56.57 -44.46 81.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.548 -0.751 . . . . 71.010000000000005 111.72 172.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 238' ' ' VAL . 98.8 m-85 -78.9 -22.2 46.24 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.002 0.429 . . . . 75.400000000000006 111.462 177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -73.03 -13.01 61.13 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.357 0.663 . . . . 62.219999999999999 111.803 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -63.67 -14.48 52.39 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 120.662 0.268 . . . . 75.549999999999997 111.505 171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 40.9 mm -104.57 -47.99 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 122.924 0.49 . . . . 55.439999999999998 111.313 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -140.41 -161.52 8.74 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.066 -0.588 . . . . 62.210000000000001 113.667 -173.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 8.9 mt -104.24 138.1 30.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 C-N-CA 123.324 0.65 . . . . 52.450000000000003 110.836 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 34.3 mm -69.01 116.05 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.709 -0.678 . . . . 64.129999999999995 110.911 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -98.57 142.89 29.59 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.323 -0.853 . . . . 74.340000000000003 111.111 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 51.0 m -84.75 117.29 23.73 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.25 -1.018 . . . . 64.329999999999998 108.25 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -73.68 133.11 43.33 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.328 -0.396 . . . . 75.109999999999999 110.211 -175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -80.0 -8.03 59.14 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.572 0.582 . . . . 75.140000000000001 112.572 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 266' ' ' THR . 21.8 pttt -67.24 -36.85 82.51 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.275 0.23 . . . . 74.120000000000005 111.529 177.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.43 ' N ' ' HG3' ' A' ' 265' ' ' LYS . 15.0 p -124.15 -30.19 3.49 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.654 0.382 . . . . 63.200000000000003 111.372 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 92.24 6.7 64.48 Favored Glycine 0 C--N 1.337 0.618 0 CA-C-N 116.14 -0.482 . . . . 62.200000000000003 112.952 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -98.23 151.53 37.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 112.182 0.438 . . . . 60.450000000000003 112.182 173.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.57 155.34 69.45 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 123.464 2.776 . . . . 65.219999999999999 112.597 167.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.485 ' CB ' ' H ' ' A' ' 289' ' ' SER . 1.6 ptm -71.48 102.01 2.58 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.665 0.987 . . . . 71.409999999999997 113.665 -172.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 23.8 mm -143.06 113.02 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.618 -1.623 . . . . 61.43 106.618 163.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -128.12 115.9 19.12 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.016 0.825 . . . . 73.219999999999999 109.98 162.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.95 111.72 21.58 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.183 -0.303 . . . . 74.420000000000002 110.183 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.467 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 45.2 m-85 -102.92 112.25 24.98 Favored 'General case' 0 C--O 1.259 1.6 0 CA-C-O 121.222 0.534 . . . . 72.409999999999997 110.388 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.443 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 18.4 p -144.7 122.91 12.2 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.295 -1.321 . . . . 70.129999999999995 110.003 -177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -85.82 111.95 20.66 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.113 0.482 . . . . 74.349999999999994 111.36 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.23 -10.52 54.48 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.884 0.698 . . . . 73.219999999999999 112.884 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -71.38 -32.82 68.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.046 0.45 . . . . 60.200000000000003 110.381 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 77.6 p -90.71 -18.94 24.16 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.667 -0.697 . . . . 73.129999999999995 109.547 174.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 96.78 -29.29 10.73 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.557 -0.747 . . . . 72.340000000000003 113.102 170.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -105.84 142.49 24.92 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 110.196 -0.298 . . . . 74.219999999999999 110.196 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -56.5 136.86 78.12 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 123.422 2.748 . . . . 75.400000000000006 114.594 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.443 ' H ' ' HA ' ' A' ' 275' ' ' THR . 45.8 mttt -64.33 -38.48 91.2 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.045 -0.979 . . . . 72.099999999999994 111.873 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.85 23.67 17.38 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-N 115.459 -0.791 . . . . 72.129999999999995 113.057 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 43.6 mt-10 -116.55 142.2 47.18 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 120.333 -0.547 . . . . 62.329999999999998 110.454 -175.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -152.27 143.86 23.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.751 -0.659 . . . . 74.129999999999995 109.948 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.66 HG22 ' HA ' ' A' ' 237' ' ' PHE . 77.1 p -127.25 138.71 53.15 Favored 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.181 0.515 . . . . 74.519999999999996 110.445 171.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.48 147.45 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-N 115.836 -0.62 . . . . 71.299999999999997 110.783 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.485 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.8 t -98.19 136.55 38.23 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.213 0.605 . . . . 65.349999999999994 112.526 -174.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.72 164.35 11.83 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.596 0.221 . . . . 71.019999999999996 111.596 176.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.84 -46.46 68.48 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.914 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -123.49 136.55 27.31 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 109.49 -0.559 . . . . 75.319999999999993 109.49 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.41 -37.59 80.36 Favored 'Trans proline' 0 CA--C 1.568 2.216 0 C-N-CA 123.381 2.72 . . . . 74.319999999999993 117.076 176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 -29.12 12.68 Favored 'Trans proline' 0 C--N 1.387 2.581 0 CA-C-N 123.3 2.214 . . . . 41.43 113.023 -178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 70.5 m -61.39 -27.96 68.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.732 -0.667 . . . . 72.519999999999996 111.517 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -75.06 -35.44 61.86 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.094 -0.503 . . . . 74.409999999999997 111.439 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 30.5 pttt -72.12 -33.25 67.66 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 120.74 -0.384 . . . . 64.530000000000001 110.934 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.29 -40.03 86.04 Favored 'General case' 0 C--N 1.348 0.522 0 CA-C-O 120.839 0.352 . . . . 72.109999999999999 110.869 175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.626 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -67.42 -26.62 66.51 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.74 -0.664 . . . . 74.25 112.337 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . . . . . . . . . 86.1 mt -72.84 -33.97 45.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 O-C-N 121.731 -0.605 . . . . 54.009999999999998 110.214 174.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.4 -56.06 5.29 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.623 0.971 . . . . 63.520000000000003 113.623 -176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -89.71 -31.78 17.31 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.809 1.781 . . . . 74.310000000000002 115.809 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 63.4 t80 -88.51 -8.82 54.2 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 118.535 0.607 . . . . 71.200000000000003 111.647 -167.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.28 167.53 9.76 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.66 -0.867 . . . . 75.129999999999995 108.66 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.84 51.33 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 120.207 -0.997 . . . . 73.25 112.369 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -126.9 -162.84 1.19 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.32 -0.622 . . . . 60.43 109.32 177.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.96 147.53 46.51 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.568 0.699 . . . . 61.399999999999999 112.197 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -115.46 112.4 22.22 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.836 -1.172 . . . . 71.340000000000003 107.836 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.14 29.43 14.04 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.695 1.198 . . . . 75.439999999999998 112.427 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.55 11.97 73.53 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 121.458 -0.401 . . . . 33.140000000000001 113.675 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -128.0 143.3 51.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.047 -0.723 . . . . 73.209999999999994 109.047 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.63 127.66 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.043 0.449 . . . . 71.430000000000007 111.457 -169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 19.4 tt -110.42 131.7 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.835 0.826 . . . . 71.109999999999999 111.133 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -123.54 139.18 54.27 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.877 -1.056 . . . . 72.129999999999995 109.643 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.8 t -122.29 137.43 55.86 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.981 0 CA-C-O 121.058 0.456 . . . . 73.519999999999996 111.112 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -131.65 176.5 8.28 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.547 1.139 . . . . 72.409999999999997 110.164 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.45 -8.77 58.88 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.761 1.022 . . . . 73.25 113.761 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.86 -168.61 0.21 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.612 1.165 . . . . 70.200000000000003 113.494 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.7 m -82.63 134.52 35.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.855 . . . . 64.25 110.599 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -85.81 178.12 7.42 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.982 -0.554 . . . . 73.219999999999999 110.794 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER 44.83 86.62 0.13 Allowed Pre-proline 0 N--CA 1.497 1.901 0 C-N-CA 125.952 1.701 . . . . 74.109999999999999 114.481 -177.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -85.96 81.7 1.6 Allowed 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 122.626 2.218 . . . . 65.310000000000002 114.192 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 C--O 1.25 1.103 0 C-N-CA 124.997 1.319 . . . . 72.299999999999997 112.1 178.494 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.875 0 N-CA-C 111.887 -0.485 . . . . 52.450000000000003 111.887 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 8.0 t -94.01 56.04 2.19 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 117.3 0.55 . . . . 51.520000000000003 111.483 -175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . 0.411 ' CE1' ' HB3' ' A' ' 294' ' ' PRO . 3.0 m-70 71.38 -77.66 0.05 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.706 1.602 . . . . 64.409999999999997 111.734 174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.51 30.61 15.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.726 1.21 . . . . 52.329999999999998 112.247 171.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 32.9 t -156.4 133.36 10.44 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.904 -0.406 . . . . 64.439999999999998 109.904 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -93.71 8.67 40.09 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.129 0.49 . . . . 63.130000000000003 110.847 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -93.52 108.1 19.85 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.227 -0.442 . . . . 70.530000000000001 110.21 177.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.68 103.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.495 -0.882 . . . . 72.299999999999997 109.452 162.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 17.3 m -143.58 143.96 31.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.455 -1.313 . . . . 72.140000000000001 107.455 165.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.13 139.15 50.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.144 0.884 . . . . 63.409999999999997 110.652 165.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.42 134.16 42.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.52 -0.918 . . . . 72.129999999999995 108.52 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.77 140.14 47.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 109.39 -0.596 . . . . 72.519999999999996 109.39 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -124.59 143.34 50.76 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 124.256 0.972 . . . . 72.420000000000002 109.231 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 89.59 22.66 36.1 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.836 -0.697 . . . . 53.539999999999999 113.366 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.567 HD13 HG11 ' A' ' 250' ' ' VAL . 11.2 mt -103.91 70.83 1.02 Allowed 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.344 -0.984 . . . . 74.340000000000003 108.344 173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -148.37 -176.86 22.18 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.13 -1.033 . . . . 72.439999999999998 112.779 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 42.15 86.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.686 1.994 . . . . 71.319999999999993 114.867 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.71 22.46 26.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.333 -0.849 . . . . 61.32 111.528 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -81.0 150.92 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.33 0.586 . . . . 73.230000000000004 110.094 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.4 m -84.55 169.47 14.39 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.691 -0.686 . . . . 75.030000000000001 110.939 174.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.16 -167.81 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 126.323 1.849 . . . . 60.32 113.592 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -44.24 -13.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 126.949 2.1 . . . . 72.0 115.671 176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -46.93 -23.42 0.45 Allowed 'General case' 0 CA--C 1.559 1.315 0 C-N-CA 126.72 2.008 . . . . 62.049999999999997 114.348 172.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.567 HG11 HD13 ' A' ' 241' ' ' LEU . 0.5 OUTLIER -56.92 -32.23 38.6 Favored 'Isoleucine or valine' 0 C--N 1.366 1.31 0 CA-C-N 118.735 0.698 . . . . 73.120000000000005 109.767 -179.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.06 -33.82 86.97 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-O 119.825 -0.431 . . . . 63.439999999999998 113.445 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -75.41 -29.14 59.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.206 0.602 . . . . 64.409999999999997 111.055 176.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.4 t80 -56.41 -42.52 78.14 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.075 -0.512 . . . . 72.129999999999995 110.708 168.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -77.58 -24.1 49.82 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.067 0.395 . . . . 71.099999999999994 112.067 176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.516 ' HB2' HD11 ' A' ' 260' ' ' ILE . 0.7 OUTLIER -71.19 -16.25 62.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.638 0.775 . . . . 53.420000000000002 111.675 178.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -64.61 -15.09 60.62 Favored 'General case' 0 CA--C 1.557 1.247 0 O-C-N 121.572 -0.705 . . . . 63.310000000000002 112.012 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 9.3 mm -119.14 20.41 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 CA-C-O 121.592 0.711 . . . . 74.439999999999998 110.327 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 167.49 -160.5 34.15 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 119.386 -2.071 . . . . 24.309999999999999 116.009 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 23.2 mt -107.31 138.13 34.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.167 -1.017 . . . . 74.5 110.204 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 255' ' ' LYS . 48.7 mm -73.17 114.7 12.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 O-C-N 123.576 0.547 . . . . 72.129999999999995 110.001 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.5 tptt -98.88 143.92 28.66 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.142 -0.936 . . . . 74.219999999999999 110.311 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 10.0 t -84.51 131.59 34.63 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.55 -0.908 . . . . 74.010000000000005 108.55 166.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -82.52 122.04 27.56 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 108.974 -0.751 . . . . 50.329999999999998 108.974 -178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -67.14 -8.57 32.01 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 114.275 1.213 . . . . 61.009999999999998 114.275 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -69.02 -30.39 68.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 117.679 0.218 . . . . 74.239999999999995 111.053 176.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 268' ' ' LYS . 3.6 t -126.75 -29.06 2.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.735 0.302 . . . . 74.340000000000003 111.376 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.73 7.49 68.71 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 116.104 -0.498 . . . . 73.439999999999998 112.387 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.48 ' H ' HG23 ' A' ' 266' ' ' THR . 39.4 mtpt -98.91 149.13 35.46 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 122.81 0.444 . . . . 74.319999999999993 111.051 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.15 153.86 71.31 Favored 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.839 3.026 . . . . 73.420000000000002 112.76 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.474 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -69.28 97.51 0.95 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.758 1.021 . . . . 73.200000000000003 113.758 -175.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.0 mm -144.5 112.37 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.425 -1.324 . . . . 61.340000000000003 107.425 165.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -130.19 117.55 20.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.015 0.825 . . . . 71.409999999999997 109.836 162.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.99 112.03 22.62 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.802 -0.444 . . . . 64.420000000000002 109.802 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -101.87 112.92 25.71 Favored 'General case' 0 C--O 1.253 1.259 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.8 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 16.3 p -141.56 122.02 14.09 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.497 -1.229 . . . . 53.219999999999999 109.993 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -86.22 111.83 20.78 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.405 1.097 . . . . 52.340000000000003 111.602 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -6.54 59.27 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.484 -0.78 . . . . 64.239999999999995 112.765 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.64 -28.1 65.62 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.136 -0.484 . . . . 64.25 111.186 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 46.6 p -90.63 -29.48 17.75 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.822 -0.436 . . . . 64.239999999999995 109.822 168.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 101.55 -10.01 57.49 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 115.645 -0.707 . . . . 75.030000000000001 112.658 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -113.54 144.32 31.11 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.349 -0.612 . . . . 71.140000000000001 109.349 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.83 126.48 21.28 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.201 1.934 . . . . 74.450000000000003 113.507 175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -57.28 -43.0 82.72 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.285 0.991 . . . . 75.310000000000002 110.757 173.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.92 23.77 19.43 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 115.024 -0.989 . . . . 55.43 112.706 174.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -116.78 148.44 41.16 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 119.599 -0.84 . . . . 65.019999999999996 109.929 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . 0.53 ' HB3' HD12 ' A' ' 241' ' ' LEU . . . -151.81 160.35 43.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.140000000000001 111.669 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.21 137.11 42.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.905 -0.588 . . . . 73.209999999999994 109.878 169.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.402 ' HB ' ' SD ' ' A' ' 270' ' ' MET . 27.4 m -134.09 143.33 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.663 -0.866 . . . . 63.299999999999997 108.663 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.474 ' H ' ' CB ' ' A' ' 270' ' ' MET . 1.1 p -101.06 121.35 41.63 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.238 0.615 . . . . 71.140000000000001 112.304 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.36 165.9 13.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 111.836 -175.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -65.48 -49.31 69.56 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 124.029 0.831 . . . . 74.319999999999993 112.442 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -126.99 138.05 31.88 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 110.115 -0.328 . . . . 74.510000000000005 110.115 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -59.16 -38.02 88.68 Favored 'Trans proline' 0 CA--C 1.568 2.19 0 C-N-CA 123.686 2.924 . . . . 73.120000000000005 117.735 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . 0.411 ' HB3' ' CE1' ' A' ' 229' ' ' HIS . 51.0 Cg_endo -68.01 -30.29 32.59 Favored 'Trans proline' 0 C--N 1.386 2.509 0 CA-C-N 123.681 2.35 . . . . 74.239999999999995 112.992 -178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 19.7 m -62.88 -28.27 69.92 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.248 1.019 . . . . 72.329999999999998 112.21 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.85 -40.2 75.92 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 123.876 0.735 . . . . 42.130000000000003 112.434 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -71.16 -38.64 72.19 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-O 121.128 0.489 . . . . 75.019999999999996 111.08 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.66 81.11 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.446 -0.797 . . . . 74.519999999999996 111.041 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -68.76 -28.55 66.9 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.725 -0.67 . . . . 52.329999999999998 112.05 174.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 296' ' ' ALA . 45.7 mt -67.4 -32.83 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.996 -0.44 . . . . 75.439999999999998 110.647 173.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.87 -60.34 2.41 Favored 'General case' 0 CA--C 1.553 1.081 0 N-CA-C 113.783 1.031 . . . . 61.43 113.783 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -91.09 -32.71 15.76 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 116.125 1.898 . . . . 75.319999999999993 116.125 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 41.1 t80 -84.37 -25.27 29.26 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.243 0.474 . . . . 72.200000000000003 110.237 -170.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -94.89 177.05 6.03 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.968 -1.015 . . . . 41.420000000000002 110.127 175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.97 13.49 59.02 Favored Glycine 0 CA--C 1.509 -0.326 0 C-N-CA 121.22 -0.514 . . . . 62.140000000000001 112.223 176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.34 -153.75 0.59 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 108.814 -0.81 . . . . 73.319999999999993 108.814 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -131.61 142.18 49.82 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.569 0.699 . . . . 64.140000000000001 111.357 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -113.74 117.36 31.29 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.604 -1.258 . . . . 72.120000000000005 107.604 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 25.9 m170 64.15 27.78 14.05 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.756 1.222 . . . . 64.430000000000007 112.51 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.21 -3.85 86.53 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 113.848 0.299 . . . . 61.420000000000002 113.848 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -108.77 146.11 34.1 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.723 -0.843 . . . . 75.530000000000001 108.723 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.78 131.59 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.99 0.424 . . . . 73.019999999999996 110.904 -172.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 15.0 tt -108.54 140.0 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.91 -0.774 . . . . 74.129999999999995 108.91 -178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -137.18 125.0 22.51 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 109.591 -0.522 . . . . 64.329999999999998 109.591 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.468 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -113.23 139.98 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.156 0 N-CA-C 107.733 -1.21 . . . . 65.329999999999998 107.733 -170.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 1.4 m -140.57 171.62 13.86 Favored 'General case' 0 C--O 1.213 -0.854 0 O-C-N 121.716 -0.615 . . . . 72.450000000000003 110.936 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.01 -3.13 50.72 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.881 0.697 . . . . 71.0 112.881 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 66.0 -166.22 0.22 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.766 1.227 . . . . 35.439999999999998 112.985 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.92 168.84 18.7 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.654 -0.703 . . . . 74.409999999999997 109.343 171.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -164.17 0.83 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.583 0.23 . . . . 74.109999999999999 111.408 -177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -63.52 148.94 93.11 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.591 0.756 . . . . 72.040000000000006 112.99 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.76 -170.21 0.51 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 123.899 3.066 . . . . 64.030000000000001 115.229 -176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 C--O 1.247 0.922 0 CA-C-N 115.157 -0.929 . . . . 71.549999999999997 111.367 -179.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 111.92 -0.472 . . . . 70.120000000000005 111.92 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 21.1 m -96.89 102.9 14.77 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.167 0.508 . . . . 55.409999999999997 111.734 -172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -94.62 -179.23 4.81 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.884 -0.598 . . . . 75.049999999999997 110.204 169.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 44.43 43.56 6.31 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.197 1.799 . . . . 72.540000000000006 113.552 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 47.0 t -130.46 131.85 45.39 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.216 -0.902 . . . . 72.200000000000003 109.812 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -86.93 -6.58 58.73 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.579 0.55 . . . . 73.310000000000002 110.85 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.1 108.61 12.72 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 60.43 110.77 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.99 105.4 17.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.463 -0.495 . . . . 65.549999999999997 110.287 164.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 13.8 m -142.1 147.83 37.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.679 -1.23 . . . . 50.32 107.679 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 21.0 pt -125.46 138.45 54.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-N 119.279 0.945 . . . . 73.140000000000001 110.072 165.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.475 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.3 OUTLIER -100.84 119.86 39.28 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 109.546 -0.539 . . . . 75.439999999999998 109.546 -178.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.45 138.87 45.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.545 -0.752 . . . . 72.0 109.288 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -128.87 142.33 50.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.365 0.666 . . . . 75.310000000000002 109.226 -175.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 98.58 27.51 8.49 Favored Glycine 0 C--N 1.332 0.358 0 O-C-N 123.331 0.394 . . . . 14.31 113.259 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 76.39 1.52 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.565 -0.902 . . . . 73.230000000000004 108.565 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -138.22 -77.13 0.06 OUTLIER Glycine 0 CA--C 1.499 -0.944 0 C-N-CA 120.237 -0.983 . . . . 60.450000000000003 112.999 -175.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.54 109.18 11.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.638 0.732 . . . . 75.040000000000006 111.633 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 92.72 20.62 33.63 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.185 -0.916 . . . . 71.329999999999998 111.349 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.441 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -82.87 151.56 4.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 121.331 0.586 . . . . 72.430000000000007 109.901 -173.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 13.8 t -91.7 170.44 9.91 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 109.152 -0.684 . . . . 50.240000000000002 109.152 171.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 127.529 2.332 . . . . 72.239999999999995 113.829 -173.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -44.86 -11.56 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 126.161 1.784 . . . . 73.519999999999996 115.513 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 252' ' ' GLU . 1.3 pp0? -46.79 -22.11 0.27 Allowed 'General case' 0 CA--C 1.562 1.425 0 C-N-CA 126.72 2.008 . . . . 71.340000000000003 113.73 168.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 0.7 OUTLIER -56.23 -30.66 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 121.384 -0.822 . . . . 73.030000000000001 109.33 178.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -58.02 -39.26 91.7 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.964 -0.909 . . . . 32.030000000000001 114.718 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 249' ' ' GLN . 8.9 pt-20 -75.55 -27.65 58.72 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.367 1.084 . . . . 72.150000000000006 111.457 177.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 9.7 t80 -55.61 -45.06 77.56 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 124.046 0.841 . . . . 75.150000000000006 110.612 170.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -78.79 -23.77 45.02 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 112.12 0.415 . . . . 73.439999999999998 112.12 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -75.5 -11.22 59.98 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.45 0.7 . . . . 70.129999999999995 111.93 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -65.53 -16.16 63.4 Favored 'General case' 0 CA--C 1.555 1.137 0 O-C-N 121.883 -0.51 . . . . 62.409999999999997 111.827 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.7 mm -107.06 -36.87 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 123.257 0.623 . . . . 54.310000000000002 111.133 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -148.04 -161.13 9.35 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 119.29 -1.433 . . . . 71.299999999999997 114.31 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.7 mt -105.41 139.24 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 122.759 0.424 . . . . 74.340000000000003 110.959 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 35.0 mm -67.37 115.87 6.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.496 -0.774 . . . . 73.099999999999994 110.874 177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -97.47 138.86 34.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.209 -0.905 . . . . 65.519999999999996 110.962 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 35.7 m -84.49 116.17 22.96 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.982 -1.118 . . . . 74.329999999999998 107.982 169.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -75.92 129.21 36.58 Favored 'General case' 0 C--O 1.212 -0.876 0 N-CA-C 109.274 -0.639 . . . . 75.030000000000001 109.274 -175.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -78.63 -7.1 57.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.417 0.895 . . . . 73.120000000000005 113.417 -173.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -68.54 -30.28 69.05 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.354 0.262 . . . . 71.230000000000004 111.439 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.5 t -125.94 -32.41 2.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.559 0.219 . . . . 62.310000000000002 111.579 177.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.76 11.23 64.02 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 112.232 -0.347 . . . . 53.229999999999997 112.232 -175.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.472 ' H ' HG23 ' A' ' 266' ' ' THR . 8.8 mttp -98.52 151.29 37.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.438 0.695 . . . . 61.520000000000003 111.781 173.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.04 154.84 72.43 Favored 'Trans proline' 0 C--N 1.364 1.375 0 C-N-CA 123.671 2.914 . . . . 35.43 112.459 168.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.469 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.4 ptm -73.56 100.81 3.4 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.713 1.005 . . . . 75.540000000000006 113.713 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.0 mm -143.66 112.51 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 106.684 -1.599 . . . . 73.200000000000003 106.684 162.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -127.89 117.35 21.63 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.495 1.043 . . . . 61.439999999999998 110.363 162.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.43 113.2 24.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.087 0.47 . . . . 74.340000000000003 110.776 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.482 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 51.0 m-85 -101.96 110.72 22.76 Favored 'General case' 0 C--O 1.258 1.523 0 CA-C-N 115.596 -0.729 . . . . 73.329999999999998 109.285 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.445 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 37.8 p -143.11 122.04 12.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.64 -1.164 . . . . 63.0 109.676 -175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -86.45 112.44 21.5 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.399 0.619 . . . . 75.340000000000003 111.718 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -85.73 -10.56 55.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.664 0.616 . . . . 71.129999999999995 112.664 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.42 -33.96 67.48 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.031 0.382 . . . . 44.32 112.031 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 12.9 t -91.03 -16.21 28.3 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.43 0.633 . . . . 75.310000000000002 109.723 170.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.92 -48.87 1.43 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 115.585 -0.734 . . . . 52.520000000000003 112.607 175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -74.34 138.52 74.95 Favored Pre-proline 0 N--CA 1.456 -0.172 0 N-CA-C 110.122 -0.325 . . . . 71.209999999999994 110.122 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -58.99 139.38 90.65 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.541 2.161 . . . . 64.549999999999997 113.238 171.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.445 ' H ' ' HA ' ' A' ' 275' ' ' THR . 72.1 mttt -59.4 -39.98 85.14 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.357 1.036 . . . . 75.140000000000001 111.874 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 96.91 24.78 12.41 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.612 -0.722 . . . . 62.100000000000001 112.969 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 2.1 mp0 -117.72 144.01 45.67 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.859 -0.736 . . . . 72.299999999999997 110.621 -178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -148.84 142.37 25.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 72.150000000000006 109.107 174.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 237' ' ' PHE . 81.5 p -125.31 138.12 54.07 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.708 -0.478 . . . . 71.230000000000004 109.708 172.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.6 m -137.68 148.22 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-O 121.066 0.46 . . . . 65.310000000000002 110.826 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.469 ' H ' ' CB ' ' A' ' 270' ' ' MET . 45.9 t -101.23 127.6 47.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.856 0.862 . . . . 65.140000000000001 112.505 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -98.83 164.33 12.26 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.177 -0.327 . . . . 65.439999999999998 111.606 178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -73.03 -46.82 49.75 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.66 0.6 . . . . 64.140000000000001 110.76 -178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -109.41 135.36 20.3 Favored Pre-proline 0 C--O 1.239 0.518 0 C-N-CA 120.795 -0.362 . . . . 73.519999999999996 110.302 177.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -65.61 -39.51 20.93 Favored 'Trans proline' 0 CA--C 1.566 2.109 0 C-N-CA 122.775 2.317 . . . . 61.530000000000001 116.887 171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.49 -29.92 52.83 Favored 'Trans proline' 0 C--N 1.39 2.752 0 CA-C-N 123.459 2.271 . . . . 54.420000000000002 113.721 177.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 47.8 m -63.72 -27.34 69.14 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.829 0.852 . . . . 73.439999999999998 112.174 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -71.59 -34.19 69.68 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.602 0.564 . . . . 73.150000000000006 112.204 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -71.82 -39.13 70.02 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 120.959 0.409 . . . . 71.319999999999993 110.338 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.99 74.98 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.359 -0.837 . . . . 45.32 111.013 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.47 -29.31 66.94 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 116.14 -0.482 . . . . 65.409999999999997 112.129 174.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 296' ' ' ALA . 52.7 mt -67.33 -31.48 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 122.229 -0.294 . . . . 73.310000000000002 110.49 172.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -78.52 -61.4 2.02 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.958 1.096 . . . . 63.240000000000002 113.958 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -92.07 -29.63 16.46 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.296 1.961 . . . . 73.439999999999998 116.296 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 45.0 t80 -87.6 -21.56 25.27 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.469 0.652 . . . . 64.439999999999998 109.914 -171.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.565 ' HB2' HG12 ' A' ' 315' ' ' VAL . 26.2 t0 -93.31 175.33 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 114.975 -1.011 . . . . 70.109999999999999 109.672 171.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 90.54 12.4 61.12 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 121.305 -0.474 . . . . 62.149999999999999 112.047 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -126.14 -158.13 0.83 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.267 -0.642 . . . . 62.340000000000003 109.267 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.76 143.97 50.62 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.573 0.701 . . . . 74.420000000000002 110.601 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -114.1 114.03 25.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.716 -1.129 . . . . 72.120000000000005 108.155 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 21.0 m170 64.66 29.12 13.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 124.597 1.186 . . . . 65.140000000000001 112.611 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.35 10.11 80.61 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 113.923 0.329 . . . . 74.430000000000007 113.923 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.58 146.01 50.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.699 -0.852 . . . . 73.099999999999994 108.699 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 51.0 mm -69.33 127.99 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.271 0.557 . . . . 74.299999999999997 111.02 -170.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 16.3 tt -109.7 137.11 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.324 -0.853 . . . . 73.129999999999995 109.374 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -130.24 128.38 41.51 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.61 -0.723 . . . . 65.140000000000001 110.228 175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.565 HG12 ' HB2' ' A' ' 304' ' ' ASP . 0.4 OUTLIER -115.57 142.05 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 108.658 -0.867 . . . . 73.420000000000002 108.658 -174.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -142.1 175.23 9.9 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.331 0.652 . . . . 70.230000000000004 110.492 -174.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -83.33 -4.34 58.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.048 1.129 . . . . 70.030000000000001 114.048 174.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 63.5 -163.11 0.27 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.944 0.898 . . . . 64.109999999999999 112.865 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 14.4 t -98.51 165.35 11.87 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.027 -0.533 . . . . 60.310000000000002 109.887 175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -88.54 137.95 31.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 73.25 110.418 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 73.79 163.42 0.14 Allowed Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 124.786 1.304 . . . . 55.219999999999999 112.365 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -69.96 103.01 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 121.441 1.427 . . . . 74.329999999999998 113.424 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 C--O 1.255 1.381 0 CA-C-N 115.393 -0.821 . . . . 74.430000000000007 109.553 175.828 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.107 -0.397 . . . . 62.119999999999997 112.107 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 11.8 p -143.47 -64.65 0.39 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 119.446 -0.311 . . . . 73.230000000000004 111.567 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 61.54 39.89 14.25 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.315 1.446 . . . . 74.109999999999999 111.551 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 64.9 mtt -95.09 74.86 3.46 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.21 0.529 . . . . 73.140000000000001 110.803 -175.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 26.4 p -162.85 122.75 2.28 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.11 -0.95 . . . . 61.520000000000003 110.801 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.39 -22.53 41.22 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.836 -0.62 . . . . 64.140000000000001 110.765 173.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -85.11 106.45 16.58 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.279 -0.873 . . . . 61.219999999999999 110.149 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.14 106.61 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.276 0.56 . . . . 62.219999999999999 109.98 165.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 16.0 m -141.79 148.06 38.31 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.902 -1.148 . . . . 63.329999999999998 107.902 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 23.8 pt -122.66 137.23 56.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-N 118.891 0.769 . . . . 52.149999999999999 110.051 164.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.704 ' HA ' HG22 ' A' ' 287' ' ' THR . 0.6 OUTLIER -100.46 119.0 37.82 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 109.243 -0.651 . . . . 73.349999999999994 109.243 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.63 141.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.496 -0.775 . . . . 64.239999999999995 109.44 -175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.457 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.01 149.17 50.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.831 -0.622 . . . . 72.439999999999998 110.461 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 94.74 18.47 34.87 Favored Glycine 0 C--N 1.334 0.443 0 O-C-N 123.63 0.581 . . . . 70.409999999999997 113.362 174.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.78 76.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 73.209999999999994 108.551 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.526 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -132.02 -91.76 0.53 Allowed Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.333 -0.937 . . . . 73.150000000000006 113.873 -171.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.05 114.42 16.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.024 0.44 . . . . 75.030000000000001 110.943 -172.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.55 19.86 33.73 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 115.263 -0.88 . . . . 74.219999999999999 111.89 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -83.58 151.47 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.351 -0.611 . . . . 55.229999999999997 109.351 -173.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 43.3 m -90.35 170.36 10.31 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.162 -0.472 . . . . 74.109999999999999 109.944 171.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -167.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.108 2.163 . . . . 73.230000000000004 113.198 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -43.26 -13.66 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.253 0 C-N-CA 127.44 2.296 . . . . 62.210000000000001 115.018 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 252' ' ' GLU . 0.7 OUTLIER -47.7 -21.3 0.36 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.751 2.021 . . . . 61.100000000000001 114.136 169.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.0 OUTLIER -55.34 -31.25 26.76 Favored 'Isoleucine or valine' 0 C--N 1.358 0.975 0 CA-C-N 119.207 0.912 . . . . 65.230000000000004 109.363 177.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -56.74 -37.85 79.48 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 119.003 -0.887 . . . . 64.409999999999997 114.419 173.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 249' ' ' GLN . 0.0 OUTLIER -74.91 -28.6 60.69 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.046 0.923 . . . . 70.409999999999997 110.468 177.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.1 t80 -56.44 -45.7 80.67 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 123.805 0.69 . . . . 74.200000000000003 110.833 172.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.63 -24.5 45.24 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.228 0.455 . . . . 74.209999999999994 112.228 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 252' ' ' GLU . 12.3 tptm -63.1 -24.97 68.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.186 0.994 . . . . 63.0 111.744 176.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -62.95 -22.09 66.55 Favored 'General case' 0 CA--C 1.556 1.177 0 N-CA-C 112.403 0.52 . . . . 72.329999999999998 112.403 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 3.6 mm -125.1 55.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-N 117.979 0.354 . . . . 73.340000000000003 110.114 171.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 148.41 -176.43 27.23 Favored Glycine 0 C--O 1.223 -0.581 0 C-N-CA 119.143 -1.503 . . . . 72.230000000000004 114.573 170.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.32 137.96 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.531 -0.334 . . . . 64.310000000000002 110.156 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 33.0 mm -73.77 114.24 13.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 115.723 -0.671 . . . . 71.310000000000002 110.121 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -98.59 140.24 33.12 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.67 0.748 . . . . 75.129999999999995 110.886 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 64.0 m -84.43 121.15 27.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.502 -1.226 . . . . 72.019999999999996 108.415 169.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -68.73 134.73 50.22 Favored 'General case' 0 C--O 1.213 -0.835 0 O-C-N 123.528 0.518 . . . . 61.100000000000001 111.246 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -81.98 -7.54 59.62 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.875 1.065 . . . . 75.340000000000003 113.875 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -68.38 -42.9 78.43 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.238 0.336 . . . . 55.130000000000003 111.485 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 24.6 p -124.4 -25.62 4.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.758 0.313 . . . . 75.129999999999995 111.337 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.26 16.46 57.37 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-N 115.905 -0.588 . . . . 22.309999999999999 113.601 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.38 152.13 38.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.794 0.297 . . . . 71.239999999999995 111.715 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.92 152.66 81.49 Favored 'Trans proline' 0 C--N 1.362 1.25 0 C-N-CA 122.579 2.186 . . . . 71.510000000000005 111.361 165.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.478 ' CB ' ' H ' ' A' ' 289' ' ' SER . 2.1 ptm -72.82 99.48 2.65 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.808 1.04 . . . . 52.409999999999997 113.808 -174.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.4 mm -143.72 114.07 2.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 106.781 -1.563 . . . . 73.510000000000005 106.781 165.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -129.02 113.63 15.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 118.901 0.773 . . . . 73.430000000000007 109.425 162.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.08 111.34 21.45 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.828 0.347 . . . . 74.299999999999997 110.081 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 43.8 m-85 -103.81 111.83 24.52 Favored 'General case' 0 C--O 1.263 1.767 0 CA-C-O 121.308 0.575 . . . . 71.549999999999997 110.555 -179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.486 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 22.2 p -143.26 121.97 12.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.196 -1.365 . . . . 74.140000000000001 110.165 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -86.52 113.97 22.88 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.649 0.738 . . . . 74.219999999999999 112.24 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.54 -9.78 56.89 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 113.021 0.749 . . . . 71.010000000000005 113.021 176.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.94 -33.94 66.23 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.963 0.411 . . . . 72.099999999999994 110.904 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.1 t -90.56 -14.99 31.44 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.443 0.64 . . . . 63.119999999999997 110.114 170.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 89.67 -12.19 67.87 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.704 -0.68 . . . . 53.119999999999997 113.907 171.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.11 142.02 27.9 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 109.618 -0.512 . . . . 63.509999999999998 109.618 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -55.18 133.01 55.7 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.108 2.539 . . . . 75.209999999999994 113.796 176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.486 ' H ' ' HA ' ' A' ' 275' ' ' THR . 22.5 mttt -62.3 -33.93 75.6 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 114.493 -1.231 . . . . 73.099999999999994 112.116 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 94.38 23.78 20.79 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.495 -0.775 . . . . 65.329999999999998 112.782 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 38.9 mt-10 -119.75 141.86 49.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.072 -0.651 . . . . 53.229999999999997 109.822 -174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.94 143.46 23.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.01 -0.541 . . . . 72.150000000000006 109.665 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.704 HG22 ' HA ' ' A' ' 237' ' ' PHE . 70.8 p -128.6 140.35 51.82 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.924 -0.399 . . . . 72.540000000000006 109.924 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.18 146.7 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.208 0.527 . . . . 51.399999999999999 109.993 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.478 ' H ' ' CB ' ' A' ' 270' ' ' MET . 25.6 t -98.95 119.96 38.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.566 0.747 . . . . 73.109999999999999 111.83 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.52 165.1 12.7 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.23 0.456 . . . . 60.299999999999997 112.23 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -72.34 -47.93 45.86 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 124.481 1.113 . . . . 71.129999999999995 111.988 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -124.12 137.23 28.64 Favored Pre-proline 0 C--O 1.243 0.737 0 N-CA-C 109.558 -0.534 . . . . 75.310000000000002 109.558 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -59.43 -38.06 86.04 Favored 'Trans proline' 0 CA--C 1.568 2.176 0 C-N-CA 123.58 2.853 . . . . 72.230000000000004 116.977 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.73 -29.27 29.57 Favored 'Trans proline' 0 C--N 1.397 3.082 0 CA-C-N 123.419 2.257 . . . . 71.200000000000003 113.373 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 20.7 m -65.84 -27.81 68.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.013 0.925 . . . . 63.509999999999998 112.208 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -74.89 -44.02 51.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.167 0.587 . . . . 51.399999999999999 112.086 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -74.77 -31.3 61.73 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.257 0.551 . . . . 75.329999999999998 111.916 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.14 73.52 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.635 -0.711 . . . . 71.450000000000003 110.601 174.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -67.56 -28.3 67.67 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.58 -0.736 . . . . 63.350000000000001 111.497 172.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 315' ' ' VAL . 43.7 mt -67.41 -32.34 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 122.171 -0.331 . . . . 72.319999999999993 111.08 172.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -77.24 -60.07 2.52 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.72 1.007 . . . . 73.109999999999999 113.72 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -90.18 -35.52 15.32 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.032 1.864 . . . . 73.349999999999994 116.032 -177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -85.78 -18.4 33.06 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.158 0.504 . . . . 52.539999999999999 110.325 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.499 ' HB2' HG12 ' A' ' 315' ' ' VAL . 28.2 t0 -98.3 -178.29 3.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.266 -0.879 . . . . 71.120000000000005 109.601 172.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.16 64.31 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 120.943 0.19 . . . . 25.41 112.717 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -133.29 -158.64 0.9 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.286 -0.457 . . . . 73.129999999999995 109.997 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.87 145.78 50.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.658 0.742 . . . . 50.340000000000003 111.257 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -115.86 116.07 27.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.35 -1.295 . . . . 74.019999999999996 107.828 174.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 23.3 m170 64.29 28.89 13.84 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.657 1.183 . . . . 74.540000000000006 112.631 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 84.66 7.0 84.97 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 114.126 0.41 . . . . 63.140000000000001 114.126 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -125.23 147.93 48.87 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.803 -0.814 . . . . 51.310000000000002 108.803 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.7 mm -68.86 130.66 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.083 0.468 . . . . 75.510000000000005 111.269 -170.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 17.4 tt -109.14 142.04 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 115.009 -0.996 . . . . 73.540000000000006 109.502 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.1 ttpp -136.28 128.01 29.05 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.715 -0.675 . . . . 63.450000000000003 110.718 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.11 141.87 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.359 0 N-CA-C 108.478 -0.934 . . . . 70.439999999999998 108.478 -173.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 2.1 m -144.52 174.25 11.11 Favored 'General case' 0 C--O 1.211 -0.943 0 O-C-N 121.633 -0.667 . . . . 73.120000000000005 110.623 -173.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.2 -3.35 54.84 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 113.636 0.976 . . . . 75.010000000000005 113.636 173.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.54 -166.54 0.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.552 1.141 . . . . 70.420000000000002 112.991 176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.9 t -91.42 154.21 19.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.798 -0.637 . . . . 52.329999999999998 109.395 174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -103.26 172.55 6.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.459 -0.791 . . . . 74.219999999999999 109.139 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 68.9 89.03 0.1 OUTLIER Pre-proline 0 N--CA 1.482 1.154 0 O-C-N 124.614 1.196 . . . . 73.310000000000002 112.744 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.43 -162.26 0.18 Allowed 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 122.87 2.38 . . . . 53.140000000000001 113.656 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 N--CA 1.485 1.317 0 C-N-CA 126.043 1.737 . . . . 63.0 110.812 -179.355 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.087 0 N-CA-C 111.821 -0.512 . . . . 64.319999999999993 111.821 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 25.0 m -95.87 -172.75 2.66 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 109.844 -0.428 . . . . 71.329999999999998 109.844 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -63.79 -70.24 0.23 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.743 0.417 . . . . 74.209999999999994 111.382 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 23.5 ptp -154.43 9.74 0.35 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.217 -0.447 . . . . 60.219999999999999 110.283 176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 66.9 m 63.31 111.41 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.955 1.302 . . . . 70.030000000000001 111.54 -166.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -74.29 -24.34 59.23 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.402 -0.817 . . . . 73.319999999999993 110.502 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -72.81 106.73 4.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.299 -0.864 . . . . 72.430000000000007 110.113 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -91.11 104.99 17.49 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.121 -0.632 . . . . 74.310000000000002 109.564 165.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 8.1 m -142.39 148.84 38.51 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.413 -0.958 . . . . 71.010000000000005 108.413 169.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.11 137.8 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 118.675 0.671 . . . . 54.340000000000003 111.061 164.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -99.43 130.55 45.71 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.018 -0.734 . . . . 71.030000000000001 109.018 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.59 141.01 44.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 115.356 -0.838 . . . . 63.119999999999997 109.41 -173.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 313' ' ' ILE . 0.0 OUTLIER -128.65 150.62 50.16 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.959 -0.564 . . . . 73.109999999999999 110.36 -179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 88.12 31.58 14.17 Favored Glycine 0 N--CA 1.451 -0.359 0 O-C-N 124.067 0.854 . . . . 72.099999999999994 112.857 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.03 74.88 1.32 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.903 -1.147 . . . . 64.099999999999994 107.903 175.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.446 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -136.05 -77.24 0.08 OUTLIER Glycine 0 CA--C 1.495 -1.165 0 C-N-CA 120.249 -0.976 . . . . 73.530000000000001 112.957 -175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -78.26 102.86 7.85 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.964 0.888 . . . . 75.239999999999995 111.919 -168.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 96.53 20.67 24.11 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.109 -0.951 . . . . 71.109999999999999 112.064 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -79.16 152.5 4.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.549 0.69 . . . . 64.430000000000007 110.492 -171.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t -91.71 168.57 11.38 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 115.297 -0.865 . . . . 65.109999999999999 109.715 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.6 t -63.52 -168.26 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.903 0 C-N-CA 127.274 2.23 . . . . 73.299999999999997 113.497 -174.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -43.94 -12.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 126.625 1.97 . . . . 61.130000000000003 115.645 175.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.96 -22.35 0.32 Allowed 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 126.361 1.864 . . . . 63.109999999999999 114.319 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 253' ' ' PHE . 1.6 t -55.91 -32.61 33.15 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 CA-C-N 118.899 0.772 . . . . 62.109999999999999 111.001 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.42 -34.17 84.19 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 121.646 -0.312 . . . . 73.349999999999994 113.416 175.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -74.6 -30.43 61.68 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 123.675 0.79 . . . . 70.439999999999998 111.289 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 8.5 t80 -56.05 -45.19 79.31 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.471 0.708 . . . . 70.230000000000004 111.232 170.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -77.52 -23.71 50.16 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.823 0.305 . . . . 73.120000000000005 111.823 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -72.98 -14.32 61.41 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.477 0.711 . . . . 70.430000000000007 112.382 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -65.2 -11.81 44.67 Favored 'General case' 0 CA--C 1.557 1.223 0 O-C-N 121.666 -0.646 . . . . 75.400000000000006 112.14 173.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 50.0 mm -106.56 -42.18 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 122.972 0.509 . . . . 64.030000000000001 111.102 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . -143.61 -158.97 7.78 Favored Glycine 0 C--N 1.344 0.98 0 C-N-CA 120.898 -0.668 . . . . 65.209999999999994 113.942 -172.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 14.5 mt -104.93 139.88 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.138 0.575 . . . . 62.299999999999997 110.589 -175.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 47.6 mm -65.98 113.29 2.38 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 109.523 -0.547 . . . . 64.120000000000005 109.523 173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -100.04 141.64 32.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.338 -0.847 . . . . 74.239999999999995 110.767 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 11.0 m -85.07 117.71 24.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.85 -1.068 . . . . 61.310000000000002 108.511 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.61 130.29 39.28 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.152 -0.684 . . . . 73.219999999999999 109.152 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -73.36 -9.15 58.39 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.674 0.99 . . . . 73.019999999999996 113.674 -178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -69.67 -34.35 73.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 111.997 0.369 . . . . 60.43 111.997 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 268' ' ' LYS . 2.5 t -125.68 -30.24 3.07 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 122.478 0.311 . . . . 63.130000000000003 111.519 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 89.19 9.08 67.82 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.543 -0.298 . . . . 64.510000000000005 112.612 -178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.458 ' H ' HG23 ' A' ' 266' ' ' THR . 42.9 mttt -98.14 152.08 37.84 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.026 0.53 . . . . 71.420000000000002 112.196 172.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.09 156.24 63.88 Favored 'Trans proline' 0 C--N 1.37 1.697 0 C-N-CA 123.892 3.061 . . . . 70.439999999999998 112.562 169.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.449 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.0 OUTLIER -72.04 98.52 2.1 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.841 1.052 . . . . 74.099999999999994 113.841 -172.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 30.4 mm -143.43 112.38 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 107.266 -1.383 . . . . 63.43 107.266 164.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -128.71 113.74 15.73 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 118.957 0.798 . . . . 62.109999999999999 109.367 160.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -114.52 107.89 16.12 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.721 -0.844 . . . . 52.399999999999999 108.721 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 285' ' ' GLU . 26.1 m-85 -103.81 112.72 25.8 Favored 'General case' 0 C--O 1.26 1.634 0 CA-C-O 121.211 0.529 . . . . 73.209999999999994 110.935 -178.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.464 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.6 p -144.42 122.92 12.42 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.468 -1.242 . . . . 63.409999999999997 110.308 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -85.99 113.39 22.05 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.427 0.632 . . . . 63.409999999999997 112.118 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.14 -8.95 57.48 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.517 -0.765 . . . . 73.219999999999999 112.715 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.28 -35.4 71.33 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.753 0.279 . . . . 74.409999999999997 111.753 175.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 14.0 t -90.97 -14.26 31.83 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.204 0.526 . . . . 75.010000000000005 110.136 171.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 97.2 -46.32 1.7 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-N 115.579 -0.737 . . . . 60.409999999999997 113.043 173.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -86.19 142.84 36.2 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 110.547 -0.168 . . . . 72.349999999999994 110.547 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.75 139.13 83.2 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.563 2.842 . . . . 64.439999999999998 114.459 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 275' ' ' THR . 49.5 mttt -67.22 -34.21 76.99 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.179 -0.919 . . . . 61.520000000000003 112.146 178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 93.76 21.76 27.75 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 121.093 -0.575 . . . . 62.43 112.772 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 274' ' ' TYR . 41.7 mt-10 -115.92 143.12 45.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 120.812 -0.355 . . . . 75.400000000000006 110.429 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.47 154.74 37.15 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.233 -0.44 . . . . 70.430000000000007 110.78 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.2 137.39 37.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.782 -0.451 . . . . 74.310000000000002 109.782 168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.35 144.75 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.361 -0.607 . . . . 45.140000000000001 109.361 176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.449 ' H ' ' CB ' ' A' ' 270' ' ' MET . 26.7 t -93.35 121.69 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.61 0.764 . . . . 72.340000000000003 111.789 -178.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -94.15 164.14 13.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.664 -0.244 . . . . 74.420000000000002 111.596 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -64.5 -48.78 73.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.926 0.891 . . . . 65.510000000000005 112.852 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -127.11 137.89 31.56 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 109.512 -0.551 . . . . 73.510000000000005 109.512 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.27 -38.41 75.81 Favored 'Trans proline' 0 CA--C 1.567 2.136 0 C-N-CA 123.078 2.519 . . . . 71.219999999999999 117.137 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.18 -28.92 15.03 Favored 'Trans proline' 0 C--N 1.391 2.799 0 CA-C-N 124.139 2.514 . . . . 72.439999999999998 113.054 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 37.9 m -61.45 -28.31 69.19 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 124.381 1.072 . . . . 64.439999999999998 112.027 174.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.21 -37.13 77.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.644 0.778 . . . . 54.539999999999999 112.777 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.8 -35.14 62.49 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 120.981 0.419 . . . . 74.540000000000006 111.288 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.65 78.6 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.563 -0.744 . . . . 74.519999999999996 111.035 174.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 303' ' ' PHE . . . -69.66 -28.12 65.61 Favored 'General case' 0 C--O 1.213 -0.816 0 CA-C-N 115.809 -0.632 . . . . 71.299999999999997 112.08 174.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.521 HG12 HG13 ' A' ' 315' ' ' VAL . 42.3 mt -67.84 -31.86 54.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 O-C-N 122.026 -0.421 . . . . 75.299999999999997 110.811 172.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -76.43 -59.76 2.63 Favored 'General case' 0 CA--C 1.559 1.321 0 N-CA-C 113.863 1.061 . . . . 74.319999999999993 113.863 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . . 2.2 p-90 -91.27 -34.97 14.74 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.48 2.03 . . . . 62.450000000000003 116.48 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 299' ' ' ALA . 44.3 t80 -83.44 -25.28 31.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.177 0.513 . . . . 73.109999999999999 110.188 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.5 ' HB2' HG12 ' A' ' 315' ' ' VAL . 16.7 t0 -93.46 176.38 6.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.801 -1.09 . . . . 71.439999999999998 109.95 173.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 92.53 12.95 57.74 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.275 -0.488 . . . . 61.25 112.31 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -128.99 -154.58 0.65 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.854 -0.424 . . . . 73.409999999999997 109.854 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -131.72 139.84 49.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.268 0.556 . . . . 75.409999999999997 110.868 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -112.52 112.74 24.49 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.716 -1.216 . . . . 70.430000000000007 107.716 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 26.9 m170 64.66 28.4 13.15 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.947 1.299 . . . . 75.040000000000006 112.205 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 85.46 -1.98 88.19 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 121.629 -0.32 . . . . 43.039999999999999 113.428 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -105.03 143.29 33.41 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.28 -1.007 . . . . 60.329999999999998 108.28 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 48.4 mm -70.82 126.73 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 120.655 0.264 . . . . 53.340000000000003 110.501 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 239' ' ' GLN . 19.1 tt -107.9 140.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 CA-C-N 115.976 -0.556 . . . . 60.450000000000003 109.636 -175.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.89 126.23 28.31 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.863 -0.608 . . . . 75.099999999999994 109.654 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.521 HG13 HG12 ' A' ' 300' ' ' ILE . 0.3 OUTLIER -115.52 138.69 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 107.76 -1.2 . . . . 71.140000000000001 107.76 -175.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.0 m -144.56 171.7 14.0 Favored 'General case' 0 C--O 1.203 -1.384 0 C-N-CA 123.0 0.52 . . . . 72.409999999999997 110.192 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -76.48 -4.49 42.89 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.229 1.196 . . . . 71.530000000000001 114.229 175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 65.42 -168.56 0.21 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.403 1.081 . . . . 64.140000000000001 113.097 177.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 5.8 m -88.67 132.21 34.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.474 -0.784 . . . . 44.409999999999997 109.573 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 4.3 mpp_? -83.23 -176.0 6.11 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.318 -0.401 . . . . 71.310000000000002 109.982 175.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 13.8 ptt85 48.3 87.31 0.13 Allowed Pre-proline 0 N--CA 1.493 1.72 0 C-N-CA 125.853 1.661 . . . . 74.140000000000001 114.663 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.33 -178.09 4.08 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.753 2.302 . . . . 70.230000000000004 114.308 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.062 1.745 . . . . 51.0 111.587 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.136 0 CA-C-O 118.668 -1.074 . . . . 63.43 113.217 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.9 m 53.4 87.32 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.902 1.281 . . . . 64.200000000000003 113.474 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -91.26 -173.35 3.59 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.7 -0.682 . . . . 54.130000000000003 109.927 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 65.1 mtt 67.58 27.18 7.87 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.555 1.142 . . . . 61.219999999999999 111.772 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' SER . . . . . . . . . . . . . 29.2 m -125.26 103.19 7.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.229 -0.441 . . . . 70.25 110.084 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -82.54 -22.21 35.07 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.538 0.685 . . . . 44.439999999999998 110.809 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -90.92 117.7 29.72 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.94 -1.027 . . . . 61.140000000000001 110.878 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.33 105.74 18.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.424 0.631 . . . . 70.439999999999998 110.509 167.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' THR . . . . . . . . . . . . . 23.6 m -143.17 150.06 38.87 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.861 -1.162 . . . . 55.520000000000003 107.861 167.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 288' ' ' VAL . 2.8 pp -124.58 140.71 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.023 0.828 . . . . 62.310000000000002 111.223 164.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.67 136.18 41.95 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 115.791 -0.64 . . . . 65.549999999999997 109.433 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 315' ' ' VAL . 0.0 OUTLIER -128.36 142.51 43.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 122.028 0.918 . . . . 70.310000000000002 112.401 177.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -127.25 141.34 51.75 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 113.594 -1.639 . . . . 62.140000000000001 108.151 -177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.68 29.25 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.044 -0.598 . . . . 63.100000000000001 112.193 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.513 HD13 HG11 ' A' ' 250' ' ' VAL . 9.2 mt -107.72 71.72 0.83 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.632 -0.877 . . . . 74.340000000000003 108.632 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.478 ' O ' ' HB ' ' A' ' 245' ' ' VAL . . . -139.46 -79.91 0.07 OUTLIER Glycine 0 CA--C 1.498 -0.983 0 C-N-CA 119.89 -1.148 . . . . 73.230000000000004 113.741 -174.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.99 106.76 7.76 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.106 0.955 . . . . 74.010000000000005 111.756 -171.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 93.7 20.02 32.86 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 114.83 -1.077 . . . . 72.430000000000007 111.58 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 242' ' ' GLY . 0.3 OUTLIER -81.38 151.34 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.13 0.491 . . . . 72.409999999999997 109.825 -171.464 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 28.7 m -92.01 170.85 9.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.98 -0.555 . . . . 72.120000000000005 110.072 170.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 126.814 2.046 . . . . 74.439999999999998 114.042 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -42.44 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 127.181 2.193 . . . . 74.349999999999994 115.854 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -21.92 0.41 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 126.56 1.944 . . . . 75.340000000000003 114.408 169.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.513 HG11 HD13 ' A' ' 241' ' ' LEU . 1.3 t -56.36 -32.03 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 119.114 0.87 . . . . 40.200000000000003 110.762 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -64.4 -31.56 81.26 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.878 -0.401 . . . . 71.439999999999998 113.559 174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -75.51 -30.7 59.91 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.34 0.591 . . . . 73.109999999999999 110.251 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' A' ' 250' ' ' VAL . 5.5 t80 -59.21 -42.91 92.07 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.412 -0.813 . . . . 62.409999999999997 110.72 172.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -78.17 -24.04 47.41 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 120.894 0.378 . . . . 65.409999999999997 112.015 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.47 ' HD3' HG12 ' A' ' 260' ' ' ILE . 22.7 tptm -66.83 -21.88 66.02 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.475 1.11 . . . . 72.120000000000005 112.197 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -63.42 -20.54 65.64 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 112.119 0.414 . . . . 63.130000000000003 112.119 177.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 2.8 mm -123.91 54.83 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 117.871 0.305 . . . . 72.340000000000003 110.191 171.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 255' ' ' LYS . . . 147.04 -168.72 28.19 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 119.178 -1.487 . . . . 30.300000000000001 115.011 171.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ILE . . . . . . . . . . . . . 2.6 mp -108.55 138.42 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.407 0.683 . . . . 74.430000000000007 110.994 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.47 HG12 ' HD3' ' A' ' 255' ' ' LYS . 6.7 mm -74.12 116.67 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 123.306 0.379 . . . . 74.150000000000006 110.17 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -98.93 142.92 29.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.401 0.619 . . . . 53.530000000000001 111.11 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 12.7 m -84.62 115.66 22.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.334 -0.988 . . . . 74.319999999999993 108.334 166.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.76 136.07 48.63 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 111.789 0.292 . . . . 65.219999999999999 111.789 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.86 -11.05 59.98 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.739 0.644 . . . . 63.329999999999998 112.739 -174.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -74.11 -26.94 60.63 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.452 0.168 . . . . 73.030000000000001 111.236 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 268' ' ' LYS . 1.8 t -125.32 -31.54 3.03 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.096 0.406 . . . . 62.049999999999997 112.096 -179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . 83.97 8.8 83.57 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 116.308 -0.405 . . . . 53.310000000000002 112.934 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 266' ' ' THR . 53.3 mmtt -96.24 148.41 34.45 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.442 0.697 . . . . 73.219999999999999 111.325 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.0 153.58 74.79 Favored 'Trans proline' 0 C--N 1.364 1.372 0 C-N-CA 122.787 2.325 . . . . 41.130000000000003 111.022 165.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.477 ' CB ' ' H ' ' A' ' 289' ' ' SER . 0.6 OUTLIER -76.32 101.24 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.263 0.838 . . . . 73.409999999999997 113.263 -170.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 29.2 mm -142.55 112.82 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 107.024 -1.473 . . . . 71.109999999999999 107.024 162.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -129.07 113.34 15.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.333 -0.617 . . . . 71.239999999999995 109.333 162.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 273' ' ' LEU . 0.8 OUTLIER -114.42 110.5 19.97 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.032 -0.729 . . . . 62.109999999999999 109.032 -178.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -103.44 111.83 24.45 Favored 'General case' 0 C--O 1.251 1.169 0 CA-C-O 121.095 0.474 . . . . 72.120000000000005 110.897 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.426 ' HA ' ' H ' ' A' ' 283' ' ' LYS . 17.1 p -145.39 120.81 10.31 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.56 -1.2 . . . . 74.420000000000002 109.815 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -87.76 113.87 23.83 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.411 1.1 . . . . 75.230000000000004 112.595 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.29 -4.05 58.06 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.119 -0.946 . . . . 63.149999999999999 112.574 178.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.65 -35.64 79.26 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.451 0.7 . . . . 64.420000000000002 110.836 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 8.9 t -92.69 -21.43 20.0 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.691 -0.686 . . . . 64.519999999999996 109.801 171.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . 103.67 -45.29 1.34 Allowed Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.905 -0.588 . . . . 74.129999999999995 112.673 176.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 45.9 pttt -79.75 143.98 59.42 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 121.224 -0.19 . . . . 72.340000000000003 110.628 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -57.12 140.51 92.92 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.959 2.439 . . . . 74.230000000000004 114.378 174.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 275' ' ' THR . 9.3 tttt -67.52 -37.24 82.48 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.877 -1.056 . . . . 64.099999999999994 111.571 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.11 17.18 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.872 -0.604 . . . . 64.430000000000007 113.891 174.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.44 146.18 47.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.449 -0.5 . . . . 73.340000000000003 111.478 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ALA . . . . . . . . . . . . . . . -151.48 152.67 33.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.81 -0.632 . . . . 55.32 110.632 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.75 135.17 50.72 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.101 166.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.435 HG22 HD11 ' A' ' 236' ' ' ILE . 3.3 m -134.96 146.81 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 N-CA-C 107.848 -1.168 . . . . 73.019999999999996 107.848 173.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . 0.477 ' H ' ' CB ' ' A' ' 270' ' ' MET . 54.7 m -113.58 133.82 55.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.502 0.556 . . . . 62.520000000000003 112.502 -169.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.71 165.23 11.49 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.661 0.615 . . . . 75.209999999999994 112.661 -171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.89 -47.95 60.59 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.339 -0.846 . . . . 64.230000000000004 111.949 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -117.79 135.78 23.47 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 109.351 -0.611 . . . . 71.230000000000004 109.351 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.13 -38.84 53.25 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 C-N-CA 123.274 2.649 . . . . 54.149999999999999 117.238 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.19 -28.39 15.6 Favored 'Trans proline' 0 C--N 1.393 2.874 0 CA-C-N 123.426 2.259 . . . . 51.420000000000002 112.544 -176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' SER . . . . . . . . . . . . . 50.4 m -61.92 -27.44 68.82 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.301 1.04 . . . . 71.519999999999996 111.946 173.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 300' ' ' ILE . . . -69.26 -39.58 78.36 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 123.307 0.38 . . . . 71.450000000000003 111.712 175.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -41.07 87.74 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.744 0.307 . . . . 73.120000000000005 110.387 175.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.72 -33.82 76.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.722 -0.672 . . . . 54.509999999999998 111.395 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -66.64 -31.18 71.7 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 122.806 0.443 . . . . 60.219999999999999 111.725 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 315' ' ' VAL . 57.2 mt -68.86 -31.11 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 O-C-N 122.197 -0.315 . . . . 72.319999999999993 110.86 174.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -79.11 -59.74 2.65 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.385 0.883 . . . . 71.209999999999994 113.385 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' TRP . . . . . . . . . . . . 0.253 1.7 p-90 -91.69 -34.26 14.72 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 116.534 2.049 . . . . 72.230000000000004 116.534 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -84.82 -22.48 29.48 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.376 0.607 . . . . 61.439999999999998 110.193 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.401 ' HB2' HG12 ' A' ' 315' ' ' VAL . 21.9 t0 -83.31 -176.02 6.11 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.009 -0.996 . . . . 61.409999999999997 109.435 171.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' GLY . . . . . . . . . . . . . . . 84.53 9.83 80.76 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 114.123 0.409 . . . . 64.519999999999996 114.123 168.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 -160.97 1.04 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.151 -0.685 . . . . 63.32 109.151 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -125.21 146.14 49.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.694 0.759 . . . . 74.340000000000003 111.401 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -112.88 114.28 26.72 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.749 -1.204 . . . . 73.310000000000002 107.749 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' HIS . . . . . . . . . . . . . 29.7 m170 62.54 28.37 16.68 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.672 1.189 . . . . 62.539999999999999 111.613 -178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 88.89 -2.34 84.11 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.462 -0.399 . . . . 70.409999999999997 114.092 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -110.5 142.58 42.09 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.399 0.599 . . . . 55.539999999999999 109.597 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ILE . . . . . . . . . . . . . 50.9 mm -68.82 126.61 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.177 0.513 . . . . 70.150000000000006 110.944 -173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ILE . . . . . . . . . . . . . 10.6 tt -108.78 139.42 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 115.65 -0.704 . . . . 74.129999999999995 109.963 -175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -136.4 123.79 22.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.151 -0.477 . . . . 75.549999999999997 111.075 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.541 HG23 HG13 ' A' ' 238' ' ' VAL . 4.7 p -109.29 138.85 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.38 0 CA-C-N 115.022 -0.99 . . . . 75.319999999999993 110.226 -175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . . . . . . . . . 3.3 m -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.208 -1.089 0 CA-C-N 115.767 -0.652 . . . . 73.340000000000003 109.866 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -79.14 -3.63 46.49 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 114.618 1.34 . . . . 73.420000000000002 114.618 174.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . 64.66 -169.22 0.2 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.402 1.081 . . . . 72.219999999999999 112.535 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 2.8 m -96.34 137.36 35.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.573 -0.528 . . . . 73.420000000000002 109.573 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.76 176.05 5.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.492 -0.322 . . . . 71.239999999999995 111.141 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 72.34 89.41 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 124.851 1.261 . . . . 75.519999999999996 111.517 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.84 -166.55 0.42 Allowed 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.106 2.537 . . . . 73.329999999999998 113.48 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 N--CA 1.481 1.114 0 C-N-CA 124.866 1.266 . . . . 74.219999999999999 110.312 -177.783 . . . . . . . . 0 0 . 1 stop_ save_